By NE Xx NE
contrast NE xxx NE
, NE , NE
the NE xxx NE
MAP G#protein_family_or_group_B XXX G#protein_family_or_group_B
kinases G#protein_family_or_group_E xxx G#protein_family_or_group_E
ERK1 G#protein_molecule XXXd G#protein_molecule
and NE xxx NE
ERK2 G#protein_molecule XXXd G#protein_molecule
were NE xxx NE
fully NE xxx NE
activated NE xxx NE
by NE xx NE
TPA G#other_organic_compound XXX G#other_organic_compound
or NE xx NE
TCR G#protein_family_or_group XXX G#protein_family_or_group
stimulation NE xxx NE
and NE xxx NE
were NE xxx NE
not NE xxx NE
affected NE xxx NE
by NE xx NE
Ca2+ G#atom Xxd+ G#atom
, NE , NE
CD28 NE XXdd NE
, NE , NE
or NE xx NE
CsA G#other_organic_compound XxX G#other_organic_compound
. NE . NE

Hence NE Xxxx NE
, NE , NE
integration NE xxx NE
of NE xx NE
signals NE xxx NE
that NE xxx NE
lead NE xxx NE
to NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
occurs NE xxx NE
at NE xx NE
the NE xxx NE
level NE xxx NE
of NE xx NE
JNK G#protein_molecule XXX G#protein_molecule
activation NE xxx NE
. NE . NE

Inhibition NE Xxxx NE
of NE xx NE
rat G#other_name_B xxx G#other_name_B
splenocyte G#other_name_M xxx G#other_name_M
proliferation G#other_name_E xxx G#other_name_E
with NE xxx NE
methylprednisolone G#lipid xxx G#lipid
: NE : NE
in NE xx NE
vivo NE xxx NE
effect NE xxx NE
of NE xx NE
liposomal G#other_name_B xxx G#other_name_B
formulation G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
effect NE xxx NE
of NE xx NE
a NE x NE
liposomal G#other_name_B xxx G#other_name_B
formulation G#other_name_E xxx G#other_name_E
of NE xx NE
methylprednisolone G#lipid xxx G#lipid
( NE ( NE
MPL G#lipid XXX G#lipid
) NE ) NE
on NE xx NE
the NE xxx NE
inhibition NE xxx NE
of NE xx NE
lymphocyte G#other_name_B xxx G#other_name_B
proliferation G#other_name_E xxx G#other_name_E
in NE xx NE
spleen G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
was NE xxx NE
investigated NE xxx NE
following NE xxx NE
IV G#other_name_B XX G#other_name_B
dosing G#other_name_E xxx G#other_name_E
in NE xx NE
rats G#multi_cell xxx G#multi_cell
. NE . NE

Liposomes NE Xxxx NE
do NE xx NE
not NE xxx NE
alter NE xxx NE
the NE xxx NE
suppressive NE xxx NE
action NE xxx NE
of NE xx NE
MPL G#lipid XXX G#lipid
when NE xxx NE
placed NE xxx NE
in NE xx NE
lymphocyte G#cell_line_B xxx G#cell_line_B
culture G#cell_line_E xxx G#cell_line_E
. NE . NE

Rat G#cell_type_B Xxx G#cell_type_B
splenocytes G#cell_type_E xxx G#cell_type_E
were NE xxx NE
found NE xxx NE
to NE xx NE
have NE xxx NE
greater NE xxx NE
sensitivity NE xxx NE
to NE xx NE
MPL G#lipid XXX G#lipid
(EC50 NE (XXdd NE
= NE = NE
7.9 NE d.d NE
nM) NE xX) NE
than NE xxx NE
do NE xx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
(EC50 NE (XXdd NE
= NE = NE
28 NE dd NE
nM) NE xX) NE
. NE . NE

In NE Xx NE
vivo NE xxx NE
studies NE xxx NE
in NE xx NE
rats G#multi_cell xxx G#multi_cell
utilized NE xxx NE
2 NE d NE
mg/kg NE xx/xx NE
IV NE XX NE
bolus NE xxx NE
doses NE xxx NE
of NE xx NE
liposomal G#lipid_B xxx G#lipid_B
MPL G#lipid_E XXX G#lipid_E
compared NE xxx NE
to NE xx NE
drug NE xxx NE
in NE xx NE
solution NE xxx NE
. NE . NE

Animals NE Xxxx NE
were NE xxx NE
sacrificed NE xxx NE
at NE xx NE
various NE xxx NE
times NE xxx NE
post-dosing NE xxx-xxx NE
until NE xxx NE
120 NE ddd NE
h NE x NE
, NE , NE
spleen G#body_part xxx G#body_part
was NE xxx NE
excised NE xxx NE
and NE xxx NE
, NE , NE
after NE xxx NE
incubation NE xxx NE
of NE xx NE
lymphocytes G#cell_type xxx G#cell_type
with NE xxx NE
PHA G#protein_molecule XXX G#protein_molecule
, NE , NE
splenocyte G#other_name_B xxx G#other_name_B
blastogenic G#other_name_M xxx G#other_name_M
responses G#other_name_E xxx G#other_name_E
were NE xxx NE
assessed NE xxx NE
by NE xx NE
measuring NE xxx NE
cellular NE xxx NE
incorporation NE xxx NE
of NE xx NE
3H-thymidine G#nucleotide dX-xxx G#nucleotide
. NE . NE

The NE Xxx NE
suppressive NE xxx NE
effect NE xxx NE
of NE xx NE
liposomal G#lipid_B xxx G#lipid_B
MPL G#lipid_E XXX G#lipid_E
in NE xx NE
comparison NE xxx NE
with NE xxx NE
free NE xxx NE
drug NE xxx NE
was NE xxx NE
significantly NE xxx NE
prolonged NE xxx NE
(> NE (> NE
120 NE ddd NE
h NE x NE
vs NE xx NE
< NE < NE
18 NE dd NE
h) NE x) NE
. NE . NE

Inhibition NE Xxxx NE
effects NE xxx NE
versus NE xxx NE
time NE xxx NE
were NE xxx NE
described NE xxx NE
by NE xx NE
a NE x NE
pharmacodynamic G#other_name_B xxx G#other_name_B
model G#other_name_E xxx G#other_name_E
using NE xxx NE
MPL G#lipid XXX G#lipid
concentrations NE xxx NE
in NE xx NE
plasma G#cell_type xxx G#cell_type
as NE xx NE
an NE xx NE
input NE xxx NE
function NE xxx NE
. NE . NE

A NE X NE
nonlinear NE xxx NE
relationship NE xxx NE
was NE xxx NE
found NE xxx NE
between NE xxx NE
suppression NE xxx NE
of NE xx NE
splenocyte G#other_name_B xxx G#other_name_B
proliferation G#other_name_E xxx G#other_name_E
and NE xxx NE
the NE xxx NE
concentration NE xxx NE
of NE xx NE
bound NE xxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
spleen G#body_part xxx G#body_part
. NE . NE

Only NE Xxxx NE
partial NE xxx NE
receptor NE xxx NE
occupancy NE xxx NE
accompanied NE xxx NE
complete NE xxx NE
lymphocyte G#other_name_B xxx G#other_name_B
suppression G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
suppression NE xxx NE
of NE xx NE
endogenous G#lipid_B xxx G#lipid_B
corticosterone G#lipid_E xxx G#lipid_E
in NE xx NE
plasma G#cell_type xxx G#cell_type
for NE xxx NE
both NE xxx NE
treatments NE xxx NE
was NE xxx NE
similar NE xxx NE
with NE xxx NE
values NE xxx NE
from NE xxx NE
L- NE X- NE
MPL NE XXX NE
rats NE xxx NE
returning NE xxx NE
to NE xx NE
baseline NE xxx NE
after NE xxx NE
24 NE dd NE
h NE x NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
demonstrate NE xxx NE
enhanced NE xxx NE
efficacy NE xxx NE
of NE xx NE
local G#other_name_B xxx G#other_name_B
immunosuppression G#other_name_E xxx G#other_name_E
by NE xx NE
targeting NE xxx NE
spleen G#body_part xxx G#body_part
with NE xxx NE
liposomal G#lipid_B xxx G#lipid_B
MPL G#lipid_E XXX G#lipid_E
. NE . NE

Function NE Xxxx NE
of NE xx NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
/Rel G#DNA_domain_or_region_M /Xxx G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
major G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
histocompatibility G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
complex G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
class G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
II G#DNA_domain_or_region_M XX G#DNA_domain_or_region_M
invariant G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
chain G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
dependent NE xxx NE
on NE xx NE
cell-specific NE xxx-xxx NE
binding NE xxx NE
of NE xx NE
different NE xxx NE
NF-kappa G#protein_subunit_B XX-xxx G#protein_subunit_B
B G#protein_subunit_M X G#protein_subunit_M
/Rel G#protein_subunit_M /Xxx G#protein_subunit_M
subunits G#protein_subunit_E xxx G#protein_subunit_E
. NE . NE

The NE Xxx NE
promoter G#DNA_domain_or_region xxx G#DNA_domain_or_region
of NE xx NE
the NE xxx NE
human NE xxx NE
major NE xxx NE
histocompatibility G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
complex G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
class G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
II-associated G#DNA_domain_or_region_M XX-xxx G#DNA_domain_or_region_M
invariant-chain G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
Ii G#DNA_domain_or_region Xx G#DNA_domain_or_region
) NE ) NE
contains NE xxx NE
two NE xxx NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
/Rel G#DNA_domain_or_region_M /Xxx G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
located NE xxx NE
at NE xx NE
-109 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-118 G#DNA_domain_or_region_E -ddd G#DNA_domain_or_region_E
( NE ( NE
Ii G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
kappa G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
B-1 G#DNA_domain_or_region_E X-d G#DNA_domain_or_region_E
) NE ) NE
and NE xxx NE
-163 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-172 G#DNA_domain_or_region_E -ddd G#DNA_domain_or_region_E
( NE ( NE
Ii G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
kappa G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
B-2 G#DNA_domain_or_region_E X-d G#DNA_domain_or_region_E
) NE ) NE
from NE xxx NE
the NE xxx NE
transcription NE xxx NE
start NE xxx NE
site NE xxx NE
. NE . NE

We NE Xx NE
report NE xxx NE
here NE xxx NE
that NE xxx NE
the NE xxx NE
differential NE xxx NE
function NE xxx NE
of NE xx NE
each NE xxx NE
of NE xx NE
these NE xxx NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
/Rel G#DNA_domain_or_region_M /Xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
several NE xxx NE
distinct NE xxx NE
cell NE xxx NE
types NE xxx NE
depends NE xxx NE
on NE xx NE
cell-specific NE xxx-xxx NE
binding NE xxx NE
of NE xx NE
NF-kappa G#protein_family_or_group_B XX-xxx G#protein_family_or_group_B
B G#protein_family_or_group_M X G#protein_family_or_group_M
/Rel G#protein_family_or_group_M /Xxx G#protein_family_or_group_M
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Ii G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
kappa G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
B-1 G#DNA_domain_or_region_E X-d G#DNA_domain_or_region_E
is NE xx NE
a NE x NE
positive G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
regulatory G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
element G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
in NE xx NE
B-cell G#cell_line_B X-xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
and NE xxx NE
in NE xx NE
the NE xxx NE
Ii-expressing G#cell_line_B Xx-xxx G#cell_line_B
T-cell G#cell_line_M X-xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
H9 G#cell_line Xd G#cell_line
, NE , NE
but NE xxx NE
acts NE xxx NE
as NE xx NE
a NE x NE
negative G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
regulatory G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
element G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
in NE xx NE
myelomonocytic G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
glia G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E

In G#other_name_B Xx G#other_name_B
vivo G#other_name_M xxx G#other_name_M
protein-DNA G#other_name_M xxx-XXX G#other_name_M
contacts G#other_name_E xxx G#other_name_E
are NE xxx NE
detectable NE xxx NE
at NE xx NE
Ii G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
kappa G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
B-1 G#DNA_domain_or_region_E X-d G#DNA_domain_or_region_E
in NE xx NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
in NE xx NE
which NE xxx NE
this NE xxx NE
site NE xxx NE
is NE xx NE
functional NE xxx NE
as NE xx NE
either NE xxx NE
a NE x NE
positive G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
regulator G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
or G#DNA_family_or_group_M xx G#DNA_family_or_group_M
negative G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
regulator G#DNA_family_or_group_E xxx G#DNA_family_or_group_E

Electrophoretic G#other_name_B Xxxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
supershift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
determine NE xxx NE
that NE xxx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
NF-kappa G#protein_family_or_group_B XX-xxx G#protein_family_or_group_B
B G#protein_family_or_group_M X G#protein_family_or_group_M
/Rel G#protein_family_or_group_M /Xxx G#protein_family_or_group_M
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
can NE xxx NE
bind NE xxx NE
to NE xx NE
this NE xxx NE
site NE xxx NE
in NE xx NE
vitro NE xxx NE
and NE xxx NE
that NE xxx NE
DNA-binding NE XXX-xxx NE
complexes NE xxx NE
that NE xxx NE
contain NE xxx NE
p50 NE xdd NE
, NE , NE
p52 NE xdd NE
, NE , NE
p65 NE xdd NE
, NE , NE
and NE xxx NE
cRel NE xXxx NE
correlate NE xxx NE
with NE xxx NE
positive NE xxx NE
regulation NE xxx NE
whereas NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
p50 NE xdd NE
correlates NE xxx NE
with NE xxx NE
negative NE xxx NE
regulation NE xxx NE
. NE . NE

Ii G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
kappa G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
B-2 G#DNA_domain_or_region_E X-d G#DNA_domain_or_region_E
is NE xx NE
a NE x NE
site NE xxx NE
of NE xx NE
positive G#other_name_B xxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
in NE xx NE
B-cell G#cell_line_B X-xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
and NE xxx NE
a NE x NE
site NE xxx NE
of NE xx NE
negative G#other_name_B xxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
in NE xx NE
H9 G#cell_line_B Xd G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
myelomonocytic G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
glial G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E

In NE Xx NE
vivo NE xxx NE
occupancy NE xxx NE
of NE xx NE
this NE xxx NE
site NE xxx NE
is NE xx NE
observed NE xxx NE
only NE xxx NE
in NE xx NE
the NE xxx NE
H9 G#cell_line_B Xd G#cell_line_B
T-cell G#cell_line_M X-xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
. NE . NE

Again NE Xxxx NE
, NE , NE
in NE xx NE
vitro NE xxx NE
supershift NE xxx NE
studies NE xxx NE
indicate NE xxx NE
that NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
p50 G#protein_subunit xdd G#protein_subunit
, NE , NE
p52 G#protein_subunit xdd G#protein_subunit
, NE , NE
p65 G#protein_subunit xdd G#protein_subunit
, NE , NE
and NE xxx NE
cRel G#protein_subunit xXxx G#protein_subunit
correlates NE xxx NE
with NE xxx NE
positive G#other_name_B xxx G#other_name_B
function G#other_name_E xxx G#other_name_E
whereas NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
only NE xxx NE
p50 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
p52 G#protein_subunit xdd G#protein_subunit
correlates NE xxx NE
with NE xxx NE
negative G#other_name_B xxx G#other_name_B
function G#other_name_E xxx G#other_name_E
. NE . NE

This NE Xxxx NE
differential NE xxx NE
binding NE xxx NE
of NE xx NE
specific NE xxx NE
NF-kappa G#protein_subunit_B XX-xxx G#protein_subunit_B
B G#protein_subunit_M X G#protein_subunit_M
/Rel G#protein_subunit_M /Xxx G#protein_subunit_M
subunits G#protein_subunit_E xxx G#protein_subunit_E
is NE xx NE
likely NE xxx NE
to NE xx NE
mediate NE xxx NE
the NE xxx NE
disparate NE xxx NE
functions NE xxx NE
of NE xx NE
these NE xxx NE
two NE xxx NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
/Rel G#DNA_domain_or_region_M /Xxx G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Epstein-Barr NE Xxxx-Xxxx NE
virus NE xxx NE
( NE ( NE
EBV NE XXX NE
) NE ) NE
replicative NE xxx NE
gene NE xxx NE
expression NE xxx NE
in NE xx NE
tumour NE xxx NE
cells NE xxx NE
of NE xx NE
AIDS-related NE XXXX-xxx NE
non-Hodgkin's NE xxx-Xxxx'x NE
lymphoma NE xxx NE
in NE xx NE
relation NE xxx NE
to NE xx NE
CD4 NE XXd NE
cell NE xxx NE
number NE xxx NE
and NE xxx NE
antibody NE xxx NE
titres NE xxx NE
to NE xx NE
EBV NE XXX NE
. NE . NE

OBJECTIVE NE XXXXXXXXX NE
: NE : NE
To NE Xx NE
determine NE xxx NE
whether NE xxx NE
activation NE xxx NE
of NE xx NE
Epstein-Barr NE Xxxx-Xxxx NE
virus NE xxx NE
( NE ( NE
EBV NE XXX NE
) NE ) NE
replication NE xxx NE
in NE xx NE
tumour NE xxx NE
cells NE xxx NE
of NE xx NE
AIDS-related NE XXXX-xxx NE
non-Hodgkin's NE xxx-Xxxx'x NE
lymphoma NE xxx NE
( NE ( NE
ARNHL NE XXXXX NE
) NE ) NE
is NE xx NE
correlated NE xxx NE
with NE xxx NE
CD4+ NE XXd+ NE
cell NE xxx NE
counts NE xxx NE
and NE xxx NE
influences NE xxx NE
antibody NE xxx NE
response NE xxx NE
to NE xx NE
EBV NE XXX NE
[ NE [ NE
anti-Z NE xxx-X NE
Epstein-Barr NE Xxxx-Xxxx NE
replicative NE xxx NE
activator NE xxx NE
( NE ( NE
ZEBRA NE XXXXX NE
) NE ) NE
, NE , NE
anti-early NE xxx-xxx NE
antigen NE xxx NE
( NE ( NE
EA NE XX NE
) NE ) NE
, NE , NE
anti-viral NE xxx-xxx NE
capsid NE xxx NE
antigen NE xxx NE
( NE ( NE
VCA NE XXX NE
)] NE )] NE
. NE . NE

DESIGN NE XXXXXX NE
: NE : NE
Retrospective NE Xxxx NE
study NE xxx NE
based NE xxx NE
on NE xx NE
immunohistochemistry G#other_name xxx G#other_name
and NE xxx NE
in NE xx NE
situ NE xxx NE
hybridization NE xxx NE
to NE xx NE
detect NE xxx NE
EBV G#virus XXX G#virus
replicative NE xxx NE
gene NE xxx NE
products NE xxx NE
in NE xx NE
tissue NE xxx NE
samples NE xxx NE
from NE xxx NE
patients G#multi_cell xxx G#multi_cell
affected NE xxx NE
by NE xx NE
ARNHL G#other_name XXXXX G#other_name
and NE xxx NE
correlation NE xxx NE
with NE xxx NE
CD4+ G#other_name_B XXd+ G#other_name_B
cell G#other_name_M xxx G#other_name_M
counts G#other_name_E xxx G#other_name_E
and NE xxx NE
results NE xxx NE
of NE xx NE
EBV G#other_name_B XXX G#other_name_B
serology G#other_name_E xxx G#other_name_E
(including NE (xxx NE
anti- NE xxx- NE
ZEBRA NE XXXXX NE
activity NE xxx NE
) NE ) NE
in NE xx NE
sera NE xxx NE
from NE xxx NE
the NE xxx NE
same NE xxx NE
patients NE xxx NE
. NE . NE

METHODS NE XXXXXXX NE
: NE : NE
Seventeen NE Xxxx NE
out NE xxx NE
of NE xx NE
22 NE dd NE
cases NE xxx NE
of NE xx NE
ARNHL G#other_name XXXXX G#other_name
were NE xxx NE
selected NE xxx NE
for NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
EBV G#virus XXX G#virus
[ NE [ NE
Epstein-Barr G#other_name_B Xxxx-Xxxx G#other_name_B
early G#other_name_M xxx G#other_name_M
region G#other_name_M xxx G#other_name_M
(EBER) G#other_name_M (XXXX) G#other_name_M
RNA-positive G#other_name_E XXX-xxx G#other_name_E
] NE ] NE
. NE . NE

Immunohistochemistry G#other_name Xxxx G#other_name
was NE xxx NE
performed NE xxx NE
with NE xxx NE
anti- NE xxx- NE
ZEBRA NE XXXXX NE
, NE , NE
anti- NE xxx- NE
EA NE XX NE
-restricted NE -xxx NE
, NE , NE
anti- NE xxx- NE
VCA NE XXX NE
antibodies NE xxx NE
and NE xxx NE
in NE xx NE
situ NE xxx NE
hybridization NE xxx NE
with NE xxx NE
BHLF1/NotI NE XXXXd/XxxX NE
oligoprobes NE xxx NE
on NE xx NE
tumour NE xxx NE
samples NE xxx NE
. NE . NE

Results NE Xxxx NE
were NE xxx NE
statistically NE xxx NE
correlated NE xxx NE
with NE xxx NE
those NE xxx NE
of NE xx NE
CD4+ G#other_name_B XXd+ G#other_name_B
cell G#other_name_M xxx G#other_name_M
counts G#other_name_E xxx G#other_name_E
(17 NE (dd NE
out NE xxx NE
of NE xx NE
17) NE dd) NE
and NE xxx NE
with NE xxx NE
anti- NE xxx- NE
EBV G#other_name_B XXX G#other_name_B
antibody G#other_name_M xxx G#other_name_M
titres G#other_name_E xxx G#other_name_E
(13 NE (dd NE
out NE xxx NE
of NE xx NE
17) NE dd) NE
assessed NE xxx NE
using NE xxx NE
standard G#other_name_B xxx G#other_name_B
immunofluorescence G#other_name_M xxx G#other_name_M
method G#other_name_E xxx G#other_name_E
and NE xxx NE
enzyme-linked G#other_name_B xxx-xxx G#other_name_B
immunosorbent G#other_name_M xxx G#other_name_M
assay G#other_name_M xxx G#other_name_M
procedure G#other_name_E xxx G#other_name_E
using NE xxx NE
recombinant G#protein_family_or_group_B xxx G#protein_family_or_group_B
ZEBRA G#protein_family_or_group_M XXXXX G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
synthetic G#peptide_B xxx G#peptide_B
peptides G#peptide_E xxx G#peptide_E
as NE xx NE
antigens G#protein_family_or_group xxx G#protein_family_or_group
. NE . NE

RESULTS NE XXXXXXX NE
: NE : NE
BZLF1 G#protein_molecule XXXXd G#protein_molecule
( NE ( NE
ZEBRA G#protein_molecule XXXXX G#protein_molecule
) NE ) NE
or NE xx NE
early G#protein_family_or_group_B xxx G#protein_family_or_group_B
gene G#protein_family_or_group_M xxx G#protein_family_or_group_M
products G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
EA-R G#protein_molecule XX-X G#protein_molecule
and NE xxx NE
EA-D/BHLF1/NotI G#protein_molecule XX-X/XXXXd/XxxX G#protein_molecule
) NE ) NE
were NE xxx NE
detected NE xxx NE
in NE xx NE
a NE x NE
small NE xxx NE
proportion NE xxx NE
(< NE (< NE
0.01-5%) NE d.dd-d%) NE
of NE xx NE
tumour G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
eight NE xxx NE
of NE xx NE
these NE xxx NE
17 NE dd NE
cases NE xxx NE
by NE xx NE
immunohistochemistry G#other_name xxx G#other_name
and NE xxx NE
in G#other_name_B xx G#other_name_B
situ G#other_name_M xxx G#other_name_M
hybridization G#other_name_E xxx G#other_name_E
. NE . NE

Demonstration NE Xxxx NE
of NE xx NE
replicative NE xxx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
did NE xxx NE
not NE xxx NE
correlate NE xxx NE
with NE xxx NE
either NE xxx NE
low NE xxx NE
CD4+ G#other_name_B XXd+ G#other_name_B
cell G#other_name_M xxx G#other_name_M
counts G#other_name_E xxx G#other_name_E
(P NE (X NE
> NE > NE
0.05) NE d.dd) NE
or NE xx NE
anti- NE xxx- NE
EBV NE XXX NE
antibody NE xxx NE
titres NE xxx NE
(P NE (X NE
> NE > NE
0.05) NE d.dd) NE
. NE . NE

Anti- NE Xxxx- NE
ZEBRA NE XXXXX NE
activity NE xxx NE
was NE xxx NE
not NE xxx NE
significantly NE xxx NE
increased NE xxx NE
in NE xx NE
patients NE xxx NE
affected NE xxx NE
with NE xxx NE
ARNHL NE XXXXX NE
, NE , NE
the NE xxx NE
cells NE xxx NE
of NE xx NE
which NE xxx NE
expressed NE xxx NE
replicative NE xxx NE
gene NE xxx NE
products NE xxx NE
(P NE (X NE
> NE > NE
0.05) NE d.dd) NE
. NE . NE

CONCLUSION NE XXXXXXXXXX NE
: NE : NE
The NE Xxx NE
degree NE xxx NE
of NE xx NE
immunodeficiency G#other_name xxx G#other_name
does NE xxx NE
not NE xxx NE
clearly NE xxx NE
enhance NE xxx NE
replicative NE xxx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
tumour G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
of NE xx NE
ARNHL G#other_name XXXXX G#other_name
. NE . NE

EBV G#other_name_B XXX G#other_name_B
serology G#other_name_E xxx G#other_name_E
, NE , NE
including NE xxx NE
anti- NE xxx- NE
ZEBRA NE XXXXX NE
activity NE xxx NE
, NE , NE
is NE xx NE
not NE xxx NE
a NE x NE
reliable NE xxx NE
tool NE xxx NE
for NE xxx NE
predicting NE xxx NE
the NE xxx NE
occurrence NE xxx NE
of NE xx NE
such NE xxx NE
proliferations NE xxx NE
. NE . NE

Effects NE Xxxx NE
of NE xx NE
prostaglandin G#protein_molecule_B xxx G#protein_molecule_B
E2 G#protein_molecule_E Xd G#protein_molecule_E
on NE xx NE
Th0-type G#cell_line_B Xxd-xxx G#cell_line_B
human G#cell_line_M xxx G#cell_line_M
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
clones G#cell_line_E xxx G#cell_line_E
: NE : NE
modulation NE xxx NE
of NE xx NE
functions NE xxx NE
of NE xx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
involved NE xxx NE
in NE xx NE
cytokine G#other_name_B xxx G#other_name_B
production G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
effects NE xxx NE
of NE xx NE
prostaglandin G#protein_molecule_B xxx G#protein_molecule_B
E2 G#protein_molecule_E Xd G#protein_molecule_E
( NE ( NE
PGE2 G#protein_molecule XXXd G#protein_molecule
) NE ) NE
on NE xx NE
cytokine G#other_name_B xxx G#other_name_B
production G#other_name_E xxx G#other_name_E
and NE xxx NE
proliferation G#other_name xxx G#other_name
of NE xx NE
the NE xxx NE
CD4+ G#cell_line_B XXd+ G#cell_line_B
human G#cell_line_M xxx G#cell_line_M
helper G#cell_line_M xxx G#cell_line_M
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
clone G#cell_line_M xxx G#cell_line_M
SP-B21 G#cell_line_E XX-Xdd G#cell_line_E
were NE xxx NE
investigated NE xxx NE
. NE . NE

In NE Xx NE
cells NE xxx NE
stimulated NE xxx NE
with NE xxx NE
anti-CD3 G#protein_molecule_B xxx-XXd G#protein_molecule_B
mAb G#protein_molecule_E xXx G#protein_molecule_E
, NE , NE
PGE2 G#protein_molecule XXXd G#protein_molecule
inhibited NE xxx NE
cell G#other_name_B xxx G#other_name_B
proliferation G#other_name_E xxx G#other_name_E
and NE xxx NE
the NE xxx NE
production NE xxx NE
of NE xx NE
all NE xxx NE
the NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
examined NE xxx NE
. NE . NE

Addition NE Xxxx NE
of NE xx NE
rIL-2 G#protein_molecule xXX-d G#protein_molecule
fully NE xxx NE
restored NE xxx NE
the NE xxx NE
proliferative NE xxx NE
response NE xxx NE
and NE xxx NE
partially NE xxx NE
restored NE xxx NE
the NE xxx NE
production NE xxx NE
of NE xx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-5 G#protein_molecule XX-d G#protein_molecule
, NE , NE
but NE xxx NE
not NE xxx NE
that NE xxx NE
of NE xx NE
other NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
in NE xx NE
cells NE xxx NE
stimulated NE xxx NE
with NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
myristate G#other_organic_compound_M xxx G#other_organic_compound_M
acetate G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
PMA NE XXX NE
) NE ) NE
/ NE / NE
A23187 NE Xddddd NE
, NE , NE
PGE2 NE XXXd NE
enhanced NE xxx NE
the NE xxx NE
production NE xxx NE
of NE xx NE
IL-4 NE XX-d NE
and NE xxx NE
IL-5 NE XX-d NE
, NE , NE
and NE xxx NE
only NE xxx NE
partially NE xxx NE
inhibited NE xxx NE
the NE xxx NE
production NE xxx NE
of NE xx NE
other NE xxx NE
cytokines NE xxx NE
. NE . NE

Therefore NE Xxxx NE
, NE , NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
PGE2 G#protein_molecule XXXd G#protein_molecule
vary NE xxx NE
depending NE xxx NE
on NE xx NE
the NE xxx NE
mode NE xxx NE
of NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
the NE xxx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-5 G#protein_molecule XX-d G#protein_molecule
are NE xxx NE
regulated NE xxx NE
differently NE xxx NE
from NE xxx NE
other NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
. NE . NE

In NE Xx NE
a NE x NE
mobility G#other_name_B xxx G#other_name_B
shift G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
, NE , NE
only NE xxx NE
the NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
( NE ( NE
p50 NE xdd NE
/p50 NE /xdd NE
) NE ) NE
homodimer NE xxx NE
was NE xxx NE
observed NE xxx NE
in NE xx NE
a NE x NE
complex NE xxx NE
formed NE xxx NE
with NE xxx NE
the NE xxx NE
kappa NE xxx NE
B NE X NE
sequence NE xxx NE
in NE xx NE
unstimulated NE xxx NE
SP-B21 NE XX-Xdd NE
cells NE xxx NE
. NE . NE

When NE Xxxx NE
cells NE xxx NE
were NE xxx NE
stimulated NE xxx NE
with NE xxx NE
anti-CD3 G#protein_molecule_B xxx-XXd G#protein_molecule_B
mAb G#protein_molecule_E xXx G#protein_molecule_E
or NE xx NE
PMA G#other_organic_compound XXX G#other_organic_compound
/A23187 NE /Xddddd NE
, NE , NE
a NE x NE
complex NE xxx NE
formation NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
( NE ( NE
p50 NE xdd NE
/p65 NE /xdd NE
) NE ) NE
heterodimer NE xxx NE
with NE xxx NE
the NE xxx NE
kappa NE xxx NE
B NE X NE
sequence NE xxx NE
was NE xxx NE
induced NE xxx NE
. NE . NE

Interestingly NE Xxxx NE
, NE , NE
PGE2 G#protein_molecule XXXd G#protein_molecule
or NE xx NE
di-butyryl NE xx-xxx NE
(Bt2) NE (Xxd) NE
cAMP NE xXXX NE
abolished NE xxx NE
the NE xxx NE
binding NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
( NE ( NE
p50 NE xdd NE
/p65 NE /xdd NE
) NE ) NE
heterodimer NE xxx NE
to NE xx NE
the NE xxx NE
kappa NE xxx NE
B NE X NE
sequence NE xxx NE
in NE xx NE
cells NE xxx NE
stimulated NE xxx NE
with NE xxx NE
anti-CD3 NE xxx-XXd NE
mAb NE xXx NE
but NE xxx NE
not NE xxx NE
with NE xxx NE
PMA NE XXX NE
/A23187 NE /Xddddd NE
. NE . NE

Our NE Xxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
target NE xxx NE
of NE xx NE
PGE2 G#other_name_B XXXd G#other_name_B
action G#other_name_E xxx G#other_name_E
is NE xx NE
a NE x NE
component NE xxx NE
in NE xx NE
the NE xxx NE
signal NE xxx NE
transduction NE xxx NE
pathway NE xxx NE
leading NE xxx NE
to NE xx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
. NE . NE

However NE Xxxx NE
, NE , NE
the NE xxx NE
inhibition NE xxx NE
of NE xx NE
the NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
signals NE xxx NE
by NE xx NE
PGE2 G#protein_molecule XXXd G#protein_molecule
is NE xx NE
selective NE xxx NE
. NE . NE

PGE2 G#protein_molecule XXXd G#protein_molecule
enhanced NE xxx NE
the NE xxx NE
complex NE xxx NE
formation NE xxx NE
with NE xxx NE
NF-AT G#DNA_domain_or_region_B XX-XX G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
AP-1 G#DNA_domain_or_region_M XX-d G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
CLE0 G#DNA_domain_or_region_M XXXd G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
when NE xxx NE
the NE xxx NE
cells NE xxx NE
were NE xxx NE
activated NE xxx NE
by NE xx NE
either NE xxx NE
anti-CD3 G#protein_molecule_B xxx-XXd G#protein_molecule_B
mAb G#protein_molecule_E xXx G#protein_molecule_E
or NE xx NE
PMA G#other_name XXX G#other_name
/A23187 NE /Xddddd NE
stimulation NE xxx NE
. NE . NE

It NE Xx NE
seems NE xxx NE
therefore NE xxx NE
that NE xxx NE
PGE2 G#protein_molecule XXXd G#protein_molecule
, NE , NE
by NE xx NE
elevating NE xxx NE
cAMP G#other_name_B xXXX G#other_name_B
levels G#other_name_E xxx G#other_name_E
, NE , NE
interferes NE xxx NE
with NE xxx NE
the NE xxx NE
activation NE xxx NE
pathway NE xxx NE
for NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
but NE xxx NE
not NE xxx NE
for NE xxx NE
NF-AT G#protein_molecule XX-XX G#protein_molecule
, NE , NE
AP-1 G#protein_molecule XX-d G#protein_molecule
or NE xx NE
CLE0 G#protein_molecule_B XXXd G#protein_molecule_B
binding G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Characterization NE Xxxx NE
of NE xx NE
NF(P) G#protein_molecule XX(X) G#protein_molecule
, NE , NE
the NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
interacts NE xxx NE
with NE xxx NE
the NE xxx NE
regulatory NE xxx NE
P G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
5'-CGAAAATTTCC-3' G#polynucleotide d'-XXXXXXXXXXX-d' G#polynucleotide
) NE ) NE
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
interleukin-4 G#DNA_domain_or_region_M xxx-d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
: NE : NE
relationship NE xxx NE
to NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
NF-AT G#protein_molecule XX-XX G#protein_molecule
. NE . NE

The NE Xxx NE
P G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
human NE xxx NE
interleukin-4 NE xxx-d NE
( NE ( NE
IL-4 NE XX-d NE
) NE ) NE
gene NE xxx NE
, NE , NE
which NE xxx NE
was NE xxx NE
defined NE xxx NE
as NE xx NE
a NE x NE
responsive NE xxx NE
element NE xxx NE
for NE xxx NE
phorbol NE xxx NE
12-myristate NE dd-xxx NE
13-acetate NE dd-xxx NE
and NE xxx NE
calcium NE xxx NE
ionophore NE xxx NE
( NE ( NE
A23187 NE Xddddd NE
) NE ) NE
in NE xx NE
Jurkat NE Xxxx NE
T NE X NE
cells NE xxx NE
, NE , NE
shares NE xxx NE
sequence NE xxx NE
similarity NE xxx NE
with NE xxx NE
the NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
and NE xxx NE
the NE xxx NE
NF-AT NE XX-XX NE
binding NE xxx NE
sites NE xxx NE
. NE . NE

We NE Xx NE
examined NE xxx NE
whether NE xxx NE
NF(P) G#protein_molecule XX(X) G#protein_molecule
, NE , NE
a NE x NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
specific NE xxx NE
for NE xxx NE
the NE xxx NE
P G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
is NE xx NE
related NE xxx NE
to NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
NF-AT G#protein_molecule XX-XX G#protein_molecule
. NE . NE

NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
P65 G#protein_subunit Xdd G#protein_subunit
or NE xx NE
P65/P50 G#protein_complex_B Xdd/Xdd G#protein_complex_B
heterodimer G#protein_complex_E xxx G#protein_complex_E
) NE ) NE
bound NE xxx NE
to NE xx NE
the NE xxx NE
P G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
( NE ( NE
EMSA G#other_name XXXX G#other_name
) NE ) NE
and NE xxx NE
activated NE xxx NE
transcription NE xxx NE
through NE xxx NE
the NE xxx NE
P G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
when NE xxx NE
expression G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
plasmids G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
were NE xxx NE
cotransfected NE xxx NE
with NE xxx NE
P NE X NE
sequence NE xxx NE
-driven NE -xxx NE
reporter NE xxx NE
plasmids NE xxx NE
in NE xx NE
Jurkat NE Xxxx NE
T NE X NE
cells NE xxx NE
. NE . NE

In NE Xx NE
EMSAs G#other_name XXXXx G#other_name
, NE , NE
NF(P) G#protein_molecule XX(X) G#protein_molecule
binding NE xxx NE
was NE xxx NE
inhibited NE xxx NE
by NE xx NE
the NE xxx NE
unlabeled G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
NF-AT G#DNA_domain_or_region_M XX-XX G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
but NE xxx NE
not NE xxx NE
by NE xx NE
the NE xxx NE
unlabeled G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
AP1 G#DNA_domain_or_region_M XXd G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
purified G#protein_family_or_group_B xxx G#protein_family_or_group_B
NF-AT G#protein_family_or_group_E XX-XX G#protein_family_or_group_E
contained NE xxx NE
an NE xx NE
activity NE xxx NE
that NE xxx NE
bound NE xxx NE
to NE xx NE
the NE xxx NE
P G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Both NE Xxxx NE
mobility G#other_name_B xxx G#other_name_B
shift G#other_name_E xxx G#other_name_E
and NE xxx NE
sequence G#other_name_B xxx G#other_name_B
specificity G#other_name_E xxx G#other_name_E
of NE xx NE
NF-AT G#protein_molecule XX-XX G#protein_molecule
were NE xxx NE
similar NE xxx NE
to NE xx NE
those NE xxx NE
of NE xx NE
NF(P) G#protein_molecule XX(X) G#protein_molecule
and NE xxx NE
only NE xxx NE
a NE x NE
small NE xxx NE
amount NE xxx NE
of NE xx NE
P65 G#protein_subunit Xdd G#protein_subunit
was NE xxx NE
detected NE xxx NE
in NE xx NE
NF(P) G#protein_molecule XX(X) G#protein_molecule
in NE xx NE
crude G#cell_component_B xxx G#cell_component_B
nuclear G#cell_component_M xxx G#cell_component_M
extracts G#cell_component_E xxx G#cell_component_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
the NE xxx NE
component(s) NE xxx(x) NE
of NE xx NE
NF-AT G#protein_molecule XX-XX G#protein_molecule
has NE xxx NE
the NE xxx NE
potential NE xxx NE
to NE xx NE
reconstitute NE xxx NE
NF(P) G#protein_molecule XX(X) G#protein_molecule
whereas NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
alone NE xxx NE
cannot NE xxx NE
account NE xxx NE
for NE xxx NE
NF(P) G#protein_molecule XX(X) G#protein_molecule
in NE xx NE
crude G#other_name_B xxx G#other_name_B
extracts G#other_name_E xxx G#other_name_E
. NE . NE

Unlike NE Xxxx NE
NF-AT G#protein_molecule XX-XX G#protein_molecule
, NE , NE
NF(P) G#protein_molecule XX(X) G#protein_molecule
does NE xxx NE
not NE xxx NE
contain NE xxx NE
AP1 G#protein_molecule XXd G#protein_molecule
as NE xx NE
its NE xxx NE
DNA G#protein_subunit_B XXX G#protein_subunit_B
binding G#protein_subunit_M xxx G#protein_subunit_M
component G#protein_subunit_E xxx G#protein_subunit_E
. NE . NE

Activation NE Xxxx NE
of NE xx NE
early G#other_name_B xxx G#other_name_B
growth G#other_name_M xxx G#other_name_M
response G#other_name_M xxx G#other_name_M
1 G#other_name_M d G#other_name_M
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
and NE xxx NE
pp90rsk G#protein_molecule xxddxxx G#protein_molecule
during NE xxx NE
induction NE xxx NE
of NE xx NE
monocytic G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
present NE xxx NE
work NE xxx NE
has NE xxx NE
studied NE xxx NE
mechanisms NE xxx NE
responsible NE xxx NE
for NE xxx NE
induction NE xxx NE
of NE xx NE
early G#other_name_B xxx G#other_name_B
growth G#other_name_M xxx G#other_name_M
response G#other_name_M xxx G#other_name_M
1 G#other_name_M d G#other_name_M
(EGR-1) G#other_name_M (XXX-d) G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
during NE xxx NE
monocytic G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
of NE xx NE
U-937 G#cell_line_B X-ddd G#cell_line_B
myeloid G#cell_line_M xxx G#cell_line_M
leukemia G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Differentiation NE Xxxx NE
of NE xx NE
U-937 G#cell_line_B X-ddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
12-O-tetradecanoylphorbol-13-acetate NE dd-X-xxx-dd-xxx NE
( NE ( NE
TPA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
, NE , NE
an NE xx NE
activator NE xxx NE
of NE xx NE
the NE xxx NE
serine/threonine G#protein_molecule_B xxx/xxx G#protein_molecule_B
protein G#protein_molecule_M xxx G#protein_molecule_M
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
, NE , NE
was NE xxx NE
associated NE xxx NE
with NE xxx NE
transcriptional NE xxx NE
activation NE xxx NE
of NE xx NE
EGR-1 G#DNA_molecule_B XXX-d G#DNA_molecule_B
promoter-reporter G#DNA_molecule_M xxx-xxx G#DNA_molecule_M
constructs G#DNA_molecule_E xxx G#DNA_molecule_E
. NE . NE

The NE Xxx NE
EGR-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
contains NE xxx NE
six NE xxx NE
CC(A/T)6GG G#DNA_substructure_B XX(X/X)dXX G#DNA_substructure_B
(CArG) G#DNA_substructure_M (XXxX) G#DNA_substructure_M
motifs G#DNA_substructure_E xxx G#DNA_substructure_E
. NE . NE

The NE Xxx NE
two NE xxx NE
5'-most G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
distal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
CArG G#DNA_domain_or_region_M XXxX G#DNA_domain_or_region_M
sequences G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
conferred NE xxx NE
TPA G#other_organic_compound XXX G#other_organic_compound
inducibility NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
there NE xxx NE
was NE xxx NE
little NE xxx NE
effect NE xxx NE
of NE xx NE
TPA G#other_organic_compound XXX G#other_organic_compound
on NE xx NE
EGR-1 G#other_name_B XXX-d G#other_name_B
transcription G#other_name_E xxx G#other_name_E
in NE xx NE
a NE x NE
TPA NE XXX NE
-resistant NE -xxx NE
U-937 NE X-ddd NE
cell NE xxx NE
variant NE xxx NE
, NE , NE
designated NE xxx NE
TUR NE XXX NE
. NE . NE

Treatment NE Xxxx NE
of NE xx NE
both NE xxx NE
U-937 G#cell_line X-ddd G#cell_line
and NE xxx NE
TUR G#cell_line_B XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
okadaic G#other_organic_compound_B xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
an NE xx NE
inhibitor NE xxx NE
of NE xx NE
serine/threonine NE xxx/xxx NE
protein NE xxx NE
phosphatases NE xxx NE
serine/threonine G#protein_molecule_B xxx/xxx G#protein_molecule_B
protein G#protein_molecule_M xxx G#protein_molecule_M
phosphatase G#protein_molecule_M xxx G#protein_molecule_M
1 G#protein_molecule_M d G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
serine/threonine G#protein_molecule_M xxx/xxx G#protein_molecule_M
protein G#protein_molecule_M xxx G#protein_molecule_M
phosphatase G#protein_molecule_M xxx G#protein_molecule_M
2A G#protein_molecule_E dX G#protein_molecule_E
1 G#other_name d G#other_name
monocytic NE xxx NE
differentiation NE xxx NE
and NE xxx NE
EGR-1 NE XXX-d NE
transcription NE xxx NE
through NE xxx NE
the NE xxx NE
5'-most G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
CArG G#DNA_domain_or_region_M XXxX G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Since NE Xxxx NE
these NE xxx NE
findings NE xxx NE
supported NE xxx NE
the NE xxx NE
involvement NE xxx NE
of NE xx NE
serine NE xxx NE
/threonine NE /xxx NE
protein NE xxx NE
phosphorylation NE xxx NE
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
EGR-1 NE XXX-d NE
expression NE xxx NE
, NE , NE
we NE xx NE
studied NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
40S NE ddX NE
ribosomal NE xxx NE
protein NE xxx NE
S6 NE Xd NE
serine NE xxx NE
/threonine NE /xxx NE
kinases NE xxx NE
, NE , NE
pp70S6K NE xxddXdX NE
and NE xxx NE
pp90rsk NE xxddxxx NE
. NE . NE

Although NE Xxxx NE
both NE xxx NE
kinases NE xxx NE
participate NE xxx NE
in NE xx NE
regulating NE xxx NE
cell G#other_name_B xxx G#other_name_B
growth G#other_name_E xxx G#other_name_E
, NE , NE
there NE xxx NE
was NE xxx NE
no NE xx NE
detectable NE xxx NE
activation NE xxx NE
of NE xx NE
pp70S6K G#protein_family_or_group xxddXdX G#protein_family_or_group
during NE xxx NE
TPA-induced G#other_name_B XXX-xxx G#other_name_B
monocytic G#other_name_M xxx G#other_name_M
differentiation G#other_name_M xxx G#other_name_M
or G#other_name_M xx G#other_name_M
okadaic G#other_name_M xxx G#other_name_M
acid-induced G#other_name_M xxx-xxx G#other_name_M
monocytic G#other_name_M xxx G#other_name_M
differentiation G#other_name_E xxx G#other_name_E

Moreover NE Xxxx NE
, NE , NE
rapamycin NE xxx NE
, NE , NE
an NE xx NE
inhibitor NE xxx NE
of NE xx NE
pp70S6K G#other_name_B xxddXdX G#other_name_B
activation G#other_name_E xxx G#other_name_E
, NE , NE
had NE xxx NE
no NE xx NE
effect NE xxx NE
on NE xx NE
induction NE xxx NE
of NE xx NE
EGR-1 G#other_name_B XXX-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
analysis NE xxx NE
of NE xx NE
pp90rsk G#other_name_B xxddxxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
by NE xx NE
phosphorylation G#other_name xxx G#other_name
of NE xx NE
a NE x NE
peptide G#peptide xxx G#peptide
derived NE xxx NE
from NE xxx NE
S6 G#protein_molecule_B Xd G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
demonstrated NE xxx NE
stimulation NE xxx NE
of NE xx NE
this NE xxx NE
kinase G#protein_family_or_group xxx G#protein_family_or_group
in NE xx NE
TPA-treated G#cell_line_B XXX-xxx G#cell_line_B
U-937 G#cell_line_M X-ddd G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
not G#cell_line_M xxx G#cell_line_M
TPA-treated G#cell_line_M XXX-xxx G#cell_line_M
TUR G#cell_line_M XXX G#cell_line_M
cell G#cell_line_E xxx G#cell_line_E

Okadaic G#other_name_B Xxxx G#other_name_B
acid G#other_name_M xxx G#other_name_M
treatment G#other_name_E xxx G#other_name_E
of NE xx NE
both NE xxx NE
cell NE xxx NE
types NE xxx NE
was NE xxx NE
associated NE xxx NE
with NE xxx NE
activation NE xxx NE
of NE xx NE
pp90rsk G#protein_molecule xxddxxx G#protein_molecule
. NE . NE

Antioxidants G#other_organic_compound Xxxx G#other_organic_compound
inhibit NE xxx NE
monocyte G#other_name_B xxx G#other_name_B
adhesion G#other_name_E xxx G#other_name_E
by NE xx NE
suppressing NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
factor-kappa G#other_name_M xxx-xxx G#other_name_M
B G#other_name_M X G#other_name_M
mobilization G#other_name_E xxx G#other_name_E
and NE xxx NE
induction NE xxx NE
of NE xx NE
vascular G#protein_molecule_B xxx G#protein_molecule_B
cell G#protein_molecule_M xxx G#protein_molecule_M
adhesion G#protein_molecule_M xxx G#protein_molecule_M
molecule-1 G#protein_molecule_E xxx-d G#protein_molecule_E
in NE xx NE
endothelial G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
stimulated NE xxx NE
to NE xx NE
generate NE xxx NE
radicals G#inorganic xxx G#inorganic
. NE . NE

Cell G#other_name_B Xxxx G#other_name_B
adhesion G#other_name_E xxx G#other_name_E
to NE xx NE
endothelial G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
stimulated G#protein_molecule_B xxx G#protein_molecule_B
by G#protein_molecule_M xx G#protein_molecule_M
tumor G#protein_molecule_M xxx G#protein_molecule_M
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor-alpha G#protein_molecule_E xxx-xxx G#protein_molecule_E
( NE ( NE
TNF G#protein_molecule XXX G#protein_molecule
) NE ) NE
is NE xx NE
due NE xxx NE
to NE xx NE
induction NE xxx NE
of NE xx NE
surface G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
such NE xxx NE
as NE xx NE
vascular G#protein_molecule_B xxx G#protein_molecule_B
cell G#protein_molecule_M xxx G#protein_molecule_M
adhesion G#protein_molecule_M xxx G#protein_molecule_M
molecule-1 G#protein_molecule_E xxx-d G#protein_molecule_E
( NE ( NE
VCAM-1 G#protein_molecule XXXX-d G#protein_molecule
) NE ) NE
. NE . NE

The NE Xxx NE
antioxidant NE xxx NE
pyrrolidine G#other_organic_compound_B xxx G#other_organic_compound_B
dithiocarbamate G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
PDTC G#other_organic_compound XXXX G#other_organic_compound
) NE ) NE
specifically NE xxx NE
inhibits NE xxx NE
activation NE xxx NE
of NE xx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor-kappa G#protein_molecule_M xxx-xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
) NE ) NE
. NE . NE

Since NE Xxxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
motifs G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
are NE xxx NE
present NE xxx NE
in NE xx NE
VCAM-1 NE XXXX-d NE
and NE xxx NE
intercellular NE xxx NE
adhesion NE xxx NE
molecule-1 NE xxx-d NE
( NE ( NE
ICAM-1 NE XXXX-d NE
) NE ) NE
promoters NE xxx NE
, NE , NE
we NE xx NE
used NE xxx NE
PDTC NE XXXX NE
to NE xx NE
study NE xxx NE
the NE xxx NE
regulatory NE xxx NE
mechanisms NE xxx NE
of NE xx NE
VCAM-1 NE XXXX-d NE
and NE xxx NE
ICAM-1 NE XXXX-d NE
induction NE xxx NE
and NE xxx NE
subsequent NE xxx NE
monocyte NE xxx NE
adhesion NE xxx NE
in NE xx NE
TNF-treated NE XXX-xxx NE
human NE xxx NE
umbilical NE xxx NE
vein NE xxx NE
endothelial NE xxx NE
cells NE xxx NE
( NE ( NE
HUVECs NE XXXXXx NE
) NE ) NE
. NE . NE

PDTC G#other_organic_compound XXXX G#other_organic_compound
or NE xx NE
N-acetylcysteine NE X-xxx NE
dose NE xxx NE
dependently NE xxx NE
reduced NE xxx NE
TNF-induced G#protein_molecule_B XXX-xxx G#protein_molecule_B
VCAM-1 G#protein_molecule_E XXXX-d G#protein_molecule_E
but NE xxx NE
not NE xxx NE
ICAM-1 G#protein_molecule_B XXXX-d G#protein_molecule_B
surface G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
(also NE (xxx NE
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
umbilical G#cell_type_M xxx G#cell_type_M
arterial G#cell_type_M xxx G#cell_type_M
endothelial G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
) NE ) NE
and NE xxx NE
mRNA G#other_name_B xXXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
(by NE (xx NE
70% NE dd% NE
at NE xx NE
100 NE ddd NE
mumol/L NE xxx/X NE
PDTC G#other_organic_compound XXXX G#other_organic_compound
) NE ) NE
in NE xx NE
HUVECs G#cell_line XXXXXx G#cell_line
as NE xx NE
assessed NE xxx NE
by NE xx NE
flow G#other_name_B xxx G#other_name_B
cytometry G#other_name_E xxx G#other_name_E
and NE xxx NE
polymerase G#other_name_B xxx G#other_name_B
chain G#other_name_M xxx G#other_name_M
reaction G#other_name_E xxx G#other_name_E
. NE . NE

Gel-shift NE Xxx-xxx NE
analysis NE xxx NE
in NE xx NE
HUVECs G#cell_line XXXXXx G#cell_line
demonstrated NE xxx NE
that NE xxx NE
PDTC G#other_organic_compound XXXX G#other_organic_compound
prevented NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
mobilization NE xxx NE
by NE xx NE
TNF G#protein_family_or_group XXX G#protein_family_or_group
, NE , NE
suggesting NE xxx NE
that NE xxx NE
only NE xxx NE
VCAM-1 G#other_name_B XXXX-d G#other_name_B
induction G#other_name_E xxx G#other_name_E
was NE xxx NE
controlled NE xxx NE
by NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
. NE . NE

Since NE Xxxx NE
HUVECs G#cell_line XXXXXx G#cell_line
released NE xxx NE
superoxide G#inorganic_B xxx G#inorganic_B
anions G#inorganic_E xxx G#inorganic_E
in NE xx NE
response NE xxx NE
to NE xx NE
TNF NE XXX NE
, NE , NE
and NE xxx NE
H2O2 NE XdXd NE
induces NE xxx NE
VCAM-1 G#protein_molecule XXXX-d G#protein_molecule
, NE , NE
PDTC G#other_organic_compound XXXX G#other_organic_compound
may NE xxx NE
act NE xxx NE
as NE xx NE
a NE x NE
radical G#other_name_B xxx G#other_name_B
scavenger G#other_name_E xxx G#other_name_E
. NE . NE

Although NE Xxxx NE
ICAM-1 G#protein_molecule XXXX-d G#protein_molecule
induction NE xxx NE
was NE xxx NE
unaffected NE xxx NE
, NE , NE
inhibitors NE xxx NE
of NE xx NE
NADPH G#protein_molecule_B XXXXX G#protein_molecule_B
oxidase G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
apocynin G#other_organic_compound xxx G#other_organic_compound
) NE ) NE
or NE xx NE
cytochrome G#protein_molecule_B xxx G#protein_molecule_B
P-450 G#protein_molecule_E X-ddd G#protein_molecule_E
( NE ( NE
SKF525a G#other_organic_compound XXXdddx G#other_organic_compound
) NE ) NE
suppressed NE xxx NE
VCAM-1 G#protein_molecule XXXX-d G#protein_molecule
induction NE xxx NE
by NE xx NE
TNF NE XXX NE
, NE , NE
revealing NE xxx NE
that NE xxx NE
several NE xxx NE
radical-generating G#other_name_B xxx-xxx G#other_name_B
systems G#other_name_E xxx G#other_name_E
are NE xxx NE
involved NE xxx NE
in NE xx NE
its NE xxx NE
regulation NE xxx NE
. NE . NE

PDTC G#other_organic_compound XXXX G#other_organic_compound
, NE , NE
apocynin G#other_organic_compound xxx G#other_organic_compound
, NE , NE
or NE xx NE
SKF525a G#other_organic_compound XXXdddx G#other_organic_compound
decreased NE xxx NE
adhesion NE xxx NE
of NE xx NE
monocytic G#cell_line_B xxx G#cell_line_B
U937 G#cell_line_M Xddd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
to NE xx NE
TNF-treated G#cell_line_B XXX-xxx G#cell_line_B
HUVECs G#cell_line_E XXXXXx G#cell_line_E
(by NE (xx NE
75% NE dd% NE
at NE xx NE
100 NE ddd NE
mumol/L NE xxx/X NE
PDTC G#other_organic_compound XXXX G#other_organic_compound
) NE ) NE
. NE . NE

Inhibition NE Xxxx NE
by NE xx NE
anti- NE xxx- NE
VCAM-1 NE XXXX-d NE
monoclonal NE xxx NE
antibody NE xxx NE
1G11 NE dXdd NE
indicated NE xxx NE
that NE xxx NE
U937 NE Xddd NE
adhesion NE xxx NE
was NE xxx NE
VCAM-1 NE XXXX-d NE
dependent NE xxx NE
and NE xxx NE
suppression NE xxx NE
by NE xx NE
antioxidants NE xxx NE
was NE xxx NE
due NE xxx NE
to NE xx NE
reduced NE xxx NE
VCAM-1 NE XXXX-d NE
induction NE xxx NE
. NE . NE

(ABSTRACT NE (XXXXXXXX NE
TRUNCATED NE XXXXXXXXX NE
AT NE XX NE
250 NE ddd NE
WORDS) NE XXXXX) NE

Displacement NE Xxxx NE
of NE xx NE
an NE xx NE
E-box-binding G#protein_family_or_group_B X-xxx-xxx G#protein_family_or_group_B
repressor G#protein_family_or_group_E xxx G#protein_family_or_group_E
by NE xx NE
basic G#protein_family_or_group_B xxx G#protein_family_or_group_B
helix-loop-helix G#protein_family_or_group_M xxx-xxx-xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
: NE : NE
implications NE xxx NE
for NE xxx NE
B-cell G#other_name_B X-xxx G#other_name_B
specificity G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
immunoglobulin G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
heavy-chain G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
activity NE xxx NE
of NE xx NE
the NE xxx NE
immunoglobulin G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
heavy-chain G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
(IgH) G#DNA_domain_or_region_M (XxX) G#DNA_domain_or_region_M
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
restricted NE xxx NE
to NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
although NE xxx NE
it NE xx NE
binds NE xxx NE
both NE xxx NE
B-cell-restricted G#protein_family_or_group_B X-xxx-xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
ubiquitous G#protein_family_or_group_M xxx G#protein_family_or_group_M
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E

Activation NE Xxxx NE
of NE xx NE
the NE xxx NE
enhancer G#DNA_domain_or_region xxx G#DNA_domain_or_region
in NE xx NE
non- NE xxx- NE
B NE X NE
cells NE xxx NE
upon NE xxx NE
overexpression NE xxx NE
of NE xx NE
the NE xxx NE
basic NE xxx NE
helix-loop-helix NE xxx-xxx-xxx NE
(bHLH) NE (xXXX) NE
protein NE xxx NE
E2A NE XdX NE
appears NE xxx NE
to NE xx NE
be NE xx NE
mediated NE xxx NE
not NE xxx NE
only NE xxx NE
by NE xx NE
the NE xxx NE
binding NE xxx NE
of NE xx NE
E2A NE XdX NE
to NE xx NE
its NE xxx NE
cognate NE xxx NE
E NE X NE
box NE xxx NE
but NE xxx NE
also NE xxx NE
by NE xx NE
the NE xxx NE
resulting NE xxx NE
displacement NE xxx NE
of NE xx NE
a NE x NE
repressor NE xxx NE
from NE xxx NE
that NE xxx NE
same NE xxx NE
site NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
identified NE xxx NE
a NE x NE
"two-handed" G#protein_family_or_group_B "xxx-xxx" G#protein_family_or_group_B
zinc G#protein_family_or_group_M xxx G#protein_family_or_group_M
finger G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
denoted NE xxx NE
ZEB G#protein_molecule XXX G#protein_molecule
, NE , NE
the NE xxx NE
DNA-binding G#other_name_B XXX-xxx G#other_name_B
specificity G#other_name_E xxx G#other_name_E
of NE xx NE
which NE xxx NE
mimics NE xxx NE
that NE xxx NE
of NE xx NE
the NE xxx NE
cellular G#protein_family_or_group_B xxx G#protein_family_or_group_B
repressor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

By NE Xx NE
employing NE xxx NE
a NE x NE
derivative NE xxx NE
E G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
box G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
that NE xxx NE
binds NE xxx NE
ZEB G#protein_molecule XXX G#protein_molecule
but NE xxx NE
not NE xxx NE
E2A G#protein_molecule XdX G#protein_molecule
, NE , NE
we NE xx NE
have NE xxx NE
shown NE xxx NE
that NE xxx NE
the NE xxx NE
repressor G#protein_family_or_group xxx G#protein_family_or_group
is NE xx NE
active NE xxx NE
in NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
the NE xxx NE
IgH G#DNA_domain_or_region_B XxX G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
silenced NE xxx NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
binding NE xxx NE
competition NE xxx NE
by NE xx NE
bHLH G#protein_family_or_group_B xXXX G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Hence NE Xxxx NE
, NE , NE
we NE xx NE
propose NE xxx NE
that NE xxx NE
a NE x NE
necessary NE xxx NE
prerequisite NE xxx NE
of NE xx NE
enhancer G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
is NE xx NE
the NE xxx NE
B-cell-specific G#other_name_B X-xxx-xxx G#other_name_B
displacement G#other_name_E xxx G#other_name_E
of NE xx NE
a NE x NE
ZEB NE XXX NE
-like NE -xxx NE
repressor NE xxx NE
by NE xx NE
bHLH NE xXXX NE
proteins NE xxx NE
. NE . NE

Inhibition NE Xxxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
by NE xx NE
sodium G#other_organic_compound_B xxx G#other_organic_compound_B
salicylate G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
aspirin G#other_organic_compound xxx G#other_organic_compound
[see NE [xxx NE
comments] NE xxx] NE

The NE Xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
nuclear NE xxx NE
factor-kappa NE xxx-xxx NE
B NE X NE
( NE ( NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
) NE ) NE
is NE xx NE
critical NE xxx NE
for NE xxx NE
the NE xxx NE
inducible NE xxx NE
expression NE xxx NE
of NE xx NE
multiple NE xxx NE
cellular G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
and G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
viral G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
adhesion NE xxx NE
molecules NE xxx NE
. NE . NE

The NE Xxx NE
anti-inflammatory G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
drugs G#other_organic_compound_E xxx G#other_organic_compound_E
sodium G#other_organic_compound_B xxx G#other_organic_compound_B
salicylate G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
aspirin G#other_organic_compound xxx G#other_organic_compound
inhibited NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
which NE xxx NE
further NE xxx NE
explains NE xxx NE
the NE xxx NE
mechanism NE xxx NE
of NE xx NE
action NE xxx NE
of NE xx NE
these NE xxx NE
drugs NE xxx NE
. NE . NE

This NE Xxxx NE
inhibition NE xxx NE
prevented NE xxx NE
the NE xxx NE
degradation NE xxx NE
of NE xx NE
the NE xxx NE
NF-kappa G#protein_family_or_group_B XX-xxx G#protein_family_or_group_B
B G#protein_family_or_group_M X G#protein_family_or_group_M
inhibitor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
and NE xxx NE
therefore NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
was NE xxx NE
retained NE xxx NE
in NE xx NE
the NE xxx NE
cytosol G#cell_component xxx G#cell_component
. NE . NE

Sodium G#other_organic_compound_B Xxxx G#other_organic_compound_B
salicylate G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
aspirin G#other_organic_compound xxx G#other_organic_compound
also NE xxx NE
inhibited NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
-dependent NE -xxx NE
transcription NE xxx NE
from NE xxx NE
the NE xxx NE
Ig NE Xx NE
kappa NE xxx NE
enhancer NE xxx NE
and NE xxx NE
the NE xxx NE
human NE xxx NE
immunodeficiency NE xxx NE
virus NE xxx NE
(HIV) NE (XXX) NE
long NE xxx NE
terminal NE xxx NE
repeat NE xxx NE
( NE ( NE
LTR NE XXX NE
) NE ) NE
in NE xx NE
transfected NE xxx NE
T NE X NE
cells NE xxx NE
. NE . NE

Effects NE Xxxx NE
of NE xx NE
the NE xxx NE
antisense G#other_name_B xxx G#other_name_B
myb G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
on NE xx NE
hemin- G#other_name_B xxx- G#other_name_B
induced G#other_name_M xxx G#other_name_M
erythroid G#other_name_M xxx G#other_name_M
differentiation G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
erythropoietin- G#other_name_M xxx- G#other_name_M
induced G#other_name_M xxx G#other_name_M
erythroid G#other_name_M xxx G#other_name_M
differentiation G#other_name_E xxx G#other_name_E
of NE xx NE
K562 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

In NE Xx NE
order NE xxx NE
to NE xx NE
elucidate NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
c-myb G#DNA_domain_or_region_B x-xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
erythroid G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
of NE xx NE
K562 G#cell_line_B Xddd G#cell_line_B
cell G#cell_line_E xxx G#cell_line_E
induced NE xxx NE
by NE xx NE
hemin G#protein_molecule xxx G#protein_molecule
( NE ( NE
Hm G#protein_molecule Xx G#protein_molecule
) NE ) NE
and NE xxx NE
erythropoietin G#protein_molecule xxx G#protein_molecule
( NE ( NE
Epo G#protein_molecule Xxx G#protein_molecule
) NE ) NE
, NE , NE
we NE xx NE
constructed NE xxx NE
recombinant G#DNA_molecule_B xxx G#DNA_molecule_B
plasmid G#DNA_molecule_E xxx G#DNA_molecule_E
that NE xxx NE
could NE xxx NE
produce NE xxx NE
antisense G#RNA_molecule_B xxx G#RNA_molecule_B
myb G#RNA_molecule_M xxx G#RNA_molecule_M
RNA G#RNA_molecule_E XXX G#RNA_molecule_E
after NE xxx NE
induction NE xxx NE
with NE xxx NE
dexamethasone G#lipid xxx G#lipid
. NE . NE

During NE Xxxx NE
treatment NE xxx NE
with NE xxx NE
Hm G#protein_molecule Xx G#protein_molecule
, NE , NE
K562 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
constitutively NE xxx NE
expressed NE xxx NE
c-myb G#RNA_molecule_B x-xxx G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
, NE , NE
and NE xxx NE
50% NE dd% NE
of NE xx NE
them NE xxx NE
began NE xxx NE
to NE xx NE
synthesize NE xxx NE
hemoglobin G#protein_molecule xxx G#protein_molecule
( NE ( NE
Hb G#protein_molecule Xx G#protein_molecule
) NE ) NE
. NE . NE

Expression NE Xxxx NE
of NE xx NE
antisense G#RNA_molecule_B xxx G#RNA_molecule_B
myb G#RNA_molecule_M xxx G#RNA_molecule_M
RNA G#RNA_molecule_E XXX G#RNA_molecule_E
reduced NE xxx NE
the NE xxx NE
amount NE xxx NE
of NE xx NE
c-myb G#RNA_molecule_B x-xxx G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
, NE , NE
and NE xxx NE
the NE xxx NE
percentage NE xxx NE
of NE xx NE
Hb NE Xx NE
-synthesizing NE -xxx NE
cells NE xxx NE
was NE xxx NE
decreased NE xxx NE
to NE xx NE
20% NE dd% NE
. NE . NE

In NE Xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
Epo G#protein_molecule Xxx G#protein_molecule
, NE , NE
c-myb G#RNA_molecule_B x-xxx G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
declined NE xxx NE
and NE xxx NE
20% NE dd% NE
of NE xx NE
K562 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
synthesized NE xxx NE
Hb G#protein_molecule Xx G#protein_molecule
regardless NE xxx NE
of NE xx NE
antisense G#RNA_molecule_B xxx G#RNA_molecule_B
myb G#RNA_molecule_M xxx G#RNA_molecule_M
RNA G#RNA_molecule_E XXX G#RNA_molecule_E
expression NE xxx NE
. NE . NE

It NE Xx NE
is NE xx NE
suggested NE xxx NE
that NE xxx NE
constitutive G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
c-myb G#RNA_molecule_B x-xxx G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
is NE xx NE
necessary NE xxx NE
for NE xxx NE
Hm NE Xx NE
-induced NE -xxx NE
differentiation NE xxx NE
, NE , NE
and NE xxx NE
that NE xxx NE
a NE x NE
decrease NE xxx NE
in NE xx NE
the NE xxx NE
amount NE xxx NE
of NE xx NE
c-myb NE x-xxx NE
mRNA NE xXXX NE
induced NE xxx NE
by NE xx NE
antisense NE xxx NE
myb NE xxx NE
RNA NE XXX NE
expression NE xxx NE
suppresses NE xxx NE
Hm NE Xx NE
-induced NE -xxx NE
differentiation NE xxx NE
. NE . NE

The NE Xxx NE
amount NE xxx NE
of NE xx NE
c-myb G#RNA_molecule_B x-xxx G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
in NE xx NE
K562 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
was NE xxx NE
reduced NE xxx NE
during NE xxx NE
the NE xxx NE
differentiation NE xxx NE
induced NE xxx NE
by NE xx NE
Epo G#protein_molecule Xxx G#protein_molecule
. NE . NE

Expression NE Xxxx NE
of NE xx NE
GATA-1 G#RNA_molecule_B XXXX-d G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
was NE xxx NE
almost NE xxx NE
constant NE xxx NE
during NE xxx NE
Hm NE Xx NE
-induced NE -xxx NE
differentiation NE xxx NE
, NE , NE
but NE xxx NE
increased NE xxx NE
during NE xxx NE
Epo NE Xxx NE
treatment NE xxx NE
. NE . NE

It NE Xx NE
is NE xx NE
supposed NE xxx NE
that NE xxx NE
the NE xxx NE
mechanism NE xxx NE
of NE xx NE
Hm NE Xx NE
-induced NE -xxx NE
differentiation NE xxx NE
is NE xx NE
distinguished NE xxx NE
from NE xxx NE
that NE xxx NE
of NE xx NE
Epo NE Xxx NE
-induced NE -xxx NE
differentiation NE xxx NE
in NE xx NE
K562 NE Xddd NE
cells NE xxx NE
. NE . NE

Prenatal G#other_name_B Xxxx G#other_name_B
immune G#other_name_M xxx G#other_name_M
challenge G#other_name_E xxx G#other_name_E
alters NE xxx NE
the NE xxx NE
hypothalamic-pituitary-adrenocortical G#body_part_B xxx-xxx-xxx G#body_part_B
axis G#body_part_E xxx G#body_part_E
in NE xx NE
adult G#multi_cell_B xxx G#multi_cell_B
rats G#multi_cell_E xxx G#multi_cell_E
. NE . NE

We NE Xx NE
investigated NE xxx NE
whether NE xxx NE
non-abortive G#other_name_B xxx-xxx G#other_name_B
maternal G#other_name_M xxx G#other_name_M
infections G#other_name_E xxx G#other_name_E
would NE xxx NE
compromise NE xxx NE
fetal G#other_name_B xxx G#other_name_B
brain G#other_name_M xxx G#other_name_M
development G#other_name_E xxx G#other_name_E
and NE xxx NE
alter NE xxx NE
hypothalamic-pituitary-adrenocortical G#other_name_B xxx-xxx-xxx G#other_name_B
(HPA) G#other_name_M (XXX) G#other_name_M
axis G#other_name_M xxx G#other_name_M
functioning G#other_name_E xxx G#other_name_E
when NE xxx NE
adult NE xxx NE
. NE . NE

To NE Xx NE
study NE xxx NE
putative NE xxx NE
teratogenic G#other_name_B xxx G#other_name_B
effects G#other_name_E xxx G#other_name_E
of NE xx NE
a NE x NE
T G#other_name_B X G#other_name_B
cell-mediated G#other_name_M xxx-xxx G#other_name_M
immune G#other_name_M xxx G#other_name_M
response G#other_name_E xxx G#other_name_E
versus NE xxx NE
an NE xx NE
endotoxic G#other_name_B xxx G#other_name_B
challenge G#other_name_E xxx G#other_name_E
, NE , NE
10-d-pregnant G#multi_cell_B dd-x-xxx G#multi_cell_B
rats G#multi_cell_E xxx G#multi_cell_E
received NE xxx NE
a NE x NE
single NE xxx NE
intraperitoneal NE xxx NE
injection NE xxx NE
of NE xx NE
5 NE d NE
x NE x NE
10(8) NE dd(d) NE
human G#cell_type_B xxx G#cell_type_B
red G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
HRBC G#cell_type XXXX G#cell_type
) NE ) NE
or NE xx NE
gram-negative G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
bacterial G#other_organic_compound_M xxx G#other_organic_compound_M
endotoxin G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
Escherichia G#other_organic_compound_B Xxxx G#other_organic_compound_B
coli G#other_organic_compound_M xxx G#other_organic_compound_M
LPS G#other_organic_compound_E XXX G#other_organic_compound_E
: NE : NE
30 NE dd NE
micrograms/kg) NE xxx/xx) NE
. NE . NE

The NE Xxx NE
adult G#multi_cell_B xxx G#multi_cell_B
male G#multi_cell_M xxx G#multi_cell_M
progeny G#multi_cell_E xxx G#multi_cell_E
(3 NE (d NE
mo NE xx NE
old) NE xxx) NE
of NE xx NE
both NE xxx NE
experimental NE xxx NE
groups NE xxx NE
showed NE xxx NE
increased NE xxx NE
basal G#other_name_B xxx G#other_name_B
plasma G#other_name_M xxx G#other_name_M
corticosterone G#other_name_M xxx G#other_name_M
levels G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
after NE xxx NE
novelty G#other_name_B xxx G#other_name_B
stress G#other_name_E xxx G#other_name_E
the NE xxx NE
HRBC G#cell_type XXXX G#cell_type
group NE xxx NE
, NE , NE
but NE xxx NE
not NE xxx NE
the NE xxx NE
LPS G#cell_line_B XXX G#cell_line_B
group G#cell_line_E xxx G#cell_line_E
, NE , NE
showed NE xxx NE
increased NE xxx NE
ACTH G#peptide XXXX G#peptide
and NE xxx NE
corticosterone G#other_name_B xxx G#other_name_B
levels G#other_name_E xxx G#other_name_E
. NE . NE

Both NE Xxxx NE
groups NE xxx NE
showed NE xxx NE
substantial NE xxx NE
decreases NE xxx NE
in NE xx NE
mineralocorticoid NE xxx NE
(MR) NE (XX) NE
and NE xxx NE
mineralocorticoid G#other_name_B xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
(MR) G#other_name_M (XX) G#other_name_M
level G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
glucocorticoid G#other_name_M xxx G#other_name_M
receptor G#other_name_M xxx G#other_name_M
(GR) G#other_name_M (XX) G#other_name_M
level G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
hippocampus G#body_part xxx G#body_part
, NE , NE
a NE x NE
limbic G#body_part_B xxx G#body_part_B
brain G#body_part_M xxx G#body_part_M
structure G#body_part_E xxx G#body_part_E
critical NE xxx NE
for NE xxx NE
HPA G#other_name_B XXX G#other_name_B
axis G#other_name_M xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
, NE , NE
whereas NE xxx NE
GR G#other_name XX G#other_name
concentrations NE xxx NE
in NE xx NE
the NE xxx NE
hypothalamus NE xxx NE
were NE xxx NE
unchanged NE xxx NE
and NE xxx NE
in NE xx NE
anterior G#body_part_B xxx G#body_part_B
pituitary G#body_part_E xxx G#body_part_E
were NE xxx NE
slightly NE xxx NE
increased NE xxx NE
. NE . NE

HRBC G#cell_type XXXX G#cell_type
and NE xxx NE
LPS G#lipid XXX G#lipid
indeed NE xxx NE
stimulated NE xxx NE
the NE xxx NE
maternal NE xxx NE
immune NE xxx NE
system NE xxx NE
as NE xx NE
revealed NE xxx NE
by NE xx NE
specific NE xxx NE
anti- NE xxx- NE
HRBC NE XXXX NE
antibody NE xxx NE
production NE xxx NE
and NE xxx NE
enhanced NE xxx NE
IL-1 NE XX-d NE
beta NE xxx NE
mRNA NE xXXX NE
expression NE xxx NE
in NE xx NE
splenocytes NE xxx NE
, NE , NE
respectively NE xxx NE
. NE . NE

This NE Xxxx NE
study NE xxx NE
demonstrates NE xxx NE
that NE xxx NE
a NE x NE
T G#other_name_B X G#other_name_B
cell-mediated G#other_name_M xxx-xxx G#other_name_M
immune G#other_name_M xxx G#other_name_M
response G#other_name_E xxx G#other_name_E
as NE xx NE
well NE xxx NE
as NE xx NE
an NE xx NE
endotoxic G#other_name_B xxx G#other_name_B
challenge G#other_name_E xxx G#other_name_E
during NE xxx NE
pregnancy G#other_name xxx G#other_name
can NE xxx NE
induce NE xxx NE
anomalies NE xxx NE
in NE xx NE
HPA G#body_part_B XXX G#body_part_B
axis G#body_part_E xxx G#body_part_E
function NE xxx NE
in NE xx NE
adulthood NE xxx NE
. NE . NE

Clinically NE Xxxx NE
, NE , NE
it NE xx NE
may NE xxx NE
be NE xx NE
postulated NE xxx NE
that NE xxx NE
disturbed NE xxx NE
fetal G#other_name_B xxx G#other_name_B
brain G#other_name_M xxx G#other_name_M
development G#other_name_E xxx G#other_name_E
due NE xxx NE
to NE xx NE
prenatal G#other_name_B xxx G#other_name_B
immune G#other_name_M xxx G#other_name_M
challenge G#other_name_E xxx G#other_name_E
increases NE xxx NE
the NE xxx NE
vulnerability NE xxx NE
to NE xx NE
develop NE xxx NE
mental G#other_name_B xxx G#other_name_B
illness G#other_name_E xxx G#other_name_E
involving NE xxx NE
inadequate NE xxx NE
responses NE xxx NE
to NE xx NE
stress G#other_name xxx G#other_name
. NE . NE

A NE X NE
low NE xxx NE
NM23.H1 G#other_name_B XXdd.Xd G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
identifying NE xxx NE
high G#other_name_B xxx G#other_name_B
malignancy G#other_name_M xxx G#other_name_M
human G#other_name_M xxx G#other_name_M
melanomas G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
NM23 G#DNA_domain_or_region_B XXdd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
has NE xxx NE
been NE xxx NE
proposed NE xxx NE
as NE xx NE
a NE x NE
metastasis-suppressor G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
and NE xxx NE
its NE xxx NE
use NE xxx NE
has NE xxx NE
been NE xxx NE
suggested NE xxx NE
as NE xx NE
prognostic G#other_name_B xxx G#other_name_B
factor G#other_name_E xxx G#other_name_E
. NE . NE

NM23 G#protein_molecule XXdd G#protein_molecule
was NE xxx NE
identified NE xxx NE
in NE xx NE
a NE x NE
system NE xxx NE
of NE xx NE
murine G#cell_line_B xxx G#cell_line_B
melanoma G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
, NE , NE
in NE xx NE
which NE xxx NE
an NE xx NE
inverse NE xxx NE
relationship NE xxx NE
was NE xxx NE
found NE xxx NE
between NE xxx NE
NM23 G#other_name_B XXdd G#other_name_B
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
metastatic G#other_name_B xxx G#other_name_B
ability G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
a NE x NE
human G#other_name_B xxx G#other_name_B
malignant G#other_name_M xxx G#other_name_M
melanoma G#other_name_M xxx G#other_name_M
study G#other_name_E xxx G#other_name_E
NM23 G#other_name_B XXdd G#other_name_B
expression G#other_name_E xxx G#other_name_E
was NE xxx NE
found NE xxx NE
to NE xx NE
be NE xx NE
significantly NE xxx NE
lower NE xxx NE
in NE xx NE
metastases G#tissue xxx G#tissue
that NE xxx NE
developed NE xxx NE
less NE xxx NE
than NE xxx NE
24 NE dd NE
months NE xxx NE
after NE xxx NE
diagnosis NE xxx NE
of NE xx NE
the NE xxx NE
primary G#tissue_B xxx G#tissue_B
tumours G#tissue_E xxx G#tissue_E
. NE . NE

The NE Xxx NE
present NE xxx NE
paper NE xxx NE
studies NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
NM23 NE XXdd NE
.H1 NE .Xd NE
gene NE xxx NE
in NE xx NE
cell NE xxx NE
lines NE xxx NE
which NE xxx NE
derive NE xxx NE
from NE xxx NE
primary NE xxx NE
or NE xx NE
metastatic NE xxx NE
human NE xxx NE
malignant NE xxx NE
melanomas NE xxx NE
in NE xx NE
relation NE xxx NE
to NE xx NE
staging NE xxx NE
, NE , NE
infiltration NE xxx NE
degree NE xxx NE
, NE , NE
lymphocytic NE xxx NE
infiltration NE xxx NE
, NE , NE
cell NE xxx NE
morphology NE xxx NE
, NE , NE
cell NE xxx NE
pigmentation NE xxx NE
, NE , NE
karyotype NE xxx NE
, NE , NE
and NE xxx NE
disease-free NE xxx-xxx NE
survival NE xxx NE
. NE . NE

The NE Xxx NE
level NE xxx NE
of NE xx NE
mRNA G#other_name_B xXXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
NM23 G#DNA_domain_or_region_B XXdd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
significantly NE xxx NE
lower NE xxx NE
in NE xx NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
that NE xxx NE
derive NE xxx NE
from NE xxx NE
more NE xxx NE
infiltrating G#tissue_B xxx G#tissue_B
primary G#tissue_M xxx G#tissue_M
melanomas G#tissue_E xxx G#tissue_E
than NE xxx NE
in NE xx NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
obtained NE xxx NE
from NE xxx NE
less NE xxx NE
infiltrating NE xxx NE
tumours G#tissue xxx G#tissue
. NE . NE

Moreover NE Xxxx NE
, NE , NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
derived NE xxx NE
from NE xxx NE
tumours G#tissue xxx G#tissue
of NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
a NE x NE
disease-free G#other_name_B xxx-xxx G#other_name_B
survival G#other_name_E xxx G#other_name_E
of NE xx NE
more NE xxx NE
than NE xxx NE
24 NE dd NE
months NE xxx NE
(24-58 NE (dd-dd NE
months) NE xxx) NE
express NE xxx NE
the NE xxx NE
NM23 G#DNA_domain_or_region_B XXdd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
at NE xx NE
higher NE xxx NE
levels NE xxx NE
than NE xxx NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
obtained NE xxx NE
from NE xxx NE
melanomas G#tissue xxx G#tissue
of NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
a NE x NE
disease-free G#other_name_B xxx-xxx G#other_name_B
survival G#other_name_E xxx G#other_name_E
of NE xx NE
less NE xxx NE
than NE xxx NE
24 NE dd NE
months NE xxx NE
(6-15 NE (d-dd NE
months) NE xxx) NE
. NE . NE

Activation NE Xxxx NE
of NE xx NE
a NE x NE
novel NE xxx NE
serine G#protein_family_or_group xxx G#protein_family_or_group
/threonine NE /xxx NE
kinase NE xxx NE
that NE xxx NE
phosphorylates NE xxx NE
c-Fos G#protein_molecule x-Xxx G#protein_molecule
upon NE xxx NE
stimulation NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocyte G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
B G#cell_type_M X G#cell_type_M
lymphocyte G#cell_type_E xxx G#cell_type_E
cytokine NE xxx NE
receptors NE xxx NE
. NE . NE

Ligation NE Xxxx NE
of NE xx NE
Ag G#protein_molecule_B Xx G#protein_molecule_B
receptors G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocyte G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
B G#cell_type_M X G#cell_type_M
lymphocyte G#cell_type_E xxx G#cell_type_E
T G#other_name X G#other_name
initiates NE xxx NE
signal NE xxx NE
transduction NE xxx NE
cascades NE xxx NE
which NE xxx NE
alter NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
genes NE xxx NE
that NE xxx NE
regulate NE xxx NE
cellular G#other_name_B xxx G#other_name_B
proliferation G#other_name_E xxx G#other_name_E
and NE xxx NE
differentiation NE xxx NE
. NE . NE

The NE Xxx NE
transmission G#other_name_B xxx G#other_name_B
of G#other_name_M xx G#other_name_M
signals G#other_name_E xxx G#other_name_E
from NE xxx NE
the NE xxx NE
membrane G#cell_component xxx G#cell_component
to NE xx NE
the NE xxx NE
nucleus G#cell_component xxx G#cell_component
is NE xx NE
mediated NE xxx NE
principally NE xxx NE
through NE xxx NE
the NE xxx NE
action NE xxx NE
of NE xx NE
protein G#protein_family_or_group_B xxx G#protein_family_or_group_B
tyrosine G#protein_family_or_group_M xxx G#protein_family_or_group_M
kinase G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_M xxx G#protein_family_or_group_M
serine/threonine G#protein_family_or_group_M xxx/xxx G#protein_family_or_group_M
kinase G#protein_family_or_group_E xxx G#protein_family_or_group_E

We NE Xx NE
have NE xxx NE
identified NE xxx NE
and NE xxx NE
characterized NE xxx NE
a NE x NE
novel NE xxx NE
serine NE xxx NE
/threonine NE /xxx NE
kinase NE xxx NE
that NE xxx NE
phosphorylated NE xxx NE
the NE xxx NE
proto-oncogene NE xxx-xxx NE
product NE xxx NE
, NE , NE
c-Fos NE x-Xxx NE
, NE , NE
and NE xxx NE
is NE xx NE
termed NE xxx NE
Fos NE Xxx NE
kinase NE xxx NE
. NE . NE

Fos G#protein_molecule_B Xxx G#protein_molecule_B
kinase G#protein_molecule_E xxx G#protein_molecule_E
was NE xxx NE
rapidly NE xxx NE
activated NE xxx NE
after NE xxx NE
ligation NE xxx NE
of NE xx NE
the NE xxx NE
CD3 G#protein_molecule_B XXd G#protein_molecule_B
receptor G#protein_molecule_M xxx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
CD2 G#protein_molecule_M XXd G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
Jurkat G#cell_line Xxxx G#cell_line
and NE xxx NE
normal G#cell_type_B xxx G#cell_type_B
human G#cell_type_M xxx G#cell_type_M
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
and NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
IL-6 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
anti-IgM G#protein_family_or_group xxx-XxX G#protein_family_or_group
in NE xx NE
the NE xxx NE
human G#cell_line_B xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
AF10 NE XXdd NE
and NE xxx NE
Ramos G#cell_line Xxxx G#cell_line
, NE , NE
respectively NE xxx NE
. NE . NE

The NE Xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
PMA G#other_organic_compound XXX G#other_organic_compound
, NE , NE
was NE xxx NE
also NE xxx NE
a NE x NE
potent NE xxx NE
inducer NE xxx NE
of NE xx NE
Fos G#protein_molecule_B Xxx G#protein_molecule_B
kinase G#protein_molecule_E xxx G#protein_molecule_E
activity NE xxx NE
in NE xx NE
all NE xxx NE
of NE xx NE
the NE xxx NE
above NE xxx NE
populations NE xxx NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
PKC G#protein_molecule XXX G#protein_molecule
plays NE xxx NE
a NE x NE
role NE xxx NE
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
this NE xxx NE
enzyme G#protein_family_or_group xxx G#protein_family_or_group
. NE . NE

Fos G#protein_molecule_B Xxx G#protein_molecule_B
kinase G#protein_molecule_E xxx G#protein_molecule_E
phosphorylates NE xxx NE
c-Fos G#protein_molecule x-Xxx G#protein_molecule
at NE xx NE
a NE x NE
site NE xxx NE
near NE xxx NE
the NE xxx NE
C-terminus G#protein_domain_or_region X-xxx G#protein_domain_or_region
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
a NE x NE
peptide NE xxx NE
derived NE xxx NE
from NE xxx NE
this NE xxx NE
region NE xxx NE
( NE ( NE
residues G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
359-370 G#protein_domain_or_region_E ddd-ddd G#protein_domain_or_region_E
, NE , NE
RKGSSSNEPSSD G#protein_domain_or_region XXXXXXXXXXXX G#protein_domain_or_region
) NE ) NE
, NE , NE
and NE xxx NE
Fos G#peptide_B Xxx G#peptide_B
peptide G#peptide_E xxx G#peptide_E
competitively NE xxx NE
inhibited NE xxx NE
c-Fos G#protein_molecule x-Xxx G#protein_molecule
phosphorylation NE xxx NE
. NE . NE

Fos G#protein_molecule_B Xxx G#protein_molecule_B
kinase G#protein_molecule_E xxx G#protein_molecule_E
was NE xxx NE
shown NE xxx NE
to NE xx NE
be NE xx NE
distinct NE xxx NE
from NE xxx NE
other NE xxx NE
identified NE xxx NE
serine NE xxx NE
/threonine NE /xxx NE
kinases NE xxx NE
, NE , NE
including NE xxx NE
protein NE xxx NE
kinase NE xxx NE
A NE X NE
, NE , NE
protein NE xxx NE
kinase NE xxx NE
C NE X NE
, NE , NE
casein NE xxx NE
kinase NE xxx NE
II NE XX NE
, NE , NE
MAP NE XXX NE
kinases NE xxx NE
, NE , NE
p70S6K NE xddXdX NE
and NE xxx NE
p90RSK NE xddXXX NE
. NE . NE

Fos G#protein_molecule_B Xxx G#protein_molecule_B
kinase G#protein_molecule_E xxx G#protein_molecule_E
was NE xxx NE
purified NE xxx NE
by NE xx NE
anion G#other_name_B xxx G#other_name_B
exchange G#other_name_M xxx G#other_name_M
chromatography G#other_name_E xxx G#other_name_E
and NE xxx NE
exhibited NE xxx NE
an NE xx NE
apparent NE xxx NE
M(r) NE X(x) NE
= NE = NE
65,000 NE dd,ddd NE
and NE xxx NE
isoelectric NE xxx NE
point NE xxx NE
= NE = NE
6.1 NE d.d NE
. NE . NE

Fos G#protein_molecule_B Xxx G#protein_molecule_B
kinase G#protein_molecule_E xxx G#protein_molecule_E
may NE xxx NE
play NE xxx NE
a NE x NE
role NE xxx NE
in NE xx NE
transcriptional G#other_name_B xxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
through NE xxx NE
its NE xxx NE
capacity NE xxx NE
to NE xx NE
phosphorylate NE xxx NE
c-Fos G#protein_molecule x-Xxx G#protein_molecule
at NE xx NE
a NE x NE
site NE xxx NE
required NE xxx NE
for NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
transrepressive G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
of NE xx NE
this NE xxx NE
molecule NE xxx NE
. NE . NE

Moreover NE Xxxx NE
, NE , NE
its NE xxx NE
rapid NE xxx NE
activation NE xxx NE
suggests NE xxx NE
it NE xx NE
may NE xxx NE
have NE xxx NE
a NE x NE
wider NE xxx NE
role NE xxx NE
within NE xxx NE
signal G#other_name_B xxx G#other_name_B
transduction G#other_name_M xxx G#other_name_M
cascades G#other_name_E xxx G#other_name_E
in NE xx NE
lymphocytes G#cell_type xxx G#cell_type
. NE . NE

Antigenic NE Xxxx NE
specificities NE xxx NE
of NE xx NE
human NE xxx NE
CD4+ NE XXd+ NE
T-cell NE X-xxx NE
clones NE xxx NE
recovered NE xxx NE
from NE xxx NE
recurrent NE xxx NE
genital NE xxx NE
herpes NE xxx NE
simplex NE xxx NE
virus NE xxx NE
type NE xxx NE
2 NE d NE
lesions NE xxx NE
. NE . NE

Lesions NE Xxxx NE
resulting NE xxx NE
from NE xxx NE
recurrent NE xxx NE
genital NE xxx NE
herpes NE xxx NE
simplex NE xxx NE
virus NE xxx NE
( NE ( NE
HSV NE XXX NE
) NE ) NE
infection NE xxx NE
are NE xxx NE
characterized NE xxx NE
by NE xx NE
infiltration NE xxx NE
of NE xx NE
CD4+ NE XXd+ NE
lymphocytes NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
investigated NE xxx NE
the NE xxx NE
antigenic G#other_name_B xxx G#other_name_B
specificity G#other_name_E xxx G#other_name_E
of NE xx NE
47 NE dd NE
HSV-specific G#cell_line_B XXX-xxx G#cell_line_B
CD4+ G#cell_line_M XXd+ G#cell_line_M
T-cell G#cell_line_M X-xxx G#cell_line_M
clones G#cell_line_E xxx G#cell_line_E
recovered NE xxx NE
from NE xxx NE
the NE xxx NE
HSV-2 G#other_name_B XXX-d G#other_name_B
buttock G#other_name_M xxx G#other_name_M
lesion G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
HSV-2 G#other_name_M XXX-d G#other_name_M
thigh G#other_name_M xxx G#other_name_M
lesion G#other_name_E xxx G#other_name_E
of NE xx NE
five NE xxx NE
patients G#multi_cell xxx G#multi_cell
. NE . NE

Clones NE Xxxx NE
with NE xxx NE
proliferative G#other_name_B xxx G#other_name_B
responses G#other_name_E xxx G#other_name_E
to NE xx NE
recombinant G#protein_molecule_B xxx G#protein_molecule_B
truncated G#protein_molecule_M xxx G#protein_molecule_M
glycoprotein G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
gB G#protein_molecule xX G#protein_molecule
) NE ) NE
or NE xx NE
gD G#protein_molecule xX G#protein_molecule
of NE xx NE
HSV-2 G#virus XXX-d G#virus
or NE xx NE
purified NE xxx NE
natural NE xxx NE
gC NE xX NE
of NE xx NE
HSV-2 G#virus XXX-d G#virus
comprised NE xxx NE
a NE x NE
minority NE xxx NE
of NE xx NE
the NE xxx NE
total NE xxx NE
number NE xxx NE
of NE xx NE
HSV-specific G#cell_line_B XXX-xxx G#cell_line_B
clones G#cell_line_E xxx G#cell_line_E
isolated NE xxx NE
from NE xxx NE
lesions G#other_name xxx G#other_name
. NE . NE

The NE Xxx NE
gC2-specific G#cell_line_B xXd-xxx G#cell_line_B
CD4+ G#cell_line_M XXd+ G#cell_line_M
clone G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
gD2-specific G#cell_line_M xXd-xxx G#cell_line_M
CD4+ G#cell_line_M XXd+ G#cell_line_M
clone G#cell_line_E xxx G#cell_line_E
had NE xxx NE
cytotoxic G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
approximate NE xxx NE
locations NE xxx NE
of NE xx NE
the NE xxx NE
HSV-2 G#virus XXX-d G#virus
genes NE xxx NE
encoding NE xxx NE
HSV-2 G#virus XXX-d G#virus
type-specific NE xxx-xxx NE
CD4+ G#protein_molecule_B XXd+ G#protein_molecule_B
antigens G#protein_molecule_E xxx G#protein_molecule_E
have NE xxx NE
been NE xxx NE
determined NE xxx NE
by NE xx NE
using NE xxx NE
HSV-1 G#virus_B XXX-d G#virus_B
x G#virus_M x G#virus_M
HSV-2 G#virus_M XXX-d G#virus_M
intertypic G#virus_M xxx G#virus_M
recombinant G#virus_M xxx G#virus_M
virus G#virus_E xxx G#virus_E
and NE xxx NE
include NE xxx NE
the NE xxx NE
approximate NE xxx NE
map NE xxx NE
regions NE xxx NE
0.30 NE d.dd NE
to NE xx NE
0.46 NE d.dd NE
, NE , NE
0.59 NE d.dd NE
to NE xx NE
0.67 NE d.dd NE
, NE , NE
0.67 NE d.dd NE
to NE xx NE
0.73 NE d.dd NE
, NE , NE
and NE xxx NE
0.82 NE d.dd NE
to NE xx NE
1.0 NE d.d NE
units NE xxx NE
. NE . NE

The NE Xxx NE
antigenic G#other_name_B xxx G#other_name_B
specificity G#other_name_E xxx G#other_name_E
of NE xx NE
an NE xx NE
HLA G#cell_line_B XXX G#cell_line_B
DQ2-restricted, G#cell_line_M XXd-xxx, G#cell_line_M
HSV-2 G#cell_line_M XXX-d G#cell_line_M
type-specific G#cell_line_M xxx-xxx G#cell_line_M
T-cell G#cell_line_M X-xxx G#cell_line_M
clone G#cell_line_E xxx G#cell_line_E
was NE xxx NE
mapped NE xxx NE
to NE xx NE
amino NE xxx NE
acids NE xxx NE
425 NE ddd NE
to NE xx NE
444 NE ddd NE
of NE xx NE
VP16 NE XXdd NE
of NE xx NE
HSV-2 NE XXX-d NE
by NE xx NE
sequential NE xxx NE
use NE xxx NE
of NE xx NE
an NE xx NE
intertypic NE xxx NE
recombinant NE xxx NE
virus NE xxx NE
containing NE xxx NE
VP16 NE XXdd NE
of NE xx NE
HSV-2 NE XXX-d NE
in NE xx NE
an NE xx NE
HSV-1 NE XXX-d NE
background NE xxx NE
, NE , NE
recombinant NE xxx NE
VP16 NE XXdd NE
fusion NE xxx NE
proteins NE xxx NE
, NE , NE
and NE xxx NE
synthetic NE xxx NE
peptides NE xxx NE
. NE . NE

Each NE Xxxx NE
of NE xx NE
the NE xxx NE
remaining NE xxx NE
four NE xxx NE
patients G#multi_cell xxx G#multi_cell
also NE xxx NE
yielded NE xxx NE
at NE xx NE
least NE xxx NE
one NE xxx NE
type-specific G#cell_line_B xxx-xxx G#cell_line_B
T-cell G#cell_line_M X-xxx G#cell_line_M
clone G#cell_line_E xxx G#cell_line_E
reactive NE xxx NE
with NE xxx NE
an NE xx NE
HSV-2 G#virus XXX-d G#virus
epitope NE xxx NE
mapping NE xxx NE
to NE xx NE
approximately NE xxx NE
0.67 G#other_name_B d.dd G#other_name_B
to G#other_name_M xx G#other_name_M
0.73 G#other_name_M d.dd G#other_name_M
map G#other_name_M xxx G#other_name_M
units G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
antigenic NE xxx NE
specificities NE xxx NE
of NE xx NE
lesion-derived G#cell_line_B xxx-xxx G#cell_line_B
CD4+ G#cell_line_M XXd+ G#cell_line_M
T-cell G#cell_line_M X-xxx G#cell_line_M
clones G#cell_line_E xxx G#cell_line_E
are NE xxx NE
quite NE xxx NE
diverse NE xxx NE
and NE xxx NE
include NE xxx NE
at NE xx NE
least NE xxx NE
10 NE dd NE
epitopes NE xxx NE
. NE . NE

Human G#cell_line_B Xxxx G#cell_line_B
T-cell G#cell_line_M X-xxx G#cell_line_M
clones G#cell_line_E xxx G#cell_line_E
reactive NE xxx NE
with NE xxx NE
gC G#protein_molecule xX G#protein_molecule
and NE xxx NE
VP16 G#protein_molecule XXdd G#protein_molecule
are NE xxx NE
reported NE xxx NE
here NE xxx NE
for NE xxx NE
the NE xxx NE
first NE xxx NE
time NE xxx NE
. NE . NE

Marked G#other_name_B Xxxx G#other_name_B
basophilia G#other_name_E xxx G#other_name_E
in NE xx NE
acute G#other_name_B xxx G#other_name_B
promyelocytic G#other_name_M xxx G#other_name_M
leukaemia G#other_name_E xxx G#other_name_E
treated NE xxx NE
with NE xxx NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
retinoic G#other_organic_compound_M xxx G#other_organic_compound_M
acid G#other_organic_compound_E xxx G#other_organic_compound_E
: NE : NE
molecular NE xxx NE
analysis NE xxx NE
of NE xx NE
the NE xxx NE
cell NE xxx NE
origin NE xxx NE
of NE xx NE
the NE xxx NE
basophils G#cell_type xxx G#cell_type
. NE . NE

We NE Xx NE
report NE xxx NE
a NE x NE
patient G#multi_cell xxx G#multi_cell
with NE xxx NE
acute G#other_name_B xxx G#other_name_B
promyelocytic G#other_name_M xxx G#other_name_M
leukaemia G#other_name_E xxx G#other_name_E
who NE xxx NE
developed NE xxx NE
marked NE xxx NE
basophilia NE xxx NE
during NE xxx NE
all-trans G#other_name_B xxx-xxx G#other_name_B
retinoic G#other_name_M xxx G#other_name_M
acid G#other_name_M xxx G#other_name_M
treatment G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
studied NE xxx NE
genomic G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
DNA G#DNA_family_or_group_E XXX G#DNA_family_or_group_E
and NE xxx NE
RNA G#RNA_N/A XXX G#RNA_N/A
extracted NE xxx NE
from NE xxx NE
the NE xxx NE
patient's NE xxx'x NE
peripheral G#cell_type_B xxx G#cell_type_B
leucocytes G#cell_type_E xxx G#cell_type_E
in NE xx NE
order NE xxx NE
to NE xx NE
determine NE xxx NE
the NE xxx NE
origin NE xxx NE
of NE xx NE
the NE xxx NE
basophils G#cell_type xxx G#cell_type
. NE . NE

The NE Xxx NE
RAR G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
rearranged NE xxx NE
band NE xxx NE
in NE xx NE
the NE xxx NE
Southern G#other_name_B Xxxx G#other_name_B
blot G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
and NE xxx NE
a NE x NE
chimaeric G#protein_family_or_group_B xxx G#protein_family_or_group_B
product G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
PML-RAR G#protein_molecule_B XXX-XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
by NE xx NE
polymerase G#other_name_B xxx G#other_name_B
chain G#other_name_M xxx G#other_name_M
reaction G#other_name_E xxx G#other_name_E
were NE xxx NE
strongly NE xxx NE
visible NE xxx NE
before NE xxx NE
ATRA G#other_name_B XXXX G#other_name_B
treatment G#other_name_E xxx G#other_name_E
, NE , NE
but NE xxx NE
at NE xx NE
the NE xxx NE
time NE xxx NE
of NE xx NE
maximal G#other_name_B xxx G#other_name_B
basophilia G#other_name_E xxx G#other_name_E
both NE xxx NE
of NE xx NE
them NE xxx NE
were NE xxx NE
markedly NE xxx NE
diminished NE xxx NE
. NE . NE

These NE Xxxx NE
findings NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
basophils G#cell_type xxx G#cell_type
which NE xxx NE
appeared NE xxx NE
during NE xxx NE
the NE xxx NE
ATRA G#other_name_B XXXX G#other_name_B
treatment G#other_name_E xxx G#other_name_E
are NE xxx NE
reactive NE xxx NE
in NE xx NE
nature NE xxx NE
rather NE xxx NE
than NE xxx NE
a NE x NE
leukaemic G#cell_line_B xxx G#cell_line_B
clone G#cell_line_E xxx G#cell_line_E
. NE . NE

Activation NE Xxxx NE
of NE xx NE
the NE xxx NE
interleukin G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
6 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
by NE xx NE
Mycobacterium G#mono_cell_B Xxxx G#mono_cell_B
tuberculosis G#mono_cell_E xxx G#mono_cell_E
or NE xx NE
lipopolysaccharide G#lipid xxx G#lipid
is NE xx NE
mediated NE xxx NE
by NE xx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factors G#protein_molecule_M xxx G#protein_molecule_M
NF-IL6 G#protein_molecule_E XX-XXd G#protein_molecule_E
and NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
[published NE [xxx NE
erratum NE xxx NE
appears NE xxx NE
in NE xx NE
Proc NE Xxxx NE
Natl NE Xxxx NE
Acad NE Xxxx NE
Sci NE Xxx NE
U NE X NE
S NE X NE
A NE X NE
1995 NE dddd NE
Apr NE Xxx NE
11;92(8):3632] NE dd;dd(d):dddd] NE

The NE Xxx NE
host NE xxx NE
response NE xxx NE
to NE xx NE
Mycobacterium G#mono_cell_B Xxxx G#mono_cell_B
tuberculosis G#mono_cell_E xxx G#mono_cell_E
includes NE xxx NE
granuloma G#other_name_B xxx G#other_name_B
formation G#other_name_E xxx G#other_name_E
at NE xx NE
sites NE xxx NE
of NE xx NE
infection NE xxx NE
and NE xxx NE
systemic G#other_name_B xxx G#other_name_B
symptoms G#other_name_E xxx G#other_name_E
. NE . NE

Cytokines G#protein_family_or_group Xxxx G#protein_family_or_group
have NE xxx NE
been NE xxx NE
identified NE xxx NE
by NE xx NE
immunohistochemistry G#other_name xxx G#other_name
in NE xx NE
granulomas NE xxx NE
in NE xx NE
animal NE xxx NE
models NE xxx NE
of NE xx NE
bacillus G#other_name_B xxx G#other_name_B
Calmette-Guerin G#other_name_M Xxxx-Xxxx G#other_name_M
(BCG) G#other_name_M (XXX) G#other_name_M
infection G#other_name_E xxx G#other_name_E
and NE xxx NE
are NE xxx NE
released NE xxx NE
by NE xx NE
mononuclear G#cell_type_B xxx G#cell_type_B
phagocytes G#cell_type_E xxx G#cell_type_E
upon NE xxx NE
stimulation NE xxx NE
by NE xx NE
mycobacterial NE xxx NE
proteins NE xxx NE
. NE . NE

In NE Xx NE
this NE xxx NE
regard NE xxx NE
, NE , NE
the NE xxx NE
cytokine G#protein_family_or_group xxx G#protein_family_or_group
interleukin G#protein_molecule_B xxx G#protein_molecule_B
6 G#protein_molecule_E d G#protein_molecule_E
( NE ( NE
IL-6 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
may NE xxx NE
play NE xxx NE
a NE x NE
role NE xxx NE
in NE xx NE
the NE xxx NE
clinical NE xxx NE
manifestations NE xxx NE
and NE xxx NE
pathological NE xxx NE
events NE xxx NE
of NE xx NE
tuberculosis G#protein_N/A_B xxx G#protein_N/A_B
infection G#protein_N/A_E xxx G#protein_N/A_E
. NE . NE

We NE Xx NE
have NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
lipoarabinomannan G#protein_molecule xxx G#protein_molecule
( NE ( NE
LAM G#protein_molecule XXX G#protein_molecule
) NE ) NE
from NE xxx NE
the NE xxx NE
mycobacterial NE xxx NE
cell NE xxx NE
wall NE xxx NE
, NE , NE
which NE xxx NE
was NE xxx NE
virtually NE xxx NE
devoid NE xxx NE
of NE xx NE
lipopolysaccharide G#lipid xxx G#lipid
( NE ( NE
LPS G#lipid XXX G#lipid
) NE ) NE
, NE , NE
stimulated NE xxx NE
mononuclear G#cell_type_B xxx G#cell_type_B
phagocytes G#cell_type_E xxx G#cell_type_E
to NE xx NE
release NE xxx NE
IL-6 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
a NE x NE
dose-response G#other_name_B xxx-xxx G#other_name_B
manner G#other_name_E xxx G#other_name_E
. NE . NE

LAM G#protein_molecule XXX G#protein_molecule
and NE xxx NE
LPS G#lipid XXX G#lipid
were NE xxx NE
potent NE xxx NE
inducers NE xxx NE
of NE xx NE
IL-6 G#other_name_B XX-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
monocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

Both NE Xxxx NE
LAM G#protein_molecule XXX G#protein_molecule
-and NE -xxx NE
LPS NE XXX NE
-inducible NE -xxx NE
IL-6 NE XX-d NE
promoter NE xxx NE
activity NE xxx NE
was NE xxx NE
localized NE xxx NE
to NE xx NE
a NE x NE
DNA NE XXX NE
fragment NE xxx NE
, NE , NE
positions NE xxx NE
-158 NE -ddd NE
to NE xx NE
-49 NE -dd NE
, NE , NE
by NE xx NE
deletion NE xxx NE
analysis NE xxx NE
and NE xxx NE
chloramphenicol NE xxx NE
acetyltransferase NE xxx NE
assay NE xxx NE
. NE . NE

Two NE Xxx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
NF-IL6 G#protein_molecule_E XX-XXd G#protein_molecule_E
(positions NE (xxx NE
-153 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-145 G#DNA_domain_or_region_E -ddd G#DNA_domain_or_region_E
and NE xxx NE
-83 NE -dd NE
to NE xx NE
-75) NE -dd) NE
and NE xxx NE
one NE xxx NE
nuclear G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
factor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
NF-kappa G#DNA_domain_or_region_M XX-xxx G#DNA_domain_or_region_M
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
(positions G#DNA_domain_or_region_M (xxx G#DNA_domain_or_region_M
-72 G#DNA_domain_or_region_M -dd G#DNA_domain_or_region_M
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-63) G#DNA_domain_or_region_M -dd) G#DNA_domain_or_region_M
motifs G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
are NE xxx NE
present NE xxx NE
within NE xxx NE
this NE xxx NE
fragment NE xxx NE
. NE . NE

Site-directed G#other_name_B Xxxx-xxx G#other_name_B
mutagenesis G#other_name_E xxx G#other_name_E
of NE xx NE
one NE xxx NE
or NE xx NE
more NE xxx NE
of NE xx NE
these NE xxx NE
motifs NE xxx NE
within NE xxx NE
the NE xxx NE
IL-6 G#protein_molecule XX-d G#protein_molecule
promoter NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
each NE xxx NE
has NE xxx NE
positive G#other_name_B xxx G#other_name_B
regulatory G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
and NE xxx NE
that NE xxx NE
they NE xxx NE
could NE xxx NE
act NE xxx NE
in NE xx NE
a NE x NE
function- NE xxx- NE
and NE xxx NE
orientation-independent G#other_name_B xxx-xxx G#other_name_B
manner G#other_name_E xxx G#other_name_E
. NE . NE

Deletion NE Xxxx NE
of NE xx NE
all NE xxx NE
three NE xxx NE
elements NE xxx NE
abolished NE xxx NE
inducibility NE xxx NE
of NE xx NE
IL-6 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
activity NE xxx NE
by NE xx NE
both NE xxx NE
LAM G#protein_molecule XXX G#protein_molecule
and NE xxx NE
LPS G#lipid XXX G#lipid
. NE . NE

We NE Xx NE
conclude NE xxx NE
that NE xxx NE
the NE xxx NE
NF-IL6 G#DNA_domain_or_region_B XX-XXd G#DNA_domain_or_region_B
site G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
NF-kappa G#DNA_domain_or_region_M XX-xxx G#DNA_domain_or_region_M
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
mediate NE xxx NE
IL-6 G#other_name_B XX-d G#other_name_B
induction G#other_name_E xxx G#other_name_E
in NE xx NE
response NE xxx NE
to NE xx NE
both NE xxx NE
LPS G#lipid XXX G#lipid
and NE xxx NE
LAM G#protein_molecule XXX G#protein_molecule
, NE , NE
acting NE xxx NE
as NE xx NE
bacterial G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
response G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
or G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
mycobacterial G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
response G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E

Regulation NE Xxxx NE
of NE xx NE
CD14 G#other_name_B XXdd G#other_name_B
expression G#other_name_E xxx G#other_name_E
during NE xxx NE
monocytic G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
induced NE xxx NE
with NE xxx NE
1 G#lipid_B d G#lipid_B
alpha,25-dihydroxyvitamin G#lipid_M xxx,dd-xxx G#lipid_M
D3 G#lipid_E Xd G#lipid_E
. NE . NE

CD14 G#protein_molecule XXdd G#protein_molecule
, NE , NE
a NE x NE
monocyte/macrophage G#protein_family_or_group_B xxx/xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
for NE xxx NE
the NE xxx NE
complex NE xxx NE
of NE xx NE
LPS G#lipid XXX G#lipid
and NE xxx NE
LPS G#protein_family_or_group_B XXX G#protein_family_or_group_B
binding G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
is NE xx NE
a NE x NE
differentiation NE xxx NE
marker NE xxx NE
for NE xxx NE
the NE xxx NE
monocyte/macrophage G#cell_type_B xxx/xxx G#cell_type_B
lineage G#cell_type_E xxx G#cell_type_E
. NE . NE

We NE Xx NE
have NE xxx NE
analyzed NE xxx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
CD14 G#other_name_B XXdd G#other_name_B
expression G#other_name_E xxx G#other_name_E
during NE xxx NE
1 G#lipid_B d G#lipid_B
alpha,25-dihydroxyvitamin G#lipid_M xxx,dd-xxx G#lipid_M
D3 G#lipid_E Xd G#lipid_E
(VitD3)-induced NE (XxxXd)-xxx NE
monocytic G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

Using NE Xxxx NE
FACS G#other_name XXXX G#other_name
, NE , NE
Northern G#other_name_B Xxxx G#other_name_B
blotting G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
nuclear NE xxx NE
run-on NE xxx-xx NE
analyses NE xxx NE
, NE , NE
we NE xx NE
demonstrate NE xxx NE
that NE xxx NE
the NE xxx NE
up-regulation NE xx-xxx NE
of NE xx NE
CD14 NE XXdd NE
expression NE xxx NE
during NE xxx NE
monocytic NE xxx NE
cell NE xxx NE
maturation NE xxx NE
is NE xx NE
regulated NE xxx NE
mainly NE xxx NE
at NE xx NE
the NE xxx NE
level NE xxx NE
of NE xx NE
gene NE xxx NE
transcription NE xxx NE
, NE , NE
and NE xxx NE
that NE xxx NE
new NE xxx NE
protein NE xxx NE
synthesis NE xxx NE
is NE xx NE
required NE xxx NE
for NE xxx NE
CD14 NE XXdd NE
induction NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
recently NE xxx NE
cloned NE xxx NE
the NE xxx NE
CD14 G#DNA_domain_or_region_B XXdd G#DNA_domain_or_region_B
5' G#DNA_domain_or_region_M d' G#DNA_domain_or_region_M
upstream G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
demonstrated NE xxx NE
its NE xxx NE
tissue-specific G#other_name_B xxx-xxx G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
. NE . NE

Using NE Xxxx NE
stable NE xxx NE
transfection NE xxx NE
of NE xx NE
the NE xxx NE
monocytoid G#cell_line_B xxx G#cell_line_B
U937 G#cell_line_M Xddd G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
with NE xxx NE
a NE x NE
series NE xxx NE
of NE xx NE
deletion NE xxx NE
mutants NE xxx NE
of NE xx NE
the NE xxx NE
CD14 G#DNA_domain_or_region_B XXdd G#DNA_domain_or_region_B
5' G#DNA_domain_or_region_M d' G#DNA_domain_or_region_M
upstream G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
coupled NE xxx NE
to NE xx NE
a NE x NE
reporter NE xxx NE
gene NE xxx NE
construct NE xxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
bp G#DNA_domain_or_region_B xx G#DNA_domain_or_region_B
-128 G#DNA_domain_or_region_M -ddd G#DNA_domain_or_region_M
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-70 G#DNA_domain_or_region_E -dd G#DNA_domain_or_region_E
is NE xx NE
the NE xxx NE
critical NE xxx NE
region NE xxx NE
for NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
CD14 G#other_name_B XXdd G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

This NE Xxxx NE
region NE xxx NE
contains NE xxx NE
two NE xxx NE
binding G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
the NE xxx NE
Sp1 G#protein_molecule_B Xxd G#protein_molecule_B
transcription G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

A NE X NE
3-bp NE d-xx NE
mutation NE xxx NE
at NE xx NE
the NE xxx NE
distal NE xxx NE
Sp1-binding G#DNA_domain_or_region_B Xxd-xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
not NE xxx NE
only NE xxx NE
eliminates NE xxx NE
Sp1 G#other_name_B Xxd G#other_name_B
interaction G#other_name_E xxx G#other_name_E
, NE , NE
but NE xxx NE
also NE xxx NE
abolishes NE xxx NE
most NE xxx NE
of NE xx NE
the NE xxx NE
VitD3 NE XxxXd NE
induction NE xxx NE
of NE xx NE
CD14 G#other_name_B XXdd G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

Electrophoretic G#other_name_B Xxxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
does NE xxx NE
not NE xxx NE
detect NE xxx NE
a NE x NE
direct NE xxx NE
interaction NE xxx NE
of NE xx NE
the NE xxx NE
CD14 G#protein_molecule XXdd G#protein_molecule
distal NE xxx NE
Sp1-binding G#DNA_domain_or_region_B Xxd-xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
with NE xxx NE
the NE xxx NE
vitamin G#protein_family_or_group_B xxx G#protein_family_or_group_B
D3 G#protein_family_or_group_M Xd G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
its NE xxx NE
partner NE xxx NE
, NE , NE
the NE xxx NE
retinoid G#protein_molecule_B xxx G#protein_molecule_B
X G#protein_molecule_M X G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

These NE Xxxx NE
data NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
VitD3 G#lipid XxxXd G#lipid
induces NE xxx NE
CD14 G#protein_molecule XXdd G#protein_molecule
indirectly NE xxx NE
through NE xxx NE
some NE xxx NE
intermediary G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
and NE xxx NE
suggest NE xxx NE
a NE x NE
critical NE xxx NE
role NE xxx NE
for NE xxx NE
Sp1 G#protein_molecule Xxd G#protein_molecule
in NE xx NE
this NE xxx NE
process NE xxx NE
. NE . NE

DNA-binding NE XXX-xxx NE
and NE xxx NE
transcriptional NE xxx NE
regulatory NE xxx NE
properties NE xxx NE
of NE xx NE
hepatic NE xxx NE
leukemia NE xxx NE
factor NE xxx NE
( NE ( NE
HLF NE XXX NE
) NE ) NE
and NE xxx NE
the NE xxx NE
t(17;19) NE x(dd;dd) NE
acute NE xxx NE
lymphoblastic NE xxx NE
leukemia NE xxx NE
chimera NE xxx NE
E2A- NE XdX- NE
HLF NE XXX NE
. NE . NE

The NE Xxx NE
t(17;19) G#other_name_B x(dd;dd) G#other_name_B
translocation G#other_name_E xxx G#other_name_E
in NE xx NE
acute G#other_name_B xxx G#other_name_B
lymphoblastic G#other_name_M xxx G#other_name_M
leukemias G#other_name_E xxx G#other_name_E
results NE xxx NE
in NE xx NE
creation NE xxx NE
of NE xx NE
E2A- NE XdX- NE
hepatic NE xxx NE
leukemia NE xxx NE
factor NE xxx NE
( NE ( NE
HLF NE XXX NE
) NE ) NE
chimeric NE xxx NE
proteins NE xxx NE
that NE xxx NE
contain NE xxx NE
the NE xxx NE
DNA-binding NE XXX-xxx NE
and NE xxx NE
protein NE xxx NE
dimerization NE xxx NE
domains NE xxx NE
of NE xx NE
the NE xxx NE
basic NE xxx NE
leucine NE xxx NE
zipper NE xxx NE
(bZIP) NE (xXXX) NE
protein NE xxx NE
HLF NE XXX NE
fused NE xxx NE
to NE xx NE
a NE x NE
portion NE xxx NE
of NE xx NE
E2A NE XdX NE
proteins NE xxx NE
with NE xxx NE
transcriptional NE xxx NE
activation NE xxx NE
properties NE xxx NE
. NE . NE

An NE Xx NE
in G#other_name_B xx G#other_name_B
vitro G#other_name_M xxx G#other_name_M
binding G#other_name_M xxx G#other_name_M
site G#other_name_M xxx G#other_name_M
selection G#other_name_M xxx G#other_name_M
procedure G#other_name_E xxx G#other_name_E
was NE xxx NE
used NE xxx NE
to NE xx NE
determine NE xxx NE
DNA NE XXX NE
sequences NE xxx NE
preferentially NE xxx NE
bound NE xxx NE
by NE xx NE
wild-type G#protein_molecule_B xxx-xxx G#protein_molecule_B
HLF G#protein_molecule_E XXX G#protein_molecule_E
and NE xxx NE
chimeric NE xxx NE
E2A- NE XdX- NE
HLF NE XXX NE
proteins NE xxx NE
isolated NE xxx NE
from NE xxx NE
various NE xxx NE
t(17;19)-bearing NE x(dd;dd)-xxx NE
leukemias NE xxx NE
. NE . NE

All NE Xxx NE
were NE xxx NE
found NE xxx NE
to NE xx NE
selectively NE xxx NE
bind NE xxx NE
the NE xxx NE
consensus G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
5'-GTTACGTAAT-3' G#polynucleotide d'-XXXXXXXXXX-d' G#polynucleotide
with NE xxx NE
high NE xxx NE
affinity NE xxx NE
. NE . NE

Wild-type NE Xxxx-xxx NE
and NE xxx NE
chimeric G#protein_family_or_group_B xxx G#protein_family_or_group_B
HLF G#protein_family_or_group_M XXX G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
also NE xxx NE
bound NE xxx NE
closely NE xxx NE
related NE xxx NE
sites NE xxx NE
identified NE xxx NE
previously NE xxx NE
for NE xxx NE
bZIP G#protein_family_or_group_B xXXX G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
both NE xxx NE
the NE xxx NE
proline NE xxx NE
-and NE -xxx NE
acidic NE xxx NE
amino NE xxx NE
acid-rich NE xxx-xxx NE
( NE ( NE
PAR NE XXX NE
) NE ) NE
and NE xxx NE
C/EBP NE X/XXX NE
subfamilies NE xxx NE
; NE ; NE
however NE xxx NE
, NE , NE
E2A- NE XdX- NE
HLF NE XXX NE
proteins NE xxx NE
were NE xxx NE
significantly NE xxx NE
less NE xxx NE
tolerant NE xxx NE
of NE xx NE
certain NE xxx NE
deviations NE xxx NE
from NE xxx NE
the NE xxx NE
HLF NE XXX NE
consensus NE xxx NE
binding NE xxx NE
site NE xxx NE
. NE . NE

These NE Xxxx NE
differences NE xxx NE
were NE xxx NE
directly NE xxx NE
attributable NE xxx NE
to NE xx NE
loss NE xxx NE
of NE xx NE
an NE xx NE
HLF G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
ancillary G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
DNA-binding G#DNA_domain_or_region_M XXX-xxx G#DNA_domain_or_region_M
domain G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
all NE xxx NE
E2A- NE XdX- NE
HLF NE XXX NE
chimeras NE xxx NE
and NE xxx NE
were NE xxx NE
further NE xxx NE
exacerbated NE xxx NE
by NE xx NE
a NE x NE
zipper NE xxx NE
mutation NE xxx NE
in NE xx NE
one NE xxx NE
isolate NE xxx NE
. NE . NE

Both NE Xxxx NE
wild-type G#protein_molecule xxx-xxx G#protein_molecule
and NE xxx NE
chimeric G#protein_family_or_group_B xxx G#protein_family_or_group_B
HLF G#protein_family_or_group_M XXX G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
displayed NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
activator G#other_name_E xxx G#other_name_E
properties NE xxx NE
HLF G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
consensus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
or G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
C/EBP G#DNA_domain_or_region_M X/XXX G#DNA_domain_or_region_M
consensus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
lymphoid NE xxx NE
and NE xxx NE
lymphoid G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
nonlymphoid G#cell_type_M xxx G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E
reporter NE xxx NE
genes NE xxx NE
containing NE xxx NE
HLF NE XXX NE
or G#DNA_family_or_group xx G#DNA_family_or_group
C/EBP NE X/XXX NE
consensus NE xxx NE
binding NE xxx NE
sites NE xxx NE
. NE . NE

But NE Xxx NE
on NE xx NE
reporter G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
with NE xxx NE
nonoptimal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
their NE xxx NE
transcriptional NE xxx NE
properties NE xxx NE
diverged NE xxx NE
and NE xxx NE
E2A- NE XdX- NE
HLF NE XXX NE
competitively NE xxx NE
inhibited NE xxx NE
activation NE xxx NE
by NE xx NE
wild-type NE xxx-xxx NE
PAR NE XXX NE
proteins NE xxx NE
. NE . NE

These NE Xxxx NE
findings NE xxx NE
establish NE xxx NE
a NE x NE
spectrum NE xxx NE
of NE xx NE
binding NE xxx NE
site-specific NE xxx-xxx NE
transcriptional NE xxx NE
properties NE xxx NE
for NE xxx NE
E2A- NE XdX- NE
HLF NE XXX NE
which NE xxx NE
may NE xxx NE
preferentially NE xxx NE
activate NE xxx NE
expression NE xxx NE
of NE xx NE
select NE xxx NE
subordinate NE xxx NE
genes NE xxx NE
as NE xx NE
a NE x NE
homodimer NE xxx NE
and NE xxx NE
potentially NE xxx NE
antagonize NE xxx NE
expression NE xxx NE
of NE xx NE
others NE xxx NE
through NE xxx NE
heteromeric NE xxx NE
interactions NE xxx NE
. NE . NE

ZAP-70 G#protein_molecule_B XXX-dd G#protein_molecule_B
tyrosine G#protein_molecule_M xxx G#protein_molecule_M
kinase G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
CD45 G#protein_molecule XXdd G#protein_molecule
, NE , NE
and NE xxx NE
T G#protein_family_or_group_B X G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
involvement NE xxx NE
in NE xx NE
UV-induced G#other_name_B XX-xxx G#other_name_B
T G#other_name_M X G#other_name_M
cell G#other_name_M xxx G#other_name_M
signal G#other_name_M xxx G#other_name_M
transduction G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
H2O2-induced G#other_name_M XdXd-xxx G#other_name_M
T G#other_name_M X G#other_name_M
cell G#other_name_M xxx G#other_name_M
signal G#other_name_M xxx G#other_name_M
transduction G#other_name_E xxx G#other_name_E

Several NE Xxxx NE
mammalian NE xxx NE
responses NE xxx NE
to NE xx NE
UV G#other_name_B XX G#other_name_B
irradiation G#other_name_E xxx G#other_name_E
, NE , NE
including NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
are NE xxx NE
believed NE xxx NE
to NE xx NE
involve NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
. NE . NE

UV G#other_name_B XX G#other_name_B
irradiation G#other_name_E xxx G#other_name_E
and NE xxx NE
H2O2 G#inorganic XdXd G#inorganic
treatment NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
induce NE xxx NE
protein NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
and NE xxx NE
Ca2+ NE Xxd+ NE
signals NE xxx NE
similar NE xxx NE
to NE xx NE
those NE xxx NE
observed NE xxx NE
following NE xxx NE
biological NE xxx NE
stimulation NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
examined NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
cell NE xxx NE
surface NE xxx NE
molecules NE xxx NE
in NE xx NE
these NE xxx NE
responses NE xxx NE
. NE . NE

Normal NE Xxxx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
whose NE xxx NE
surface NE xxx NE
expression NE xxx NE
of NE xx NE
CD3 G#protein_molecule XXd G#protein_molecule
was NE xxx NE
depleted NE xxx NE
showed NE xxx NE
impaired NE xxx NE
UV-induced NE XX-xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
and NE xxx NE
Ca2+ G#other_name_B Xxd+ G#other_name_B
signals G#other_name_E xxx G#other_name_E
. NE . NE

Similarly NE Xxxx NE
, NE , NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
deficient NE xxx NE
in NE xx NE
CD3 G#other_name_B XXd G#other_name_B
expression G#other_name_M xxx G#other_name_M
or G#other_name_M xx G#other_name_M
CD45 G#other_name_M XXdd G#other_name_M
expression G#other_name_E xxx G#other_name_E
also NE xxx NE
gave NE xxx NE
impaired G#other_name_B xxx G#other_name_B
UV G#other_name_M XX G#other_name_M
responses G#other_name_E xxx G#other_name_E
. NE . NE

However NE Xxxx NE
, NE , NE
all NE xxx NE
these NE xxx NE
cell NE xxx NE
types NE xxx NE
still NE xxx NE
gave NE xxx NE
strong NE xxx NE
Ca2+ G#atom Xxd+ G#atom
and NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
responses NE xxx NE
to NE xx NE
H2O2 G#inorganic XdXd G#inorganic
. NE . NE

The NE Xxx NE
T NE X NE
cell NE xxx NE
tyrosine G#amino_acid_monomer xxx G#amino_acid_monomer
kinase G#protein_molecule_B xxx G#protein_molecule_B
ZAP-70 G#protein_molecule_E XXX-dd G#protein_molecule_E
was NE xxx NE
found NE xxx NE
to NE xx NE
be NE xx NE
highly NE xxx NE
responsive NE xxx NE
to NE xx NE
UV G#other_name XX G#other_name
and NE xxx NE
H2O2 G#inorganic XdXd G#inorganic
treatment NE xxx NE
. NE . NE

ZAP-70 G#other_name_B XXX-dd G#other_name_B
responsiveness G#other_name_E xxx G#other_name_E
to NE xx NE
UV G#other_name XX G#other_name
required NE xxx NE
expression NE xxx NE
of NE xx NE
both NE xxx NE
CD3 G#protein_molecule XXd G#protein_molecule
and NE xxx NE
CD45 G#protein_molecule XXdd G#protein_molecule
, NE , NE
whereas NE xxx NE
only NE xxx NE
CD3 G#protein_molecule XXd G#protein_molecule
was NE xxx NE
required NE xxx NE
for NE xxx NE
the NE xxx NE
response NE xxx NE
to NE xx NE
H2O2 G#inorganic XdXd G#inorganic
. NE . NE

UV NE XX NE
-induced NE -xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
was NE xxx NE
blocked NE xxx NE
by NE xx NE
CD3 NE XXd NE
depletion NE xxx NE
, NE , NE
indicating NE xxx NE
the NE xxx NE
importance NE xxx NE
of NE xx NE
such NE xxx NE
cell NE xxx NE
surface NE xxx NE
molecules NE xxx NE
in NE xx NE
biological NE xxx NE
responses NE xxx NE
to NE xx NE
UV NE XX NE
. NE . NE

In NE Xx NE
nonlymphoid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
the NE xxx NE
epidermal G#protein_family_or_group_B xxx G#protein_family_or_group_B
growth G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
displayed NE xxx NE
increased NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
within NE xxx NE
seconds NE xxx NE
of NE xx NE
UV G#other_name_B XX G#other_name_B
irradiation G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
UV NE XX NE
-induced NE -xxx NE
signal NE xxx NE
transduction NE xxx NE
is NE xx NE
mediated NE xxx NE
via NE xxx NE
cell NE xxx NE
surface NE xxx NE
receptors NE xxx NE
that NE xxx NE
normally NE xxx NE
respond NE xxx NE
to NE xx NE
biological NE xxx NE
stimulation NE xxx NE
, NE , NE
whereas NE xxx NE
H2O2 NE XdXd NE
is NE xx NE
able NE xxx NE
to NE xx NE
partially NE xxx NE
bypass NE xxx NE
this NE xxx NE
requirement NE xxx NE
. NE . NE

Inhibition NE Xxxx NE
of NE xx NE
the NE xxx NE
differentiation G#other_name xxx G#other_name
of NE xx NE
human G#cell_line_B xxx G#cell_line_B
myeloid G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
by NE xx NE
redox G#other_name_B xxx G#other_name_B
changes G#other_name_E xxx G#other_name_E
induced NE xxx NE
through NE xxx NE
glutathione G#other_name_B xxx G#other_name_B
depletion G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
have NE xxx NE
investigated NE xxx NE
the NE xxx NE
effect NE xxx NE
of NE xx NE
redox G#other_name_B xxx G#other_name_B
changes G#other_name_E xxx G#other_name_E
in NE xx NE
vivo NE xxx NE
on NE xx NE
the NE xxx NE
differentiation G#other_name xxx G#other_name
of NE xx NE
two NE xxx NE
human G#cell_line_B xxx G#cell_line_B
myeloid G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
, NE , NE
HL-60 G#cell_line XX-dd G#cell_line
and NE xxx NE
KG-1 G#cell_line XX-d G#cell_line
. NE . NE

The NE Xxx NE
glutathione G#other_organic_compound xxx G#other_organic_compound
-depleting NE -xxx NE
agent NE xxx NE
diethyl G#other_organic_compound_B xxx G#other_organic_compound_B
maleate G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
DEM G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
prevented NE xxx NE
the NE xxx NE
development NE xxx NE
of NE xx NE
differentiated NE xxx NE
features NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
esters G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
including NE xxx NE
adherence NE xxx NE
of NE xx NE
the NE xxx NE
cells NE xxx NE
to NE xx NE
plastic G#other_organic_compound_B xxx G#other_organic_compound_B
surfaces G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
repression NE xxx NE
of NE xx NE
the NE xxx NE
myeloperoxidase G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
CD34 G#DNA_domain_or_region_M XXdd G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E

Moreover NE Xxxx NE
, NE , NE
DEM G#other_organic_compound XXX G#other_organic_compound
abolished NE xxx NE
phorbol NE xxx NE
12-myristate NE dd-xxx NE
13-acetate NE dd-xxx NE
-induced NE -xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
transcription NE xxx NE
factors NE xxx NE
AP-1 NE XX-d NE
and NE xxx NE
Egr-1 NE Xxx-d NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
inhibition NE xxx NE
of NE xx NE
differentiation NE xxx NE
may NE xxx NE
be NE xx NE
due NE xxx NE
, NE , NE
at NE xx NE
least NE xxx NE
in NE xx NE
part NE xxx NE
, NE , NE
to NE xx NE
redox NE xxx NE
modifications NE xxx NE
of NE xx NE
these NE xxx NE
proteins NE xxx NE
. NE . NE

Lipopolysaccharide G#other_name_B Xxxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
of NE xx NE
tissue G#other_name_B xxx G#other_name_B
factor G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
monocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
is NE xx NE
mediated NE xxx NE
by NE xx NE
binding NE xxx NE
of NE xx NE
c-Rel/p65 G#protein_family_or_group_B x-Xxx/xdd G#protein_family_or_group_B
heterodimers G#protein_family_or_group_E xxx G#protein_family_or_group_E
to NE xx NE
a NE x NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B-like G#DNA_domain_or_region_M X-xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Exposure NE Xxxx NE
of NE xx NE
monocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
to NE xx NE
bacterial G#lipid_B xxx G#lipid_B
lipopolysaccharide G#lipid_E xxx G#lipid_E
( NE ( NE
LPS G#lipid XXX G#lipid
) NE ) NE
activates NE xxx NE
the NE xxx NE
NF-kappa G#protein_family_or_group_B XX-xxx G#protein_family_or_group_B
B G#protein_family_or_group_M X G#protein_family_or_group_M
/Rel G#protein_family_or_group_M /Xxx G#protein_family_or_group_M
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
proteins NE xxx NE
and NE xxx NE
leads NE xxx NE
to NE xx NE
the NE xxx NE
rapid NE xxx NE
induction NE xxx NE
of NE xx NE
inflammatory G#protein_family_or_group_B xxx G#protein_family_or_group_B
gene G#protein_family_or_group_M xxx G#protein_family_or_group_M
products G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
including NE xxx NE
tissue G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
TF G#protein_family_or_group XX G#protein_family_or_group
) NE ) NE
. NE . NE

TF G#protein_family_or_group XX G#protein_family_or_group
is NE xx NE
the NE xxx NE
primary NE xxx NE
cellular G#other_name_B xxx G#other_name_B
initiator G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
coagulation G#other_name_B xxx G#other_name_B
protease G#other_name_M xxx G#other_name_M
cascades G#other_name_E xxx G#other_name_E
. NE . NE

Here NE Xxxx NE
we NE xx NE
report NE xxx NE
the NE xxx NE
characterization NE xxx NE
of NE xx NE
a NE x NE
nuclear G#protein_complex_B xxx G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
from NE xxx NE
human NE xxx NE
monocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
that NE xxx NE
bound NE xxx NE
to NE xx NE
a NE x NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B-like G#DNA_domain_or_region_M X-xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
5'-CGGAGTTTCC-3' G#DNA_domain_or_region d'-XXXXXXXXXX-d' G#DNA_domain_or_region
, NE , NE
in NE xx NE
the NE xxx NE
5'-flanking G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
TF G#DNA_domain_or_region_M XX G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

This NE Xxxx NE
nuclear G#protein_complex_B xxx G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
was NE xxx NE
activated NE xxx NE
by NE xx NE
LPS G#lipid XXX G#lipid
with NE xxx NE
kinetics NE xxx NE
that NE xxx NE
preceded NE xxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
TF G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

In NE Xx NE
vitro NE xxx NE
binding NE xxx NE
studies NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
the NE xxx NE
TF G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
bound NE xxx NE
translated NE xxx NE
c-Rel G#protein_complex_B x-Xxx G#protein_complex_B
homodimer G#protein_complex_M xxx G#protein_complex_M
and G#protein_complex_M xxx G#protein_complex_M
p65 G#protein_complex_M xdd G#protein_complex_M
homodimer G#protein_complex_E xxx G#protein_complex_E
but NE xxx NE
not NE xxx NE
p50/p65 G#protein_complex_B xdd/xdd G#protein_complex_B
heterodimers G#protein_complex_E xxx G#protein_complex_E
or NE xx NE
p50 G#protein_complex_B xdd G#protein_complex_B
homodimers G#protein_complex_E xxx G#protein_complex_E
. NE . NE

Base-pair NE Xxxx-xxx NE
substitutions NE xxx NE
in NE xx NE
the NE xxx NE
TF G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
indicated NE xxx NE
that NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
a NE x NE
cytosine G#amino_acid_monomer xxx G#amino_acid_monomer
at NE xx NE
position G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
1 G#protein_domain_or_region_E d G#protein_domain_or_region_E
precluded NE xxx NE
binding NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
. NE . NE

In NE Xx NE
fact NE xxx NE
, NE , NE
under NE xxx NE
low-ionic-strength G#other_name_B xxx-xxx-xxx G#other_name_B
conditions G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
TF G#protein_complex_B XX G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
did NE xxx NE
not NE xxx NE
migrate NE xxx NE
with NE xxx NE
translated NE xxx NE
p50/p65 G#protein_complex_B xdd/xdd G#protein_complex_B
dimers G#protein_complex_E xxx G#protein_complex_E
but NE xxx NE
instead NE xxx NE
comigrated NE xxx NE
with NE xxx NE
c-Rel NE x-Xxx NE
/p65 NE /xdd NE
dimers NE xxx NE
. NE . NE

Antibodies NE Xxxx NE
against NE xxx NE
the NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
Rel NE Xxx NE
proteins NE xxx NE
and NE xxx NE
UV NE XX NE
cross-linking NE xxx-xxx NE
studies NE xxx NE
revealed NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
c-Rel NE x-Xxx NE
and NE xxx NE
p65 NE xdd NE
and NE xxx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
p50 NE xdd NE
in NE xx NE
the NE xxx NE
TF NE XX NE
complex NE xxx NE
and NE xxx NE
further NE xxx NE
showed NE xxx NE
that NE xxx NE
c-Rel NE x-Xxx NE
/ NE / NE
p65 NE xdd NE
heterodimers NE xxx NE
selectively NE xxx NE
bound NE xxx NE
to NE xx NE
the NE xxx NE
TF NE XX NE
kappa NE xxx NE
B-like NE X-xxx NE
site NE xxx NE
. NE . NE

Functional NE Xxxx NE
studies NE xxx NE
indicated NE xxx NE
that NE xxx NE
the NE xxx NE
TF G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
conferred NE xxx NE
LPS G#other_name_B XXX G#other_name_B
inducibility G#other_name_E xxx G#other_name_E
on NE xx NE
a NE x NE
heterologous G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
was NE xxx NE
transactivated NE xxx NE
by NE xx NE
c-Rel G#protein_molecule x-Xxx G#protein_molecule
or NE xx NE
p65 G#protein_N/A xdd G#protein_N/A
. NE . NE

Taken NE Xxxx NE
together NE xxx NE
, NE , NE
our NE xxx NE
results NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
binding NE xxx NE
of NE xx NE
c-Rel NE x-Xxx NE
/ NE / NE
p65 NE xdd NE
heterodimers NE xxx NE
to NE xx NE
a NE x NE
novel NE xxx NE
kappa NE xxx NE
B-like NE X-xxx NE
site NE xxx NE
mediated NE xxx NE
LPS NE XXX NE
induction NE xxx NE
of NE xx NE
TF NE XX NE
gene NE xxx NE
expression NE xxx NE
in NE xx NE
monocytic NE xxx NE
cells NE xxx NE
. NE . NE

Inhibition NE Xxxx NE
of NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
by NE xx NE
the NE xxx NE
extracellular G#protein_family_or_group_B xxx G#protein_family_or_group_B
matrix G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
tenascin G#protein_molecule xxx G#protein_molecule
. NE . NE

Tenascin G#protein_molecule Xxxx G#protein_molecule
( NE ( NE
TN G#protein_molecule XX G#protein_molecule
) NE ) NE
is NE xx NE
an NE xx NE
extracellular G#protein_family_or_group_B xxx G#protein_family_or_group_B
matrix G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
is NE xx NE
expressed NE xxx NE
widely NE xxx NE
in NE xx NE
the NE xxx NE
fetus G#multi_cell xxx G#multi_cell
and NE xxx NE
sparingly NE xxx NE
in NE xx NE
the NE xxx NE
adult G#multi_cell xxx G#multi_cell
, NE , NE
but NE xxx NE
reappears NE xxx NE
at NE xx NE
high NE xxx NE
levels NE xxx NE
in NE xx NE
certain NE xxx NE
areas NE xxx NE
of NE xx NE
tissue NE xxx NE
insult NE xxx NE
such NE xxx NE
as NE xx NE
tumor G#tissue_B xxx G#tissue_B
matrices G#tissue_E xxx G#tissue_E
and NE xxx NE
sites G#other_name_B xxx G#other_name_B
of G#other_name_M xx G#other_name_M
wound G#other_name_M xxx G#other_name_M
healing G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
show NE xxx NE
here NE xxx NE
that NE xxx NE
soluble NE xxx NE
TN G#protein_molecule XX G#protein_molecule
inhibits NE xxx NE
proliferation G#other_name xxx G#other_name
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
response NE xxx NE
to NE xx NE
alpha G#protein_family_or_group_B xxx G#protein_family_or_group_B
CD3 G#protein_family_or_group_M XXd G#protein_family_or_group_M
Ab G#protein_family_or_group_E Xx G#protein_family_or_group_E
co-immobilized NE xx-xxx NE
with NE xxx NE
the NE xxx NE
extracellular G#protein_family_or_group_B xxx G#protein_family_or_group_B
matrix G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
fibronectin G#protein_molecule xxx G#protein_molecule
( NE ( NE
FN G#protein_molecule XX G#protein_molecule
) NE ) NE
. NE . NE

TN G#protein_molecule XX G#protein_molecule
also NE xxx NE
inhibits NE xxx NE
proliferation G#other_name xxx G#other_name
driven NE xxx NE
by NE xx NE
alpha NE xxx NE
CD3 NE XXd NE
/IL-2 NE /XX-d NE
or NE xx NE
by NE xx NE
phorbol NE xxx NE
ester/IL-2 NE xxx/XX-d NE
, NE , NE
and NE xxx NE
it NE xx NE
prevents NE xxx NE
high NE xxx NE
level NE xxx NE
induction NE xxx NE
of NE xx NE
IL-2R NE XX-dX NE
. NE . NE

The NE Xxx NE
presence NE xxx NE
of NE xx NE
TN G#protein_molecule XX G#protein_molecule
in NE xx NE
culture G#other_name_B xxx G#other_name_B
medium G#other_name_E xxx G#other_name_E
does NE xxx NE
not NE xxx NE
detectably NE xxx NE
alter NE xxx NE
the NE xxx NE
pattern NE xxx NE
of NE xx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
resulting NE xxx NE
from NE xxx NE
T NE X NE
cell NE xxx NE
triggering NE xxx NE
with NE xxx NE
alpha G#protein_molecule_B xxx G#protein_molecule_B
CD3 G#protein_molecule_E XXd G#protein_molecule_E
, NE , NE
but NE xxx NE
at NE xx NE
later NE xxx NE
time NE xxx NE
points NE xxx NE
prevents NE xxx NE
the NE xxx NE
appearance NE xxx NE
of NE xx NE
functional NE xxx NE
NF-AT1 NE XX-XXd NE
transcription NE xxx NE
factor NE xxx NE
complexes NE xxx NE
in NE xx NE
T NE X NE
cell NE xxx NE
nuclear NE xxx NE
extracts NE xxx NE
. NE . NE

These NE Xxxx NE
findings NE xxx NE
are NE xxx NE
consistent NE xxx NE
with NE xxx NE
the NE xxx NE
postulated NE xxx NE
role NE xxx NE
for NE xxx NE
TN G#protein_molecule XX G#protein_molecule
as NE xx NE
a NE x NE
natural G#other_organic_compound_B xxx G#other_organic_compound_B
antagonist G#other_organic_compound_E xxx G#other_organic_compound_E
to NE xx NE
FN G#protein_molecule XX G#protein_molecule
action NE xxx NE
, NE , NE
and NE xxx NE
suggest NE xxx NE
that NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
responses G#other_name_E xxx G#other_name_E
occurring NE xxx NE
at NE xx NE
tissue G#tissue_B xxx G#tissue_B
sites G#tissue_E xxx G#tissue_E
in NE xx NE
which NE xxx NE
TN G#protein_molecule XX G#protein_molecule
is NE xx NE
expressed NE xxx NE
could NE xxx NE
be NE xx NE
influenced NE xxx NE
by NE xx NE
its NE xxx NE
presence NE xxx NE
. NE . NE

Human G#protein_N/A_B Xxxx G#protein_N/A_B
immunodeficiency G#protein_N/A_M xxx G#protein_N/A_M
virus G#protein_N/A_M xxx G#protein_N/A_M
type G#protein_N/A_M xxx G#protein_N/A_M
1 G#protein_N/A_M d G#protein_N/A_M
Nef G#protein_N/A_M Xxx G#protein_N/A_M
protein G#protein_N/A_E xxx G#protein_N/A_E
down-regulates NE xxx-xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
vitro NE xxx NE
after NE xxx NE
T-cell NE X-xxx NE
receptor NE xxx NE
stimulation NE xxx NE
. NE . NE

Human G#virus_B Xxxx G#virus_B
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
type G#virus_M xxx G#virus_M
1 G#virus_E d G#virus_E
( NE ( NE
HIV-1 G#virus XXX-d G#virus
) NE ) NE
negative G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
Nef G#protein_molecule Xxx G#protein_molecule
) NE ) NE
has NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
down-regulate NE xxx-xxx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
vitro NE xxx NE
. NE . NE

To NE Xx NE
define NE xxx NE
the NE xxx NE
mechanism G#other_name_B xxx G#other_name_B
of G#other_name_M xx G#other_name_M
action G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
Nef G#protein_molecule Xxx G#protein_molecule
protein NE xxx NE
, NE , NE
the NE xxx NE
signal G#other_name_B xxx G#other_name_B
transduction G#other_name_E xxx G#other_name_E
pathways NE xxx NE
which NE xxx NE
may NE xxx NE
be NE xx NE
affected NE xxx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
constitutive NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
nef NE xxx NE
gene NE xxx NE
were NE xxx NE
examined NE xxx NE
. NE . NE

Stimulation NE Xxxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
with NE xxx NE
tumor NE xxx NE
necrosis NE xxx NE
factor NE xxx NE
, NE , NE
interleukin-1 NE xxx-d NE
, NE , NE
or NE xx NE
lipopolysaccharide NE xxx NE
resulted NE xxx NE
in NE xx NE
the NE xxx NE
recruitment NE xxx NE
of NE xx NE
transcriptional NE xxx NE
factors NE xxx NE
to NE xx NE
a NE x NE
similar NE xxx NE
level NE xxx NE
whether NE xxx NE
or NE xx NE
not NE xxx NE
the NE xxx NE
cells NE xxx NE
expressed NE xxx NE
the NE xxx NE
nef NE xxx NE
gene NE xxx NE
. NE . NE

On NE Xx NE
the NE xxx NE
other NE xxx NE
hand NE xxx NE
, NE , NE
stimulation NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
mitogens NE xxx NE
or NE xx NE
antibodies NE xxx NE
to NE xx NE
the NE xxx NE
T-cell NE X-xxx NE
receptor NE xxx NE
(TCR)- NE (XXX)- NE
CD3 G#protein_molecule XXd G#protein_molecule
complex NE xxx NE
resulted NE xxx NE
in NE xx NE
the NE xxx NE
down-regulation NE xxx-xxx NE
of NE xx NE
transcriptional NE xxx NE
factors NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
cells NE xxx NE
expressing NE xxx NE
the NE xxx NE
nef NE xxx NE
gene NE xxx NE
compared NE xxx NE
with NE xxx NE
cells NE xxx NE
not NE xxx NE
expressing NE xxx NE
the NE xxx NE
nef NE xxx NE
gene NE xxx NE
. NE . NE

Because NE Xxxx NE
the NE xxx NE
Nef G#protein_molecule Xxx G#protein_molecule
protein NE xxx NE
does NE xxx NE
not NE xxx NE
affect NE xxx NE
the NE xxx NE
surface NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
CD3 G#protein_molecule XXd G#protein_molecule
-TCR NE -XXX NE
complex NE xxx NE
, NE , NE
we NE xx NE
conclude NE xxx NE
that NE xxx NE
the NE xxx NE
Nef G#protein_molecule Xxx G#protein_molecule
protein NE xxx NE
down-regulates NE xxx-xxx NE
the NE xxx NE
transcriptional NE xxx NE
factors NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
vitro NE xxx NE
through NE xxx NE
an NE xx NE
effect NE xxx NE
on NE xx NE
the NE xxx NE
TCR-dependent NE XXX-xxx NE
signal G#other_name_B xxx G#other_name_B
transduction G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
. NE . NE

Effects NE Xxxx NE
of NE xx NE
alpha-lipoic G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
dihydrolipoic G#other_organic_compound_B xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
on NE xx NE
expression NE xxx NE
of NE xx NE
proto-oncogene G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
c-fos G#DNA_domain_or_region_E x-xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
AP-1 G#protein_molecule XX-d G#protein_molecule
is NE xx NE
an NE xx NE
important NE xxx NE
human NE xxx NE
mediator NE xxx NE
of NE xx NE
the NE xxx NE
cellular G#other_name_B xxx G#other_name_B
response G#other_name_E xxx G#other_name_E
to NE xx NE
serum G#tissue xxx G#tissue
, NE , NE
growth G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
and NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
esters G#other_organic_compound_E xxx G#other_organic_compound_E
such NE xxx NE
as NE xx NE
12-O-tetradecanoyl-phorbol-13 G#other_organic_compound_B dd-X-xxx-xxx-dd G#other_organic_compound_B
acetate G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
TPA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
. NE . NE

The NE Xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
complex NE xxx NE
consists NE xxx NE
of NE xx NE
distinct NE xxx NE
protein G#protein_complex_B xxx G#protein_complex_B
heterodimers G#protein_complex_E xxx G#protein_complex_E
encoded NE xxx NE
by NE xx NE
the NE xxx NE
proto-oncogene G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
c-fos G#DNA_domain_or_region_E x-xxx G#DNA_domain_or_region_E
and NE xxx NE
c-jun G#RNA_molecule_B x-xxx G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
whose NE xxx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
can NE xxx NE
be NE xx NE
induced NE xxx NE
by NE xx NE
TPA G#other_organic_compound XXX G#other_organic_compound
, NE , NE
cyclic G#nucleotide_B xxx G#nucleotide_B
AMP G#nucleotide_E XXX G#nucleotide_E
and NE xxx NE
growth G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Recent NE Xxxx NE
findings NE xxx NE
suggest NE xxx NE
an NE xx NE
involvement NE xxx NE
of NE xx NE
reactive G#inorganic_B xxx G#inorganic_B
oxygen G#inorganic_M xxx G#inorganic_M
species G#inorganic_E xxx G#inorganic_E
in NE xx NE
the NE xxx NE
pathway NE xxx NE
of NE xx NE
TPA G#other_organic_compound XXX G#other_organic_compound
and NE xxx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
leading NE xxx NE
to NE xx NE
expression NE xxx NE
of NE xx NE
c-fos G#RNA_molecule_B x-xxx G#RNA_molecule_B
mRNA G#RNA_molecule_M xXXX G#RNA_molecule_M
and G#RNA_molecule_M xxx G#RNA_molecule_M
c-jun G#RNA_molecule_M x-xxx G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E

To NE Xx NE
investigate NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
reactive G#inorganic_B xxx G#inorganic_B
oxygen G#inorganic_M xxx G#inorganic_M
species G#inorganic_E xxx G#inorganic_E
we NE xx NE
studied NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
alpha-lipoic G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
dihydrolipoic G#other_organic_compound_B xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
natural G#other_organic_compound_B xxx G#other_organic_compound_B
thiol G#other_organic_compound_M xxx G#other_organic_compound_M
antioxidants G#other_organic_compound_E xxx G#other_organic_compound_E
) NE ) NE
on NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
c-fos G#RNA_molecule_B x-xxx G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
in NE xx NE
human G#cell_line_B xxx G#cell_line_B
Jurkat G#cell_line_M Xxxx G#cell_line_M
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

When NE Xxxx NE
cells NE xxx NE
were NE xxx NE
preincubated NE xxx NE
with NE xxx NE
dihydrolipoic G#other_organic_compound_B xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
(0.2 NE (d.d NE
mM) NE xX) NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
c-fos G#RNA_molecule_B x-xxx G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
was NE xxx NE
suppressed NE xxx NE
at NE xx NE
30 NE dd NE
min NE xxx NE
after NE xxx NE
stimulation NE xxx NE
of NE xx NE
TPA G#other_organic_compound XXX G#other_organic_compound
(0.5 NE (d.d NE
microM) NE xxxX) NE
whereas NE xxx NE
in NE xx NE
the NE xxx NE
case NE xxx NE
of NE xx NE
preincubation NE xxx NE
of NE xx NE
alpha-lipoic G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
(0.2 NE (d.d NE
microM) NE xxxX) NE
, NE , NE
the NE xxx NE
expression NE xxx NE
was NE xxx NE
enhanced NE xxx NE
at NE xx NE
30 NE dd NE
min NE xxx NE
. NE . NE

These NE Xxxx NE
studies NE xxx NE
support NE xxx NE
the NE xxx NE
idea NE xxx NE
that NE xxx NE
superoxide G#inorganic_B xxx G#inorganic_B
anion G#inorganic_M xxx G#inorganic_M
radical G#inorganic_E xxx G#inorganic_E
plays NE xxx NE
a NE x NE
role NE xxx NE
in NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
c-fos G#RNA_molecule_B x-xxx G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
. NE . NE

Appraisal NE Xxxx NE
of NE xx NE
potential G#other_name_B xxx G#other_name_B
therapeutic G#other_name_M xxx G#other_name_M
index G#other_name_E xxx G#other_name_E
of NE xx NE
antioxidants G#other_organic_compound xxx G#other_organic_compound
on NE xx NE
the NE xxx NE
basis NE xxx NE
of NE xx NE
their NE xxx NE
in NE xx NE
vitro NE xxx NE
effects NE xxx NE
on NE xx NE
HIV G#other_name_B XXX G#other_name_B
replication G#other_name_E xxx G#other_name_E
in NE xx NE
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
interleukin NE xxx NE
2 NE d NE
-induced NE -xxx NE
lymphocyte NE xxx NE
proliferation NE xxx NE
. NE . NE

Antioxidant NE Xxxx NE
molecules NE xxx NE
have NE xxx NE
been NE xxx NE
suggested NE xxx NE
to NE xx NE
be NE xx NE
of NE xx NE
therapeutic NE xxx NE
value NE xxx NE
in NE xx NE
the NE xxx NE
treatment NE xxx NE
of NE xx NE
HIV NE XXX NE
-infected NE -xxx NE
patients NE xxx NE
. NE . NE

To NE Xx NE
evaluate NE xxx NE
this NE xxx NE
possibility NE xxx NE
, NE , NE
we NE xx NE
examined NE xxx NE
in NE xx NE
vitro NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
two NE xxx NE
types NE xxx NE
of NE xx NE
antioxidant NE xxx NE
molecules NE xxx NE
in NE xx NE
terms NE xxx NE
of NE xx NE
inhibition NE xxx NE
of NE xx NE
HIV G#other_name_B XXX G#other_name_B
replication G#other_name_E xxx G#other_name_E
in NE xx NE
monocytes G#cell_type xxx G#cell_type
, NE , NE
one NE xxx NE
of NE xx NE
the NE xxx NE
main NE xxx NE
reservoirs NE xxx NE
of NE xx NE
HIV G#virus XXX G#virus
, NE , NE
and NE xxx NE
also NE xxx NE
in NE xx NE
terms NE xxx NE
of NE xx NE
modulation NE xxx NE
of NE xx NE
the NE xxx NE
immune NE xxx NE
competence NE xxx NE
as NE xx NE
measured NE xxx NE
by NE xx NE
PBMC G#other_name_B XXXX G#other_name_B
proliferation G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
tested NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
BHA G#other_organic_compound XXX G#other_organic_compound
, NE , NE
a NE x NE
phenolic, G#other_organic_compound_B xxx, G#other_organic_compound_B
lipid-soluble, G#other_organic_compound_M xxx-xxx, G#other_organic_compound_M
chain-breaking G#other_organic_compound_M xxx-xxx G#other_organic_compound_M
antioxidant G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
and NE xxx NE
NAC G#other_organic_compound XXX G#other_organic_compound
, NE , NE
a NE x NE
known NE xxx NE
glutathione G#other_organic_compound_B xxx G#other_organic_compound_B
precursor G#other_organic_compound_E xxx G#other_organic_compound_E
with NE xxx NE
some NE xxx NE
direct NE xxx NE
free-radical NE xxx-xxx NE
scavenging NE xxx NE
properties NE xxx NE
as NE xx NE
well NE xxx NE
, NE , NE
on NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
HIV NE XXX NE
-1 NE -d NE
expression NE xxx NE
in NE xx NE
latently NE xxx NE
infected NE xxx NE
U1 NE Xd NE
cells NE xxx NE
and NE xxx NE
in NE xx NE
productively NE xxx NE
and NE xxx NE
chronically NE xxx NE
infected NE xxx NE
U937 NE Xddd NE
cells NE xxx NE
. NE . NE

Both NE Xxxx NE
antioxidants G#other_organic_compound xxx G#other_organic_compound
inhibited NE xxx NE
TNF-induced G#other_name_B XXX-xxx G#other_name_B
NF-kappa G#other_name_M XX-xxx G#other_name_M
B G#other_name_M X G#other_name_M
activity G#other_name_M xxx G#other_name_M
or G#other_name_M xx G#other_name_M
PMA-induced G#other_name_M XXX-xxx G#other_name_M
NF-kappa G#other_name_M XX-xxx G#other_name_M
B G#other_name_M X G#other_name_M
activity G#other_name_E xxx G#other_name_E
U1 NE Xd NE
cells NE xxx NE
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
the NE xxx NE
sustained NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
activity NE xxx NE
permanently NE xxx NE
induced NE xxx NE
by NE xx NE
the NE xxx NE
virus NE xxx NE
itself NE xxx NE
in NE xx NE
chronically NE xxx NE
HIV G#virus XXX G#virus
-infected NE -xxx NE
U937 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

This NE Xxxx NE
resulted NE xxx NE
in NE xx NE
only NE xxx NE
a NE x NE
partial NE xxx NE
inhibition NE xxx NE
of NE xx NE
TNF- G#other_name_B XXX- G#other_name_B
induced G#other_name_M xxx G#other_name_M
HIV G#other_name_M XXX G#other_name_M
replication G#other_name_M xxx G#other_name_M
or G#other_name_M xx G#other_name_M
PMA- G#other_name_M XXX- G#other_name_M
induced G#other_name_M xxx G#other_name_M
HIV G#other_name_M XXX G#other_name_M
replication G#other_name_E xxx G#other_name_E
U1 NE Xd NE
cells NE xxx NE
, NE , NE
and NE xxx NE
no NE xx NE
detectable NE xxx NE
effect NE xxx NE
on NE xx NE
HIV G#other_name_B XXX G#other_name_B
replication G#other_name_E xxx G#other_name_E
in NE xx NE
chronically G#cell_line_B xxx G#cell_line_B
infected G#cell_line_M xxx G#cell_line_M
U937 G#cell_line_M Xddd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

This NE Xxxx NE
may NE xxx NE
be NE xx NE
the NE xxx NE
first NE xxx NE
limitation NE xxx NE
to NE xx NE
potential NE xxx NE
antiviral NE xxx NE
effects NE xxx NE
of NE xx NE
antioxidant NE xxx NE
therapies NE xxx NE
. NE . NE

Another NE Xxxx NE
limitation NE xxx NE
is NE xx NE
that NE xxx NE
antioxidant NE xxx NE
concentrations NE xxx NE
high NE xxx NE
enough NE xxx NE
to NE xx NE
block NE xxx NE
NK-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
were NE xxx NE
shown NE xxx NE
to NE xx NE
have NE xxx NE
a NE x NE
suppressive NE xxx NE
effect NE xxx NE
on NE xx NE
immune G#other_name_B xxx G#other_name_B
functions G#other_name_E xxx G#other_name_E
in G#other_name_B xx G#other_name_B
vitro G#other_name_E xxx G#other_name_E
, NE , NE
because NE xxx NE
NAC G#other_organic_compound XXX G#other_organic_compound
and NE xxx NE
BHA G#other_organic_compound XXX G#other_organic_compound
blocked NE xxx NE
IL-2 NE XX-d NE
-induced NE -xxx NE
PBMC NE XXXX NE
proliferation NE xxx NE
. NE . NE

These NE Xxxx NE
data NE xxx NE
warrant NE xxx NE
prudence NE xxx NE
in NE xx NE
the NE xxx NE
design NE xxx NE
of NE xx NE
antioxidant-based NE xxx-xxx NE
therapies NE xxx NE
aimed NE xxx NE
at NE xx NE
suppressing NE xxx NE
HIV NE XXX NE
replication NE xxx NE
. NE . NE

Isolation NE Xxxx NE
and NE xxx NE
characterization NE xxx NE
of NE xx NE
gelatinase G#cell_component_B xxx G#cell_component_B
granules G#cell_component_E xxx G#cell_component_E
from NE xxx NE
human G#cell_type_B xxx G#cell_type_B
neutrophils G#cell_type_E xxx G#cell_type_E
. NE . NE

We NE Xx NE
recently NE xxx NE
confirmed NE xxx NE
the NE xxx NE
existence NE xxx NE
of NE xx NE
gelatinase G#cell_component_B xxx G#cell_component_B
granules G#cell_component_E xxx G#cell_component_E
as NE xx NE
a NE x NE
subpopulation NE xxx NE
of NE xx NE
peroxidase-negative G#cell_component_B xxx-xxx G#cell_component_B
granules G#cell_component_E xxx G#cell_component_E
by NE xx NE
double-labeling G#other_name_B xxx-xxx G#other_name_B
immunogold G#other_name_M xxx G#other_name_M
electron G#other_name_M xxx G#other_name_M
microscopy G#other_name_E xxx G#other_name_E
on NE xx NE
intact NE xxx NE
cells NE xxx NE
and NE xxx NE
by NE xx NE
subcellular G#other_name_B xxx G#other_name_B
fractionation G#other_name_E xxx G#other_name_E
. NE . NE

Further NE Xxxx NE
characterization NE xxx NE
of NE xx NE
gelatinase G#cell_component_B xxx G#cell_component_B
granules G#cell_component_E xxx G#cell_component_E
has NE xxx NE
been NE xxx NE
hampered NE xxx NE
by NE xx NE
poor NE xxx NE
separation NE xxx NE
of NE xx NE
specific NE xxx NE
and NE xxx NE
gelatinase G#cell_component_B xxx G#cell_component_B
granules G#cell_component_E xxx G#cell_component_E
on NE xx NE
both NE xxx NE
two-layer G#other_name_B xxx-xxx G#other_name_B
Percoll G#other_name_M Xxxx G#other_name_M
gradients G#other_name_E xxx G#other_name_E
and NE xxx NE
sucrose G#other_name_B xxx G#other_name_B
gradients G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
have NE xxx NE
developed NE xxx NE
a NE x NE
three-layer G#other_name_B xxx-xxx G#other_name_B
Percoll G#other_name_M Xxxx G#other_name_M
density G#other_name_M xxx G#other_name_M
gradient G#other_name_E xxx G#other_name_E
that NE xxx NE
allows NE xxx NE
separation NE xxx NE
of NE xx NE
the NE xxx NE
different NE xxx NE
granules G#cell_component xxx G#cell_component
and NE xxx NE
vesicles NE xxx NE
from NE xxx NE
human G#cell_type_B xxx G#cell_type_B
neutrophils G#cell_type_E xxx G#cell_type_E
; NE ; NE
in NE xx NE
particular NE xxx NE
, NE , NE
it NE xx NE
allows NE xxx NE
separation NE xxx NE
of NE xx NE
specific NE xxx NE
and NE xxx NE
gelatinase G#cell_component_B xxx G#cell_component_B
granules G#cell_component_E xxx G#cell_component_E
. NE . NE

This NE Xxxx NE
allows NE xxx NE
us NE xx NE
to NE xx NE
characterize NE xxx NE
these NE xxx NE
two NE xxx NE
granule G#cell_component_B xxx G#cell_component_B
populations G#cell_component_E xxx G#cell_component_E
with NE xxx NE
regard NE xxx NE
to NE xx NE
their NE xxx NE
content NE xxx NE
of NE xx NE
membrane G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
which NE xxx NE
become NE xxx NE
incorporated NE xxx NE
into NE xxx NE
the NE xxx NE
plasma G#cell_component_B xxx G#cell_component_B
membrane G#cell_component_E xxx G#cell_component_E
during NE xxx NE
exocytosis G#other_name xxx G#other_name
. NE . NE

We NE Xx NE
found NE xxx NE
that NE xxx NE
gelatinase G#cell_component_B xxx G#cell_component_B
granules G#cell_component_E xxx G#cell_component_E
, NE , NE
defined NE xxx NE
as NE xx NE
peroxidase-negative G#cell_component_B xxx-xxx G#cell_component_B
granules G#cell_component_E xxx G#cell_component_E
containing NE xxx NE
gelatinase G#protein_molecule xxx G#protein_molecule
but NE xxx NE
lacking NE xxx NE
lactoferrin G#protein_molecule xxx G#protein_molecule
, NE , NE
contain NE xxx NE
50% NE dd% NE
of NE xx NE
total NE xxx NE
cell NE xxx NE
gelatinase G#protein_molecule xxx G#protein_molecule
, NE , NE
with NE xxx NE
the NE xxx NE
remaining NE xxx NE
residing NE xxx NE
in NE xx NE
specific G#cell_component_B xxx G#cell_component_B
granules G#cell_component_E xxx G#cell_component_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
we NE xx NE
found NE xxx NE
that NE xxx NE
20% NE dd% NE
to NE xx NE
25% NE dd% NE
of NE xx NE
both NE xxx NE
the NE xxx NE
adhesion G#protein_molecule_B xxx G#protein_molecule_B
protein G#protein_molecule_M xxx G#protein_molecule_M
Mac-1 G#protein_molecule_E Xxx-d G#protein_molecule_E
and NE xxx NE
the NE xxx NE
NADPH-oxidase G#protein_molecule_B XXXXX-xxx G#protein_molecule_B
component G#protein_molecule_M xxx G#protein_molecule_M
cytochrome G#protein_molecule_E xxx G#protein_molecule_E
b558 G#protein_molecule xddd G#protein_molecule
is NE xx NE
localized NE xxx NE
in NE xx NE
gelatinase G#cell_component_B xxx G#cell_component_B
granules G#cell_component_E xxx G#cell_component_E
. NE . NE

Although NE Xxxx NE
no NE xx NE
qualitative NE xxx NE
difference NE xxx NE
was NE xxx NE
observed NE xxx NE
between NE xxx NE
specific G#cell_component_B xxx G#cell_component_B
granules G#cell_component_E xxx G#cell_component_E
and NE xxx NE
gelatinase G#cell_component_B xxx G#cell_component_B
granules G#cell_component_E xxx G#cell_component_E
with NE xxx NE
respect NE xxx NE
to NE xx NE
cytochrome G#protein_molecule_B xxx G#protein_molecule_B
b558 G#protein_molecule_E xddd G#protein_molecule_E
and NE xxx NE
Mac-1 G#protein_molecule Xxx-d G#protein_molecule
, NE , NE
stimulation NE xxx NE
of NE xx NE
the NE xxx NE
neutrophil G#cell_type xxx G#cell_type
with NE xxx NE
FMLP G#protein_family_or_group XXXX G#protein_family_or_group
resulted NE xxx NE
in NE xx NE
a NE x NE
selective G#other_name_B xxx G#other_name_B
mobilization G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
least NE xxx NE
dense NE xxx NE
peroxidase-negative G#cell_component_B xxx-xxx G#cell_component_B
granules G#cell_component_E xxx G#cell_component_E
, NE , NE
ie NE xx NE
, NE , NE
gelatinase G#cell_component_B xxx G#cell_component_B
granules G#cell_component_E xxx G#cell_component_E
, NE , NE
which NE xxx NE
, NE , NE
in NE xx NE
concert NE xxx NE
with NE xxx NE
secretory G#cell_component_B xxx G#cell_component_B
vesicles G#cell_component_E xxx G#cell_component_E
, NE , NE
furnish NE xxx NE
the NE xxx NE
plasma G#cell_component_B xxx G#cell_component_B
membrane G#cell_component_E xxx G#cell_component_E
with NE xxx NE
Mac-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
cytochrome G#protein_molecule_B xxx G#protein_molecule_B
b558 G#protein_molecule_E xddd G#protein_molecule_E
. NE . NE

This NE Xxxx NE
shows NE xxx NE
that NE xxx NE
gelatinase G#cell_component_B xxx G#cell_component_B
granules G#cell_component_E xxx G#cell_component_E
are NE xxx NE
functionally NE xxx NE
important NE xxx NE
relative NE xxx NE
to NE xx NE
specific G#cell_component_B xxx G#cell_component_B
granules G#cell_component_E xxx G#cell_component_E
in NE xx NE
mediating NE xxx NE
early G#other_name_B xxx G#other_name_B
inflammatory G#other_name_M xxx G#other_name_M
responses G#other_name_E xxx G#other_name_E
. NE . NE

Regulation NE Xxxx NE
of NE xx NE
interleukin-2 G#other_name_B xxx-d G#other_name_B
receptor G#other_name_M xxx G#other_name_M
alpha G#other_name_M xxx G#other_name_M
chain G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
factor.kappa G#other_name_M xxx.xxx G#other_name_M
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
by NE xx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

Autocrine NE Xxxx NE
role NE xxx NE
of NE xx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

The NE Xxx NE
regulation NE xxx NE
of NE xx NE
interleukin-2 NE xxx-d NE
receptor NE xxx NE
alpha NE xxx NE
chain NE xxx NE
( NE ( NE
IL-2R NE XX-dX NE
alpha NE xxx NE
) NE ) NE
expression NE xxx NE
and NE xxx NE
nuclear NE xxx NE
factor NE xxx NE
(NF) NE (XX) NE
activation NE xxx NE
by NE xx NE
protein NE xxx NE
kinase NE xxx NE
C NE X NE
( NE ( NE
PKC NE XXX NE
) NE ) NE
in NE xx NE
resting NE xxx NE
T NE X NE
cells NE xxx NE
, NE , NE
has NE xxx NE
been NE xxx NE
studied NE xxx NE
. NE . NE

Treatment NE Xxxx NE
of NE xx NE
human NE xxx NE
resting G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
with NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
esters G#other_organic_compound_E xxx G#other_organic_compound_E
strongly NE xxx NE
induced NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
IL-2R G#protein_subunit_B XX-dX G#protein_subunit_B
alpha G#protein_subunit_E xxx G#protein_subunit_E
and NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
NF.kappa G#protein_molecule_B XX.xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
. NE . NE

This NE Xxxx NE
activation NE xxx NE
was NE xxx NE
due NE xxx NE
to NE xx NE
the NE xxx NE
translocation NE xxx NE
of NE xx NE
p65 G#protein_molecule xdd G#protein_molecule
and NE xxx NE
c-Rel G#protein_molecule x-Xxx G#protein_molecule
NF.kappa G#protein_molecule_B XX.xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
proteins NE xxx NE
from NE xxx NE
cytoplasmic G#cell_component_B xxx G#cell_component_B
stores G#cell_component_E xxx G#cell_component_E
to NE xx NE
the NE xxx NE
nucleus NE xxx NE
, NE , NE
where NE xxx NE
they NE xxx NE
bound NE xxx NE
the NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
IL-2R G#DNA_domain_or_region_B XX-dX G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
either NE xxx NE
as NE xx NE
p50.p65 G#protein_complex xdd.xdd G#protein_complex
or NE xx NE
as NE xx NE
p50 NE xdd NE
. NE . NE
c-Rel NE x-Xxx NE
heterodimers NE xxx NE
. NE . NE

Interestingly NE Xxxx NE
, NE , NE
all NE xxx NE
of NE xx NE
those NE xxx NE
events NE xxx NE
were NE xxx NE
largely NE xxx NE
indirect NE xxx NE
and NE xxx NE
mediated NE xxx NE
by NE xx NE
endogenously NE xxx NE
secreted NE xxx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
TNF G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
) NE ) NE
, NE , NE
as NE xx NE
they NE xxx NE
were NE xxx NE
strongly NE xxx NE
inhibited NE xxx NE
by NE xx NE
a NE x NE
neutralizing NE xxx NE
anti- NE xxx- NE
TNF NE XXX NE
alpha NE xxx NE
monoclonal NE xxx NE
antibody NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
cyclosporin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
, NE , NE
which NE xxx NE
blocked NE xxx NE
TNF G#other_name_B XXX G#other_name_B
alpha G#other_name_M xxx G#other_name_M
production G#other_name_E xxx G#other_name_E
induced NE xxx NE
by NE xx NE
PKC G#protein_molecule XXX G#protein_molecule
, NE , NE
strongly NE xxx NE
inhibited NE xxx NE
IL-2R NE XX-dX NE
alpha NE xxx NE
and NE xxx NE
NF.kappa NE XX.xxx NE
B NE X NE
activation NE xxx NE
. NE . NE

The NE Xxx NE
addition NE xxx NE
of NE xx NE
either NE xxx NE
TNF G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
or NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
partially NE xxx NE
recovered NE xxx NE
cyclosporin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
-induced NE -xxx NE
IL-2R G#protein_subunit_B XX-dX G#protein_subunit_B
alpha G#protein_subunit_E xxx G#protein_subunit_E
inhibition NE xxx NE
, NE , NE
but NE xxx NE
only NE xxx NE
TNF G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
completely NE xxx NE
recovered NE xxx NE
NF.kappa G#protein_molecule_B XX.xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
activation NE xxx NE
. NE . NE

Those NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
, NE , NE
in NE xx NE
resting G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
PKC G#protein_molecule XXX G#protein_molecule
activation NE xxx NE
has NE xxx NE
only NE xxx NE
a NE x NE
triggering NE xxx NE
role NE xxx NE
, NE , NE
whereas NE xxx NE
the NE xxx NE
endogenously NE xxx NE
secreted NE xxx NE
TNF G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
plays NE xxx NE
an NE xx NE
essential NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
quantitative G#other_name_B xxx G#other_name_B
control G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
expression G#other_name xxx G#other_name
of NE xx NE
IL-2R G#protein_subunit_B XX-dX G#protein_subunit_B
alpha G#protein_subunit_E xxx G#protein_subunit_E
chain NE xxx NE
or NE xx NE
NF.kappa G#other_name_B XX.xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

Superantigens G#protein_family_or_group Xxxx G#protein_family_or_group
activate NE xxx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
monocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Binding NE Xxxx NE
of NE xx NE
superantigens NE xxx NE
to NE xx NE
MHC G#protein_family_or_group_B XXX G#protein_family_or_group_B
class G#protein_family_or_group_M xxx G#protein_family_or_group_M
II G#protein_family_or_group_M XX G#protein_family_or_group_M
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
results NE xxx NE
in NE xx NE
transduction NE xxx NE
of NE xx NE
biochemical G#other_name_B xxx G#other_name_B
signals G#other_name_E xxx G#other_name_E
leading NE xxx NE
to NE xx NE
cellular G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
and NE xxx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
demonstrate NE xxx NE
that NE xxx NE
the NE xxx NE
staphylococcal G#protein_family_or_group_B xxx G#protein_family_or_group_B
superantigens G#protein_family_or_group_E xxx G#protein_family_or_group_E
toxic G#protein_molecule_B xxx G#protein_molecule_B
shock G#protein_molecule_M xxx G#protein_molecule_M
syndrome G#protein_molecule_M xxx G#protein_molecule_M
toxin-1 G#protein_molecule_E xxx-d G#protein_molecule_E
( NE ( NE
TSST-1 G#protein_molecule XXXX-d G#protein_molecule
) NE ) NE
and NE xxx NE
staphylococcal G#protein_molecule_B xxx G#protein_molecule_B
enterotoxin G#protein_molecule_M xxx G#protein_molecule_M
A G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
SEA G#protein_molecule XXX G#protein_molecule
) NE ) NE
activate NE xxx NE
HIV-1 NE XXX-d NE
-LTR NE -XXX NE
-driven NE -xxx NE
transcription NE xxx NE
of NE xx NE
chloramphenicol NE xxx NE
acetyl NE xxx NE
transferase NE xxx NE
in NE xx NE
the NE xxx NE
human NE xxx NE
monocytic NE xxx NE
cell NE xxx NE
line NE xxx NE
THP-1 NE XXX-d NE
. NE . NE

Induction NE Xxxx NE
of NE xx NE
HIV-1 NE XXX-d NE
- NE - NE
LTR NE XXX NE
-driven NE -xxx NE
transcription NE xxx NE
in NE xx NE
THP-1 NE XXX-d NE
cells NE xxx NE
by NE xx NE
superantigens NE xxx NE
was NE xxx NE
associated NE xxx NE
with NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
nuclear NE xxx NE
factor-kappa NE xxx-xxx NE
B NE X NE
DNA-binding NE XXX-xxx NE
activity NE xxx NE
. NE . NE

Superantigens G#protein_family_or_group Xxxx G#protein_family_or_group
also NE xxx NE
increased NE xxx NE
viral G#other_name_B xxx G#other_name_B
protein G#other_name_M xxx G#other_name_M
secretion G#other_name_E xxx G#other_name_E
from NE xxx NE
the NE xxx NE
granulocyte-macrophage NE xxx-xxx NE
colony-stimulating NE xxx-xxx NE
factor NE xxx NE
-pretreated NE -xxx NE
chronically NE xxx NE
infected NE xxx NE
human NE xxx NE
monocytic NE xxx NE
cell NE xxx NE
line NE xxx NE
U1 NE Xd NE
. NE . NE

Induction NE Xxxx NE
of NE xx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
monocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
superantigens G#protein_family_or_group xxx G#protein_family_or_group
occurred NE xxx NE
via NE xxx NE
tumor G#other_name_B xxx G#other_name_B
necrosis G#other_name_M xxx G#other_name_M
factor-alpha-dependent G#other_name_M xxx-xxx-xxx G#other_name_M
mechanism G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
tumor G#other_name_M xxx G#other_name_M
necrosis G#other_name_M xxx G#other_name_M
factor-alpha-independent G#other_name_M xxx-xxx-xxx G#other_name_M
mechanism G#other_name_E xxx G#other_name_E

Our NE Xxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
superantigens G#protein_family_or_group xxx G#protein_family_or_group
and NE xxx NE
other NE xxx NE
MHC G#protein_family_or_group_B XXX G#protein_family_or_group_B
class G#protein_family_or_group_M xxx G#protein_family_or_group_M
II G#protein_family_or_group_M XX G#protein_family_or_group_M
ligands G#protein_family_or_group_E xxx G#protein_family_or_group_E
may NE xxx NE
activate NE xxx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
monocytes/macrophages G#cell_type xxx/xxx G#cell_type
. NE . NE

Mitogen G#other_name_B Xxxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
induces NE xxx NE
the NE xxx NE
formation NE xxx NE
of NE xx NE
new NE xxx NE
cyclic NE xxx NE
AMP NE XXX NE
response NE xxx NE
element-binding NE xxx-xxx NE
protein NE xxx NE
nuclear NE xxx NE
complexes NE xxx NE
. NE . NE

A NE X NE
large NE xxx NE
body NE xxx NE
of NE xx NE
evidence NE xxx NE
indicates NE xxx NE
that NE xxx NE
experimental G#other_name_B xxx G#other_name_B
agents G#other_name_E xxx G#other_name_E
which NE xxx NE
raise NE xxx NE
cellular G#other_name_B xxx G#other_name_B
cAMP G#other_name_M xXXX G#other_name_M
levels G#other_name_E xxx G#other_name_E
inhibit NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
growth G#other_name_E xxx G#other_name_E
and NE xxx NE
division NE xxx NE
. NE . NE

By NE Xx NE
contrast NE xxx NE
, NE , NE
many NE xxx NE
studies NE xxx NE
have NE xxx NE
reported NE xxx NE
that NE xxx NE
mitogen G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
increases NE xxx NE
cAMP G#nucleotide xXXX G#nucleotide
levels NE xxx NE
, NE , NE
implying NE xxx NE
a NE x NE
positive NE xxx NE
physiological NE xxx NE
role NE xxx NE
for NE xxx NE
cAMP G#nucleotide xXXX G#nucleotide
in NE xx NE
the NE xxx NE
activation NE xxx NE
process NE xxx NE
. NE . NE

In NE Xx NE
the NE xxx NE
present NE xxx NE
study NE xxx NE
we NE xx NE
demonstrate NE xxx NE
that NE xxx NE
mitogen G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
induces NE xxx NE
nuclear NE xxx NE
factors NE xxx NE
that NE xxx NE
form NE xxx NE
complexes NE xxx NE
with NE xxx NE
cyclic G#protein_molecule_B xxx G#protein_molecule_B
AMP G#protein_molecule_M XXX G#protein_molecule_M
response G#protein_molecule_M xxx G#protein_molecule_M
element-binding G#protein_molecule_M xxx-xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
CREB G#protein_molecule XXXX G#protein_molecule
) NE ) NE
. NE . NE

Four NE Xxxx NE
complexes NE xxx NE
are NE xxx NE
identified NE xxx NE
by NE xx NE
the NE xxx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
, NE , NE
two NE xxx NE
of NE xx NE
which NE xxx NE
are NE xxx NE
induced NE xxx NE
by NE xx NE
mitogen G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

All NE Xxx NE
four NE xxx NE
complexes NE xxx NE
contain NE xxx NE
CREB G#protein_molecule XXXX G#protein_molecule
and NE xxx NE
are NE xxx NE
bound NE xxx NE
to NE xx NE
the NE xxx NE
cAMP NE xXXX NE
response NE xxx NE
element NE xxx NE
( NE ( NE
CRE NE XXX NE
) NE ) NE
core NE xxx NE
sequence NE xxx NE
( NE ( NE
TGACGTCA NE XXXXXXXX NE
) NE ) NE
, NE , NE
as NE xx NE
indicated NE xxx NE
by NE xx NE
antibody NE xxx NE
and NE xxx NE
oligonucleotide NE xxx NE
competition NE xxx NE
experiments NE xxx NE
. NE . NE

Binding NE Xxxx NE
of NE xx NE
the NE xxx NE
four NE xxx NE
complexes NE xxx NE
to NE xx NE
CRE G#DNA_domain_or_region XXX G#DNA_domain_or_region
is NE xx NE
prevented NE xxx NE
by NE xx NE
dephosphorylation NE xxx NE
of NE xx NE
nuclear NE xxx NE
extracts NE xxx NE
and NE xxx NE
is NE xx NE
restored NE xxx NE
by NE xx NE
rephosphorylation NE xxx NE
with NE xxx NE
cAMP NE xXXX NE
-dependent NE -xxx NE
protein NE xxx NE
kinase NE xxx NE
or NE xx NE
endogenous NE xxx NE
kinases NE xxx NE
. NE . NE

Similar NE Xxxx NE
complexes NE xxx NE
are NE xxx NE
detected NE xxx NE
in NE xx NE
nuclear G#cell_component_B xxx G#cell_component_B
extracts G#cell_component_E xxx G#cell_component_E
of NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Mitogen NE Xxxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
electrophoretic NE xxx NE
mobility NE xxx NE
shift NE xxx NE
assay NE xxx NE
complexes NE xxx NE
is NE xx NE
not NE xxx NE
accounted NE xxx NE
for NE xxx NE
by NE xx NE
protein NE xxx NE
phosphorylation NE xxx NE
or NE xx NE
by NE xx NE
induction NE xxx NE
of NE xx NE
CREB NE XXXX NE
. NE . NE

Rather NE Xxxx NE
, NE , NE
the NE xxx NE
data NE xxx NE
indicate NE xxx NE
that NE xxx NE
mitogen G#other_organic_compound xxx G#other_organic_compound
increases NE xxx NE
the NE xxx NE
levels NE xxx NE
of NE xx NE
a NE x NE
nuclear NE xxx NE
factor(s) NE xxx(x) NE
that NE xxx NE
dimerizes NE xxx NE
with NE xxx NE
CREB G#protein_molecule XXXX G#protein_molecule
. NE . NE

Induction NE Xxxx NE
of NE xx NE
new NE xxx NE
CREB NE XXXX NE
complexes NE xxx NE
implies NE xxx NE
a NE x NE
physiological NE xxx NE
role NE xxx NE
for NE xxx NE
cAMP NE xXXX NE
in NE xx NE
mitogen NE xxx NE
activation NE xxx NE
of NE xx NE
T NE X NE
lymphocytes NE xxx NE
. NE . NE

Alpha-tocopherol G#other_organic_compound Xxxx-xxx G#other_organic_compound
inhibits NE xxx NE
agonist-induced G#other_name_B xxx-xxx G#other_name_B
monocytic G#other_name_M xxx G#other_name_M
cell G#other_name_M xxx G#other_name_M
adhesion G#other_name_E xxx G#other_name_E
to NE xx NE
cultured G#cell_line_B xxx G#cell_line_B
human G#cell_line_M xxx G#cell_line_M
endothelial G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Antioxidants G#other_organic_compound Xxxx G#other_organic_compound
have NE xxx NE
been NE xxx NE
proposed NE xxx NE
to NE xx NE
be NE xx NE
anti-atherosclerotic G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
agents G#other_organic_compound_E xxx G#other_organic_compound_E
; NE ; NE
however NE xxx NE
, NE , NE
the NE xxx NE
mechanisms NE xxx NE
underlying NE xxx NE
their NE xxx NE
beneficial NE xxx NE
effects NE xxx NE
are NE xxx NE
poorly NE xxx NE
understood NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
examined NE xxx NE
the NE xxx NE
effect NE xxx NE
of NE xx NE
alpha-tocopherol G#other_organic_compound xxx-xxx G#other_organic_compound
( NE ( NE
alpha-tcp G#other_organic_compound xxx-xxx G#other_organic_compound
) NE ) NE
on NE xx NE
one NE xxx NE
cellular NE xxx NE
event NE xxx NE
in NE xx NE
atherosclerotic G#other_name_B xxx G#other_name_B
plaque G#other_name_M xxx G#other_name_M
development G#other_name_E xxx G#other_name_E
, NE , NE
monocyte NE xxx NE
adhesion NE xxx NE
to NE xx NE
stimulated G#cell_type_B xxx G#cell_type_B
endothelial G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
ECs G#cell_type XXx G#cell_type
) NE ) NE
. NE . NE

Human NE Xxxx NE
umbilical NE xxx NE
vein NE xxx NE
ECs G#cell_type XXx G#cell_type
were NE xxx NE
pretreated NE xxx NE
with NE xxx NE
alpha-tcp G#other_organic_compound xxx-xxx G#other_organic_compound
before NE xxx NE
stimulation NE xxx NE
with NE xxx NE
known NE xxx NE
agonists NE xxx NE
of NE xx NE
monocyte G#other_name_B xxx G#other_name_B
adhesion G#other_name_E xxx G#other_name_E
: NE : NE
IL-1 G#protein_molecule XX-d G#protein_molecule
(10 NE (dd NE
ng/ml) NE xx/xx) NE
, NE , NE
LPS G#lipid XXX G#lipid
(10 NE (dd NE
ng/ml) NE xx/xx) NE
, NE , NE
thrombin G#protein_molecule xxx G#protein_molecule
(30 NE (dd NE
U/ml) NE X/xx) NE
, NE , NE
or NE xx NE
PMA G#other_organic_compound XXX G#other_organic_compound
(10 NE (dd NE
nM) NE xX) NE
. NE . NE

Agonist-induced G#other_name_B Xxxx-xxx G#other_name_B
monocytic G#other_name_M xxx G#other_name_M
cell G#other_name_M xxx G#other_name_M
adhesion G#other_name_E xxx G#other_name_E
, NE , NE
but NE xxx NE
not NE xxx NE
basal G#other_name_B xxx G#other_name_B
adhesion G#other_name_E xxx G#other_name_E
, NE , NE
was NE xxx NE
inhibited NE xxx NE
in NE xx NE
a NE x NE
time- G#other_name_B xxx- G#other_name_B
and G#other_name_M xxx G#other_name_M
concentration-dependent G#other_name_M xxx-xxx G#other_name_M
manner G#other_name_E xxx G#other_name_E
by NE xx NE
alpha-tcp G#other_organic_compound xxx-xxx G#other_organic_compound
. NE . NE

The NE Xxx NE
IC50 NE XXdd NE
of NE xx NE
alpha-tcp G#other_organic_compound xxx-xxx G#other_organic_compound
on NE xx NE
an NE xx NE
IL-1 NE XX-d NE
-induced NE -xxx NE
response NE xxx NE
was NE xxx NE
45 NE dd NE
microM NE xxxX NE
. NE . NE

The NE Xxx NE
inhibition NE xxx NE
correlated NE xxx NE
with NE xxx NE
a NE x NE
decrease NE xxx NE
in NE xx NE
steady NE xxx NE
state NE xxx NE
levels NE xxx NE
of NE xx NE
E-selectin G#RNA_molecule_B X-xxx G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
and NE xxx NE
cell G#other_name_B xxx G#other_name_B
surface G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
of NE xx NE
E-selectin G#protein_molecule X-xxx G#protein_molecule
which NE xxx NE
is NE xx NE
consistent NE xxx NE
with NE xxx NE
the NE xxx NE
ability NE xxx NE
of NE xx NE
a NE x NE
monoclonal G#protein_family_or_group_B xxx G#protein_family_or_group_B
antibody G#protein_family_or_group_E xxx G#protein_family_or_group_E
to NE xx NE
E-selectin G#protein_molecule X-xxx G#protein_molecule
to NE xx NE
inhibit NE xxx NE
monocytic G#other_name_B xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
adhesion G#other_name_E xxx G#other_name_E
in NE xx NE
this NE xxx NE
system NE xxx NE
. NE . NE

Probucol G#other_organic_compound Xxxx G#other_organic_compound
(50 NE (dd NE
microM) NE xxxX) NE
and NE xxx NE
N-acetylcysteine G#amino_acid_monomer X-xxx G#amino_acid_monomer
(20 NE (dd NE
mM) NE xX) NE
also NE xxx NE
inhibited NE xxx NE
agonist-induced G#other_name_B xxx-xxx G#other_name_B
monocytic G#other_name_M xxx G#other_name_M
cell G#other_name_M xxx G#other_name_M
adhesion G#other_name_E xxx G#other_name_E
; NE ; NE
whereas NE xxx NE
, NE , NE
several NE xxx NE
other NE xxx NE
antioxidants NE xxx NE
had NE xxx NE
no NE xx NE
significant NE xxx NE
effect NE xxx NE
. NE . NE

Protein G#protein_molecule_B Xxxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
PKC G#protein_molecule XXX G#protein_molecule
) NE ) NE
does NE xxx NE
not NE xxx NE
appear NE xxx NE
to NE xx NE
play NE xxx NE
a NE x NE
role NE xxx NE
in NE xx NE
the NE xxx NE
alpha-tcp G#other_organic_compound xxx-xxx G#other_organic_compound
effect NE xxx NE
since NE xxx NE
no NE xx NE
suppression NE xxx NE
of NE xx NE
phosphorylation G#other_name xxx G#other_name
of NE xx NE
PKC G#protein_molecule XXX G#protein_molecule
substrates NE xxx NE
was NE xxx NE
observed NE xxx NE
. NE . NE

Activation NE Xxxx NE
of NE xx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
is NE xx NE
reported NE xxx NE
to NE xx NE
be NE xx NE
necessary NE xxx NE
but NE xxx NE
not NE xxx NE
sufficient NE xxx NE
for NE xxx NE
E-selectin G#protein_molecule X-xxx G#protein_molecule
expression NE xxx NE
in NE xx NE
EC G#cell_line XX G#cell_line
. NE . NE

Electrophoretic NE Xxxx NE
mobility NE xxx NE
shift NE xxx NE
assays NE xxx NE
failed NE xxx NE
to NE xx NE
show NE xxx NE
an NE xx NE
alpha-tcp NE xxx-xxx NE
-induced NE -xxx NE
decrease NE xxx NE
in NE xx NE
activation NE xxx NE
of NE xx NE
this NE xxx NE
transcription NE xxx NE
factor NE xxx NE
after NE xxx NE
cytokine NE xxx NE
stimulation NE xxx NE
. NE . NE

It NE Xx NE
has NE xxx NE
been NE xxx NE
hypothesized NE xxx NE
that NE xxx NE
alpha-tcp G#other_organic_compound xxx-xxx G#other_organic_compound
acts NE xxx NE
as NE xx NE
an NE xx NE
anti-atherosclerotic G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
molecule G#other_organic_compound_E xxx G#other_organic_compound_E
by NE xx NE
inhibiting NE xxx NE
generation NE xxx NE
of NE xx NE
oxidized G#lipid_B xxx G#lipid_B
LDL G#lipid_E XXX G#lipid_E
--a NE --x NE
putative G#other_organic_compound_B xxx G#other_organic_compound_B
triggering G#other_organic_compound_M xxx G#other_organic_compound_M
molecule G#other_organic_compound_E xxx G#other_organic_compound_E
in NE xx NE
the NE xxx NE
atherosclerotic G#other_name_B xxx G#other_name_B
process G#other_name_E xxx G#other_name_E
. NE . NE

Our NE Xxx NE
results NE xxx NE
point NE xxx NE
to NE xx NE
a NE x NE
novel NE xxx NE
alternative NE xxx NE
mechanism NE xxx NE
of NE xx NE
action NE xxx NE
of NE xx NE
alpha-tcp G#other_organic_compound xxx-xxx G#other_organic_compound
. NE . NE

Central NE Xxxx NE
nervous NE xxx NE
system NE xxx NE
-derived NE -xxx NE
cells NE xxx NE
express NE xxx NE
a NE x NE
kappa NE xxx NE
B-binding NE X-xxx NE
activity NE xxx NE
that NE xxx NE
enhances NE xxx NE
human NE xxx NE
immunodeficiency NE xxx NE
virus NE xxx NE
type NE xxx NE
1 NE d NE
transcription NE xxx NE
in NE xx NE
vitro NE xxx NE
and NE xxx NE
facilitates NE xxx NE
TAR NE XXX NE
-independent NE -xxx NE
transactivation NE xxx NE
by NE xx NE
Tat NE Xxx NE
. NE . NE

The NE Xxx NE
Tat G#protein_molecule_B Xxx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
of NE xx NE
human G#virus_B xxx G#virus_B
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
type G#virus_M xxx G#virus_M
1 G#virus_E d G#virus_E
( NE ( NE
HIV-1 G#virus XXX-d G#virus
) NE ) NE
is NE xx NE
a NE x NE
potent NE xxx NE
activator NE xxx NE
of NE xx NE
long NE xxx NE
terminal NE xxx NE
repeat NE xxx NE
-directed NE -xxx NE
transcription NE xxx NE
. NE . NE

While NE Xxxx NE
in NE xx NE
most NE xxx NE
cell NE xxx NE
types NE xxx NE
, NE , NE
activation NE xxx NE
requires NE xxx NE
interaction NE xxx NE
of NE xx NE
Tat NE Xxx NE
with NE xxx NE
the NE xxx NE
unusual NE xxx NE
transcription G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
element G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
TAR G#DNA_domain_or_region XXX G#DNA_domain_or_region
, NE , NE
astrocytic G#cell_type_B xxx G#cell_type_B
glial G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
support NE xxx NE
TAR NE XXX NE
-independent NE -xxx NE
transactivation NE xxx NE
of NE xx NE
HIV-1 NE XXX-d NE
transcription NE xxx NE
by NE xx NE
Tat NE Xxx NE
. NE . NE

This NE Xxxx NE
alternative NE xxx NE
pathway NE xxx NE
of NE xx NE
Tat G#other_name_B Xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
is NE xx NE
mediated NE xxx NE
by NE xx NE
the NE xxx NE
viral G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
a NE x NE
kappa NE xxx NE
B NE X NE
domain NE xxx NE
capable NE xxx NE
of NE xx NE
binding NE xxx NE
the NE xxx NE
prototypical NE xxx NE
form NE xxx NE
of NE xx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
nuclear NE xxx NE
factor NE xxx NE
kappa NE xxx NE
B NE X NE
( NE ( NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
) NE ) NE
present NE xxx NE
in NE xx NE
many NE xxx NE
cell NE xxx NE
types NE xxx NE
, NE , NE
including NE xxx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

Tat G#protein_molecule Xxx G#protein_molecule
transactivation NE xxx NE
mediated NE xxx NE
by NE xx NE
the NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
domain G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
sufficient NE xxx NE
to NE xx NE
allow NE xxx NE
replication NE xxx NE
of NE xx NE
TAR NE XXX NE
-deleted NE -xxx NE
mutant NE xxx NE
HIV-1 NE XXX-d NE
in NE xx NE
astrocytes NE xxx NE
. NE . NE

The NE Xxx NE
present NE xxx NE
study NE xxx NE
demonstrates NE xxx NE
the NE xxx NE
existence NE xxx NE
of NE xx NE
kappa G#protein_family_or_group_B xxx G#protein_family_or_group_B
B-specific G#protein_family_or_group_M X-xxx G#protein_family_or_group_M
binding G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
present NE xxx NE
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
glial G#cell_type_M xxx G#cell_type_M
astrocytes G#cell_type_E xxx G#cell_type_E
that NE xxx NE
differ NE xxx NE
from NE xxx NE
prototypical NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
. NE . NE

The NE Xxx NE
novel NE xxx NE
astrocyte-derived NE xxx-xxx NE
kappa G#other_name_B xxx G#other_name_B
B-binding G#other_name_M X-xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
is NE xx NE
retained NE xxx NE
on NE xx NE
an NE xx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
Tat G#other_name_M Xxx G#other_name_M
affinity G#other_name_M xxx G#other_name_M
column G#other_name_E xxx G#other_name_E
, NE , NE
while NE xxx NE
prototypical NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
from NE xxx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
is NE xx NE
not NE xxx NE
. NE . NE

In NE Xx NE
vitro NE xxx NE
transcription NE xxx NE
studies NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
astrocyte-derived G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
kappa G#protein_family_or_group_M xxx G#protein_family_or_group_M
B-binding G#protein_family_or_group_M X-xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
activate NE xxx NE
transcription NE xxx NE
of NE xx NE
the NE xxx NE
HIV-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
long G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
terminal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
repeat G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
that NE xxx NE
this NE xxx NE
activation NE xxx NE
is NE xx NE
dependent NE xxx NE
on NE xx NE
the NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
domain G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Moreover NE Xxxx NE
, NE , NE
TAR NE XXX NE
-independent NE -xxx NE
transactivation NE xxx NE
of NE xx NE
HIV-1 NE XXX-d NE
transcription NE xxx NE
is NE xx NE
reproduced NE xxx NE
in NE xx NE
vitro NE xxx NE
in NE xx NE
an NE xx NE
astrocyte NE xxx NE
factor-dependent NE xxx-xxx NE
manner NE xxx NE
which NE xxx NE
correlates NE xxx NE
with NE xxx NE
kappa NE xxx NE
B-binding NE X-xxx NE
activity NE xxx NE
. NE . NE

The NE Xxx NE
importance NE xxx NE
of NE xx NE
the NE xxx NE
central NE xxx NE
nervous NE xxx NE
system NE xxx NE
-enriched NE -xxx NE
kappa NE xxx NE
B NE X NE
transcription NE xxx NE
factor NE xxx NE
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
HIV-1 NE XXX-d NE
expression NE xxx NE
is NE xx NE
discussed NE xxx NE
. NE . NE

Human G#protein_molecule_B Xxxx G#protein_molecule_B
interleukin-13 G#protein_molecule_E xxx-dd G#protein_molecule_E
activates NE xxx NE
the NE xxx NE
interleukin-4-dependent G#protein_family_or_group_B xxx-d-xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
NF-IL4 G#protein_molecule XX-XXd G#protein_molecule
sharing NE xxx NE
a NE x NE
DNA G#protein_substructure_B XXX G#protein_substructure_B
binding G#protein_substructure_M xxx G#protein_substructure_M
motif G#protein_substructure_E xxx G#protein_substructure_E
with NE xxx NE
an NE xx NE
interferon-gamma-induced G#protein_molecule_B xxx-xxx-xxx G#protein_molecule_B
nuclear G#protein_molecule_M xxx G#protein_molecule_M
binding G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

The NE Xxx NE
effects NE xxx NE
of NE xx NE
interleukin-13 G#protein_molecule xxx-dd G#protein_molecule
( NE ( NE
IL-13 G#protein_molecule XX-dd G#protein_molecule
) NE ) NE
and NE xxx NE
interleukin-4 G#protein_molecule xxx-d G#protein_molecule
( NE ( NE
IL-4 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
on NE xx NE
cellular G#other_name_B xxx G#other_name_B
functions G#other_name_E xxx G#other_name_E
were NE xxx NE
shown NE xxx NE
to NE xx NE
be NE xx NE
quite NE xxx NE
similar NE xxx NE
. NE . NE

We NE Xx NE
provide NE xxx NE
evidence NE xxx NE
that NE xxx NE
in NE xx NE
monocytes NE xxx NE
as NE xx NE
well NE xxx NE
as NE xx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
both NE xxx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-13 G#protein_molecule XX-dd G#protein_molecule
activate NE xxx NE
the NE xxx NE
same NE xxx NE
recently NE xxx NE
identified NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
NF-IL4 G#protein_molecule XX-XXd G#protein_molecule
which NE xxx NE
binds NE xxx NE
to NE xx NE
the NE xxx NE
specific G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
responsive G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
IL-4RE G#DNA_domain_or_region_E XX-dXX G#DNA_domain_or_region_E
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
a NE x NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
activated NE xxx NE
by NE xx NE
interferon-gamma NE xxx-xxx NE
also NE xxx NE
interacts NE xxx NE
with NE xxx NE
the NE xxx NE
IL-4RE G#DNA_domain_or_region XX-dXX G#DNA_domain_or_region
. NE . NE

It NE Xx NE
differs NE xxx NE
from NE xxx NE
NF-IL4 G#protein_molecule XX-XXd G#protein_molecule
in NE xx NE
the NE xxx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
complex NE xxx NE
with NE xxx NE
DNA NE XXX NE
, NE , NE
in NE xx NE
its NE xxx NE
DNA-binding G#other_name_B XXX-xxx G#other_name_B
specificity G#other_name_E xxx G#other_name_E
and NE xxx NE
in NE xx NE
the NE xxx NE
proteins NE xxx NE
interacting NE xxx NE
with NE xxx NE
the NE xxx NE
DNA G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Sensitivity NE Xxxx NE
against NE xxx NE
various NE xxx NE
enzyme G#other_organic_compound_B xxx G#other_organic_compound_B
inhibitors G#other_organic_compound_E xxx G#other_organic_compound_E
suggests NE xxx NE
that NE xxx NE
components NE xxx NE
of NE xx NE
the NE xxx NE
signal G#other_name_B xxx G#other_name_B
transduction G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
are NE xxx NE
shared NE xxx NE
by NE xx NE
all NE xxx NE
three NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
. NE . NE

Encephalomyocarditis G#virus_B Xxxx G#virus_B
virus G#virus_E xxx G#virus_E
internal G#cell_component_B xxx G#cell_component_B
ribosomal G#cell_component_M xxx G#cell_component_M
entry G#cell_component_M xxx G#cell_component_M
site G#cell_component_E xxx G#cell_component_E
RNA-protein G#other_name_B XXX-xxx G#other_name_B
interactions G#other_name_E xxx G#other_name_E
. NE . NE

Translational NE Xxxx NE
initiation NE xxx NE
of NE xx NE
encephalomyocarditis NE xxx NE
virus NE xxx NE
( NE ( NE
EMCV NE XXXX NE
) NE ) NE
mRNA NE xXXX NE
occurs NE xxx NE
by NE xx NE
ribosomal NE xxx NE
entry NE xxx NE
into NE xxx NE
the NE xxx NE
5' NE d' NE
nontranslated NE xxx NE
region NE xxx NE
of NE xx NE
the NE xxx NE
EMCV NE XXXX NE
mRNA NE xXXX NE
, NE , NE
rather NE xxx NE
than NE xxx NE
by NE xx NE
ribosomal NE xxx NE
scanning NE xxx NE
. NE . NE

Internal NE Xxxx NE
ribosomal G#other_name_B xxx G#other_name_B
binding G#other_name_E xxx G#other_name_E
requires NE xxx NE
a NE x NE
cis-acting G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
termed NE xxx NE
the NE xxx NE
internal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
ribosomal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
entry G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
IRES G#DNA_domain_or_region XXXX G#DNA_domain_or_region
) NE ) NE
. NE . NE

IRES G#DNA_family_or_group_B XXXX G#DNA_family_or_group_B
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
have NE xxx NE
been NE xxx NE
proposed NE xxx NE
to NE xx NE
be NE xx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
translation NE xxx NE
of NE xx NE
picornavirus G#RNA_family_or_group_B xxx G#RNA_family_or_group_B
mRNAs G#RNA_family_or_group_E xXXXx G#RNA_family_or_group_E
and NE xxx NE
some NE xxx NE
cellular G#RNA_family_or_group_B xxx G#RNA_family_or_group_B
mRNAs G#RNA_family_or_group_E xXXXx G#RNA_family_or_group_E
. NE . NE

Internal NE Xxxx NE
ribosome NE xxx NE
binding NE xxx NE
likely NE xxx NE
requires NE xxx NE
the NE xxx NE
interaction NE xxx NE
of NE xx NE
trans-acting G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
recognize NE xxx NE
both NE xxx NE
the NE xxx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
and NE xxx NE
the NE xxx NE
ribosomal G#protein_complex_B xxx G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
. NE . NE

Five NE Xxxx NE
cellular G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
p52 G#protein_molecule xdd G#protein_molecule
, NE , NE
p57 G#protein_molecule xdd G#protein_molecule
, NE , NE
p70 G#protein_molecule xdd G#protein_molecule
, NE , NE
p72 G#protein_molecule xdd G#protein_molecule
, NE , NE
and NE xxx NE
p100 G#protein_molecule xddd G#protein_molecule
) NE ) NE
cross-link NE xxx-xxx NE
the NE xxx NE
EMCV G#virus XXXX G#virus
IRES G#DNA_domain_or_region XXXX G#DNA_domain_or_region
or NE xx NE
fragments NE xxx NE
of NE xx NE
the NE xxx NE
IRES G#DNA_domain_or_region XXXX G#DNA_domain_or_region
. NE . NE

For NE Xxx NE
one NE xxx NE
of NE xx NE
these NE xxx NE
proteins NE xxx NE
, NE , NE
p57 G#protein_molecule xdd G#protein_molecule
, NE , NE
binding NE xxx NE
to NE xx NE
the NE xxx NE
IRES G#DNA_domain_or_region XXXX G#DNA_domain_or_region
correlates NE xxx NE
with NE xxx NE
translation NE xxx NE
. NE . NE

Recently NE Xxxx NE
, NE , NE
p57 G#protein_molecule xdd G#protein_molecule
was NE xxx NE
identified NE xxx NE
to NE xx NE
be NE xx NE
very NE xxx NE
similar NE xxx NE
, NE , NE
if NE xx NE
not NE xxx NE
identical NE xxx NE
, NE , NE
to NE xx NE
polypyrimidine G#protein_molecule_B xxx G#protein_molecule_B
tract-binding G#protein_molecule_M xxx-xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

On NE Xx NE
the NE xxx NE
basis NE xxx NE
of NE xx NE
cross-linking NE xxx-xxx NE
results NE xxx NE
with NE xxx NE
21 NE dd NE
different NE xxx NE
EMCV G#DNA_molecule_B XXXX G#DNA_molecule_B
IRES G#DNA_molecule_M XXXX G#DNA_molecule_M
fragments G#DNA_molecule_E xxx G#DNA_molecule_E
and NE xxx NE
cytoplasmic G#cell_component_B xxx G#cell_component_B
HeLa G#cell_component_M XxXx G#cell_component_M
extract G#cell_component_E xxx G#cell_component_E
or NE xx NE
rabbit G#cell_component_B xxx G#cell_component_B
reticulocyte G#cell_component_M xxx G#cell_component_M
lysate G#cell_component_E xxx G#cell_component_E
as NE xx NE
the NE xxx NE
source NE xxx NE
of NE xx NE
polypeptides G#peptide xxx G#peptide
, NE , NE
consensus G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
p52 G#protein_molecule xdd G#protein_molecule
, NE , NE
p57 G#protein_molecule xdd G#protein_molecule
, NE , NE
p70 G#protein_molecule xdd G#protein_molecule
, NE , NE
and NE xxx NE
p100 G#protein_molecule xddd G#protein_molecule
are NE xxx NE
proposed NE xxx NE
. NE . NE

It NE Xx NE
is NE xx NE
suggested NE xxx NE
that NE xxx NE
each NE xxx NE
of NE xx NE
these NE xxx NE
proteins NE xxx NE
recognizes NE xxx NE
primarily NE xxx NE
a NE x NE
structural NE xxx NE
feature NE xxx NE
of NE xx NE
the NE xxx NE
RNA G#RNA_N/A XXX G#RNA_N/A
rather NE xxx NE
than NE xxx NE
a NE x NE
specific NE xxx NE
sequence NE xxx NE
. NE . NE

A NE X NE
novel NE xxx NE
heterodimerization G#protein_family_or_group_B xxx G#protein_family_or_group_B
partner G#protein_family_or_group_E xxx G#protein_family_or_group_E
for NE xxx NE
thyroid G#protein_family_or_group_B xxx G#protein_family_or_group_B
hormone G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Peroxisome G#protein_molecule_B Xxxx G#protein_molecule_B
proliferator-activated G#protein_molecule_M xxx-xxx G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Retinoid-like G#protein_family_or_group_B Xxxx-xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
play NE xxx NE
a NE x NE
central NE xxx NE
role NE xxx NE
in NE xx NE
hormonal G#other_name_B xxx G#other_name_B
responses G#other_name_E xxx G#other_name_E
by NE xx NE
forming NE xxx NE
heterodimers G#protein_complex xxx G#protein_complex
with NE xxx NE
other NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
hormone G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
we NE xx NE
have NE xxx NE
identified NE xxx NE
the NE xxx NE
peroxisome G#protein_molecule_B xxx G#protein_molecule_B
proliferator-activated G#protein_molecule_M xxx-xxx G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
PPAR G#protein_molecule XXXX G#protein_molecule
) NE ) NE
as NE xx NE
a NE x NE
new NE xxx NE
thyroid NE xxx NE
hormone NE xxx NE
receptor NE xxx NE
( NE ( NE
THR NE XXX NE
) NE ) NE
auxiliary NE xxx NE
nuclear NE xxx NE
protein NE xxx NE
, NE , NE
heterodimerizing NE xxx NE
with NE xxx NE
THR NE XXX NE
in NE xx NE
solution NE xxx NE
. NE . NE

Although NE Xxxx NE
these NE xxx NE
heterodimers G#protein_complex xxx G#protein_complex
do NE xx NE
not NE xxx NE
recognize NE xxx NE
a NE x NE
classical NE xxx NE
thyroid G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
hormone G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
response G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
TRE G#DNA_domain_or_region XXX G#DNA_domain_or_region
) NE ) NE
characterized NE xxx NE
by NE xx NE
direct G#DNA_substructure_B xxx G#DNA_substructure_B
repeat G#DNA_substructure_E xxx G#DNA_substructure_E
separated NE xxx NE
by NE xx NE
four G#nucleotide_B xxx G#nucleotide_B
nucleotides G#nucleotide_E xxx G#nucleotide_E
( NE ( NE
DR+4 G#DNA_domain_or_region XX+d G#DNA_domain_or_region
) NE ) NE
, NE , NE
PPAR G#protein_molecule XXXX G#protein_molecule
behaves NE xxx NE
as NE xx NE
a NE x NE
dominant G#other_name_B xxx G#other_name_B
negative G#other_name_M xxx G#other_name_M
regulator G#other_name_E xxx G#other_name_E
of NE xx NE
thyroid NE xxx NE
hormone NE xxx NE
( NE ( NE
TH NE XX NE
) NE ) NE
action NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
a NE x NE
TH NE XX NE
-dependent NE -xxx NE
positive NE xxx NE
effect NE xxx NE
is NE xx NE
elicited NE xxx NE
by NE xx NE
selective NE xxx NE
interaction NE xxx NE
of NE xx NE
the NE xxx NE
THR NE XXX NE
beta- NE xxx- NE
PPAR NE XXXX NE
but NE xxx NE
not NE xxx NE
the NE xxx NE
THR NE XXX NE
alpha- NE xxx- NE
PPAR NE XXXX NE
heterodimer NE xxx NE
with NE xxx NE
a NE x NE
novel NE xxx NE
TRE NE XXX NE
( NE ( NE
DR+2 NE XX+d NE
) NE ) NE
. NE . NE

The NE Xxx NE
critical NE xxx NE
region NE xxx NE
of NE xx NE
THR G#protein_family_or_group XXX G#protein_family_or_group
beta NE xxx NE
was NE xxx NE
mapped NE xxx NE
to NE xx NE
3 NE d NE
amino G#amino_acid_monomer_B xxx G#amino_acid_monomer_B
acids G#amino_acid_monomer_E xxx G#amino_acid_monomer_E
in NE xx NE
the NE xxx NE
distal G#protein_substructure_B xxx G#protein_substructure_B
box G#protein_substructure_E xxx G#protein_substructure_E
of NE xx NE
the NE xxx NE
DNA G#protein_domain_or_region_B XXX G#protein_domain_or_region_B
binding G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

Hence NE Xxxx NE
, NE , NE
PPAR G#protein_molecule XXXX G#protein_molecule
can NE xxx NE
positively NE xxx NE
or NE xx NE
negatively NE xxx NE
influence NE xxx NE
TH G#peptide XX G#peptide
action NE xxx NE
depending NE xxx NE
on NE xx NE
TRE G#other_name_B XXX G#other_name_B
structure G#other_name_E xxx G#other_name_E
and NE xxx NE
THR G#protein_family_or_group_B XXX G#protein_family_or_group_B
isotype G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Comparison NE Xxxx NE
of NE xx NE
retinoic G#other_organic_compound_B xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
myristate G#other_organic_compound_M xxx G#other_organic_compound_M
acetate G#other_organic_compound_E xxx G#other_organic_compound_E
as NE xx NE
inducers NE xxx NE
of NE xx NE
monocytic G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

Several NE Xxxx NE
human G#cell_line_B xxx G#cell_line_B
myeloid G#cell_line_M xxx G#cell_line_M
leukemia G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
growing NE xxx NE
in NE xx NE
vitro NE xxx NE
can NE xxx NE
be NE xx NE
induced NE xxx NE
to NE xx NE
differentiate NE xxx NE
to NE xx NE
more NE xxx NE
mature NE xxx NE
monocyte/macrophage-like G#cell_type_B xxx/xxx-xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
treatment NE xxx NE
with NE xxx NE
protein NE xxx NE
kinase NE xxx NE
C NE X NE
-activating NE -xxx NE
phorbol NE xxx NE
esters NE xxx NE
, NE , NE
such NE xxx NE
as NE xx NE
PMA NE XXX NE
. NE . NE

In NE Xx NE
addition NE xxx NE
to NE xx NE
PMA G#other_organic_compound XXX G#other_organic_compound
, NE , NE
cells NE xxx NE
of NE xx NE
the NE xxx NE
THP-1 G#cell_line_B XXX-d G#cell_line_B
myeloid G#cell_line_M xxx G#cell_line_M
leukemia G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
acquire NE xxx NE
macrophage-like G#other_name_B xxx-xxx G#other_name_B
characteristics G#other_name_E xxx G#other_name_E
after NE xxx NE
treatment NE xxx NE
with NE xxx NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
retinoic G#other_organic_compound_M xxx G#other_organic_compound_M
acid G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
RA G#other_organic_compound XX G#other_organic_compound
) NE ) NE
. NE . NE

To NE Xx NE
analyze NE xxx NE
the NE xxx NE
signal G#other_name_B xxx G#other_name_B
transduction G#other_name_M xxx G#other_name_M
mechanisms G#other_name_E xxx G#other_name_E
induced NE xxx NE
by NE xx NE
RA G#other_organic_compound XX G#other_organic_compound
, NE , NE
we NE xx NE
first NE xxx NE
compared NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
PMA G#other_organic_compound XXX G#other_organic_compound
and NE xxx NE
RA G#other_organic_compound XX G#other_organic_compound
on NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
genes NE xxx NE
which NE xxx NE
are NE xxx NE
known NE xxx NE
to NE xx NE
be NE xx NE
regulated NE xxx NE
during NE xxx NE
monocytic G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

Both NE Xxxx NE
RA G#other_organic_compound XX G#other_organic_compound
and NE xxx NE
PMA G#other_organic_compound XXX G#other_organic_compound
effectively NE xxx NE
down-regulated NE xxx-xxx NE
c-myc G#other_name_B x-xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
, NE , NE
while NE xxx NE
c-myb G#other_name_B x-xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
decreased NE xxx NE
only NE xxx NE
after NE xxx NE
PMA G#other_name_B XXX G#other_name_B
treatment G#other_name_E xxx G#other_name_E
. NE . NE

Expression NE Xxxx NE
of NE xx NE
the NE xxx NE
beta G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
2-integrin G#DNA_family_or_group_M d-xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
CD11a G#DNA_domain_or_region XXddx G#DNA_domain_or_region
and NE xxx NE
CD11b G#DNA_domain_or_region XXddx G#DNA_domain_or_region
, NE , NE
was NE xxx NE
clearly NE xxx NE
increased NE xxx NE
after NE xxx NE
both NE xxx NE
of NE xx NE
these NE xxx NE
treatments NE xxx NE
. NE . NE

Their NE Xxxx NE
effects NE xxx NE
on NE xx NE
the NE xxx NE
src-family G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
tyrosine G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
kinase G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
were NE xxx NE
different NE xxx NE
: NE : NE
hck G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
was NE xxx NE
similarly NE xxx NE
induced NE xxx NE
by NE xx NE
these NE xxx NE
agents NE xxx NE
but NE xxx NE
lyn G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
was NE xxx NE
stronger NE xxx NE
and NE xxx NE
more NE xxx NE
rapid NE xxx NE
after NE xxx NE
RA G#other_name_B XX G#other_name_B
treatment G#other_name_E xxx G#other_name_E
. NE . NE

RA G#other_organic_compound XX G#other_organic_compound
also NE xxx NE
enhanced NE xxx NE
lyn G#other_name_B xxx G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
production G#other_name_E xxx G#other_name_E
rapidly NE xxx NE
in NE xx NE
HL-60 G#cell_line XX-dd G#cell_line
, NE , NE
indicating NE xxx NE
that NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
lyn G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
is NE xx NE
common NE xxx NE
in NE xx NE
monocytic G#other_name_B xxx G#other_name_B
maturation G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
granulocytic G#other_name_M xxx G#other_name_M
maturation G#other_name_E xxx G#other_name_E
of NE xx NE
myeloid G#cell_type_B xxx G#cell_type_B
leukemia G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

To NE Xx NE
examine NE xxx NE
whether NE xxx NE
the NE xxx NE
AP-1 G#other_name_B XX-d G#other_name_B
enhancer G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
is NE xx NE
involved NE xxx NE
in NE xx NE
RA G#other_organic_compound XX G#other_organic_compound
-induced NE -xxx NE
monocytic G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
, NE , NE
THP-1 G#cell_line_B XXX-d G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
were NE xxx NE
transiently NE xxx NE
transfected NE xxx NE
with NE xxx NE
a NE x NE
chloramphenicol NE xxx NE
acetyl NE xxx NE
transferase NE xxx NE
( NE ( NE
CAT NE XXX NE
)-reporter NE )-xxx NE
gene NE xxx NE
containing NE xxx NE
5 NE d NE
copies NE xxx NE
of NE xx NE
the NE xxx NE
AP-1 NE XX-d NE
binding NE xxx NE
sites NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
to NE xx NE
PMA G#other_organic_compound XXX G#other_organic_compound
, NE , NE
RA G#other_organic_compound XX G#other_organic_compound
did NE xxx NE
not NE xxx NE
induce NE xxx NE
any NE xxx NE
CAT G#other_name_B XXX G#other_name_B
activity G#other_name_E xxx G#other_name_E
in NE xx NE
these NE xxx NE
cells NE xxx NE
, NE , NE
thus NE xxx NE
suggesting NE xxx NE
that NE xxx NE
the NE xxx NE
RA NE XX NE
-induced NE -xxx NE
changes NE xxx NE
in NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
those NE xxx NE
genes NE xxx NE
described NE xxx NE
above NE xxx NE
were NE xxx NE
not NE xxx NE
dependent NE xxx NE
on NE xx NE
the NE xxx NE
AP-1 NE XX-d NE
enhancer NE xxx NE
activity NE xxx NE
. NE . NE

An NE Xx NE
active NE xxx NE
v-abl G#protein_molecule_B x-xxx G#protein_molecule_B
protein G#protein_molecule_M xxx G#protein_molecule_M
tyrosine G#protein_molecule_M xxx G#protein_molecule_M
kinase G#protein_molecule_E xxx G#protein_molecule_E
blocks NE xxx NE
immunoglobulin G#other_name_B xxx G#other_name_B
light-chain G#other_name_M xxx-xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
rearrangement G#other_name_E xxx G#other_name_E
. NE . NE

Lymphoid G#cell_type_B Xxxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
transformed NE xxx NE
by NE xx NE
Abelson G#virus_B Xxxx G#virus_B
murine G#virus_M xxx G#virus_M
leukemia G#virus_M xxx G#virus_M
virus G#virus_E xxx G#virus_E
have NE xxx NE
provided NE xxx NE
one NE xxx NE
of NE xx NE
the NE xxx NE
classic NE xxx NE
models NE xxx NE
for NE xxx NE
study NE xxx NE
of NE xx NE
early G#other_name_B xxx G#other_name_B
B-cell G#other_name_M X-xxx G#other_name_M
development G#other_name_E xxx G#other_name_E
and NE xxx NE
immunoglobulin G#other_name_B xxx G#other_name_B
rearrangement G#other_name_E xxx G#other_name_E
. NE . NE

Most NE Xxxx NE
of NE xx NE
these NE xxx NE
cells NE xxx NE
have NE xxx NE
rearranged NE xxx NE
their NE xxx NE
heavy-chain G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
locus G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
but NE xxx NE
not NE xxx NE
their NE xxx NE
light G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
chain G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
genes G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
suggesting NE xxx NE
that NE xxx NE
an NE xx NE
active NE xxx NE
v-abl G#protein_molecule_B x-xxx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
interferes NE xxx NE
with NE xxx NE
this NE xxx NE
differentiation NE xxx NE
step NE xxx NE
. NE . NE

To NE Xx NE
test NE xxx NE
this NE xxx NE
hypothesis NE xxx NE
, NE , NE
light-chain G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
structure G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
examined NE xxx NE
in NE xx NE
pre-B G#cell_line_B xxx-X G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
transformed NE xxx NE
by NE xx NE
temperature-sensitive G#virus_B xxx-xxx G#virus_B
mutants G#virus_E xxx G#virus_E
of NE xx NE
the NE xxx NE
Abelson G#virus_B Xxxx G#virus_B
virus G#virus_E xxx G#virus_E
and NE xxx NE
in NE xx NE
derivatives NE xxx NE
that NE xxx NE
survive NE xxx NE
at NE xx NE
the NE xxx NE
nonpermissive NE xxx NE
temperature NE xxx NE
because NE xxx NE
they NE xxx NE
express NE xxx NE
a NE x NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
BCL-2 G#DNA_domain_or_region_M XXX-d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Our NE Xxx NE
studies NE xxx NE
reveal NE xxx NE
that NE xxx NE
inactivation NE xxx NE
of NE xx NE
the NE xxx NE
v-abl G#protein_molecule_B x-xxx G#protein_molecule_B
protein G#protein_molecule_M xxx G#protein_molecule_M
tyrosine G#protein_molecule_M xxx G#protein_molecule_M
kinase G#protein_molecule_E xxx G#protein_molecule_E
triggers NE xxx NE
high-frequency NE xxx-xxx NE
rearrangement NE xxx NE
of NE xx NE
kappa G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
light-chain G#DNA_family_or_group_M xxx-xxx G#DNA_family_or_group_M
gene G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
and G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
lambda G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
light-chain G#DNA_family_or_group_M xxx-xxx G#DNA_family_or_group_M
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E

These NE Xxxx NE
events NE xxx NE
are NE xxx NE
accompanied NE xxx NE
by NE xx NE
marked NE xxx NE
increases NE xxx NE
in NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
RAG-1 G#RNA_family_or_group_B XXX-d G#RNA_family_or_group_B
and G#RNA_family_or_group_M xxx G#RNA_family_or_group_M
RAG-2 G#RNA_family_or_group_M XXX-d G#RNA_family_or_group_M
RNAs G#RNA_family_or_group_E XXXx G#RNA_family_or_group_E
. NE . NE

These NE Xxxx NE
increases NE xxx NE
occur NE xxx NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
protein G#other_name_B xxx G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
but NE xxx NE
are NE xxx NE
dependent NE xxx NE
on NE xx NE
inactivation NE xxx NE
of NE xx NE
the NE xxx NE
v-abl G#protein_molecule_B x-xxx G#protein_molecule_B
protein G#protein_molecule_M xxx G#protein_molecule_M
tyrosine G#protein_molecule_M xxx G#protein_molecule_M
kinase G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

As NE Xx NE
documented NE xxx NE
in NE xx NE
the NE xxx NE
accompanying NE xxx NE
paper NE xxx NE
(Klug NE (Xxxx NE
et NE xx NE
al. NE xx. NE
, NE , NE
this NE xxx NE
issue) NE xxx) NE
, NE , NE
an NE xx NE
active NE xxx NE
v-abl G#protein_molecule_B x-xxx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
also NE xxx NE
suppresses NE xxx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
/rel NE /xxx NE
and NE xxx NE
expression NE xxx NE
controlled NE xxx NE
by NE xx NE
the NE xxx NE
kappa NE xxx NE
intron NE xxx NE
enhancer NE xxx NE
. NE . NE

Together NE Xxxx NE
these NE xxx NE
data NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
the NE xxx NE
v-abl G#protein_molecule_B x-xxx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
specifically NE xxx NE
interferes NE xxx NE
with NE xxx NE
light-chain G#other_name_B xxx-xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
rearrangement G#other_name_E xxx G#other_name_E
by NE xx NE
suppressing NE xxx NE
at NE xx NE
least NE xxx NE
two NE xxx NE
pathways NE xxx NE
essential NE xxx NE
for NE xxx NE
this NE xxx NE
stage NE xxx NE
of NE xx NE
B-cell G#other_name_B X-xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
and NE xxx NE
suggest NE xxx NE
that NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
is NE xx NE
important NE xxx NE
in NE xx NE
regulating NE xxx NE
RAG G#other_name_B XXX G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

Calcium G#other_name_B Xxxx G#other_name_B
signalling G#other_name_E xxx G#other_name_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
stimulated NE xxx NE
by NE xx NE
a NE x NE
cyclophilin G#protein_family_or_group_B xxx G#protein_family_or_group_B
B-binding G#protein_family_or_group_M X-xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

The NE Xxx NE
immunosuppressant G#other_organic_compound_B xxx G#other_organic_compound_B
drug G#other_organic_compound_E xxx G#other_organic_compound_E
cyclosporin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
blocks NE xxx NE
a NE x NE
calcium NE xxx NE
-dependent NE -xxx NE
signal NE xxx NE
from NE xxx NE
the NE xxx NE
T-cell NE X-xxx NE
receptor NE xxx NE
( NE ( NE
TCR NE XXX NE
) NE ) NE
that NE xxx NE
normally NE xxx NE
leads NE xxx NE
to NE xx NE
T-cell NE X-xxx NE
activation NE xxx NE
. NE . NE

When NE Xxxx NE
bound NE xxx NE
to NE xx NE
cyclophilin G#protein_molecule xxx G#protein_molecule
, NE , NE
cyclosporin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
binds NE xxx NE
and NE xxx NE
inactivates NE xxx NE
the NE xxx NE
key G#other_name_B xxx G#other_name_B
signalling G#other_name_M xxx G#other_name_M
intermediate G#other_name_E xxx G#other_name_E
calcineurin G#protein_molecule xxx G#protein_molecule
. NE . NE

To NE Xx NE
identify NE xxx NE
potential NE xxx NE
cellular NE xxx NE
homologues NE xxx NE
of NE xx NE
cyclosporin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
that NE xxx NE
might NE xxx NE
regulate NE xxx NE
calcium G#other_name_B xxx G#other_name_B
signalling G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
have NE xxx NE
cloned NE xxx NE
human NE xxx NE
genes NE xxx NE
encoding NE xxx NE
cyclophilin G#protein_family_or_group_B xxx G#protein_family_or_group_B
B-binding-proteins G#protein_family_or_group_E X-xxx-xxx G#protein_family_or_group_E
using NE xxx NE
the NE xxx NE
yeast G#other_name_B xxx G#other_name_B
two-hybrid G#other_name_M xxx-xxx G#other_name_M
system G#other_name_E xxx G#other_name_E
. NE . NE

One NE Xxx NE
gene NE xxx NE
product NE xxx NE
, NE , NE
when NE xxx NE
overexpressed NE xxx NE
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
specifically NE xxx NE
induced NE xxx NE
transcription NE xxx NE
from NE xxx NE
the NE xxx NE
interleukin-2 G#DNA_domain_or_region_B xxx-d G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
by NE xx NE
activating NE xxx NE
the NE xxx NE
T-cell-specific G#protein_family_or_group_B X-xxx-xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
NF-AT G#protein_molecule XX-XX G#protein_molecule
and NE xxx NE
NF-IL2A G#protein_molecule XX-XXdX G#protein_molecule
. NE . NE

This NE Xxxx NE
protein NE xxx NE
, NE , NE
termed NE xxx NE
calcium NE xxx NE
-signal NE -xxx NE
modulating NE xxx NE
cyclophilin NE xxx NE
ligand NE xxx NE
( NE ( NE
CAML NE XXXX NE
) NE ) NE
, NE , NE
acts NE xxx NE
downstream NE xxx NE
of NE xx NE
the NE xxx NE
TCR NE XXX NE
and NE xxx NE
upstream NE xxx NE
of NE xx NE
calcineurin NE xxx NE
by NE xx NE
causing NE xxx NE
an NE xx NE
influx NE xxx NE
of NE xx NE
calcium NE xxx NE
. NE . NE

CAML G#protein_molecule XXXX G#protein_molecule
appears NE xxx NE
to NE xx NE
be NE xx NE
a NE x NE
new NE xxx NE
participant NE xxx NE
in NE xx NE
the NE xxx NE
calcium NE xxx NE
-signal NE -xxx NE
transduction NE xxx NE
pathway NE xxx NE
, NE , NE
implicating NE xxx NE
cyclophilin NE xxx NE
B NE X NE
in NE xx NE
calcium NE xxx NE
signalling NE xxx NE
, NE , NE
even NE xxx NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
cyclosporin NE xxx NE
. NE . NE

Expression NE Xxxx NE
and NE xxx NE
genomic NE xxx NE
configuration NE xxx NE
of NE xx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
, NE , NE
IL-3 G#protein_molecule XX-d G#protein_molecule
, NE , NE
M-CSF G#protein_molecule_B X-XXX G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
C-FMS G#protein_molecule X-XXX G#protein_molecule
) NE ) NE
, NE , NE
early G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
growth G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
response G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene-1 G#DNA_domain_or_region_E xxx-d G#DNA_domain_or_region_E
( NE ( NE
EGR-1 G#DNA_domain_or_region XXX-d G#DNA_domain_or_region
) NE ) NE
and NE xxx NE
M-CSF G#DNA_domain_or_region_B X-XXX G#DNA_domain_or_region_B
genes G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
primary G#other_name_B xxx G#other_name_B
myelodysplastic G#other_name_M xxx G#other_name_M
syndromes G#other_name_E xxx G#other_name_E
. NE . NE

Peripheral NE Xxxx NE
blood NE xxx NE
mononuclear NE xxx NE
cells NE xxx NE
from NE xxx NE
seventeen NE xxx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
primary G#other_name_B xxx G#other_name_B
myelodysplastic G#other_name_M xxx G#other_name_M
syndromes G#other_name_E xxx G#other_name_E
( NE ( NE
MDS G#other_name XXX G#other_name
) NE ) NE
in NE xx NE
advanced NE xxx NE
stage NE xxx NE
were NE xxx NE
enriched NE xxx NE
for NE xxx NE
blasts G#cell_type xxx G#cell_type
and NE xxx NE
tested NE xxx NE
for NE xxx NE
(1) NE (d) NE
karyotype G#other_name xxx G#other_name
, NE , NE
(2) NE (d) NE
genomic G#other_name_B xxx G#other_name_B
configuration G#other_name_E xxx G#other_name_E
and NE xxx NE
(3) NE (d) NE
expression NE xxx NE
of NE xx NE
IL-3 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
GM-CSF G#DNA_domain_or_region_M XX-XXX G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
FMS G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
EGR-1 G#DNA_domain_or_region_M XXX-d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
which NE xxx NE
are NE xxx NE
all NE xxx NE
located NE xxx NE
on NE xx NE
the NE xxx NE
long G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
arm G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
of G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
chromosome G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
5 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
M-CSF G#DNA_domain_or_region_B X-XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
that NE xxx NE
has NE xxx NE
been NE xxx NE
recently NE xxx NE
reassigned NE xxx NE
to NE xx NE
the NE xxx NE
short G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
arm G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
of G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
chromosome G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
1 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
( NE ( NE
lp G#DNA_domain_or_region xx G#DNA_domain_or_region
) NE ) NE
, NE , NE
was NE xxx NE
also NE xxx NE
investigated NE xxx NE
. NE . NE

Aims NE Xxxx NE
of NE xx NE
the NE xxx NE
study NE xxx NE
were NE xxx NE
to NE xx NE
(1) NE (d) NE
assess NE xxx NE
the NE xxx NE
potential NE xxx NE
role NE xxx NE
of NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
these NE xxx NE
genes NE xxx NE
in NE xx NE
the NE xxx NE
maintenance NE xxx NE
and NE xxx NE
expansion NE xxx NE
of NE xx NE
the NE xxx NE
neoplastic G#cell_line_B xxx G#cell_line_B
clones G#cell_line_E xxx G#cell_line_E
and NE xxx NE
(2) NE (d) NE
search NE xxx NE
for NE xxx NE
constitutional NE xxx NE
losses NE xxx NE
or NE xx NE
rearrangements NE xxx NE
of NE xx NE
one NE xxx NE
allele G#DNA_domain_or_region xxx G#DNA_domain_or_region
followed NE xxx NE
by NE xx NE
a NE x NE
deletion NE xxx NE
of NE xx NE
the NE xxx NE
second NE xxx NE
allele G#DNA_domain_or_region xxx G#DNA_domain_or_region
of NE xx NE
the NE xxx NE
same NE xxx NE
genes NE xxx NE
in NE xx NE
the NE xxx NE
leukemic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
latter NE xxx NE
issue NE xxx NE
was NE xxx NE
investigated NE xxx NE
by NE xx NE
comparing NE xxx NE
, NE , NE
in NE xx NE
8 NE d NE
cases NE xxx NE
, NE , NE
constitutive G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
DNA G#DNA_family_or_group_E XXX G#DNA_family_or_group_E
from NE xxx NE
skin G#cell_type_B xxx G#cell_type_B
fibroblasts G#cell_type_E xxx G#cell_type_E
with NE xxx NE
leukemic G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
DNA G#DNA_family_or_group_E XXX G#DNA_family_or_group_E
. NE . NE

Eleven NE Xxxx NE
of NE xx NE
the NE xxx NE
17 NE dd NE
patients G#multi_cell xxx G#multi_cell
had NE xxx NE
abnormal G#other_name_B xxx G#other_name_B
karyotypes G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
M-CSF G#DNA_domain_or_region_B X-XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
expressed NE xxx NE
in NE xx NE
6 NE d NE
cases NE xxx NE
and NE xxx NE
the NE xxx NE
FMS G#DNA_domain_or_region XXX G#DNA_domain_or_region
and NE xxx NE
the NE xxx NE
EGR-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
genes G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
were NE xxx NE
expressed NE xxx NE
in NE xx NE
2 NE d NE
of NE xx NE
the NE xxx NE
latter NE xxx NE
cases NE xxx NE
. NE . NE

An NE Xx NE
autocrine NE xxx NE
mechanism NE xxx NE
of NE xx NE
growth NE xxx NE
could NE xxx NE
be NE xx NE
hypothesized NE xxx NE
only NE xxx NE
for NE xxx NE
the NE xxx NE
2 NE d NE
patients G#multi_cell xxx G#multi_cell
whose NE xxx NE
cells NE xxx NE
expressed NE xxx NE
both NE xxx NE
the NE xxx NE
M-CSF G#DNA_domain_or_region_B X-XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
FMS G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E

No NE Xx NE
germline NE xxx NE
changes NE xxx NE
or NE xx NE
rearrangements NE xxx NE
were NE xxx NE
observed NE xxx NE
in NE xx NE
any NE xxx NE
of NE xx NE
the NE xxx NE
genes NE xxx NE
studied NE xxx NE
. NE . NE

Thus NE Xxxx NE
, NE , NE
deregulation NE xxx NE
of NE xx NE
genes NE xxx NE
encoding NE xxx NE
for NE xxx NE
certain NE xxx NE
hemopoietic G#protein_family_or_group_B xxx G#protein_family_or_group_B
growth G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
or NE xx NE
receptors NE xxx NE
does NE xxx NE
not NE xxx NE
seem NE xxx NE
to NE xx NE
represent NE xxx NE
a NE x NE
major NE xxx NE
mechanism NE xxx NE
of NE xx NE
MDS G#other_name_B XXX G#other_name_B
progression G#other_name_E xxx G#other_name_E
. NE . NE

A NE X NE
novel NE xxx NE
human G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
homeobox G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
distantly NE xxx NE
related NE xxx NE
to NE xx NE
proboscipedia G#DNA_domain_or_region xxx G#DNA_domain_or_region
is NE xx NE
expressed NE xxx NE
in NE xx NE
lymphoid G#tissue_B xxx G#tissue_B
tissue G#tissue_M xxx G#tissue_M
and G#tissue_M xxx G#tissue_M
pancreatic G#tissue_M xxx G#tissue_M
tissue G#tissue_E xxx G#tissue_E

A NE X NE
novel NE xxx NE
human G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
homeobox G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
HB9 G#DNA_domain_or_region XXd G#DNA_domain_or_region
, NE , NE
was NE xxx NE
isolated NE xxx NE
from NE xxx NE
a NE x NE
cDNA G#DNA_family_or_group_B xXXX G#DNA_family_or_group_B
library G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
prepared NE xxx NE
from NE xxx NE
in NE xx NE
vitro G#cell_type_B xxx G#cell_type_B
stimulated G#cell_type_M xxx G#cell_type_M
human G#cell_type_M xxx G#cell_type_M
tonsil G#cell_type_M xxx G#cell_type_M
B G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
and NE xxx NE
from NE xxx NE
a NE x NE
human G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genomic G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
library G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

The NE Xxx NE
HB9 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
composed NE xxx NE
of NE xx NE
3 NE d NE
exons G#DNA_family_or_group xxx G#DNA_family_or_group
spread NE xxx NE
over NE xxx NE
6 NE d NE
kilobases NE xxx NE
of NE xx NE
DNA NE XXX NE
. NE . NE

An NE Xx NE
open G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
reading G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
frame G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
1206 G#polynucleotide_B dddd G#polynucleotide_B
nucleotides G#polynucleotide_E xxx G#polynucleotide_E
is NE xx NE
in NE xx NE
frame NE xxx NE
with NE xxx NE
a NE x NE
diverged G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
homeodomain G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
predicted NE xxx NE
HB9 G#protein_molecule_B XXd G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
has NE xxx NE
a NE x NE
molecular NE xxx NE
mass NE xxx NE
of NE xx NE
41 G#other_name_B dd G#other_name_B
kilodaltons G#other_name_E xxx G#other_name_E
and NE xxx NE
is NE xx NE
enriched NE xxx NE
for NE xxx NE
alanine G#amino_acid_monomer xxx G#amino_acid_monomer
, NE , NE
glycine G#amino_acid_monomer xxx G#amino_acid_monomer
, NE , NE
and NE xxx NE
leucine G#amino_acid_monomer xxx G#amino_acid_monomer
. NE . NE

The NE Xxx NE
HB9 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
homeodomain G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
most NE xxx NE
similar NE xxx NE
to NE xx NE
that NE xxx NE
of NE xx NE
the NE xxx NE
Drosophila G#DNA_domain_or_region_B Xxxx G#DNA_domain_or_region_B
melanogaster G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
homeobox G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
proboscipedia G#DNA_domain_or_region xxx G#DNA_domain_or_region
. NE . NE

Northern G#other_name_B Xxxx G#other_name_B
blot G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
of NE xx NE
poly(A) G#RNA_family_or_group_B xxx(X) G#RNA_family_or_group_B
RNA G#RNA_family_or_group_E XXX G#RNA_family_or_group_E
purified NE xxx NE
from NE xxx NE
the NE xxx NE
human G#cell_line_B xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
RPMI G#cell_line_M XXXX G#cell_line_M
8226 G#cell_line_E dddd G#cell_line_E
and NE xxx NE
from NE xxx NE
activated G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
revealed NE xxx NE
a NE x NE
major G#RNA_molecule_B xxx G#RNA_molecule_B
mRNA G#RNA_molecule_M xXXX G#RNA_molecule_M
transcript G#RNA_molecule_E xxx G#RNA_molecule_E
of NE xx NE
2.2 G#polynucleotide_B d.d G#polynucleotide_B
kilobases G#polynucleotide_E xxx G#polynucleotide_E
. NE . NE

Similar NE Xxxx NE
analysis NE xxx NE
of NE xx NE
poly(A) G#RNA_family_or_group_B xxx(X) G#RNA_family_or_group_B
RNA G#RNA_family_or_group_E XXX G#RNA_family_or_group_E
from NE xxx NE
a NE x NE
variety NE xxx NE
of NE xx NE
adult G#tissue_B xxx G#tissue_B
tissues G#tissue_E xxx G#tissue_E
demonstrated NE xxx NE
HB9 G#DNA_domain_or_region XXd G#DNA_domain_or_region
transcripts NE xxx NE
in NE xx NE
pancreas G#body_part xxx G#body_part
, NE , NE
small G#body_part_B xxx G#body_part_B
intestine G#body_part_E xxx G#body_part_E
, NE , NE
and NE xxx NE
colon G#body_part xxx G#body_part
. NE . NE

Reverse G#other_name_B Xxxx G#other_name_B
transcriptase-polymerase G#other_name_M xxx-xxx G#other_name_M
chain G#other_name_M xxx G#other_name_M
reaction G#other_name_E xxx G#other_name_E
was NE xxx NE
used NE xxx NE
to NE xx NE
examine NE xxx NE
HB9 G#RNA_family_or_group_B XXd G#RNA_family_or_group_B
RNA G#RNA_family_or_group_M XXX G#RNA_family_or_group_M
transcripts G#RNA_family_or_group_E xxx G#RNA_family_or_group_E
in NE xx NE
hematopoietic G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

HB9 G#RNA_family_or_group_B XXd G#RNA_family_or_group_B
RNA G#RNA_family_or_group_M XXX G#RNA_family_or_group_M
transcripts G#RNA_family_or_group_E xxx G#RNA_family_or_group_E
were NE xxx NE
most NE xxx NE
prevalent NE xxx NE
in NE xx NE
several NE xxx NE
human G#cell_line_B xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
and NE xxx NE
K562 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
transcripts NE xxx NE
were NE xxx NE
detected NE xxx NE
in NE xx NE
RNA NE XXX NE
prepared NE xxx NE
from NE xxx NE
tonsil G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
in NE xx NE
situ NE xxx NE
hybridization NE xxx NE
studies NE xxx NE
localized NE xxx NE
them NE xxx NE
in NE xx NE
the NE xxx NE
germinal NE xxx NE
center NE xxx NE
region NE xxx NE
of NE xx NE
adult NE xxx NE
tonsil NE xxx NE
. NE . NE

These NE Xxxx NE
findings NE xxx NE
suggest NE xxx NE
the NE xxx NE
involvement NE xxx NE
of NE xx NE
HB9 G#DNA_domain_or_region XXd G#DNA_domain_or_region
in NE xx NE
regulating NE xxx NE
gene G#other_name_B xxx G#other_name_B
transcription G#other_name_E xxx G#other_name_E
in NE xx NE
lymphoid G#tissue_B xxx G#tissue_B
tissue G#tissue_M xxx G#tissue_M
and G#tissue_M xxx G#tissue_M
pancreatic G#tissue_M xxx G#tissue_M
tissue G#tissue_E xxx G#tissue_E

Human G#protein_molecule_B Xxxx G#protein_molecule_B
immunodeficiency G#protein_molecule_M xxx G#protein_molecule_M
virus G#protein_molecule_M xxx G#protein_molecule_M
type G#protein_molecule_M xxx G#protein_molecule_M
1 G#protein_molecule_M d G#protein_molecule_M
Tat G#protein_molecule_E Xxx G#protein_molecule_E
upregulates NE xxx NE
interleukin-2 G#other_name_B xxx-d G#other_name_B
secretion G#other_name_E xxx G#other_name_E
in NE xx NE
activated G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Dysregulation NE Xxxx NE
of NE xx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
secreted NE xxx NE
by NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
may NE xxx NE
play NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
pathogenesis NE xxx NE
of NE xx NE
AIDS G#other_name XXXX G#other_name
. NE . NE

To NE Xx NE
investigate NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
human NE xxx NE
immunodeficiency NE xxx NE
virus NE xxx NE
type NE xxx NE
1 NE d NE
( NE ( NE
HIV-1 NE XXX-d NE
) NE ) NE
Tat NE Xxx NE
on NE xx NE
interleukin-2 NE xxx-d NE
( NE ( NE
IL-2 NE XX-d NE
) NE ) NE
expression NE xxx NE
, NE , NE
we NE xx NE
used NE xxx NE
IL-2 NE XX-d NE
promoter NE xxx NE
-chloramphenicol NE -xxx NE
acetyltransferase NE xxx NE
constructs NE xxx NE
and NE xxx NE
IL-2 NE XX-d NE
-secreting NE -xxx NE
Jurkat NE Xxxx NE
T NE X NE
cells NE xxx NE
as NE xx NE
a NE x NE
model NE xxx NE
system NE xxx NE
. NE . NE

Transient NE Xxxx NE
expression NE xxx NE
of NE xx NE
HIV-1 G#protein_molecule_B XXX-d G#protein_molecule_B
Tat G#protein_molecule_E Xxx G#protein_molecule_E
induced NE xxx NE
a NE x NE
five- NE xxx- NE
to NE xx NE
eightfold NE xxx NE
increase NE xxx NE
in NE xx NE
IL-2 G#other_name_B XX-d G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
stimulated NE xxx NE
with NE xxx NE
phytohemagglutinin G#protein_molecule xxx G#protein_molecule
and NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
myristate G#other_organic_compound_M xxx G#other_organic_compound_M
acetate G#other_organic_compound_E xxx G#other_organic_compound_E
. NE . NE

IL-2 G#protein_molecule XX-d G#protein_molecule
secretion NE xxx NE
was NE xxx NE
increased NE xxx NE
more NE xxx NE
than NE xxx NE
twofold NE xxx NE
in NE xx NE
both NE xxx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
primary G#cell_line_B xxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
stimulated NE xxx NE
by NE xx NE
extracellular G#protein_molecule_B xxx G#protein_molecule_B
HIV-1 G#protein_molecule_M XXX-d G#protein_molecule_M
Tat G#protein_molecule_M Xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Analysis NE Xxxx NE
of NE xx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
suggested NE xxx NE
that NE xxx NE
Tat NE Xxx NE
exerts NE xxx NE
its NE xxx NE
effect NE xxx NE
on NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
primarily NE xxx NE
at NE xx NE
the NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
level G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
at NE xx NE
positions NE xxx NE
-206 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-195 G#DNA_domain_or_region_E -ddd G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
required NE xxx NE
but NE xxx NE
not NE xxx NE
sufficient NE xxx NE
for NE xxx NE
the NE xxx NE
Tat G#other_name_B Xxx G#other_name_B
effect G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
Tat NE Xxx NE
-mediated NE -xxx NE
increase NE xxx NE
in NE xx NE
IL-2 NE XX-d NE
promoter NE xxx NE
activity NE xxx NE
could NE xxx NE
selectively NE xxx NE
be NE xx NE
blocked NE xxx NE
by NE xx NE
antisense NE xxx NE
tat NE xxx NE
or-unlike NE xx-xxx NE
the NE xxx NE
analogous NE xxx NE
effect NE xxx NE
of NE xx NE
human NE xxx NE
T-cell NE X-xxx NE
lymphotropic NE xxx NE
virus NE xxx NE
type NE xxx NE
1 NE d NE
Tax NE Xxx NE
-by NE -xx NE
cyclosporin NE xxx NE
A NE X NE
. NE . NE

The NE Xxx NE
observed NE xxx NE
increase NE xxx NE
in NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
levels NE xxx NE
might NE xxx NE
facilitate NE xxx NE
virus NE xxx NE
spread NE xxx NE
from NE xxx NE
or NE xx NE
to NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
it NE xx NE
might NE xxx NE
contribute NE xxx NE
to NE xx NE
the NE xxx NE
hypergammaglobulinemia G#other_name xxx G#other_name
or NE xx NE
, NE , NE
together NE xxx NE
with NE xxx NE
other NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
found NE xxx NE
to NE xx NE
be NE xx NE
dysregulated NE xxx NE
, NE , NE
the NE xxx NE
T-helper G#other_name_B X-xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
dysfunctions G#other_name_E xxx G#other_name_E
observed NE xxx NE
in NE xx NE
AIDS G#other_name XXXX G#other_name
patients G#multi_cell xxx G#multi_cell
. NE . NE

Activation NE Xxxx NE
of NE xx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
lymphoblastoid G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
low-dose G#other_name_B xxx-xxx G#other_name_B
ionizing G#other_name_M xxx G#other_name_M
radiation G#other_name_E xxx G#other_name_E
. NE . NE

Nuclear G#protein_molecule_B Xxxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
) NE ) NE
is NE xx NE
a NE x NE
pleiotropic G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
which NE xxx NE
is NE xx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
of NE xx NE
several NE xxx NE
specific NE xxx NE
genes NE xxx NE
. NE . NE

Recent NE Xxxx NE
reports NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
ionizing G#other_name_B xxx G#other_name_B
radiation G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
dose NE xxx NE
range NE xxx NE
of NE xx NE
2-50 G#other_name_B d-dd G#other_name_B
Gy G#other_name_E Xx G#other_name_E
results NE xxx NE
in NE xx NE
expression NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
human G#cell_line_B xxx G#cell_line_B
KG-1 G#cell_line_M XX-d G#cell_line_M
myeloid G#cell_line_M xxx G#cell_line_M
leukemia G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
human G#cell_type_B xxx G#cell_type_B
B-lymphocyte G#cell_type_M X-xxx G#cell_type_M
precursor G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
; NE ; NE
the NE xxx NE
precise NE xxx NE
mechanism NE xxx NE
involved NE xxx NE
and NE xxx NE
the NE xxx NE
significance NE xxx NE
are NE xxx NE
not NE xxx NE
yet NE xxx NE
known NE xxx NE
. NE . NE

The NE Xxx NE
present NE xxx NE
report NE xxx NE
demonstrates NE xxx NE
that NE xxx NE
even NE xxx NE
lower NE xxx NE
doses NE xxx NE
of NE xx NE
ionizing G#other_name_B xxx G#other_name_B
radiation G#other_name_E xxx G#other_name_E
, NE , NE
0.25-2.0 G#other_name_B d.dd-d.d G#other_name_B
Gy G#other_name_E Xx G#other_name_E
, NE , NE
are NE xxx NE
capable NE xxx NE
of NE xx NE
inducing NE xxx NE
expression NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
EBV-transformed G#cell_line_B XXX-xxx G#cell_line_B
244B G#cell_line_M dddX G#cell_line_M
human G#cell_line_M xxx G#cell_line_M
lymphoblastoid G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
are NE xxx NE
in NE xx NE
a NE x NE
dose NE xxx NE
range NE xxx NE
where NE xxx NE
the NE xxx NE
viability NE xxx NE
of NE xx NE
the NE xxx NE
cells NE xxx NE
remains NE xxx NE
very NE xxx NE
high NE xxx NE
. NE . NE

After NE Xxxx NE
exposure NE xxx NE
to NE xx NE
137Cs G#other_name_B dddXx G#other_name_B
gamma G#other_name_M xxx G#other_name_M
rays G#other_name_E xxx G#other_name_E
at NE xx NE
a NE x NE
dose NE xxx NE
rate NE xxx NE
of NE xx NE
1.17 G#other_name_B d.dd G#other_name_B
Gy/min G#other_name_E Xx/xxx G#other_name_E
, NE , NE
a NE x NE
maximum NE xxx NE
in NE xx NE
expression NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
was NE xxx NE
seen NE xxx NE
at NE xx NE
8 NE d NE
h NE x NE
after NE xxx NE
a NE x NE
0.5-Gy G#other_name_B d.d-Xx G#other_name_B
exposure G#other_name_E xxx G#other_name_E
. NE . NE

Time-course NE Xxxx-xxx NE
studies NE xxx NE
revealed NE xxx NE
a NE x NE
biphasic NE xxx NE
time-dependent NE xxx-xxx NE
expression NE xxx NE
after NE xxx NE
0.5-, G#other_name_B d.d-, G#other_name_B
1- G#other_name_M d- G#other_name_M
and G#other_name_M xxx G#other_name_M
2-Gy G#other_name_M d-Xx G#other_name_M
exposures G#other_name_E xxx G#other_name_E
. NE . NE

However NE Xxxx NE
, NE , NE
for NE xxx NE
each NE xxx NE
time NE xxx NE
examined NE xxx NE
, NE , NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
was NE xxx NE
maximum NE xxx NE
after NE xxx NE
the NE xxx NE
0.5-Gy G#other_name_B d.d-Xx G#other_name_B
exposure G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
p50 G#protein_subunit_B xdd G#protein_subunit_B
NF-kappa G#protein_subunit_M XX-xxx G#protein_subunit_M
B G#protein_subunit_M X G#protein_subunit_M
subunit G#protein_subunit_M xxx G#protein_subunit_M
and G#protein_subunit_M xxx G#protein_subunit_M
p65 G#protein_subunit_M xdd G#protein_subunit_M
NF-kappa G#protein_subunit_M XX-xxx G#protein_subunit_M
B G#protein_subunit_M X G#protein_subunit_M
subunit G#protein_subunit_E xxx G#protein_subunit_E
was NE xxx NE
also NE xxx NE
shown NE xxx NE
to NE xx NE
be NE xx NE
regulated NE xxx NE
differentially NE xxx NE
after NE xxx NE
exposures NE xxx NE
to NE xx NE
1.0 G#other_name_B d.d G#other_name_B
and G#other_name_M xxx G#other_name_M
2.0 G#other_name_M d.d G#other_name_M
Gy G#other_name_E Xx G#other_name_E
. NE . NE

Alternative NE Xxxx NE
splicing NE xxx NE
of NE xx NE
RNA G#RNA_family_or_group_B XXX G#RNA_family_or_group_B
transcripts G#RNA_family_or_group_E xxx G#RNA_family_or_group_E
encoded NE xxx NE
by NE xx NE
the NE xxx NE
murine G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
p105 G#DNA_domain_or_region_M xddd G#DNA_domain_or_region_M
NF-kappa G#DNA_domain_or_region_M XX-xxx G#DNA_domain_or_region_M
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
generates NE xxx NE
I G#protein_family_or_group_B X G#protein_family_or_group_B
kappa G#protein_family_or_group_M xxx G#protein_family_or_group_M
B G#protein_family_or_group_M X G#protein_family_or_group_M
gamma G#protein_family_or_group_M xxx G#protein_family_or_group_M
isoforms G#protein_family_or_group_E xxx G#protein_family_or_group_E
with NE xxx NE
different NE xxx NE
inhibitory NE xxx NE
activities NE xxx NE
. NE . NE

The NE Xxx NE
gene NE xxx NE
encoding NE xxx NE
the NE xxx NE
105-kDa NE ddd-xXx NE
protein NE xxx NE
( NE ( NE
p105 NE xddd NE
) NE ) NE
precursor NE xxx NE
of NE xx NE
the NE xxx NE
p50 NE xdd NE
subunit NE xxx NE
of NE xx NE
transcription NE xxx NE
factor NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
also NE xxx NE
encodes NE xxx NE
a NE x NE
p70 NE xdd NE
I NE X NE
kappa NE xxx NE
B NE X NE
protein NE xxx NE
, NE , NE
I NE X NE
kappa NE xxx NE
B NE X NE
gamma NE xxx NE
, NE , NE
which NE xxx NE
is NE xx NE
identical NE xxx NE
to NE xx NE
the NE xxx NE
C-terminal NE X-xxx NE
607 NE ddd NE
amino NE xxx NE
acids NE xxx NE
of NE xx NE
p105 NE xddd NE
. NE . NE

Here NE Xxxx NE
we NE xx NE
show NE xxx NE
that NE xxx NE
alternative NE xxx NE
RNA G#other_name_B XXX G#other_name_B
splicing G#other_name_E xxx G#other_name_E
generates NE xxx NE
I G#protein_family_or_group_B X G#protein_family_or_group_B
kappa G#protein_family_or_group_M xxx G#protein_family_or_group_M
B G#protein_family_or_group_M X G#protein_family_or_group_M
gamma G#protein_family_or_group_M xxx G#protein_family_or_group_M
isoforms G#protein_family_or_group_E xxx G#protein_family_or_group_E
with NE xxx NE
properties NE xxx NE
different NE xxx NE
from NE xxx NE
those NE xxx NE
of NE xx NE
p70 G#protein_subunit xdd G#protein_subunit
. NE . NE

One NE Xxx NE
63-kDa G#protein_molecule_B dd-xXx G#protein_molecule_B
isoform G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
termed NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
gamma-1 G#protein_molecule_E xxx-d G#protein_molecule_E
, NE , NE
which NE xxx NE
lacks NE xxx NE
59 G#peptide_B dd G#peptide_B
amino G#peptide_M xxx G#peptide_M
acids G#peptide_E xxx G#peptide_E
C-terminal NE X-xxx NE
to NE xx NE
ankyrin G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
repeat G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
7 G#protein_domain_or_region_E d G#protein_domain_or_region_E
, NE , NE
has NE xxx NE
a NE x NE
novel NE xxx NE
35-amino G#protein_domain_or_region_B dd-xxx G#protein_domain_or_region_B
acid G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
C G#protein_domain_or_region_M X G#protein_domain_or_region_M
terminus G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
encoded NE xxx NE
by NE xx NE
an NE xx NE
alternative G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
reading G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
frame G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
p105 G#DNA_domain_or_region_B xddd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

A NE X NE
55-kDa G#protein_molecule_B dd-xXx G#protein_molecule_B
isoform G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
gamma-2 G#protein_molecule_E xxx-d G#protein_molecule_E
, NE , NE
lacks NE xxx NE
the NE xxx NE
190 G#protein_domain_or_region_B ddd G#protein_domain_or_region_B
C-terminal G#protein_domain_or_region_M X-xxx G#protein_domain_or_region_M
amino G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
acids G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
p70 G#protein_subunit xdd G#protein_subunit
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
gamma G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

In NE Xx NE
contrast NE xxx NE
to NE xx NE
p70 G#protein_subunit xdd G#protein_subunit
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
gamma G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
which NE xxx NE
is NE xx NE
a NE x NE
cytoplasmic G#protein_family_or_group_B xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
gamma-1 G#protein_molecule_E xxx-d G#protein_molecule_E
is NE xx NE
found NE xxx NE
in NE xx NE
both NE xxx NE
the NE xxx NE
cytoplasm G#cell_component xxx G#cell_component
and NE xxx NE
nucleus NE xxx NE
, NE , NE
whereas NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
gamma-2 G#protein_molecule_E xxx-d G#protein_molecule_E
is NE xx NE
predominantly NE xxx NE
nuclear NE xxx NE
. NE . NE

The NE Xxx NE
I G#protein_family_or_group_B X G#protein_family_or_group_B
kappa G#protein_family_or_group_M xxx G#protein_family_or_group_M
B G#protein_family_or_group_M X G#protein_family_or_group_M
gamma G#protein_family_or_group_M xxx G#protein_family_or_group_M
isoforms G#protein_family_or_group_E xxx G#protein_family_or_group_E
also NE xxx NE
display NE xxx NE
differences NE xxx NE
in NE xx NE
specificity NE xxx NE
and NE xxx NE
affinity NE xxx NE
for NE xxx NE
Rel NE Xxx NE
/ NE / NE
NF-kappa NE XX-xxx NE
B NE X NE
proteins NE xxx NE
. NE . NE

While NE Xxxx NE
p70 G#protein_subunit xdd G#protein_subunit
I NE X NE
kappa NE xxx NE
B NE X NE
gamma NE xxx NE
inhibits NE xxx NE
p50-mediated G#other_name_B xdd-xxx G#other_name_B
transactivation G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
p65-mediated G#other_name_M xdd-xxx G#other_name_M
transactivation G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
c-Rel-mediated G#other_name_M x-Xxx-xxx G#other_name_M
transactivation G#other_name_E xxx G#other_name_E
DNA NE XXX NE
binding NE xxx NE
, NE , NE
both NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
gamma-1 G#protein_molecule_E xxx-d G#protein_molecule_E
and NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
gamma-2 G#protein_molecule_E xxx-d G#protein_molecule_E
are NE xxx NE
specific NE xxx NE
for NE xxx NE
p50 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
have NE xxx NE
different NE xxx NE
affinities NE xxx NE
for NE xxx NE
this NE xxx NE
subunit NE xxx NE
. NE . NE

The NE Xxx NE
absence NE xxx NE
in NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
gamma-1 G#protein_molecule_E xxx-d G#protein_molecule_E
and NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
gamma-2 G#protein_molecule_E xxx-d G#protein_molecule_E
of NE xx NE
a NE x NE
protein G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
kinase G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
A G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
whose NE xxx NE
phosphorylation NE xxx NE
modulates NE xxx NE
p70 G#protein_subunit xdd G#protein_subunit
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
gamma G#protein_molecule_E xxx G#protein_molecule_E
inhibitory NE xxx NE
activity NE xxx NE
suggests NE xxx NE
that NE xxx NE
alternative NE xxx NE
RNA G#other_name_B XXX G#other_name_B
splicing G#other_name_E xxx G#other_name_E
may NE xxx NE
be NE xx NE
used NE xxx NE
to NE xx NE
generate NE xxx NE
I G#protein_family_or_group_B X G#protein_family_or_group_B
kappa G#protein_family_or_group_M xxx G#protein_family_or_group_M
B G#protein_family_or_group_M X G#protein_family_or_group_M
gamma G#protein_family_or_group_M xxx G#protein_family_or_group_M
isoforms G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
respond NE xxx NE
differently NE xxx NE
to NE xx NE
intracellular G#other_name_B xxx G#other_name_B
signals G#other_name_E xxx G#other_name_E
. NE . NE

Structure NE Xxxx NE
and NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
GATA3 G#DNA_domain_or_region_M XXXXd G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

GATA3 G#protein_molecule XXXXd G#protein_molecule
, NE , NE
a NE x NE
member NE xxx NE
of NE xx NE
the NE xxx NE
GATA G#protein_family_or_group_B XXXX G#protein_family_or_group_B
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
is NE xx NE
abundantly NE xxx NE
expressed NE xxx NE
in NE xx NE
the NE xxx NE
T-lymphocyte G#cell_type_B X-xxx G#cell_type_B
lineage G#cell_type_E xxx G#cell_type_E
, NE , NE
is NE xx NE
thought NE xxx NE
to NE xx NE
participate NE xxx NE
in NE xx NE
T-cell G#other_name_B X-xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
through NE xxx NE
binding NE xxx NE
to NE xx NE
enhancers G#DNA_domain_or_region xxx G#DNA_domain_or_region
. NE . NE

To NE Xx NE
understand NE xxx NE
GATA3 G#other_name_B XXXXd G#other_name_B
gene G#other_name_M xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
cloned NE xxx NE
the NE xxx NE
human G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
and NE xxx NE
the NE xxx NE
5' G#DNA_domain_or_region_B d' G#DNA_domain_or_region_B
end G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
mouse G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
GATA3 G#DNA_domain_or_region_M XXXXd G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

We NE Xx NE
show NE xxx NE
that NE xxx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
GATA3 G#DNA_domain_or_region_M XXXXd G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
contains NE xxx NE
six NE xxx NE
exons G#DNA_family_or_group xxx G#DNA_family_or_group
distributed NE xxx NE
over NE xxx NE
17 G#polynucleotide_B dd G#polynucleotide_B
kb G#polynucleotide_M xx G#polynucleotide_M
of G#polynucleotide_M xx G#polynucleotide_M
DNA G#polynucleotide_E XXX G#polynucleotide_E
. NE . NE

The NE Xxx NE
two NE xxx NE
human G#protein_substructure_B xxx G#protein_substructure_B
GATA3 G#protein_substructure_M XXXXd G#protein_substructure_M
zinc G#protein_substructure_M xxx G#protein_substructure_M
fingers G#protein_substructure_E xxx G#protein_substructure_E
are NE xxx NE
encoded NE xxx NE
by NE xx NE
two NE xxx NE
separate NE xxx NE
exons G#DNA_family_or_group xxx G#DNA_family_or_group
highly NE xxx NE
conserved NE xxx NE
with NE xxx NE
those NE xxx NE
of NE xx NE
GATA1 G#protein_molecule XXXXd G#protein_molecule
, NE , NE
but NE xxx NE
no NE xx NE
other NE xxx NE
structural NE xxx NE
homologies NE xxx NE
between NE xxx NE
these NE xxx NE
two NE xxx NE
genes NE xxx NE
can NE xxx NE
be NE xx NE
found NE xxx NE
. NE . NE

The NE Xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
GATA3 G#DNA_domain_or_region_M XXXXd G#DNA_domain_or_region_M
transcription G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
unit G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
mouse G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
GATA3 G#DNA_domain_or_region_M XXXXd G#DNA_domain_or_region_M
transcription G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
unit G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
start NE xxx NE
at NE xx NE
a NE x NE
major G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
initiation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
promoter NE xxx NE
sequence NE xxx NE
analysis NE xxx NE
of NE xx NE
these NE xxx NE
two NE xxx NE
genes NE xxx NE
revealed NE xxx NE
that NE xxx NE
they NE xxx NE
are NE xxx NE
embedded NE xxx NE
within NE xxx NE
a NE x NE
CpG G#DNA_domain_or_region_B XxX G#DNA_domain_or_region_B
island G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
share NE xxx NE
structural NE xxx NE
features NE xxx NE
often NE xxx NE
found NE xxx NE
in NE xx NE
the NE xxx NE
promoters G#DNA_family_or_group xxx G#DNA_family_or_group
of NE xx NE
housekeeping G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

Finally NE Xxxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
a NE x NE
DNA G#DNA_molecule_B XXX G#DNA_molecule_B
fragment G#DNA_molecule_E xxx G#DNA_molecule_E
containing NE xxx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
GATA3 G#DNA_domain_or_region_M XXXXd G#DNA_domain_or_region_M
transcription G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
unit G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
3 G#DNA_domain_or_region_B d G#DNA_domain_or_region_B
kb G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
upstream G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
from NE xxx NE
the NE xxx NE
initiation G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
4 G#DNA_domain_or_region_B d G#DNA_domain_or_region_B
kb G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
downstream G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
from NE xxx NE
the NE xxx NE
polyadenylation G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
displays NE xxx NE
T-cell G#other_name_B X-xxx G#other_name_B
specificity G#other_name_E xxx G#other_name_E
. NE . NE

Characterization NE Xxxx NE
of NE xx NE
the NE xxx NE
human G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
encoding NE xxx NE
LBR G#protein_molecule XXX G#protein_molecule
, NE , NE
an NE xx NE
integral G#protein_family_or_group_B xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
the NE xxx NE
nuclear G#cell_component_B xxx G#cell_component_B
envelope G#cell_component_M xxx G#cell_component_M
inner G#cell_component_M xxx G#cell_component_M
membrane G#cell_component_E xxx G#cell_component_E
. NE . NE

We NE Xx NE
have NE xxx NE
characterized NE xxx NE
the NE xxx NE
human G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
encoding NE xxx NE
LBR G#protein_molecule XXX G#protein_molecule
, NE , NE
an NE xx NE
integral G#protein_family_or_group_B xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
the NE xxx NE
nuclear G#cell_component_B xxx G#cell_component_B
envelope G#cell_component_M xxx G#cell_component_M
inner G#cell_component_M xxx G#cell_component_M
membrane G#cell_component_E xxx G#cell_component_E
. NE . NE

Restriction NE Xxxx NE
mapping NE xxx NE
shows NE xxx NE
that NE xxx NE
the NE xxx NE
transcription G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
unit G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
spans NE xxx NE
approximately NE xxx NE
35 G#polynucleotide_B dd G#polynucleotide_B
kilobases G#polynucleotide_E xxx G#polynucleotide_E
. NE . NE

A NE X NE
transcription NE xxx NE
start NE xxx NE
site NE xxx NE
is NE xx NE
located NE xxx NE
approximately NE xxx NE
4 G#polynucleotide_B d G#polynucleotide_B
kilobases G#polynucleotide_M xxx G#polynucleotide_M
5' G#polynucleotide_E d' G#polynucleotide_E
to NE xx NE
the NE xxx NE
translation G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
initiation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
codon G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
and NE xxx NE
an NE xx NE
RNA G#other_name_B XXX G#other_name_B
splice G#other_name_E xxx G#other_name_E
of NE xx NE
3863 G#polynucleotide_B dddd G#polynucleotide_B
bases G#polynucleotide_E xxx G#polynucleotide_E
occurs NE xxx NE
in NE xx NE
the NE xxx NE
5'-untranslated G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
to NE xx NE
generate NE xxx NE
mature G#RNA_family_or_group_B xxx G#RNA_family_or_group_B
HeLa G#RNA_family_or_group_M XxXx G#RNA_family_or_group_M
cell G#RNA_family_or_group_M xxx G#RNA_family_or_group_M
mRNA G#RNA_family_or_group_E xXXX G#RNA_family_or_group_E
. NE . NE

5' NE d' NE
to NE xx NE
the NE xxx NE
identified NE xxx NE
transcription G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
start G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
are NE xxx NE
two NE xxx NE
CCAAT G#DNA_family_or_group_B XXXXX G#DNA_family_or_group_B
sequences G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
and NE xxx NE
potential G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
recognition G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
several NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
including NE xxx NE
Sp1 G#protein_molecule Xxd G#protein_molecule
, NE , NE
AP-1 G#protein_molecule XX-d G#protein_molecule
, NE , NE
AP-2 G#protein_molecule XX-d G#protein_molecule
, NE , NE
and NE xxx NE
NF-kB G#protein_molecule XX-xX G#protein_molecule
. NE . NE

There NE Xxxx NE
are NE xxx NE
13 NE dd NE
protein NE xxx NE
coding NE xxx NE
exons G#DNA_family_or_group xxx G#DNA_family_or_group
in NE xx NE
the NE xxx NE
LBR G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

LBR G#protein_molecule XXX G#protein_molecule
's NE 'x NE
nucleoplasmic G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
is NE xx NE
encoded NE xxx NE
by NE xx NE
exons G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
1-4 G#DNA_domain_or_region_E d-d G#DNA_domain_or_region_E
, NE , NE
and NE xxx NE
its NE xxx NE
hydrophobic G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
, NE , NE
with NE xxx NE
eight NE xxx NE
putative NE xxx NE
transmembrane G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
segments G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
, NE , NE
is NE xx NE
encoded NE xxx NE
by NE xx NE
exons G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
5-13 G#DNA_domain_or_region_E d-dd G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
hydrophobic G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
is NE xx NE
homologous NE xxx NE
to NE xx NE
three NE xxx NE
yeast G#peptide_B xxx G#peptide_B
polypeptides G#peptide_E xxx G#peptide_E
, NE , NE
suggesting NE xxx NE
that NE xxx NE
this NE xxx NE
higher G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
eukaryotic G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
could NE xxx NE
have NE xxx NE
evolved NE xxx NE
from NE xxx NE
recombination NE xxx NE
between NE xxx NE
a NE x NE
gene NE xxx NE
that NE xxx NE
encoded NE xxx NE
a NE x NE
soluble G#protein_family_or_group_B xxx G#protein_family_or_group_B
nuclear G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
a NE x NE
membrane G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
protein G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
similar NE xxx NE
to NE xx NE
those NE xxx NE
in NE xx NE
yeast G#mono_cell xxx G#mono_cell
. NE . NE

These NE Xxxx NE
results NE xxx NE
are NE xxx NE
the NE xxx NE
first NE xxx NE
to NE xx NE
demonstrate NE xxx NE
the NE xxx NE
structural NE xxx NE
organization NE xxx NE
of NE xx NE
a NE x NE
vertebrate G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
encoding NE xxx NE
an NE xx NE
integral G#protein_family_or_group_B xxx G#protein_family_or_group_B
membrane G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
the NE xxx NE
nuclear G#cell_component_B xxx G#cell_component_B
envelope G#cell_component_E xxx G#cell_component_E
that NE xxx NE
may NE xxx NE
be NE xx NE
a NE x NE
member NE xxx NE
of NE xx NE
a NE x NE
family NE xxx NE
of NE xx NE
polypeptides G#peptide xxx G#peptide
conserved NE xxx NE
in NE xx NE
evolution G#other_name xxx G#other_name
. NE . NE

Retinoic G#other_name_B Xxxx G#other_name_B
acid-induced G#other_name_M xxx-xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
of NE xx NE
CD38 G#protein_molecule_B XXdd G#protein_molecule_B
antigen G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
myeloid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
is NE xx NE
mediated NE xxx NE
through NE xxx NE
retinoic G#protein_molecule_B xxx G#protein_molecule_B
acid G#protein_molecule_M xxx G#protein_molecule_M
receptor-alpha G#protein_molecule_E xxx-xxx G#protein_molecule_E
. NE . NE

CD38 G#protein_molecule XXdd G#protein_molecule
is NE xx NE
a NE x NE
leukocyte G#protein_family_or_group_B xxx G#protein_family_or_group_B
differentiation G#protein_family_or_group_M xxx G#protein_family_or_group_M
antigen G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
has NE xxx NE
been NE xxx NE
thought NE xxx NE
to NE xx NE
be NE xx NE
a NE x NE
phenotypic NE xxx NE
marker NE xxx NE
of NE xx NE
different NE xxx NE
subpopulations NE xxx NE
of NE xx NE
T- G#cell_type_B X- G#cell_type_B
lymphocyte G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
B- G#cell_type_M X- G#cell_type_M
lymphocyte G#cell_type_E xxx G#cell_type_E

In NE Xx NE
myeloid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
CD38 G#protein_molecule XXdd G#protein_molecule
is NE xx NE
expressed NE xxx NE
during NE xxx NE
early NE xxx NE
stages NE xxx NE
of NE xx NE
differentiation G#other_name xxx G#other_name
. NE . NE

Virtually NE Xxxx NE
no NE xx NE
information NE xxx NE
is NE xx NE
available NE xxx NE
on NE xx NE
regulation NE xxx NE
and NE xxx NE
functions NE xxx NE
of NE xx NE
CD38 G#protein_molecule XXdd G#protein_molecule
. NE . NE

Recently NE Xxxx NE
we NE xx NE
reported NE xxx NE
that NE xxx NE
all-trans-retinoic G#other_organic_compound_B xxx-xxx-xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
ATRA G#other_organic_compound XXXX G#other_organic_compound
) NE ) NE
is NE xx NE
a NE x NE
potent NE xxx NE
and NE xxx NE
highly NE xxx NE
specific NE xxx NE
inducer NE xxx NE
of NE xx NE
CD38 G#other_name_B XXdd G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
promyelocytic G#cell_type_M xxx G#cell_type_M
leukemia G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Here NE Xxxx NE
we NE xx NE
report NE xxx NE
that NE xxx NE
ATRA NE XXXX NE
-induced NE -xxx NE
expression NE xxx NE
of NE xx NE
CD38 NE XXdd NE
antigen NE xxx NE
in NE xx NE
myeloid NE xxx NE
cells NE xxx NE
is NE xx NE
mediated NE xxx NE
through NE xxx NE
retinoic NE xxx NE
acid-alpha NE xxx-xxx NE
receptor NE xxx NE
( NE ( NE
RAR NE XXX NE
alpha NE xxx NE
) NE ) NE
. NE . NE

ATRA G#other_organic_compound XXXX G#other_organic_compound
failed NE xxx NE
to NE xx NE
induce NE xxx NE
CD38 G#other_name_B XXdd G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
a NE x NE
mutant G#cell_line_B xxx G#cell_line_B
subclone G#cell_line_E xxx G#cell_line_E
of NE xx NE
the NE xxx NE
HL-60 G#cell_line_B XX-dd G#cell_line_B
myeloid G#cell_line_M xxx G#cell_line_M
leukemia G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
(designated NE (xxx NE
HL-60R G#cell_line XX-ddX G#cell_line
) NE ) NE
that NE xxx NE
is NE xx NE
relatively NE xxx NE
resistant NE xxx NE
to NE xx NE
ATRA NE XXXX NE
-induced NE -xxx NE
granulocytic NE xxx NE
differentiation NE xxx NE
. NE . NE

Retroviral G#other_name_B Xxxx G#other_name_B
vector-mediated G#other_name_M xxx-xxx G#other_name_M
transduction G#other_name_E xxx G#other_name_E
of NE xx NE
RA G#protein_family_or_group_B XX G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
RAR G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
) NE ) NE
into NE xxx NE
this NE xxx NE
HL-60R G#cell_line_B XX-ddX G#cell_line_B
subclone G#cell_line_E xxx G#cell_line_E
completely NE xxx NE
restored NE xxx NE
the NE xxx NE
sensitivity NE xxx NE
of NE xx NE
these NE xxx NE
cells NE xxx NE
to NE xx NE
ATRA G#other_organic_compound XXXX G#other_organic_compound
in NE xx NE
terms NE xxx NE
of NE xx NE
their NE xxx NE
ability NE xxx NE
to NE xx NE
express NE xxx NE
CD38 G#protein_molecule XXdd G#protein_molecule
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
CD38 G#other_name_B XXdd G#other_name_B
expression G#other_name_E xxx G#other_name_E
was NE xxx NE
not NE xxx NE
inducible NE xxx NE
by NE xx NE
ATRA G#other_organic_compound XXXX G#other_organic_compound
in NE xx NE
HL-60R G#cell_line_B XX-ddX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
transfected NE xxx NE
with NE xxx NE
a NE x NE
functional NE xxx NE
RAR G#protein_molecule_B XXX G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
RAR G#protein_molecule_B XXX G#protein_molecule_B
gamma G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
or NE xx NE
RXR G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_M xxx G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Induction NE Xxxx NE
of NE xx NE
CD38 G#protein_molecule XXdd G#protein_molecule
in NE xx NE
acute G#cell_type_B xxx G#cell_type_B
promyelocytic G#cell_type_M xxx G#cell_type_M
leukemia G#cell_type_M xxx G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
acute G#cell_type_M xxx G#cell_type_M
myeloblastic G#cell_type_M xxx G#cell_type_M
leukemia G#cell_type_M xxx G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E
was NE xxx NE
independent NE xxx NE
of NE xx NE
ATRA G#other_name XXXX G#other_name
-induced NE -xxx NE
cytodifferentiation NE xxx NE
. NE . NE

Following NE Xxxx NE
culture NE xxx NE
with NE xxx NE
ATRA G#other_organic_compound XXXX G#other_organic_compound
, NE , NE
increased NE xxx NE
CD38 G#other_name_B XXdd G#other_name_B
protein G#other_name_M xxx G#other_name_M
levels G#other_name_E xxx G#other_name_E
were NE xxx NE
also NE xxx NE
observed NE xxx NE
in NE xx NE
normal G#cell_type_B xxx G#cell_type_B
CD34+ G#cell_type_M XXdd+ G#cell_type_M
bone G#cell_type_M xxx G#cell_type_M
marrow G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
but NE xxx NE
not NE xxx NE
on NE xx NE
normal G#cell_type_B xxx G#cell_type_B
circulating G#cell_type_M xxx G#cell_type_M
granulocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

From NE Xxxx NE
these NE xxx NE
results NE xxx NE
, NE , NE
we NE xx NE
conclude NE xxx NE
that NE xxx NE
CD38 G#protein_molecule XXdd G#protein_molecule
is NE xx NE
ATRA G#other_organic_compound XXXX G#other_organic_compound
inducible NE xxx NE
in NE xx NE
myeloid G#cell_type_B xxx G#cell_type_B
leukemia G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
normal G#cell_type_B xxx G#cell_type_B
CD34+ G#cell_type_M XXdd+ G#cell_type_M
bone G#cell_type_M xxx G#cell_type_M
marrow G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

This NE Xxxx NE
effect NE xxx NE
is NE xx NE
independent NE xxx NE
of NE xx NE
differentiation G#other_name xxx G#other_name
and NE xxx NE
is NE xx NE
mediated NE xxx NE
by NE xx NE
RAR G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
HL-60 G#cell_type_B XX-dd G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
suggesting NE xxx NE
a NE x NE
similar NE xxx NE
role NE xxx NE
for NE xxx NE
RAR G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
CD38 G#other_name_B XXdd G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
other NE xxx NE
hematopoietic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Some NE Xxxx NE
antioxidants G#other_organic_compound xxx G#other_organic_compound
inhibit NE xxx NE
, NE , NE
in NE xx NE
a NE x NE
co-ordinate NE xx-xxx NE
fashion NE xxx NE
, NE , NE
the NE xxx NE
production NE xxx NE
of NE xx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor-alpha G#protein_molecule_E xxx-xxx G#protein_molecule_E
, NE , NE
IL-beta G#protein_molecule XX-xxx G#protein_molecule
, NE , NE
and NE xxx NE
IL-6 G#protein_molecule XX-d G#protein_molecule
by NE xx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Some NE Xxxx NE
antioxidants G#other_organic_compound xxx G#other_organic_compound
, NE , NE
including NE xxx NE
butylated G#other_organic_compound_B xxx G#other_organic_compound_B
hydroxyanisole G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
BHA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
, NE , NE
tetrahydropapaveroline G#other_organic_compound xxx G#other_organic_compound
( NE ( NE
THP G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
, NE , NE
nordihydroguiauretic G#other_organic_compound_B xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
and NE xxx NE
10,11-dihydroxyaporphine G#other_organic_compound dd,dd-xxx G#other_organic_compound
( NE ( NE
DHA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
, NE , NE
were NE xxx NE
found NE xxx NE
to NE xx NE
be NE xx NE
potent NE xxx NE
inhibitors NE xxx NE
of NE xx NE
the NE xxx NE
production NE xxx NE
of NE xx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
(TNF)-alpha G#protein_molecule_E (XXX)-xxx G#protein_molecule_E
, NE , NE
IL-1 G#protein_molecule_B XX-d G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
and NE xxx NE
IL-6 G#protein_molecule XX-d G#protein_molecule
by NE xx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
PBMC G#cell_type XXXX G#cell_type
) NE ) NE
stimulated NE xxx NE
by NE xx NE
lipopolysaccharide G#lipid xxx G#lipid
( NE ( NE
LPS G#lipid XXX G#lipid
) NE ) NE
( NE ( NE
IC50s G#other_name XXddx G#other_name
in NE xx NE
the NE xxx NE
low NE xxx NE
micromolar NE xxx NE
range) NE xxx) NE
. NE . NE

Inhibition NE Xxxx NE
of NE xx NE
cytokine G#other_name_B xxx G#other_name_B
production G#other_name_E xxx G#other_name_E
was NE xxx NE
gene NE xxx NE
selective NE xxx NE
and NE xxx NE
not NE xxx NE
due NE xxx NE
to NE xx NE
general NE xxx NE
effects NE xxx NE
on NE xx NE
protein G#other_name_B xxx G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
. NE . NE

Inhibition NE Xxxx NE
of NE xx NE
cytokine G#other_name_B xxx G#other_name_B
production G#other_name_E xxx G#other_name_E
by NE xx NE
PBMC G#cell_type XXXX G#cell_type
was NE xxx NE
observed NE xxx NE
also NE xxx NE
when NE xxx NE
other NE xxx NE
inducers NE xxx NE
were NE xxx NE
used NE xxx NE
( NE ( NE
staphylococci G#mono_cell xxx G#mono_cell
, NE , NE
silica G#mono_cell xxx G#mono_cell
, NE , NE
zymosan G#mono_cell xxx G#mono_cell
) NE ) NE
. NE . NE

Much NE Xxxx NE
higher NE xxx NE
concentrations NE xxx NE
of NE xx NE
other NE xxx NE
antioxidants G#other_organic_compound xxx G#other_organic_compound
--including NE --xxx NE
ascorbic G#other_organic_compound_B xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
trolox G#other_organic_compound xxx G#other_organic_compound
, NE , NE
alpha-tocopherol G#other_organic_compound xxx-xxx G#other_organic_compound
, NE , NE
butylated G#other_organic_compound_B xxx G#other_organic_compound_B
hydroxytoluene G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
and NE xxx NE
the NE xxx NE
5-lipoxygenase G#other_organic_compound_B d-xxx G#other_organic_compound_B
inhibitor G#other_organic_compound_E xxx G#other_organic_compound_E
zileuton G#other_organic_compound xxx G#other_organic_compound
--did NE --xxx NE
not NE xxx NE
affect NE xxx NE
the NE xxx NE
production NE xxx NE
of NE xx NE
these NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
. NE . NE

The NE Xxx NE
active NE xxx NE
compounds NE xxx NE
did NE xxx NE
not NE xxx NE
inhibit NE xxx NE
IL-1 NE XX-d NE
-induced NE -xxx NE
production NE xxx NE
of NE xx NE
IL-6 NE XX-d NE
in NE xx NE
fibroblasts NE xxx NE
, NE , NE
showing NE xxx NE
the NE xxx NE
cell NE xxx NE
selectivity NE xxx NE
of NE xx NE
the NE xxx NE
effect NE xxx NE
. NE . NE

Antioxidant-mediated G#other_name_B Xxxx-xxx G#other_name_B
inhibition G#other_name_E xxx G#other_name_E
of NE xx NE
cytokine G#other_name_B xxx G#other_name_B
production G#other_name_E xxx G#other_name_E
was NE xxx NE
correlated NE xxx NE
with NE xxx NE
low NE xxx NE
levels NE xxx NE
of NE xx NE
the NE xxx NE
corresponding NE xxx NE
messenger G#RNA_family_or_group_B xxx G#RNA_family_or_group_B
RNAs G#RNA_family_or_group_E XXXx G#RNA_family_or_group_E
. NE . NE

Nuclear NE Xxxx NE
run-on NE xxx-xx NE
experiments NE xxx NE
showed NE xxx NE
that NE xxx NE
THP G#other_organic_compound XXX G#other_organic_compound
inhibited NE xxx NE
transcription NE xxx NE
of NE xx NE
the NE xxx NE
IL-1 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
beta G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

THP G#other_organic_compound XXX G#other_organic_compound
decreased NE xxx NE
the NE xxx NE
concentration NE xxx NE
of NE xx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
detected NE xxx NE
in NE xx NE
nuclear G#cell_component_B xxx G#cell_component_B
extracts G#cell_component_E xxx G#cell_component_E
of NE xx NE
PBMC G#cell_type XXXX G#cell_type
cultured NE xxx NE
in NE xx NE
the NE xxx NE
presence NE xxx NE
or NE xx NE
absence NE xxx NE
of NE xx NE
LPS G#lipid XXX G#lipid
. NE . NE

THP G#other_organic_compound XXX G#other_organic_compound
and NE xxx NE
DHA G#other_organic_compound XXX G#other_organic_compound
markedly NE xxx NE
decreased NE xxx NE
the NE xxx NE
levels NE xxx NE
of NE xx NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
and NE xxx NE
IL-1 G#protein_molecule_B XX-d G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
the NE xxx NE
circulation NE xxx NE
of NE xx NE
mice G#multi_cell xxx G#multi_cell
following NE xxx NE
LPS G#lipid XXX G#lipid
injection NE xxx NE
. NE . NE

Thus NE Xxxx NE
antioxidants G#other_organic_compound xxx G#other_organic_compound
vary NE xxx NE
widely NE xxx NE
in NE xx NE
potency NE xxx NE
as NE xx NE
inhibitors NE xxx NE
of NE xx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
of NE xx NE
the NE xxx NE
transcription NE xxx NE
of NE xx NE
genes G#DNA_family_or_group xxx G#DNA_family_or_group
for NE xxx NE
pro-inflammatory G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
cytokines G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Coordinate NE Xxxx NE
inhibition NE xxx NE
of NE xx NE
the NE xxx NE
transcription G#other_name xxx G#other_name
of NE xx NE
genes NE xxx NE
for NE xxx NE
inflammatory NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
could NE xxx NE
provide NE xxx NE
a NE x NE
strategy NE xxx NE
for NE xxx NE
therapy NE xxx NE
of NE xx NE
diseases G#other_name xxx G#other_name
with NE xxx NE
inflammatory G#other_name_B xxx G#other_name_B
pathogenesis G#other_name_E xxx G#other_name_E
and NE xxx NE
for NE xxx NE
septic G#other_name_B xxx G#other_name_B
shock G#other_name_E xxx G#other_name_E
. NE . NE

An NE Xx NE
interleukin-4-induced G#protein_family_or_group_B xxx-d-xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
: NE : NE
IL-4 G#protein_molecule_B XX-d G#protein_molecule_B
Stat G#protein_molecule_E Xxxx G#protein_molecule_E
. NE . NE

Interleukin-4 G#protein_molecule Xxxx-d G#protein_molecule
( NE ( NE
IL-4 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
is NE xx NE
an NE xx NE
immunomodulatory NE xxx NE
cytokine NE xxx NE
secreted NE xxx NE
by NE xx NE
activated NE xxx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
basophils G#cell_type xxx G#cell_type
, NE , NE
and NE xxx NE
mast G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

It NE Xx NE
plays NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
modulating NE xxx NE
the NE xxx NE
balance NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
helper G#cell_type_M xxx G#cell_type_M
(Th) G#cell_type_M (Xx) G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
subsets G#cell_type_E xxx G#cell_type_E
, NE , NE
favoring NE xxx NE
expansion NE xxx NE
of NE xx NE
the NE xxx NE
Th2 G#cell_type_B Xxd G#cell_type_B
lineage G#cell_type_E xxx G#cell_type_E
relative NE xxx NE
to NE xx NE
Th1 G#cell_type Xxd G#cell_type
. NE . NE

Imbalance NE Xxxx NE
of NE xx NE
these NE xxx NE
T G#cell_type_B X G#cell_type_B
lymphocyte G#cell_type_M xxx G#cell_type_M
subsets G#cell_type_E xxx G#cell_type_E
has NE xxx NE
been NE xxx NE
implicated NE xxx NE
in NE xx NE
immunological NE xxx NE
diseases NE xxx NE
including NE xxx NE
allergy G#other_name xxx G#other_name
, NE , NE
inflammation G#other_name xxx G#other_name
, NE , NE
and NE xxx NE
autoimmune G#other_name_B xxx G#other_name_B
disease G#other_name_E xxx G#other_name_E
. NE . NE

IL-4 G#protein_molecule XX-d G#protein_molecule
may NE xxx NE
mediate NE xxx NE
its NE xxx NE
biological NE xxx NE
effects NE xxx NE
, NE , NE
at NE xx NE
least NE xxx NE
in NE xx NE
part NE xxx NE
, NE , NE
by NE xx NE
activating NE xxx NE
a NE x NE
tyrosine-phosphorylated G#protein_molecule_B xxx-xxx G#protein_molecule_B
DNA G#protein_molecule_M XXX G#protein_molecule_M
binding G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

This NE Xxxx NE
protein NE xxx NE
has NE xxx NE
now NE xxx NE
been NE xxx NE
purified NE xxx NE
and NE xxx NE
its NE xxx NE
encoding NE xxx NE
gene NE xxx NE
cloned NE xxx NE
. NE . NE

Examination NE Xxxx NE
of NE xx NE
the NE xxx NE
primary G#protein_N/A_B xxx G#protein_N/A_B
amino G#protein_N/A_M xxx G#protein_N/A_M
acid G#protein_N/A_M xxx G#protein_N/A_M
sequence G#protein_N/A_E xxx G#protein_N/A_E
of NE xx NE
this NE xxx NE
protein NE xxx NE
indicates NE xxx NE
that NE xxx NE
it NE xx NE
is NE xx NE
a NE x NE
member NE xxx NE
of NE xx NE
the NE xxx NE
signal G#protein_family_or_group_B xxx G#protein_family_or_group_B
transducers G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
activators G#protein_family_or_group_M xxx G#protein_family_or_group_M
of G#protein_family_or_group_M xx G#protein_family_or_group_M
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
(Stat) G#protein_family_or_group_M (Xxxx) G#protein_family_or_group_M
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
DNA G#protein_family_or_group_B XXX G#protein_family_or_group_B
binding G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
hereby NE xxx NE
designated NE xxx NE
IL-4 G#protein_molecule_B XX-d G#protein_molecule_B
Stat G#protein_molecule_E Xxxx G#protein_molecule_E
. NE . NE

Study NE Xxxx NE
of NE xx NE
the NE xxx NE
inhibitory NE xxx NE
activities NE xxx NE
of NE xx NE
phosphotyrosine-containing G#peptide_B xxx-xxx G#peptide_B
peptides G#peptide_E xxx G#peptide_E
derived NE xxx NE
from NE xxx NE
the NE xxx NE
intracellular G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
of G#protein_domain_or_region_M xx G#protein_domain_or_region_M
the G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
IL-4 G#protein_domain_or_region_M XX-d G#protein_domain_or_region_M
receptor G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
provided NE xxx NE
evidence NE xxx NE
for NE xxx NE
direct NE xxx NE
coupling NE xxx NE
of NE xx NE
receptor G#protein_family_or_group xxx G#protein_family_or_group
and NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
during NE xxx NE
the NE xxx NE
IL-4 G#other_name_B XX-d G#other_name_B
Stat G#other_name_M Xxxx G#other_name_M
activation G#other_name_M xxx G#other_name_M
cycle G#other_name_E xxx G#other_name_E
. NE . NE

Such NE Xxxx NE
observations NE xxx NE
indicate NE xxx NE
that NE xxx NE
IL-4 G#protein_molecule_B XX-d G#protein_molecule_B
Stat G#protein_molecule_E Xxxx G#protein_molecule_E
has NE xxx NE
the NE xxx NE
same NE xxx NE
functional G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
for NE xxx NE
both NE xxx NE
receptor G#other_name_B xxx G#other_name_B
coupling G#other_name_E xxx G#other_name_E
and NE xxx NE
dimerization G#other_name xxx G#other_name
. NE . NE

Evaluation NE Xxxx NE
of NE xx NE
the NE xxx NE
respiratory G#tissue_B xxx G#tissue_B
epithelium G#tissue_E xxx G#tissue_E
of NE xx NE
normals NE xxx NE
and NE xxx NE
individuals NE xxx NE
with NE xxx NE
cystic G#other_name_B xxx G#other_name_B
fibrosis G#other_name_E xxx G#other_name_E
for NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
adenovirus G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
E1a G#DNA_domain_or_region_M Xdx G#DNA_domain_or_region_M
sequences G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
relevant NE xxx NE
to NE xx NE
the NE xxx NE
use NE xxx NE
of NE xx NE
E1a- G#virus_B Xdx- G#virus_B
adenovirus G#virus_M xxx G#virus_M
vectors G#virus_E xxx G#virus_E
for NE xxx NE
gene G#other_name_B xxx G#other_name_B
therapy G#other_name_E xxx G#other_name_E
for NE xxx NE
the NE xxx NE
respiratory G#other_name_B xxx G#other_name_B
manifestations G#other_name_E xxx G#other_name_E
of NE xx NE
cystic G#other_name_B xxx G#other_name_B
fibrosis G#other_name_E xxx G#other_name_E
. NE . NE

Lung G#other_name_B Xxxx G#other_name_B
disease G#other_name_E xxx G#other_name_E
associated NE xxx NE
with NE xxx NE
disorders NE xxx NE
such NE xxx NE
as NE xx NE
cystic G#other_name_B xxx G#other_name_B
fibrosis G#other_name_E xxx G#other_name_E
(CF) NE (XX) NE
may NE xxx NE
be NE xx NE
amenable NE xxx NE
to NE xx NE
somatic G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
therapy G#other_name_E xxx G#other_name_E
in NE xx NE
which NE xxx NE
there NE xxx NE
is NE xx NE
delivery NE xxx NE
of NE xx NE
the NE xxx NE
normal G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
directly NE xxx NE
to NE xx NE
the NE xxx NE
respiratory G#tissue_B xxx G#tissue_B
epithelium G#tissue_E xxx G#tissue_E
using NE xxx NE
E1a- G#virus_B Xdx- G#virus_B
adenovirus G#virus_M xxx G#virus_M
(Ad) G#virus_M (Xx) G#virus_M
type G#virus_M xxx G#virus_M
2- G#virus_E d- G#virus_E
or NE xx NE
5-based NE d-xxx NE
vectors NE xxx NE
. NE . NE

For NE Xxx NE
safety NE xxx NE
reasons NE xxx NE
, NE , NE
the NE xxx NE
Ad G#virus_B Xx G#virus_B
vectors G#virus_E xxx G#virus_E
are NE xxx NE
rendered NE xxx NE
replication G#other_name_B xxx G#other_name_B
deficient G#other_name_E xxx G#other_name_E
by NE xx NE
deletion NE xxx NE
of NE xx NE
the NE xxx NE
E1a G#DNA_domain_or_region_B Xdx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Because NE Xxxx NE
there NE xxx NE
is NE xx NE
the NE xxx NE
theoretical NE xxx NE
possibility NE xxx NE
of NE xx NE
an NE xx NE
E1a- G#virus_B Xdx- G#virus_B
replication-deficient G#virus_M xxx-xxx G#virus_M
vector G#virus_E xxx G#virus_E
replicating NE xxx NE
as NE xx NE
a NE x NE
result NE xxx NE
of NE xx NE
recombination G#other_name xxx G#other_name
or NE xx NE
complementation G#other_name xxx G#other_name
with NE xxx NE
Ad G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
2/5 G#DNA_domain_or_region_M d/d G#DNA_domain_or_region_M
E1a G#DNA_domain_or_region_M Xdx G#DNA_domain_or_region_M
sequences G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
present NE xxx NE
in NE xx NE
the NE xxx NE
target NE xxx NE
cell NE xxx NE
, NE , NE
this NE xxx NE
study NE xxx NE
is NE xx NE
directed NE xxx NE
toward NE xxx NE
evaluating NE xxx NE
respiratory G#tissue_B xxx G#tissue_B
epithelium G#tissue_E xxx G#tissue_E
of NE xx NE
normals G#multi_cell xxx G#multi_cell
and NE xxx NE
individuals G#multi_cell xxx G#multi_cell
with NE xxx NE
CF G#other_name XX G#other_name
for NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
E1a NE Xdx NE
sequences NE xxx NE
. NE . NE

Using NE Xxxx NE
Ad G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
2/5 G#DNA_domain_or_region_M d/d G#DNA_domain_or_region_M
E1a-specific G#DNA_domain_or_region_M Xdx-xxx G#DNA_domain_or_region_M
primers G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
the NE xxx NE
polymerase G#other_name_B xxx G#other_name_B
chain G#other_name_M xxx G#other_name_M
reaction G#other_name_E xxx G#other_name_E
to NE xx NE
evaluate NE xxx NE
DNA NE XXX NE
recovered NE xxx NE
from NE xxx NE
freshly NE xxx NE
isolated NE xxx NE
nasal G#tissue_B xxx G#tissue_B
epithelium G#tissue_M xxx G#tissue_M
and G#tissue_M xxx G#tissue_M
bronchial G#tissue_M xxx G#tissue_M
epithelium G#tissue_E xxx G#tissue_E
E1a NE Xdx NE
sequences NE xxx NE
were NE xxx NE
detected NE xxx NE
in NE xx NE
respiratory G#tissue_B xxx G#tissue_B
epithelium G#tissue_E xxx G#tissue_E
of NE xx NE
19 NE dd NE
of NE xx NE
91 NE dd NE
normals G#multi_cell xxx G#multi_cell
(21%) NE (dd%) NE
. NE . NE

In NE Xx NE
the NE xxx NE
E1a-positive G#tissue_B Xdx-xxx G#tissue_B
samples G#tissue_E xxx G#tissue_E
, NE , NE
the NE xxx NE
average NE xxx NE
of NE xx NE
E1a G#other_name_B Xdx G#other_name_B
copy G#other_name_M xxx G#other_name_M
number G#other_name_E xxx G#other_name_E
was NE xxx NE
55 NE dd NE
+/- NE +/- NE
18/10(3) NE dd/dd(d) NE
recovered NE xxx NE
cells NE xxx NE
. NE . NE

In NE Xx NE
CF G#other_name XX G#other_name
individuals G#multi_cell xxx G#multi_cell
, NE , NE
7 NE d NE
of NE xx NE
52 NE dd NE
(13%) NE (dd%) NE
had NE xxx NE
detectable NE xxx NE
E1a G#DNA_domain_or_region_B Xdx G#DNA_domain_or_region_B
sequences G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
respiratory G#tissue_B xxx G#tissue_B
epithelium G#tissue_E xxx G#tissue_E
, NE , NE
with NE xxx NE
E1a G#other_name_B Xdx G#other_name_B
copy G#other_name_M xxx G#other_name_M
number G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
positive NE xxx NE
samples NE xxx NE
of NE xx NE
80 NE dd NE
+/- NE +/- NE
21/10(3) NE dd/dd(d) NE
recovered NE xxx NE
cells NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
there NE xxx NE
are NE xxx NE
detectable NE xxx NE
Ad G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
2/5 G#DNA_domain_or_region_M d/d G#DNA_domain_or_region_M
E1a G#DNA_domain_or_region_M Xdx G#DNA_domain_or_region_M
sequences G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
respiratory G#tissue_B xxx G#tissue_B
epithelium G#tissue_E xxx G#tissue_E
of NE xx NE
a NE x NE
small NE xxx NE
percentage NE xxx NE
of NE xx NE
normals G#multi_cell xxx G#multi_cell
and NE xxx NE
individuals G#multi_cell xxx G#multi_cell
with NE xxx NE
CF G#other_name XX G#other_name
. NE . NE

Because NE Xxxx NE
of NE xx NE
the NE xxx NE
theoretical NE xxx NE
potential NE xxx NE
of NE xx NE
such NE xxx NE
sequences NE xxx NE
supporting NE xxx NE
replication NE xxx NE
of NE xx NE
E1a- G#virus_B Xdx- G#virus_B
Ad G#virus_M Xx G#virus_M
vectors G#virus_E xxx G#virus_E
, NE , NE
human NE xxx NE
gene NE xxx NE
therapy NE xxx NE
protocols NE xxx NE
for NE xxx NE
CF G#other_name XX G#other_name
utilizing NE xxx NE
such NE xxx NE
vectors NE xxx NE
should NE xxx NE
consider NE xxx NE
evaluating NE xxx NE
study NE xxx NE
individuals G#multi_cell xxx G#multi_cell
for NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
Ad G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
2/5 G#DNA_domain_or_region_M d/d G#DNA_domain_or_region_M
E1a G#DNA_domain_or_region_M Xdx G#DNA_domain_or_region_M
sequences G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
respiratory G#tissue_B xxx G#tissue_B
epithelium G#tissue_E xxx G#tissue_E
. NE . NE

Leiomyosarcoma G#other_name Xxxx G#other_name
of NE xx NE
the NE xxx NE
vulva G#body_part xxx G#body_part
: NE : NE
report NE xxx NE
of NE xx NE
a NE x NE
case NE xxx NE
. NE . NE

A NE X NE
52-year-old NE dd-xxx-xxx NE
female G#multi_cell xxx G#multi_cell
presented NE xxx NE
with NE xxx NE
a NE x NE
progressively NE xxx NE
enlarging G#tissue_B xxx G#tissue_B
vulvar G#tissue_M xxx G#tissue_M
mass G#tissue_E xxx G#tissue_E
. NE . NE

Pathological NE Xxxx NE
evaluation NE xxx NE
revealed NE xxx NE
a NE x NE
high-grade G#other_name_B xxx-xxx G#other_name_B
vulvar G#other_name_M xxx G#other_name_M
leiomyosarcoma G#other_name_E xxx G#other_name_E
. NE . NE

immunohistochemical G#other_name_B xxx G#other_name_B
study G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
ultrastructural G#other_name_M xxx G#other_name_M
study G#other_name_E xxx G#other_name_E
studies NE xxx NE
were NE xxx NE
performed NE xxx NE
to NE xx NE
support NE xxx NE
the NE xxx NE
diagnosis NE xxx NE
. NE . NE

In NE Xx NE
an NE xx NE
effort NE xxx NE
to NE xx NE
better NE xxx NE
understand NE xxx NE
the NE xxx NE
biology NE xxx NE
of NE xx NE
this NE xxx NE
tumor G#tissue xxx G#tissue
additional NE xxx NE
immunohistochemical NE xxx NE
studies NE xxx NE
for NE xxx NE
the NE xxx NE
protein NE xxx NE
product NE xxx NE
of NE xx NE
p53 NE xdd NE
tumor NE xxx NE
suppressor NE xxx NE
gene NE xxx NE
and NE xxx NE
estrogen NE xxx NE
receptor NE xxx NE
expression NE xxx NE
by NE xx NE
tumor NE xxx NE
cells NE xxx NE
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
the NE xxx NE
type NE xxx NE
of NE xx NE
immune NE xxx NE
cells NE xxx NE
infiltrating NE xxx NE
the NE xxx NE
tumor NE xxx NE
were NE xxx NE
performed NE xxx NE
. NE . NE

Tumor G#cell_type_B Xxxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
showed NE xxx NE
an NE xx NE
overexpression NE xxx NE
of NE xx NE
p53 G#protein_molecule_B xdd G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
were NE xxx NE
estrogen NE xxx NE
receptor NE xxx NE
-positive NE -xxx NE
. NE . NE

Macrophages G#cell_type Xxxx G#cell_type
and NE xxx NE
T G#cell_type_B X G#cell_type_B
lymphocyte G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
B G#cell_type_M X G#cell_type_M
lymphocyte G#cell_type_E xxx G#cell_type_E
T G#other_name X G#other_name
infiltrated NE xxx NE
the NE xxx NE
tumor G#tissue xxx G#tissue
in NE xx NE
moderate NE xxx NE
numbers NE xxx NE
with NE xxx NE
occasional NE xxx NE
lymphoid NE xxx NE
aggregate NE xxx NE
formation NE xxx NE
. NE . NE

This NE Xxxx NE
study NE xxx NE
is NE xx NE
the NE xxx NE
first NE xxx NE
attempt NE xxx NE
to NE xx NE
better NE xxx NE
understand NE xxx NE
the NE xxx NE
biology NE xxx NE
of NE xx NE
these NE xxx NE
tumors G#tissue xxx G#tissue
. NE . NE

Stimulation NE Xxxx NE
of NE xx NE
HIV G#other_name_B XXX G#other_name_B
replication G#other_name_E xxx G#other_name_E
in NE xx NE
mononuclear G#cell_type_B xxx G#cell_type_B
phagocytes G#cell_type_E xxx G#cell_type_E
by NE xx NE
leukemia G#protein_molecule_B xxx G#protein_molecule_B
inhibitory G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

This NE Xxxx NE
study NE xxx NE
examined NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
leukemia G#protein_molecule_B xxx G#protein_molecule_B
inhibitory G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
LIF G#protein_molecule XXX G#protein_molecule
) NE ) NE
on NE xx NE
human NE xxx NE
immunodeficiency NE xxx NE
virus NE xxx NE
( NE ( NE
HIV NE XXX NE
) NE ) NE
replication NE xxx NE
in NE xx NE
mononuclear NE xxx NE
phagocytes NE xxx NE
( NE ( NE
MNP NE XXX NE
) NE ) NE
. NE . NE

LIF G#protein_molecule XXX G#protein_molecule
induced NE xxx NE
a NE x NE
dose-dependent NE xxx-xxx NE
increase NE xxx NE
in NE xx NE
p24 G#protein_molecule_B xdd G#protein_molecule_B
antigen G#protein_molecule_E xxx G#protein_molecule_E
production NE xxx NE
in NE xx NE
the NE xxx NE
chronically G#cell_line_B xxx G#cell_line_B
infected G#cell_line_M xxx G#cell_line_M
promonocytic G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
U1 G#cell_line_E Xd G#cell_line_E
. NE . NE

The NE Xxx NE
magnitude NE xxx NE
and NE xxx NE
time NE xxx NE
kinetics NE xxx NE
of NE xx NE
the NE xxx NE
LIF G#protein_molecule XXX G#protein_molecule
effects NE xxx NE
were NE xxx NE
similar NE xxx NE
to NE xx NE
interleukin G#protein_molecule_B xxx G#protein_molecule_B
1 G#protein_molecule_E d G#protein_molecule_E
( NE ( NE
IL-1 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
, NE , NE
IL-6 G#protein_molecule XX-d G#protein_molecule
, NE , NE
and NE xxx NE
tumor G#protein_family_or_group_B xxx G#protein_family_or_group_B
necrosis G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
TNF G#protein_family_or_group XXX G#protein_family_or_group
) NE ) NE
, NE , NE
other NE xxx NE
cytokines NE xxx NE
known NE xxx NE
to NE xx NE
induce NE xxx NE
HIV G#other_name_B XXX G#other_name_B
replication G#other_name_E xxx G#other_name_E
in NE xx NE
this NE xxx NE
cell NE xxx NE
line NE xxx NE
. NE . NE

To NE Xx NE
characterize NE xxx NE
mechanisms NE xxx NE
responsible NE xxx NE
for NE xxx NE
these NE xxx NE
LIF G#other_name_B XXX G#other_name_B
effects G#other_name_E xxx G#other_name_E
, NE , NE
levels NE xxx NE
of NE xx NE
HIV G#RNA_family_or_group_B XXX G#RNA_family_or_group_B
mRNA G#RNA_family_or_group_E xXXX G#RNA_family_or_group_E
, NE , NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
DNA G#protein_family_or_group_B XXX G#protein_family_or_group_B
binding G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_M xxx G#protein_family_or_group_M
nuclear G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
(NF)-kB G#protein_family_or_group (XX)-xX G#protein_family_or_group
, NE , NE
signal G#other_name_B xxx G#other_name_B
transduction G#other_name_M xxx G#other_name_M
pathways G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
potential NE xxx NE
interactions NE xxx NE
with NE xxx NE
other NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
were NE xxx NE
analyzed NE xxx NE
. NE . NE

LIF G#protein_molecule XXX G#protein_molecule
increased NE xxx NE
steady-state NE xxx-xxx NE
levels NE xxx NE
of NE xx NE
HIV G#RNA_family_or_group_B XXX G#RNA_family_or_group_B
mRNA G#RNA_family_or_group_E xXXX G#RNA_family_or_group_E
at NE xx NE
2.0 NE d.d NE
, NE , NE
4.3 NE d.d NE
, NE , NE
and NE xxx NE
9.2 NE d.d NE
kB NE xX NE
. NE . NE

This NE Xxxx NE
was NE xxx NE
detectable NE xxx NE
by NE xx NE
24 NE dd NE
h NE x NE
and NE xxx NE
persisted NE xxx NE
until NE xxx NE
72 NE dd NE
h NE x NE
. NE . NE

The NE Xxx NE
DNA G#protein_molecule_B XXX G#protein_molecule_B
binding G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_M xxx G#protein_molecule_M
NF-kB G#protein_molecule_E XX-xX G#protein_molecule_E
is NE xx NE
a NE x NE
central NE xxx NE
mediator NE xxx NE
in NE xx NE
cytokine G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
of NE xx NE
HIV G#other_name_B XXX G#other_name_B
transcription G#other_name_E xxx G#other_name_E
. NE . NE

NF-kB G#other_name_B XX-xX G#other_name_B
levels G#other_name_E xxx G#other_name_E
were NE xxx NE
higher NE xxx NE
in NE xx NE
unstimulated G#cell_line_B xxx G#cell_line_B
U1 G#cell_line_M Xd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
as NE xx NE
compared NE xxx NE
to NE xx NE
the NE xxx NE
parent G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
U937 G#cell_line Xddd G#cell_line
. NE . NE

In NE Xx NE
both NE xxx NE
cell NE xxx NE
lines NE xxx NE
LIF G#protein_molecule XXX G#protein_molecule
increased NE xxx NE
NF-kB G#other_name_B XX-xX G#other_name_B
activity G#other_name_E xxx G#other_name_E
. NE . NE

Induction NE Xxxx NE
of NE xx NE
NF-kB G#protein_molecule XX-xX G#protein_molecule
and NE xxx NE
HIV G#other_name_B XXX G#other_name_B
replication G#other_name_E xxx G#other_name_E
by NE xx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
are NE xxx NE
at NE xx NE
least NE xxx NE
in NE xx NE
part NE xxx NE
dependent NE xxx NE
on NE xx NE
reactive G#inorganic_B xxx G#inorganic_B
oxygen G#inorganic_M xxx G#inorganic_M
intermediates G#inorganic_E xxx G#inorganic_E
. NE . NE

The NE Xxx NE
oxygen G#other_name_B xxx G#other_name_B
radical G#other_name_M xxx G#other_name_M
scavenger G#other_name_E xxx G#other_name_E
N-acetyl-L-cysteine G#amino_acid_monomer X-xxx-X-xxx G#amino_acid_monomer
, NE , NE
but NE xxx NE
not NE xxx NE
an NE xx NE
inhibitor NE xxx NE
of NE xx NE
nitric G#protein_molecule_B xxx G#protein_molecule_B
oxide G#protein_molecule_M xxx G#protein_molecule_M
synthase G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
inhibited NE xxx NE
LIF NE XXX NE
-induced NE -xxx NE
HIV NE XXX NE
replication NE xxx NE
. NE . NE

LIF G#protein_molecule XXX G#protein_molecule
induces NE xxx NE
the NE xxx NE
production NE xxx NE
of NE xx NE
other NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
in NE xx NE
monocytes NE xxx NE
but NE xxx NE
its NE xxx NE
effects NE xxx NE
on NE xx NE
HIV G#other_name_B XXX G#other_name_B
replication G#other_name_E xxx G#other_name_E
were NE xxx NE
not NE xxx NE
inhibited NE xxx NE
by NE xx NE
antibodies NE xxx NE
to NE xx NE
IL-1 NE XX-d NE
, NE , NE
TNF NE XXX NE
, NE , NE
or NE xx NE
IL-6 NE XX-d NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
identify NE xxx NE
LIF G#protein_molecule XXX G#protein_molecule
as NE xx NE
a NE x NE
stimulus NE xxx NE
of NE xx NE
HIV G#other_name_B XXX G#other_name_B
replication G#other_name_E xxx G#other_name_E
. NE . NE

(ABSTRACT NE (XXXXXXXX NE
TRUNCATED NE XXXXXXXXX NE
AT NE XX NE
250 NE ddd NE
WORDS) NE XXXXX) NE

Mechanisms NE Xxxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
inhibition NE xxx NE
of NE xx NE
growth NE xxx NE
of NE xx NE
a NE x NE
human G#cell_line_B xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
lymphoma G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
B104 G#cell_line Xddd G#cell_line
, NE , NE
by NE xx NE
anti-MHC NE xxx-XXX NE
class NE xxx NE
II NE XX NE
antibodies NE xxx NE
. NE . NE

The NE Xxx NE
mechanisms NE xxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
inhibition NE xxx NE
of NE xx NE
growth NE xxx NE
of NE xx NE
a NE x NE
human G#cell_line_B xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
lymphoma G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
B104 G#cell_line Xddd G#cell_line
, NE , NE
by NE xx NE
anti-MHC NE xxx-XXX NE
class NE xxx NE
II NE XX NE
antibodies NE xxx NE
( NE ( NE
Ab NE Xx NE
) NE ) NE
were NE xxx NE
compared NE xxx NE
with NE xxx NE
those NE xxx NE
in NE xx NE
anti-IgM NE xxx-XxX NE
Ab NE Xx NE
-induced NE -xxx NE
B104 NE Xddd NE
growth NE xxx NE
inhibition NE xxx NE
. NE . NE

Two NE Xxx NE
anti-MHC G#protein_family_or_group_B xxx-XXX G#protein_family_or_group_B
class G#protein_family_or_group_M xxx G#protein_family_or_group_M
II G#protein_family_or_group_M XX G#protein_family_or_group_M
Ab G#protein_family_or_group_E Xx G#protein_family_or_group_E
, NE , NE
L227 G#protein_molecule Xddd G#protein_molecule
and NE xxx NE
2.06 G#protein_molecule d.dd G#protein_molecule
, NE , NE
inhibited NE xxx NE
the NE xxx NE
growth NE xxx NE
of NE xx NE
B104 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
although NE xxx NE
2.06 G#protein_molecule d.dd G#protein_molecule
, NE , NE
but NE xxx NE
not NE xxx NE
L227 G#protein_molecule Xddd G#protein_molecule
, NE , NE
needed NE xxx NE
to NE xx NE
be NE xx NE
further NE xxx NE
cross-linked NE xxx-xxx NE
with NE xxx NE
a NE x NE
goat G#protein_family_or_group_B xxx G#protein_family_or_group_B
anti-mouse G#protein_family_or_group_M xxx-xxx G#protein_family_or_group_M
IgG G#protein_family_or_group_M XxX G#protein_family_or_group_M
Ab G#protein_family_or_group_E Xx G#protein_family_or_group_E
( NE ( NE
GAM G#protein_family_or_group XXX G#protein_family_or_group
) NE ) NE
to NE xx NE
show NE xxx NE
the NE xxx NE
effect NE xxx NE
. NE . NE

L227 G#protein_molecule Xddd G#protein_molecule
induced NE xxx NE
an NE xx NE
increase NE xxx NE
in NE xx NE
intracellular NE xxx NE
free NE xxx NE
Ca2+ G#other_name_B Xxd+ G#other_name_B
concentration G#other_name_E xxx G#other_name_E
( NE ( NE
[ NE [ NE
Ca2+ NE Xxd+ NE
]i NE ]x NE
) NE ) NE
from NE xxx NE
the NE xxx NE
intracellular NE xxx NE
pool NE xxx NE
and NE xxx NE
little NE xxx NE
or NE xx NE
no NE xx NE
protein NE xxx NE
tyrosine NE xxx NE
phosphorylation NE xxx NE
, NE , NE
phosphatidyl NE xxx NE
inositol NE xxx NE
turnover NE xxx NE
, NE , NE
or NE xx NE
expression NE xxx NE
of NE xx NE
Egr-1 NE Xxx-d NE
mRNA NE xXXX NE
, NE , NE
whereas NE xxx NE
2.06 NE d.dd NE
plus NE xxx NE
GAM NE XXX NE
induced NE xxx NE
an NE xx NE
increase NE xxx NE
in NE xx NE
[ NE [ NE
Ca2+ NE Xxd+ NE
]i NE ]x NE
from NE xxx NE
both NE xxx NE
the NE xxx NE
intracellular NE xxx NE
and NE xxx NE
, NE , NE
in NE xx NE
particular NE xxx NE
, NE , NE
the NE xxx NE
extracellular NE xxx NE
pools NE xxx NE
. NE . NE

The NE Xxx NE
inhibition NE xxx NE
of NE xx NE
B104 G#other_name_B Xddd G#other_name_B
cell G#other_name_M xxx G#other_name_M
growth G#other_name_E xxx G#other_name_E
induced NE xxx NE
by NE xx NE
anti-MHC G#protein_family_or_group_B xxx-XXX G#protein_family_or_group_B
class G#protein_family_or_group_M xxx G#protein_family_or_group_M
II G#protein_family_or_group_M XX G#protein_family_or_group_M
Ab G#protein_family_or_group_E Xx G#protein_family_or_group_E
was NE xxx NE
Ca(2+) NE Xx(d+) NE
-independent NE -xxx NE
and NE xxx NE
not NE xxx NE
inhibited NE xxx NE
by NE xx NE
actinomycin NE xxx NE
D NE X NE
or NE xx NE
cyclosporin NE xxx NE
A NE X NE
, NE , NE
and NE xxx NE
cell NE xxx NE
cycle NE xxx NE
arrest NE xxx NE
at NE xx NE
the NE xxx NE
G2/M NE Xd/X NE
interphase NE xxx NE
was NE xxx NE
not NE xxx NE
observed NE xxx NE
. NE . NE

These NE Xxxx NE
features NE xxx NE
are NE xxx NE
very NE xxx NE
different NE xxx NE
from NE xxx NE
those NE xxx NE
observed NE xxx NE
in NE xx NE
B104 G#other_name_B Xddd G#other_name_B
cell G#other_name_M xxx G#other_name_M
death G#other_name_E xxx G#other_name_E
induced NE xxx NE
by NE xx NE
anti-IgM G#protein_family_or_group_B xxx-XxX G#protein_family_or_group_B
Ab G#protein_family_or_group_E Xx G#protein_family_or_group_E
. NE . NE

Neither NE Xxxx NE
DNA G#other_name_B XXX G#other_name_B
fragmentation G#other_name_E xxx G#other_name_E
nor NE xxx NE
the NE xxx NE
morphology NE xxx NE
of NE xx NE
apoptosis G#other_name xxx G#other_name
was NE xxx NE
observed NE xxx NE
. NE . NE

These NE Xxxx NE
findings NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
cross-linking NE xxx-xxx NE
of NE xx NE
MHC G#protein_family_or_group_B XXX G#protein_family_or_group_B
class G#protein_family_or_group_M xxx G#protein_family_or_group_M
II G#protein_family_or_group_M XX G#protein_family_or_group_M
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
transduced NE xxx NE
the NE xxx NE
negative NE xxx NE
signals NE xxx NE
through NE xxx NE
intracellular NE xxx NE
mechanisms NE xxx NE
different NE xxx NE
from NE xxx NE
those NE xxx NE
present NE xxx NE
in NE xx NE
the NE xxx NE
cross-linking NE xxx-xxx NE
of NE xx NE
surface NE xxx NE
IgM G#protein_family_or_group XxX G#protein_family_or_group
. NE . NE

Functional NE Xxxx NE
block NE xxx NE
for NE xxx NE
1 NE d NE
alpha,25-dihydroxyvitamin NE xxx,dd-xxx NE
D3 NE Xd NE
-mediated NE -xxx NE
gene NE xxx NE
regulation NE xxx NE
in NE xx NE
human NE xxx NE
B NE X NE
lymphocytes NE xxx NE
. NE . NE

Elements NE Xxxx NE
necessary NE xxx NE
for NE xxx NE
the NE xxx NE
steroid NE xxx NE
hormone NE xxx NE
1 G#lipid_B d G#lipid_B
alpha,25-dihydroxyvitamin G#lipid_M xxx,dd-xxx G#lipid_M
D3 G#lipid_E Xd G#lipid_E
( NE ( NE
1 G#lipid_B d G#lipid_B
alpha,25-(OH)2D3 G#lipid_E xxx,dd-(XX)dXd G#lipid_E
) NE ) NE
to NE xx NE
induce NE xxx NE
a NE x NE
biological NE xxx NE
response NE xxx NE
include NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
specific NE xxx NE
intracellular G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
vitamin G#protein_family_or_group_B xxx G#protein_family_or_group_B
D3 G#protein_family_or_group_M Xd G#protein_family_or_group_M
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
VDR G#protein_family_or_group XXX G#protein_family_or_group
)) NE )) NE
and NE xxx NE
modulation NE xxx NE
of NE xx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
via NE xxx NE
hormone-activated NE xxx-xxx NE
receptor NE xxx NE
binding NE xxx NE
to NE xx NE
regulatory G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
regions G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
target G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
genes G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

These NE Xxxx NE
parameters NE xxx NE
were NE xxx NE
examined NE xxx NE
in NE xx NE
normal NE xxx NE
and NE xxx NE
Epstein-Barr G#cell_line_B Xxxx-Xxxx G#cell_line_B
virus-immortalized G#cell_line_M xxx-xxx G#cell_line_M
human G#cell_line_M xxx G#cell_line_M
B G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
compared NE xxx NE
with NE xxx NE
1 G#cell_line_B d G#cell_line_B
alpha,25-(OH)2D3 G#cell_line_E xxx,dd-(XX)dXd G#cell_line_E
-responsive NE -xxx NE
cells NE xxx NE
of NE xx NE
the NE xxx NE
T G#cell_type_B X G#cell_type_B
lineage G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
monocytic G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_E xxx G#cell_type_E

Although NE Xxxx NE
resting NE xxx NE
tonsillar NE xxx NE
B NE X NE
cells NE xxx NE
did NE xxx NE
not NE xxx NE
express NE xxx NE
VDR G#RNA_family_or_group_B XXX G#RNA_family_or_group_B
mRNA G#RNA_family_or_group_E xXXX G#RNA_family_or_group_E
, NE , NE
activation NE xxx NE
of NE xx NE
these NE xxx NE
cells NE xxx NE
with NE xxx NE
interleukin-4 G#protein_molecule xxx-d G#protein_molecule
induced NE xxx NE
VDR G#protein_family_or_group XXX G#protein_family_or_group
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
exogenously NE xxx NE
supplemented NE xxx NE
1 G#lipid_B d G#lipid_B
alpha,25-(OH)2D3 G#lipid_E xxx,dd-(XX)dXd G#lipid_E
. NE . NE

As NE Xx NE
indicators NE xxx NE
of NE xx NE
hormone-mediated G#other_name_B xxx-xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
we NE xx NE
analyzed NE xxx NE
modulation NE xxx NE
of NE xx NE
CD23 G#protein_molecule XXdd G#protein_molecule
, NE , NE
a NE x NE
common G#protein_family_or_group_B xxx G#protein_family_or_group_B
B G#protein_family_or_group_M X G#protein_family_or_group_M
cell/monocyte G#protein_family_or_group_M xxx/xxx G#protein_family_or_group_M
surface G#protein_family_or_group_M xxx G#protein_family_or_group_M
antigen G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
and NE xxx NE
24-hydroxylase G#protein_molecule dd-xxx G#protein_molecule
. NE . NE

1 G#lipid_B d G#lipid_B
alpha,25-(OH)2D3 G#lipid_E xxx,dd-(XX)dXd G#lipid_E
inhibited NE xxx NE
CD23 G#protein_molecule XXdd G#protein_molecule
expression NE xxx NE
in NE xx NE
U937 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
yet NE xxx NE
failed NE xxx NE
to NE xx NE
modulate NE xxx NE
CD23 G#protein_molecule XXdd G#protein_molecule
expression NE xxx NE
in NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
1 G#lipid_B d G#lipid_B
alpha,25-(OH)2D3 G#lipid_E xxx,dd-(XX)dXd G#lipid_E
induced NE xxx NE
24-hydroxylase G#protein_molecule dd-xxx G#protein_molecule
mRNA NE xXXX NE
expression NE xxx NE
and NE xxx NE
metabolic G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
in NE xx NE
both NE xxx NE
U937 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
lectin-activated G#cell_type_B xxx-xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
yet NE xxx NE
failed NE xxx NE
to NE xx NE
induce NE xxx NE
24-hydroxylase G#RNA_molecule_B dd-xxx G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
or NE xx NE
its NE xxx NE
metabolic NE xxx NE
activity NE xxx NE
in NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

These NE Xxxx NE
findings NE xxx NE
suggest NE xxx NE
that NE xxx NE
although NE xxx NE
human G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
can NE xxx NE
express NE xxx NE
VDR G#RNA_family_or_group_B XXX G#RNA_family_or_group_B
mRNA G#RNA_family_or_group_E xXXX G#RNA_family_or_group_E
and NE xxx NE
protein NE xxx NE
, NE , NE
they NE xxx NE
exhibit NE xxx NE
a NE x NE
functional NE xxx NE
block NE xxx NE
for NE xxx NE
vitamin NE xxx NE
D NE X NE
-dependent NE -xxx NE
gene NE xxx NE
regulation NE xxx NE
. NE . NE

Positive NE Xxxx NE
and NE xxx NE
negative NE xxx NE
regulation NE xxx NE
of NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
: NE : NE
role NE xxx NE
of NE xx NE
multiple NE xxx NE
regulatory NE xxx NE
sites NE xxx NE
. NE . NE

Interleukin G#protein_N/A_B Xxxx G#protein_N/A_B
2 G#protein_N/A_E d G#protein_N/A_E
( NE ( NE
IL-2 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
is NE xx NE
an NE xx NE
important NE xxx NE
lymphokine G#protein_family_or_group xxx G#protein_family_or_group
required NE xxx NE
in NE xx NE
the NE xxx NE
process NE xxx NE
of NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
, NE , NE
proliferation G#other_name xxx G#other_name
, NE , NE
clonal G#other_name_B xxx G#other_name_B
expansion G#other_name_E xxx G#other_name_E
and NE xxx NE
differentiation G#other_name xxx G#other_name
. NE . NE

The NE Xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
displays NE xxx NE
both NE xxx NE
T NE X NE
cell NE xxx NE
specific NE xxx NE
and NE xxx NE
inducible NE xxx NE
expression NE xxx NE
: NE : NE
it NE xx NE
is NE xx NE
only NE xxx NE
expressed NE xxx NE
in NE xx NE
CD4+ G#cell_type_B XXd+ G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
after NE xxx NE
antigenic G#other_name_B xxx G#other_name_B
stimulation G#other_name_M xxx G#other_name_M
or G#other_name_M xx G#other_name_M
mitogenic G#other_name_M xxx G#other_name_M
stimulation G#other_name_E xxx G#other_name_E

Several NE Xxxx NE
cis-acting G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
regulatory G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
are NE xxx NE
required NE xxx NE
for NE xxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
after NE xxx NE
stimulation NE xxx NE
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
we NE xx NE
have NE xxx NE
analysed NE xxx NE
the NE xxx NE
function NE xxx NE
of NE xx NE
these NE xxx NE
cis-acting G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
regulatory G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
context NE xxx NE
of NE xx NE
the NE xxx NE
native NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
promoter NE xxx NE
sequence NE xxx NE
. NE . NE

The NE Xxx NE
results NE xxx NE
of NE xx NE
this NE xxx NE
study NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
NFAT G#protein_molecule XXXX G#protein_molecule
( NE ( NE
-276 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-261 G#DNA_domain_or_region_E -ddd G#DNA_domain_or_region_E
) NE ) NE
, NE , NE
the NE xxx NE
distal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
octamer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
-256 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-248 G#DNA_domain_or_region_E -ddd G#DNA_domain_or_region_E
) NE ) NE
and NE xxx NE
the NE xxx NE
proximal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
octamer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
-75 G#DNA_domain_or_region_B -dd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-66 G#DNA_domain_or_region_E -dd G#DNA_domain_or_region_E
) NE ) NE
sites NE xxx NE
not NE xxx NE
only NE xxx NE
act NE xxx NE
as NE xx NE
enhancers NE xxx NE
of NE xx NE
IL-2 G#other_name_B XX-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
cellular G#other_name_B xxx G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
, NE , NE
but NE xxx NE
also NE xxx NE
have NE xxx NE
a NE x NE
silencing NE xxx NE
effect NE xxx NE
on NE xx NE
IL-2 G#other_name_B XX-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
resting NE xxx NE
cells NE xxx NE
. NE . NE

Two NE Xxx NE
other NE xxx NE
sites NE xxx NE
display NE xxx NE
disparate NE xxx NE
effects NE xxx NE
on NE xx NE
IL-2 G#other_name_B XX-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
different NE xxx NE
T G#cell_line_B X G#cell_line_B
leukemia G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
: NE : NE
the NE xxx NE
distal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
purine G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
box G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
-291 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-277 G#DNA_domain_or_region_E -ddd G#DNA_domain_or_region_E
) NE ) NE
and NE xxx NE
the NE xxx NE
proximal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
purine G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
box G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
-145 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-128 G#DNA_domain_or_region_E -ddd G#DNA_domain_or_region_E
) NE ) NE
. NE . NE

Finally NE Xxxx NE
, NE , NE
the NE xxx NE
AP-1 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
(-186 G#DNA_domain_or_region_M (-ddd G#DNA_domain_or_region_M
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-176) G#DNA_domain_or_region_M -ddd) G#DNA_domain_or_region_M
site G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
the G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
kappa G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
EL4 NE XXd NE
cells NE xxx NE
. NE . NE

The NE Xxx NE
AP-1 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
mediated NE xxx NE
the NE xxx NE
response NE xxx NE
to NE xx NE
PMA G#other_name_B XXX G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
while NE xxx NE
the NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
responded NE xxx NE
to NE xx NE
IL-1 G#other_name_B XX-d G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
IL-2 G#other_name_B XX-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
is NE xx NE
a NE x NE
complex NE xxx NE
process NE xxx NE
and NE xxx NE
multiple NE xxx NE
cis-acting G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
regulatory G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
interact NE xxx NE
to NE xx NE
exert NE xxx NE
different NE xxx NE
effects NE xxx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
representative NE xxx NE
of NE xx NE
alternative NE xxx NE
stages NE xxx NE
of NE xx NE
differentiation G#other_name xxx G#other_name
. NE . NE

Sp1 G#protein_molecule Xxd G#protein_molecule
is NE xx NE
a NE x NE
critical NE xxx NE
factor NE xxx NE
for NE xxx NE
the NE xxx NE
monocytic NE xxx NE
specific NE xxx NE
expression NE xxx NE
of NE xx NE
human G#protein_molecule_B xxx G#protein_molecule_B
CD14 G#protein_molecule_E XXdd G#protein_molecule_E
. NE . NE

CD14 G#protein_molecule XXdd G#protein_molecule
is NE xx NE
a NE x NE
membrane G#protein_family_or_group_B xxx G#protein_family_or_group_B
glycoprotein G#protein_family_or_group_E xxx G#protein_family_or_group_E
expressed NE xxx NE
specifically NE xxx NE
on NE xx NE
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
macrophages G#cell_type xxx G#cell_type
, NE , NE
and NE xxx NE
its NE xxx NE
expression NE xxx NE
is NE xx NE
markedly NE xxx NE
increased NE xxx NE
during NE xxx NE
the NE xxx NE
process NE xxx NE
of NE xx NE
monocyte G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
order NE xxx NE
to NE xx NE
study NE xxx NE
CD14 G#other_name_B XXdd G#other_name_B
gene G#other_name_M xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
CD14 G#DNA_domain_or_region_M XXdd G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
cloned NE xxx NE
from NE xxx NE
a NE x NE
partial NE xxx NE
EcoRI G#DNA_family_or_group_B XxxXX G#DNA_family_or_group_B
digested G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
chromosome G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
5 G#DNA_family_or_group_M d G#DNA_family_or_group_M
library G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

A NE X NE
5.5-kilobase G#DNA_molecule_B d.d-xxx G#DNA_molecule_B
genomic G#DNA_molecule_M xxx G#DNA_molecule_M
clone G#DNA_molecule_E xxx G#DNA_molecule_E
contained NE xxx NE
the NE xxx NE
full-length NE xxx-xxx NE
CD14 G#DNA_domain_or_region_B XXdd G#DNA_domain_or_region_B
coding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
4.2 G#DNA_domain_or_region_B d.d G#DNA_domain_or_region_B
kilobases G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
of G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
5'-upstream G#DNA_domain_or_region_M d'-xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

One NE Xxx NE
major G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
transcription G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
start G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
minor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
transcription G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
start G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
were NE xxx NE
identified NE xxx NE
101 G#DNA_domain_or_region_B ddd G#DNA_domain_or_region_B
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
130 G#DNA_domain_or_region_M ddd G#DNA_domain_or_region_M
base G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
pairs G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
(bp) G#DNA_domain_or_region_M (xx) G#DNA_domain_or_region_M
upstream G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
respectively NE xxx NE
, NE , NE
from NE xxx NE
the NE xxx NE
protein G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
translation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
start G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
ATG G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
. NE . NE

A NE X NE
DNA G#DNA_molecule_B XXX G#DNA_molecule_B
fragment G#DNA_molecule_E xxx G#DNA_molecule_E
containing NE xxx NE
128 G#DNA_domain_or_region_B ddd G#DNA_domain_or_region_B
bp G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
of G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
upstream G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
had NE xxx NE
strong NE xxx NE
, NE , NE
monocyte-specific G#other_name_B xxx-xxx G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
CD14 G#cell_line_B XXdd G#cell_line_B
positive G#cell_line_M xxx G#cell_line_M
monocytic G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
Mono G#cell_line_B Xxxx G#cell_line_B
Mac G#cell_line_M Xxx G#cell_line_M
6 G#cell_line_E d G#cell_line_E
as NE xx NE
compared NE xxx NE
to NE xx NE
the NE xxx NE
nonmonocytic G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
HeLa G#cell_line XxXx G#cell_line
and NE xxx NE
REX G#cell_line XXX G#cell_line
. NE . NE

Four NE Xxxx NE
regions NE xxx NE
in NE xx NE
this NE xxx NE
DNA G#DNA_molecule_B XXX G#DNA_molecule_B
fragment G#DNA_molecule_E xxx G#DNA_molecule_E
interact NE xxx NE
with NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
isolated NE xxx NE
from NE xxx NE
monocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
Sp1 G#protein_molecule Xxd G#protein_molecule
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
bound NE xxx NE
to NE xx NE
three NE xxx NE
different NE xxx NE
regions NE xxx NE
in NE xx NE
the NE xxx NE
CD14 G#DNA_domain_or_region_B XXdd G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Mutation NE Xxxx NE
of NE xx NE
the NE xxx NE
major G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
Sp1 G#DNA_domain_or_region_M Xxd G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
-110 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
bp G#DNA_domain_or_region_E xx G#DNA_domain_or_region_E
) NE ) NE
decreased NE xxx NE
tissue-specific NE xxx-xxx NE
promoter NE xxx NE
activity NE xxx NE
, NE , NE
and NE xxx NE
these NE xxx NE
results NE xxx NE
, NE , NE
together NE xxx NE
with NE xxx NE
transactivation G#other_name_B xxx G#other_name_B
experiments G#other_name_E xxx G#other_name_E
, NE , NE
demonstrate NE xxx NE
that NE xxx NE
Sp1 G#protein_molecule Xxd G#protein_molecule
plays NE xxx NE
a NE x NE
critical NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
tissue-specific NE xxx-xxx NE
expression NE xxx NE
of NE xx NE
CD14 G#protein_molecule XXdd G#protein_molecule
in NE xx NE
monocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

CD14 G#protein_molecule XXdd G#protein_molecule
Sp1 G#polynucleotide_B Xxd G#polynucleotide_B
site G#polynucleotide_M xxx G#polynucleotide_M
oligonucleotides G#polynucleotide_E xxx G#polynucleotide_E
bound NE xxx NE
preferentially NE xxx NE
to NE xx NE
a NE x NE
105-kDa G#protein_molecule_B ddd-xXx G#protein_molecule_B
Sp1 G#protein_molecule_M Xxd G#protein_molecule_M
species G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
which NE xxx NE
is NE xx NE
present NE xxx NE
in NE xx NE
higher NE xxx NE
relative NE xxx NE
levels NE xxx NE
in NE xx NE
monocytic NE xxx NE
than NE xxx NE
non-monocytic NE xxx-xxx NE
cells NE xxx NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
modification NE xxx NE
of NE xx NE
Sp1 NE Xxd NE
, NE , NE
such NE xxx NE
as NE xx NE
phosphorylation NE xxx NE
, NE , NE
may NE xxx NE
explain NE xxx NE
how NE xxx NE
the NE xxx NE
Sp1 NE Xxd NE
site NE xxx NE
mediates NE xxx NE
monocytic NE xxx NE
specific NE xxx NE
promoter NE xxx NE
activity NE xxx NE
. NE . NE

The NE Xxx NE
interleukin-8 G#DNA_domain_or_region_B xxx-d G#DNA_domain_or_region_B
AP-1 G#DNA_domain_or_region_M XX-d G#DNA_domain_or_region_M
site G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
kappa G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
B-like G#DNA_domain_or_region_M X-xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
are NE xxx NE
genetic NE xxx NE
end NE xxx NE
targets NE xxx NE
of NE xx NE
FK506-sensitive G#other_name_B XXddd-xxx G#other_name_B
pathway G#other_name_E xxx G#other_name_E
accompanied NE xxx NE
by NE xx NE
calcium G#other_name_B xxx G#other_name_B
mobilization G#other_name_E xxx G#other_name_E
. NE . NE

FK506 G#other_organic_compound XXddd G#other_organic_compound
, NE , NE
an NE xx NE
immunosuppressant G#other_name xxx G#other_name
, NE , NE
inhibits NE xxx NE
the NE xxx NE
production NE xxx NE
of NE xx NE
several NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
in NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

We NE Xx NE
observed NE xxx NE
that NE xxx NE
FK506 G#other_organic_compound XXddd G#other_organic_compound
suppressed NE xxx NE
the NE xxx NE
transcription NE xxx NE
of NE xx NE
a NE x NE
chemotactic G#protein_family_or_group_B xxx G#protein_family_or_group_B
cytokine G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
interleukin-8 G#protein_molecule xxx-d G#protein_molecule
( NE ( NE
IL-8 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
in NE xx NE
a NE x NE
human G#cell_line_B xxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
activated NE xxx NE
by NE xx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
12-myristate G#other_organic_compound_M dd-xxx G#other_organic_compound_M
13-acetate G#other_organic_compound_E dd-xxx G#other_organic_compound_E
( NE ( NE
PMA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
and NE xxx NE
calcium NE xxx NE
( NE ( NE
Ca2+ NE Xxd+ NE
) NE ) NE
ionophore NE xxx NE
( NE ( NE
ionomycin NE xxx NE
) NE ) NE
. NE . NE

By NE Xx NE
deleted NE xxx NE
and NE xxx NE
mutated NE xxx NE
analysis NE xxx NE
of NE xx NE
the NE xxx NE
IL-8 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoters G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
the NE xxx NE
AP-1 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
kappa G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
B-like G#DNA_domain_or_region_M X-xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
were NE xxx NE
identified NE xxx NE
as NE xx NE
the NE xxx NE
responsive NE xxx NE
elements NE xxx NE
for NE xxx NE
PMA G#other_organic_compound XXX G#other_organic_compound
and NE xxx NE
ionomycin G#other_organic_compound xxx G#other_organic_compound
. NE . NE

FK506 G#other_organic_compound XXddd G#other_organic_compound
suppressed NE xxx NE
the NE xxx NE
transcriptions NE xxx NE
through NE xxx NE
the NE xxx NE
AP-1 NE XX-d NE
or NE xx NE
kappa NE xxx NE
B-like NE X-xxx NE
sites NE xxx NE
induced NE xxx NE
by NE xx NE
PMA NE XXX NE
plus NE xxx NE
Ca(2+)-mobilizing NE Xx(d+)-xxx NE
agents NE xxx NE
, NE , NE
but NE xxx NE
not NE xxx NE
those NE xxx NE
induced NE xxx NE
by NE xx NE
Ca(2+)-independent NE Xx(d+)-xxx NE
stimuli NE xxx NE
. NE . NE

In NE Xx NE
gel NE xxx NE
retardation NE xxx NE
analysis NE xxx NE
, NE , NE
FK506 G#other_organic_compound XXddd G#other_organic_compound
had NE xxx NE
little NE xxx NE
effect NE xxx NE
on NE xx NE
the NE xxx NE
binding NE xxx NE
to NE xx NE
the NE xxx NE
AP-1 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
PMA G#other_organic_compound XXX G#other_organic_compound
/ NE / NE
ionomycin G#other_organic_compound xxx G#other_organic_compound
-induced NE -xxx NE
nuclear NE xxx NE
factors NE xxx NE
, NE , NE
which NE xxx NE
were NE xxx NE
recognized NE xxx NE
with NE xxx NE
anti-JunD G#protein_family_or_group xxx-XxxX G#protein_family_or_group
or NE xx NE
c-Fos G#protein_family_or_group_B x-Xxx G#protein_family_or_group_B
antibody G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
FK506 G#other_organic_compound XXddd G#other_organic_compound
or NE xx NE
EGTA G#other_organic_compound XXXX G#other_organic_compound
( NE ( NE
Ca2+ G#other_name_B Xxd+ G#other_name_B
chelator G#other_name_E xxx G#other_name_E
) NE ) NE
similarly NE xxx NE
affected NE xxx NE
the NE xxx NE
formation NE xxx NE
of NE xx NE
kappa NE xxx NE
B-like NE X-xxx NE
site NE xxx NE
binding NE xxx NE
complexes NE xxx NE
, NE , NE
which NE xxx NE
were NE xxx NE
not NE xxx NE
recognized NE xxx NE
by NE xx NE
any NE xxx NE
antibodies NE xxx NE
against NE xxx NE
the NE xxx NE
human NE xxx NE
Rel NE Xxx NE
family NE xxx NE
proteins NE xxx NE
( NE ( NE
c-Rel NE x-Xxx NE
, NE , NE
p65 NE xdd NE
, NE , NE
p50 NE xdd NE
, NE , NE
and NE xxx NE
p49 NE xdd NE
) NE ) NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
we NE xx NE
confirmed NE xxx NE
the NE xxx NE
previous NE xxx NE
report NE xxx NE
that NE xxx NE
FK506 G#other_organic_compound XXddd G#other_organic_compound
suppressed NE xxx NE
the NE xxx NE
PMA G#other_organic_compound XXX G#other_organic_compound
/ NE / NE
ionomycin G#other_organic_compound xxx G#other_organic_compound
-induced NE -xxx NE
activation NE xxx NE
through NE xxx NE
authentic NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
immunoglobulin G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
(Ig) G#DNA_domain_or_region_M (Xx) G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
to NE xx NE
which NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
binding G#other_name_E xxx G#other_name_E
was NE xxx NE
also NE xxx NE
decreased NE xxx NE
by NE xx NE
FK506 G#other_organic_compound XXddd G#other_organic_compound
, NE , NE
indicating NE xxx NE
that NE xxx NE
both NE xxx NE
IL-8 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
kappa G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
B-like G#DNA_domain_or_region_M X-xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
Ig NE Xx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
are NE xxx NE
FK506 NE XXddd NE
-sensitive NE -xxx NE
in NE xx NE
spite NE xxx NE
of NE xx NE
the NE xxx NE
difference NE xxx NE
of NE xx NE
binding NE xxx NE
factors NE xxx NE
. NE . NE

Our NE Xxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
not NE xxx NE
only NE xxx NE
the NE xxx NE
reported NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
NF-AT G#DNA_domain_or_region_M XX-XX G#DNA_domain_or_region_M
site G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
NFIL-2A G#DNA_domain_or_region_M XXXX-dX G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
kappa NE xxx NE
B NE X NE
site NE xxx NE
, NE , NE
but NE xxx NE
also NE xxx NE
the NE xxx NE
IL-8 G#protein_molecule XX-d G#protein_molecule
AP-1 NE XX-d NE
and NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B-like G#DNA_domain_or_region_M X-xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
are NE xxx NE
terminals NE xxx NE
of NE xx NE
FK506 G#other_name XXddd G#other_name
-sensitive NE -xxx NE
pathway NE xxx NE
involving NE xxx NE
Ca2+ G#other_name_B Xxd+ G#other_name_B
mobilization G#other_name_E xxx G#other_name_E
. NE . NE

Androgen G#protein_domain_or_region_B Xxxx G#protein_domain_or_region_B
binding G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
sites G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
in NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
human G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
leukocytes G#cell_type_E xxx G#cell_type_E
of NE xx NE
healthy G#multi_cell_B xxx G#multi_cell_B
males G#multi_cell_E xxx G#multi_cell_E
and NE xxx NE
females G#multi_cell xxx G#multi_cell
. NE . NE

Androgen G#protein_domain_or_region_B Xxxx G#protein_domain_or_region_B
binding G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
sites G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
have NE xxx NE
been NE xxx NE
identified NE xxx NE
in NE xx NE
circulating G#cell_type_B xxx G#cell_type_B
human G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
leukocytes G#cell_type_E xxx G#cell_type_E
of NE xx NE
healthy G#multi_cell_B xxx G#multi_cell_B
donors G#multi_cell_E xxx G#multi_cell_E
of NE xx NE
both NE xxx NE
sexes NE xxx NE
. NE . NE

Cells NE Xxxx NE
were NE xxx NE
separated NE xxx NE
from NE xxx NE
blood G#tissue_B xxx G#tissue_B
samples G#tissue_E xxx G#tissue_E
on NE xx NE
a NE x NE
Ficoll G#other_name_B Xxxx G#other_name_B
gradient G#other_name_E xxx G#other_name_E
and NE xxx NE
incubated NE xxx NE
with NE xxx NE
different NE xxx NE
concentrations NE xxx NE
of NE xx NE
[3H]testosterone G#lipid [dX]xxx G#lipid
in NE xx NE
the NE xxx NE
presence NE xxx NE
or NE xx NE
absence NE xxx NE
of NE xx NE
a NE x NE
400-fold NE ddd-xxx NE
excess NE xxx NE
of NE xx NE
unlabelled G#lipid_B xxx G#lipid_B
testosterone G#lipid_E xxx G#lipid_E
. NE . NE

Binding NE Xxxx NE
data NE xxx NE
were NE xxx NE
derived NE xxx NE
from NE xxx NE
Scatchard G#other_name_B Xxxx G#other_name_B
analysis G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
binding G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
sites G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
fulfil NE xxx NE
the NE xxx NE
required NE xxx NE
criteria NE xxx NE
for NE xxx NE
specific NE xxx NE
steroid G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
binding G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
sites G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
however NE xxx NE
differ NE xxx NE
somewhat NE xxx NE
from NE xxx NE
the NE xxx NE
classic NE xxx NE
androgen G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
from NE xxx NE
genital G#cell_type_B xxx G#cell_type_B
skin G#cell_type_M xxx G#cell_type_M
fibroblast G#cell_type_E xxx G#cell_type_E
: NE : NE
in NE xx NE
fertile G#multi_cell_B xxx G#multi_cell_B
adult G#multi_cell_M xxx G#multi_cell_M
males G#multi_cell_E xxx G#multi_cell_E
(n NE (x NE
= NE = NE
20) NE dd) NE
the NE xxx NE
binding G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
sites G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
showed NE xxx NE
(1) NE (d) NE
a NE x NE
high NE xxx NE
affinity NE xxx NE
for NE xxx NE
testosterone G#lipid xxx G#lipid
(1.32 NE (d.dd NE
+/- NE +/- NE
0.49 NE d.dd NE
nM NE xX NE
; NE ; NE
mean NE xxx NE
+/- NE +/- NE
SD) NE XX) NE
, NE , NE
(2) NE (d) NE
a NE x NE
saturable NE xxx NE
capacity NE xxx NE
(184 NE (ddd NE
+/- NE +/- NE
52 NE dd NE
binding G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
sites G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
per NE xxx NE
cell NE xxx NE
; NE ; NE
mean NE xxx NE
+/- NE +/- NE
SD) NE XX) NE
, NE , NE
and NE xxx NE
(3) NE (d) NE
a NE x NE
characteristic NE xxx NE
competitive NE xxx NE
binding NE xxx NE
profile NE xxx NE
for NE xxx NE
other NE xxx NE
steroid G#lipid_B xxx G#lipid_B
hormones G#lipid_E xxx G#lipid_E
(relative NE (xxx NE
binding NE xxx NE
affinities NE xxx NE
: NE : NE
testosterone G#lipid xxx G#lipid
= NE = NE
dihydrotestosterone G#lipid xxx G#lipid
> NE > NE
17 G#lipid_B dd G#lipid_B
beta-estradiol G#lipid_E xxx-xxx G#lipid_E
> NE > NE
progesterone G#lipid xxx G#lipid
, NE , NE
whereas NE xxx NE
aldosterone NE xxx NE
, NE , NE
17-hydroxy-progesterone G#lipid dd-xxx-xxx G#lipid
and NE xxx NE
cortisol NE xxx NE
did NE xxx NE
not NE xxx NE
compete NE xxx NE
appreciably) NE xxx) NE
. NE . NE

Furthermore NE Xxxx NE
the NE xxx NE
number NE xxx NE
of NE xx NE
binding G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
sites G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
determined NE xxx NE
using NE xxx NE
[3H]dihydrotestosterone G#lipid [dX]xxx G#lipid
, NE , NE
[3H]RU-1881 G#other_organic_compound [dX]XX-dddd G#other_organic_compound
, NE , NE
or NE xx NE
[3H] NE [dX] NE
testosterone NE xxx NE
were NE xxx NE
comparable NE xxx NE
. NE . NE

This NE Xxxx NE
raises NE xxx NE
the NE xxx NE
possibility NE xxx NE
that NE xxx NE
androgen G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
mononuclear G#cell_type_M xxx G#cell_type_M
leukocytes G#cell_type_E xxx G#cell_type_E
differ NE xxx NE
from NE xxx NE
those NE xxx NE
in NE xx NE
genital G#cell_type_B xxx G#cell_type_B
skin G#cell_type_M xxx G#cell_type_M
fibroblasts G#cell_type_E xxx G#cell_type_E
. NE . NE

There NE Xxxx NE
was NE xxx NE
no NE xx NE
apparent NE xxx NE
correlation NE xxx NE
between NE xxx NE
serum G#other_name_B xxx G#other_name_B
testosterone G#other_name_M xxx G#other_name_M
concentrations G#other_name_E xxx G#other_name_E
and NE xxx NE
androgen G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
binding G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
sites G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

In NE Xx NE
fertile G#multi_cell_B xxx G#multi_cell_B
women G#multi_cell_E xxx G#multi_cell_E
remarkable NE xxx NE
changes NE xxx NE
in NE xx NE
androgen G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
binding G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
sites G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
were NE xxx NE
seen NE xxx NE
in NE xx NE
the NE xxx NE
course NE xxx NE
of NE xx NE
the NE xxx NE
menstrual G#other_name_B xxx G#other_name_B
cycle G#other_name_E xxx G#other_name_E
, NE , NE
with NE xxx NE
a NE x NE
significant NE xxx NE
increase NE xxx NE
in NE xx NE
the NE xxx NE
immediate G#other_name_B xxx G#other_name_B
preovulatory G#other_name_M xxx G#other_name_M
period G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
presence NE xxx NE
of NE xx NE
androgen G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
mononuclear G#cell_type_M xxx G#cell_type_M
leukocytes G#cell_type_E xxx G#cell_type_E
provides NE xxx NE
for NE xxx NE
the NE xxx NE
first NE xxx NE
time NE xxx NE
the NE xxx NE
experimental NE xxx NE
basis NE xxx NE
for NE xxx NE
an NE xx NE
hypothesis NE xxx NE
of NE xx NE
direct, G#other_name_B xxx, G#other_name_B
receptor-mediated G#other_name_M xxx-xxx G#other_name_M
effects G#other_name_E xxx G#other_name_E
of NE xx NE
androgens G#lipid xxx G#lipid
on NE xx NE
mature G#cell_type_B xxx G#cell_type_B
immunocompetent G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
immunological G#other_name_B xxx G#other_name_B
implications G#other_name_E xxx G#other_name_E
of NE xx NE
these NE xxx NE
results NE xxx NE
are NE xxx NE
discussed NE xxx NE
. NE . NE

Induction NE Xxxx NE
of NE xx NE
IL-8 G#other_name_B XX-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
uses NE xxx NE
the NE xxx NE
CD28 G#other_name_B XXdd G#other_name_B
costimulatory G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
. NE . NE

IL-8 G#protein_molecule XX-d G#protein_molecule
, NE , NE
a NE x NE
potent NE xxx NE
chemotactic G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
for NE xxx NE
neutrophil G#cell_type_B xxx G#cell_type_B
granulocytes G#cell_type_E xxx G#cell_type_E
and NE xxx NE
lymphocytes G#cell_type xxx G#cell_type
, NE , NE
is NE xx NE
a NE x NE
proinflammatory NE xxx NE
cytokine NE xxx NE
secreted NE xxx NE
by NE xx NE
a NE x NE
variety NE xxx NE
of NE xx NE
cell NE xxx NE
types NE xxx NE
, NE , NE
including NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Stimulation NE Xxxx NE
of NE xx NE
the NE xxx NE
CD28 G#protein_molecule_B XXdd G#protein_molecule_B
cell G#protein_molecule_M xxx G#protein_molecule_M
surface G#protein_molecule_M xxx G#protein_molecule_M
molecule G#protein_molecule_E xxx G#protein_molecule_E
delivers NE xxx NE
costimulatory G#other_name_B xxx G#other_name_B
signals G#other_name_E xxx G#other_name_E
essential NE xxx NE
for NE xxx NE
lymphokine G#other_name_B xxx G#other_name_B
production G#other_name_E xxx G#other_name_E
in NE xx NE
activated G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
via NE xxx NE
a NE x NE
conserved G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
found NE xxx NE
in NE xx NE
the NE xxx NE
promoter G#DNA_domain_or_region xxx G#DNA_domain_or_region
of NE xx NE
several NE xxx NE
lymphokine G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

Anti- NE Xxxx- NE
CD28 NE XXdd NE
-stimulated NE -xxx NE
T NE X NE
cells NE xxx NE
produced NE xxx NE
significant NE xxx NE
amounts NE xxx NE
of NE xx NE
IL-8 NE XX-d NE
; NE ; NE
additionally NE xxx NE
, NE , NE
costimulation NE xxx NE
with NE xxx NE
anti-CD3 NE xxx-XXd NE
and NE xxx NE
anti- NE xxx- NE
CD28 NE XXdd NE
Abs NE Xxx NE
resulted NE xxx NE
in NE xx NE
a NE x NE
synergistic NE xxx NE
induction NE xxx NE
of NE xx NE
IL-8 NE XX-d NE
secretion NE xxx NE
. NE . NE

Sequence NE Xxxx NE
homology NE xxx NE
, NE , NE
single G#nucleotide_B xxx G#nucleotide_B
nucleotide G#nucleotide_M xxx G#nucleotide_M
mutations G#nucleotide_E xxx G#nucleotide_E
, NE , NE
and NE xxx NE
anti- NE xxx- NE
CD28 NE XXdd NE
Ab NE Xx NE
stimulation NE xxx NE
studies NE xxx NE
established NE xxx NE
that NE xxx NE
the NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
-like NE -xxx NE
sequence NE xxx NE
in NE xx NE
the NE xxx NE
promoter NE xxx NE
of NE xx NE
the NE xxx NE
IL-8 NE XX-d NE
gene NE xxx NE
functioned NE xxx NE
as NE xx NE
a NE x NE
CD28 NE XXdd NE
response NE xxx NE
element NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
cyclosporin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
, NE , NE
but NE xxx NE
not NE xxx NE
rapamycin G#other_organic_compound xxx G#other_organic_compound
, NE , NE
blocked NE xxx NE
the NE xxx NE
synergistic NE xxx NE
induction NE xxx NE
of NE xx NE
IL-8 G#other_name_B XX-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
achieved NE xxx NE
with NE xxx NE
anti-CD3 G#protein_family_or_group xxx-XXd G#protein_family_or_group
and NE xxx NE
anti- NE xxx- NE
CD28 NE XXdd NE
costimulation NE xxx NE
. NE . NE

The NE Xxx NE
involvement NE xxx NE
of NE xx NE
a NE x NE
CD28 G#DNA_domain_or_region_B XXdd G#DNA_domain_or_region_B
response G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
IL-8 G#other_name_B XX-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
activated G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
may NE xxx NE
provide NE xxx NE
new NE xxx NE
insights NE xxx NE
into NE xxx NE
the NE xxx NE
pathogenesis NE xxx NE
and NE xxx NE
persistence NE xxx NE
of NE xx NE
immune G#other_name_B xxx G#other_name_B
disorders G#other_name_E xxx G#other_name_E
characterized NE xxx NE
by NE xx NE
increased NE xxx NE
levels NE xxx NE
of NE xx NE
IL-8 G#protein_molecule XX-d G#protein_molecule
, NE , NE
such NE xxx NE
as NE xx NE
psoriasis G#other_name xxx G#other_name
and NE xxx NE
rheumatoid G#other_name_B xxx G#other_name_B
arthritis G#other_name_E xxx G#other_name_E
. NE . NE

MHC G#other_name_B XXX G#other_name_B
class G#other_name_M xxx G#other_name_M
II G#other_name_M XX G#other_name_M
signaling G#other_name_E xxx G#other_name_E
in NE xx NE
B-cell G#other_name_B X-xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
[see NE [xxx NE
comments] NE xxx] NE

The NE Xxx NE
cognate NE xxx NE
interaction NE xxx NE
between NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
antigen-presenting G#cell_type_B xxx-xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
APCs G#cell_type XXXx G#cell_type
) NE ) NE
, NE , NE
mediated NE xxx NE
by NE xx NE
major G#protein_family_or_group_B xxx G#protein_family_or_group_B
histocompatibility G#protein_family_or_group_M xxx G#protein_family_or_group_M
complex G#protein_family_or_group_M xxx G#protein_family_or_group_M
(MHC) G#protein_family_or_group_M (XXX) G#protein_family_or_group_M
class G#protein_family_or_group_M xxx G#protein_family_or_group_M
II G#protein_family_or_group_M XX G#protein_family_or_group_M
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
results NE xxx NE
in NE xx NE
the NE xxx NE
delivery NE xxx NE
of NE xx NE
activation NE xxx NE
signals NE xxx NE
to NE xx NE
the NE xxx NE
APC G#cell_type XXX G#cell_type
. NE . NE

These NE Xxxx NE
signals NE xxx NE
contribute NE xxx NE
to NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
co-stimulatory G#other_name_B xx-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
by NE xx NE
APCs G#cell_type XXXx G#cell_type
and NE xxx NE
have NE xxx NE
important NE xxx NE
consequences NE xxx NE
for NE xxx NE
cell G#other_name_B xxx G#other_name_B
effector G#other_name_M xxx G#other_name_M
function G#other_name_E xxx G#other_name_E
. NE . NE

MHC G#protein_family_or_group_B XXX G#protein_family_or_group_B
class G#protein_family_or_group_M xxx G#protein_family_or_group_M
II G#protein_family_or_group_E XX G#protein_family_or_group_E
molecules NE xxx NE
also NE xxx NE
serve NE xxx NE
as NE xx NE
receptors NE xxx NE
for NE xxx NE
B-cell G#other_name_B X-xxx G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
by NE xx NE
microbial G#protein_family_or_group_B xxx G#protein_family_or_group_B
superantigens G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

In NE Xx NE
this NE xxx NE
review NE xxx NE
, NE , NE
Paul NE Xxxx NE
Scholl NE Xxxx NE
and NE xxx NE
Raif NE Xxxx NE
Geha NE Xxxx NE
discuss NE xxx NE
recent NE xxx NE
advances NE xxx NE
in NE xx NE
our NE xxx NE
understanding NE xxx NE
of NE xx NE
mechanisms NE xxx NE
of NE xx NE
MHC G#other_name_B XXX G#other_name_B
class G#other_name_M xxx G#other_name_M
II G#other_name_M XX G#other_name_M
signaling G#other_name_E xxx G#other_name_E
and NE xxx NE
analyse NE xxx NE
their NE xxx NE
role NE xxx NE
in NE xx NE
human G#other_name_B xxx G#other_name_B
B-cell G#other_name_M X-xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

Effects NE Xxxx NE
of NE xx NE
glucocorticoids G#lipid xxx G#lipid
in NE xx NE
rheumatoid G#other_name_B xxx G#other_name_B
arthritis G#other_name_E xxx G#other_name_E
. NE . NE

Diminished NE Xxxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
do NE xx NE
not NE xxx NE
result NE xxx NE
in NE xx NE
glucocorticoid G#other_name_B xxx G#other_name_B
resistance G#other_name_E xxx G#other_name_E
. NE . NE

OBJECTIVE NE XXXXXXXXX NE
. NE . NE

Lymphocytes NE Xxxx NE
of NE xx NE
patients NE xxx NE
with NE xxx NE
rheumatoid G#other_name_B xxx G#other_name_B
arthritis G#other_name_E xxx G#other_name_E
( NE ( NE
RA G#other_name XX G#other_name
) NE ) NE
have NE xxx NE
diminished NE xxx NE
receptor NE xxx NE
density NE xxx NE
; NE ; NE
thus NE xxx NE
, NE , NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
RA G#other_name XX G#other_name
should NE xxx NE
show NE xxx NE
partial NE xxx NE
resistance NE xxx NE
to NE xx NE
glucocorticoids G#lipid xxx G#lipid
. NE . NE

We NE Xx NE
investigated NE xxx NE
the NE xxx NE
glucocorticoid G#lipid xxx G#lipid
sensitivity NE xxx NE
of NE xx NE
lymphocytes G#cell_type xxx G#cell_type
in NE xx NE
RA G#multi_cell_B XX G#multi_cell_B
patients G#multi_cell_E xxx G#multi_cell_E
compared NE xxx NE
with NE xxx NE
healthy G#multi_cell_B xxx G#multi_cell_B
subjects G#multi_cell_E xxx G#multi_cell_E
. NE . NE

METHODS NE XXXXXXX NE
. NE . NE

We NE Xx NE
determined NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
glucocorticoids G#lipid xxx G#lipid
on NE xx NE
lymphocyte G#other_name_B xxx G#other_name_B
proliferation G#other_name_E xxx G#other_name_E
and NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
release G#other_name_E xxx G#other_name_E
. NE . NE

RESULTS NE XXXXXXX NE
. NE . NE

Proliferation NE Xxxx NE
and NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
release G#other_name_E xxx G#other_name_E
were NE xxx NE
inhibited NE xxx NE
in NE xx NE
RA G#other_name XX G#other_name
patients G#multi_cell xxx G#multi_cell
to NE xx NE
the NE xxx NE
same NE xxx NE
extent NE xxx NE
as NE xx NE
in NE xx NE
healthy G#multi_cell_B xxx G#multi_cell_B
controls G#multi_cell_E xxx G#multi_cell_E
. NE . NE

CONCLUSION NE XXXXXXXXXX NE
. NE . NE

Diminished NE Xxxx NE
receptor NE xxx NE
density NE xxx NE
in NE xx NE
RA G#other_name XX G#other_name
patients G#multi_cell xxx G#multi_cell
does NE xxx NE
not NE xxx NE
result NE xxx NE
in NE xx NE
glucocorticoid G#other_name_B xxx G#other_name_B
resistance G#other_name_E xxx G#other_name_E
. NE . NE

Arrested G#other_name_B Xxxx G#other_name_B
development G#other_name_E xxx G#other_name_E
: NE : NE
understanding NE xxx NE
v-abl G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
. NE . NE

The NE Xxx NE
protein G#other_name_B xxx G#other_name_B
tyrosine G#other_name_M xxx G#other_name_M
kinase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
v-abl G#DNA_domain_or_region_B x-xxx G#DNA_domain_or_region_B
oncogene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
has NE xxx NE
been NE xxx NE
demonstrated NE xxx NE
to NE xx NE
subvert NE xxx NE
the NE xxx NE
normal G#other_name_B xxx G#other_name_B
second G#other_name_M xxx G#other_name_M
messenger G#other_name_M xxx G#other_name_M
systems G#other_name_E xxx G#other_name_E
used NE xxx NE
by NE xx NE
lymphoid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
for NE xxx NE
growth NE xxx NE
and NE xxx NE
differentiation G#other_name xxx G#other_name
. NE . NE

Transformation G#other_name Xxxx G#other_name
of NE xx NE
bone G#tissue_B xxx G#tissue_B
marrow G#tissue_E xxx G#tissue_E
with NE xxx NE
the NE xxx NE
Abelson G#virus_B Xxxx G#virus_B
murine G#virus_M xxx G#virus_M
leukemia G#virus_M xxx G#virus_M
virus G#virus_E xxx G#virus_E
results NE xxx NE
in NE xx NE
the NE xxx NE
appearance NE xxx NE
of NE xx NE
B G#cell_type_B X G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
arrested NE xxx NE
at NE xx NE
the NE xxx NE
pre-B G#other_name_B xxx-X G#other_name_B
cell G#other_name_M xxx G#other_name_M
stage G#other_name_E xxx G#other_name_E
. NE . NE

Recent NE Xxxx NE
reports NE xxx NE
have NE xxx NE
characterized NE xxx NE
these NE xxx NE
cells NE xxx NE
expressing NE xxx NE
high NE xxx NE
v-abl G#other_name_B x-xxx G#other_name_B
kinase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
as NE xx NE
deficient NE xxx NE
in NE xx NE
detectable NE xxx NE
NF-kappaB G#other_name_B XX-xxxX G#other_name_B
DNA G#other_name_M XXX G#other_name_M
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
and NE xxx NE
low NE xxx NE
level NE xxx NE
RAG G#other_name_B XXX G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
observations NE xxx NE
suggest NE xxx NE
that NE xxx NE
v-abl G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
may NE xxx NE
be NE xx NE
inhibiting NE xxx NE
the NE xxx NE
differentiation G#other_name xxx G#other_name
of NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
blocking NE xxx NE
these NE xxx NE
two NE xxx NE
crucial NE xxx NE
elements NE xxx NE
in NE xx NE
the NE xxx NE
maturation G#other_name_B xxx G#other_name_B
pathway G#other_name_E xxx G#other_name_E
. NE . NE

Corticosteroid G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
lymphocytes G#cell_type xxx G#cell_type
: NE : NE
a NE x NE
possible NE xxx NE
marker NE xxx NE
of NE xx NE
brain G#other_name_B xxx G#other_name_B
involution G#other_name_E xxx G#other_name_E
? NE ? NE

A NE X NE
similarity NE xxx NE
has NE xxx NE
recently NE xxx NE
been NE xxx NE
found NE xxx NE
between NE xxx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
corticosteroid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
brain G#tissue_B xxx G#tissue_B
and G#tissue_M xxx G#tissue_M
in G#tissue_M xx G#tissue_M
lymphoid G#tissue_M xxx G#tissue_M
tissue G#tissue_E xxx G#tissue_E
. NE . NE

We NE Xx NE
have NE xxx NE
studied NE xxx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
corticosteroid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
mononuclear G#cell_type_M xxx G#cell_type_M
leukocytes G#cell_type_E xxx G#cell_type_E
as NE xx NE
a NE x NE
possible NE xxx NE
marker NE xxx NE
of NE xx NE
brain G#other_name_B xxx G#other_name_B
involution G#other_name_E xxx G#other_name_E
. NE . NE

Type G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
I G#protein_family_or_group_M X G#protein_family_or_group_M
corticosteroid G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
are NE xxx NE
down NE xxx NE
regulated NE xxx NE
by NE xx NE
excess NE xxx NE
of NE xx NE
mineralocorticoids G#lipid xxx G#lipid
(primary NE (xxx NE
and NE xxx NE
secondary NE xxx NE
hyperaldosteronism G#other_name xxx G#other_name
, NE , NE
pseudohyperaldosteronism G#other_name xxx G#other_name
) NE ) NE
and NE xxx NE
of NE xx NE
glucocorticoids G#lipid xxx G#lipid
( NE ( NE
Cushing's G#other_name_B Xxxx'x G#other_name_B
syndrome G#other_name_E xxx G#other_name_E
) NE ) NE
. NE . NE
Type G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
II G#protein_family_or_group_M XX G#protein_family_or_group_M
corticosteroid G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
are NE xxx NE
not NE xxx NE
reduced NE xxx NE
by NE xx NE
excess NE xxx NE
of NE xx NE
endogenous G#lipid_B xxx G#lipid_B
corticosteroids G#lipid_E xxx G#lipid_E
( NE ( NE
Cushing's G#other_name_B Xxxx'x G#other_name_B
syndrome G#other_name_E xxx G#other_name_E
) NE ) NE
. NE . NE

In NE Xx NE
normal NE xxx NE
adults NE xxx NE
there NE xxx NE
is NE xx NE
a NE x NE
direct NE xxx NE
significant NE xxx NE
correlation NE xxx NE
between NE xxx NE
plasma G#lipid_B xxx G#lipid_B
cortisol G#lipid_E xxx G#lipid_E
and NE xxx NE
Type NE Xxxx NE
I NE X NE
and NE xxx NE
between NE xxx NE
plasma NE xxx NE
cortisol NE xxx NE
and NE xxx NE
Type NE Xxxx NE
II NE XX NE
receptors NE xxx NE
in NE xx NE
mononuclear NE xxx NE
leukocytes NE xxx NE
, NE , NE
while NE xxx NE
in NE xx NE
Cushing's NE Xxxx'x NE
syndrome NE xxx NE
the NE xxx NE
correlation NE xxx NE
is NE xx NE
inverse NE xxx NE
between NE xxx NE
plasma NE xxx NE
cortisol NE xxx NE
at NE xx NE
8 NE d NE
a.m NE x.x NE
. NE . NE
and NE xxx NE
Type NE Xxxx NE
II NE XX NE
receptors NE xxx NE
. NE . NE

In NE Xx NE
an NE xx NE
aged NE xxx NE
population NE xxx NE
the NE xxx NE
mean NE xxx NE
numbers NE xxx NE
of NE xx NE
Type NE Xxxx NE
I NE X NE
and NE xxx NE
of NE xx NE
Type NE Xxxx NE
II NE XX NE
receptors NE xxx NE
are NE xxx NE
lower NE xxx NE
and NE xxx NE
plasma NE xxx NE
cortisol NE xxx NE
is NE xx NE
higher NE xxx NE
than NE xxx NE
in NE xx NE
adult NE xxx NE
controls NE xxx NE
, NE , NE
but NE xxx NE
the NE xxx NE
increase NE xxx NE
of NE xx NE
plasma NE xxx NE
cortisol NE xxx NE
is NE xx NE
not NE xxx NE
followed NE xxx NE
by NE xx NE
a NE x NE
clinical NE xxx NE
picture NE xxx NE
of NE xx NE
hypercorticism NE xxx NE
. NE . NE

corticosteroid G#protein_family_or_group_B xxx G#protein_family_or_group_B
Type G#protein_family_or_group_M Xxxx G#protein_family_or_group_M
I G#protein_family_or_group_M X G#protein_family_or_group_M
receptor G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
corticosteroid G#protein_family_or_group_M xxx G#protein_family_or_group_M
Type G#protein_family_or_group_M Xxxx G#protein_family_or_group_M
II G#protein_family_or_group_M XX G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E

After NE Xxxx NE
dexamethasone G#other_name_B xxx G#other_name_B
suppression G#other_name_E xxx G#other_name_E
(1 NE (d NE
mg NE xx NE
at NE xx NE
11 NE dd NE
p.m.) NE x.x.) NE
Type G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
I G#protein_family_or_group_M X G#protein_family_or_group_M
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
always NE xxx NE
decrease NE xxx NE
in NE xx NE
controls NE xxx NE
while NE xxx NE
the NE xxx NE
response NE xxx NE
of NE xx NE
Type NE Xxxx NE
II NE XX NE
is NE xx NE
not NE xxx NE
homogeneous NE xxx NE
. NE . NE

In NE Xx NE
an NE xx NE
aged NE xxx NE
group NE xxx NE
of NE xx NE
patients G#multi_cell xxx G#multi_cell
, NE , NE
both NE xxx NE
receptors NE xxx NE
are NE xxx NE
reduced NE xxx NE
by NE xx NE
dexamethasone G#lipid xxx G#lipid
. NE . NE

We NE Xx NE
conclude NE xxx NE
that NE xxx NE
the NE xxx NE
decrease NE xxx NE
with NE xxx NE
age NE xxx NE
of NE xx NE
corticosteroid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
is NE xx NE
possibly NE xxx NE
related NE xxx NE
to NE xx NE
a NE x NE
physiological NE xxx NE
involution NE xxx NE
of NE xx NE
corticosteroid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
that NE xxx NE
this NE xxx NE
reduction NE xxx NE
does NE xxx NE
increase NE xxx NE
plasma G#lipid_B xxx G#lipid_B
cortisol G#lipid_E xxx G#lipid_E
concentration NE xxx NE
, NE , NE
without NE xxx NE
affecting NE xxx NE
the NE xxx NE
glucocorticoid G#other_name_B xxx G#other_name_B
effector G#other_name_M xxx G#other_name_M
mechanism G#other_name_E xxx G#other_name_E
. NE . NE

All-trans G#other_organic_compound_B Xxx-xxx G#other_organic_compound_B
retinoic G#other_organic_compound_M xxx G#other_organic_compound_M
acid G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
1 G#lipid_B d G#lipid_B
alpha,25-dihydroxyvitamin G#lipid_M xxx,dd-xxx G#lipid_M
D3 G#lipid_E Xd G#lipid_E
co-operate NE xx-xxx NE
to NE xx NE
promote NE xxx NE
differentiation G#other_name xxx G#other_name
of NE xx NE
the NE xxx NE
human G#cell_line_B xxx G#cell_line_B
promyeloid G#cell_line_M xxx G#cell_line_M
leukemia G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
HL60 G#cell_line XXdd G#cell_line
to NE xx NE
monocytes G#cell_type xxx G#cell_type
. NE . NE

A NE X NE
basis NE xxx NE
for NE xxx NE
differentiation G#other_name xxx G#other_name
therapy NE xxx NE
of NE xx NE
leukemias G#other_name xxx G#other_name
is NE xx NE
provided NE xxx NE
by NE xx NE
knowledge NE xxx NE
of NE xx NE
agents NE xxx NE
which NE xxx NE
induce NE xxx NE
specific NE xxx NE
lineage NE xxx NE
maturation NE xxx NE
. NE . NE

All-trans G#other_organic_compound_B Xxx-xxx G#other_organic_compound_B
retinoic G#other_organic_compound_M xxx G#other_organic_compound_M
acid G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
RA G#other_organic_compound XX G#other_organic_compound
) NE ) NE
induces NE xxx NE
differentiation G#other_name xxx G#other_name
of NE xx NE
HL60 G#cell_line_B XXdd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
to NE xx NE
neutrophils G#cell_type xxx G#cell_type
and NE xxx NE
is NE xx NE
used NE xxx NE
to NE xx NE
treat NE xxx NE
acute G#other_name_B xxx G#other_name_B
promyelocytic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
observed NE xxx NE
that NE xxx NE
RA G#other_organic_compound XX G#other_organic_compound
did NE xxx NE
not NE xxx NE
induced NE xxx NE
neutrophil G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
in NE xx NE
serum-free G#cell_line_B xxx-xxx G#cell_line_B
grown G#cell_line_M xxx G#cell_line_M
HL60 G#cell_line_M XXdd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
whereas NE xxx NE
50 NE dd NE
nM NE xX NE
1 G#lipid_B d G#lipid_B
alpha,25-dihydroxyvitamin G#lipid_M xxx,dd-xxx G#lipid_M
D3 G#lipid_E Xd G#lipid_E
( NE ( NE
D3 G#lipid Xd G#lipid
) NE ) NE
induced NE xxx NE
maximal NE xxx NE
monocyte NE xxx NE
differentiation G#other_name xxx G#other_name
. NE . NE

Increasing NE Xxxx NE
RA G#other_organic_compound XX G#other_organic_compound
concentrations NE xxx NE
reduced NE xxx NE
the NE xxx NE
D3 G#other_name_B Xd G#other_name_B
concentration G#other_name_E xxx G#other_name_E
required NE xxx NE
for NE xxx NE
monocyte G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

Cells NE Xxxx NE
treated NE xxx NE
with NE xxx NE
5 NE d NE
nM NE xX NE
D3 G#lipid Xd G#lipid
showed NE xxx NE
little NE xxx NE
response NE xxx NE
, NE , NE
but NE xxx NE
differentiated NE xxx NE
maximally NE xxx NE
with NE xxx NE
5 NE d NE
nM NE xX NE
D3 G#lipid Xd G#lipid
and NE xxx NE
10 NE dd NE
nM NE xX NE
RA G#other_organic_compound XX G#other_organic_compound
. NE . NE

The NE Xxx NE
D3 G#lipid Xd G#lipid
analogs NE xxx NE
MC903 G#other_organic_compound XXddd G#other_organic_compound
, NE , NE
EB1089 G#other_organic_compound XXdddd G#other_organic_compound
and NE xxx NE
KH1060 G#other_organic_compound XXdddd G#other_organic_compound
were NE xxx NE
more NE xxx NE
potent NE xxx NE
inducers NE xxx NE
of NE xx NE
monocyte G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
extent NE xxx NE
to NE xx NE
which NE xxx NE
analog G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
increased NE xxx NE
after NE xxx NE
cotreatment NE xxx NE
with NE xxx NE
RA G#other_organic_compound XX G#other_organic_compound
was NE xxx NE
inversely NE xxx NE
related NE xxx NE
to NE xx NE
potency NE xxx NE
. NE . NE

Twenty-four NE Xxxx-xxx NE
hour NE xxx NE
treatment NE xxx NE
with NE xxx NE
10 NE dd NE
nM NE xX NE
RA G#cell_line_B XX G#cell_line_B
primed G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
for NE xxx NE
response NE xxx NE
to NE xx NE
5 NE d NE
nM NE xX NE
D3 G#lipid Xd G#lipid
; NE ; NE
the NE xxx NE
reverse NE xxx NE
sequence NE xxx NE
being NE xxx NE
ineffective NE xxx NE
. NE . NE

Priming NE Xxxx NE
with NE xxx NE
10 NE dd NE
nM NE xX NE
RA G#other_organic_compound XX G#other_organic_compound
, NE , NE
or NE xx NE
subsequent NE xxx NE
treatment NE xxx NE
with NE xxx NE
D3 G#lipid Xd G#lipid
(5 NE (d NE
nM) NE xX) NE
, NE , NE
did NE xxx NE
not NE xxx NE
alter NE xxx NE
expression NE xxx NE
of NE xx NE
mRNAs G#RNA_family_or_group xXXXx G#RNA_family_or_group
encoding NE xxx NE
receptors G#protein_family_or_group xxx G#protein_family_or_group
for NE xxx NE
D3 G#lipid Xd G#lipid
( NE ( NE
VDR G#protein_family_or_group XXX G#protein_family_or_group
) NE ) NE
, NE , NE
RA G#other_organic_compound XX G#other_organic_compound
( NE ( NE
RAR G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
) NE ) NE
or NE xx NE
9-CIS G#other_organic_compound_B d-XXX G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
( NE ( NE
RXR G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_M xxx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
RXR G#protein_molecule_M XXX G#protein_molecule_M
beta G#protein_molecule_M xxx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
RXR G#protein_molecule_M XXX G#protein_molecule_M
gamma G#protein_molecule_E xxx G#protein_molecule_E

That NE Xxxx NE
RA G#other_organic_compound XX G#other_organic_compound
promotes NE xxx NE
both NE xxx NE
neutrophil NE xxx NE
and NE xxx NE
monocyte NE xxx NE
differentiation NE xxx NE
has NE xxx NE
implications NE xxx NE
for NE xxx NE
the NE xxx NE
use NE xxx NE
of NE xx NE
RA NE XX NE
and NE xxx NE
D3 NE Xd NE
in NE xx NE
treatment NE xxx NE
of NE xx NE
leukemias NE xxx NE
and NE xxx NE
provides NE xxx NE
insight NE xxx NE
into NE xxx NE
mechanisms NE xxx NE
whereby NE xxx NE
RAR NE XXX NE
, NE , NE
VDR NE XXX NE
and NE xxx NE
RXR NE XXX NE
facilitate NE xxx NE
monocyte NE xxx NE
differentiation NE xxx NE
. NE . NE

[An NE [Xx NE
overexpression NE xxx NE
of NE xx NE
retinoic G#protein_molecule_B xxx G#protein_molecule_B
acid G#protein_molecule_M xxx G#protein_molecule_M
receptor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
blocks NE xxx NE
myeloid G#other_name_B xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
differentiation G#other_name_E xxx G#other_name_E
at NE xx NE
the NE xxx NE
promyelocyte G#other_name_B xxx G#other_name_B
stage G#other_name_E xxx G#other_name_E
] NE ] NE

Retinoic NE Xxxx NE
acid NE xxx NE
( NE ( NE
RA G#other_organic_compound XX G#other_organic_compound
) NE ) NE
, NE , NE
a NE x NE
vitamin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_M X G#other_organic_compound_M
derivative G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
exerts NE xxx NE
a NE x NE
wide NE xxx NE
range NE xxx NE
of NE xx NE
biological NE xxx NE
effects NE xxx NE
related NE xxx NE
to NE xx NE
cell G#other_name_B xxx G#other_name_B
proliferation G#other_name_E xxx G#other_name_E
and NE xxx NE
differentiation G#other_name xxx G#other_name
. NE . NE

The NE Xxx NE
pleiotropic G#other_name_B xxx G#other_name_B
effects G#other_name_E xxx G#other_name_E
of NE xx NE
RA G#other_organic_compound XX G#other_organic_compound
are NE xxx NE
thought NE xxx NE
to NE xx NE
be NE xx NE
mediated NE xxx NE
through NE xxx NE
specific NE xxx NE
nuclear NE xxx NE
RA G#protein_family_or_group_B XX G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
RARs G#protein_family_or_group XXXx G#protein_family_or_group
) NE ) NE
. NE . NE

RARs G#protein_family_or_group XXXx G#protein_family_or_group
are NE xxx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
steroid/thyroid G#protein_family_or_group_B xxx/xxx G#protein_family_or_group_B
hormone G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_M xxx G#protein_family_or_group_M
superfamily G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
exhibit NE xxx NE
a NE x NE
molecular NE xxx NE
structure NE xxx NE
that NE xxx NE
possess NE xxx NE
discrete NE xxx NE
DNA-binding NE XXX-xxx NE
and NE xxx NE
RA G#protein_domain_or_region_B XX G#protein_domain_or_region_B
(ligand)-binding G#protein_domain_or_region_M (xxx)-xxx G#protein_domain_or_region_M
domains G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

In NE Xx NE
hematopoietic NE xxx NE
system NE xxx NE
, NE , NE
RA G#other_organic_compound XX G#other_organic_compound
and NE xxx NE
RARs G#protein_family_or_group XXXx G#protein_family_or_group
, NE , NE
predominantly NE xxx NE
RAR G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
may NE xxx NE
play NE xxx NE
key NE xxx NE
roles NE xxx NE
for NE xxx NE
the NE xxx NE
proliferation NE xxx NE
and NE xxx NE
differentiation G#other_name xxx G#other_name
of NE xx NE
hematopoietic G#cell_type_B xxx G#cell_type_B
progenitors G#cell_type_E xxx G#cell_type_E
. NE . NE

However NE Xxxx NE
, NE , NE
it NE xx NE
is NE xx NE
currently NE xxx NE
unknown NE xxx NE
how NE xxx NE
RA G#other_organic_compound XX G#other_organic_compound
and NE xxx NE
RARs G#protein_family_or_group XXXx G#protein_family_or_group
are NE xxx NE
involved NE xxx NE
in NE xx NE
regulating NE xxx NE
normal NE xxx NE
hematopoietic G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

To NE Xx NE
make NE xxx NE
clear NE xxx NE
the NE xxx NE
roles NE xxx NE
of NE xx NE
RA G#other_organic_compound XX G#other_organic_compound
and NE xxx NE
RAR G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
the NE xxx NE
normal NE xxx NE
hematopoiesis G#other_name xxx G#other_name
, NE , NE
I NE X NE
have NE xxx NE
introduced NE xxx NE
the NE xxx NE
construct NE xxx NE
of NE xx NE
human G#protein_molecule_B xxx G#protein_molecule_B
RAR G#protein_molecule_M XXX G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
hRAR G#protein_molecule_B xXXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
) NE ) NE
into NE xxx NE
murine G#cell_type_B xxx G#cell_type_B
bone G#cell_type_M xxx G#cell_type_M
marrow G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
with NE xxx NE
retroviral G#virus_B xxx G#virus_B
vector G#virus_E xxx G#virus_E
, NE , NE
and NE xxx NE
selected NE xxx NE
infected NE xxx NE
cells NE xxx NE
with NE xxx NE
drug G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
resistant G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
marker G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
Neo(r) G#DNA_domain_or_region Xxx(x) G#DNA_domain_or_region
) NE ) NE
cultured NE xxx NE
on NE xx NE
the NE xxx NE
stroma G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
( NE ( NE
PA6-neo G#cell_line XXd-xxx G#cell_line
) NE ) NE
, NE , NE
and NE xxx NE
analyzed NE xxx NE
the NE xxx NE
behavior NE xxx NE
of NE xx NE
infected G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

All NE Xxx NE
of NE xx NE
procedure NE xxx NE
were NE xxx NE
done NE xxx NE
in NE xx NE
vitro NE xxx NE
. NE . NE

Most NE Xxxx NE
cells NE xxx NE
infected NE xxx NE
with NE xxx NE
hRAR G#protein_molecule_B xXXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
exhibited NE xxx NE
promyelocytic G#cell_type_B xxx G#cell_type_B
morphology G#cell_type_E xxx G#cell_type_E
and NE xxx NE
were NE xxx NE
thought NE xxx NE
to NE xx NE
be NE xx NE
blocked NE xxx NE
at NE xx NE
the NE xxx NE
promyelocytic NE xxx NE
stage NE xxx NE
in NE xx NE
their NE xxx NE
myeloid G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
these NE xxx NE
immature G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
differentiated NE xxx NE
terminally NE xxx NE
into NE xxx NE
mature NE xxx NE
granulocytes NE xxx NE
by NE xx NE
adding NE xxx NE
with NE xxx NE
RA G#other_organic_compound XX G#other_organic_compound
(10(-6) NE (dd(-d) NE
M) NE X) NE
. NE . NE

RAR G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
infected G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
were NE xxx NE
also NE xxx NE
able NE xxx NE
to NE xx NE
differentiate NE xxx NE
into NE xxx NE
mature G#cell_type_B xxx G#cell_type_B
macrophages G#cell_type_E xxx G#cell_type_E
in NE xx NE
the NE xxx NE
both NE xxx NE
of NE xx NE
long NE xxx NE
term NE xxx NE
culture NE xxx NE
and NE xxx NE
IL3 G#cell_line_B XXd G#cell_line_B
colony G#cell_line_E xxx G#cell_line_E
. NE . NE

These NE Xxxx NE
observations NE xxx NE
suggest NE xxx NE
that NE xxx NE
an NE xx NE
overexpression G#other_name xxx G#other_name
of NE xx NE
RAR G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
alone NE xxx NE
is NE xx NE
effective NE xxx NE
to NE xx NE
suppress NE xxx NE
myeloid G#other_name_B xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
differentiation G#other_name_E xxx G#other_name_E
and NE xxx NE
RAR G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
plays NE xxx NE
a NE x NE
crucial NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
terminal G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
of NE xx NE
myeloid NE xxx NE
precursors NE xxx NE
. NE . NE

The NE Xxx NE
system NE xxx NE
described NE xxx NE
here NE xxx NE
may NE xxx NE
serve NE xxx NE
as NE xx NE
a NE x NE
model NE xxx NE
for NE xxx NE
studying NE xxx NE
the NE xxx NE
the NE xxx NE
essential G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
for NE xxx NE
differentiation G#other_name xxx G#other_name
of NE xx NE
normal G#cell_type_B xxx G#cell_type_B
bone G#cell_type_M xxx G#cell_type_M
marrow G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Hypoxic NE Xxxx NE
induction NE xxx NE
of NE xx NE
interleukin-8 G#other_name_B xxx-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
endothelial G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Because NE Xxxx NE
leukocyte-mediated G#other_name_B xxx-xxx G#other_name_B
tissue G#other_name_M xxx G#other_name_M
damage G#other_name_E xxx G#other_name_E
is NE xx NE
an NE xx NE
important NE xxx NE
component NE xxx NE
of NE xx NE
the NE xxx NE
pathologic NE xxx NE
picture NE xxx NE
in NE xx NE
ischemia/reperfusion G#other_name xxx/xxx G#other_name
, NE , NE
we NE xx NE
have NE xxx NE
sought NE xxx NE
mechanisms NE xxx NE
by NE xx NE
which NE xxx NE
PMNs G#cell_type XXXx G#cell_type
are NE xxx NE
directed NE xxx NE
into NE xxx NE
hypoxic G#tissue_B xxx G#tissue_B
tissue G#tissue_E xxx G#tissue_E
. NE . NE

Incubation NE Xxxx NE
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
endothelial G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
ECs G#cell_type XXx G#cell_type
) NE ) NE
in NE xx NE
hypoxia G#other_name xxx G#other_name
, NE , NE
PO2 NE XXd NE
approximately NE xxx NE
14-18 NE dd-dd NE
Torr NE Xxxx NE
, NE , NE
led NE xxx NE
to NE xx NE
time-dependent G#other_name_B xxx-xxx G#other_name_B
release G#other_name_E xxx G#other_name_E
of NE xx NE
IL-8 G#protein_molecule XX-d G#protein_molecule
antigen NE xxx NE
into NE xxx NE
the NE xxx NE
conditioned NE xxx NE
medium NE xxx NE
; NE ; NE
this NE xxx NE
was NE xxx NE
accompanied NE xxx NE
by NE xx NE
increased NE xxx NE
chemotactic NE xxx NE
activity NE xxx NE
for NE xxx NE
PMNs G#cell_type XXXx G#cell_type
, NE , NE
blocked NE xxx NE
by NE xx NE
antibody NE xxx NE
to NE xx NE
IL-8 G#protein_molecule XX-d G#protein_molecule
. NE . NE

Production NE Xxxx NE
of NE xx NE
IL-8 G#protein_molecule XX-d G#protein_molecule
by NE xx NE
hypoxic NE xxx NE
ECs G#cell_type XXx G#cell_type
occurred NE xxx NE
concomitantly NE xxx NE
with NE xxx NE
both NE xxx NE
increased NE xxx NE
levels NE xxx NE
of NE xx NE
IL-8 G#RNA_molecule_B XX-d G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
, NE , NE
based NE xxx NE
on NE xx NE
polymerase G#other_name_B xxx G#other_name_B
chain G#other_name_M xxx G#other_name_M
reaction G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
increased NE xxx NE
IL-8 G#other_name_B XX-d G#other_name_B
transcription G#other_name_E xxx G#other_name_E
, NE , NE
based NE xxx NE
on NE xx NE
nuclear G#other_name_B xxx G#other_name_B
run-on G#other_name_M xxx-xx G#other_name_M
assays G#other_name_E xxx G#other_name_E
. NE . NE

Northern NE Xxxx NE
analysis NE xxx NE
of NE xx NE
mRNA NE xXXX NE
from NE xxx NE
hypoxic NE xxx NE
ECs G#cell_type XXx G#cell_type
also NE xxx NE
demonstrated NE xxx NE
increased NE xxx NE
levels NE xxx NE
of NE xx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
for NE xxx NE
macrophage G#protein_molecule_B xxx G#protein_molecule_B
chemotactic G#protein_molecule_M xxx G#protein_molecule_M
protein-1 G#protein_molecule_E xxx-d G#protein_molecule_E
, NE , NE
another NE xxx NE
member NE xxx NE
of NE xx NE
the NE xxx NE
chemokine G#protein_family_or_group_B xxx G#protein_family_or_group_B
superfamily G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
proinflammatory G#protein_family_or_group_B xxx G#protein_family_or_group_B
cytokines G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

IL-8 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
induction NE xxx NE
was NE xxx NE
associated NE xxx NE
with NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
increased NE xxx NE
binding NE xxx NE
activity NE xxx NE
in NE xx NE
nuclear G#cell_component_B xxx G#cell_component_B
extracts G#cell_component_E xxx G#cell_component_E
from NE xxx NE
hypoxic G#cell_type_B xxx G#cell_type_B
ECs G#cell_type_E XXx G#cell_type_E
for NE xxx NE
the NE xxx NE
NF-kB NE XX-xX NE
site NE xxx NE
. NE . NE

Studies NE Xxxx NE
with NE xxx NE
human G#tissue_B xxx G#tissue_B
umbilical G#tissue_M xxx G#tissue_M
vein G#tissue_M xxx G#tissue_M
segments G#tissue_E xxx G#tissue_E
exposed NE xxx NE
to NE xx NE
hypoxia G#other_name xxx G#other_name
also NE xxx NE
demonstrated NE xxx NE
increased NE xxx NE
elaboration NE xxx NE
of NE xx NE
IL-8 G#protein_molecule_B XX-d G#protein_molecule_B
antigen G#protein_molecule_E xxx G#protein_molecule_E
compared NE xxx NE
with NE xxx NE
normoxic NE xxx NE
controls NE xxx NE
. NE . NE

In NE Xx NE
mice NE xxx NE
exposed NE xxx NE
to NE xx NE
hypoxia G#other_name xxx G#other_name
(PO2 NE (XXd NE
approximately NE xxx NE
30-40 NE dd-dd NE
Torr) NE Xxxx) NE
, NE , NE
there NE xxx NE
was NE xxx NE
increased NE xxx NE
pulmonary NE xxx NE
leukostasis NE xxx NE
, NE , NE
as NE xx NE
evidenced NE xxx NE
by NE xx NE
increased NE xxx NE
myeloperoxidase G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
in NE xx NE
tissue G#other_name_B xxx G#other_name_B
homogenates G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
parallel NE xxx NE
, NE , NE
increased NE xxx NE
levels NE xxx NE
of NE xx NE
transcripts NE xxx NE
for NE xxx NE
IP-10 G#protein_molecule XX-dd G#protein_molecule
, NE , NE
a NE x NE
murine NE xxx NE
homologue NE xxx NE
in NE xx NE
the NE xxx NE
chemokine G#protein_family_or_group_B xxx G#protein_family_or_group_B
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
related NE xxx NE
to NE xx NE
IL-8 G#protein_molecule XX-d G#protein_molecule
, NE , NE
were NE xxx NE
observed NE xxx NE
in NE xx NE
hypoxic G#tissue_B xxx G#tissue_B
lung G#tissue_M xxx G#tissue_M
tissue G#tissue_E xxx G#tissue_E
. NE . NE

Taken NE Xxxx NE
together NE xxx NE
, NE , NE
these NE xxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
hypoxia G#other_name xxx G#other_name
constitutes NE xxx NE
a NE x NE
stimulus NE xxx NE
for NE xxx NE
leukocyte G#other_name_B xxx G#other_name_B
chemotaxis G#other_name_E xxx G#other_name_E
and NE xxx NE
tissue G#other_name_B xxx G#other_name_B
leukostasis G#other_name_E xxx G#other_name_E
. NE . NE

Thrombin G#protein_molecule Xxxx G#protein_molecule
and NE xxx NE
thrombin G#peptide_B xxx G#peptide_B
receptor G#peptide_M xxx G#peptide_M
agonist G#peptide_M xxx G#peptide_M
peptide G#peptide_E xxx G#peptide_E
induce NE xxx NE
early NE xxx NE
events NE xxx NE
of NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
and NE xxx NE
synergize NE xxx NE
with NE xxx NE
TCR G#other_name_B XXX G#other_name_B
cross-linking G#other_name_E xxx-xxx G#other_name_E
for NE xxx NE
CD69 G#other_name_B XXdd G#other_name_B
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
interleukin NE xxx NE
2 NE d NE
production NE xxx NE
. NE . NE

Thrombin G#protein_molecule Xxxx G#protein_molecule
stimulation NE xxx NE
of NE xx NE
the NE xxx NE
T G#cell_line_B X G#cell_line_B
leukemic G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
Jurkat G#cell_line_E Xxxx G#cell_line_E
induced NE xxx NE
a NE x NE
transient G#other_name_B xxx G#other_name_B
increase G#other_name_E xxx G#other_name_E
in NE xx NE
[ NE [ NE
Ca2+ NE Xxd+ NE
]i NE ]x NE
. NE . NE

Proteolytic G#other_name_B Xxxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
enzyme G#protein_family_or_group xxx G#protein_family_or_group
was NE xxx NE
required NE xxx NE
for NE xxx NE
this NE xxx NE
effect NE xxx NE
since NE xxx NE
diisopropyl G#protein_molecule_B xxx G#protein_molecule_B
fluorophosphate-thrombin G#protein_molecule_E xxx-xxx G#protein_molecule_E
failed NE xxx NE
to NE xx NE
increase NE xxx NE
[ NE [ NE
Ca2+ NE Xxd+ NE
]i NE ]x NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
hirudin G#peptide xxx G#peptide
and NE xxx NE
anti-thrombin G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
III G#protein_family_or_group_E XXX G#protein_family_or_group_E
inhibited NE xxx NE
the NE xxx NE
thrombin-induced NE xxx-xxx NE
[ NE [ NE
Ca2+ NE Xxd+ NE
]i NE ]x NE
rise NE xxx NE
in NE xx NE
Jurkat NE Xxxx NE
T NE X NE
cells NE xxx NE
. NE . NE

A NE X NE
synthetic NE xxx NE
thrombin G#peptide_B xxx G#peptide_B
receptor G#peptide_M xxx G#peptide_M
agonist G#peptide_M xxx G#peptide_M
peptide G#peptide_E xxx G#peptide_E
( NE ( NE
TRP G#peptide XXX G#peptide
) NE ) NE
of NE xx NE
7 G#peptide_B d G#peptide_B
residues G#peptide_E xxx G#peptide_E
( NE ( NE
SFLLRNP G#peptide XXXXXXX G#peptide
) NE ) NE
was NE xxx NE
found NE xxx NE
to NE xx NE
be NE xx NE
as NE xx NE
effective NE xxx NE
as NE xx NE
thrombin G#protein_molecule xxx G#protein_molecule
for NE xxx NE
[ NE [ NE
Ca2+ NE Xxd+ NE
]i NE ]x NE
mobilization NE xxx NE
, NE , NE
and NE xxx NE
both NE xxx NE
agonists NE xxx NE
induced NE xxx NE
Ca2+ NE Xxd+ NE
release NE xxx NE
exclusively NE xxx NE
from NE xxx NE
internal NE xxx NE
stores NE xxx NE
. NE . NE

Thrombin G#protein_molecule Xxxx G#protein_molecule
stimulated NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
several NE xxx NE
proteins NE xxx NE
of NE xx NE
molecular G#protein_molecule_B xxx G#protein_molecule_B
mass G#protein_molecule_M xxx G#protein_molecule_M
40 G#protein_molecule_M dd G#protein_molecule_M
kDa G#protein_molecule_M xXx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
molecular G#protein_molecule_M xxx G#protein_molecule_M
mass G#protein_molecule_M xxx G#protein_molecule_M
42 G#protein_molecule_M dd G#protein_molecule_M
kDa G#protein_molecule_M xXx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
molecular G#protein_molecule_M xxx G#protein_molecule_M
mass G#protein_molecule_M xxx G#protein_molecule_M
70 G#protein_molecule_M dd G#protein_molecule_M
kDa G#protein_molecule_M xXx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
molecular G#protein_molecule_M xxx G#protein_molecule_M
mass G#protein_molecule_M xxx G#protein_molecule_M
120 G#protein_molecule_M ddd G#protein_molecule_M
kDa G#protein_molecule_M xXx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
molecular G#protein_molecule_M xxx G#protein_molecule_M
mass G#protein_molecule_M xxx G#protein_molecule_M
130 G#protein_molecule_M ddd G#protein_molecule_M
kDa G#protein_molecule_E xXx G#protein_molecule_E

There NE Xxxx NE
was NE xxx NE
a NE x NE
good NE xxx NE
correlation NE xxx NE
between NE xxx NE
thrombin NE xxx NE
-induced NE -xxx NE
tyrosine NE xxx NE
phosphorylation NE xxx NE
of NE xx NE
the NE xxx NE
latter NE xxx NE
three NE xxx NE
proteins NE xxx NE
and NE xxx NE
Ca2+ NE Xxd+ NE
mobilization NE xxx NE
. NE . NE

Thrombin G#protein_molecule Xxxx G#protein_molecule
and NE xxx NE
TRP G#peptide XXX G#peptide
also NE xxx NE
caused NE xxx NE
translocation NE xxx NE
of NE xx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
from NE xxx NE
the NE xxx NE
cytosol G#cell_component xxx G#cell_component
to NE xx NE
the NE xxx NE
plasma G#cell_component_B xxx G#cell_component_B
membrane G#cell_component_E xxx G#cell_component_E
. NE . NE

As NE Xx NE
a NE x NE
likely NE xxx NE
consequence NE xxx NE
of NE xx NE
these NE xxx NE
events NE xxx NE
, NE , NE
thrombin G#protein_molecule xxx G#protein_molecule
activated NE xxx NE
the NE xxx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
NF-kB G#protein_molecule_E XX-xX G#protein_molecule_E
. NE . NE

Several NE Xxxx NE
cell NE xxx NE
lines NE xxx NE
of NE xx NE
hematopoietic NE xxx NE
origin NE xxx NE
including NE xxx NE
the NE xxx NE
leukemic G#cell_line_B xxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
HPB.ALL G#cell_line_E XXX.XXX G#cell_line_E
and NE xxx NE
the NE xxx NE
erythroleukemic G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
K562 G#cell_line_E Xddd G#cell_line_E
were NE xxx NE
responsive NE xxx NE
to NE xx NE
thrombin G#protein_molecule xxx G#protein_molecule
, NE , NE
whereas NE xxx NE
others NE xxx NE
such NE xxx NE
as NE xx NE
THP1 G#cell_line XXXd G#cell_line
, NE , NE
a NE x NE
myelomonocytic G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
and NE xxx NE
BL2 NE XXd NE
, NE , NE
a NE x NE
Burkitt NE Xxxx NE
lymphoma NE xxx NE
were NE xxx NE
refractory NE xxx NE
to NE xx NE
thrombin NE xxx NE
or NE xx NE
TRP NE XXX NE
stimulation NE xxx NE
. NE . NE

The NE Xxx NE
magnitude NE xxx NE
of NE xx NE
the NE xxx NE
thrombin G#protein_molecule xxx G#protein_molecule
response NE xxx NE
in NE xx NE
the NE xxx NE
different NE xxx NE
cell NE xxx NE
types NE xxx NE
paralleled NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
thrombin G#RNA_molecule_B xxx G#RNA_molecule_B
receptor G#RNA_molecule_M xxx G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
. NE . NE

We NE Xx NE
found NE xxx NE
that NE xxx NE
activation NE xxx NE
of NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
by NE xx NE
a NE x NE
combination NE xxx NE
of NE xx NE
phytohemagglutinin G#protein_molecule xxx G#protein_molecule
and NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
12-myristate G#other_organic_compound_M dd-xxx G#other_organic_compound_M
13-acetate G#other_organic_compound_E dd-xxx G#other_organic_compound_E
led NE xxx NE
to NE xx NE
a NE x NE
dramatic NE xxx NE
inhibition NE xxx NE
of NE xx NE
thrombin G#other_name_B xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
to NE xx NE
a NE x NE
concomitant NE xxx NE
loss NE xxx NE
of NE xx NE
the NE xxx NE
thrombin G#other_name_B xxx G#other_name_B
response G#other_name_E xxx G#other_name_E
. NE . NE

Finally NE Xxxx NE
, NE , NE
we NE xx NE
demonstrate NE xxx NE
that NE xxx NE
thrombin G#protein_molecule xxx G#protein_molecule
and NE xxx NE
TRP G#other_name_B XXX G#other_name_B
enhanced G#other_name_M xxx G#other_name_M
CD69 G#other_name_M XXdd G#other_name_M
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
interleukin G#other_name_B xxx G#other_name_B
2 G#other_name_M d G#other_name_M
production G#other_name_E xxx G#other_name_E
induced NE xxx NE
by NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
receptor G#other_name_M xxx G#other_name_M
cross-linking G#other_name_E xxx-xxx G#other_name_E
in NE xx NE
both NE xxx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
peripheral NE xxx NE
blood NE xxx NE
lymphocytes G#cell_type xxx G#cell_type
. NE . NE

These NE Xxxx NE
findings NE xxx NE
highlight NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
thrombin G#protein_molecule xxx G#protein_molecule
as NE xx NE
a NE x NE
potential NE xxx NE
regulator NE xxx NE
of NE xx NE
T G#other_name_B X G#other_name_B
lymphocyte G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

Stress G#other_name_B Xxxx G#other_name_B
response G#other_name_E xxx G#other_name_E
of NE xx NE
senescent G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
: NE : NE
reduced NE xxx NE
hsp70 G#protein_molecule xxxdd G#protein_molecule
is NE xx NE
independent NE xxx NE
of NE xx NE
the NE xxx NE
proliferative G#other_name_B xxx G#other_name_B
block G#other_name_E xxx G#other_name_E
. NE . NE

Senescent G#cell_line_B Xxxx G#cell_line_B
human G#cell_line_M xxx G#cell_line_M
T G#cell_line_M X G#cell_line_M
lymphocyte G#cell_line_M xxx G#cell_line_M
cultures G#cell_line_E xxx G#cell_line_E
are NE xxx NE
unable NE xxx NE
to NE xx NE
undergo NE xxx NE
proliferation NE xxx NE
, NE , NE
but NE xxx NE
show NE xxx NE
no NE xx NE
difference NE xxx NE
from NE xxx NE
early G#cell_line_B xxx G#cell_line_B
passage G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
in NE xx NE
cytotoxic G#other_name_B xxx G#other_name_B
function G#other_name_E xxx G#other_name_E
or NE xx NE
surface G#other_name_B xxx G#other_name_B
antigenic G#other_name_M xxx G#other_name_M
profile G#other_name_E xxx G#other_name_E
. NE . NE

A NE X NE
second NE xxx NE
feature NE xxx NE
of NE xx NE
senescent G#cell_line_B xxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
is NE xx NE
the NE xxx NE
dramatic NE xxx NE
reduction NE xxx NE
in NE xx NE
hsp70 G#other_name_B xxxdd G#other_name_B
production G#other_name_E xxx G#other_name_E
in NE xx NE
response NE xxx NE
to NE xx NE
heat G#other_name_B xxx G#other_name_B
shock G#other_name_E xxx G#other_name_E
. NE . NE

This NE Xxxx NE
decline NE xxx NE
is NE xx NE
associated NE xxx NE
with NE xxx NE
a NE x NE
decrease NE xxx NE
in NE xx NE
binding NE xxx NE
of NE xx NE
nuclear G#cell_component_B xxx G#cell_component_B
extracts G#cell_component_E xxx G#cell_component_E
to NE xx NE
the NE xxx NE
consensus G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
heat G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
shock G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Interestingly NE Xxxx NE
, NE , NE
the NE xxx NE
progressive NE xxx NE
decline NE xxx NE
in NE xx NE
the NE xxx NE
heat G#other_name_B xxx G#other_name_B
shock G#other_name_M xxx G#other_name_M
response G#other_name_E xxx G#other_name_E
of NE xx NE
cultured G#cell_line_B xxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
correlates NE xxx NE
with NE xxx NE
the NE xxx NE
percent NE xxx NE
proliferative G#other_name_B xxx G#other_name_B
life G#other_name_M xxx G#other_name_M
span G#other_name_E xxx G#other_name_E
completed NE xxx NE
rather NE xxx NE
than NE xxx NE
with NE xxx NE
the NE xxx NE
actual NE xxx NE
proliferative G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
at NE xx NE
the NE xxx NE
time NE xxx NE
of NE xx NE
heat G#other_name_B xxx G#other_name_B
shock G#other_name_E xxx G#other_name_E
. NE . NE

This NE Xxxx NE
suggests NE xxx NE
that NE xxx NE
for NE xxx NE
senescent G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
the NE xxx NE
reduced NE xxx NE
ability NE xxx NE
to NE xx NE
respond NE xxx NE
to NE xx NE
heat G#other_name_B xxx G#other_name_B
shock G#other_name_E xxx G#other_name_E
by NE xx NE
producing NE xxx NE
hsp70 G#protein_molecule xxxdd G#protein_molecule
, NE , NE
although NE xxx NE
possibly NE xxx NE
lying NE xxx NE
at NE xx NE
the NE xxx NE
level NE xxx NE
of NE xx NE
transcriptional G#other_name_B xxx G#other_name_B
control G#other_name_E xxx G#other_name_E
, NE , NE
may NE xxx NE
nevertheless NE xxx NE
be NE xx NE
unrelated NE xxx NE
to NE xx NE
the NE xxx NE
reduced G#other_name_B xxx G#other_name_B
DNA G#other_name_M XXX G#other_name_M
synthesis G#other_name_E xxx G#other_name_E
or NE xx NE
the NE xxx NE
diminished G#other_name_B xxx G#other_name_B
proliferative G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
also NE xxx NE
manifested NE xxx NE
by NE xx NE
these NE xxx NE
cells NE xxx NE
. NE . NE

Involvement NE Xxxx NE
of NE xx NE
phospholipase G#protein_molecule_B xxx G#protein_molecule_B
D G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
transcription G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
AP-1 G#protein_molecule_E XX-d G#protein_molecule_E
in NE xx NE
human G#cell_line_B xxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
lymphoid G#cell_line_M xxx G#cell_line_M
Jurkat G#cell_line_M Xxxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
has NE xxx NE
been NE xxx NE
ascribed NE xxx NE
to NE xx NE
the NE xxx NE
early NE xxx NE
events NE xxx NE
leading NE xxx NE
to NE xx NE
T G#other_name_B X G#other_name_B
lymphocyte G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
have NE xxx NE
examined NE xxx NE
the NE xxx NE
possibility NE xxx NE
that NE xxx NE
stimulation NE xxx NE
of NE xx NE
phospholipase G#protein_molecule_B xxx G#protein_molecule_B
D G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
PLD G#protein_molecule XXX G#protein_molecule
) NE ) NE
may NE xxx NE
regulate NE xxx NE
activation NE xxx NE
of NE xx NE
transcription G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
AP-1 G#protein_molecule_E XX-d G#protein_molecule_E
in NE xx NE
human NE xxx NE
T NE X NE
cells NE xxx NE
by NE xx NE
transfecting NE xxx NE
human NE xxx NE
T G#cell_line_B X G#cell_line_B
lymphocyte G#cell_line_M xxx G#cell_line_M
Jurkat G#cell_line_M Xxxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
a NE x NE
plasmid NE xxx NE
containing NE xxx NE
an NE xx NE
AP-1 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
a NE x NE
chloramphenicol G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
acetyltransferase G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
reporter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

We NE Xx NE
have NE xxx NE
detected NE xxx NE
activatable NE xxx NE
PLD G#protein_molecule XXX G#protein_molecule
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
and NE xxx NE
we NE xx NE
have NE xxx NE
found NE xxx NE
that NE xxx NE
addition NE xxx NE
of NE xx NE
phosphatidic G#other_organic_compound_B xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
PA G#other_organic_compound XX G#other_organic_compound
) NE ) NE
, NE , NE
the NE xxx NE
physiologic NE xxx NE
product NE xxx NE
of NE xx NE
PLD G#protein_molecule XXX G#protein_molecule
action NE xxx NE
on NE xx NE
phospholipids G#lipid xxx G#lipid
, NE , NE
is NE xx NE
rapidly NE xxx NE
incorporated NE xxx NE
into NE xxx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
leads NE xxx NE
to NE xx NE
activation NE xxx NE
of NE xx NE
transcription G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
AP-1 G#protein_molecule_E XX-d G#protein_molecule_E
. NE . NE

Treatment NE Xxxx NE
of NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
anti-CD3 G#protein_family_or_group_B xxx-XXd G#protein_family_or_group_B
mAb G#protein_family_or_group_E xXx G#protein_family_or_group_E
activated NE xxx NE
both NE xxx NE
PLD G#protein_molecule XXX G#protein_molecule
and NE xxx NE
transcription G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
AP-1 G#protein_molecule_E XX-d G#protein_molecule_E
. NE . NE

Wortmannin NE Xxxx NE
, NE , NE
an NE xx NE
inhibitor NE xxx NE
of NE xx NE
receptor-coupled NE xxx-xxx NE
PLD G#protein_molecule XXX G#protein_molecule
activation NE xxx NE
, NE , NE
blocked NE xxx NE
the NE xxx NE
anti-CD3 NE xxx-XXd NE
-induced NE -xxx NE
increases NE xxx NE
in NE xx NE
both NE xxx NE
PLD NE XXX NE
activity NE xxx NE
and NE xxx NE
AP-1 NE XX-d NE
enhancer NE xxx NE
activity NE xxx NE
. NE . NE

We NE Xx NE
found NE xxx NE
a NE x NE
good NE xxx NE
correlation NE xxx NE
in NE xx NE
the NE xxx NE
transfected G#cell_line_B xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
between NE xxx NE
PLD G#other_name_B XXX G#other_name_B
activation G#other_name_E xxx G#other_name_E
and NE xxx NE
induction NE xxx NE
of NE xx NE
AP-1 G#other_name_B XX-d G#other_name_B
enhancer G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
under NE xxx NE
different NE xxx NE
experimental NE xxx NE
conditions NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
ethanol G#other_organic_compound xxx G#other_organic_compound
, NE , NE
an NE xx NE
inhibitor NE xxx NE
of NE xx NE
the NE xxx NE
PLD G#protein_molecule XXX G#protein_molecule
pathway NE xxx NE
, NE , NE
blocked NE xxx NE
the NE xxx NE
anti-CD3-stimulated G#other_name_B xxx-XXd-xxx G#other_name_B
AP-1 G#other_name_M XX-d G#other_name_M
enhancer G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
. NE . NE

However NE Xxxx NE
, NE , NE
this NE xxx NE
anti-CD3 NE xxx-XXd NE
-mediated NE -xxx NE
response NE xxx NE
was NE xxx NE
not NE xxx NE
inhibited NE xxx NE
by NE xx NE
neomycin NE xxx NE
, NE , NE
an NE xx NE
inhibitor NE xxx NE
of NE xx NE
phosphoinositide NE xxx NE
hydrolysis NE xxx NE
. NE . NE

The NE Xxx NE
increases NE xxx NE
in NE xx NE
AP-1 G#other_name_B XX-d G#other_name_B
enhancer G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
induced NE xxx NE
by NE xx NE
PA G#other_organic_compound XX G#other_organic_compound
or NE xx NE
anti-CD3 G#protein_family_or_group_B xxx-XXd G#protein_family_or_group_B
mAb G#protein_family_or_group_E xXx G#protein_family_or_group_E
were NE xxx NE
efficiently NE xxx NE
abrogated NE xxx NE
by NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
propranolol G#lipid xxx G#lipid
, NE , NE
an NE xx NE
inhibitor NE xxx NE
of NE xx NE
PA G#other_organic_compound XX G#other_organic_compound
phosphohydrolase G#protein_molecule xxx G#protein_molecule
and NE xxx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
PKC G#protein_molecule XXX G#protein_molecule
) NE ) NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
the NE xxx NE
PA G#other_organic_compound XX G#other_organic_compound
-and NE -xxx NE
the NE xxx NE
anti-CD3 NE xxx-XXd NE
-induced NE -xxx NE
increases NE xxx NE
in NE xx NE
AP-1 NE XX-d NE
enhancer NE xxx NE
activity NE xxx NE
were NE xxx NE
blocked NE xxx NE
by NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
PKC NE XXX NE
inhibitors NE xxx NE
or NE xx NE
by NE xx NE
PKC NE XXX NE
down-regulation NE xxx-xxx NE
. NE . NE

These NE Xxxx NE
data NE xxx NE
indicate NE xxx NE
that NE xxx NE
PLD G#other_name_B XXX G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
can NE xxx NE
activate NE xxx NE
the NE xxx NE
transcription G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
AP-1 G#protein_molecule_E XX-d G#protein_molecule_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
and NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
AP-1 G#other_name_B XX-d G#other_name_B
enhancer G#other_name_M xxx G#other_name_M
factor G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
by NE xx NE
PA G#other_organic_compound XX G#other_organic_compound
is NE xx NE
mediated NE xxx NE
via NE xxx NE
PKC G#other_name_B XXX G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
, NE , NE
either NE xxx NE
through NE xxx NE
a NE x NE
direct NE xxx NE
activating NE xxx NE
effect NE xxx NE
of NE xx NE
PA G#other_organic_compound XX G#other_organic_compound
or NE xx NE
through NE xxx NE
PA NE XX NE
-derived NE -xxx NE
diacylglycerol NE xxx NE
formation NE xxx NE
. NE . NE

These NE Xxxx NE
data NE xxx NE
also NE xxx NE
provide NE xxx NE
evidence NE xxx NE
for NE xxx NE
a NE x NE
role NE xxx NE
of NE xx NE
PLD NE XXX NE
-derived NE -xxx NE
lipids NE xxx NE
in NE xx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
AP-1 NE XX-d NE
enhancer NE xxx NE
activity NE xxx NE
resulting NE xxx NE
from NE xxx NE
stimulation NE xxx NE
of NE xx NE
the NE xxx NE
TCR/CD3 NE XXX/XXd NE
complex NE xxx NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
increased NE xxx NE
PLD NE XXX NE
activity NE xxx NE
can NE xxx NE
play NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
T NE X NE
lymphocyte NE xxx NE
activation NE xxx NE
. NE . NE

Upregulation NE Xxxx NE
of NE xx NE
bcl-2 G#DNA_domain_or_region xxx-d G#DNA_domain_or_region
by NE xx NE
the NE xxx NE
Epstein-Barr G#protein_molecule_B Xxxx-Xxxx G#protein_molecule_B
virus G#protein_molecule_M xxx G#protein_molecule_M
latent G#protein_molecule_M xxx G#protein_molecule_M
membrane G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
LMP1 G#protein_molecule XXXd G#protein_molecule
: NE : NE
a NE x NE
B-cell-specific G#other_name_B X-xxx-xxx G#other_name_B
response G#other_name_E xxx G#other_name_E
that NE xxx NE
is NE xx NE
delayed NE xxx NE
relative NE xxx NE
to NE xx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
and NE xxx NE
to NE xx NE
induction NE xxx NE
of NE xx NE
cell G#protein_family_or_group_B xxx G#protein_family_or_group_B
surface G#protein_family_or_group_M xxx G#protein_family_or_group_M
markers G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

An NE Xx NE
ability NE xxx NE
of NE xx NE
the NE xxx NE
Epstein-Barr G#protein_molecule_B Xxxx-Xxxx G#protein_molecule_B
virus G#protein_molecule_M xxx G#protein_molecule_M
latent G#protein_molecule_M xxx G#protein_molecule_M
membrane G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
LMP1 G#protein_molecule XXXd G#protein_molecule
to NE xx NE
enhance NE xxx NE
the NE xxx NE
survival NE xxx NE
of NE xx NE
infected G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
through NE xxx NE
upregulation NE xxx NE
of NE xx NE
the NE xxx NE
bcl-2 G#DNA_domain_or_region_B xxx-d G#DNA_domain_or_region_B
oncogene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
first NE xxx NE
suggested NE xxx NE
by NE xx NE
experiments NE xxx NE
involving NE xxx NE
gene G#other_name_B xxx G#other_name_B
transfection G#other_name_E xxx G#other_name_E
and NE xxx NE
the NE xxx NE
selection NE xxx NE
of NE xx NE
stable NE xxx NE
LMP1 NE XXXd NE
+ NE + NE
clones NE xxx NE
(S.Henderson NE (X.Xxxx NE
, NE , NE
M NE X NE
. NE . NE
Rowe NE Xxxx NE
, NE , NE
C.Gregory NE X.Xxxx NE
, NE , NE
F.Wang NE X.Xxxx NE
, NE , NE
E.Kieff NE X.Xxxx NE
, NE , NE
and NE xxx NE
A.Rickinson NE X.Xxxx NE
, NE , NE
Cell NE Xxxx NE
65:1107-1115 NE dd:dddd-dddd NE
, NE , NE
1991) NE dddd) NE
. NE . NE

However NE Xxxx NE
, NE , NE
it NE xx NE
was NE xxx NE
not NE xxx NE
possible NE xxx NE
to NE xx NE
ascertain NE xxx NE
whether NE xxx NE
Bcl-2 G#protein_molecule Xxx-d G#protein_molecule
upregulation NE xxx NE
was NE xxx NE
a NE x NE
specific NE xxx NE
consequence NE xxx NE
of NE xx NE
LMP1 G#protein_molecule XXXd G#protein_molecule
expression NE xxx NE
or NE xx NE
an NE xx NE
artifact NE xxx NE
of NE xx NE
the NE xxx NE
selection NE xxx NE
procedure NE xxx NE
whereby NE xxx NE
rare NE xxx NE
Bcl-2 NE Xxx-d NE
+ NE + NE
cells NE xxx NE
already NE xxx NE
present NE xxx NE
in NE xx NE
the NE xxx NE
starting NE xxx NE
population NE xxx NE
might NE xxx NE
best NE xxx NE
be NE xx NE
able NE xxx NE
to NE xx NE
tolerate NE xxx NE
the NE xxx NE
potentially NE xxx NE
toxic NE xxx NE
effects NE xxx NE
of NE xx NE
LMP1 NE XXXd NE
. NE . NE

We NE Xx NE
therefore NE xxx NE
reexamined NE xxx NE
this NE xxx NE
issue NE xxx NE
by NE xx NE
using NE xxx NE
two NE xxx NE
different NE xxx NE
experimental NE xxx NE
approaches NE xxx NE
that NE xxx NE
allowed NE xxx NE
LMP1 NE XXXd NE
-induced NE -xxx NE
effects NE xxx NE
to NE xx NE
be NE xx NE
monitored NE xxx NE
immediately NE xxx NE
following NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
viral NE xxx NE
protein NE xxx NE
and NE xxx NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
selective NE xxx NE
pressures NE xxx NE
; NE ; NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
transcription NE xxx NE
factor NE xxx NE
and NE xxx NE
upregulation NE xxx NE
of NE xx NE
the NE xxx NE
cell NE xxx NE
adhesion NE xxx NE
molecule NE xxx NE
ICAM-1 NE XXXX-d NE
were NE xxx NE
used NE xxx NE
as NE xx NE
early NE xxx NE
indices NE xxx NE
of NE xx NE
LMP1 NE XXXd NE
function NE xxx NE
. NE . NE

In NE Xx NE
the NE xxx NE
first NE xxx NE
approach NE xxx NE
, NE , NE
stable NE xxx NE
clones NE xxx NE
of NE xx NE
two NE xxx NE
B-cell G#cell_line_B X-xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
carrying NE xxx NE
an NE xx NE
LMP1 G#protein_molecule XXXd G#protein_molecule
gene NE xxx NE
under NE xxx NE
the NE xxx NE
control NE xxx NE
of NE xx NE
an NE xx NE
inducible NE xxx NE
metallothionein G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
were NE xxx NE
induced NE xxx NE
to NE xx NE
express NE xxx NE
LMP1 G#protein_molecule XXXd G#protein_molecule
in NE xx NE
all NE xxx NE
cells NE xxx NE
. NE . NE

Activation NE Xxxx NE
of NE xx NE
NK-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
upregulation G#other_name xxx G#other_name
of NE xx NE
ICAM-1 G#protein_molecule XXXX-d G#protein_molecule
occurred NE xxx NE
within NE xxx NE
24 NE dd NE
h NE x NE
and NE xxx NE
were NE xxx NE
followed NE xxx NE
at NE xx NE
48 NE dd NE
to NE xx NE
72 NE dd NE
h NE x NE
by NE xx NE
upregulation G#other_name xxx G#other_name
of NE xx NE
Bcl-2 G#protein_molecule Xxx-d G#protein_molecule
. NE . NE

In NE Xx NE
the NE xxx NE
second NE xxx NE
approach NE xxx NE
, NE , NE
we NE xx NE
tested NE xxx NE
the NE xxx NE
generality NE xxx NE
of NE xx NE
this NE xxx NE
phenomenon NE xxx NE
by NE xx NE
transiently NE xxx NE
expressing NE xxx NE
LMP1 G#protein_molecule XXXd G#protein_molecule
from NE xxx NE
a NE x NE
strong NE xxx NE
constitutively NE xxx NE
active NE xxx NE
promoter NE xxx NE
in NE xx NE
a NE x NE
range NE xxx NE
of NE xx NE
different NE xxx NE
cell NE xxx NE
types NE xxx NE
. NE . NE

All NE Xxx NE
six NE xxx NE
B-cell G#cell_line_B X-xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
tested NE xxx NE
showed NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
in NE xx NE
response NE xxx NE
to NE xx NE
LMP1 G#other_name_B XXXd G#other_name_B
expression G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
this NE xxx NE
was NE xxx NE
followed NE xxx NE
in NE xx NE
five NE xxx NE
of NE xx NE
six NE xxx NE
lines NE xxx NE
by NE xx NE
expression NE xxx NE
of NE xx NE
ICAM-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
Bcl-2 G#protein_molecule Xxx-d G#protein_molecule
. NE . NE

In NE Xx NE
the NE xxx NE
same NE xxx NE
experiments NE xxx NE
, NE , NE
all NE xxx NE
three NE xxx NE
non- NE xxx- NE
B-cell G#cell_line_B X-xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
showed NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
and NE xxx NE
ICAM-1 G#protein_molecule XXXX-d G#protein_molecule
upregulation G#other_name xxx G#other_name
but NE xxx NE
never NE xxx NE
any NE xxx NE
effect NE xxx NE
upon NE xxx NE
Bcl-2 G#protein_molecule Xxx-d G#protein_molecule
. NE . NE

We NE Xx NE
therefore NE xxx NE
conclude NE xxx NE
that NE xxx NE
Bcl-2 G#other_name_B Xxx-d G#other_name_B
upregulation G#other_name_E xxx G#other_name_E
is NE xx NE
part NE xxx NE
of NE xx NE
the NE xxx NE
panoply NE xxx NE
of NE xx NE
cellular NE xxx NE
changes NE xxx NE
induced NE xxx NE
by NE xx NE
LMP1 G#protein_molecule XXXd G#protein_molecule
but NE xxx NE
that NE xxx NE
the NE xxx NE
effect NE xxx NE
is NE xx NE
cell NE xxx NE
type NE xxx NE
specific NE xxx NE
. NE . NE

Our NE Xxx NE
data NE xxx NE
also NE xxx NE
suggest NE xxx NE
that NE xxx NE
whilst NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
may NE xxx NE
be NE xx NE
an NE xx NE
essential NE xxx NE
component NE xxx NE
of NE xx NE
LMP1 G#other_name_B XXXd G#other_name_B
signal G#other_name_M xxx G#other_name_M
transduction G#other_name_E xxx G#other_name_E
, NE , NE
other NE xxx NE
cell-specific G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
may NE xxx NE
be NE xx NE
required NE xxx NE
to NE xx NE
effect NE xxx NE
some NE xxx NE
functions NE xxx NE
of NE xx NE
the NE xxx NE
viral G#protein_family_or_group_B xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Long-term G#other_name_B Xxxx-xxx G#other_name_B
inositol G#other_name_M xxx G#other_name_M
phosphate G#other_name_M xxx G#other_name_M
release G#other_name_E xxx G#other_name_E
, NE , NE
but NE xxx NE
not NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
kinase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
, NE , NE
correlates NE xxx NE
with NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
secretion G#other_name_E xxx G#other_name_E
and NE xxx NE
NF-AT G#other_name_B XX-XX G#other_name_B
induction G#other_name_E xxx G#other_name_E
in NE xx NE
anti-CD3-activated G#cell_line_B xxx-XXd-xxx G#cell_line_B
peripheral G#cell_line_M xxx G#cell_line_M
human G#cell_line_M xxx G#cell_line_M
T G#cell_line_M X G#cell_line_M
lymphocytes G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
cascade NE xxx NE
of NE xx NE
events NE xxx NE
within NE xxx NE
the NE xxx NE
first NE xxx NE
few NE xxx NE
minutes NE xxx NE
of NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
stimulation G#other_name_E xxx G#other_name_E
has NE xxx NE
been NE xxx NE
well NE xxx NE
characterized NE xxx NE
. NE . NE

Although NE Xxxx NE
many NE xxx NE
second G#other_organic_compound_B xxx G#other_organic_compound_B
messengers G#other_organic_compound_E xxx G#other_organic_compound_E
have NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
be NE xx NE
necessary NE xxx NE
and NE xxx NE
sufficient NE xxx NE
for NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
in NE xx NE
a NE x NE
number NE xxx NE
of NE xx NE
model NE xxx NE
systems NE xxx NE
, NE , NE
the NE xxx NE
rate-limiting NE xxx-xxx NE
step NE xxx NE
in NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
has NE xxx NE
not NE xxx NE
been NE xxx NE
demonstrated NE xxx NE
. NE . NE

To NE Xx NE
model NE xxx NE
effective NE xxx NE
versus NE xxx NE
ineffective NE xxx NE
CD3 NE XXd NE
-mediated NE -xxx NE
stimulation NE xxx NE
in NE xx NE
peripheral NE xxx NE
T NE X NE
cells NE xxx NE
, NE , NE
we NE xx NE
used NE xxx NE
two NE xxx NE
anti-CD3 NE xxx-XXd NE
mAbs NE xXxx NE
that NE xxx NE
differ NE xxx NE
in NE xx NE
their NE xxx NE
ability NE xxx NE
to NE xx NE
stimulate NE xxx NE
purified NE xxx NE
T NE X NE
cells NE xxx NE
: NE : NE
OKT3 NE XXXd NE
, NE , NE
which NE xxx NE
causes NE xxx NE
early NE xxx NE
second NE xxx NE
messenger NE xxx NE
generation NE xxx NE
but NE xxx NE
is NE xx NE
unable NE xxx NE
to NE xx NE
activate NE xxx NE
T NE X NE
cells NE xxx NE
without NE xxx NE
a NE x NE
second NE xxx NE
signal NE xxx NE
, NE , NE
and NE xxx NE
64.1 NE dd.d NE
, NE , NE
which NE xxx NE
stimulates NE xxx NE
T NE X NE
cell NE xxx NE
proliferation NE xxx NE
on NE xx NE
its NE xxx NE
own NE xxx NE
. NE . NE

We NE Xx NE
found NE xxx NE
that NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
kinase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
similar NE xxx NE
for NE xxx NE
both NE xxx NE
mAbs G#protein_family_or_group xXxx G#protein_family_or_group
over NE xxx NE
a NE x NE
period NE xxx NE
of NE xx NE
hours NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
the NE xxx NE
inositol G#lipid_B xxx G#lipid_B
phosphate G#lipid_E xxx G#lipid_E
response NE xxx NE
was NE xxx NE
stronger NE xxx NE
for NE xxx NE
64.1 G#protein_molecule dd.d G#protein_molecule
than NE xxx NE
for NE xxx NE
OKT3 G#protein_molecule XXXd G#protein_molecule
. NE . NE

To NE Xx NE
tie NE xxx NE
these NE xxx NE
events NE xxx NE
to NE xx NE
gene G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
measured NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
NF-AT G#other_name_B XX-XX G#other_name_B
activity G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
nucleus NE xxx NE
after NE xxx NE
anti-CD3 G#other_name_B xxx-XXd G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
. NE . NE

Both NE Xxxx NE
stimuli NE xxx NE
induced NE xxx NE
the NE xxx NE
appearance NE xxx NE
of NE xx NE
the NE xxx NE
NF-kappa G#protein_subunit_B XX-xxx G#protein_subunit_B
B G#protein_subunit_M X G#protein_subunit_M
components G#protein_subunit_E xxx G#protein_subunit_E
( NE ( NE
c-Rel G#protein_subunit x-Xxx G#protein_subunit
, NE , NE
p65 G#protein_subunit xdd G#protein_subunit
( NE ( NE
RelA G#protein_subunit XxxX G#protein_subunit
) NE ) NE
, NE , NE
and NE xxx NE
p50 G#protein_subunit xdd G#protein_subunit
( NE ( NE
NF-kappa G#protein_subunit_B XX-xxx G#protein_subunit_B
B1 G#protein_subunit_E Xd G#protein_subunit_E
)) NE )) NE
and NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
DNA NE XXX NE
binding NE xxx NE
activity NE xxx NE
in NE xx NE
the NE xxx NE
nucleus NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
only NE xxx NE
64.1 G#protein_molecule dd.d G#protein_molecule
induced NE xxx NE
NF-AT G#protein_molecule XX-XX G#protein_molecule
in NE xx NE
the NE xxx NE
nucleus NE xxx NE
, NE , NE
correlating NE xxx NE
with NE xxx NE
its NE xxx NE
ability NE xxx NE
to NE xx NE
activate NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Thus NE Xxxx NE
, NE , NE
NF-AT G#other_name_B XX-XX G#other_name_B
induction G#other_name_E xxx G#other_name_E
and NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
secretion G#other_name_E xxx G#other_name_E
were NE xxx NE
correlated NE xxx NE
with NE xxx NE
the NE xxx NE
levels NE xxx NE
of NE xx NE
inositol G#other_name_B xxx G#other_name_B
phosphate G#other_name_M xxx G#other_name_M
release G#other_name_E xxx G#other_name_E
but NE xxx NE
not NE xxx NE
with NE xxx NE
gross NE xxx NE
levels NE xxx NE
of NE xx NE
tyrosine G#other_name_B xxx G#other_name_B
kinase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
induced NE xxx NE
late NE xxx NE
following NE xxx NE
the NE xxx NE
response NE xxx NE
. NE . NE

On NE Xx NE
the NE xxx NE
other NE xxx NE
hand NE xxx NE
, NE , NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
induction NE xxx NE
and NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
receptor NE xxx NE
expression NE xxx NE
occurred NE xxx NE
even NE xxx NE
with NE xxx NE
the NE xxx NE
smaller G#other_name_B xxx G#other_name_B
second G#other_name_M xxx G#other_name_M
messenger G#other_name_M xxx G#other_name_M
response G#other_name_E xxx G#other_name_E
generated NE xxx NE
by NE xx NE
OKT3 G#protein_molecule XXXd G#protein_molecule
. NE . NE

HLA-DR- G#other_name_B XXX-XX- G#other_name_B
myeloid/natural G#other_name_M xxx/xxx G#other_name_M
killer G#other_name_M xxx G#other_name_M
cell G#other_name_M xxx G#other_name_M
acute G#other_name_M xxx G#other_name_M
leukemia G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
CD33+ G#other_name_M XXdd+ G#other_name_M
myeloid/natural G#other_name_M xxx/xxx G#other_name_M
killer G#other_name_M xxx G#other_name_M
cell G#other_name_M xxx G#other_name_M
acute G#other_name_M xxx G#other_name_M
leukemia G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
CD56+ G#other_name_M XXdd+ G#other_name_M
myeloid/natural G#other_name_M xxx/xxx G#other_name_M
killer G#other_name_M xxx G#other_name_M
cell G#other_name_M xxx G#other_name_M
acute G#other_name_M xxx G#other_name_M
leukemia G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
CD16- G#other_name_M XXdd- G#other_name_M
myeloid/natural G#other_name_M xxx/xxx G#other_name_M
killer G#other_name_M xxx G#other_name_M
cell G#other_name_M xxx G#other_name_M
acute G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
potentially NE xxx NE
misdiagnosed NE xxx NE
as NE xx NE
French-American-British G#other_name_B Xxxx-Xxxx-Xxxx G#other_name_B
acute G#other_name_M xxx G#other_name_M
myeloid G#other_name_M xxx G#other_name_M
leukemia-M3 G#other_name_E xxx-Xd G#other_name_E
[see NE [xxx NE
comments] NE xxx] NE

We NE Xx NE
have NE xxx NE
identified NE xxx NE
and NE xxx NE
characterized NE xxx NE
a NE x NE
previously NE xxx NE
unrecognized NE xxx NE
form NE xxx NE
of NE xx NE
acute G#other_name_B xxx G#other_name_B
leukemia G#other_name_E xxx G#other_name_E
that NE xxx NE
shares NE xxx NE
features NE xxx NE
of NE xx NE
both NE xxx NE
myeloid G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
natural G#cell_type_M xxx G#cell_type_M
killer G#cell_type_M xxx G#cell_type_M
(NK) G#cell_type_M (XX) G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E

From NE Xxxx NE
a NE x NE
consecutive NE xxx NE
series NE xxx NE
of NE xx NE
350 NE ddd NE
cases NE xxx NE
of NE xx NE
adult G#other_name_B xxx G#other_name_B
de G#other_name_M xx G#other_name_M
novo G#other_name_M xxx G#other_name_M
acute G#other_name_M xxx G#other_name_M
myeloid G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
( NE ( NE
AML G#other_name XXX G#other_name
) NE ) NE
, NE , NE
we NE xx NE
identified NE xxx NE
20 NE dd NE
cases NE xxx NE
(6%) NE (d%) NE
with NE xxx NE
a NE x NE
unique NE xxx NE
immunophenotype NE xxx NE
: NE : NE
CD33+ NE XXdd+ NE
, NE , NE
CD56+ NE XXdd+ NE
, NE , NE
CD11a+ NE XXddx+ NE
, NE , NE
CD13lo NE XXddxx NE
, NE , NE
CD15lo NE XXddxx NE
, NE , NE
CD34+/- NE XXdd+/- NE
, NE , NE
HLA-DR NE XXX-XX NE
- NE - NE
, NE , NE
CD16 NE XXdd NE
- NE - NE
. NE . NE

Multicolor NE Xxxx NE
flow NE xxx NE
cytometric NE xxx NE
assays NE xxx NE
confirmed NE xxx NE
the NE xxx NE
coexpression NE xxx NE
of NE xx NE
myeloid G#protein_family_or_group_B xxx G#protein_family_or_group_B
(CD33, G#protein_family_or_group_M (XXdd, G#protein_family_or_group_M
CD13, G#protein_family_or_group_M XXdd, G#protein_family_or_group_M
CD15) G#protein_family_or_group_M XXdd) G#protein_family_or_group_M
antigen G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
NK G#protein_family_or_group_M XX G#protein_family_or_group_M
cell-associated G#protein_family_or_group_M xxx-xxx G#protein_family_or_group_M
(CD56) G#protein_family_or_group_M (XXdd) G#protein_family_or_group_M
antigen G#protein_family_or_group_E xxx G#protein_family_or_group_E
confirmed NE xxx NE
the NE xxx NE
identity NE xxx NE
of NE xx NE
CD56 G#protein_molecule XXdd G#protein_molecule
( NE ( NE
neural G#protein_family_or_group_B xxx G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
adhesion G#protein_family_or_group_M xxx G#protein_family_or_group_M
molecule G#protein_family_or_group_E xxx G#protein_family_or_group_E
) NE ) NE
in NE xx NE
leukemic G#cell_type_B xxx G#cell_type_B
blasts G#cell_type_E xxx G#cell_type_E
. NE . NE

Although NE Xxxx NE
two NE xxx NE
cases NE xxx NE
expressed NE xxx NE
CD4 G#protein_molecule XXd G#protein_molecule
, NE , NE
no NE xx NE
case NE xxx NE
expressed NE xxx NE
CD2 G#protein_molecule XXd G#protein_molecule
, NE , NE
CD3 G#protein_molecule XXd G#protein_molecule
, NE , NE
or NE xx NE
CD8 G#protein_molecule XXd G#protein_molecule
and NE xxx NE
no NE xx NE
case NE xxx NE
showed NE xxx NE
clonal NE xxx NE
rearrangement NE xxx NE
of NE xx NE
genes NE xxx NE
encoding NE xxx NE
the NE xxx NE
T-cell G#protein_family_or_group_B X-xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
TCR G#protein_molecule_B XXX G#protein_molecule_B
beta G#protein_molecule_M xxx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
TCR G#protein_molecule_M XXX G#protein_molecule_M
gamma G#protein_molecule_M xxx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
TCR G#protein_molecule_M XXX G#protein_molecule_M
delta G#protein_molecule_E xxx G#protein_molecule_E

Leukemic NE Xxxx NE
blasts NE xxx NE
in NE xx NE
the NE xxx NE
majority NE xxx NE
of NE xx NE
cases NE xxx NE
shared NE xxx NE
unique NE xxx NE
morphologic G#other_name_B xxx G#other_name_B
features G#other_name_E xxx G#other_name_E
( NE ( NE
deeply G#cell_component_B xxx G#cell_component_B
invaginated G#cell_component_M xxx G#cell_component_M
nuclear G#cell_component_M xxx G#cell_component_M
membranes G#cell_component_E xxx G#cell_component_E
, NE , NE
scant G#cell_component_B xxx G#cell_component_B
cytoplasm G#cell_component_E xxx G#cell_component_E
with NE xxx NE
fine G#other_name_B xxx G#other_name_B
azurophilic G#other_name_M xxx G#other_name_M
granularity G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
finely G#other_name_B xxx G#other_name_B
granular G#other_name_M xxx G#other_name_M
Sudan G#other_name_M Xxxx G#other_name_M
black G#other_name_M xxx G#other_name_M
B G#other_name_M X G#other_name_M
and G#other_name_M xxx G#other_name_M
myeloperoxidase G#other_name_M xxx G#other_name_M
cytochemical G#other_name_M xxx G#other_name_M
reactivity G#other_name_E xxx G#other_name_E
) NE ) NE
that NE xxx NE
were NE xxx NE
remarkably NE xxx NE
similar NE xxx NE
to NE xx NE
those NE xxx NE
of NE xx NE
acute G#other_name_B xxx G#other_name_B
promyelocytic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
( NE ( NE
APL G#other_name XXX G#other_name
) NE ) NE
; NE ; NE
particularly NE xxx NE
the NE xxx NE
microgranular G#protein_family_or_group_B xxx G#protein_family_or_group_B
variant G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
FAB NE XXX NE
AML NE XXX NE
-M3v NE -Xdx NE
) NE ) NE
. NE . NE

However NE Xxxx NE
, NE , NE
all NE xxx NE
20 NE dd NE
cases NE xxx NE
lacked NE xxx NE
the NE xxx NE
t(15;17) NE x(dd;dd) NE
and NE xxx NE
17 NE dd NE
cases NE xxx NE
tested NE xxx NE
lacked NE xxx NE
the NE xxx NE
promyelocytic/retinoic G#RNA_molecule_B xxx/xxx G#RNA_molecule_B
acid G#RNA_molecule_M xxx G#RNA_molecule_M
receptor G#RNA_molecule_M xxx G#RNA_molecule_M
alpha G#RNA_molecule_M xxx G#RNA_molecule_M
( G#RNA_molecule_E ( G#RNA_molecule_E
RAR NE XXX NE
alpha NE xxx NE
) NE ) NE
fusion NE xxx NE
transcript NE xxx NE
in G#RNA_molecule xx G#RNA_molecule
RT-PCR NE XX-XXX NE
assays NE xxx NE
; NE ; NE
12 NE dd NE
cases NE xxx NE
had NE xxx NE
46,XX G#other_name_B dd,XX G#other_name_B
karyotype G#other_name_M xxx G#other_name_M
or G#other_name_M xx G#other_name_M
46,XY G#other_name_M dd,XX G#other_name_M
karyotype G#other_name_E xxx G#other_name_E
chromosome NE xxx NE
17q NE ddx NE
: NE : NE
1 NE d NE
with NE xxx NE
del(17)(q25) G#DNA_domain_or_region xxx(dd)(xdd) G#DNA_domain_or_region
and NE xxx NE
the NE xxx NE
other NE xxx NE
with NE xxx NE
t(11;17)(q23;q21) G#DNA_domain_or_region x(dd;dd)(xdd;xdd) G#DNA_domain_or_region
and NE xxx NE
the NE xxx NE
promyelocytic NE xxx NE
leukemia NE xxx NE
zinc NE xxx NE
finger NE xxx NE
/ NE / NE
RAR NE XXX NE
alpha NE xxx NE
fusion NE xxx NE
transcript NE xxx NE
. NE . NE

All NE Xxx NE
cases NE xxx NE
tested NE xxx NE
(6/20) NE (d/dd) NE
, NE , NE
including NE xxx NE
the NE xxx NE
case NE xxx NE
with NE xxx NE
t(11;17) G#DNA_domain_or_region x(dd;dd) G#DNA_domain_or_region
, NE , NE
failed NE xxx NE
to NE xx NE
differentiate NE xxx NE
in NE xx NE
vitro NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
retinoic G#other_organic_compound_M xxx G#other_organic_compound_M
acid G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
ATRA G#other_organic_compound XXXX G#other_organic_compound
) NE ) NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
these NE xxx NE
cases NE xxx NE
may NE xxx NE
account NE xxx NE
for NE xxx NE
some NE xxx NE
APLs NE XXXx NE
that NE xxx NE
have NE xxx NE
not NE xxx NE
shown NE xxx NE
a NE x NE
clinical NE xxx NE
response NE xxx NE
to NE xx NE
ATRA G#other_organic_compound XXXX G#other_organic_compound
. NE . NE

Four NE Xxxx NE
of NE xx NE
6 NE d NE
cases NE xxx NE
tested NE xxx NE
showed NE xxx NE
functional NE xxx NE
NK G#other_name_B XX G#other_name_B
cell-mediated G#other_name_M xxx-xxx G#other_name_M
cytotoxicity G#other_name_E xxx G#other_name_E
, NE , NE
suggesting NE xxx NE
a NE x NE
relationship NE xxx NE
between NE xxx NE
these NE xxx NE
unique NE xxx NE
CD33+ NE XXdd+ NE
, NE , NE
CD56+ NE XXdd+ NE
, NE , NE
CD16 NE XXdd NE
-acute NE -xxx NE
leukemias NE xxx NE
and NE xxx NE
normal NE xxx NE
CD56+ NE XXdd+ NE
, NE , NE
CD16- NE XXdd- NE
NK NE XX NE
precursor NE xxx NE
cells NE xxx NE
. NE . NE

Using NE Xxxx NE
a NE x NE
combination NE xxx NE
of NE xx NE
panning NE xxx NE
and NE xxx NE
multiparameter NE xxx NE
flow NE xxx NE
cytometric NE xxx NE
sorting NE xxx NE
, NE , NE
we NE xx NE
identified NE xxx NE
a NE x NE
normal G#cell_type_B xxx G#cell_type_B
CD56+, G#cell_type_M XXdd+, G#cell_type_M
CD33+, G#cell_type_M XXdd+, G#cell_type_M
CD16- G#cell_type_M XXdd- G#cell_type_M
counterpart G#cell_type_M xxx G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E
at NE xx NE
a NE x NE
frequency NE xxx NE
of NE xx NE
1% NE d% NE
to NE xx NE
2% NE d% NE
in NE xx NE
the NE xxx NE
peripheral G#tissue_B xxx G#tissue_B
blood G#tissue_E xxx G#tissue_E
of NE xx NE
healthy G#multi_cell_B xxx G#multi_cell_B
individuals G#multi_cell_E xxx G#multi_cell_E
. NE . NE

Our NE Xxx NE
studies NE xxx NE
suggest NE xxx NE
that NE xxx NE
this NE xxx NE
form NE xxx NE
of NE xx NE
acute G#other_name_B xxx G#other_name_B
leukemia G#other_name_E xxx G#other_name_E
may NE xxx NE
arise NE xxx NE
from NE xxx NE
transformation NE xxx NE
of NE xx NE
a NE x NE
precursor NE xxx NE
cell NE xxx NE
common NE xxx NE
to NE xx NE
both NE xxx NE
the NE xxx NE
myeloid G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
NK G#cell_type_M XX G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_E xxx G#cell_type_E
acute NE xxx NE
leukemia NE xxx NE
. NE . NE

Recognition NE Xxxx NE
of NE xx NE
this NE xxx NE
new G#other_name_B xxx G#other_name_B
leukemic G#other_name_M xxx G#other_name_M
entity G#other_name_E xxx G#other_name_E
will NE xxx NE
be NE xx NE
important NE xxx NE
in NE xx NE
distinguishing NE xxx NE
these NE xxx NE
ATRA G#other_organic_compound XXXX G#other_organic_compound
-nonresponsive NE -xxx NE
cases NE xxx NE
from NE xxx NE
ATRA NE XXXX NE
-responsive NE -xxx NE
true NE xxx NE
APL NE XXX NE
. NE . NE

IL-4 G#protein_molecule XX-d G#protein_molecule
down-regulates NE xxx-xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
- NE - NE
, NE , NE
IL-3 G#protein_molecule XX-d G#protein_molecule
- NE - NE
, NE , NE
and NE xxx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
-induced NE -xxx NE
cytokine NE xxx NE
gene NE xxx NE
expression NE xxx NE
in NE xx NE
peripheral G#tissue_B xxx G#tissue_B
blood G#tissue_E xxx G#tissue_E
monocytes NE xxx NE
. NE . NE

IL-4 G#protein_molecule XX-d G#protein_molecule
, NE , NE
a NE x NE
product NE xxx NE
of NE xx NE
the NE xxx NE
T-helper G#cell_type_B X-xxx G#cell_type_B
0 G#cell_type_M d G#cell_type_M
(Th0) G#cell_type_M (Xxd) G#cell_type_M
subset G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
T-helper G#cell_type_M X-xxx G#cell_type_M
2 G#cell_type_M d G#cell_type_M
(Th2) G#cell_type_M (Xxd) G#cell_type_M
subset G#cell_type_E xxx G#cell_type_E
gene NE xxx NE
expression NE xxx NE
in NE xx NE
monocytes G#cell_type xxx G#cell_type
stimulated NE xxx NE
with NE xxx NE
LPS G#lipid XXX G#lipid
, NE , NE
and NE xxx NE
to NE xx NE
upregulate NE xxx NE
IL-1 G#other_name_B XX-d G#other_name_B
receptor G#other_name_M xxx G#other_name_M
antagonist G#other_name_M xxx G#other_name_M
(IL1-RA) G#other_name_M (XXd-XX) G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
we NE xx NE
investigated NE xxx NE
the NE xxx NE
effect NE xxx NE
of NE xx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
on NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
cytokine G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
in NE xx NE
monocytes G#cell_type xxx G#cell_type
evoked NE xxx NE
by NE xx NE
other NE xxx NE
T-helper G#protein_family_or_group_B X-xxx G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
cytokines G#protein_family_or_group_E xxx G#protein_family_or_group_E
: NE : NE
IL-2 G#protein_molecule XX-d G#protein_molecule
, NE , NE
IL-3 G#protein_molecule XX-d G#protein_molecule
, NE , NE
and NE xxx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
. NE . NE

IL-4 G#other_name_B XX-d G#other_name_B
down-regulated G#other_name_M xxx-xxx G#other_name_M
mRNA G#other_name_M xXXX G#other_name_M
accumulation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
proinflammatory G#protein_family_or_group_B xxx G#protein_family_or_group_B
cytokines G#protein_family_or_group_E xxx G#protein_family_or_group_E
IL-1 G#protein_molecule_B XX-d G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
IL-8 G#protein_molecule XX-d G#protein_molecule
, NE , NE
and NE xxx NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
in NE xx NE
monocytes G#cell_type xxx G#cell_type
stimulated NE xxx NE
with NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
, NE , NE
IL-3 G#protein_molecule XX-d G#protein_molecule
, NE , NE
and NE xxx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
. NE . NE

IL-4 G#protein_molecule XX-d G#protein_molecule
also NE xxx NE
suppressed NE xxx NE
the NE xxx NE
IL-2 NE XX-d NE
-induced NE -xxx NE
IL-6 NE XX-d NE
mRNA NE xXXX NE
expression NE xxx NE
. NE . NE

Temporal NE Xxxx NE
analysis NE xxx NE
of NE xx NE
the NE xxx NE
IL-4 G#other_name_B XX-d G#other_name_B
down-regulatory G#other_name_M xxx-xxx G#other_name_M
effect G#other_name_E xxx G#other_name_E
on NE xx NE
the NE xxx NE
IL-2-induced G#other_name_B XX-d-xxx G#other_name_B
proinflammatory G#other_name_M xxx G#other_name_M
cytokine G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_M xxx G#other_name_M
or G#other_name_M xx G#other_name_M
IL-3-induced G#other_name_M XX-d-xxx G#other_name_M
proinflammatory G#other_name_M xxx G#other_name_M
cytokine G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_M xxx G#other_name_M
or G#other_name_M xx G#other_name_M
GM-CSF-induced G#other_name_M XX-XXX-xxx G#other_name_M
proinflammatory G#other_name_M xxx G#other_name_M
cytokine G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
monocytes NE xxx NE
provided NE xxx NE
evidence NE xxx NE
that NE xxx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
acts NE xxx NE
predominantly NE xxx NE
on NE xx NE
the NE xxx NE
post-transcriptional G#other_name_B xxx-xxx G#other_name_B
level G#other_name_E xxx G#other_name_E
. NE . NE

This NE Xxxx NE
was NE xxx NE
supported NE xxx NE
by NE xx NE
the NE xxx NE
observation NE xxx NE
that NE xxx NE
the NE xxx NE
down-regulatory NE xxx-xxx NE
capacity NE xxx NE
of NE xx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
appeared NE xxx NE
to NE xx NE
be NE xx NE
dependent NE xxx NE
on NE xx NE
de G#other_name_B xx G#other_name_B
novo G#other_name_M xxx G#other_name_M
protein G#other_name_M xxx G#other_name_M
synthesis G#other_name_E xxx G#other_name_E
. NE . NE

IL-4 G#protein_molecule XX-d G#protein_molecule
did NE xxx NE
not NE xxx NE
exert NE xxx NE
significant NE xxx NE
influence NE xxx NE
on NE xx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
expression NE xxx NE
of NE xx NE
IL-1-RA G#protein_molecule XX-d-XX G#protein_molecule
or NE xx NE
various NE xxx NE
CSFs G#protein_family_or_group XXXx G#protein_family_or_group
by NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
, NE , NE
IL-3 G#protein_molecule XX-d G#protein_molecule
, NE , NE
and NE xxx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
. NE . NE

(ABSTRACT NE (XXXXXXXX NE
TRUNCATED NE XXXXXXXXX NE
AT NE XX NE
250 NE ddd NE
WORDS) NE XXXXX) NE

Induction NE Xxxx NE
of NE xx NE
proto-oncogene G#DNA_molecule xxx-xxx G#DNA_molecule
and NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
human NE xxx NE
peripheral G#tissue_B xxx G#tissue_B
blood G#tissue_E xxx G#tissue_E
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
the NE xxx NE
monocytic G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
THP-1 G#cell_line XXX-d G#cell_line
after NE xxx NE
stimulation NE xxx NE
with NE xxx NE
mycoplasma-derived G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
material G#other_organic_compound_E xxx G#other_organic_compound_E
MDHM G#other_organic_compound XXXX G#other_organic_compound
. NE . NE

Mycoplasma G#other_organic_compound_B Xxxx G#other_organic_compound_B
fermentans-derived G#other_organic_compound_M xxx-xxx G#other_organic_compound_M
high-molecular-weight G#other_organic_compound_M xxx-xxx-xxx G#other_organic_compound_M
material G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
MDHM G#other_organic_compound XXXX G#other_organic_compound
) NE ) NE
was NE xxx NE
originally NE xxx NE
described NE xxx NE
to NE xx NE
induce NE xxx NE
differentiation NE xxx NE
of NE xx NE
murine G#cell_type_B xxx G#cell_type_B
thymocytes G#cell_type_E xxx G#cell_type_E
to NE xx NE
cytolytic G#cell_type_B xxx G#cell_type_B
effector G#cell_type_M xxx G#cell_type_M
T-cells G#cell_type_E X-xxx G#cell_type_E
by NE xx NE
stimulating NE xxx NE
IL-6 G#protein_molecule XX-d G#protein_molecule
release NE xxx NE
from NE xxx NE
adherent G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

This NE Xxxx NE
study NE xxx NE
shows NE xxx NE
that NE xxx NE
human NE xxx NE
peripheral G#tissue_B xxx G#tissue_B
blood G#tissue_E xxx G#tissue_E
monocytes G#cell_type xxx G#cell_type
( NE ( NE
PBMo G#cell_type XXXx G#cell_type
) NE ) NE
also NE xxx NE
respond NE xxx NE
to NE xx NE
MDHM G#other_organic_compound XXXX G#other_organic_compound
with NE xxx NE
increases NE xxx NE
in NE xx NE
IL-1 G#protein_molecule_B XX-d G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
IL-6 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
TNF G#other_name_B XXX G#other_name_B
alpha G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
, NE , NE
both NE xxx NE
at NE xx NE
the NE xxx NE
mRNA NE xXXX NE
and NE xxx NE
protein NE xxx NE
level NE xxx NE
. NE . NE

The NE Xxx NE
induced NE xxx NE
expression NE xxx NE
of NE xx NE
IL-1 G#RNA_molecule_B XX-d G#RNA_molecule_B
beta G#RNA_molecule_M xxx G#RNA_molecule_M
mRNA G#RNA_molecule_M xXXX G#RNA_molecule_M
and G#RNA_molecule_M xxx G#RNA_molecule_M
TNF G#RNA_molecule_M XXX G#RNA_molecule_M
alpha G#RNA_molecule_M xxx G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
in NE xx NE
the NE xxx NE
monocytic NE xxx NE
THP-1 G#cell_line_B XXX-d G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
increased NE xxx NE
as NE xx NE
quickly NE xxx NE
as NE xx NE
in NE xx NE
primary G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

In NE Xx NE
contrast NE xxx NE
to NE xx NE
PBMo G#cell_type XXXx G#cell_type
, NE , NE
THP-1 G#cell_line XXX-d G#cell_line
and NE xxx NE
14 NE dd NE
other NE xxx NE
monocytic/myeloid G#cell_line_B xxx/xxx G#cell_line_B
leukemia-derived G#cell_line_M xxx-xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
did NE xxx NE
not NE xxx NE
secrete NE xxx NE
measurable NE xxx NE
amounts NE xxx NE
of NE xx NE
the NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
upon NE xxx NE
treatment NE xxx NE
with NE xxx NE
MDHM G#other_organic_compound XXXX G#other_organic_compound
. NE . NE

IL-1 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
beta G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
IL-6 G#DNA_domain_or_region_M XX-d G#DNA_domain_or_region_M
genes G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
contain NE xxx NE
AP-1 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
as NE xx NE
regulatory G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
the NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
protein NE xxx NE
being NE xxx NE
composed NE xxx NE
of NE xx NE
c-jun G#protein_family_or_group_B x-xxx G#protein_family_or_group_B
gene G#protein_family_or_group_M xxx G#protein_family_or_group_M
product G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
c-fos G#protein_family_or_group_M x-xxx G#protein_family_or_group_M
gene G#protein_family_or_group_M xxx G#protein_family_or_group_M
product G#protein_family_or_group_E xxx G#protein_family_or_group_E

In NE Xx NE
THP-1 G#cell_line_B XXX-d G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
c-jun G#other_name_B x-xxx G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_E xxx G#other_name_E
increased NE xxx NE
after NE xxx NE
incubation NE xxx NE
with NE xxx NE
MDHM G#other_organic_compound XXXX G#other_organic_compound
while NE xxx NE
positive NE xxx NE
c-fos G#other_name_B x-xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
remained NE xxx NE
unaffected NE xxx NE
. NE . NE

Although NE Xxxx NE
these NE xxx NE
data NE xxx NE
suggest NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
regulated NE xxx NE
cytokine G#protein_family_or_group xxx G#protein_family_or_group
mRNA NE xXXX NE
expression NE xxx NE
, NE , NE
results NE xxx NE
from NE xxx NE
PBMo G#cell_type XXXx G#cell_type
are NE xxx NE
not NE xxx NE
in NE xx NE
accordance NE xxx NE
with NE xxx NE
this NE xxx NE
notion NE xxx NE
. NE . NE

In NE Xx NE
the NE xxx NE
primary G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
MDHM G#other_organic_compound XXXX G#other_organic_compound
-induced NE -xxx NE
elevation NE xxx NE
of NE xx NE
cytokine G#other_name_B xxx G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
levels G#other_name_E xxx G#other_name_E
was NE xxx NE
preceded NE xxx NE
by NE xx NE
a NE x NE
downregulation NE xxx NE
of NE xx NE
c-fos G#other_name_B x-xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
while NE xxx NE
positive NE xxx NE
c-jun G#other_name_B x-xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
was NE xxx NE
not NE xxx NE
modulated NE xxx NE
. NE . NE

c-myc G#other_name_B x-xxx G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_E xxx G#other_name_E
, NE , NE
constitutively NE xxx NE
high NE xxx NE
in NE xx NE
THP-1 G#cell_line_B XXX-d G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
was NE xxx NE
induced NE xxx NE
in NE xx NE
MDHM G#other_organic_compound XXXX G#other_organic_compound
-stimulated NE -xxx NE
PBMo G#cell_type XXXx G#cell_type
. NE . NE

In NE Xx NE
conclusion NE xxx NE
, NE , NE
MDHM G#other_organic_compound XXXX G#other_organic_compound
-stimulated NE -xxx NE
induction NE xxx NE
of NE xx NE
cytokine G#RNA_family_or_group_B xxx G#RNA_family_or_group_B
mRNA G#RNA_family_or_group_E xXXX G#RNA_family_or_group_E
expression NE xxx NE
was NE xxx NE
accompanied NE xxx NE
by NE xx NE
different NE xxx NE
proto-oncogene G#DNA_molecule xxx-xxx G#DNA_molecule
responses NE xxx NE
in NE xx NE
PBMo G#cell_type XXXx G#cell_type
and NE xxx NE
THP-1 G#cell_line_B XXX-d G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

These NE Xxxx NE
differences NE xxx NE
may NE xxx NE
represent NE xxx NE
different NE xxx NE
regulatory NE xxx NE
pathways NE xxx NE
of NE xx NE
the NE xxx NE
two NE xxx NE
cell NE xxx NE
systems NE xxx NE
. NE . NE

Alternatively NE Xxxx NE
, NE , NE
these NE xxx NE
data NE xxx NE
support NE xxx NE
the NE xxx NE
notion NE xxx NE
that NE xxx NE
neither NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
nor NE xxx NE
the NE xxx NE
c-myc G#protein_molecule_B x-xxx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
are NE xxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
MDHM G#other_name XXXX G#other_name
-induced NE -xxx NE
increase NE xxx NE
in NE xx NE
IL-1 G#other_name_B XX-d G#other_name_B
beta G#other_name_M xxx G#other_name_M
mRNA G#other_name_M xXXX G#other_name_M
level G#other_name_M xxx G#other_name_M
or G#other_name_M xx G#other_name_M
IL-6 G#other_name_M XX-d G#other_name_M
mRNA G#other_name_M xXXX G#other_name_M
level G#other_name_M xxx G#other_name_M
or G#other_name_M xx G#other_name_M
TNF G#other_name_M XXX G#other_name_M
alpha G#other_name_M xxx G#other_name_M
mRNA G#other_name_M xXXX G#other_name_M
level G#other_name_E xxx G#other_name_E

Furthermore NE Xxxx NE
, NE , NE
the NE xxx NE
present NE xxx NE
results NE xxx NE
demonstrate NE xxx NE
clearly NE xxx NE
that NE xxx NE
mycoplasma G#protein_family_or_group_B xxx G#protein_family_or_group_B
products G#protein_family_or_group_E xxx G#protein_family_or_group_E
can NE xxx NE
have NE xxx NE
a NE x NE
profound NE xxx NE
impact NE xxx NE
on NE xx NE
the NE xxx NE
activation NE xxx NE
status NE xxx NE
of NE xx NE
eukaryotic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Novel G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
membrane G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
for NE xxx NE
aldosterone G#lipid xxx G#lipid
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
: NE : NE
a NE x NE
50 G#protein_molecule_B dd G#protein_molecule_B
kDa G#protein_molecule_M xXx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
on NE xx NE
SDS-PAGE G#other_name XXX-XXXX G#other_name
. NE . NE

Fast NE Xxxx NE
in NE xx NE
vitro NE xxx NE
effects NE xxx NE
of NE xx NE
aldosterone G#lipid xxx G#lipid
on NE xx NE
the NE xxx NE
Na+/H(+)-exchanger G#protein_molecule Xx+/X(+)-xxx G#protein_molecule
, NE , NE
inositoltrisphosphate G#other_name_B xxx G#other_name_B
generation G#other_name_E xxx G#other_name_E
and NE xxx NE
corresponding NE xxx NE
specific NE xxx NE
binding NE xxx NE
to NE xx NE
plasma G#cell_component_B xxx G#cell_component_B
membranes G#cell_component_E xxx G#cell_component_E
at NE xx NE
Kd-values NE Xx-xxx NE
of NE xx NE
approximately NE xxx NE
0.1 NE d.d NE
nM NE xX NE
have NE xxx NE
been NE xxx NE
found NE xxx NE
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
mononuclear G#cell_type_M xxx G#cell_type_M
leukocytes G#cell_type_E xxx G#cell_type_E
and NE xxx NE
vascular G#cell_type_B xxx G#cell_type_B
smooth G#cell_type_M xxx G#cell_type_M
muscle G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
novel NE xxx NE
aldosterone G#lipid xxx G#lipid
membrane NE xxx NE
receptor NE xxx NE
was NE xxx NE
analyzed NE xxx NE
on NE xx NE
SDS-PAGE G#other_name XXX-XXXX G#other_name
after NE xxx NE
labeling NE xxx NE
of NE xx NE
microsomal NE xxx NE
membranes NE xxx NE
from NE xxx NE
human G#cell_type_B xxx G#cell_type_B
mononuclear G#cell_type_M xxx G#cell_type_M
leukocytes G#cell_type_E xxx G#cell_type_E
with NE xxx NE
a NE x NE
[125I]- NE [dddX]- NE
aldosterone G#lipid xxx G#lipid
-derivative NE -xxx NE
by NE xx NE
use NE xxx NE
of NE xx NE
BASED G#other_organic_compound XXXXX G#other_organic_compound
as NE xx NE
a NE x NE
photoactivatable G#other_name_B xxx G#other_name_B
crosslinker G#other_name_E xxx G#other_name_E
. NE . NE

Binding NE Xxxx NE
of NE xx NE
1 NE d NE
nM NE xX NE
[125I]- NE [dddX]- NE
aldosterone G#lipid xxx G#lipid
was NE xxx NE
found NE xxx NE
at NE xx NE
a NE x NE
molecular NE xxx NE
weight NE xxx NE
of NE xx NE
approximately NE xxx NE
50 G#other_name_B dd G#other_name_B
kDa G#other_name_E xXx G#other_name_E
which NE xxx NE
was NE xxx NE
absent NE xxx NE
with NE xxx NE
1 NE d NE
microM NE xxxX NE
cold NE xxx NE
aldosterone G#lipid xxx G#lipid
, NE , NE
but NE xxx NE
not NE xxx NE
cortisol G#lipid xxx G#lipid
in NE xx NE
the NE xxx NE
binding G#other_organic_compound_B xxx G#other_organic_compound_B
media G#other_organic_compound_E xxx G#other_organic_compound_E
. NE . NE

This NE Xxxx NE
aldosterone G#lipid xxx G#lipid
-selectivity NE -xxx NE
is NE xx NE
typical NE xxx NE
and NE xxx NE
discriminatory NE xxx NE
for NE xxx NE
the NE xxx NE
new NE xxx NE
aldosterone G#protein_molecule_B xxx G#protein_molecule_B
membrane G#protein_molecule_M xxx G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Solubilization NE Xxxx NE
of NE xx NE
the NE xxx NE
receptor G#protein_family_or_group_B xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
from NE xxx NE
membranes G#cell_component xxx G#cell_component
by NE xx NE
high G#other_name_B xxx G#other_name_B
salt G#other_name_M xxx G#other_name_M
concentrations G#other_name_E xxx G#other_name_E
(1 NE (d NE
M NE X NE
NaCl G#inorganic XxXx G#inorganic
, NE , NE
1 NE d NE
mM NE xX NE
EDTA G#other_organic_compound XXXX G#other_organic_compound
) NE ) NE
was NE xxx NE
not NE xxx NE
achieved NE xxx NE
. NE . NE

It NE Xx NE
, NE , NE
thus NE xxx NE
, NE , NE
appears NE xxx NE
as NE xx NE
an NE xx NE
integral G#protein_family_or_group_B xxx G#protein_family_or_group_B
membrane G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Dithiothreitol G#other_organic_compound Xxxx G#other_organic_compound
, NE , NE
a NE x NE
sulfhydryl G#other_name_B xxx G#other_name_B
agent G#other_name_E xxx G#other_name_E
, NE , NE
does NE xxx NE
not NE xxx NE
reduce NE xxx NE
specific NE xxx NE
aldosterone G#lipid xxx G#lipid
binding NE xxx NE
indicating NE xxx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
SH-groups G#protein_substructure XX-xxx G#protein_substructure
in NE xx NE
the NE xxx NE
binding G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
or NE xx NE
sensitive NE xxx NE
structures NE xxx NE
of NE xx NE
the NE xxx NE
receptors NE xxx NE
. NE . NE

The NE Xxx NE
results NE xxx NE
are NE xxx NE
the NE xxx NE
first NE xxx NE
to NE xx NE
characterize NE xxx NE
the NE xxx NE
novel G#protein_family_or_group_B xxx G#protein_family_or_group_B
membrane G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
for NE xxx NE
aldosterone G#lipid xxx G#lipid
with NE xxx NE
regard NE xxx NE
to NE xx NE
molecular G#other_name_B xxx G#other_name_B
weight G#other_name_E xxx G#other_name_E
and NE xxx NE
basic NE xxx NE
properties NE xxx NE
. NE . NE

These NE Xxxx NE
findings NE xxx NE
and NE xxx NE
other NE xxx NE
related NE xxx NE
results NE xxx NE
are NE xxx NE
reviewed NE xxx NE
here NE xxx NE
. NE . NE

A NE X NE
transcriptional G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
regulatory G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
element G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
is NE xx NE
associated NE xxx NE
with NE xxx NE
a NE x NE
nuclease-hypersensitive G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
pol G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
human G#virus_B xxx G#virus_B
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
type G#virus_M xxx G#virus_M
1 G#virus_E d G#virus_E
. NE . NE

Analysis NE Xxxx NE
of NE xx NE
the NE xxx NE
chromatin NE xxx NE
organization NE xxx NE
of NE xx NE
the NE xxx NE
integrated NE xxx NE
human NE xxx NE
immunodeficiency NE xxx NE
virus NE xxx NE
type NE xxx NE
1 NE d NE
( NE ( NE
HIV-1 NE XXX-d NE
) NE ) NE
genome NE xxx NE
has NE xxx NE
previously NE xxx NE
revealed NE xxx NE
a NE x NE
major NE xxx NE
constitutive NE xxx NE
DNase NE XXxxx NE
I-hypersensitive NE X-xxx NE
site NE xxx NE
associated NE xxx NE
with NE xxx NE
the NE xxx NE
pol NE xxx NE
gene NE xxx NE
(E NE (X NE
. NE . NE
Verdin NE Xxxx NE
, NE , NE
J NE X NE
. NE . NE
Virol NE Xxxx NE
. NE . NE
65:6790-6799 NE dd:dddd-dddd NE
, NE , NE
1991) NE dddd) NE
. NE . NE

In NE Xx NE
the NE xxx NE
present NE xxx NE
report NE xxx NE
, NE , NE
high-resolution G#other_name_B xxx-xxx G#other_name_B
mapping G#other_name_E xxx G#other_name_E
of NE xx NE
this NE xxx NE
site NE xxx NE
with NE xxx NE
DNase G#protein_molecule_B XXxxx G#protein_molecule_B
I G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
micrococcal G#protein_family_or_group_B xxx G#protein_family_or_group_B
nuclease G#protein_family_or_group_E xxx G#protein_family_or_group_E
identified NE xxx NE
a NE x NE
nucleosome-free G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
centered NE xxx NE
around NE xxx NE
nucleotides G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
(nt) G#DNA_domain_or_region_M (xx) G#DNA_domain_or_region_M
4490 G#DNA_domain_or_region_M dddd G#DNA_domain_or_region_M
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
4766 G#DNA_domain_or_region_E dddd G#DNA_domain_or_region_E
. NE . NE

A NE X NE
500-bp G#DNA_domain_or_region_B ddd-xx G#DNA_domain_or_region_B
fragment G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
encompassing NE xxx NE
this NE xxx NE
hypersensitive G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
nt G#DNA_domain_or_region_B xx G#DNA_domain_or_region_B
4481 G#DNA_domain_or_region_M dddd G#DNA_domain_or_region_M
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
4982 G#DNA_domain_or_region_E dddd G#DNA_domain_or_region_E
) NE ) NE
exhibited NE xxx NE
transcription-enhancing G#other_name_B xxx-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
(two- NE (xxx- NE
to NE xx NE
threefold) NE xxx) NE
when NE xxx NE
it NE xx NE
was NE xxx NE
cloned NE xxx NE
in NE xx NE
its NE xxx NE
natural NE xxx NE
position NE xxx NE
with NE xxx NE
respect NE xxx NE
to NE xx NE
the NE xxx NE
HIV-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
after NE xxx NE
transient NE xxx NE
transfection NE xxx NE
in NE xx NE
U937 G#cell_line Xddd G#cell_line
and NE xxx NE
CEM G#cell_line_B XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Using NE Xxxx NE
in NE xx NE
vitro G#other_name_B xxx G#other_name_B
footprinting G#other_name_E xxx G#other_name_E
and NE xxx NE
gel G#other_name_B xxx G#other_name_B
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
have NE xxx NE
identified NE xxx NE
four NE xxx NE
distinct NE xxx NE
binding G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
within NE xxx NE
this NE xxx NE
positive G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
regulatory G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Site G#DNA_domain_or_region_B Xxxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_E X G#DNA_domain_or_region_E
( NE ( NE
nt G#DNA_domain_or_region_B xx G#DNA_domain_or_region_B
4519 G#DNA_domain_or_region_M dddd G#DNA_domain_or_region_M
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
4545 G#DNA_domain_or_region_E dddd G#DNA_domain_or_region_E
) NE ) NE
specifically NE xxx NE
bound NE xxx NE
four NE xxx NE
distinct NE xxx NE
nuclear NE xxx NE
protein NE xxx NE
complexes NE xxx NE
: NE : NE
a NE x NE
ubiquitous NE xxx NE
factor NE xxx NE
, NE , NE
a NE x NE
T-cell-specific NE X-xxx-xxx NE
factor NE xxx NE
, NE , NE
a NE x NE
B-cell-specific NE X-xxx-xxx NE
factor NE xxx NE
, NE , NE
and NE xxx NE
the NE xxx NE
monocyte/macrophage- NE xxx/xxx- NE
and NE xxx NE
B-cell-specific NE X-xxx-xxx NE
transcription NE xxx NE
factor NE xxx NE
PU.1/Spi-1 NE XX.d/Xxx-d NE
. NE . NE

In NE Xx NE
most NE xxx NE
HIV-1 G#virus_B XXX-d G#virus_B
isolates G#virus_E xxx G#virus_E
in NE xx NE
which NE xxx NE
this NE xxx NE
PU G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
box G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
not NE xxx NE
conserved NE xxx NE
, NE , NE
it NE xx NE
was NE xxx NE
replaced NE xxx NE
by NE xx NE
a NE x NE
binding G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
the NE xxx NE
related NE xxx NE
factor NE xxx NE
Ets1 G#protein_molecule Xxxd G#protein_molecule
. NE . NE

Factors NE Xxxx NE
binding NE xxx NE
to NE xx NE
site G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
C G#DNA_domain_or_region_E X G#DNA_domain_or_region_E
( NE ( NE
nt G#DNA_domain_or_region_B xx G#DNA_domain_or_region_B
4681 G#DNA_domain_or_region_M dddd G#DNA_domain_or_region_M
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
4701 G#DNA_domain_or_region_E dddd G#DNA_domain_or_region_E
) NE ) NE
had NE xxx NE
a NE x NE
DNA-binding G#other_name_B XXX-xxx G#other_name_B
specificity G#other_name_E xxx G#other_name_E
similar NE xxx NE
to NE xx NE
that NE xxx NE
of NE xx NE
factors NE xxx NE
binding NE xxx NE
to NE xx NE
site G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_E X G#DNA_domain_or_region_E
, NE , NE
except NE xxx NE
for NE xxx NE
PU.1/Spi-1 G#protein_molecule XX.d/Xxx-d G#protein_molecule
. NE . NE

A NE X NE
GC G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
box G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
containing NE xxx NE
a NE x NE
binding G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
Sp1 G#protein_molecule Xxd G#protein_molecule
was NE xxx NE
identified NE xxx NE
( NE ( NE
nt G#DNA_domain_or_region_B xx G#DNA_domain_or_region_B
4623 G#DNA_domain_or_region_M dddd G#DNA_domain_or_region_M
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
4631 G#DNA_domain_or_region_E dddd G#DNA_domain_or_region_E
) NE ) NE
. NE . NE

Site G#DNA_domain_or_region_B Xxxx G#DNA_domain_or_region_B
D G#DNA_domain_or_region_E X G#DNA_domain_or_region_E
( NE ( NE
nt G#DNA_domain_or_region_B xx G#DNA_domain_or_region_B
4816 G#DNA_domain_or_region_M dddd G#DNA_domain_or_region_M
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
4851 G#DNA_domain_or_region_E dddd G#DNA_domain_or_region_E
) NE ) NE
specifically NE xxx NE
bound NE xxx NE
a NE x NE
ubiquitously G#protein_family_or_group_B xxx G#protein_family_or_group_B
expressed G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
identify NE xxx NE
a NE x NE
transcriptional G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
regulatory G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
element G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
associated NE xxx NE
with NE xxx NE
a NE x NE
nuclease- NE xxx- NE
hypersensitive NE xxx NE
site NE xxx NE
in NE xx NE
the NE xxx NE
pol NE xxx NE
gene NE xxx NE
of NE xx NE
HIV-1 NE XXX-d NE
and NE xxx NE
suggest NE xxx NE
that NE xxx NE
its NE xxx NE
activity NE xxx NE
may NE xxx NE
be NE xx NE
controlled NE xxx NE
by NE xx NE
a NE x NE
complex NE xxx NE
interplay NE xxx NE
of NE xx NE
cis- NE xxx- NE
regulatory NE xxx NE
elements NE xxx NE
. NE . NE

Expression NE Xxxx NE
of NE xx NE
v-src G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
correlates NE xxx NE
with NE xxx NE
nuclear NE xxx NE
expression NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
. NE . NE

NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
is NE xx NE
a NE x NE
rapidly NE xxx NE
inducible NE xxx NE
transcriptional G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
activator G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
that NE xxx NE
responds NE xxx NE
to NE xx NE
a NE x NE
variety NE xxx NE
of NE xx NE
signals NE xxx NE
and NE xxx NE
influences NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
many NE xxx NE
genes NE xxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
immune G#other_name_B xxx G#other_name_B
response G#other_name_E xxx G#other_name_E
. NE . NE

Protein NE Xxxx NE
tyrosine G#protein_molecule_B xxx G#protein_molecule_B
kinases G#protein_molecule_E xxx G#protein_molecule_E
transmit NE xxx NE
signals NE xxx NE
from NE xxx NE
cytokine G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
immune G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E

Very NE Xxxx NE
little NE xxx NE
information NE xxx NE
exists NE xxx NE
linking NE xxx NE
these NE xxx NE
two NE xxx NE
important NE xxx NE
classes NE xxx NE
of NE xx NE
signaling G#protein_family_or_group_B xxx G#protein_family_or_group_B
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

We NE Xx NE
now NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
v-src G#other_name_B x-xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
correlates NE xxx NE
with NE xxx NE
nuclear NE xxx NE
expression NE xxx NE
of NE xx NE
a NE x NE
kappa G#protein_complex_B xxx G#protein_complex_B
B G#protein_complex_M X G#protein_complex_M
binding G#protein_complex_M xxx G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
similar NE xxx NE
to NE xx NE
that NE xxx NE
induced NE xxx NE
by NE xx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
ionomycin G#other_organic_compound xxx G#other_organic_compound
, NE , NE
as NE xx NE
detected NE xxx NE
by NE xx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
using NE xxx NE
a NE x NE
variety NE xxx NE
of NE xx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

This NE Xxxx NE
complex NE xxx NE
was NE xxx NE
blocked NE xxx NE
by NE xx NE
the NE xxx NE
tyrosine G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_E xxx G#protein_molecule_E
inhibitor NE xxx NE
, NE , NE
herbimycin NE xxx NE
A NE X NE
. NE . NE

The NE Xxx NE
v-src G#protein_complex x-xxx G#protein_complex
-induced NE -xxx NE
complex NE xxx NE
comprised NE xxx NE
the NE xxx NE
p50 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
p65 G#protein_subunit xdd G#protein_subunit
components NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
as NE xx NE
determined NE xxx NE
by NE xx NE
supershift G#other_name_B xxx G#other_name_B
analysis G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
immunoblot G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E

As NE Xx NE
a NE x NE
functional NE xxx NE
correlate NE xxx NE
of NE xx NE
this NE xxx NE
finding NE xxx NE
, NE , NE
transient NE xxx NE
co-transfection NE xx-xxx NE
of NE xx NE
HIV-1 G#DNA_family_or_group_B XXX-d G#DNA_family_or_group_B
LTR G#DNA_family_or_group_M XXX G#DNA_family_or_group_M
reporter G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
constructs G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
in NE xx NE
a NE x NE
different NE xxx NE
T G#cell_line_B X G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
demonstrated NE xxx NE
that NE xxx NE
v-src G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
activated NE xxx NE
this NE xxx NE
promoter G#protein_domain_or_region xxx G#protein_domain_or_region
in NE xx NE
a NE x NE
kappa G#other_name_B xxx G#other_name_B
B-dependent G#other_name_M X-xxx G#other_name_M
manner G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
found NE xxx NE
that NE xxx NE
transactivation NE xxx NE
of NE xx NE
the NE xxx NE
HIV-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
LTR G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
by NE xx NE
v-src G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
was NE xxx NE
more NE xxx NE
sensitive NE xxx NE
to NE xx NE
mutations NE xxx NE
of NE xx NE
the NE xxx NE
proximal NE xxx NE
, NE , NE
rather NE xxx NE
than NE xxx NE
the NE xxx NE
distal NE xxx NE
, NE , NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
implications NE xxx NE
for NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
receptor G#other_name_M xxx G#other_name_M
signaling G#other_name_E xxx G#other_name_E
and NE xxx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
are NE xxx NE
considered NE xxx NE
. NE . NE

trans-activation NE xxx-xxx NE
of NE xx NE
the NE xxx NE
HIV G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
by NE xx NE
a NE x NE
cDNA NE xXXX NE
and NE xxx NE
its NE xxx NE
genomic NE xxx NE
clones NE xxx NE
of NE xx NE
human G#virus_B xxx G#virus_B
herpesvirus-6 G#virus_E xxx-d G#virus_E
. NE . NE

Human G#virus_B Xxxx G#virus_B
herpesvirus G#virus_M xxx G#virus_M
6 G#virus_E d G#virus_E
( NE ( NE
HHV-6 G#virus XXX-d G#virus
) NE ) NE
is NE xx NE
a NE x NE
lymphotropic G#virus_B xxx G#virus_B
herpesvirus G#virus_E xxx G#virus_E
, NE , NE
and NE xxx NE
in NE xx NE
vitro NE xxx NE
, NE , NE
it NE xx NE
can NE xxx NE
productively NE xxx NE
infect NE xxx NE
human NE xxx NE
CD4+ G#cell_line_B XXd+ G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
as NE xx NE
HIV-1 G#virus XXX-d G#virus
. NE . NE

Co-infection NE Xx-xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
HIV-1 G#virus XXX-d G#virus
and NE xxx NE
HHV-6 G#virus XXX-d G#virus
can NE xxx NE
lead NE xxx NE
to NE xx NE
both NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
HIV-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
acceleration NE xxx NE
of NE xx NE
the NE xxx NE
cytopathic NE xxx NE
effects NE xxx NE
. NE . NE

An NE Xx NE
HHV-6 G#DNA_molecule_B XXX-d G#DNA_molecule_B
(GS) G#DNA_molecule_M (XX) G#DNA_molecule_M
cDNA G#DNA_molecule_M xXXX G#DNA_molecule_M
clone G#DNA_molecule_E xxx G#DNA_molecule_E
, NE , NE
pCD41 G#DNA_molecule xXXdd G#DNA_molecule
, NE , NE
encoding NE xxx NE
for NE xxx NE
a NE x NE
41-kDa G#protein_molecule_B dd-xXx G#protein_molecule_B
nuclear G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
was NE xxx NE
identified NE xxx NE
and NE xxx NE
characterized NE xxx NE
previously NE xxx NE
(Chang NE (Xxxx NE
and NE xxx NE
Balachandran NE Xxxx NE
, NE , NE
J NE X NE
. NE . NE
Virol NE Xxxx NE
. NE . NE
65 NE dd NE
, NE , NE
2884-2894 NE dddd-dddd NE
and NE xxx NE
7085 NE dddd NE
, NE , NE
1991) NE dddd) NE
. NE . NE

Sequence NE Xxxx NE
analyses NE xxx NE
show NE xxx NE
that NE xxx NE
this NE xxx NE
protein NE xxx NE
has NE xxx NE
significant NE xxx NE
homology NE xxx NE
with NE xxx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
cytomegalovirus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
UL44 G#DNA_domain_or_region_M XXdd G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
coding NE xxx NE
for NE xxx NE
the NE xxx NE
ICP36 G#protein_family_or_group_B XXXdd G#protein_family_or_group_B
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
early-late-class G#protein_family_or_group_B xxx-xxx-xxx G#protein_family_or_group_B
phosphoprotein G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Using NE Xxxx NE
this NE xxx NE
cDNA G#DNA_family_or_group xXXX G#DNA_family_or_group
as NE xx NE
the NE xxx NE
probe NE xxx NE
, NE , NE
a NE x NE
3.8-kb G#DNA_molecule_B d.d-xx G#DNA_molecule_B
EcoRI G#DNA_molecule_M XxxXX G#DNA_molecule_M
genomic G#DNA_molecule_M xxx G#DNA_molecule_M
fragment G#DNA_molecule_E xxx G#DNA_molecule_E
encoding NE xxx NE
the NE xxx NE
HHV-6 NE XXX-d NE
(GS)P41 NE (XX)Xdd NE
was NE xxx NE
cloned NE xxx NE
and NE xxx NE
designated NE xxx NE
as NE xx NE
pGD41 NE xXXdd NE
. NE . NE

When NE Xxxx NE
cotransfected NE xxx NE
with NE xxx NE
the NE xxx NE
HIV G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
LTR G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
CAT G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
into NE xxx NE
CV-1 G#cell_line_B XX-d G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
both NE xxx NE
the NE xxx NE
pCD41 G#DNA_molecule xXXdd G#DNA_molecule
and NE xxx NE
pGD41 G#DNA_molecule xXXdd G#DNA_molecule
clones NE xxx NE
trans-activated NE xxx-xxx NE
the NE xxx NE
HIV G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
LTR G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
. NE . NE

Sequence NE Xxxx NE
analyses NE xxx NE
of NE xx NE
pCD41 G#DNA_molecule xXXdd G#DNA_molecule
indicate NE xxx NE
that NE xxx NE
there NE xxx NE
are NE xxx NE
two NE xxx NE
potential NE xxx NE
open G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
reading G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
frames G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
ORFs G#DNA_domain_or_region XXXx G#DNA_domain_or_region
) NE ) NE
, NE , NE
A G#DNA_domain_or_region X G#DNA_domain_or_region
and NE xxx NE
B G#DNA_domain_or_region X G#DNA_domain_or_region
, NE , NE
which NE xxx NE
are NE xxx NE
homologous NE xxx NE
to NE xx NE
the NE xxx NE
ORFs G#DNA_domain_or_region XXXx G#DNA_domain_or_region
found NE xxx NE
in NE xx NE
the NE xxx NE
genomic NE xxx NE
clone NE xxx NE
pGD41 G#DNA_molecule xXXdd G#DNA_molecule
. NE . NE

Deletion NE Xxxx NE
constructs NE xxx NE
of NE xx NE
the NE xxx NE
pCD41 G#DNA_molecule_B xXXdd G#DNA_molecule_B
clone G#DNA_molecule_E xxx G#DNA_molecule_E
demonstrated NE xxx NE
that NE xxx NE
ORF-A G#protein_molecule XXX-X G#protein_molecule
was NE xxx NE
critical NE xxx NE
for NE xxx NE
the NE xxx NE
HIV G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
LTR G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
activation NE xxx NE
. NE . NE

Deletion NE Xxxx NE
analyses NE xxx NE
of NE xx NE
the NE xxx NE
pCD41 G#DNA_molecule xXXdd G#DNA_molecule
ORF-A G#protein_molecule XXX-X G#protein_molecule
and NE xxx NE
the NE xxx NE
use NE xxx NE
of NE xx NE
promoter G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
constructs G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
further NE xxx NE
mapped NE xxx NE
an NE xx NE
internal NE xxx NE
functional NE xxx NE
promoter NE xxx NE
within NE xxx NE
the NE xxx NE
pCD41 G#DNA_molecule xXXdd G#DNA_molecule
sequence NE xxx NE
that NE xxx NE
can NE xxx NE
direct NE xxx NE
the NE xxx NE
synthesis NE xxx NE
of NE xx NE
the NE xxx NE
trans-activating G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

By NE Xx NE
using NE xxx NE
HIV G#DNA_family_or_group_B XXX G#DNA_family_or_group_B
LTR G#DNA_family_or_group_M XXX G#DNA_family_or_group_M
deletion G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
mutants G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
the NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
binding G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
were NE xxx NE
found NE xxx NE
to NE xx NE
be NE xx NE
critical NE xxx NE
for NE xxx NE
response NE xxx NE
to NE xx NE
the NE xxx NE
pCD41 G#other_name_B xXXdd G#other_name_B
trans-activation G#other_name_E xxx-xxx G#other_name_E
. NE . NE

CD14 NE XXdd NE
-mediated NE -xxx NE
translocation NE xxx NE
of NE xx NE
nuclear NE xxx NE
factor-kappa NE xxx-xxx NE
B NE X NE
induced NE xxx NE
by NE xx NE
lipopolysaccharide NE xxx NE
does NE xxx NE
not NE xxx NE
require NE xxx NE
tyrosine NE xxx NE
kinase NE xxx NE
activity NE xxx NE
. NE . NE

During NE Xxxx NE
the NE xxx NE
course NE xxx NE
of NE xx NE
serious G#other_name_B xxx G#other_name_B
bacterial G#other_name_M xxx G#other_name_M
infections G#other_name_E xxx G#other_name_E
, NE , NE
lipopolysaccharide G#lipid xxx G#lipid
( NE ( NE
LPS G#lipid XXX G#lipid
) NE ) NE
is NE xx NE
believed NE xxx NE
to NE xx NE
interact NE xxx NE
with NE xxx NE
macrophage G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
resulting NE xxx NE
in NE xx NE
the NE xxx NE
generation NE xxx NE
of NE xx NE
inflammatory G#other_name_B xxx G#other_name_B
mediators G#other_name_E xxx G#other_name_E
and NE xxx NE
systemic NE xxx NE
symptoms NE xxx NE
including NE xxx NE
hemodynamic G#other_name_B xxx G#other_name_B
instability G#other_name_E xxx G#other_name_E
and NE xxx NE
shock G#other_name xxx G#other_name
. NE . NE

CD14 G#protein_molecule XXdd G#protein_molecule
, NE , NE
a NE x NE
glycosylphosphatidylinositol-linked G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
antigen G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
functions NE xxx NE
as NE xx NE
an NE xx NE
LPS G#protein_family_or_group_B XXX G#protein_family_or_group_B
signaling G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

A NE X NE
critical NE xxx NE
issue NE xxx NE
concerns NE xxx NE
the NE xxx NE
mechanism NE xxx NE
by NE xx NE
which NE xxx NE
CD14 G#protein_molecule XXdd G#protein_molecule
, NE , NE
which NE xxx NE
has NE xxx NE
no NE xx NE
transmembrane G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
, NE , NE
transduces NE xxx NE
its NE xxx NE
signal NE xxx NE
following NE xxx NE
LPS G#lipid XXX G#lipid
binding NE xxx NE
. NE . NE

Recently NE Xxxx NE
, NE , NE
investigators NE xxx NE
have NE xxx NE
hypothesized NE xxx NE
that NE xxx NE
CD14 NE XXdd NE
-mediated NE -xxx NE
signaling NE xxx NE
is NE xx NE
effected NE xxx NE
through NE xxx NE
a NE x NE
receptor-associated NE xxx-xxx NE
tyrosine NE xxx NE
kinase NE xxx NE
(TK) NE (XX) NE
, NE , NE
suggesting NE xxx NE
a NE x NE
multicomponent NE xxx NE
receptor NE xxx NE
model NE xxx NE
of NE xx NE
LPS NE XXX NE
signaling NE xxx NE
. NE . NE

Wild-type NE Xxxx-xxx NE
Chinese G#cell_line_B Xxxx G#cell_line_B
hamster G#cell_line_M xxx G#cell_line_M
ovary G#cell_line_M xxx G#cell_line_M
(CHO)-K1 G#cell_line_M (XXX)-Xd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
can NE xxx NE
be NE xx NE
activated NE xxx NE
by NE xx NE
endotoxin NE xxx NE
to NE xx NE
release NE xxx NE
arachidonate G#other_organic_compound xxx G#other_organic_compound
following NE xxx NE
transfection NE xxx NE
with NE xxx NE
human NE xxx NE
CD14 G#protein_molecule XXdd G#protein_molecule
( NE ( NE
CHO NE XXX NE
/ NE / NE
CD14 NE XXdd NE
) NE ) NE
. NE . NE

Nuclear NE Xxxx NE
translocation NE xxx NE
of NE xx NE
cytosolic NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
is NE xx NE
correlated NE xxx NE
with NE xxx NE
a NE x NE
number NE xxx NE
of NE xx NE
LPS NE XXX NE
-inducible NE -xxx NE
responses NE xxx NE
. NE . NE

We NE Xx NE
sought NE xxx NE
to NE xx NE
determine NE xxx NE
if NE xx NE
this NE xxx NE
pathway NE xxx NE
were NE xxx NE
present NE xxx NE
in NE xx NE
CHO NE XXX NE
/ NE / NE
CD14 NE XXdd NE
cells NE xxx NE
and NE xxx NE
to NE xx NE
elucidate NE xxx NE
the NE xxx NE
relationship NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
activation NE xxx NE
to NE xx NE
the NE xxx NE
CD14 NE XXdd NE
receptor NE xxx NE
system NE xxx NE
. NE . NE

LPS NE XXX NE
-stimulated NE -xxx NE
translocation NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
in NE xx NE
CHO NE XXX NE
/ NE / NE
CD14 NE XXdd NE
cells NE xxx NE
resembled NE xxx NE
the NE xxx NE
same NE xxx NE
response NE xxx NE
in NE xx NE
the NE xxx NE
murine NE xxx NE
macrophage-like NE xxx-xxx NE
cell NE xxx NE
line NE xxx NE
RAW NE XXX NE
264.7 NE ddd.d NE
. NE . NE

Protein NE Xxxx NE
synthesis NE xxx NE
inhibitors NE xxx NE
and NE xxx NE
corticosteroids G#lipid xxx G#lipid
, NE , NE
which NE xxx NE
suppress NE xxx NE
arachidonate G#other_organic_compound xxx G#other_organic_compound
release NE xxx NE
and NE xxx NE
the NE xxx NE
synthesis NE xxx NE
of NE xx NE
proinflammatory G#protein_family_or_group_B xxx G#protein_family_or_group_B
cytokines G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
had NE xxx NE
no NE xx NE
effect NE xxx NE
on NE xx NE
translocation NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
CHO NE XXX NE
/ NE / NE
CD14 G#protein_molecule XXdd G#protein_molecule
or NE xx NE
RAW G#cell_line_B XXX G#cell_line_B
264.7 G#cell_line_M ddd.d G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
demonstrating NE xxx NE
that NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
translocation G#other_name_E xxx G#other_name_E
is NE xx NE
an NE xx NE
early NE xxx NE
event NE xxx NE
. NE . NE

Although NE Xxxx NE
TK G#other_name_B XX G#other_name_B
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
consistently NE xxx NE
observed NE xxx NE
by NE xx NE
immunoblotting G#other_name_B xxx G#other_name_B
extracts G#other_name_E xxx G#other_name_E
from NE xxx NE
activated NE xxx NE
RAW G#cell_line_B XXX G#cell_line_B
264.7 G#cell_line_M ddd.d G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
LPS-induced G#amino_acid_monomer_B XXX-xxx G#amino_acid_monomer_B
phosphotyrosine G#amino_acid_monomer_M xxx G#amino_acid_monomer_M
residues G#amino_acid_monomer_E xxx G#amino_acid_monomer_E
were NE xxx NE
not NE xxx NE
observed NE xxx NE
from NE xxx NE
similarly NE xxx NE
treated NE xxx NE
CHO/CD14 G#cell_line_B XXX/XXdd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
the NE xxx NE
TK G#other_name_B XX G#other_name_B
inhibitors G#other_name_E xxx G#other_name_E
herbimycin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
and NE xxx NE
genistein G#other_organic_compound xxx G#other_organic_compound
failed NE xxx NE
to NE xx NE
inhibit NE xxx NE
translocation NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
CHO/CD14 NE XXX/XXdd NE
or NE xx NE
RAW NE XXX NE
264.7 NE ddd.d NE
cells NE xxx NE
, NE , NE
although NE xxx NE
both NE xxx NE
of NE xx NE
these NE xxx NE
agents NE xxx NE
inhibited NE xxx NE
LPS NE XXX NE
-induced NE -xxx NE
TK NE XX NE
activity NE xxx NE
in NE xx NE
RAW NE XXX NE
264.7 NE ddd.d NE
cells NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
imply NE xxx NE
that NE xxx NE
TK G#other_name_B XX G#other_name_B
activity G#other_name_E xxx G#other_name_E
is NE xx NE
not NE xxx NE
obligatory NE xxx NE
for NE xxx NE
CD14 NE XXdd NE
-mediated NE -xxx NE
signal NE xxx NE
transduction NE xxx NE
to NE xx NE
occur NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
LPS NE XXX NE
. NE . NE

Signals NE Xxxx NE
transduced NE xxx NE
through NE xxx NE
the NE xxx NE
CD4 G#protein_molecule_B XXd G#protein_molecule_B
molecule G#protein_molecule_E xxx G#protein_molecule_E
on NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
activate NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
. NE . NE

We NE Xx NE
have NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
native G#protein_family_or_group_B xxx G#protein_family_or_group_B
envelope G#protein_family_or_group_M xxx G#protein_family_or_group_M
glycoproteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
HIV-1 G#virus XXX-d G#virus
, NE , NE
gp160 G#virus xxddd G#virus
can NE xxx NE
induce NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
. NE . NE

The NE Xxx NE
stimulatory NE xxx NE
effects NE xxx NE
of NE xx NE
gp160 G#virus xxddd G#virus
are NE xxx NE
mediated NE xxx NE
through NE xxx NE
the NE xxx NE
CD4 G#protein_molecule_B XXd G#protein_molecule_B
molecule G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
since NE xxx NE
pretreatment NE xxx NE
with NE xxx NE
soluble NE xxx NE
CD4 G#protein_molecule XXd G#protein_molecule
abrogates NE xxx NE
its NE xxx NE
activity NE xxx NE
. NE . NE

The NE Xxx NE
gp160 NE xxddd NE
-induced NE -xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
complex NE xxx NE
consists NE xxx NE
of NE xx NE
p65 NE xdd NE
, NE , NE
p50 NE xdd NE
and NE xxx NE
c-rel NE x-xxx NE
proteins NE xxx NE
. NE . NE

The NE Xxx NE
stimulatory NE xxx NE
effect NE xxx NE
of NE xx NE
gp160 G#virus xxddd G#virus
on NE xx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
is NE xx NE
protein NE xxx NE
synthesis NE xxx NE
independent NE xxx NE
, NE , NE
is NE xx NE
dependent NE xxx NE
upon NE xxx NE
protein NE xxx NE
tyrosine G#amino_acid_monomer xxx G#amino_acid_monomer
phosphorylation NE xxx NE
, NE , NE
and NE xxx NE
abrogated NE xxx NE
by NE xx NE
inhibitors NE xxx NE
of NE xx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
. NE . NE

The NE Xxx NE
gp160 NE xxddd NE
-mediated NE -xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
in NE xx NE
CD4 NE XXd NE
positive NE xxx NE
T NE X NE
cells NE xxx NE
may NE xxx NE
be NE xx NE
involved NE xxx NE
in NE xx NE
biological NE xxx NE
effects NE xxx NE
, NE , NE
e.g. NE x.x. NE
, NE , NE
enhanced NE xxx NE
HIV NE XXX NE
replication NE xxx NE
, NE , NE
hypergammaglobulinemia NE xxx NE
, NE , NE
increased NE xxx NE
cytokine NE xxx NE
secretion NE xxx NE
, NE , NE
hypercellularity NE xxx NE
in NE xx NE
bone NE xxx NE
marrow NE xxx NE
and NE xxx NE
apoptosis NE xxx NE
. NE . NE

No NE Xx NE
evidence NE xxx NE
for NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
progesterone G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
on NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
during NE xxx NE
pregnancy G#other_name xxx G#other_name
[see NE [xxx NE
comments] NE xxx] NE

The NE Xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
progesterone G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
was NE xxx NE
analysed NE xxx NE
, NE , NE
using NE xxx NE
an NE xx NE
enzyme G#other_name_B xxx G#other_name_B
linked G#other_name_M xxx G#other_name_M
immunosorbent G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
( NE ( NE
Abbott G#other_name_B Xxxx G#other_name_B
PgR-EIA G#other_name_M XxX-XXX G#other_name_M
monoclonal G#other_name_E xxx G#other_name_E
) NE ) NE
, NE , NE
in NE xx NE
order NE xxx NE
to NE xx NE
evaluate NE xxx NE
its NE xxx NE
prognostic NE xxx NE
character NE xxx NE
in NE xx NE
the NE xxx NE
context NE xxx NE
of NE xx NE
spontaneous G#other_name_B xxx G#other_name_B
abortion G#other_name_E xxx G#other_name_E
. NE . NE

Cytosols G#cell_component Xxxx G#cell_component
were NE xxx NE
prepared NE xxx NE
from NE xxx NE
lymphocytes NE xxx NE
of NE xx NE
24 NE dd NE
healthy NE xxx NE
pregnant G#multi_cell_B xxx G#multi_cell_B
women G#multi_cell_E xxx G#multi_cell_E
(11 NE (dd NE
first NE xxx NE
, NE , NE
10 NE dd NE
second NE xxx NE
and NE xxx NE
three NE xxx NE
third NE xxx NE
trimester) NE xxx) NE
, NE , NE
seven NE xxx NE
healthy NE xxx NE
non-pregnant G#multi_cell_B xxx-xxx G#multi_cell_B
women G#multi_cell_E xxx G#multi_cell_E
, NE , NE
nine NE xxx NE
women NE xxx NE
with NE xxx NE
recurrent NE xxx NE
spontaneous G#other_name_B xxx G#other_name_B
abortion G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
six NE xxx NE
healthy G#multi_cell_B xxx G#multi_cell_B
men G#multi_cell_E xxx G#multi_cell_E
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
a NE x NE
human G#cell_line_B xxx G#cell_line_B
breast G#cell_line_M xxx G#cell_line_M
carcinoma G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
( NE ( NE
ZR-75-1 G#cell_line XX-dd-d G#cell_line
) NE ) NE
, NE , NE
which NE xxx NE
expresses NE xxx NE
the NE xxx NE
progesterone G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
was NE xxx NE
analysed NE xxx NE
throughout NE xxx NE
. NE . NE

The NE Xxx NE
ZR-75-1 G#cell_line_B XX-dd-d G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
showed NE xxx NE
an NE xx NE
expression NE xxx NE
of NE xx NE
642 NE ddd NE
fmol/mg NE xxx/xx NE
whereas NE xxx NE
lymphocytes NE xxx NE
of NE xx NE
pregnant G#multi_cell_B xxx G#multi_cell_B
women G#multi_cell_E xxx G#multi_cell_E
showed NE xxx NE
an NE xx NE
expression NE xxx NE
< NE < NE
or NE xx NE
= NE = NE
4 NE d NE
fmol/mg NE xxx/xx NE
. NE . NE

Lymphocytes G#cell_type Xxxx G#cell_type
of NE xx NE
non-pregnant G#multi_cell_B xxx-xxx G#multi_cell_B
women G#multi_cell_E xxx G#multi_cell_E
, NE , NE
women NE xxx NE
with NE xxx NE
threatened NE xxx NE
pre-term NE xxx-xxx NE
delivery NE xxx NE
, NE , NE
and NE xxx NE
men G#multi_cell xxx G#multi_cell
showed NE xxx NE
equivalent NE xxx NE
levels NE xxx NE
: NE : NE
3 NE d NE
+/- NE +/- NE
1 NE d NE
, NE , NE
3 NE d NE
+/- NE +/- NE
2 NE d NE
and NE xxx NE
5 NE d NE
+/- NE +/- NE
4 NE d NE
fmol/mg NE xxx/xx NE
respectively NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
show NE xxx NE
that NE xxx NE
there NE xxx NE
is NE xx NE
no NE xx NE
evidence NE xxx NE
of NE xx NE
specific NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
progesterone G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
pregnancy G#other_name xxx G#other_name
and NE xxx NE
exclude NE xxx NE
any NE xxx NE
prognostic NE xxx NE
character NE xxx NE
in NE xx NE
spontaneous G#other_name_B xxx G#other_name_B
abortion G#other_name_E xxx G#other_name_E
. NE . NE

A NE X NE
role NE xxx NE
for NE xxx NE
the NE xxx NE
progesterone G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
the NE xxx NE
mechanism NE xxx NE
of NE xx NE
the NE xxx NE
known NE xxx NE
effect NE xxx NE
of NE xx NE
progesterone G#lipid xxx G#lipid
on NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
is NE xx NE
also NE xxx NE
excluded NE xxx NE
. NE . NE

Tolerance NE Xxxx NE
to NE xx NE
lipopolysaccharide G#lipid xxx G#lipid
involves NE xxx NE
mobilization NE xxx NE
of NE xx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
with NE xxx NE
predominance NE xxx NE
of NE xx NE
p50 G#protein_subunit xdd G#protein_subunit
homodimers NE xxx NE
. NE . NE

Stimulation NE Xxxx NE
of NE xx NE
the NE xxx NE
human G#cell_line_B xxx G#cell_line_B
monocytic G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
Mono G#cell_line_B Xxxx G#cell_line_B
Mac G#cell_line_M Xxx G#cell_line_M
6 G#cell_line_E d G#cell_line_E
with NE xxx NE
lipopolysaccharide G#lipid xxx G#lipid
( NE ( NE
LPS G#lipid XXX G#lipid
) NE ) NE
leads NE xxx NE
to NE xx NE
rapid NE xxx NE
and NE xxx NE
transient NE xxx NE
expression NE xxx NE
of NE xx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
like NE xxx NE
tumor G#protein_family_or_group_B xxx G#protein_family_or_group_B
necrosis G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
TNF G#protein_family_or_group XXX G#protein_family_or_group
) NE ) NE
. NE . NE

When NE Xxxx NE
such NE xxx NE
cells NE xxx NE
are NE xxx NE
precultured NE xxx NE
for NE xxx NE
2 NE d NE
days NE xxx NE
with NE xxx NE
a NE x NE
low NE xxx NE
dose NE xxx NE
of NE xx NE
LPS G#lipid XXX G#lipid
(20 NE (dd NE
ng/ml) NE xx/xx) NE
followed NE xxx NE
by NE xx NE
stimulation NE xxx NE
with NE xxx NE
a NE x NE
high NE xxx NE
dose NE xxx NE
of NE xx NE
LPS G#lipid XXX G#lipid
(1 NE (d NE
microgram/ml) NE xxx/xx) NE
, NE , NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
TNF G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
minimal NE xxx NE
, NE , NE
i.e NE x.x NE
. NE . NE
the NE xxx NE
cells NE xxx NE
are NE xxx NE
tolerant NE xxx NE
. NE . NE

In NE Xx NE
nuclear G#other_name_B xxx G#other_name_B
run-on G#other_name_M xxx-xx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
, NE , NE
such NE xxx NE
tolerant G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
show NE xxx NE
only NE xxx NE
a NE x NE
low NE xxx NE
degree NE xxx NE
of NE xx NE
transcription NE xxx NE
, NE , NE
indicating NE xxx NE
that NE xxx NE
tolerance NE xxx NE
operates NE xxx NE
at NE xx NE
or NE xx NE
upstream NE xxx NE
of NE xx NE
the NE xxx NE
transcription G#other_name_B xxx G#other_name_B
level G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
CD14 G#protein_molecule XXdd G#protein_molecule
LPS G#lipid XXX G#lipid
receptor NE xxx NE
is NE xx NE
, NE , NE
however NE xxx NE
, NE , NE
up-regulated NE xx-xxx NE
(not NE (xxx NE
down-regulated) NE xxx-xxx) NE
in NE xx NE
tolerant G#cell_line_B xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
and NE xxx NE
LPS G#lipid XXX G#lipid
can NE xxx NE
, NE , NE
in NE xx NE
fact NE xxx NE
, NE , NE
still NE xxx NE
lead NE xxx NE
to NE xx NE
activation NE xxx NE
of NE xx NE
tolerant G#cell_line_B xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
as NE xx NE
evidenced NE xxx NE
by NE xx NE
mobilization NE xxx NE
of NE xx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
) NE ) NE
. NE . NE

Resolution NE Xxxx NE
of NE xx NE
the NE xxx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_M X G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
in NE xx NE
gel NE xxx NE
shift NE xxx NE
analysis NE xxx NE
shows NE xxx NE
that NE xxx NE
the NE xxx NE
binding G#protein_family_or_group_B xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
mobilized NE xxx NE
in NE xx NE
naive G#cell_line_B xxx G#cell_line_B
Mono G#cell_line_M Xxxx G#cell_line_M
Mac G#cell_line_M Xxx G#cell_line_M
6 G#cell_line_M d G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
consists NE xxx NE
mainly NE xxx NE
of NE xx NE
p50 NE xdd NE
-p65 NE -xdd NE
heterodimers NE xxx NE
, NE , NE
while NE xxx NE
in NE xx NE
tolerant NE xxx NE
cells NE xxx NE
, NE , NE
the NE xxx NE
p50 NE xdd NE
homodimer NE xxx NE
is NE xx NE
predominant NE xxx NE
. NE . NE

This NE Xxxx NE
increase NE xxx NE
in NE xx NE
p50 G#protein_complex_B xdd G#protein_complex_B
homodimers G#protein_complex_E xxx G#protein_complex_E
coincides NE xxx NE
with NE xxx NE
an NE xx NE
increase NE xxx NE
in NE xx NE
p105 G#RNA_molecule_B xddd G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
, NE , NE
suggestive NE xxx NE
of NE xx NE
a NE x NE
transcriptional NE xxx NE
up-regulation NE xx-xxx NE
of NE xx NE
p50 G#protein_subunit xdd G#protein_subunit
. NE . NE

Reporter NE Xxxx NE
gene NE xxx NE
analysis NE xxx NE
reveals NE xxx NE
that NE xxx NE
the NE xxx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_M X G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
mobilized NE xxx NE
in NE xx NE
tolerant G#cell_line_B xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
is NE xx NE
functionally NE xxx NE
inactive NE xxx NE
in NE xx NE
that NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
-dependent NE -xxx NE
luciferase NE xxx NE
constructs NE xxx NE
containing NE xxx NE
the NE xxx NE
human NE xxx NE
immunodeficiency NE xxx NE
virus NE xxx NE
long NE xxx NE
terminal NE xxx NE
repeat NE xxx NE
or NE xx NE
the NE xxx NE
TNF NE XXX NE
5'-region NE d'-xxx NE
show NE xxx NE
only NE xxx NE
minimal NE xxx NE
transactivation NE xxx NE
after NE xxx NE
LPS NE XXX NE
stimulation NE xxx NE
. NE . NE

Similar NE Xxxx NE
to NE xx NE
Mono G#cell_line_B Xxxx G#cell_line_B
Mac G#cell_line_M Xxx G#cell_line_M
6 G#cell_line_M d G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
primary G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
monocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
when NE xxx NE
precultured NE xxx NE
with NE xxx NE
a NE x NE
low NE xxx NE
dose NE xxx NE
of NE xx NE
LPS G#lipid XXX G#lipid
, NE , NE
also NE xxx NE
become NE xxx NE
tolerant NE xxx NE
and NE xxx NE
produce NE xxx NE
little NE xxx NE
TNF G#protein_family_or_group XXX G#protein_family_or_group
after NE xxx NE
LPS G#other_name_B XXX G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
tolerant G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
monocytes G#cell_type_E xxx G#cell_type_E
also NE xxx NE
up-regulate NE xx-xxx NE
CD14 G#protein_molecule XXdd G#protein_molecule
, NE , NE
and NE xxx NE
they NE xxx NE
mobilize NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
with NE xxx NE
a NE x NE
predominance NE xxx NE
of NE xx NE
p50 G#protein_complex_B xdd G#protein_complex_B
homodimers G#protein_complex_E xxx G#protein_complex_E
. NE . NE

Taken NE Xxxx NE
together NE xxx NE
, NE , NE
these NE xxx NE
results NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
tolerance NE xxx NE
to NE xx NE
LPS G#lipid XXX G#lipid
is NE xx NE
determined NE xxx NE
by NE xx NE
post-receptor G#other_name_B xxx-xxx G#other_name_B
mechanisms G#other_name_E xxx G#other_name_E
that NE xxx NE
involve NE xxx NE
an NE xx NE
altered NE xxx NE
composition NE xxx NE
of NE xx NE
the NE xxx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_M X G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
. NE . NE

Analysis NE Xxxx NE
of NE xx NE
Oct2-isoform G#other_name_B Xxxd-xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
lipopolysaccharide NE xxx NE
-stimulated NE -xxx NE
B NE X NE
lymphocytes NE xxx NE
. NE . NE

Oct2-isoform G#other_name_B Xxxd-xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
splenic G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
stimulated NE xxx NE
with NE xxx NE
lipopolysaccharide G#lipid xxx G#lipid
or NE xx NE
lipopolysaccharide G#lipid xxx G#lipid
plus NE xxx NE
phorbol-di-butyrate G#other_artificial_source xxx-xx-xxx G#other_artificial_source
was NE xxx NE
analysed NE xxx NE
by NE xx NE
cDNA G#other_name_B xXXX G#other_name_B
cloning G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
frequency NE xxx NE
of NE xx NE
Oct2-positive G#cell_line_B Xxxd-xxx G#cell_line_B
clones G#cell_line_E xxx G#cell_line_E
was NE xxx NE
1/15,000 NE d/dd,ddd NE
in NE xx NE
both NE xxx NE
libraries NE xxx NE
. NE . NE

Two NE Xxx NE
new NE xxx NE
isoforms NE xxx NE
were NE xxx NE
found NE xxx NE
that NE xxx NE
generate NE xxx NE
novel NE xxx NE
amino-terminal G#protein_domain_or_region_B xxx-xxx G#protein_domain_or_region_B
sequence G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
or G#protein_domain_or_region_M xx G#protein_domain_or_region_M
carboxy-terminal G#protein_domain_or_region_M xxx-xxx G#protein_domain_or_region_M
sequence G#protein_domain_or_region_E xxx G#protein_domain_or_region_E

An NE Xx NE
isoform NE xxx NE
lacking NE xxx NE
exon G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
11 G#DNA_domain_or_region_E dd G#DNA_domain_or_region_E
destroyed NE xxx NE
the NE xxx NE
carboxy-terminal G#protein_domain_or_region_B xxx-xxx G#protein_domain_or_region_B
leucin-zipper G#protein_domain_or_region_M xxx-xxx G#protein_domain_or_region_M
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
and NE xxx NE
introduced NE xxx NE
a NE x NE
frame NE xxx NE
shift NE xxx NE
creating NE xxx NE
a NE x NE
novel NE xxx NE
, NE , NE
proline NE xxx NE
-rich NE -xxx NE
carboxy NE xxx NE
terminus NE xxx NE
. NE . NE

A NE X NE
new NE xxx NE
exon G#DNA_domain_or_region xxx G#DNA_domain_or_region
containing NE xxx NE
a NE x NE
highly NE xxx NE
basic NE xxx NE
region NE xxx NE
(4c) NE (dx) NE
was NE xxx NE
characterized NE xxx NE
, NE , NE
between G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
exons G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
4 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
5 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
. NE . NE

This NE Xxxx NE
exon NE xxx NE
was NE xxx NE
inserted NE xxx NE
between G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
glutamine-rich G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
regions G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
2 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
3 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
, NE , NE
carboxy G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
terminal G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
a NE x NE
tentative NE xxx NE
leucine-zipper G#protein_substructure_B xxx-xxx G#protein_substructure_B
structure G#protein_substructure_E xxx G#protein_substructure_E
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
a NE x NE
new NE xxx NE
combination NE xxx NE
isoform NE xxx NE
containing NE xxx NE
Oct2a NE Xxxdx NE
's NE 'x NE
amino NE xxx NE
terminal NE xxx NE
insert NE xxx NE
( NE ( NE
exon NE xxx NE
7a NE dx NE
) NE ) NE
and NE xxx NE
Oct2b NE Xxxdx NE
's NE 'x NE
carboxy NE xxx NE
terminal NE xxx NE
insert NE xxx NE
( NE ( NE
exon NE xxx NE
13 NE dd NE
) NE ) NE
was NE xxx NE
found NE xxx NE
that NE xxx NE
created NE xxx NE
a NE x NE
novel NE xxx NE
large NE xxx NE
isoform NE xxx NE
, NE , NE
Oct2ab NE Xxxdxx NE
. NE . NE

More NE Xxxx NE
frequent NE xxx NE
use NE xxx NE
of NE xx NE
the NE xxx NE
classical NE xxx NE
Oct2a G#protein_molecule Xxxdx G#protein_molecule
and NE xxx NE
Oct2b G#protein_molecule Xxxdx G#protein_molecule
isoforms NE xxx NE
was NE xxx NE
observed NE xxx NE
in NE xx NE
the NE xxx NE
lipopolysaccharide NE xxx NE
-stimulated NE -xxx NE
B NE X NE
cells NE xxx NE
, NE , NE
while NE xxx NE
a NE x NE
preference NE xxx NE
for NE xxx NE
the NE xxx NE
Oct2ab NE Xxxdxx NE
and NE xxx NE
Oct2ba NE Xxxdxx NE
isoforms NE xxx NE
was NE xxx NE
observed NE xxx NE
in NE xx NE
lipopolysaccharide NE xxx NE
plus NE xxx NE
phorbol-di-butyrate NE xxx-xx-xxx NE
-treated NE -xxx NE
cells NE xxx NE
. NE . NE

Positive NE Xxxx NE
regulators NE xxx NE
of NE xx NE
the NE xxx NE
lineage-specific NE xxx-xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
in NE xx NE
differentiating G#cell_type_B xxx G#cell_type_B
erythroid G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
zinc G#protein_family_or_group_B xxx G#protein_family_or_group_B
finger G#protein_family_or_group_M xxx G#protein_family_or_group_M
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
GATA-1 NE XXXX-d NE
is NE xx NE
a NE x NE
major NE xxx NE
regulator NE xxx NE
of NE xx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
erythroid G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
megakaryocyte G#cell_type_M xxx G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
mast G#cell_type_M xxx G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_E xxx G#cell_type_E

GATA-1 G#protein_molecule XXXX-d G#protein_molecule
binds NE xxx NE
to NE xx NE
WGATAR G#DNA_domain_or_region_B XXXXXX G#DNA_domain_or_region_B
consensus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
motifs G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
regulatory G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
regions G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
virtually NE xxx NE
all NE xxx NE
erythroid G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
cell-specific G#DNA_family_or_group_M xxx-xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

Analyses NE Xxxx NE
with NE xxx NE
cultured G#cell_line_B xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
cell-free G#other_name_B xxx-xxx G#other_name_B
systems G#other_name_E xxx G#other_name_E
have NE xxx NE
provided NE xxx NE
strong NE xxx NE
evidence NE xxx NE
that NE xxx NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
is NE xx NE
involved NE xxx NE
in NE xx NE
control NE xxx NE
of NE xx NE
globin G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
during NE xxx NE
erythroid G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

Targeted NE Xxxx NE
mutagenesis NE xxx NE
of NE xx NE
the NE xxx NE
GATA-1 G#DNA_domain_or_region_B XXXX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
embryonic G#cell_type_B xxx G#cell_type_B
stem G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
has NE xxx NE
demonstrated NE xxx NE
its NE xxx NE
requirement NE xxx NE
in NE xx NE
normal G#other_name_B xxx G#other_name_B
erythroid G#other_name_M xxx G#other_name_M
development G#other_name_E xxx G#other_name_E
. NE . NE

Efficient NE Xxxx NE
rescue NE xxx NE
of NE xx NE
the NE xxx NE
defect NE xxx NE
requires NE xxx NE
an NE xx NE
intact NE xxx NE
GATA G#DNA_domain_or_region_B XXXX G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
distal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
suggesting NE xxx NE
autoregulatory G#other_name_B xxx G#other_name_B
control G#other_name_E xxx G#other_name_E
of NE xx NE
GATA-1 G#other_name_B XXXX-d G#other_name_B
transcription G#other_name_E xxx G#other_name_E
. NE . NE

To NE Xx NE
examine NE xxx NE
whether NE xxx NE
GATA-1 G#other_name_B XXXX-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
involves NE xxx NE
additional NE xxx NE
regulatory G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
or NE xx NE
is NE xx NE
maintained NE xxx NE
entirely NE xxx NE
by NE xx NE
an NE xx NE
autoregulatory G#other_name_B xxx G#other_name_B
loop G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
have NE xxx NE
used NE xxx NE
a NE x NE
transient NE xxx NE
heterokaryon NE xxx NE
system NE xxx NE
to NE xx NE
test NE xxx NE
the NE xxx NE
ability NE xxx NE
of NE xx NE
erythroid G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
to NE xx NE
activate NE xxx NE
the NE xxx NE
GATA-1 G#DNA_domain_or_region_B XXXX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
nonerythroid G#cell_component_B xxx G#cell_component_B
nuclei G#cell_component_E xxx G#cell_component_E
. NE . NE

We NE Xx NE
show NE xxx NE
here NE xxx NE
that NE xxx NE
proerythroblasts G#cell_type xxx G#cell_type
and NE xxx NE
mature G#cell_type_B xxx G#cell_type_B
erythroid G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
contain NE xxx NE
a NE x NE
diffusible G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
( NE ( NE
TAG G#other_name XXX G#other_name
) NE ) NE
capable NE xxx NE
of NE xx NE
transcriptional G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
of NE xx NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
that NE xxx NE
this NE xxx NE
activity NE xxx NE
decreases NE xxx NE
during NE xxx NE
the NE xxx NE
terminal G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
of NE xx NE
erythroid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Nuclei G#cell_component Xxxx G#cell_component
from NE xxx NE
GATA-1 NE XXXX-d NE
-mutant NE -xxx NE
embryonic NE xxx NE
stem NE xxx NE
cells NE xxx NE
can NE xxx NE
still NE xxx NE
be NE xx NE
reprogrammed NE xxx NE
to NE xx NE
express NE xxx NE
their NE xxx NE
globin NE xxx NE
genes NE xxx NE
in NE xx NE
erythroid NE xxx NE
heterokaryons NE xxx NE
, NE , NE
indicating NE xxx NE
that NE xxx NE
de NE xx NE
novo NE xxx NE
induction NE xxx NE
of NE xx NE
GATA-1 NE XXXX-d NE
is NE xx NE
not NE xxx NE
required NE xxx NE
for NE xxx NE
globin NE xxx NE
gene NE xxx NE
activation NE xxx NE
following NE xxx NE
cell NE xxx NE
fusion NE xxx NE
. NE . NE

Role NE Xxxx NE
of NE xx NE
HIV-1 G#protein_molecule_B XXX-d G#protein_molecule_B
Nef G#protein_molecule_E Xxx G#protein_molecule_E
expression NE xxx NE
in NE xx NE
activation G#other_name_B xxx G#other_name_B
pathways G#other_name_E xxx G#other_name_E
in NE xx NE
CD4 G#protein_molecule XXd G#protein_molecule
+ NE + NE
T NE X NE
cells NE xxx NE
. NE . NE

The NE Xxx NE
role NE xxx NE
of NE xx NE
the NE xxx NE
human NE xxx NE
immunodeficiency NE xxx NE
virus NE xxx NE
( NE ( NE
HIV-1 NE XXX-d NE
) NE ) NE
Nef NE Xxx NE
protein NE xxx NE
in NE xx NE
T NE X NE
cell NE xxx NE
activation NE xxx NE
pathways NE xxx NE
was NE xxx NE
investigated NE xxx NE
using NE xxx NE
a NE x NE
Jurkat NE Xxxx NE
CD4 NE XXd NE
+ NE + NE
cell NE xxx NE
line NE xxx NE
stably NE xxx NE
transfected NE xxx NE
with NE xxx NE
a NE x NE
Nef NE Xxx NE
expression NE xxx NE
vector NE xxx NE
. NE . NE

Secretion NE Xxxx NE
of NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
, NE , NE
surface G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
IL-2R G#protein_molecule XX-dX G#protein_molecule
, NE , NE
and NE xxx NE
DNA-binding NE XXX-xxx NE
activity NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
AP-1 G#protein_complex_B XX-d G#protein_complex_B
(Fos/Jun) G#protein_complex_M (Xxx/Xxx) G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
in NE xx NE
response NE xxx NE
to NE xx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
myristate G#other_organic_compound_M xxx G#other_organic_compound_M
acetate G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
, NE , NE
or NE xx NE
immobilized NE xxx NE
antibodies NE xxx NE
to NE xx NE
CD3 G#protein_molecule XXd G#protein_molecule
were NE xxx NE
monitored NE xxx NE
. NE . NE

These NE Xxxx NE
parameters NE xxx NE
were NE xxx NE
not NE xxx NE
modified NE xxx NE
by NE xx NE
Nef G#other_name_B Xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
whereas NE xxx NE
stimulation NE xxx NE
with NE xxx NE
the NE xxx NE
same NE xxx NE
stimuli NE xxx NE
resulted NE xxx NE
in NE xx NE
partial NE xxx NE
inhibition NE xxx NE
of NE xx NE
LTR G#other_name_B XXX G#other_name_B
activation G#other_name_E xxx G#other_name_E
in NE xx NE
Nef NE Xxx NE
+ NE + NE
Jurkat NE Xxxx NE
cells NE xxx NE
. NE . NE

This NE Xxxx NE
inhibition NE xxx NE
was NE xxx NE
not NE xxx NE
mediated NE xxx NE
through NE xxx NE
Nef G#other_name_B Xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
on NE xx NE
Thr-15 G#amino_acid_monomer Xxx-dd G#amino_acid_monomer
or NE xx NE
GTP NE XXX NE
-binding NE -xxx NE
activity NE xxx NE
because NE xxx NE
mutations NE xxx NE
in NE xx NE
critical NE xxx NE
sites NE xxx NE
did NE xxx NE
not NE xxx NE
alter NE xxx NE
this NE xxx NE
inhibition NE xxx NE
. NE . NE

Analysis NE Xxxx NE
of NE xx NE
truncated NE xxx NE
LTRs G#DNA_domain_or_region XXXx G#DNA_domain_or_region
confirmed NE xxx NE
that NE xxx NE
inhibition NE xxx NE
of NE xx NE
LTR G#other_name_B XXX G#other_name_B
activation G#other_name_E xxx G#other_name_E
was NE xxx NE
not NE xxx NE
mediated NE xxx NE
through NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
-binding NE -xxx NE
activity NE xxx NE
but NE xxx NE
through NE xxx NE
the NE xxx NE
region NE xxx NE
containing NE xxx NE
the NE xxx NE
negative NE xxx NE
responding NE xxx NE
elements NE xxx NE
( NE ( NE
NREs NE XXXx NE
) NE ) NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
Nef G#protein_molecule Xxx G#protein_molecule
downmodulates NE xxx NE
LTR G#DNA_domain_or_region XXX G#DNA_domain_or_region
activation NE xxx NE
without NE xxx NE
significantly NE xxx NE
inhibiting NE xxx NE
the NE xxx NE
capacity NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
to NE xx NE
respond NE xxx NE
to NE xx NE
immunological G#other_name_B xxx G#other_name_B
activations G#other_name_E xxx G#other_name_E
. NE . NE

Tat-binding G#protein_molecule_B Xxx-xxx G#protein_molecule_B
protein G#protein_molecule_M xxx G#protein_molecule_M
7 G#protein_molecule_E d G#protein_molecule_E
is NE xx NE
a NE x NE
subunit NE xxx NE
of NE xx NE
the NE xxx NE
26S G#protein_complex_B ddX G#protein_complex_B
protease G#protein_complex_E xxx G#protein_complex_E
. NE . NE

Subunit G#protein_subunit_B Xxxx G#protein_subunit_B
6 G#protein_subunit_E d G#protein_subunit_E
( NE ( NE
S6 G#protein_subunit Xd G#protein_subunit
) NE ) NE
, NE , NE
an NE xx NE
integral NE xxx NE
component NE xxx NE
of NE xx NE
the NE xxx NE
26S G#protein_complex_B ddX G#protein_complex_B
protease G#protein_complex_E xxx G#protein_complex_E
from NE xxx NE
human G#cell_type_B xxx G#cell_type_B
erythrocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
has NE xxx NE
been NE xxx NE
studied NE xxx NE
by NE xx NE
SDS-PAGE G#other_name XXX-XXXX G#other_name
, NE , NE
peptide G#other_name_B xxx G#other_name_B
mapping G#other_name_E xxx G#other_name_E
and NE xxx NE
sequence G#other_name_B xxx G#other_name_B
analysis G#other_name_E xxx G#other_name_E
. NE . NE

S6 G#protein_subunit Xd G#protein_subunit
was NE xxx NE
cleaved NE xxx NE
with NE xxx NE
CNBr G#protein_molecule XXXx G#protein_molecule
and NE xxx NE
three NE xxx NE
internal G#peptide_B xxx G#peptide_B
peptides G#peptide_E xxx G#peptide_E
were NE xxx NE
sequenced NE xxx NE
. NE . NE

A NE X NE
comparison NE xxx NE
with NE xxx NE
known NE xxx NE
proteins NE xxx NE
in NE xx NE
Genbank G#other_name Xxxx G#other_name
revealed NE xxx NE
that NE xxx NE
all NE xxx NE
three NE xxx NE
S6 G#peptide_B Xd G#peptide_B
peptides G#peptide_E xxx G#peptide_E
match NE xxx NE
the NE xxx NE
predicted NE xxx NE
sequence NE xxx NE
of NE xx NE
TBP7 G#protein_molecule XXXd G#protein_molecule
, NE , NE
Tat-binding G#protein_molecule_B Xxx-xxx G#protein_molecule_B
protein G#protein_molecule_M xxx G#protein_molecule_M
7 G#protein_molecule_E d G#protein_molecule_E
. NE . NE

Based NE Xxxx NE
on NE xx NE
peptide NE xxx NE
matches NE xxx NE
covering NE xxx NE
more NE xxx NE
than NE xxx NE
10% NE dd% NE
of NE xx NE
the NE xxx NE
TBP7 G#protein_N/A_B XXXd G#protein_N/A_B
sequence G#protein_N/A_E xxx G#protein_N/A_E
, NE , NE
and NE xxx NE
the NE xxx NE
fact NE xxx NE
that NE xxx NE
the NE xxx NE
migration NE xxx NE
of NE xx NE
S6 G#protein_subunit Xd G#protein_subunit
on NE xx NE
SDS-PAGE G#other_name XXX-XXXX G#other_name
is NE xx NE
consistent NE xxx NE
with NE xxx NE
the NE xxx NE
estimated NE xxx NE
molecular NE xxx NE
mass NE xxx NE
for NE xxx NE
TBP7 G#protein_molecule XXXd G#protein_molecule
, NE , NE
we NE xx NE
conclude NE xxx NE
that NE xxx NE
subunit G#protein_subunit_B xxx G#protein_subunit_B
6 G#protein_subunit_E d G#protein_subunit_E
of NE xx NE
the NE xxx NE
26S G#protein_complex_B ddX G#protein_complex_B
protease G#protein_complex_E xxx G#protein_complex_E
is NE xx NE
TBP7 G#protein_molecule XXXd G#protein_molecule
. NE . NE

Hypoxia G#other_name Xxxx G#other_name
causes NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
through NE xxx NE
the NE xxx NE
phosphorylation NE xxx NE
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
on NE xx NE
tyrosine G#amino_acid_monomer_B xxx G#amino_acid_monomer_B
residues G#amino_acid_monomer_E xxx G#amino_acid_monomer_E
. NE . NE

The NE Xxx NE
response NE xxx NE
of NE xx NE
mammalian G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
to NE xx NE
stress NE xxx NE
is NE xx NE
controlled NE xxx NE
by NE xx NE
transcriptional G#protein_family_or_group_B xxx G#protein_family_or_group_B
regulatory G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
such NE xxx NE
as NE xx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
) NE ) NE
to NE xx NE
induce NE xxx NE
a NE x NE
wide NE xxx NE
variety NE xxx NE
of NE xx NE
early G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
response G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

In NE Xx NE
this NE xxx NE
report NE xxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
exposure NE xxx NE
of NE xx NE
cells NE xxx NE
to NE xx NE
hypoxia G#other_name xxx G#other_name
(0.02% NE (d.dd% NE
O2) NE Xd) NE
results NE xxx NE
in NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
degradation NE xxx NE
, NE , NE
increased NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
DNA G#other_name_M XXX G#other_name_M
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
transactivation NE xxx NE
of NE xx NE
a NE x NE
reporter G#DNA_molecule_B xxx G#DNA_molecule_B
gene G#DNA_molecule_M xxx G#DNA_molecule_M
construct G#DNA_molecule_E xxx G#DNA_molecule_E
containing NE xxx NE
two NE xxx NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
DNA G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Pretreatment NE Xxxx NE
of NE xx NE
cells NE xxx NE
with NE xxx NE
protein G#other_organic_compound_B xxx G#other_organic_compound_B
tyrosine G#other_organic_compound_M xxx G#other_organic_compound_M
kinase G#other_organic_compound_M xxx G#other_organic_compound_M
inhibitors G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
the NE xxx NE
dominant G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
negative G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
allele G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
c-Raf-1 G#DNA_domain_or_region x-Xxx-d G#DNA_domain_or_region
( NE ( NE
Raf G#protein_molecule_B Xxx G#protein_molecule_B
301 G#protein_molecule_E ddd G#protein_molecule_E
) NE ) NE
inhibited NE xxx NE
I G#other_name_B X G#other_name_B
kappa G#other_name_M xxx G#other_name_M
B G#other_name_M X G#other_name_M
alpha G#other_name_M xxx G#other_name_M
degradation G#other_name_E xxx G#other_name_E
, NE , NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
binding G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
transactivation NE xxx NE
of NE xx NE
kappa G#DNA_molecule_B xxx G#DNA_molecule_B
B G#DNA_molecule_M X G#DNA_molecule_M
reporter G#DNA_molecule_M xxx G#DNA_molecule_M
constructs G#DNA_molecule_E xxx G#DNA_molecule_E
by NE xx NE
hypoxia G#other_name xxx G#other_name
. NE . NE

To NE Xx NE
demonstrate NE xxx NE
a NE x NE
direct NE xxx NE
link NE xxx NE
between NE xxx NE
changes NE xxx NE
in NE xx NE
the NE xxx NE
phosphorylation NE xxx NE
pattern NE xxx NE
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
with NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
immunoprecipitated NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
after NE xxx NE
varying NE xxx NE
times NE xxx NE
of NE xx NE
hypoxic G#other_name_B xxx G#other_name_B
exposure G#other_name_E xxx G#other_name_E
and NE xxx NE
found NE xxx NE
that NE xxx NE
its NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_M xxx G#other_name_M
status G#other_name_E xxx G#other_name_E
increased NE xxx NE
during NE xxx NE
hypoxic G#other_name_B xxx G#other_name_B
exposure G#other_name_E xxx G#other_name_E
. NE . NE

Inhibition NE Xxxx NE
of NE xx NE
the NE xxx NE
transfer NE xxx NE
of NE xx NE
tyrosine G#amino_acid_monomer_B xxx G#amino_acid_monomer_B
phosphoryl G#amino_acid_monomer_M xxx G#amino_acid_monomer_M
groups G#amino_acid_monomer_E xxx G#amino_acid_monomer_E
onto NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
prevented NE xxx NE
I G#other_name_B X G#other_name_B
kappa G#other_name_M xxx G#other_name_M
B G#other_name_M X G#other_name_M
alpha G#other_name_M xxx G#other_name_M
degradation G#other_name_E xxx G#other_name_E
and NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
binding G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
comparison NE xxx NE
to NE xx NE
other NE xxx NE
activators NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
such NE xxx NE
as NE xx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
myristate G#other_organic_compound_M xxx G#other_organic_compound_M
acetate G#other_organic_compound_E xxx G#other_organic_compound_E
or NE xx NE
tumor G#protein_family_or_group_B xxx G#protein_family_or_group_B
necrosis G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
we NE xx NE
did NE xxx NE
not NE xxx NE
detect NE xxx NE
changes NE xxx NE
in NE xx NE
the NE xxx NE
tyrosine G#amino_acid_monomer xxx G#amino_acid_monomer
phosphorylation NE xxx NE
status NE xxx NE
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
following NE xxx NE
treatment NE xxx NE
with NE xxx NE
either NE xxx NE
of NE xx NE
these NE xxx NE
agents NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
tyrosine G#amino_acid_monomer xxx G#amino_acid_monomer
phosphorylation NE xxx NE
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
during NE xxx NE
hypoxia G#other_name xxx G#other_name
is NE xx NE
an NE xx NE
important NE xxx NE
proximal NE xxx NE
step NE xxx NE
which NE xxx NE
precedes NE xxx NE
its NE xxx NE
dissociation NE xxx NE
and NE xxx NE
degradation NE xxx NE
from NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
. NE . NE

Overproduction NE Xxxx NE
of NE xx NE
NFKB2 G#protein_molecule XXXXd G#protein_molecule
( NE ( NE
lyt-10 G#protein_molecule xxx-dd G#protein_molecule
) NE ) NE
and NE xxx NE
c-Rel G#protein_subunit x-Xxx G#protein_subunit
: NE : NE
a NE x NE
mechanism NE xxx NE
for NE xxx NE
HTLV-I NE XXXX-X NE
Tax NE Xxx NE
-mediated NE -xxx NE
trans-activation NE xxx-xxx NE
via NE xxx NE
the NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
signalling NE xxx NE
pathway NE xxx NE
. NE . NE

Molecular NE Xxxx NE
, NE , NE
biochemical NE xxx NE
and NE xxx NE
epidemiological NE xxx NE
evidence NE xxx NE
implicate NE xxx NE
HTLV-I G#virus XXXX-X G#virus
as NE xx NE
an NE xx NE
etiologic G#other_name_B xxx G#other_name_B
agent G#other_name_E xxx G#other_name_E
of NE xx NE
adult G#other_name_B xxx G#other_name_B
T G#other_name_M X G#other_name_M
cell G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
( NE ( NE
ATL G#other_name XXX G#other_name
) NE ) NE
. NE . NE

The NE Xxx NE
Tax G#protein_molecule_B Xxx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
of NE xx NE
HTLV-I G#virus XXXX-X G#virus
, NE , NE
a NE x NE
positive G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcriptional G#protein_family_or_group_M xxx G#protein_family_or_group_M
activator G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
HTLV-I G#other_name_B XXXX-X G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
, NE , NE
is NE xx NE
a NE x NE
viral NE xxx NE
oncogene NE xxx NE
that NE xxx NE
also NE xxx NE
increases NE xxx NE
transcription NE xxx NE
of NE xx NE
cellular G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
including NE xxx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
, NE , NE
IL-2R G#protein_molecule_B XX-dX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
. NE . NE

One NE Xxx NE
of NE xx NE
the NE xxx NE
cellular NE xxx NE
targets NE xxx NE
of NE xx NE
the NE xxx NE
trans-activating G#other_name_B xxx-xxx G#other_name_B
effects G#other_name_E xxx G#other_name_E
of NE xx NE
Tax NE Xxx NE
is NE xx NE
the NE xxx NE
NF-kappa G#protein_family_or_group_B XX-xxx G#protein_family_or_group_B
B G#protein_family_or_group_M X G#protein_family_or_group_M
/Rel G#protein_family_or_group_M /Xxx G#protein_family_or_group_M
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
pleiotropic G#protein_family_or_group_B xxx G#protein_family_or_group_B
regulators G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
immunoregulatory G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
cytokine G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
viral G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E

In NE Xx NE
this NE xxx NE
report NE xxx NE
, NE , NE
we NE xx NE
demonstrate NE xxx NE
that NE xxx NE
NFKB2 G#protein_molecule XXXXd G#protein_molecule
( NE ( NE
lyt-10 G#protein_molecule xxx-dd G#protein_molecule
) NE ) NE
and NE xxx NE
c-Rel G#protein_subunit x-Xxx G#protein_subunit
are NE xxx NE
overexpressed NE xxx NE
in NE xx NE
HTLV-I G#virus XXXX-X G#virus
infected NE xxx NE
and NE xxx NE
Tax-expressing G#cell_type_B Xxx-xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
, NE , NE
together NE xxx NE
, NE , NE
account NE xxx NE
for NE xxx NE
the NE xxx NE
majority NE xxx NE
of NE xx NE
the NE xxx NE
constitutive NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
binding NE xxx NE
activity NE xxx NE
in NE xx NE
these NE xxx NE
cells NE xxx NE
before NE xxx NE
and NE xxx NE
after NE xxx NE
PMA G#other_name_B XXX G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
. NE . NE

Most NE Xxxx NE
importantly NE xxx NE
, NE , NE
we NE xx NE
show NE xxx NE
a NE x NE
Tax NE Xxx NE
-dependent NE -xxx NE
correlation NE xxx NE
between NE xxx NE
expression NE xxx NE
of NE xx NE
NFKB2 NE XXXXd NE
( NE ( NE
p100 NE xddd NE
) NE ) NE
and NE xxx NE
processing NE xxx NE
to NE xx NE
the NE xxx NE
DNA NE XXX NE
binding NE xxx NE
NFKB2 NE XXXXd NE
( NE ( NE
p52 NE xdd NE
) NE ) NE
form NE xxx NE
, NE , NE
induction NE xxx NE
of NE xx NE
c-Rel NE x-Xxx NE
, NE , NE
and NE xxx NE
trans-activation NE xxx-xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
-mediated NE -xxx NE
gene NE xxx NE
expression NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
the NE xxx NE
NFKB2 G#protein_molecule XXXXd G#protein_molecule
precursor NE xxx NE
is NE xx NE
physically NE xxx NE
associated NE xxx NE
with NE xxx NE
c-Rel G#protein_subunit x-Xxx G#protein_subunit
and NE xxx NE
with NE xxx NE
Tax G#protein_molecule Xxx G#protein_molecule
in NE xx NE
HTLV-I G#cell_type_B XXXX-X G#cell_type_B
infected G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

We NE Xx NE
propose NE xxx NE
that NE xxx NE
NFKB2 G#other_name_B XXXXd G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
and NE xxx NE
processing NE xxx NE
allows NE xxx NE
continuous NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
an NE xx NE
otherwise NE xxx NE
cytoplasmic G#protein_family_or_group_B xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
, NE , NE
in NE xx NE
conjunction NE xxx NE
with NE xxx NE
overexpression G#other_name xxx G#other_name
of NE xx NE
c-Rel G#protein_subunit x-Xxx G#protein_subunit
, NE , NE
NFKB2 G#protein_molecule XXXXd G#protein_molecule
alters NE xxx NE
the NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
signalling G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
and NE xxx NE
contributes NE xxx NE
to NE xx NE
leukemic G#other_name_B xxx G#other_name_B
transformation G#other_name_E xxx G#other_name_E
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
HTLV-I G#virus XXXX-X G#virus
. NE . NE

Retinoic NE Xxxx NE
acid NE xxx NE
downmodulates NE xxx NE
erythroid NE xxx NE
differentiation NE xxx NE
and NE xxx NE
GATA1 G#other_name_B XXXXd G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
purified G#cell_line_B xxx G#cell_line_B
adult-progenitor G#cell_line_M xxx-xxx G#cell_line_M
culture G#cell_line_E xxx G#cell_line_E
. NE . NE

All-trans G#other_organic_compound_B Xxx-xxx G#other_organic_compound_B
retinoic G#other_organic_compound_M xxx G#other_organic_compound_M
acid G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
RA G#other_organic_compound XX G#other_organic_compound
) NE ) NE
is NE xx NE
an NE xx NE
important NE xxx NE
morphogen G#other_name xxx G#other_name
in NE xx NE
vertebrate NE xxx NE
development NE xxx NE
, NE , NE
a NE x NE
normal NE xxx NE
constituent NE xxx NE
in NE xx NE
human G#tissue_B xxx G#tissue_B
adult G#tissue_M xxx G#tissue_M
blood G#tissue_E xxx G#tissue_E
and NE xxx NE
is NE xx NE
also NE xxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
control NE xxx NE
of NE xx NE
cell NE xxx NE
growth NE xxx NE
and NE xxx NE
differentiation NE xxx NE
in NE xx NE
acute G#other_name_B xxx G#other_name_B
promyelocytic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
have NE xxx NE
examined NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
RA G#other_organic_compound XX G#other_organic_compound
on NE xx NE
normal G#other_name_B xxx G#other_name_B
hematopoiesis G#other_name_E xxx G#other_name_E
by NE xx NE
using NE xxx NE
early NE xxx NE
hematopoietic G#cell_type_B xxx G#cell_type_B
progenitor G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
HPC G#cell_type XXX G#cell_type
) NE ) NE
stringently NE xxx NE
purified NE xxx NE
from NE xxx NE
adult G#tissue_B xxx G#tissue_B
peripheral G#tissue_M xxx G#tissue_M
blood G#tissue_E xxx G#tissue_E
. NE . NE

In G#protein_molecule Xx G#protein_molecule
clonogenetic NE xxx NE
fetal NE xxx NE
calf NE xxx NE
serum NE xxx NE
clonogenetic G#cell_line_B xxx G#cell_line_B
fetal G#cell_line_M xxx G#cell_line_M
calf G#cell_line_M xxx G#cell_line_M
serum-supplemented G#cell_line_M xxx-xxx G#cell_line_M
(FCS+) G#cell_line_M (XXX+) G#cell_line_M
culture G#cell_line_M xxx G#cell_line_M
or G#cell_line_M xx G#cell_line_M
clonogenetic G#cell_line_M xxx G#cell_line_M
fetal G#cell_line_M xxx G#cell_line_M
calf G#cell_line_M xxx G#cell_line_M
serum-nonsupplemented G#cell_line_M xxx-xxx G#cell_line_M
(FCS-) G#cell_line_M (XXX-) G#cell_line_M
culture G#cell_line_E xxx G#cell_line_E
treated NE xxx NE
with NE xxx NE
saturating NE xxx NE
levels NE xxx NE
of NE xx NE
interleukin-3 NE xxx-d NE
( G#other_name ( G#other_name
IL-3 NE XX-d NE
) NE ) NE
granulocyte-macrophage G#protein_molecule_B xxx-xxx G#protein_molecule_B
colony-stimulating G#protein_molecule_M xxx-xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
) NE ) NE
and NE xxx NE
erythropoietin G#protein_molecule xxx G#protein_molecule
( NE ( NE
Ep G#protein_molecule Xx G#protein_molecule
) NE ) NE
(combined NE (xxx NE
with NE xxx NE
c-kit G#other_name_B x-xxx G#other_name_B
ligand G#other_name_E xxx G#other_name_E
in NE xx NE
FCS(-)-culture NE XXX(-)-xxx NE
conditions NE xxx NE
) NE ) NE
, NE , NE
RA G#other_organic_compound XX G#other_organic_compound
induces NE xxx NE
a NE x NE
dramatic NE xxx NE
dose-dependent NE xxx-xxx NE
shift NE xxx NE
from NE xxx NE
erythroid G#other_name xxx G#other_name
to NE xx NE
granulomonocytic G#other_name_B xxx G#other_name_B
colony G#other_name_M xxx G#other_name_M
formation G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
latter NE xxx NE
colonies NE xxx NE
being NE xxx NE
essentially NE xxx NE
represented NE xxx NE
by NE xx NE
granulocytic G#cell_line_B xxx G#cell_line_B
clones G#cell_line_E xxx G#cell_line_E
. NE . NE

This NE Xxxx NE
shift NE xxx NE
is NE xx NE
apparently NE xxx NE
not NE xxx NE
caused NE xxx NE
by NE xx NE
a NE x NE
recruitment NE xxx NE
phenomenon NE xxx NE
, NE , NE
because NE xxx NE
in NE xx NE
FCS+ G#cell_line_B XXX+ G#cell_line_B
culture G#cell_line_E xxx G#cell_line_E
, NE , NE
the NE xxx NE
total NE xxx NE
number NE xxx NE
of NE xx NE
colonies NE xxx NE
is NE xx NE
not NE xxx NE
significantly NE xxx NE
modified NE xxx NE
by NE xx NE
RA G#other_organic_compound XX G#other_organic_compound
addition NE xxx NE
. NE . NE

In NE Xx NE
FCS- G#cell_line_B XXX- G#cell_line_B
liquid-suspension G#cell_line_M xxx-xxx G#cell_line_M
culture G#cell_line_E xxx G#cell_line_E
supplemented NE xxx NE
with NE xxx NE
saturating NE xxx NE
Ep G#other_name_B Xx G#other_name_B
level G#other_name_E xxx G#other_name_E
and NE xxx NE
low-dose NE xxx-xxx NE
IL-3 NE XX-d NE
/GM-CSF NE /XX-XXX NE
, NE , NE
adult NE xxx NE
HPC NE XXX NE
undergo NE xxx NE
unilineage NE xxx NE
erythropoietic NE xxx NE
differentiation NE xxx NE
: NE : NE
Here NE Xxxx NE
again NE xxx NE
, NE , NE
treatment NE xxx NE
with NE xxx NE
high-dose NE xxx-xxx NE
RA NE XX NE
induces NE xxx NE
a NE x NE
shift NE xxx NE
from NE xxx NE
the NE xxx NE
erythroid NE xxx NE
to NE xx NE
granulocytic NE xxx NE
differentiation NE xxx NE
pathway NE xxx NE
. NE . NE

Studies NE Xxxx NE
on NE xx NE
RA G#other_organic_compound XX G#other_organic_compound
time-response NE xxx-xxx NE
or NE xx NE
pulse NE xxx NE
treatment NE xxx NE
in NE xx NE
semisolid NE xxx NE
or NE xx NE
liquid NE xxx NE
culture NE xxx NE
show NE xxx NE
that NE xxx NE
early NE xxx NE
RA G#other_name_B XX G#other_name_B
addition G#other_name_E xxx G#other_name_E
is NE xx NE
most NE xxx NE
effective NE xxx NE
, NE , NE
thus NE xxx NE
indicating NE xxx NE
that NE xxx NE
early NE xxx NE
but NE xxx NE
not NE xxx NE
late NE xxx NE
HPC G#cell_type XXX G#cell_type
are NE xxx NE
sensitive NE xxx NE
to NE xx NE
its NE xxx NE
action NE xxx NE
. NE . NE

We NE Xx NE
then NE xxx NE
analyzed NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
master G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
GATA1 G#DNA_domain_or_region_M XXXXd G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
which NE xxx NE
encodes NE xxx NE
a NE x NE
finger G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
required NE xxx NE
for NE xxx NE
normal NE xxx NE
erythroid NE xxx NE
development NE xxx NE
; NE ; NE
addition NE xxx NE
of NE xx NE
RA G#other_organic_compound XX G#other_organic_compound
to NE xx NE
HPC G#cell_type XXX G#cell_type
stimulated NE xxx NE
into NE xxx NE
unilineage NE xxx NE
erythropoietic G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
in NE xx NE
liquid NE xxx NE
culture NE xxx NE
caused NE xxx NE
a NE x NE
virtually NE xxx NE
complete NE xxx NE
inhibition NE xxx NE
of NE xx NE
GATA1 G#other_name_B XXXXd G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
induction G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
RA G#other_organic_compound XX G#other_organic_compound
directly NE xxx NE
inhibits NE xxx NE
the NE xxx NE
erythroid G#other_name_B xxx G#other_name_B
differentiation G#other_name_M xxx G#other_name_M
program G#other_name_E xxx G#other_name_E
at NE xx NE
the NE xxx NE
level NE xxx NE
of NE xx NE
early NE xxx NE
adult NE xxx NE
HPC G#cell_type XXX G#cell_type
, NE , NE
and NE xxx NE
may NE xxx NE
lead NE xxx NE
to NE xx NE
a NE x NE
shift NE xxx NE
from NE xxx NE
the NE xxx NE
erythroid NE xxx NE
to NE xx NE
granulocytic G#other_name_B xxx G#other_name_B
differentiation G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
. NE . NE

This NE Xxxx NE
phenomenon NE xxx NE
is NE xx NE
correlated NE xxx NE
with NE xxx NE
inhibition NE xxx NE
of NE xx NE
GATA1 G#other_name_B XXXXd G#other_name_B
induction G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
early NE xxx NE
stages NE xxx NE
of NE xx NE
erythropoietic G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

Induction NE Xxxx NE
of NE xx NE
phosphatidylinositol G#other_name_B xxx G#other_name_B
turnover G#other_name_E xxx G#other_name_E
and NE xxx NE
EGR-1 G#other_name_B XXX-d G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_E xxx G#other_name_E
by NE xx NE
crosslinking NE xxx NE
of NE xx NE
surface NE xxx NE
IgM G#protein_family_or_group XxX G#protein_family_or_group
and NE xxx NE
IgD G#protein_family_or_group XxX G#protein_family_or_group
in NE xx NE
the NE xxx NE
human G#cell_line_B xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
B104 G#cell_line_E Xddd G#cell_line_E
. NE . NE

We NE Xx NE
have NE xxx NE
previously NE xxx NE
shown NE xxx NE
that NE xxx NE
a NE x NE
human G#cell_line_B xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
lymphoma G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line, G#cell_line_M xxx, G#cell_line_M
B104 G#cell_line_E Xddd G#cell_line_E
, NE , NE
expressed NE xxx NE
surface G#protein_molecule_B xxx G#protein_molecule_B
IgM G#protein_molecule_E XxX G#protein_molecule_E
( NE ( NE
sIgM G#protein_molecule xXxX G#protein_molecule
) NE ) NE
and NE xxx NE
surface G#protein_molecule_B xxx G#protein_molecule_B
IgD G#protein_molecule_E XxX G#protein_molecule_E
( NE ( NE
sIgD G#protein_molecule xXxX G#protein_molecule
) NE ) NE
, NE , NE
and NE xxx NE
that NE xxx NE
crosslinking NE xxx NE
of NE xx NE
sIgM G#protein_molecule xXxX G#protein_molecule
and NE xxx NE
sIgD G#protein_molecule xXxX G#protein_molecule
by NE xx NE
anti- NE xxx- NE
IgM NE XxX NE
antibody NE xxx NE
(Ab) NE (Xx) NE
and NE xxx NE
anti- NE xxx- NE
IgD NE XxX NE
Ab NE Xx NE
, NE , NE
respectively NE xxx NE
, NE , NE
induced NE xxx NE
Ca2+ NE Xxd+ NE
influx NE xxx NE
to NE xx NE
almost NE xxx NE
the NE xxx NE
same NE xxx NE
degree NE xxx NE
, NE , NE
whereas NE xxx NE
only NE xxx NE
sIgM NE xXxX NE
-crosslinking NE -xxx NE
caused NE xxx NE
B104 NE Xddd NE
cell NE xxx NE
death NE xxx NE
. NE . NE

Here NE Xxxx NE
, NE , NE
we NE xx NE
investigated NE xxx NE
the NE xxx NE
accumulation NE xxx NE
of NE xx NE
cyclic G#nucleotide_B xxx G#nucleotide_B
AMP G#nucleotide_E XXX G#nucleotide_E
( NE ( NE
cAMP G#nucleotide xXXX G#nucleotide
) NE ) NE
, NE , NE
the NE xxx NE
hydrolysis NE xxx NE
of NE xx NE
inositol G#lipid_B xxx G#lipid_B
phosphates G#lipid_E xxx G#lipid_E
, NE , NE
protein G#other_name_B xxx G#other_name_B
kinase G#other_name_M xxx G#other_name_M
C G#other_name_M X G#other_name_M
( G#other_name_E ( G#other_name_E
PKC NE XXX NE
) NE ) NE
activity NE xxx NE
and NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
Egr-1 G#other_name_B Xxx-d G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
c-fos G#other_name_M x-xxx G#other_name_M
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_E xxx G#other_name_E
by NE xx NE
sIgM-crosslinking G#other_name_B xXxX-xxx G#other_name_B
and G#other_name_M xxx G#other_name_M
sIgD-crosslinking G#other_name_E xXxX-xxx G#other_name_E
to NE xx NE
examine NE xxx NE
differences NE xxx NE
in NE xx NE
the NE xxx NE
signals NE xxx NE
mediated NE xxx NE
through NE xxx NE
sIgM G#protein_molecule xXxX G#protein_molecule
and NE xxx NE
sIgD G#protein_molecule xXxX G#protein_molecule
in NE xx NE
B104 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Both NE Xxxx NE
sIgM-crosslinking G#other_name_B xXxX-xxx G#other_name_B
and G#other_name_M xxx G#other_name_M
sIgD-crosslinking G#other_name_E xXxX-xxx G#other_name_E
sIgM- G#other_name xXxX- G#other_name
with NE xxx NE
antibodies NE xxx NE
induced NE xxx NE
elevation NE xxx NE
of NE xx NE
cAMP G#other_name_B xXXX G#other_name_B
levels G#other_name_E xxx G#other_name_E
, NE , NE
phosphatidylinositol G#other_name_B xxx G#other_name_B
turnover G#other_name_E xxx G#other_name_E
, NE , NE
PKC G#other_name_B XXX G#other_name_B
activation G#other_name_E xxx G#other_name_E
and NE xxx NE
expression NE xxx NE
of NE xx NE
Egr-1 G#RNA_molecule_B Xxx-d G#RNA_molecule_B
mRNA G#RNA_molecule_M xXXX G#RNA_molecule_M
and G#RNA_molecule_M xxx G#RNA_molecule_M
c-fos G#RNA_molecule_M x-xxx G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
sIgM NE xXxX NE
-crosslinking G#other_name -xxx G#other_name
was NE xxx NE
more NE xxx NE
effective NE xxx NE
than NE xxx NE
sIgD G#protein_molecule xXxX G#protein_molecule
-crosslinking NE -xxx NE
, NE , NE
presumably NE xxx NE
due NE xxx NE
to NE xx NE
the NE xxx NE
higher NE xxx NE
expression NE xxx NE
of NE xx NE
sIgM G#protein_molecule xXxX G#protein_molecule
than NE xxx NE
of NE xx NE
sIgD NE xXxX NE
. NE . NE

Egr-1 G#other_name_B Xxx-d G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_E xxx G#other_name_E
induced NE xxx NE
by NE xx NE
sIgM-crosslinking G#other_name_B xXxX-xxx G#other_name_B
and G#other_name_M xxx G#other_name_M
sIgD-crosslinking G#other_name_E xXxX-xxx G#other_name_E
was NE xxx NE
inhibited NE xxx NE
by NE xx NE
H7 G#protein_molecule Xd G#protein_molecule
, NE , NE
erbstatin G#other_organic_compound xxx G#other_organic_compound
and NE xxx NE
genistein G#other_organic_compound xxx G#other_organic_compound
, NE , NE
but NE xxx NE
not NE xxx NE
by NE xx NE
HA1004 G#other_organic_compound XXdddd G#other_organic_compound
. NE . NE

Erbstatin NE Xxxx NE
and NE xxx NE
genistein G#other_organic_compound xxx G#other_organic_compound
inhibited NE xxx NE
the NE xxx NE
sIg-crosslinking-induced G#other_organic_compound_B xXx-xxx-xxx G#other_organic_compound_B
Egr-1 G#other_organic_compound_M Xxx-d G#other_organic_compound_M
mRNA G#other_organic_compound_M xXXX G#other_organic_compound_M
expression G#other_organic_compound_E xxx G#other_organic_compound_E
in NE xx NE
a NE x NE
dose-dependent NE xxx-xxx NE
manner NE xxx NE
parallel NE xxx NE
to NE xx NE
that NE xxx NE
observed NE xxx NE
in NE xx NE
the NE xxx NE
inhibition NE xxx NE
of NE xx NE
sIg-crosslinking-induced NE xXx-xxx-xxx NE
protein NE xxx NE
tyrosine NE xxx NE
phosphorylation NE xxx NE
. NE . NE

Phorbol NE Xxxx NE
myristate NE xxx NE
acetate NE xxx NE
induced NE xxx NE
Egr-1 G#other_name_B Xxx-d G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_E xxx G#other_name_E
but NE xxx NE
forskolin NE xxx NE
and NE xxx NE
dibutyryl NE xxx NE
cyclic G#nucleotide_B xxx G#nucleotide_B
AMP G#nucleotide_E XXX G#nucleotide_E
did NE xxx NE
not NE xxx NE
. NE . NE

These NE Xxxx NE
findings NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
Egr-1 G#RNA_molecule_B Xxx-d G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
activating NE xxx NE
signals NE xxx NE
through NE xxx NE
sIgM G#protein_molecule xXxX G#protein_molecule
and NE xxx NE
sIgD G#protein_molecule xXxX G#protein_molecule
are NE xxx NE
protein G#other_name_B xxx G#other_name_B
tyrosine G#other_name_M xxx G#other_name_M
kinase-dependent G#other_name_M xxx-xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
PKC-dependent G#other_name_E XXX-xxx G#other_name_E
protein NE xxx NE
kinase NE xxx NE
A NE X NE
-independent G#other_name -xxx G#other_name
. NE . NE

Cyclosporin G#other_organic_compound_B Xxxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
( NE ( NE
CsA G#other_organic_compound XxX G#other_organic_compound
) NE ) NE
and NE xxx NE
FK506 G#other_organic_compound XXddd G#other_organic_compound
rescued NE xxx NE
B104 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
from NE xxx NE
death NE xxx NE
induced NE xxx NE
by NE xx NE
anti-IgM G#protein_molecule_B xxx-XxX G#protein_molecule_B
Ab G#protein_molecule_E Xx G#protein_molecule_E
, NE , NE
but NE xxx NE
did NE xxx NE
not NE xxx NE
affect NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
Egr-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
c-fos G#RNA_molecule_B x-xxx G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
, NE , NE
showing NE xxx NE
that NE xxx NE
CsA G#other_organic_compound XxX G#other_organic_compound
and NE xxx NE
FK506 G#other_organic_compound XXddd G#other_organic_compound
affect NE xxx NE
signal NE xxx NE
transducers NE xxx NE
differently NE xxx NE
from NE xxx NE
or NE xx NE
downstream NE xxx NE
to NE xx NE
these NE xxx NE
molecules NE xxx NE
. NE . NE

The NE Xxx NE
difference NE xxx NE
in NE xx NE
signals NE xxx NE
transduced NE xxx NE
through NE xxx NE
sIgM G#protein_molecule xXxX G#protein_molecule
and NE xxx NE
sIgD G#protein_molecule xXxX G#protein_molecule
in NE xx NE
B104 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
is NE xx NE
discussed NE xxx NE
. NE . NE

Direct NE Xxxx NE
exposure NE xxx NE
to NE xx NE
2,3,7,8-tetrachlorodibenzo-p-dioxin G#other_organic_compound d,d,d,d-xxx-x-xxx G#other_organic_compound
( NE ( NE
TCDD G#other_organic_compound XXXX G#other_organic_compound
) NE ) NE
increases NE xxx NE
infectivity NE xxx NE
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
erythrocytes G#cell_type_E xxx G#cell_type_E
to NE xx NE
a NE x NE
malarial G#mono_cell_B xxx G#mono_cell_B
parasite G#mono_cell_E xxx G#mono_cell_E
. NE . NE

Direct NE Xxxx NE
exposure NE xxx NE
to NE xx NE
10 NE dd NE
nM NE xX NE
2,3,7,8-TCDD G#other_organic_compound d,d,d,d-XXXX G#other_organic_compound
caused NE xxx NE
a NE x NE
75% NE dd% NE
increase NE xxx NE
and NE xxx NE
a NE x NE
2-fold NE d-xxx NE
increase NE xxx NE
in NE xx NE
the NE xxx NE
infectivity NE xxx NE
of NE xx NE
isolated NE xxx NE
human G#cell_type_B xxx G#cell_type_B
erythrocytes G#cell_type_E xxx G#cell_type_E
to NE xx NE
P. G#mono_cell_B X. G#mono_cell_B
falciparum G#mono_cell_E xxx G#mono_cell_E
after NE xxx NE
48 NE dd NE
hours NE xxx NE
when NE xxx NE
the NE xxx NE
parasites G#mono_cell xxx G#mono_cell
were NE xxx NE
in NE xx NE
an NE xx NE
unsynchronized NE xxx NE
or NE xx NE
synchronized NE xxx NE
state NE xxx NE
of NE xx NE
growth NE xxx NE
, NE , NE
respectively NE xxx NE
. NE . NE

Treatment NE Xxxx NE
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
erythrocytes G#cell_type_E xxx G#cell_type_E
with NE xxx NE
10 NE dd NE
microM NE xxxX NE
sodium G#other_organic_compound_B xxx G#other_organic_compound_B
orthovanadate G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
NaOV G#other_organic_compound XxXX G#other_organic_compound
) NE ) NE
, NE , NE
an NE xx NE
inhibitor NE xxx NE
of NE xx NE
plasma G#protein_complex_B xxx G#protein_complex_B
membrane G#protein_complex_M xxx G#protein_complex_M
Ca-ATPase G#protein_complex_E Xx-XXXxxx G#protein_complex_E
and NE xxx NE
phosphotyrosine G#protein_molecule_B xxx G#protein_molecule_B
phosphatase G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
decreased NE xxx NE
parasitemia G#other_name xxx G#other_name
by NE xx NE
30% NE dd% NE
. NE . NE

Co-treatment NE Xx-xxx NE
of NE xx NE
RBCs G#cell_type XXXx G#cell_type
with NE xxx NE
TCDD NE XXXX NE
and NE xxx NE
NaOV NE XxXX NE
completely NE xxx NE
blocked NE xxx NE
the NE xxx NE
TCDD NE XXXX NE
-induced NE -xxx NE
increase NE xxx NE
in NE xx NE
parasitemia NE xxx NE
. NE . NE

Because NE Xxxx NE
erythrocytes G#cell_type xxx G#cell_type
are NE xxx NE
anucleated NE xxx NE
, NE , NE
these NE xxx NE
results NE xxx NE
are NE xxx NE
discussed NE xxx NE
as NE xx NE
evidence NE xxx NE
for NE xxx NE
biochemical NE xxx NE
changes NE xxx NE
by NE xx NE
TCDD G#other_organic_compound XXXX G#other_organic_compound
without NE xxx NE
requiring NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
gene G#protein_family_or_group_B xxx G#protein_family_or_group_B
products G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Evidence NE Xxxx NE
for NE xxx NE
a NE x NE
trans-acting G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
activator G#protein_family_or_group_E xxx G#protein_family_or_group_E
function NE xxx NE
regulating NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
human G#protein_molecule_B xxx G#protein_molecule_B
CD5 G#protein_molecule_M XXd G#protein_molecule_M
antigen G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Interspecies NE Xxxx NE
somatic G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
hybrids G#cell_line_E xxx G#cell_line_E
were NE xxx NE
generated NE xxx NE
by NE xx NE
fusing NE xxx NE
the NE xxx NE
mouse G#cell_line_B xxx G#cell_line_B
T-lymphoma G#cell_line_M X-xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
BW5147 G#cell_line XXdddd G#cell_line
, NE , NE
with NE xxx NE
normal G#cell_type_B xxx G#cell_type_B
human G#cell_type_M xxx G#cell_type_M
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
at NE xx NE
different NE xxx NE
stages NE xxx NE
of NE xx NE
differentiation G#other_name xxx G#other_name
. NE . NE

Thymocytes G#cell_type Xxxx G#cell_type
, NE , NE
activated G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
or NE xx NE
an NE xx NE
activated G#cell_line_B xxx G#cell_line_B
T-cell G#cell_line_M X-xxx G#cell_line_M
clone G#cell_line_E xxx G#cell_line_E
were NE xxx NE
used NE xxx NE
as NE xx NE
human G#other_name_B xxx G#other_name_B
partners G#other_name_E xxx G#other_name_E
, NE , NE
respectively NE xxx NE
, NE , NE
in NE xx NE
three NE xxx NE
independent NE xxx NE
fusions NE xxx NE
. NE . NE

Irrespective NE Xxxx NE
of NE xx NE
the NE xxx NE
human G#other_name_B xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
partner G#other_name_E xxx G#other_name_E
used NE xxx NE
for NE xxx NE
fusion NE xxx NE
, NE , NE
a NE x NE
certain NE xxx NE
number NE xxx NE
of NE xx NE
hybrids G#cell_line xxx G#cell_line
lost NE xxx NE
CD5 G#other_name_B XXd G#other_name_B
surface G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
over NE xxx NE
a NE x NE
period NE xxx NE
of NE xx NE
time NE xxx NE
in NE xx NE
culture NE xxx NE
. NE . NE

Analysis NE Xxxx NE
at NE xx NE
the NE xxx NE
phenotype NE xxx NE
and NE xxx NE
genetic NE xxx NE
level NE xxx NE
showed NE xxx NE
that NE xxx NE
lack NE xxx NE
of NE xx NE
CD5 G#other_name_B XXd G#other_name_B
expression G#other_name_E xxx G#other_name_E
was NE xxx NE
due NE xxx NE
neither NE xxx NE
to NE xx NE
segregation NE xxx NE
of NE xx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
autosome G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
11 G#DNA_domain_or_region_E dd G#DNA_domain_or_region_E
, NE , NE
on NE xx NE
which NE xxx NE
the NE xxx NE
CD5 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
has NE xxx NE
been NE xxx NE
mapped NE xxx NE
, NE , NE
nor NE xxx NE
to NE xx NE
deletion NE xxx NE
of NE xx NE
the NE xxx NE
CD5 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
structural G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
loss NE xxx NE
of NE xx NE
CD5 G#other_name_B XXd G#other_name_B
surface G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
correlated NE xxx NE
with NE xxx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
specific NE xxx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
. NE . NE

Since NE Xxxx NE
these NE xxx NE
hybrids NE xxx NE
preferentially NE xxx NE
segregate NE xxx NE
human NE xxx NE
chromosomes NE xxx NE
, NE , NE
these NE xxx NE
results NE xxx NE
indicate NE xxx NE
the NE xxx NE
existence NE xxx NE
of NE xx NE
a NE x NE
non-syntenic G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
trans-active G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
locus G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
or NE xx NE
loci NE xxx NE
, NE , NE
positively NE xxx NE
controlling NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
CD5 G#DNA_domain_or_region_M XXd G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Induction NE Xxxx NE
of NE xx NE
the NE xxx NE
CD11b G#DNA_domain_or_region_B XXddx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
during NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
monocytic G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
U937 G#cell_line_E Xddd G#cell_line_E
requires NE xxx NE
a NE x NE
novel NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
MS-2 G#protein_molecule XX-d G#protein_molecule
[published NE [xxx NE
erratum NE xxx NE
appears NE xxx NE
in NE xx NE
J NE X NE
Immunol NE Xxxx NE
1999 NE dddd NE
Jul NE Xxx NE
15;163(2):1091] NE dd;ddd(d):dddd] NE

The NE Xxx NE
differentiation NE xxx NE
of NE xx NE
myeloid G#cell_type_B xxx G#cell_type_B
precursors G#cell_type_E xxx G#cell_type_E
into NE xxx NE
mature NE xxx NE
myelomonocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
is NE xx NE
characterized NE xxx NE
by NE xx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
gene NE xxx NE
encoding NE xxx NE
the NE xxx NE
beta2 G#protein_family_or_group_B xxxd G#protein_family_or_group_B
integrin G#protein_family_or_group_E xxx G#protein_family_or_group_E
CD11b G#protein_molecule XXddx G#protein_molecule
. NE . NE

The NE Xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
Sp1 G#protein_molecule Xxd G#protein_molecule
and NE xxx NE
PU.1 G#protein_molecule_B XX.d G#protein_molecule_B
prime G#protein_molecule_E xxx G#protein_molecule_E
the NE xxx NE
CD11b G#DNA_domain_or_region_B XXddx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
but NE xxx NE
the NE xxx NE
nature NE xxx NE
of NE xx NE
the NE xxx NE
factors NE xxx NE
responsible NE xxx NE
for NE xxx NE
its NE xxx NE
inducible NE xxx NE
expression NE xxx NE
are NE xxx NE
unknown NE xxx NE
. NE . NE

In NE Xx NE
addition NE xxx NE
to NE xx NE
the NE xxx NE
CD11b G#DNA_domain_or_region_B XXddx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
the NE xxx NE
homologous NE xxx NE
genes NE xxx NE
encoding NE xxx NE
CD11a G#protein_molecule XXddx G#protein_molecule
and NE xxx NE
CD11c G#protein_molecule XXddx G#protein_molecule
also NE xxx NE
exhibit NE xxx NE
inducible NE xxx NE
expression NE xxx NE
during NE xxx NE
myeloid G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

Therefore NE Xxxx NE
, NE , NE
we NE xx NE
compared NE xxx NE
the NE xxx NE
nucleotide G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sequences G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
CD11a G#DNA_domain_or_region_B XXddx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
CD11b G#DNA_domain_or_region_M XXddx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
CD11c G#DNA_domain_or_region_M XXddx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
to NE xx NE
identify NE xxx NE
common NE xxx NE
elements NE xxx NE
that NE xxx NE
might NE xxx NE
contribute NE xxx NE
to NE xx NE
inducible G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

This NE Xxxx NE
analysis NE xxx NE
identified NE xxx NE
one NE xxx NE
such NE xxx NE
element NE xxx NE
repeated NE xxx NE
four NE xxx NE
times NE xxx NE
within NE xxx NE
the NE xxx NE
CD11b G#DNA_domain_or_region_B XXddx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Mutation NE Xxxx NE
of NE xx NE
these NE xxx NE
elements NE xxx NE
indicated NE xxx NE
that NE xxx NE
two NE xxx NE
, NE , NE
MS-2beta G#protein_molecule XX-dxxx G#protein_molecule
and NE xxx NE
MS-2gamma G#protein_molecule XX-dxxx G#protein_molecule
, NE , NE
are NE xxx NE
critical NE xxx NE
to NE xx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
CD11b G#DNA_domain_or_region_B XXddx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
during NE xxx NE
differentiation NE xxx NE
of NE xx NE
the NE xxx NE
pro-monocytic G#cell_line_B xxx-xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
U937 G#cell_line_E Xddd G#cell_line_E
. NE . NE

Electrophoretic G#other_name_B Xxxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
indicate NE xxx NE
that NE xxx NE
MS-2beta G#protein_molecule XX-dxxx G#protein_molecule
and NE xxx NE
MS-2gamma G#protein_molecule XX-dxxx G#protein_molecule
interact NE xxx NE
with NE xxx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factors G#protein_molecule_E xxx G#protein_molecule_E
that NE xxx NE
are NE xxx NE
induced NE xxx NE
during NE xxx NE
U937 G#other_name_B Xddd G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
factors NE xxx NE
are NE xxx NE
detected NE xxx NE
at NE xx NE
the NE xxx NE
time NE xxx NE
the NE xxx NE
CD11b G#DNA_domain_or_region_B XXddx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
activated NE xxx NE
. NE . NE

The NE Xxx NE
molecular G#other_name_B xxx G#other_name_B
mass G#other_name_E xxx G#other_name_E
of NE xx NE
these NE xxx NE
factors NE xxx NE
is NE xx NE
approximately NE xxx NE
28 G#other_name_B dd G#other_name_B
kDa G#other_name_E xXx G#other_name_E
, NE , NE
and NE xxx NE
their NE xxx NE
DNA NE XXX NE
binding NE xxx NE
characteristics NE xxx NE
are NE xxx NE
indistinguishable NE xxx NE
from NE xxx NE
those NE xxx NE
of NE xx NE
the NE xxx NE
novel NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
MS-2 G#protein_molecule XX-d G#protein_molecule
. NE . NE

Taken NE Xxxx NE
together NE xxx NE
, NE , NE
our NE xxx NE
data NE xxx NE
indicate NE xxx NE
that NE xxx NE
MS-2 G#protein_molecule XX-d G#protein_molecule
mediates NE xxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
CD11b G#DNA_domain_or_region_B XXddx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
as NE xx NE
cells NE xxx NE
of NE xx NE
the NE xxx NE
monocytic NE xxx NE
lineage NE xxx NE
mature NE xxx NE
. NE . NE

The NE Xxx NE
presence NE xxx NE
of NE xx NE
multiple NE xxx NE
potential NE xxx NE
binding NE xxx NE
sites NE xxx NE
for NE xxx NE
MS-2 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
the NE xxx NE
promoter NE xxx NE
regions NE xxx NE
of NE xx NE
a NE x NE
wide NE xxx NE
range NE xxx NE
of NE xx NE
genes NE xxx NE
expressed NE xxx NE
in NE xx NE
mature G#cell_type_B xxx G#cell_type_B
myeloid G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
suggests NE xxx NE
this NE xxx NE
factor NE xxx NE
plays NE xxx NE
a NE x NE
general NE xxx NE
role NE xxx NE
in NE xx NE
myeloid G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

Acetylsalicylic G#other_organic_compound_B Xxxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
sodium G#other_organic_compound_B xxx G#other_organic_compound_B
salicylate G#other_organic_compound_E xxx G#other_organic_compound_E
inhibit NE xxx NE
LPS NE XXX NE
-induced NE -xxx NE
NF-kappa NE XX-xxx NE
B/c-Rel NE X/x-Xxx NE
nuclear NE xxx NE
translocation NE xxx NE
, NE , NE
and NE xxx NE
synthesis NE xxx NE
of NE xx NE
tissue NE xxx NE
factor NE xxx NE
( NE ( NE
TF NE XX NE
) NE ) NE
and NE xxx NE
tumor NE xxx NE
necrosis NE xxx NE
factor NE xxx NE
alfa NE xxx NE
( NE ( NE
TNF-alpha NE XXX-xxx NE
) NE ) NE
in NE xx NE
human NE xxx NE
monocytes NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
investigated NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
acetylsalicylic G#other_organic_compound_B xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
sodium G#other_organic_compound_B xxx G#other_organic_compound_B
salicylate G#other_organic_compound_E xxx G#other_organic_compound_E
on NE xx NE
the NE xxx NE
LPS G#lipid XXX G#lipid
-induced NE -xxx NE
synthesis NE xxx NE
of NE xx NE
the NE xxx NE
pro-coagulant NE xxx-xxx NE
protein NE xxx NE
tissue NE xxx NE
factor NE xxx NE
(TF) NE (XX) NE
and NE xxx NE
the NE xxx NE
pro-inflammatory NE xxx-xxx NE
protein NE xxx NE
tumor NE xxx NE
necrosis NE xxx NE
factor-alpha NE xxx-xxx NE
( NE ( NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
) NE ) NE
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
the NE xxx NE
prostaglandin G#protein_molecule_B xxx G#protein_molecule_B
PGE2 G#protein_molecule_E XXXd G#protein_molecule_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

Both NE Xxxx NE
drugs NE xxx NE
dose-dependently NE xxx-xxx NE
inhibited NE xxx NE
LPS NE XXX NE
-induced NE -xxx NE
TF NE XX NE
and NE xxx NE
TNF-alpha NE XXX-xxx NE
synthesis NE xxx NE
at NE xx NE
the NE xxx NE
mRNA NE xXXX NE
and NE xxx NE
the NE xxx NE
protein NE xxx NE
level NE xxx NE
, NE , NE
and NE xxx NE
reduced NE xxx NE
PGE2 NE XXXd NE
production NE xxx NE
. NE . NE

As NE Xx NE
evidenced NE xxx NE
by NE xx NE
electro G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
( NE ( NE
EMSA G#other_name XXXX G#other_name
) NE ) NE
and NE xxx NE
the NE xxx NE
use NE xxx NE
of NE xx NE
a NE x NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
prototypic G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
probe G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
these NE xxx NE
drugs NE xxx NE
probably NE xxx NE
exert NE xxx NE
their NE xxx NE
inhibitory NE xxx NE
effects NE xxx NE
by NE xx NE
interference NE xxx NE
with NE xxx NE
the NE xxx NE
nuclear NE xxx NE
translocation NE xxx NE
of NE xx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B/c-Rel G#protein_complex_M X/x-Xxx G#protein_complex_M
proteins G#protein_complex_E xxx G#protein_complex_E
. NE . NE

These NE Xxxx NE
data NE xxx NE
may NE xxx NE
expand NE xxx NE
the NE xxx NE
understanding NE xxx NE
of NE xx NE
the NE xxx NE
anti-thrombotic NE xxx-xxx NE
and NE xxx NE
anti-inflammatory NE xxx-xxx NE
effects NE xxx NE
of NE xx NE
these NE xxx NE
drugs NE xxx NE
when NE xxx NE
activation NE xxx NE
of NE xx NE
monocytes NE xxx NE
occurs NE xxx NE
. NE . NE

Interferon NE Xxxx NE
augments NE xxx NE
PML G#protein_molecule XXX G#protein_molecule
and NE xxx NE
PML/RAR G#other_name_B XXX/XXX G#other_name_B
alpha G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
normal NE xxx NE
myeloid NE xxx NE
and NE xxx NE
acute NE xxx NE
promyelocytic NE xxx NE
cells NE xxx NE
and NE xxx NE
cooperates NE xxx NE
with NE xxx NE
all-trans NE xxx-xxx NE
retinoic NE xxx NE
acid NE xxx NE
to NE xx NE
induce NE xxx NE
maturation NE xxx NE
of NE xx NE
a NE x NE
retinoid-resistant NE xxx-xxx NE
promyelocytic NE xxx NE
cell NE xxx NE
line NE xxx NE
. NE . NE

The NE Xxx NE
PML G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
fused NE xxx NE
to NE xx NE
the NE xxx NE
retinoic G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
acid G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
RAR G#DNA_molecule_B XXX G#DNA_molecule_B
alpha G#DNA_molecule_E xxx G#DNA_molecule_E
) NE ) NE
in NE xx NE
the NE xxx NE
acute G#other_name_B xxx G#other_name_B
promyelocytic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
( NE ( NE
APL G#other_name XXX G#other_name
) NE ) NE
15 NE dd NE
; NE ; NE
17 NE dd NE
translocation NE xxx NE
. NE . NE

PML G#protein_molecule XXX G#protein_molecule
is NE xx NE
expressed NE xxx NE
in NE xx NE
diverse NE xxx NE
tissues NE xxx NE
and NE xxx NE
cell NE xxx NE
lines NE xxx NE
and NE xxx NE
localized NE xxx NE
in NE xx NE
the NE xxx NE
nucleus NE xxx NE
with NE xxx NE
a NE x NE
typical NE xxx NE
speckled NE xxx NE
pattern NE xxx NE
. NE . NE

In NE Xx NE
the NE xxx NE
bone G#tissue_B xxx G#tissue_B
marrow G#tissue_E xxx G#tissue_E
, NE , NE
it NE xx NE
is NE xx NE
preferentially NE xxx NE
expressed NE xxx NE
in NE xx NE
myeloid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

PML G#protein_molecule XXX G#protein_molecule
appears NE xxx NE
to NE xx NE
be NE xx NE
transcriptionally NE xxx NE
regulated NE xxx NE
by NE xx NE
class G#protein_family_or_group_B xxx G#protein_family_or_group_B
I G#protein_family_or_group_M X G#protein_family_or_group_M
interferon G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
class G#protein_family_or_group_M xxx G#protein_family_or_group_M
II G#protein_family_or_group_M XX G#protein_family_or_group_M
interferon G#protein_family_or_group_E xxx G#protein_family_or_group_E
myeloid NE xxx NE
cells NE xxx NE
and NE xxx NE
precursors NE xxx NE
by NE xx NE
activating NE xxx NE
PML G#other_name XXX G#other_name
-dependent NE -xxx NE
pathways NE xxx NE
. NE . NE

Similarly NE Xxxx NE
, NE , NE
interferons NE xxx NE
could NE xxx NE
act NE xxx NE
on NE xx NE
APL G#cell_type_B XXX G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
alone NE xxx NE
or NE xx NE
in NE xx NE
combination NE xxx NE
with NE xxx NE
all-trans G#other_artificial_source_B xxx-xxx G#other_artificial_source_B
retinoic G#other_artificial_source_M xxx G#other_artificial_source_M
acid G#other_artificial_source_E xxx G#other_artificial_source_E
( NE ( NE
RA G#other_organic_compound XX G#other_organic_compound
) NE ) NE
, NE , NE
especially NE xxx NE
if NE xx NE
the NE xxx NE
PML/RAR G#RNA_molecule_B XXX/XXX G#RNA_molecule_B
alpha G#RNA_molecule_M xxx G#RNA_molecule_M
fusion G#RNA_molecule_M xxx G#RNA_molecule_M
transcript G#RNA_molecule_E xxx G#RNA_molecule_E
that NE xxx NE
results NE xxx NE
from NE xxx NE
the NE xxx NE
t(15; G#DNA_domain_or_region_B x(dd; G#DNA_domain_or_region_B
17) G#DNA_domain_or_region_E dd) G#DNA_domain_or_region_E
is NE xx NE
induced NE xxx NE
by NE xx NE
interferon G#protein_family_or_group xxx G#protein_family_or_group
. NE . NE

We NE Xx NE
report NE xxx NE
here NE xxx NE
that NE xxx NE
PML G#protein_molecule XXX G#protein_molecule
is NE xx NE
expressed NE xxx NE
at NE xx NE
low NE xxx NE
levels NE xxx NE
or NE xx NE
not NE xxx NE
expressed NE xxx NE
in NE xx NE
normal NE xxx NE
circulating NE xxx NE
human G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
lymphocytes G#cell_type xxx G#cell_type
, NE , NE
and NE xxx NE
polymorphonucleate G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
but NE xxx NE
is NE xx NE
markedly NE xxx NE
induced NE xxx NE
by NE xx NE
interferon G#protein_family_or_group xxx G#protein_family_or_group
; NE ; NE
that NE xxx NE
PML G#protein_molecule XXX G#protein_molecule
and NE xxx NE
PML/RAR G#other_name_B XXX/XXX G#other_name_B
alpha G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
is NE xx NE
augmented NE xxx NE
by NE xx NE
interferon G#protein_family_or_group xxx G#protein_family_or_group
in NE xx NE
the NE xxx NE
NB4 G#cell_line_B XXd G#cell_line_B
APL G#cell_line_M XXX G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
which NE xxx NE
carries NE xxx NE
the NE xxx NE
t(15; G#DNA_domain_or_region_B x(dd; G#DNA_domain_or_region_B
17) G#DNA_domain_or_region_E dd) G#DNA_domain_or_region_E
, NE , NE
and NE xxx NE
in NE xx NE
APL G#cell_type_B XXX G#cell_type_B
blasts G#cell_type_E xxx G#cell_type_E
from NE xxx NE
patients G#multi_cell xxx G#multi_cell
; NE ; NE
that NE xxx NE
interferon G#protein_family_or_group xxx G#protein_family_or_group
inhibits NE xxx NE
growth NE xxx NE
and NE xxx NE
survival NE xxx NE
of NE xx NE
NB4 NE XXd NE
APL G#cell_type_B XXX G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
cooperation NE xxx NE
with NE xxx NE
RA G#other_organic_compound XX G#other_organic_compound
; NE ; NE
that NE xxx NE
interferons NE xxx NE
alone NE xxx NE
have NE xxx NE
minimal NE xxx NE
maturation NE xxx NE
effect NE xxx NE
on NE xx NE
NB4 G#cell_line_B XXd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
; NE ; NE
and NE xxx NE
, NE , NE
finally NE xxx NE
, NE , NE
that NE xxx NE
interferon G#protein_molecule_B xxx G#protein_molecule_B
gamma G#protein_molecule_M xxx G#protein_molecule_M
but G#protein_molecule_M xxx G#protein_molecule_M
not G#protein_molecule_M xxx G#protein_molecule_M
(OR G#protein_molecule_M (XX G#protein_molecule_M
but G#protein_molecule_M xxx G#protein_molecule_M
not G#protein_molecule_M xxx G#protein_molecule_M
interferon G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_M xxx G#protein_molecule_M
but G#protein_molecule_M xxx G#protein_molecule_M
not G#protein_molecule_M xxx G#protein_molecule_M
interferon G#protein_molecule_M xxx G#protein_molecule_M
beta) G#protein_molecule_E xxx) G#protein_molecule_E
or NE xx NE
beta NE xxx NE
, NE , NE
induces NE xxx NE
maturation NE xxx NE
and NE xxx NE
growth NE xxx NE
suppression NE xxx NE
of NE xx NE
NB4 G#cell_line_B XXd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
de NE xx NE
novo NE xxx NE
retinoid G#other_name_B xxx G#other_name_B
resistance G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
partially NE xxx NE
restores NE xxx NE
RA G#other_name_B XX G#other_name_B
response G#other_name_E xxx G#other_name_E
. NE . NE

Effects NE Xxxx NE
of NE xx NE
Ara-C G#other_organic_compound Xxx-X G#other_organic_compound
on NE xx NE
neutral G#protein_molecule_B xxx G#protein_molecule_B
sphingomyelinase G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
mitogen- G#protein_family_or_group_B xxx- G#protein_family_or_group_B
activated G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_M xxx G#protein_family_or_group_M
kinase G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
stress- G#protein_family_or_group_M xxx- G#protein_family_or_group_M
activated G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_M xxx G#protein_family_or_group_M
kinase G#protein_family_or_group_E xxx G#protein_family_or_group_E

Neutral G#protein_molecule_B Xxxx G#protein_molecule_B
sphingomyelinase G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
SMase G#protein_molecule XXxxx G#protein_molecule
) NE ) NE
can NE xxx NE
be NE xx NE
activated NE xxx NE
by NE xx NE
extracellular G#other_name_B xxx G#other_name_B
signals G#other_name_E xxx G#other_name_E
to NE xx NE
produce NE xxx NE
ceramide G#other_organic_compound xxx G#other_organic_compound
, NE , NE
which NE xxx NE
may NE xxx NE
affect NE xxx NE
mitogen-activated NE xxx-xxx NE
protein NE xxx NE
kinase NE xxx NE
( NE ( NE
MAPK NE XXXX NE
) NE ) NE
activities NE xxx NE
. NE . NE

Neutral NE Xxxx NE
SMase G#other_name_B XXxxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
assessed NE xxx NE
in NE xx NE
membranes G#cell_component xxx G#cell_component
from NE xxx NE
Jurkat G#cell_line Xxxx G#cell_line
, NE , NE
a NE x NE
human G#cell_line_B xxx G#cell_line_B
T-cell G#cell_line_M X-xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
and NE xxx NE
EL4 G#cell_line XXd G#cell_line
, NE , NE
a NE x NE
murine G#cell_line_B xxx G#cell_line_B
T-cell G#cell_line_M X-xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
. NE . NE

Ara-C G#other_organic_compound Xxx-X G#other_organic_compound
activated NE xxx NE
SMase G#protein_molecule XXxxx G#protein_molecule
with NE xxx NE
10 NE dd NE
minutes NE xxx NE
in NE xx NE
both NE xxx NE
Jurkat NE Xxxx NE
and NE xxx NE
EL4 G#cell_line_B XXd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
while NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
PMA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
had NE xxx NE
no NE xx NE
effect NE xxx NE
. NE . NE

PMA G#other_organic_compound XXX G#other_organic_compound
, NE , NE
but NE xxx NE
not NE xxx NE
Ara-C G#other_organic_compound Xxx-X G#other_organic_compound
or NE xx NE
ceramides G#other_organic_compound xxx G#other_organic_compound
, NE , NE
activated NE xxx NE
ERK G#protein_molecule_B XXX G#protein_molecule_B
MAPKS G#protein_molecule_E XXXXX G#protein_molecule_E
, NE , NE
in NE xx NE
Jurkat G#cell_line Xxxx G#cell_line
and NE xxx NE
EL4 G#cell_line XXd G#cell_line
. NE . NE

PMA G#other_organic_compound XXX G#other_organic_compound
acted NE xxx NE
synergistically NE xxx NE
with NE xxx NE
ionomycin NE xxx NE
to NE xx NE
activate NE xxx NE
JNK G#protein_family_or_group_B XXX G#protein_family_or_group_B
MAPKs G#protein_family_or_group_E XXXXx G#protein_family_or_group_E
in NE xx NE
Jurkat G#cell_line Xxxx G#cell_line
and NE xxx NE
EL4 G#cell_line XXd G#cell_line
within NE xxx NE
10 NE dd NE
minutes NE xxx NE
. NE . NE

Ara-C G#other_organic_compound Xxx-X G#other_organic_compound
activated NE xxx NE
JNKs G#protein_family_or_group XXXx G#protein_family_or_group
only NE xxx NE
after NE xxx NE
prolonged NE xxx NE
incubation NE xxx NE
(90-120 NE (dd-ddd NE
minutes) NE xxx) NE
. NE . NE

Thus NE Xxxx NE
, NE , NE
ceramide G#other_organic_compound xxx G#other_organic_compound
is NE xx NE
not NE xxx NE
a NE x NE
positive NE xxx NE
signal NE xxx NE
for NE xxx NE
ERK G#other_name_B XXX G#other_name_B
activation G#other_name_E xxx G#other_name_E
in NE xx NE
T-cell G#cell_line_B X-xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
effects NE xxx NE
of NE xx NE
Ara-C G#other_organic_compound Xxx-X G#other_organic_compound
on NE xx NE
JNK G#other_name_B XXX G#other_name_B
activity G#other_name_E xxx G#other_name_E
may NE xxx NE
be NE xx NE
mediated NE xxx NE
through NE xxx NE
secondary G#other_name_B xxx G#other_name_B
response G#other_name_M xxx G#other_name_M
pathways G#other_name_E xxx G#other_name_E
. NE . NE

Comparative NE Xxxx NE
analysis NE xxx NE
identifies NE xxx NE
conserved NE xxx NE
tumor G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
necrosis G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
factor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
receptor G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
-associated NE -xxx NE
factor NE xxx NE
3 NE d NE
binding NE xxx NE
sites NE xxx NE
in NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
Epstein-Barr G#DNA_domain_or_region_M Xxxx-Xxxx G#DNA_domain_or_region_M
virus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
oncogene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
LMP1 G#DNA_domain_or_region_M XXXd G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
simian G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
Epstein-Barr G#DNA_domain_or_region_M Xxxx-Xxxx G#DNA_domain_or_region_M
virus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
oncogene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
LMP1 G#DNA_domain_or_region_E XXXd G#DNA_domain_or_region_E

Nonhuman NE Xxxx NE
primates NE xxx NE
are NE xxx NE
naturally NE xxx NE
infected NE xxx NE
with NE xxx NE
a NE x NE
B-lymphotropic NE X-xxx NE
herpesvirus NE xxx NE
closely NE xxx NE
related NE xxx NE
to NE xx NE
Epstein-Barr G#virus_B Xxxx-Xxxx G#virus_B
virus G#virus_E xxx G#virus_E
( NE ( NE
EBV G#virus XXX G#virus
) NE ) NE
. NE . NE

These NE Xxxx NE
simian G#virus_B xxx G#virus_B
EBV G#virus_E XXX G#virus_E
share NE xxx NE
considerable NE xxx NE
genetic NE xxx NE
, NE , NE
biologic NE xxx NE
, NE , NE
and NE xxx NE
epidemiologic NE xxx NE
features NE xxx NE
with NE xxx NE
human G#virus_B xxx G#virus_B
EBV G#virus_E XXX G#virus_E
, NE , NE
including NE xxx NE
virus-induced NE xxx-xxx NE
tumorigenesis NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
latent NE xxx NE
, NE , NE
transformation-associated NE xxx-xxx NE
viral NE xxx NE
genes NE xxx NE
demonstrate NE xxx NE
marked NE xxx NE
sequence NE xxx NE
divergence NE xxx NE
among NE xxx NE
species NE xxx NE
despite NE xxx NE
the NE xxx NE
conserved NE xxx NE
functions NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
cloned NE xxx NE
the NE xxx NE
latent NE xxx NE
membrane NE xxx NE
protein NE xxx NE
1 NE d NE
( NE ( NE
LMP1 NE XXXd NE
) NE ) NE
homologs NE xxx NE
from NE xxx NE
the NE xxx NE
simian NE xxx NE
EBV NE XXX NE
naturally NE xxx NE
infecting NE xxx NE
baboons NE xxx NE
( NE ( NE
cercopithicine NE xxx NE
herpesvirus NE xxx NE
12 NE dd NE
, NE , NE
herpesvirus NE xxx NE
papio NE xxx NE
) NE ) NE
and NE xxx NE
rhesus NE xxx NE
monkeys NE xxx NE
( NE ( NE
cercopithicine NE xxx NE
herpesvirus NE xxx NE
15 NE dd NE
) NE ) NE
for NE xxx NE
a NE x NE
comparative NE xxx NE
study NE xxx NE
with NE xxx NE
the NE xxx NE
human NE xxx NE
EBV NE XXX NE
oncogene NE xxx NE
. NE . NE

The NE Xxx NE
transmembrane NE xxx NE
domains NE xxx NE
are NE xxx NE
well NE xxx NE
conserved NE xxx NE
, NE , NE
but NE xxx NE
there NE xxx NE
is NE xx NE
striking NE xxx NE
sequence NE xxx NE
divergence NE xxx NE
of NE xx NE
the NE xxx NE
carboxy-terminal G#protein_domain_or_region_B xxx-xxx G#protein_domain_or_region_B
cytoplasmic G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
essential NE xxx NE
for NE xxx NE
B-cell G#other_name_B X-xxx G#other_name_B
immortalization G#other_name_E xxx G#other_name_E
and NE xxx NE
interaction NE xxx NE
with NE xxx NE
the NE xxx NE
tumor G#other_name_B xxx G#other_name_B
necrosis G#other_name_M xxx G#other_name_M
factor G#other_name_M xxx G#other_name_M
receptor G#other_name_M xxx G#other_name_M
signaling G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
. NE . NE

Nevertheless NE Xxxx NE
, NE , NE
the NE xxx NE
simian G#protein_molecule_B xxx G#protein_molecule_B
EBV G#protein_molecule_M XXX G#protein_molecule_M
LMP1s G#protein_molecule_E XXXdx G#protein_molecule_E
retain NE xxx NE
most NE xxx NE
functions NE xxx NE
in NE xx NE
common NE xxx NE
with NE xxx NE
EBV NE XXX NE
LMP1 G#protein_molecule XXXd G#protein_molecule
, NE , NE
including NE xxx NE
the NE xxx NE
ability NE xxx NE
to NE xx NE
induce NE xxx NE
NF-(kappa)B NE XX-(xxx)X NE
activity NE xxx NE
in NE xx NE
human NE xxx NE
cells NE xxx NE
, NE , NE
to NE xx NE
bind NE xxx NE
the NE xxx NE
tumor NE xxx NE
necrosis NE xxx NE
factor-associated NE xxx-xxx NE
factor NE xxx NE
3 NE d NE
( NE ( NE
TRAF3 NE XXXXd NE
) NE ) NE
in NE xx NE
vitro NE xxx NE
, NE , NE
and NE xxx NE
to NE xx NE
induce NE xxx NE
expression NE xxx NE
of NE xx NE
tumor NE xxx NE
necrosis NE xxx NE
factor-responsive NE xxx-xxx NE
genes NE xxx NE
, NE , NE
such NE xxx NE
as NE xx NE
ICAM1 NE XXXXd NE
, NE , NE
in NE xx NE
human NE xxx NE
B NE X NE
lymphocytes NE xxx NE
. NE . NE

Multiple NE Xxxx NE
TRAF3 G#DNA_domain_or_region_B XXXXd G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
containing NE xxx NE
a NE x NE
PXQXT/S G#DNA_domain_or_region_B XXXXX/X G#DNA_domain_or_region_B
core G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
can NE xxx NE
be NE xx NE
identified NE xxx NE
in NE xx NE
the NE xxx NE
simian G#protein_molecule_B xxx G#protein_molecule_B
EBV G#protein_molecule_M XXX G#protein_molecule_M
LMP1s G#protein_molecule_E XXXdx G#protein_molecule_E
by NE xx NE
an NE xx NE
in NE xx NE
vitro NE xxx NE
binding NE xxx NE
assay NE xxx NE
. NE . NE

A NE X NE
PXQXT/S-containing G#DNA_domain_or_region_B XXXXX/X-xxx G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
also NE xxx NE
present NE xxx NE
in NE xx NE
the NE xxx NE
cytoplasmic G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
the NE xxx NE
Hodgkin's G#other_name_B Xxxx'x G#other_name_B
disease G#other_name_M xxx G#other_name_M
marker G#other_name_E xxx G#other_name_E
, NE , NE
CD30 G#protein_molecule XXdd G#protein_molecule
, NE , NE
and NE xxx NE
binds NE xxx NE
TRAF3 G#protein_molecule XXXXd G#protein_molecule
in NE xx NE
vitro NE xxx NE
. NE . NE

The NE Xxx NE
last G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
13 G#protein_domain_or_region_M dd G#protein_domain_or_region_M
amino G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
acids G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
containing NE xxx NE
a NE x NE
PXQXT/S G#DNA_domain_or_region_B XXXXX/X G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
are NE xxx NE
highly NE xxx NE
conserved NE xxx NE
in NE xx NE
human NE xxx NE
and NE xxx NE
simian G#virus_B xxx G#virus_B
EBV G#virus_E XXX G#virus_E
LMP1 G#protein_molecule XXXd G#protein_molecule
but NE xxx NE
do NE xx NE
not NE xxx NE
bind NE xxx NE
TRAF3 G#protein_molecule XXXXd G#protein_molecule
, NE , NE
suggesting NE xxx NE
a NE x NE
distinct NE xxx NE
role NE xxx NE
for NE xxx NE
this NE xxx NE
conserved NE xxx NE
region NE xxx NE
of NE xx NE
LMP1 G#protein_molecule XXXd G#protein_molecule
. NE . NE

The NE Xxx NE
conserved NE xxx NE
TRAF3 G#DNA_domain_or_region_B XXXXd G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
LMP1 G#protein_molecule XXXd G#protein_molecule
and NE xxx NE
the NE xxx NE
CD30 G#protein_molecule_B XXdd G#protein_molecule_B
Hodgkin's G#protein_molecule_M Xxxx'x G#protein_molecule_M
disease G#protein_molecule_M xxx G#protein_molecule_M
marker G#protein_molecule_E xxx G#protein_molecule_E
provides NE xxx NE
further NE xxx NE
evidence NE xxx NE
that NE xxx NE
a NE x NE
TRAF3 NE XXXXd NE
-mediated NE -xxx NE
signal NE xxx NE
transduction NE xxx NE
pathway NE xxx NE
may NE xxx NE
be NE xx NE
important NE xxx NE
in NE xx NE
malignant NE xxx NE
transformation NE xxx NE
. NE . NE

Chromosome G#other_name_B Xxxx G#other_name_B
1 G#other_name_M d G#other_name_M
aneusomy G#other_name_E xxx G#other_name_E
with NE xxx NE
1p36 G#other_name_B dxdd G#other_name_B
under-representation G#other_name_E xxx-xxx G#other_name_E
is NE xx NE
related NE xxx NE
to NE xx NE
histologic NE xxx NE
grade NE xxx NE
, NE , NE
DNA G#other_name_B XXX G#other_name_B
aneuploidy G#other_name_E xxx G#other_name_E
, NE , NE
high NE xxx NE
c-erb G#protein_molecule_B x-xxx G#protein_molecule_B
B-2 G#protein_molecule_E X-d G#protein_molecule_E
and NE xxx NE
loss NE xxx NE
of NE xx NE
bcl-2 G#other_name_B xxx-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
ductal G#other_name_B xxx G#other_name_B
breast G#other_name_M xxx G#other_name_M
carcinoma G#other_name_E xxx G#other_name_E
. NE . NE

Chromosome G#DNA_molecule_B Xxxx G#DNA_molecule_B
1 G#DNA_molecule_E d G#DNA_molecule_E
abnormalities NE xxx NE
with NE xxx NE
loss NE xxx NE
of NE xx NE
1p36 G#DNA_domain_or_region dxdd G#DNA_domain_or_region
have NE xxx NE
been NE xxx NE
investigated NE xxx NE
in NE xx NE
95 NE dd NE
breast-cancer G#tissue_B xxx-xxx G#tissue_B
samples G#tissue_E xxx G#tissue_E
by NE xx NE
means NE xxx NE
of NE xx NE
a NE x NE
dual-target G#other_name_B xxx-xxx G#other_name_B
fluorescence G#other_name_M xxx G#other_name_M
in-situ G#other_name_M xx-xxx G#other_name_M
hybridization G#other_name_E xxx G#other_name_E
( NE ( NE
FISH G#other_name XXXX G#other_name
) NE ) NE
technique NE xxx NE
using NE xxx NE
the NE xxx NE
pUC G#DNA_molecule_B xXX G#DNA_molecule_B
1.77 G#DNA_molecule_E d.dd G#DNA_molecule_E
and NE xxx NE
p1-79 G#DNA_molecule_B xd-dd G#DNA_molecule_B
probes G#DNA_molecule_E xxx G#DNA_molecule_E
, NE , NE
specific NE xxx NE
for NE xxx NE
the NE xxx NE
1q12 G#DNA_domain_or_region_B dxdd G#DNA_domain_or_region_B
region G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
1p36 G#DNA_domain_or_region_M dxdd G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E

Abnormalities NE Xxxx NE
for NE xxx NE
one NE xxx NE
or NE xx NE
both NE xxx NE
probes NE xxx NE
were NE xxx NE
detected NE xxx NE
in NE xx NE
83/95 NE dd/dd NE
samples NE xxx NE
. NE . NE

Relative NE Xxxx NE
1p36 G#DNA_domain_or_region dxdd G#DNA_domain_or_region
under-representation NE xxx-xxx NE
was NE xxx NE
found NE xxx NE
in NE xx NE
79/95 NE dd/dd NE
. NE . NE

The NE Xxx NE
clinical NE xxx NE
relevance NE xxx NE
of NE xx NE
these NE xxx NE
alterations NE xxx NE
was NE xxx NE
studied NE xxx NE
by NE xx NE
comparing NE xxx NE
the NE xxx NE
FISH G#other_name_B XXXX G#other_name_B
results G#other_name_E xxx G#other_name_E
with NE xxx NE
several NE xxx NE
parameters NE xxx NE
currently NE xxx NE
used NE xxx NE
in NE xx NE
breast-cancer G#other_name_B xxx-xxx G#other_name_B
pathology G#other_name_E xxx G#other_name_E
. NE . NE

Distinct NE Xxxx NE
patterns NE xxx NE
of NE xx NE
chromosome NE xxx NE
1 NE d NE
abnormalities NE xxx NE
were NE xxx NE
found NE xxx NE
among NE xxx NE
the NE xxx NE
histologic NE xxx NE
types NE xxx NE
of NE xx NE
breast NE xxx NE
carcinoma NE xxx NE
. NE . NE

Lobular NE Xxxx NE
or NE xx NE
mucinous NE xxx NE
samples NE xxx NE
showed NE xxx NE
few NE xxx NE
or NE xx NE
no NE xx NE
alterations NE xxx NE
, NE , NE
whereas NE xxx NE
most NE xxx NE
ductal G#tissue_B xxx G#tissue_B
samples G#tissue_E xxx G#tissue_E
had NE xxx NE
high NE xxx NE
chromosome G#other_name_B xxx G#other_name_B
1 G#other_name_M d G#other_name_M
polysomy G#other_name_E xxx G#other_name_E
with NE xxx NE
under-representation NE xxx-xxx NE
of NE xx NE
1p36 G#DNA_domain_or_region dxdd G#DNA_domain_or_region
. NE . NE

In NE Xx NE
ductal G#other_name_B xxx G#other_name_B
carcinomas G#other_name_E xxx G#other_name_E
, NE , NE
chromosome G#DNA_molecule_B xxx G#DNA_molecule_B
1 G#DNA_molecule_E d G#DNA_molecule_E
alterations NE xxx NE
increased NE xxx NE
with NE xxx NE
histologic NE xxx NE
grade NE xxx NE
, NE , NE
DNA G#other_name_B XXX G#other_name_B
aneuploidy G#other_name_E xxx G#other_name_E
, NE , NE
loss NE xxx NE
of NE xx NE
bcl-2 NE xxx-d NE
and NE xxx NE
high NE xxx NE
c-erb G#protein_molecule_B x-xxx G#protein_molecule_B
B-2 G#protein_molecule_E X-d G#protein_molecule_E
expression NE xxx NE
. NE . NE

These NE Xxxx NE
associations NE xxx NE
were NE xxx NE
found NE xxx NE
to NE xx NE
be NE xx NE
statistically NE xxx NE
significant NE xxx NE
. NE . NE

No NE Xx NE
correlation NE xxx NE
between NE xxx NE
chromosome G#other_name_B xxx G#other_name_B
1 G#other_name_M d G#other_name_M
alterations G#other_name_E xxx G#other_name_E
and NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
grade G#other_name_E xxx G#other_name_E
, NE , NE
age NE xxx NE
, NE , NE
size NE xxx NE
, NE , NE
lymph-node G#other_name_B xxx-xxx G#other_name_B
involvement G#other_name_E xxx G#other_name_E
, NE , NE
hormonal G#other_name_B xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
presence G#other_name_E xxx G#other_name_E
, NE , NE
proliferation G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
or NE xx NE
p53 G#other_name_B xdd G#other_name_B
protein G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
was NE xxx NE
detected NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
the NE xxx NE
utility NE xxx NE
of NE xx NE
this NE xxx NE
FISH G#other_name_B XXXX G#other_name_B
technique G#other_name_E xxx G#other_name_E
for NE xxx NE
a NE x NE
better NE xxx NE
definition NE xxx NE
of NE xx NE
the NE xxx NE
biological G#other_name_B xxx G#other_name_B
characteristics G#other_name_E xxx G#other_name_E
of NE xx NE
ductal G#other_name_B xxx G#other_name_B
carcinomas G#other_name_E xxx G#other_name_E
. NE . NE

G(Anh)MTetra G#other_organic_compound X(Xxx)XXxxx G#other_organic_compound
, NE , NE
a NE x NE
natural NE xxx NE
bacterial G#other_organic_compound_B xxx G#other_organic_compound_B
cell G#other_organic_compound_M xxx G#other_organic_compound_M
wall G#other_organic_compound_M xxx G#other_organic_compound_M
breakdown G#other_organic_compound_M xxx G#other_organic_compound_M
product G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
induces NE xxx NE
interleukin-1 G#protein_molecule_B xxx-d G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
interleukin-6 G#other_name_B xxx-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

A NE X NE
study NE xxx NE
of NE xx NE
the NE xxx NE
molecular G#other_name_B xxx G#other_name_B
mechanisms G#other_name_E xxx G#other_name_E
involved NE xxx NE
in NE xx NE
inflammatory G#other_name_B xxx G#other_name_B
cytokine G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
[published NE [xxx NE
erratum NE xxx NE
appears NE xxx NE
in NE xx NE
J NE X NE
Biol NE Xxxx NE
Chem NE Xxxx NE
1994 NE dddd NE
Jun NE Xxx NE
17;269(24):16983] NE dd;ddd(dd):ddddd] NE

It NE Xx NE
is NE xx NE
believed NE xxx NE
that NE xxx NE
induction NE xxx NE
of NE xx NE
cytokine G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
by NE xx NE
bacterial G#other_name_B xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
wall G#other_name_M xxx G#other_name_M
components G#other_name_E xxx G#other_name_E
plays NE xxx NE
a NE x NE
role NE xxx NE
in NE xx NE
the NE xxx NE
development NE xxx NE
and NE xxx NE
course NE xxx NE
of NE xx NE
sepsis NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
most NE xxx NE
attention NE xxx NE
has NE xxx NE
been NE xxx NE
focused NE xxx NE
on NE xx NE
lipopolysaccharide G#lipid xxx G#lipid
( NE ( NE
LPS G#lipid XXX G#lipid
) NE ) NE
. NE . NE

We NE Xx NE
studied NE xxx NE
the NE xxx NE
ability NE xxx NE
of NE xx NE
N-acetylglucosaminyl-1,6-anhydro-N-acetylmuramyl-L-alanyl-D- G#other_organic_compound_B X-xxx-d,d-xxx-X-xxx-X-xxx-X- G#other_organic_compound_B
isoglutamyl-m-diaminopimelyl-D-alanine G#other_organic_compound_E xxx-x-xxx-X-xxx G#other_organic_compound_E
( NE ( NE
G(Anh)MTetra G#other_organic_compound X(Xxx)XXxxx G#other_organic_compound
) NE ) NE
, NE , NE
a NE x NE
naturally NE xxx NE
occurring NE xxx NE
breakdown NE xxx NE
product NE xxx NE
of NE xx NE
peptidoglycan G#carbohydrate xxx G#carbohydrate
that NE xxx NE
is NE xx NE
produced NE xxx NE
by NE xx NE
soluble NE xxx NE
lytic G#protein_molecule_B xxx G#protein_molecule_B
transglycosylase G#protein_molecule_E xxx G#protein_molecule_E
of NE xx NE
Escherichia G#mono_cell_B Xxxx G#mono_cell_B
coli G#mono_cell_E xxx G#mono_cell_E
, NE , NE
to NE xx NE
induce NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

G(Anh)MTetra G#other_organic_compound X(Xxx)XXxxx G#other_organic_compound
was NE xxx NE
found NE xxx NE
to NE xx NE
strongly NE xxx NE
induce NE xxx NE
interleukin G#protein_molecule_B xxx G#protein_molecule_B
(IL)-1 G#protein_molecule_M (XX)-d G#protein_molecule_M
beta G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
IL-6 G#other_name_B XX-d G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_E xxx G#other_name_E
after NE xxx NE
2 NE d NE
h NE x NE
and NE xxx NE
IL-1 G#protein_molecule_B XX-d G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
IL-6 G#other_name_B XX-d G#other_name_B
protein G#other_name_M xxx G#other_name_M
secretion G#other_name_E xxx G#other_name_E
after NE xxx NE
48 NE dd NE
h NE x NE
of NE xx NE
activation NE xxx NE
. NE . NE

The NE Xxx NE
increase NE xxx NE
in NE xx NE
mRNA G#other_name_B xXXX G#other_name_B
accumulation G#other_name_E xxx G#other_name_E
was NE xxx NE
at NE xx NE
least NE xxx NE
partly NE xxx NE
due NE xxx NE
to NE xx NE
an NE xx NE
increase NE xxx NE
in NE xx NE
the NE xxx NE
transcription G#other_name_B xxx G#other_name_B
rates G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
respective NE xxx NE
genes G#DNA_family_or_group xxx G#DNA_family_or_group
and NE xxx NE
was NE xxx NE
accompanied NE xxx NE
by NE xx NE
a NE x NE
strong NE xxx NE
induction NE xxx NE
of NE xx NE
nuclear G#other_name_B xxx G#other_name_B
factor-kappa G#other_name_M xxx-xxx G#other_name_M
B G#other_name_M X G#other_name_M
transcription G#other_name_M xxx G#other_name_M
factor G#other_name_M xxx G#other_name_M
expression G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
activator G#other_name_M xxx G#other_name_M
protein-1 G#other_name_M xxx-d G#other_name_M
transcription G#other_name_M xxx G#other_name_M
factor G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E

Experiments NE Xxxx NE
using NE xxx NE
inhibitors NE xxx NE
of NE xx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
, NE , NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
A G#protein_molecule_E X G#protein_molecule_E
, NE , NE
and NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
kinase-dependent G#other_name_M xxx-xxx G#other_name_M
pathways G#other_name_E xxx G#other_name_E
revealed NE xxx NE
that NE xxx NE
G(Anh)MTetra G#other_organic_compound X(Xxx)XXxxx G#other_organic_compound
-induced NE -xxx NE
IL-1 G#protein_molecule_B XX-d G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
IL-6 G#other_name_B XX-d G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_E xxx G#other_name_E
involves NE xxx NE
activation NE xxx NE
of NE xx NE
an NE xx NE
H7-inhibitable G#other_name_B Xd-xxx G#other_name_B
pathway G#other_name_E xxx G#other_name_E
. NE . NE

By NE Xx NE
using NE xxx NE
the NE xxx NE
protein NE xxx NE
synthesis NE xxx NE
inhibitor NE xxx NE
cycloheximide G#other_organic_compound xxx G#other_organic_compound
, NE , NE
it NE xx NE
was NE xxx NE
shown NE xxx NE
that NE xxx NE
G(Anh)MTetra NE X(Xxx)XXxxx NE
-induced NE -xxx NE
IL-6 NE XX-d NE
mRNA NE xXXX NE
expression NE xxx NE
depends NE xxx NE
on NE xx NE
the NE xxx NE
synthesis NE xxx NE
of NE xx NE
new NE xxx NE
protein NE xxx NE
, NE , NE
whereas NE xxx NE
G(Anh)MTetra NE X(Xxx)XXxxx NE
-induced NE -xxx NE
IL-1 NE XX-d NE
beta NE xxx NE
mRNA NE xXXX NE
accumulation NE xxx NE
does NE xxx NE
not NE xxx NE
. NE . NE

When NE Xxxx NE
responses NE xxx NE
to NE xx NE
G(Anh)MTetra G#other_organic_compound X(Xxx)XXxxx G#other_organic_compound
were NE xxx NE
compared NE xxx NE
with NE xxx NE
those NE xxx NE
to NE xx NE
LPS G#lipid XXX G#lipid
and NE xxx NE
muramyldipeptide G#amino_acid_monomer xxx G#amino_acid_monomer
( NE ( NE
MDP G#amino_acid_monomer XXX G#amino_acid_monomer
) NE ) NE
, NE , NE
it NE xx NE
was NE xxx NE
found NE xxx NE
that NE xxx NE
the NE xxx NE
optimal NE xxx NE
response NE xxx NE
to NE xx NE
G(Anh)MTetra G#other_organic_compound X(Xxx)XXxxx G#other_organic_compound
induction NE xxx NE
was NE xxx NE
similar NE xxx NE
to NE xx NE
that NE xxx NE
of NE xx NE
LPS G#lipid XXX G#lipid
but NE xxx NE
significantly NE xxx NE
higher NE xxx NE
than NE xxx NE
the NE xxx NE
response NE xxx NE
to NE xx NE
MDP G#amino_acid_monomer XXX G#amino_acid_monomer
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
maximal NE xxx NE
G(Anh)MTetra NE X(Xxx)XXxxx NE
-induced NE -xxx NE
IL-1 NE XX-d NE
beta NE xxx NE
and NE xxx NE
IL-6 NE XX-d NE
mRNA NE xXXX NE
expression NE xxx NE
could NE xxx NE
be NE xx NE
enhanced NE xxx NE
by NE xx NE
co-stimulation NE xx-xxx NE
with NE xxx NE
LPS NE XXX NE
or NE xx NE
MDP NE XXX NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
different NE xxx NE
receptors NE xxx NE
and/or NE xxx/xx NE
transduction NE xxx NE
pathways NE xxx NE
were NE xxx NE
involved NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
G(Anh)MTetra G#other_organic_compound X(Xxx)XXxxx G#other_organic_compound
induces NE xxx NE
IL-1 G#protein_molecule_B XX-d G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
IL-6 G#protein_molecule XX-d G#protein_molecule
expression NE xxx NE
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
suggesting NE xxx NE
a NE x NE
possible NE xxx NE
role NE xxx NE
for NE xxx NE
G(Anh)MTetra G#other_organic_compound X(Xxx)XXxxx G#other_organic_compound
in NE xx NE
the NE xxx NE
release NE xxx NE
of NE xx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
during NE xxx NE
sepsis NE xxx NE
. NE . NE

Increased NE Xxxx NE
proliferation G#other_name xxx G#other_name
, NE , NE
cytotoxicity G#other_name xxx G#other_name
, NE , NE
and NE xxx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
after NE xxx NE
stimulation NE xxx NE
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
through NE xxx NE
a NE x NE
surface G#lipid_B xxx G#lipid_B
ganglioside G#lipid_E xxx G#lipid_E
( NE ( NE
GD3 G#lipid XXd G#lipid
) NE ) NE
[published NE [xxx NE
erratum NE xxx NE
appears NE xxx NE
in NE xx NE
J NE X NE
Immunol NE Xxxx NE
1994 NE dddd NE
Jul NE Xxx NE
15;153(2):910] NE dd;ddd(d):ddd] NE

Previous NE Xxxx NE
studies NE xxx NE
have NE xxx NE
suggested NE xxx NE
that NE xxx NE
gangliosides G#lipid xxx G#lipid
have NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
cell G#other_name_B xxx G#other_name_B
signaling G#other_name_E xxx G#other_name_E
and NE xxx NE
recognition NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
their NE xxx NE
specific NE xxx NE
function NE xxx NE
in NE xx NE
these NE xxx NE
processes NE xxx NE
has NE xxx NE
not NE xxx NE
been NE xxx NE
clearly NE xxx NE
defined NE xxx NE
. NE . NE

A NE X NE
mAb G#protein_family_or_group xXx G#protein_family_or_group
, NE , NE
R24 G#protein_molecule Xdd G#protein_molecule
, NE , NE
that NE xxx NE
reacts NE xxx NE
specifically NE xxx NE
with NE xxx NE
a NE x NE
cell NE xxx NE
surface G#lipid_B xxx G#lipid_B
ganglioside G#lipid_E xxx G#lipid_E
( NE ( NE
GD3 G#lipid XXd G#lipid
) NE ) NE
has NE xxx NE
been NE xxx NE
demonstrated NE xxx NE
to NE xx NE
stimulate NE xxx NE
proliferation NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
derived NE xxx NE
from NE xxx NE
human G#tissue_B xxx G#tissue_B
peripheral G#tissue_M xxx G#tissue_M
blood G#tissue_E xxx G#tissue_E
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
we NE xx NE
have NE xxx NE
investigated NE xxx NE
the NE xxx NE
mechanisms NE xxx NE
by NE xx NE
which NE xxx NE
the NE xxx NE
R24 G#protein_molecule_B Xdd G#protein_molecule_B
mAb G#protein_molecule_E xXx G#protein_molecule_E
affects NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
functions G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
have NE xxx NE
observed NE xxx NE
that NE xxx NE
the NE xxx NE
R24 G#protein_molecule_B Xdd G#protein_molecule_B
mAb G#protein_molecule_E xXx G#protein_molecule_E
stimulates NE xxx NE
GD3 NE XXd NE
+ NE + NE
T NE X NE
cell NE xxx NE
proliferation NE xxx NE
, NE , NE
cytotoxicity NE xxx NE
, NE , NE
and NE xxx NE
surface NE xxx NE
marker NE xxx NE
expression NE xxx NE
of NE xx NE
IL-2R NE XX-dX NE
alpha-chain NE xxx-xxx NE
, NE , NE
IL-2R NE XX-dX NE
beta-chain NE xxx-xxx NE
, NE , NE
HLA-DR NE XXX-XX NE
, NE , NE
CD11a NE XXddx NE
, NE , NE
and NE xxx NE
CD11c NE XXddx NE
. NE . NE

Additionally NE Xxxx NE
, NE , NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
but NE xxx NE
not NE xxx NE
IL-1 G#other_name_B XX-d G#other_name_B
activity G#other_name_M xxx G#other_name_M
or G#other_name_M xx G#other_name_M
IL-2 G#other_name_M XX-d G#other_name_M
activity G#other_name_M xxx G#other_name_M
or G#other_name_M xx G#other_name_M
IL-4 G#other_name_M XX-d G#other_name_M
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
present NE xxx NE
in NE xx NE
culture NE xxx NE
supernatants NE xxx NE
72 NE dd NE
h NE x NE
after NE xxx NE
R24 G#other_name_B Xdd G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
some NE xxx NE
donors NE xxx NE
, NE , NE
increased NE xxx NE
IL-6 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
TNF-alpha G#other_name_B XXX-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
also NE xxx NE
was NE xxx NE
detected NE xxx NE
after NE xxx NE
R24 G#other_name_B Xdd G#other_name_B
treatment G#other_name_E xxx G#other_name_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
R24 G#protein_molecule Xdd G#protein_molecule
treatment NE xxx NE
resulted NE xxx NE
in NE xx NE
translocation NE xxx NE
of NE xx NE
c-rel G#protein_molecule x-xxx G#protein_molecule
, NE , NE
but NE xxx NE
little NE xxx NE
or NE xx NE
no NE xx NE
NF G#protein_subunit_B XX G#protein_subunit_B
kappa G#protein_subunit_M xxx G#protein_subunit_M
B G#protein_subunit_M X G#protein_subunit_M
p50 G#protein_subunit_E xdd G#protein_subunit_E
or NE xx NE
p65 G#protein_subunit xdd G#protein_subunit
, NE , NE
from NE xxx NE
the NE xxx NE
cytoplasm G#cell_component xxx G#cell_component
to NE xx NE
the NE xxx NE
nucleus G#cell_component xxx G#cell_component
and NE xxx NE
an NE xx NE
increase NE xxx NE
of NE xx NE
NF NE XX NE
kappa NE xxx NE
B NE X NE
binding NE xxx NE
complexes NE xxx NE
containing NE xxx NE
c-rel NE x-xxx NE
and NE xxx NE
p50 NE xdd NE
. NE . NE

This NE Xxxx NE
treatment NE xxx NE
also NE xxx NE
caused NE xxx NE
increased NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
specific NE xxx NE
protein NE xxx NE
substrates NE xxx NE
. NE . NE

R24 G#protein_molecule Xdd G#protein_molecule
-stimulated NE -xxx NE
increases NE xxx NE
in NE xx NE
proliferation G#other_name xxx G#other_name
, NE , NE
cytotoxicity G#other_name xxx G#other_name
, NE , NE
and NE xxx NE
cell G#other_name_B xxx G#other_name_B
surface G#other_name_M xxx G#other_name_M
protein G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
could NE xxx NE
be NE xx NE
blocked NE xxx NE
by NE xx NE
cyclosporin G#other_organic_compound xxx G#other_organic_compound
and NE xxx NE
staurosporin NE xxx NE
, NE , NE
indicating NE xxx NE
that NE xxx NE
cyclophilin/calcineurin G#protein_family_or_group xxx/xxx G#protein_family_or_group
and NE xxx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
may NE xxx NE
be NE xx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
R24 G#protein_molecule Xdd G#protein_molecule
signaling NE xxx NE
pathway NE xxx NE
. NE . NE

Additionally NE Xxxx NE
, NE , NE
herbimycin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
, NE , NE
a NE x NE
tyrosine G#other_organic_compound_B xxx G#other_organic_compound_B
kinase G#other_organic_compound_M xxx G#other_organic_compound_M
inhibitor G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
blocked NE xxx NE
the NE xxx NE
R24 NE Xdd NE
-stimulated NE -xxx NE
increase NE xxx NE
in NE xx NE
proliferation NE xxx NE
but NE xxx NE
not NE xxx NE
cytotoxicity NE xxx NE
at NE xx NE
concentrations NE xxx NE
consistent NE xxx NE
with NE xxx NE
specificity NE xxx NE
for NE xxx NE
tyrosine NE xxx NE
kinases NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
multiple NE xxx NE
biochemical NE xxx NE
pathways NE xxx NE
are NE xxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
R24 G#protein_molecule Xdd G#protein_molecule
. NE . NE

Genes NE Xxxx NE
encoding NE xxx NE
general G#protein_family_or_group_B xxx G#protein_family_or_group_B
initiation G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
for NE xxx NE
RNA G#other_name_B XXX G#other_name_B
polymerase G#other_name_M xxx G#other_name_M
II G#other_name_M XX G#other_name_M
transcription G#other_name_E xxx G#other_name_E
are NE xxx NE
dispersed NE xxx NE
in NE xx NE
the NE xxx NE
human G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genome G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

General G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
are NE xxx NE
required NE xxx NE
for NE xxx NE
accurate NE xxx NE
initiation NE xxx NE
of NE xx NE
transcription NE xxx NE
by NE xx NE
RNA G#protein_complex_B XXX G#protein_complex_B
polymerase G#protein_complex_M xxx G#protein_complex_M
II G#protein_complex_E XX G#protein_complex_E
. NE . NE

Human G#DNA_family_or_group_B Xxxx G#DNA_family_or_group_B
cDNAs G#DNA_family_or_group_E xXXXx G#DNA_family_or_group_E
encoding NE xxx NE
subunits NE xxx NE
of NE xx NE
these NE xxx NE
factors NE xxx NE
have NE xxx NE
been NE xxx NE
cloned NE xxx NE
and NE xxx NE
sequenced NE xxx NE
. NE . NE

Using NE Xxxx NE
fluorescence G#other_name_B xxx G#other_name_B
in G#other_name_M xx G#other_name_M
situ G#other_name_M xxx G#other_name_M
hybridization G#other_name_E xxx G#other_name_E
( NE ( NE
FISH G#other_name XXXX G#other_name
) NE ) NE
, NE , NE
we NE xx NE
show NE xxx NE
here NE xxx NE
that NE xxx NE
the NE xxx NE
genes G#DNA_family_or_group xxx G#DNA_family_or_group
encoding NE xxx NE
the NE xxx NE
TATA-box G#protein_family_or_group_B XXXX-xxx G#protein_family_or_group_B
binding G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
TBP G#protein_family_or_group XXX G#protein_family_or_group
) NE ) NE
, NE , NE
TFIIB G#protein_subunit XXXXX G#protein_subunit
, NE , NE
TFIIE G#protein_subunit_B XXXXX G#protein_subunit_B
alpha G#protein_subunit_E xxx G#protein_subunit_E
, NE , NE
TFIIE G#protein_subunit_B XXXXX G#protein_subunit_B
beta G#protein_subunit_E xxx G#protein_subunit_E
, NE , NE
RAP30 G#protein_subunit XXXdd G#protein_subunit
, NE , NE
RAP74 G#protein_subunit XXXdd G#protein_subunit
and NE xxx NE
the NE xxx NE
62 G#protein_subunit_B dd G#protein_subunit_B
kDa G#protein_subunit_M xXx G#protein_subunit_M
subunit G#protein_subunit_E xxx G#protein_subunit_E
, NE , NE
of NE xx NE
TFIIH G#protein_molecule XXXXX G#protein_molecule
are NE xxx NE
located NE xxx NE
at NE xx NE
the NE xxx NE
human NE xxx NE
chromosomal NE xxx NE
bands NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
chromosomal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
band G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
6q26-27 G#DNA_domain_or_region_M dxdd-dd G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
human G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
chromosomal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
band G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
1p21-22 G#DNA_domain_or_region_M dxdd-dd G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
human G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
chromosomal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
band G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
3q21-24 G#DNA_domain_or_region_M dxdd-dd G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
human G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
chromosomal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
band G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
8p12 G#DNA_domain_or_region_M dxdd G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
human G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
chromosomal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
band G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
13q14 G#DNA_domain_or_region_M ddxdd G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
human G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
chromosomal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
band G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
19p13.3 G#DNA_domain_or_region_M ddxdd.d G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
human G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
chromosomal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
band G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
11p14-15.1 G#DNA_domain_or_region_E ddxdd-dd.d G#DNA_domain_or_region_E

This NE Xxxx NE
dispersed NE xxx NE
localization NE xxx NE
of NE xx NE
a NE x NE
group NE xxx NE
of NE xx NE
functionally NE xxx NE
related NE xxx NE
gene NE xxx NE
provides NE xxx NE
insights NE xxx NE
into NE xxx NE
the NE xxx NE
molecular G#other_name_B xxx G#other_name_B
mechanism G#other_name_E xxx G#other_name_E
of NE xx NE
human G#other_name_B xxx G#other_name_B
genome G#other_name_M xxx G#other_name_M
evolution G#other_name_E xxx G#other_name_E
and NE xxx NE
their NE xxx NE
possible NE xxx NE
involvement NE xxx NE
in NE xx NE
human G#other_name_B xxx G#other_name_B
diseases G#other_name_E xxx G#other_name_E
. NE . NE

BCL-6 G#protein_molecule XXX-d G#protein_molecule
and NE xxx NE
the NE xxx NE
molecular G#other_name_B xxx G#other_name_B
pathogenesis G#other_name_E xxx G#other_name_E
of NE xx NE
B-cell G#other_name_B X-xxx G#other_name_B
lymphoma G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
results NE xxx NE
presented NE xxx NE
identify NE xxx NE
the NE xxx NE
first NE xxx NE
genetic G#other_name_B xxx G#other_name_B
lesion G#other_name_E xxx G#other_name_E
associated NE xxx NE
with NE xxx NE
DLCL G#other_name XXXX G#other_name
, NE , NE
the NE xxx NE
most NE xxx NE
clinically NE xxx NE
relevant NE xxx NE
form NE xxx NE
of NE xx NE
NHL G#other_name XXX G#other_name
. NE . NE

Although NE Xxxx NE
no NE xx NE
proof NE xxx NE
yet NE xxx NE
exists NE xxx NE
of NE xx NE
a NE x NE
role NE xxx NE
for NE xxx NE
these NE xxx NE
lesions NE xxx NE
in NE xx NE
DLCL G#other_name_B XXXX G#other_name_B
pathogenesis G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
feature NE xxx NE
of NE xx NE
the NE xxx NE
BCL-6 G#protein_molecule_B XXX-d G#protein_molecule_B
gene G#protein_molecule_M xxx G#protein_molecule_M
product G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
its NE xxx NE
specific NE xxx NE
pattern NE xxx NE
of NE xx NE
expression NE xxx NE
in NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
and NE xxx NE
the NE xxx NE
clustering NE xxx NE
of NE xx NE
lesions NE xxx NE
disrupting NE xxx NE
its NE xxx NE
regulatory NE xxx NE
domain NE xxx NE
strongly NE xxx NE
suggest NE xxx NE
that NE xxx NE
deregulation NE xxx NE
of NE xx NE
BCL-6 G#other_name_B XXX-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
may NE xxx NE
contribute NE xxx NE
to NE xx NE
DLCL G#other_name XXXX G#other_name
development NE xxx NE
. NE . NE

A NE X NE
more NE xxx NE
precise NE xxx NE
definition NE xxx NE
of NE xx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
BCL-6 G#protein_molecule XXX-d G#protein_molecule
in NE xx NE
normal NE xxx NE
and NE xxx NE
neoplastic G#other_name_B xxx G#other_name_B
B-cell G#other_name_M X-xxx G#other_name_M
development G#other_name_E xxx G#other_name_E
is NE xx NE
the NE xxx NE
goal NE xxx NE
of NE xx NE
ongoing NE xxx NE
study NE xxx NE
of NE xx NE
transgenic NE xxx NE
mice NE xxx NE
engineered NE xxx NE
either NE xxx NE
to NE xx NE
express NE xxx NE
BCL-6 NE XXX-d NE
under NE xxx NE
heterologous NE xxx NE
promoters NE xxx NE
or NE xx NE
lacking NE xxx NE
BCL-6 NE XXX-d NE
function NE xxx NE
due NE xxx NE
to NE xx NE
targeted NE xxx NE
deletions NE xxx NE
. NE . NE

In NE Xx NE
addition NE xxx NE
to NE xx NE
contributing NE xxx NE
to NE xx NE
the NE xxx NE
understanding NE xxx NE
of NE xx NE
DLCL G#other_name_B XXXX G#other_name_B
pathogenesis G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
identification NE xxx NE
of NE xx NE
BCL-6 G#other_name_B XXX-d G#other_name_B
lesions G#other_name_E xxx G#other_name_E
may NE xxx NE
have NE xxx NE
relevant NE xxx NE
clinical NE xxx NE
implications NE xxx NE
. NE . NE

DLCL G#other_name XXXX G#other_name
represent NE xxx NE
a NE x NE
heterogeneous NE xxx NE
group NE xxx NE
of NE xx NE
neoplasms G#other_name xxx G#other_name
which NE xxx NE
are NE xxx NE
treated NE xxx NE
homogeneously NE xxx NE
despite NE xxx NE
the NE xxx NE
fact NE xxx NE
that NE xxx NE
only NE xxx NE
50% NE dd% NE
of NE xx NE
patients G#multi_cell xxx G#multi_cell
experience NE xxx NE
long-term G#other_name_B xxx-xxx G#other_name_B
disease-free G#other_name_M xxx-xxx G#other_name_M
survival G#other_name_E xxx G#other_name_E
(Schneider NE (Xxxx NE
et NE xx NE
al NE xx NE
. NE . NE
1990) NE dddd) NE
. NE . NE

The NE Xxx NE
fact NE xxx NE
that NE xxx NE
BCL-6 G#other_name_B XXX-d G#other_name_B
rearrangements G#other_name_E xxx G#other_name_E
identify NE xxx NE
biologically NE xxx NE
and NE xxx NE
clinically NE xxx NE
distinct NE xxx NE
subsets NE xxx NE
of NE xx NE
DLCL G#other_name XXXX G#other_name
suggests NE xxx NE
that NE xxx NE
these NE xxx NE
lesions NE xxx NE
may NE xxx NE
be NE xx NE
useful NE xxx NE
as NE xx NE
markers NE xxx NE
in NE xx NE
selection NE xxx NE
of NE xx NE
differential NE xxx NE
therapeutic NE xxx NE
strategies NE xxx NE
based NE xxx NE
on NE xx NE
different NE xxx NE
risk NE xxx NE
groups NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
the NE xxx NE
BCL-6 G#other_name_B XXX-d G#other_name_B
rearrangements G#other_name_E xxx G#other_name_E
can NE xxx NE
be NE xx NE
used NE xxx NE
to NE xx NE
identify NE xxx NE
and NE xxx NE
monitor NE xxx NE
the NE xxx NE
malignant G#cell_type_B xxx G#cell_type_B
clone G#cell_type_E xxx G#cell_type_E
with NE xxx NE
sensitive NE xxx NE
PCR-based G#other_name_B XXX-xxx G#other_name_B
techniques G#other_name_E xxx G#other_name_E
. NE . NE

Since NE Xxxx NE
clinical NE xxx NE
remission NE xxx NE
has NE xxx NE
been NE xxx NE
observed NE xxx NE
in NE xx NE
a NE x NE
significant NE xxx NE
fraction NE xxx NE
of NE xx NE
DLCL G#other_name XXXX G#other_name
cases NE xxx NE
, NE , NE
these NE xxx NE
markers NE xxx NE
may NE xxx NE
serve NE xxx NE
as NE xx NE
critical NE xxx NE
tools NE xxx NE
for NE xxx NE
sensitive NE xxx NE
monitoring NE xxx NE
of NE xx NE
minimal NE xxx NE
residual G#other_name_B xxx G#other_name_B
disease G#other_name_E xxx G#other_name_E
and NE xxx NE
early NE xxx NE
diagnosis NE xxx NE
of NE xx NE
relapse NE xxx NE
(Gribben NE (Xxxx NE
et NE xx NE
al NE xx NE
. NE . NE
1993) NE dddd) NE
. NE . NE

Pancreatic NE Xxxx NE
development NE xxx NE
and NE xxx NE
maturation NE xxx NE
of NE xx NE
the NE xxx NE
islet G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E
. NE . NE

Studies NE Xxxx NE
of NE xx NE
pluripotent G#cell_line_B xxx G#cell_line_B
islet G#cell_line_M xxx G#cell_line_M
cultures G#cell_line_E xxx G#cell_line_E
. NE . NE

Pancreas G#other_name_B Xxxx G#other_name_B
organogenesis G#other_name_E xxx G#other_name_E
is NE xx NE
a NE x NE
highly NE xxx NE
regulated NE xxx NE
process NE xxx NE
, NE , NE
in NE xx NE
which NE xxx NE
two NE xxx NE
anlage NE xxx NE
evaginate NE xxx NE
from NE xxx NE
the NE xxx NE
primitive G#body_part_B xxx G#body_part_B
gut G#body_part_E xxx G#body_part_E
. NE . NE

They NE Xxxx NE
later NE xxx NE
fuse NE xxx NE
, NE , NE
and NE xxx NE
, NE , NE
under NE xxx NE
the NE xxx NE
influence NE xxx NE
of NE xx NE
the NE xxx NE
surrounding NE xxx NE
mesenchyme G#tissue xxx G#tissue
, NE , NE
the NE xxx NE
mature G#body_part_B xxx G#body_part_B
organ G#body_part_E xxx G#body_part_E
develops NE xxx NE
, NE , NE
being NE xxx NE
mainly NE xxx NE
composed NE xxx NE
of NE xx NE
ductal G#body_part_B xxx G#body_part_B
compartment G#body_part_M xxx G#body_part_M
and G#body_part_M xxx G#body_part_M
exocrine G#body_part_M xxx G#body_part_M
compartment G#body_part_M xxx G#body_part_M
and G#body_part_M xxx G#body_part_M
endocrine G#body_part_M xxx G#body_part_M
compartment G#body_part_E xxx G#body_part_E

Early NE Xxxx NE
buds NE xxx NE
are NE xxx NE
characterized NE xxx NE
by NE xx NE
a NE x NE
branching NE xxx NE
morphogenesis NE xxx NE
of NE xx NE
the NE xxx NE
ductal G#tissue_B xxx G#tissue_B
epithelium G#tissue_E xxx G#tissue_E
from NE xxx NE
which NE xxx NE
endocrine G#cell_type_B xxx G#cell_type_B
precursor G#cell_type_M xxx G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
exocrine G#cell_type_M xxx G#cell_type_M
precursor G#cell_type_M xxx G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E

The NE Xxx NE
three NE xxx NE
compartments NE xxx NE
are NE xxx NE
thought NE xxx NE
to NE xx NE
be NE xx NE
of NE xx NE
common NE xxx NE
endodermal G#other_name_B xxx G#other_name_B
origin G#other_name_E xxx G#other_name_E
; NE ; NE
in NE xx NE
contrast NE xxx NE
to NE xx NE
earlier NE xxx NE
hypotheses NE xxx NE
, NE , NE
which NE xxx NE
suggested NE xxx NE
that NE xxx NE
the NE xxx NE
endocrine NE xxx NE
compartment NE xxx NE
was NE xxx NE
of NE xx NE
neuroectodermal G#other_name_B xxx G#other_name_B
origin G#other_name_E xxx G#other_name_E
. NE . NE

It NE Xx NE
is NE xx NE
thus NE xxx NE
generally NE xxx NE
believed NE xxx NE
that NE xxx NE
the NE xxx NE
pancreatic G#other_name_B xxx G#other_name_B
endocrine-lineage G#other_name_E xxx-xxx G#other_name_E
possesses NE xxx NE
the NE xxx NE
ability NE xxx NE
to NE xx NE
mature NE xxx NE
along NE xxx NE
a NE x NE
differentiation G#other_name_B xxx G#other_name_B
pathway G#other_name_E xxx G#other_name_E
that NE xxx NE
shares NE xxx NE
many NE xxx NE
characteristics NE xxx NE
with NE xxx NE
those NE xxx NE
of NE xx NE
neuronal G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

During NE Xxxx NE
recent NE xxx NE
years NE xxx NE
, NE , NE
studies NE xxx NE
of NE xx NE
insulin-gene G#other_name_B xxx-xxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
and NE xxx NE
, NE , NE
in NE xx NE
particular NE xxx NE
, NE , NE
the NE xxx NE
tissue-specific G#other_name_B xxx-xxx G#other_name_B
transcriptional G#other_name_M xxx G#other_name_M
control G#other_name_E xxx G#other_name_E
of NE xx NE
insulin-gene G#other_name_B xxx-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
have NE xxx NE
provided NE xxx NE
information NE xxx NE
on NE xx NE
pancreas G#other_name_B xxx G#other_name_B
development G#other_name_E xxx G#other_name_E
in NE xx NE
general NE xxx NE
. NE . NE

The NE Xxx NE
present NE xxx NE
review NE xxx NE
summarizes NE xxx NE
these NE xxx NE
findings NE xxx NE
, NE , NE
with NE xxx NE
a NE x NE
special NE xxx NE
focus NE xxx NE
on NE xx NE
our NE xxx NE
own NE xxx NE
studies NE xxx NE
on NE xx NE
pluripotent G#cell_line_B xxx G#cell_line_B
endocrine G#cell_line_M xxx G#cell_line_M
cultures G#cell_line_E xxx G#cell_line_E
of NE xx NE
rat G#body_part_B xxx G#body_part_B
pancreas G#body_part_E xxx G#body_part_E
. NE . NE

Octamer G#other_name_B Xxxx G#other_name_B
independent G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
of NE xx NE
transcription G#other_name xxx G#other_name
from NE xxx NE
the NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
immunoglobulin G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
germline G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Previous NE Xxxx NE
analyses NE xxx NE
of NE xx NE
immunoglobulin G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
V G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
region G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoters G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
has NE xxx NE
led NE xxx NE
to NE xx NE
the NE xxx NE
discovery NE xxx NE
of NE xx NE
a NE x NE
common NE xxx NE
octamer G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
which NE xxx NE
is NE xx NE
functionally NE xxx NE
important NE xxx NE
in NE xx NE
the NE xxx NE
tissue-specific NE xxx-xxx NE
and NE xxx NE
developmentally NE xxx NE
regulated NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
of NE xx NE
immunoglobulin G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

The NE Xxx NE
germline G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
promoters G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
( NE ( NE
Ko G#DNA_family_or_group Xx G#DNA_family_or_group
) NE ) NE
located NE xxx NE
upstream NE xxx NE
of NE xx NE
the NE xxx NE
J G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
region G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
segments G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
locus G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
also NE xxx NE
contain NE xxx NE
an NE xx NE
octamer G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
(containing NE (xxx NE
a NE x NE
single NE xxx NE
base G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
pair G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
mutation G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
referred NE xxx NE
to NE xx NE
as NE xx NE
the NE xxx NE
variant NE xxx NE
octamer) NE xxx) NE
which NE xxx NE
has NE xxx NE
been NE xxx NE
shown NE xxx NE
previously NE xxx NE
to NE xx NE
bind NE xxx NE
Oct-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
vitro NE xxx NE
. NE . NE

To NE Xx NE
further NE xxx NE
elucidate NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
this NE xxx NE
variant NE xxx NE
octamer G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
germline G#other_name_B xxx G#other_name_B
transcription G#other_name_E xxx G#other_name_E
from NE xxx NE
the NE xxx NE
unrearranged NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
locus G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
we NE xx NE
have NE xxx NE
quantitated NE xxx NE
the NE xxx NE
relative NE xxx NE
binding NE xxx NE
affinity NE xxx NE
of NE xx NE
Oct-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
for NE xxx NE
the NE xxx NE
variant NE xxx NE
octamer G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
determined NE xxx NE
the NE xxx NE
functional NE xxx NE
role NE xxx NE
of NE xx NE
this NE xxx NE
octamer G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
transcriptional G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
find NE xxx NE
that NE xxx NE
, NE , NE
although NE xxx NE
the NE xxx NE
variant NE xxx NE
octamer G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
binds NE xxx NE
Oct-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
in NE xx NE
vitro NE xxx NE
with NE xxx NE
5-fold NE d-xxx NE
lower NE xxx NE
affinity NE xxx NE
than NE xxx NE
the NE xxx NE
consensus G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
octamer G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
mutation NE xxx NE
of NE xx NE
the NE xxx NE
variant NE xxx NE
octamer G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
to NE xx NE
either NE xxx NE
a NE x NE
consensus G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
octamer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
or NE xx NE
non- NE xxx- NE
octamer NE xxx NE
motif NE xxx NE
has NE xxx NE
no NE xx NE
effect NE xxx NE
on NE xx NE
transcriptional NE xxx NE
activation NE xxx NE
from NE xxx NE
the NE xxx NE
germline NE xxx NE
promoter NE xxx NE
. NE . NE

We NE Xx NE
also NE xxx NE
find NE xxx NE
significant NE xxx NE
differences NE xxx NE
in NE xx NE
activation NE xxx NE
of NE xx NE
germline NE xxx NE
and NE xxx NE
V NE X NE
region NE xxx NE
promoters NE xxx NE
by NE xx NE
kappa NE xxx NE
enhancers NE xxx NE
. NE . NE

Our NE Xxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
germline G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
promoters G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
V G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
region G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoters G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
differ NE xxx NE
in NE xx NE
their NE xxx NE
dependence NE xxx NE
on NE xx NE
octamer G#DNA_domain_or_region xxx G#DNA_domain_or_region
for NE xxx NE
activation NE xxx NE
and NE xxx NE
respond NE xxx NE
differently NE xxx NE
to NE xx NE
enhancer G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
findings NE xxx NE
have NE xxx NE
important NE xxx NE
implications NE xxx NE
in NE xx NE
regulation NE xxx NE
of NE xx NE
germline G#other_name_B xxx G#other_name_B
transcription G#other_name_E xxx G#other_name_E
as NE xx NE
well NE xxx NE
as NE xx NE
concomitant NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
V-J G#other_name_B X-X G#other_name_B
recombination G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
light G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
chain G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
locus G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Generation NE Xxxx NE
of NE xx NE
CD1+RelB+ G#cell_type_B XXd+XxxX+ G#cell_type_B
dendritic G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
tartrate-resistant G#cell_type_B xxx-xxx G#cell_type_B
acid G#cell_type_M xxx G#cell_type_M
phosphatase-positive G#cell_type_M xxx-xxx G#cell_type_M
osteoclast-like G#cell_type_M xxx-xxx G#cell_type_M
multinucleated G#cell_type_M xxx G#cell_type_M
giant G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
from NE xxx NE
human G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

We NE Xx NE
previously NE xxx NE
showed NE xxx NE
that NE xxx NE
granulocyte-macrophage G#protein_molecule_B xxx-xxx G#protein_molecule_B
colony-stimulating G#protein_molecule_M xxx-xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
) NE ) NE
and NE xxx NE
macrophage G#protein_family_or_group_B xxx G#protein_family_or_group_B
colony-stimulating G#protein_family_or_group_M xxx-xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
M-CSF G#protein_molecule X-XXX G#protein_molecule
) NE ) NE
stimulate NE xxx NE
the NE xxx NE
differentiation NE xxx NE
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
into NE xxx NE
two NE xxx NE
phenotypically NE xxx NE
distinct NE xxx NE
types NE xxx NE
of NE xx NE
macrophages G#cell_type xxx G#cell_type
. NE . NE

However NE Xxxx NE
, NE , NE
in NE xx NE
vivo NE xxx NE
, NE , NE
not NE xxx NE
only NE xxx NE
CSF G#protein_molecule XXX G#protein_molecule
but NE xxx NE
also NE xxx NE
many NE xxx NE
other NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
are NE xxx NE
produced NE xxx NE
under NE xxx NE
various NE xxx NE
conditions NE xxx NE
. NE . NE

Those NE Xxxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
may NE xxx NE
modulate NE xxx NE
the NE xxx NE
differentiation NE xxx NE
of NE xx NE
monocytes G#cell_type xxx G#cell_type
by NE xx NE
CSFs G#protein_family_or_group XXXx G#protein_family_or_group
. NE . NE

In NE Xx NE
the NE xxx NE
present NE xxx NE
study NE xxx NE
, NE , NE
we NE xx NE
showed NE xxx NE
that NE xxx NE
CD14+ G#cell_type_B XXdd+ G#cell_type_B
adherent G#cell_type_M xxx G#cell_type_M
human G#cell_type_M xxx G#cell_type_M
monocytes G#cell_type_E xxx G#cell_type_E
can NE xxx NE
differentiate NE xxx NE
into NE xxx NE
CD1+relB+ G#cell_type_B XXd+xxxX+ G#cell_type_B
dendritic G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
DC G#cell_type XX G#cell_type
) NE ) NE
by NE xx NE
the NE xxx NE
combination NE xxx NE
of NE xx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
plus NE xxx NE
interleukin-4 G#protein_molecule xxx-d G#protein_molecule
( NE ( NE
IL-4 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
and NE xxx NE
that NE xxx NE
they NE xxx NE
differentiate NE xxx NE
into NE xxx NE
tartrate-resistant G#cell_type_B xxx-xxx G#cell_type_B
acid G#cell_type_M xxx G#cell_type_M
phosphatase G#cell_type_M xxx G#cell_type_M
(TRAP)-positive G#cell_type_M (XXXX)-xxx G#cell_type_M
osteoclast-like G#cell_type_M xxx-xxx G#cell_type_M
multinucleated G#cell_type_M xxx G#cell_type_M
giant G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
MGC G#cell_type XXX G#cell_type
) NE ) NE
by NE xx NE
the NE xxx NE
combination NE xxx NE
of NE xx NE
M-CSF G#protein_molecule X-XXX G#protein_molecule
plus NE xxx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
. NE . NE

However NE Xxxx NE
, NE , NE
the NE xxx NE
monocyte-derived G#cell_line_B xxx-xxx G#cell_line_B
DC G#cell_line_E XX G#cell_line_E
were NE xxx NE
not NE xxx NE
terminally G#cell_line_B xxx G#cell_line_B
differentiated G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
; NE ; NE
they NE xxx NE
could NE xxx NE
still NE xxx NE
convert NE xxx NE
to NE xx NE
macrophages G#cell_type xxx G#cell_type
in NE xx NE
response NE xxx NE
to NE xx NE
M-CSF G#protein_molecule X-XXX G#protein_molecule
. NE . NE

Tumor G#protein_molecule_B Xxxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor-alpha G#protein_molecule_E xxx-xxx G#protein_molecule_E
( NE ( NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
) NE ) NE
stimulated NE xxx NE
the NE xxx NE
terminal G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
DC G#cell_type XX G#cell_type
by NE xx NE
downregulating NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
M-CSF G#protein_molecule_B X-XXX G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
cfms G#RNA_molecule_B xxx G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
, NE , NE
and NE xxx NE
aborting NE xxx NE
the NE xxx NE
potential NE xxx NE
to NE xx NE
convert NE xxx NE
to NE xx NE
macrophages G#cell_type xxx G#cell_type
. NE . NE

In NE Xx NE
contrast NE xxx NE
to NE xx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
, NE , NE
interferon-gamma G#protein_molecule xxx-xxx G#protein_molecule
( NE ( NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
) NE ) NE
had NE xxx NE
no NE xx NE
demonstrable NE xxx NE
effect NE xxx NE
on NE xx NE
the NE xxx NE
differentiation NE xxx NE
of NE xx NE
monocytes G#cell_type xxx G#cell_type
. NE . NE

Rather NE Xxxx NE
, NE , NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
antagonized NE xxx NE
the NE xxx NE
effect NE xxx NE
of NE xx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
suppressed NE xxx NE
the NE xxx NE
DC G#other_name_B XX G#other_name_B
and G#other_name_M xxx G#other_name_M
MGC G#other_name_M XXX G#other_name_M
formation G#other_name_E xxx G#other_name_E
induced NE xxx NE
by NE xx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
+ NE + NE
IL-4 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
M-CSF G#protein_molecule X-XXX G#protein_molecule
+ NE + NE
IL-4 G#protein_molecule XX-d G#protein_molecule
, NE , NE
respectively NE xxx NE
. NE . NE

Taken NE Xxxx NE
together NE xxx NE
, NE , NE
these NE xxx NE
results NE xxx NE
provide NE xxx NE
a NE x NE
new NE xxx NE
aspect NE xxx NE
to NE xx NE
our NE xxx NE
knowledge NE xxx NE
of NE xx NE
monocyte NE xxx NE
differentiation NE xxx NE
and NE xxx NE
provide NE xxx NE
evidence NE xxx NE
that NE xxx NE
human G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
are NE xxx NE
flexible NE xxx NE
in NE xx NE
their NE xxx NE
differentiation G#other_name_B xxx G#other_name_B
potential G#other_name_E xxx G#other_name_E
and NE xxx NE
are NE xxx NE
precursors NE xxx NE
not NE xxx NE
only NE xxx NE
of NE xx NE
macrophages G#cell_type xxx G#cell_type
but NE xxx NE
also NE xxx NE
of NE xx NE
CD1+relB+DC G#cell_type XXd+xxxX+XX G#cell_type
and NE xxx NE
TRAP-positive G#cell_type_B XXXX-xxx G#cell_type_B
MGC G#cell_type_E XXX G#cell_type_E
. NE . NE

Such NE Xxxx NE
a NE x NE
diverse NE xxx NE
pathway NE xxx NE
of NE xx NE
monocyte G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
may NE xxx NE
constitute NE xxx NE
one NE xxx NE
of NE xx NE
the NE xxx NE
basic NE xxx NE
mechanisms NE xxx NE
of NE xx NE
immune G#other_name_B xxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
NF-kappa G#other_organic_compound_B XX-xxx G#other_organic_compound_B
B G#other_organic_compound_M X G#other_organic_compound_M
inhibitor G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
tepoxalin NE xxx NE
, NE , NE
suppresses NE xxx NE
surface NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
cell G#protein_family_or_group_B xxx G#protein_family_or_group_B
adhesion G#protein_family_or_group_M xxx G#protein_family_or_group_M
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
CD62E G#protein_molecule XXddX G#protein_molecule
, NE , NE
CD11b/CD18 G#protein_molecule XXddx/XXdd G#protein_molecule
and NE xxx NE
CD106 G#protein_molecule XXddd G#protein_molecule
. NE . NE

Tepoxalin G#other_organic_compound Xxxx G#other_organic_compound
, NE , NE
a NE x NE
dual G#other_organic_compound_B xxx G#other_organic_compound_B
enzyme G#other_organic_compound_M xxx G#other_organic_compound_M
inhibitor G#other_organic_compound_E xxx G#other_organic_compound_E
of NE xx NE
cyclooxygenase G#protein_molecule xxx G#protein_molecule
and NE xxx NE
5-lipoxygenase G#protein_molecule d-xxx G#protein_molecule
has NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
inhibit NE xxx NE
T-cell G#other_name_B X-xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

Its NE Xxx NE
immunosuppressive G#other_name_B xxx G#other_name_B
property G#other_name_E xxx G#other_name_E
is NE xx NE
distinct NE xxx NE
from NE xxx NE
cyclosporin G#other_organic_compound xxx G#other_organic_compound
because NE xxx NE
only NE xxx NE
tepoxalin NE xxx NE
, NE , NE
but NE xxx NE
not NE xxx NE
cyclosporin G#other_organic_compound xxx G#other_organic_compound
, NE , NE
suppresses NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

Here NE Xxxx NE
we NE xx NE
report NE xxx NE
that NE xxx NE
tepoxalin G#other_organic_compound xxx G#other_organic_compound
selectively NE xxx NE
inhibits NE xxx NE
intercellular NE xxx NE
adhesion NE xxx NE
molecule-1 NE xxx-d NE
( NE ( NE
ICAM-1 NE XXXX-d NE
, NE , NE
CD54 NE XXdd NE
)/MAC-1 NE )/XXX-d NE
( NE ( NE
CD11b/CD18 NE XXddx/XXdd NE
) NE ) NE
dependent NE xxx NE
adhesion NE xxx NE
of NE xx NE
polymorphonuclear NE xxx NE
cells NE xxx NE
to NE xx NE
IL-1 NE XX-d NE
activated NE xxx NE
human NE xxx NE
umbilical NE xxx NE
vein NE xxx NE
endothelial NE xxx NE
cells NE xxx NE
. NE . NE

The NE Xxx NE
mechanism NE xxx NE
of NE xx NE
inhibition NE xxx NE
is NE xx NE
related NE xxx NE
to NE xx NE
the NE xxx NE
surface G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
several NE xxx NE
cell NE xxx NE
adhesion G#protein_family_or_group_B xxx G#protein_family_or_group_B
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Flow NE Xxxx NE
cytometry NE xxx NE
analyses NE xxx NE
on NE xx NE
cultured NE xxx NE
cells NE xxx NE
that NE xxx NE
were NE xxx NE
treated NE xxx NE
with NE xxx NE
tepoxalin NE xxx NE
or NE xx NE
antisense NE xxx NE
oligonucleotides NE xxx NE
to NE xx NE
the NE xxx NE
P65/p50 NE Xdd/xdd NE
subunit NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
, NE , NE
and NE xxx NE
then NE xxx NE
stimulated NE xxx NE
with NE xxx NE
PMA NE XXX NE
, NE , NE
revealed NE xxx NE
a NE x NE
reduced NE xxx NE
expression NE xxx NE
of NE xx NE
CD11b/CD18 NE XXddx/XXdd NE
on NE xx NE
monocytic NE xxx NE
HL60 NE XXdd NE
cells NE xxx NE
, NE , NE
and NE xxx NE
endothelial NE xxx NE
adhesion NE xxx NE
molecule-1 NE xxx-d NE
( NE ( NE
CD62E NE XXddX NE
) NE ) NE
and NE xxx NE
vascular NE xxx NE
adhesion NE xxx NE
molecule-1 NE xxx-d NE
( NE ( NE
CD106 NE XXddd NE
) NE ) NE
on NE xx NE
human NE xxx NE
umbilical NE xxx NE
vein NE xxx NE
endothelial NE xxx NE
cells NE xxx NE
. NE . NE

Expression NE Xxxx NE
of NE xx NE
other NE xxx NE
adhesion G#protein_family_or_group_B xxx G#protein_family_or_group_B
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
such NE xxx NE
as NE xx NE
lymphocyte G#protein_molecule_B xxx G#protein_molecule_B
function G#protein_molecule_M xxx G#protein_molecule_M
associated-antigen-1 G#protein_molecule_E xxx-xxx-d G#protein_molecule_E
( NE ( NE
CD11a NE XXddx NE
/CD18 NE /XXdd NE
) NE ) NE
and NE xxx NE
CD54 NE XXdd NE
were NE xxx NE
unaffected NE xxx NE
. NE . NE

Tepoxalin G#other_organic_compound Xxxx G#other_organic_compound
also NE xxx NE
inhibited NE xxx NE
the NE xxx NE
secretion NE xxx NE
of NE xx NE
a NE x NE
NF-kappa G#protein_family_or_group_B XX-xxx G#protein_family_or_group_B
B G#protein_family_or_group_M X G#protein_family_or_group_M
regulated G#protein_family_or_group_M xxx G#protein_family_or_group_M
chemokine G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
IL-8 G#protein_molecule XX-d G#protein_molecule
, NE , NE
a NE x NE
known NE xxx NE
inducer NE xxx NE
of NE xx NE
CD11b/CD18 G#other_name_B XXddx/XXdd G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

Thus NE Xxxx NE
the NE xxx NE
suppression NE xxx NE
of NE xx NE
CD11b/CD18 G#protein_molecule XXddx/XXdd G#protein_molecule
expression NE xxx NE
by NE xx NE
tepoxalin G#other_organic_compound xxx G#other_organic_compound
may NE xxx NE
involve NE xxx NE
IL-8 G#protein_molecule XX-d G#protein_molecule
. NE . NE

Our NE Xxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
by NE xx NE
inhibiting NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
, NE , NE
surface NE xxx NE
expression NE xxx NE
of NE xx NE
several NE xxx NE
adhesion G#protein_family_or_group_B xxx G#protein_family_or_group_B
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
can NE xxx NE
be NE xx NE
modulated NE xxx NE
and NE xxx NE
that NE xxx NE
tepoxalin G#other_organic_compound xxx G#other_organic_compound
may NE xxx NE
be NE xx NE
useful NE xxx NE
in NE xx NE
treating NE xxx NE
selected NE xxx NE
adhesion G#other_name_B xxx G#other_name_B
mediated G#other_name_M xxx G#other_name_M
events G#other_name_E xxx G#other_name_E
such NE xxx NE
as NE xx NE
leukocyte G#other_name_B xxx G#other_name_B
migration G#other_name_E xxx G#other_name_E
or NE xx NE
atherosclerotic G#other_name_B xxx G#other_name_B
plaque G#other_name_M xxx G#other_name_M
formation G#other_name_E xxx G#other_name_E
. NE . NE

Characterization NE Xxxx NE
of NE xx NE
a NE x NE
CD43/leukosialin NE XXdd/xxx NE
-mediated NE -xxx NE
pathway NE xxx NE
for NE xxx NE
inducing NE xxx NE
apoptosis NE xxx NE
in NE xx NE
human NE xxx NE
T-lymphoblastoid NE X-xxx NE
cells NE xxx NE
. NE . NE

The NE Xxx NE
monoclonal G#protein_family_or_group_B xxx G#protein_family_or_group_B
antibody G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
mAb G#protein_family_or_group xXx G#protein_family_or_group
) NE ) NE
J393 G#protein_molecule Xddd G#protein_molecule
induces NE xxx NE
apoptosis G#other_name xxx G#other_name
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T-cells G#cell_line_E X-xxx G#cell_line_E
. NE . NE

NH2 NE XXd NE
-terminal NE -xxx NE
amino NE xxx NE
acid NE xxx NE
sequence NE xxx NE
analysis NE xxx NE
identified NE xxx NE
the NE xxx NE
140-kDa NE ddd-xXx NE
surface NE xxx NE
antigen NE xxx NE
for NE xxx NE
mAb NE xXx NE
J393 NE Xddd NE
as NE xx NE
CD43/leukosialin NE XXdd/xxx NE
, NE , NE
the NE xxx NE
major NE xxx NE
sialoglycoprotein NE xxx NE
of NE xx NE
leukocytes NE xxx NE
. NE . NE

While NE Xxxx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
co-expressed NE xx-xxx NE
two NE xxx NE
discrete NE xxx NE
cell-surface G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
isoforms G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
CD43 G#protein_molecule XXdd G#protein_molecule
, NE , NE
recognized NE xxx NE
by NE xx NE
mAb G#protein_molecule_B xXx G#protein_molecule_B
J393 G#protein_molecule_E Xddd G#protein_molecule_E
and NE xxx NE
mAb G#protein_molecule_B xXx G#protein_molecule_B
G10-2 G#protein_molecule_E Xdd-d G#protein_molecule_E
, NE , NE
respectively NE xxx NE
, NE , NE
only NE xxx NE
J393 NE Xddd NE
/ NE / NE
CD43 NE XXdd NE
signaled NE xxx NE
apoptosis NE xxx NE
. NE . NE

J393/ G#protein_molecule Xddd/ G#protein_molecule
CD43 NE XXdd NE
was NE xxx NE
found NE xxx NE
to NE xx NE
be NE xx NE
hyposialylated NE xxx NE
, NE , NE
bearing NE xxx NE
predominantly NE xxx NE
O-linked G#carbohydrate_B X-xxx G#carbohydrate_B
monosaccharide G#carbohydrate_M xxx G#carbohydrate_M
glycans G#carbohydrate_E xxx G#carbohydrate_E
, NE , NE
whereas NE xxx NE
G10-2/ G#protein_molecule Xdd-d/ G#protein_molecule
CD43 NE XXdd NE
bore NE xxx NE
complex NE xxx NE
sialylated G#carbohydrate_B xxx G#carbohydrate_B
tetra-chain G#carbohydrate_M xxx-xxx G#carbohydrate_M
and G#carbohydrate_M xxx G#carbohydrate_M
hexasaccharide G#carbohydrate_M xxx G#carbohydrate_M
chain G#carbohydrate_E xxx G#carbohydrate_E

Treatment NE Xxxx NE
with NE xxx NE
soluble NE xxx NE
, NE , NE
bivalent NE xxx NE
mAb G#protein_molecule_B xXx G#protein_molecule_B
J393 G#protein_molecule_E Xddd G#protein_molecule_E
killed NE xxx NE
25-50% NE dd-dd% NE
of NE xx NE
the NE xxx NE
cell G#cell_line_B xxx G#cell_line_B
population G#cell_line_E xxx G#cell_line_E
, NE , NE
while NE xxx NE
concomitant NE xxx NE
engagement NE xxx NE
of NE xx NE
either NE xxx NE
the NE xxx NE
CD3.TcR G#protein_complex_B XXd.XxX G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
or NE xx NE
the NE xxx NE
integrins G#protein_family_or_group xxx G#protein_family_or_group
CD18 G#protein_molecule XXdd G#protein_molecule
and NE xxx NE
CD29 G#protein_molecule XXdd G#protein_molecule
significantly NE xxx NE
potentiated NE xxx NE
this NE xxx NE
effect NE xxx NE
. NE . NE

Treatment NE Xxxx NE
of NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
mAb G#protein_molecule_B xXx G#protein_molecule_B
J393 G#protein_molecule_E Xddd G#protein_molecule_E
induced NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
specific NE xxx NE
protein G#protein_family_or_group_B xxx G#protein_family_or_group_B
substrates G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
underwent NE xxx NE
hyperphosphorylation G#other_name xxx G#other_name
upon NE xxx NE
antigen G#other_name_B xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
costimulation G#other_name_E xxx G#other_name_E
. NE . NE

Tyrosine G#other_name_B Xxxx G#other_name_B
kinase G#other_name_M xxx G#other_name_M
inhibition G#other_name_E xxx G#other_name_E
by NE xx NE
herbimycin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
diminished NE xxx NE
J393 NE Xddd NE
/ NE / NE
CD43 NE XXdd NE
-mediated NE -xxx NE
apoptosis NE xxx NE
, NE , NE
whereas NE xxx NE
inhibition NE xxx NE
of NE xx NE
phosphotyrosine NE xxx NE
phosphatase NE xxx NE
activity NE xxx NE
by NE xx NE
bis(maltolato)oxovanadium-IV NE xxx(xxx)xxx-XX NE
enhanced NE xxx NE
cell NE xxx NE
death NE xxx NE
. NE . NE

Signal NE Xxxx NE
transduction NE xxx NE
through NE xxx NE
tyrosine G#amino_acid_monomer xxx G#amino_acid_monomer
kinase NE xxx NE
activation NE xxx NE
may NE xxx NE
lead NE xxx NE
to NE xx NE
altered NE xxx NE
gene NE xxx NE
expression NE xxx NE
, NE , NE
as NE xx NE
J393 NE Xddd NE
/ NE / NE
CD43 G#protein_molecule XXdd G#protein_molecule
ligation NE xxx NE
prompted NE xxx NE
decreases NE xxx NE
in NE xx NE
the NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
localization G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
transcriptional G#protein_family_or_group_B xxx G#protein_family_or_group_B
regulatory G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
NF-kappaB G#protein_complex XX-xxxX G#protein_complex
and NE xxx NE
proteins NE xxx NE
binding NE xxx NE
the NE xxx NE
interferon-inducible G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
regulatory G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Since NE Xxxx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
T-lymphocytes G#cell_type_E X-xxx G#cell_type_E
express NE xxx NE
cryptic G#protein_family_or_group_B xxx G#protein_family_or_group_B
epitopes G#protein_family_or_group_E xxx G#protein_family_or_group_E
for NE xxx NE
mAb G#protein_molecule_B xXx G#protein_molecule_B
J393 G#protein_molecule_E Xddd G#protein_molecule_E
, NE , NE
these NE xxx NE
findings NE xxx NE
demonstrate NE xxx NE
the NE xxx NE
existence NE xxx NE
of NE xx NE
a NE x NE
tightly NE xxx NE
regulated NE xxx NE
CD43 NE XXdd NE
-mediated NE -xxx NE
pathway NE xxx NE
for NE xxx NE
inducing NE xxx NE
apoptosis NE xxx NE
in NE xx NE
human NE xxx NE
T-cell NE X-xxx NE
lineages NE xxx NE
. NE . NE

Sterol G#other_name_B Xxxx G#other_name_B
dependent G#other_name_M xxx G#other_name_M
LDL-receptor G#other_name_M XXX-xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
in NE xx NE
lymphocytes G#cell_type xxx G#cell_type
from NE xxx NE
normal NE xxx NE
and NE xxx NE
CML G#multi_cell_B XXX G#multi_cell_B
patients G#multi_cell_E xxx G#multi_cell_E
. NE . NE

Sterol G#DNA_domain_or_region_B Xxxx G#DNA_domain_or_region_B
regulatory G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
SRE G#DNA_domain_or_region XXX G#DNA_domain_or_region
) NE ) NE
has NE xxx NE
been NE xxx NE
recognized NE xxx NE
to NE xx NE
regulate NE xxx NE
various NE xxx NE
key NE xxx NE
genes G#DNA_family_or_group xxx G#DNA_family_or_group
coding NE xxx NE
for NE xxx NE
especially NE xxx NE
low NE xxx NE
density NE xxx NE
lipoprotein NE xxx NE
( NE ( NE
LDL NE XXX NE
)-receptor NE )-xxx NE
, NE , NE
3-hydroxy-3-methylglutaryl NE d-xxx-d-xxx NE
coenzyme NE xxx NE
A NE X NE
(HMG-CoA) NE (XXX-XxX) NE
reductase NE xxx NE
and NE xxx NE
HMG-CoA NE XXX-XxX NE
synthase NE xxx NE
known NE xxx NE
to NE xx NE
play NE xxx NE
a NE x NE
crucial NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
cholesterol NE xxx NE
feedback NE xxx NE
mechanism NE xxx NE
. NE . NE

The NE Xxx NE
deranged NE xxx NE
cholesterol G#other_name_B xxx G#other_name_B
feedback G#other_name_M xxx G#other_name_M
mechanism G#other_name_E xxx G#other_name_E
has NE xxx NE
been NE xxx NE
widely NE xxx NE
recognised NE xxx NE
in NE xx NE
initiation NE xxx NE
as NE xx NE
well NE xxx NE
as NE xx NE
progression NE xxx NE
of NE xx NE
various NE xxx NE
types NE xxx NE
of NE xx NE
cancers G#other_name xxx G#other_name
including NE xxx NE
chronic G#other_name_B xxx G#other_name_B
myeloid G#other_name_M xxx G#other_name_M
leukaemia G#other_name_E xxx G#other_name_E
( NE ( NE
CML G#other_name XXX G#other_name
) NE ) NE
. NE . NE

Consequently NE Xxxx NE
, NE , NE
the NE xxx NE
present NE xxx NE
study NE xxx NE
was NE xxx NE
addressed NE xxx NE
to NE xx NE
understand NE xxx NE
this NE xxx NE
phenomenon NE xxx NE
and NE xxx NE
revealed NE xxx NE
the NE xxx NE
existence NE xxx NE
of NE xx NE
a NE x NE
unique G#protein_molecule_B xxx G#protein_molecule_B
47 G#protein_molecule_M dd G#protein_molecule_M
kDa G#protein_molecule_M xXx G#protein_molecule_M
protein G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
having NE xxx NE
affinity NE xxx NE
for NE xxx NE
this NE xxx NE
SRE G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
lymphocytes G#cell_type xxx G#cell_type
from NE xxx NE
normal G#multi_cell_B xxx G#multi_cell_B
subjects G#multi_cell_E xxx G#multi_cell_E
as NE xx NE
well NE xxx NE
as NE xx NE
its NE xxx NE
absence NE xxx NE
in NE xx NE
lymphocytes G#cell_type xxx G#cell_type
from NE xxx NE
untreated NE xxx NE
CML G#other_name XXX G#other_name
patients G#multi_cell xxx G#multi_cell
. NE . NE

However NE Xxxx NE
, NE , NE
this NE xxx NE
factor NE xxx NE
appeared NE xxx NE
when NE xxx NE
the NE xxx NE
CML G#other_name XXX G#other_name
patients G#multi_cell xxx G#multi_cell
achieved NE xxx NE
complete G#other_name_B xxx G#other_name_B
haematological G#other_name_M xxx G#other_name_M
remission G#other_name_E xxx G#other_name_E
( NE ( NE
CHR G#other_name XXX G#other_name
) NE ) NE
through NE xxx NE
alpha-interferon G#other_name_B xxx-xxx G#other_name_B
therapy G#other_name_E xxx G#other_name_E
. NE . NE

Further NE Xxxx NE
, NE , NE
an NE xx NE
inverse NE xxx NE
relationship NE xxx NE
was NE xxx NE
also NE xxx NE
observed NE xxx NE
between NE xxx NE
sterol NE xxx NE
modulated NE xxx NE
LDL NE XXX NE
-receptor NE -xxx NE
gene NE xxx NE
transcription NE xxx NE
and NE xxx NE
the NE xxx NE
binding NE xxx NE
affinity NE xxx NE
of NE xx NE
this NE xxx NE
47 NE dd NE
kDa NE xXx NE
factor NE xxx NE
to NE xx NE
the NE xxx NE
SRE NE XXX NE
sequence NE xxx NE
. NE . NE

Based NE Xxxx NE
upon NE xxx NE
these NE xxx NE
results NE xxx NE
we NE xx NE
propose NE xxx NE
that NE xxx NE
alpha-interferon G#protein_molecule xxx-xxx G#protein_molecule
through NE xxx NE
its NE xxx NE
receptor NE xxx NE
initiates NE xxx NE
phosphatidic G#other_name_B xxx G#other_name_B
acid G#other_name_M xxx G#other_name_M
dependent G#other_name_M xxx G#other_name_M
signalling G#other_name_E xxx G#other_name_E
which NE xxx NE
in NE xx NE
turn NE xxx NE
regulates NE xxx NE
the NE xxx NE
affinity NE xxx NE
of NE xx NE
47 G#protein_molecule_B dd G#protein_molecule_B
kDa G#protein_molecule_M xXx G#protein_molecule_M
sterol G#protein_molecule_M xxx G#protein_molecule_M
regulatory G#protein_molecule_M xxx G#protein_molecule_M
element G#protein_molecule_M xxx G#protein_molecule_M
binding G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
as NE xx NE
well NE xxx NE
as NE xx NE
LDL NE XXX NE
-receptor NE -xxx NE
gene NE xxx NE
transcription NE xxx NE
in NE xx NE
lymphocytes NE xxx NE
from NE xxx NE
CML NE XXX NE
patients NE xxx NE
. NE . NE

Multiple NE Xxxx NE
prolactin-responsive G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
mediate NE xxx NE
G1 G#other_name_B Xd G#other_name_B
phase G#other_name_M xxx G#other_name_M
expression G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
S G#other_name_M X G#other_name_M
phase G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
interferon G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
regulatory G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
factor-1 G#DNA_domain_or_region_M xxx-d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
interferon NE xxx NE
regulatory NE xxx NE
factor-1 NE xxx-d NE
( NE ( NE
IRF-1 NE XXX-d NE
) NE ) NE
gene NE xxx NE
is NE xx NE
both NE xxx NE
an NE xx NE
immediate-early NE xxx-xxx NE
G1 NE Xd NE
phase NE xxx NE
gene NE xxx NE
and NE xxx NE
an NE xx NE
S NE X NE
phase NE xxx NE
gene NE xxx NE
inducible NE xxx NE
by NE xx NE
PRL NE XXX NE
in NE xx NE
rat NE xxx NE
Nb2 NE Xxd NE
T NE X NE
lymphocytes NE xxx NE
. NE . NE

To NE Xx NE
understand NE xxx NE
the NE xxx NE
mechanism NE xxx NE
by NE xx NE
which NE xxx NE
PRL G#protein_molecule XXX G#protein_molecule
regulates NE xxx NE
the NE xxx NE
biphasic NE xxx NE
expression NE xxx NE
of NE xx NE
IRF-1 G#protein_molecule XXX-d G#protein_molecule
, NE , NE
we NE xx NE
cloned NE xxx NE
the NE xxx NE
rat G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
IRF-1 G#DNA_domain_or_region_M XXX-d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
functionally NE xxx NE
characterized NE xxx NE
the NE xxx NE
IRF-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Upon NE Xxxx NE
transfection NE xxx NE
into NE xxx NE
Nb2 G#cell_line_B Xxd G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
1.7 NE d.d NE
kilobases NE xxx NE
(kb) NE (xx) NE
of NE xx NE
IRF-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
5'-flanking G#DNA_domain_or_region_M d'-xxx G#DNA_domain_or_region_M
DNA G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
linked NE xxx NE
to NE xx NE
a NE x NE
chloramphenicol NE xxx NE
acetyl NE xxx NE
transferase NE xxx NE
( NE ( NE
CAT NE XXX NE
) NE ) NE
reporter NE xxx NE
gene NE xxx NE
mediated NE xxx NE
a NE x NE
30-fold NE dd-xxx NE
induction NE xxx NE
of NE xx NE
CAT NE XXX NE
enzyme NE xxx NE
activity NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
24 NE dd NE
h NE x NE
of NE xx NE
PRL NE XXX NE
stimulation NE xxx NE
. NE . NE

Deletion NE Xxxx NE
mutants NE xxx NE
containing NE xxx NE
1.3kb G#DNA_domain_or_region_B d.dxx G#DNA_domain_or_region_B
5'-flanking G#DNA_domain_or_region_M d'-xxx G#DNA_domain_or_region_M
DNA G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
0.6 G#DNA_domain_or_region_M d.d G#DNA_domain_or_region_M
kb G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
5'-flanking G#DNA_domain_or_region_M d'-xxx G#DNA_domain_or_region_M
DNA G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
0.2 G#DNA_domain_or_region_M d.d G#DNA_domain_or_region_M
kb G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
5'-flanking G#DNA_domain_or_region_M d'-xxx G#DNA_domain_or_region_M
DNA G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
PRL NE XXX NE
. NE . NE

The NE Xxx NE
sequence NE xxx NE
between NE xxx NE
-1.7 NE -d.d NE
and NE xxx NE
-0.2 NE -d.d NE
kb NE xx NE
linked NE xxx NE
to NE xx NE
a NE x NE
heterologous G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
thymidine G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
kinase G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
failed NE xxx NE
to NE xx NE
respond NE xxx NE
to NE xx NE
PRL G#protein_molecule XXX G#protein_molecule
stimulation NE xxx NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
upstream G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
PRL G#DNA_family_or_group_M XXX G#DNA_family_or_group_M
response G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
may NE xxx NE
require NE xxx NE
an NE xx NE
interaction NE xxx NE
with NE xxx NE
promoter-proximal G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

By NE Xx NE
assaying NE xxx NE
CAT G#other_name_B XXX G#other_name_B
enzyme G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
across NE xxx NE
a NE x NE
24-h NE dd-x NE
PRL G#other_name_B XXX G#other_name_B
induction G#other_name_E xxx G#other_name_E
time NE xxx NE
course NE xxx NE
, NE , NE
we NE xx NE
were NE xxx NE
able NE xxx NE
to NE xx NE
assign NE xxx NE
G1 NE Xd NE
vs NE xx NE
. NE . NE
S G#other_name_B X G#other_name_B
phase G#other_name_M xxx G#other_name_M
PRL G#other_name_M XXX G#other_name_M
responses G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
IRF-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
to NE xx NE
different NE xxx NE
regions NE xxx NE
of NE xx NE
the NE xxx NE
IRF-1 G#protein_molecule XXX-d G#protein_molecule
5'-flanking NE d'-xxx NE
and NE xxx NE
promoter NE xxx NE
DNA NE XXX NE
. NE . NE

The NE Xxx NE
0.2-kb NE d.d-xx NE
IRF- NE XXX- NE
CAT NE XXX NE
construct NE xxx NE
was NE xxx NE
induced NE xxx NE
by NE xx NE
PRL NE XXX NE
stimulation NE xxx NE
during NE xxx NE
the NE xxx NE
G1 NE Xd NE
phase NE xxx NE
of NE xx NE
the NE xxx NE
cell NE xxx NE
cycle NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
the NE xxx NE
1.7-kb NE d.d-xx NE
IRF- NE XXX- NE
CAT G#protein_molecule XXX G#protein_molecule
construct NE xxx NE
was NE xxx NE
inducible NE xxx NE
by NE xx NE
PRL G#protein_molecule XXX G#protein_molecule
during NE xxx NE
both NE xxx NE
G1 G#other_name_B Xd G#other_name_B
phase G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
S G#other_name_M X G#other_name_M
phase G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
cell G#other_name_B xxx G#other_name_B
cycle G#other_name_E xxx G#other_name_E
. NE . NE

Hence NE Xxxx NE
, NE , NE
the NE xxx NE
PRL G#protein_molecule XXX G#protein_molecule
-induced NE -xxx NE
biphasic NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
IRF-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
appears NE xxx NE
to NE xx NE
be NE xx NE
controlled NE xxx NE
by NE xx NE
separate NE xxx NE
PRL NE XXX NE
-responsive NE -xxx NE
elements NE xxx NE
: NE : NE
elements NE xxx NE
in NE xx NE
the NE xxx NE
first NE xxx NE
0.2 NE d.d NE
kb NE xx NE
of NE xx NE
the NE xxx NE
IRF-1 NE XXX-d NE
promoter NE xxx NE
region NE xxx NE
act NE xxx NE
during NE xxx NE
early NE xxx NE
activation NE xxx NE
, NE , NE
and NE xxx NE
elements NE xxx NE
between NE xxx NE
0.2 NE d.d NE
and NE xxx NE
1.7 NE d.d NE
kb NE xx NE
act NE xxx NE
in NE xx NE
concert NE xxx NE
with NE xxx NE
the NE xxx NE
proximal NE xxx NE
0.2-kb NE d.d-xx NE
region NE xxx NE
during NE xxx NE
S NE X NE
phase NE xxx NE
progression NE xxx NE
. NE . NE

Regulation NE Xxxx NE
of NE xx NE
the NE xxx NE
BZLF1 G#DNA_domain_or_region_B XXXXd G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
Epstein-Barr G#virus_B Xxxx-Xxxx G#virus_B
virus G#virus_E xxx G#virus_E
by NE xx NE
second G#other_organic_compound_B xxx G#other_organic_compound_B
messengers G#other_organic_compound_E xxx G#other_organic_compound_E
in NE xx NE
anti-immunoglobulin-treated G#cell_line_B xxx-xxx-xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Initiation NE Xxxx NE
of NE xx NE
the NE xxx NE
Epstein-Barr G#other_name_B Xxxx-Xxxx G#other_name_B
virus G#other_name_M xxx G#other_name_M
(EBV) G#other_name_M (XXX) G#other_name_M
lytic G#other_name_M xxx G#other_name_M
cycle G#other_name_E xxx G#other_name_E
is NE xx NE
dependent NE xxx NE
on NE xx NE
the NE xxx NE
transcription G#other_name xxx G#other_name
of NE xx NE
the NE xxx NE
BZLF1 G#DNA_domain_or_region_B XXXXd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
BZLF1 G#DNA_domain_or_region_B XXXXd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
Zp G#DNA_domain_or_region Xx G#DNA_domain_or_region
) NE ) NE
was NE xxx NE
activated NE xxx NE
by NE xx NE
crosslinking NE xxx NE
of NE xx NE
cell G#protein_family_or_group_B xxx G#protein_family_or_group_B
surface G#protein_family_or_group_M xxx G#protein_family_or_group_M
immunoglobulin G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
Ig G#protein_family_or_group Xx G#protein_family_or_group
) NE ) NE
with NE xxx NE
anti-Ig G#protein_family_or_group_B xxx-Xx G#protein_family_or_group_B
antibody G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
even NE xxx NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
other NE xxx NE
viral NE xxx NE
genes NE xxx NE
. NE . NE

We NE Xx NE
identified NE xxx NE
several NE xxx NE
anti-Ig NE xxx-Xx NE
response NE xxx NE
elements NE xxx NE
within NE xxx NE
Zp G#DNA_domain_or_region Xx G#DNA_domain_or_region
, NE , NE
which NE xxx NE
were NE xxx NE
originally NE xxx NE
defined NE xxx NE
as NE xx NE
12-O-tetradecanoylphorbol-13-acetate NE dd-X-xxx-dd-xxx NE
( NE ( NE
TPA NE XXX NE
) NE ) NE
response NE xxx NE
elements NE xxx NE
( NE ( NE
ZI NE XX NE
repeats NE xxx NE
and NE xxx NE
ZII NE XXX NE
, NE , NE
an NE xx NE
AP-1-like NE XX-d-xxx NE
domain NE xxx NE
) NE ) NE
. NE . NE

Since NE Xxxx NE
anti-Ig G#other_name_B xxx-Xx G#other_name_B
crosslinking G#other_name_E xxx G#other_name_E
leads NE xxx NE
to NE xx NE
activation NE xxx NE
of NE xx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
PKC G#protein_molecule XXX G#protein_molecule
) NE ) NE
and NE xxx NE
an NE xx NE
increase NE xxx NE
in NE xx NE
intracellular NE xxx NE
calcium NE xxx NE
level NE xxx NE
, NE , NE
Zp G#DNA_domain_or_region Xx G#DNA_domain_or_region
was NE xxx NE
tested NE xxx NE
for NE xxx NE
the NE xxx NE
response NE xxx NE
to NE xx NE
these NE xxx NE
cellular G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Treatment NE Xxxx NE
with NE xxx NE
calcium G#other_organic_compound_B xxx G#other_organic_compound_B
ionophore G#other_organic_compound_M xxx G#other_organic_compound_M
A23187 G#other_organic_compound_E Xddddd G#other_organic_compound_E
increased NE xxx NE
Zp G#other_name_B Xx G#other_name_B
activity G#other_name_E xxx G#other_name_E
. NE . NE

When NE Xxxx NE
the NE xxx NE
calcium G#other_organic_compound_B xxx G#other_organic_compound_B
ionophore G#other_organic_compound_E xxx G#other_organic_compound_E
was NE xxx NE
used NE xxx NE
in NE xx NE
conjunction NE xxx NE
with NE xxx NE
TPA G#other_organic_compound XXX G#other_organic_compound
, NE , NE
a NE x NE
PKC G#protein_molecule XXX G#protein_molecule
activator NE xxx NE
, NE , NE
the NE xxx NE
Zp G#DNA_domain_or_region Xx G#DNA_domain_or_region
induction NE xxx NE
was NE xxx NE
synergistically NE xxx NE
enhanced NE xxx NE
. NE . NE

1-(5-Isoquinolinyl G#other_organic_compound_B d-(d-Xxxx G#other_organic_compound_B
sulfonyl)-2-methylpiperazine G#other_organic_compound_E xxx)-d-xxx G#other_organic_compound_E
, NE , NE
an NE xx NE
inhibitor NE xxx NE
of NE xx NE
PKC G#protein_molecule XXX G#protein_molecule
, NE , NE
inhibited NE xxx NE
the NE xxx NE
anti-Ig G#other_name_B xxx-Xx G#other_name_B
inducibility G#other_name_E xxx G#other_name_E
of NE xx NE
Zp G#DNA_domain_or_region Xx G#DNA_domain_or_region
. NE . NE

Calmodulin G#other_organic_compound_B Xxxx G#other_organic_compound_B
antagonists G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
compound G#other_organic_compound_B xxx G#other_organic_compound_B
R24571 G#other_organic_compound_E Xddddd G#other_organic_compound_E
and NE xxx NE
trifluoperazine G#other_organic_compound xxx G#other_organic_compound
, NE , NE
blocked NE xxx NE
the NE xxx NE
Zp G#DNA_domain_or_region Xx G#DNA_domain_or_region
activation NE xxx NE
with NE xxx NE
anti-Ig G#protein_family_or_group xxx-Xx G#protein_family_or_group
. NE . NE

These NE Xxxx NE
findings NE xxx NE
suggest NE xxx NE
that NE xxx NE
Zp G#DNA_domain_or_region Xx G#DNA_domain_or_region
responds NE xxx NE
directly NE xxx NE
to NE xx NE
changes NE xxx NE
in NE xx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
both NE xxx NE
PKC G#protein_molecule XXX G#protein_molecule
and NE xxx NE
calcium NE xxx NE
/calmodulin-dependent NE /xxx-xxx NE
protein NE xxx NE
kinase NE xxx NE
. NE . NE

Requirement NE Xxxx NE
of NE xx NE
tyrosine G#other_name_B xxx G#other_name_B
kinase G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
for NE xxx NE
the NE xxx NE
anti-Ig G#protein_family_or_group xxx-Xx G#protein_family_or_group
-mediated NE -xxx NE
Zp G#other_name_B Xx G#other_name_B
activation G#other_name_E xxx G#other_name_E
was NE xxx NE
also NE xxx NE
demonstrated NE xxx NE
through NE xxx NE
the NE xxx NE
use NE xxx NE
of NE xx NE
the NE xxx NE
tyrosine G#other_organic_compound_B xxx G#other_organic_compound_B
kinase G#other_organic_compound_M xxx G#other_organic_compound_M
inhibitor G#other_organic_compound_E xxx G#other_organic_compound_E
herbimycin G#other_organic_compound xxx G#other_organic_compound
. NE . NE

These NE Xxxx NE
cellular G#protein_family_or_group_B xxx G#protein_family_or_group_B
gene G#protein_family_or_group_M xxx G#protein_family_or_group_M
regulatory G#protein_family_or_group_M xxx G#protein_family_or_group_M
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
induced NE xxx NE
with NE xxx NE
anti-Ig NE xxx-Xx NE
may NE xxx NE
cooperatively NE xxx NE
play NE xxx NE
an NE xx NE
important NE xxx NE
part NE xxx NE
in NE xx NE
achieving NE xxx NE
efficient NE xxx NE
EBV G#other_name_B XXX G#other_name_B
activation G#other_name_E xxx G#other_name_E
as NE xx NE
seen NE xxx NE
with NE xxx NE
anti-Ig G#other_name_B xxx-Xx G#other_name_B
treatment G#other_name_E xxx G#other_name_E
in NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
SCL G#protein_molecule_B XXX G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
displays NE xxx NE
cell-specific G#other_name_B xxx-xxx G#other_name_B
heterogeneity G#other_name_E xxx G#other_name_E
in NE xx NE
size NE xxx NE
. NE . NE

SCL G#protein_molecule_B XXX G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
production NE xxx NE
was NE xxx NE
examined NE xxx NE
in NE xx NE
a NE x NE
variety NE xxx NE
of NE xx NE
hemopoietic G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
by NE xx NE
immunoblotting NE xxx NE
using NE xxx NE
specific NE xxx NE
polyclonal G#other_organic_compound_B xxx G#other_organic_compound_B
antisera G#other_organic_compound_E xxx G#other_organic_compound_E
. NE . NE

SCL G#protein_molecule_B XXX G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
was NE xxx NE
detected NE xxx NE
in NE xx NE
erythroid G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
megakaryocyte G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
mast G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
early G#cell_line_M xxx G#cell_line_M
myeloid G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
lymphoid NE xxx NE
leukemia NE xxx NE
cell NE xxx NE
lines NE xxx NE
which NE xxx NE
are NE xxx NE
known NE xxx NE
to NE xx NE
harbor NE xxx NE
SCL G#DNA_family_or_group_B XXX G#DNA_family_or_group_B
gene G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
rearrangements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

In NE Xx NE
most NE xxx NE
cell NE xxx NE
lines NE xxx NE
, NE , NE
proteins NE xxx NE
of NE xx NE
molecular G#protein_N/A_B xxx G#protein_N/A_B
weight G#protein_N/A_M xxx G#protein_N/A_M
49 G#protein_N/A_M dd G#protein_N/A_M
and G#protein_N/A_M xxx G#protein_N/A_M
44 G#protein_N/A_M dd G#protein_N/A_M
kDa G#protein_N/A_E xXx G#protein_N/A_E
were NE xxx NE
found NE xxx NE
, NE , NE
however NE xxx NE
two NE xxx NE
myeloid NE xxx NE
cell NE xxx NE
lines NE xxx NE
expressed NE xxx NE
only NE xxx NE
lower NE xxx NE
molecular G#protein_family_or_group_B xxx G#protein_family_or_group_B
weight G#protein_family_or_group_M xxx G#protein_family_or_group_M
species G#protein_family_or_group_M xxx G#protein_family_or_group_M
of G#protein_family_or_group_M xx G#protein_family_or_group_M
24 G#protein_family_or_group_M dd G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
22 G#protein_family_or_group_M dd G#protein_family_or_group_M
kDa G#protein_family_or_group_E xXx G#protein_family_or_group_E
. NE . NE

This NE Xxxx NE
size NE xxx NE
discrepancy NE xxx NE
appeared NE xxx NE
to NE xx NE
be NE xx NE
due NE xxx NE
to NE xx NE
cell-specific G#other_name_B xxx-xxx G#other_name_B
translational G#other_name_M xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
, NE , NE
since NE xxx NE
overexpression NE xxx NE
of NE xx NE
a NE x NE
retrovirally NE xxx NE
transfected NE xxx NE
SCL G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
yielded NE xxx NE
the NE xxx NE
higher NE xxx NE
molecular NE xxx NE
weight NE xxx NE
forms NE xxx NE
in NE xx NE
most NE xxx NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
( NE ( NE
GP+E-86 G#cell_line XX+X-dd G#cell_line
, NE , NE
AT2.5 G#cell_line XXd.d G#cell_line
, NE , NE
M1 G#cell_line Xd G#cell_line
) NE ) NE
but NE xxx NE
only NE xxx NE
the NE xxx NE
22 G#protein_molecule_B dd G#protein_molecule_B
kDa G#protein_molecule_M xXx G#protein_molecule_M
form G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
the NE xxx NE
myeloid G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
WEHI-3B/D+ G#cell_line XXXX-dX/X+ G#cell_line
. NE . NE

Overexpression NE Xxxx NE
of NE xx NE
full-length NE xxx-xxx NE
SCL G#protein_molecule_B XXX G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
the NE xxx NE
lymphoid G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
, NE , NE
SupT1 G#other_artificial_source XxxXd G#other_artificial_source
and NE xxx NE
Raji G#other_artificial_source Xxxx G#other_artificial_source
, NE , NE
did NE xxx NE
not NE xxx NE
alter NE xxx NE
cell NE xxx NE
phenotype NE xxx NE
and NE xxx NE
there NE xxx NE
was NE xxx NE
no NE xx NE
evidence NE xxx NE
for NE xxx NE
autoregulation NE xxx NE
of NE xx NE
SCL G#other_name_B XXX G#other_name_B
transcription G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
restricted NE xxx NE
pattern NE xxx NE
of NE xx NE
SCL G#other_name_B XXX G#other_name_B
protein G#other_name_M xxx G#other_name_M
synthesis G#other_name_E xxx G#other_name_E
is NE xx NE
consistent NE xxx NE
with NE xxx NE
the NE xxx NE
restricted NE xxx NE
expression NE xxx NE
of NE xx NE
SCL G#RNA_molecule_B XXX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
documented NE xxx NE
previously NE xxx NE
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
the NE xxx NE
present NE xxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
SCL G#other_name_B XXX G#other_name_B
protein G#other_name_M xxx G#other_name_M
size G#other_name_E xxx G#other_name_E
was NE xxx NE
determined NE xxx NE
by NE xx NE
regulation NE xxx NE
of NE xx NE
translation NE xxx NE
in NE xx NE
a NE x NE
cell-specific G#other_name_B xxx-xxx G#other_name_B
manner G#other_name_E xxx G#other_name_E
. NE . NE

Description NE Xxxx NE
and NE xxx NE
functional NE xxx NE
implications NE xxx NE
of NE xx NE
a NE x NE
novel G#other_name_B xxx G#other_name_B
mutation G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
sex-determining G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
SRY G#DNA_domain_or_region XXX G#DNA_domain_or_region
. NE . NE

The NE Xxx NE
sex-determining NE xxx-xxx NE
gene NE xxx NE
SRY G#DNA_domain_or_region XXX G#DNA_domain_or_region
was NE xxx NE
screened NE xxx NE
for NE xxx NE
molecular G#other_name_B xxx G#other_name_B
alteration G#other_name_E xxx G#other_name_E
in NE xx NE
an NE xx NE
XY G#multi_cell_B XX G#multi_cell_B
sex-reversed G#multi_cell_M xxx-xxx G#multi_cell_M
female G#multi_cell_E xxx G#multi_cell_E
by NE xx NE
single-strand G#other_name_B xxx-xxx G#other_name_B
conformation G#other_name_M xxx G#other_name_M
polymorphism G#other_name_M xxx G#other_name_M
(SSCP) G#other_name_M (XXXX) G#other_name_M
technique G#other_name_E xxx G#other_name_E
. NE . NE

An NE Xx NE
A-to-G G#other_name_B X-xx-X G#other_name_B
transition G#other_name_E xxx G#other_name_E
was NE xxx NE
detected NE xxx NE
which NE xxx NE
leads NE xxx NE
to NE xx NE
an NE xx NE
exchange NE xxx NE
of NE xx NE
a NE x NE
tyrosine G#amino_acid_monomer xxx G#amino_acid_monomer
by NE xx NE
a NE x NE
cysteine G#amino_acid_monomer xxx G#amino_acid_monomer
in NE xx NE
the NE xxx NE
SRY G#protein_molecule_B XXX G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

The NE Xxx NE
affected NE xxx NE
tyrosine G#amino_acid_monomer xxx G#amino_acid_monomer
residue NE xxx NE
located NE xxx NE
at NE xx NE
the NE xxx NE
C G#protein_domain_or_region_B X G#protein_domain_or_region_B
terminus G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
the NE xxx NE
DNA G#protein_family_or_group_B XXX G#protein_family_or_group_B
binding G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
is NE xx NE
evolutionarily NE xxx NE
strongly NE xxx NE
conserved NE xxx NE
among NE xxx NE
the NE xxx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
HMG G#protein_family_or_group_B XXX G#protein_family_or_group_B
box G#protein_family_or_group_M xxx G#protein_family_or_group_M
containing G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Using NE Xxxx NE
gel G#other_name_B xxx G#other_name_B
shift G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
and NE xxx NE
peptide G#other_name_B xxx G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
such NE xxx NE
a NE x NE
mutation NE xxx NE
is NE xx NE
shown NE xxx NE
to NE xx NE
abolish NE xxx NE
the NE xxx NE
SRY G#other_name_B XXX G#other_name_B
protein G#other_name_M xxx G#other_name_M
DNA G#other_name_M XXX G#other_name_M
binding G#other_name_M xxx G#other_name_M
ability G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
involvement NE xxx NE
of NE xx NE
this NE xxx NE
particular NE xxx NE
amino G#amino_acid_monomer_B xxx G#amino_acid_monomer_B
acid G#amino_acid_monomer_E xxx G#amino_acid_monomer_E
in NE xx NE
the NE xxx NE
binding G#other_name_B xxx G#other_name_B
specificity G#other_name_E xxx G#other_name_E
is NE xx NE
also NE xxx NE
discussed NE xxx NE
. NE . NE

Induction NE Xxxx NE
of NE xx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
and NE xxx NE
T-cell G#other_name_B X-xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
by NE xx NE
vanadate G#other_organic_compound_B xxx G#other_organic_compound_B
peroxide G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
an NE xx NE
inhibitor NE xxx NE
of NE xx NE
protein G#protein_family_or_group_B xxx G#protein_family_or_group_B
tyrosine G#protein_family_or_group_M xxx G#protein_family_or_group_M
phosphatases G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Rapid NE Xxxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
key NE xxx NE
cellular NE xxx NE
proteins NE xxx NE
is NE xx NE
a NE x NE
crucial NE xxx NE
event NE xxx NE
in NE xx NE
the NE xxx NE
transduction NE xxx NE
of NE xx NE
activation NE xxx NE
signals NE xxx NE
to NE xx NE
T-lymphocytes G#cell_type X-xxx G#cell_type
. NE . NE

The NE Xxx NE
regulatory NE xxx NE
role NE xxx NE
of NE xx NE
protein G#protein_family_or_group_B xxx G#protein_family_or_group_B
tyrosine G#protein_family_or_group_M xxx G#protein_family_or_group_M
phosphatases G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
PTPases G#protein_family_or_group XXXxxx G#protein_family_or_group
) NE ) NE
in NE xx NE
this NE xxx NE
process NE xxx NE
was NE xxx NE
explored NE xxx NE
by NE xx NE
studying NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
a NE x NE
powerful NE xxx NE
PTPase G#other_name_B XXXxxx G#other_name_B
inhibitor G#other_name_E xxx G#other_name_E
, NE , NE
vanadate G#other_organic_compound_B xxx G#other_organic_compound_B
peroxide G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
pervanadate G#other_organic_compound xxx G#other_organic_compound
) NE ) NE
, NE , NE
on NE xx NE
the NE xxx NE
activation NE xxx NE
cascade NE xxx NE
of NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
human G#cell_line_M xxx G#cell_line_M
leukaemic G#cell_line_M xxx G#cell_line_M
T-cells G#cell_line_E X-xxx G#cell_line_E
. NE . NE

Pervanadate NE Xxxx NE
induced NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
tyrosine G#protein_family_or_group_B xxx G#protein_family_or_group_B
kinases G#protein_family_or_group_E xxx G#protein_family_or_group_E
lck G#protein_molecule xxx G#protein_molecule
and NE xxx NE
fyn G#protein_molecule xxx G#protein_molecule
(4- NE (d- NE
and NE xxx NE
3-fold NE d-xxx NE
respectively) NE xxx) NE
and NE xxx NE
a NE x NE
dramatic NE xxx NE
increase NE xxx NE
in NE xx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
cellular G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
notably NE xxx NE
phospholipase G#protein_molecule_B xxx G#protein_molecule_B
C G#protein_molecule_M X G#protein_molecule_M
gamma G#protein_molecule_M xxx G#protein_molecule_M
1 G#protein_molecule_E d G#protein_molecule_E
. NE . NE

After NE Xxxx NE
this NE xxx NE
event NE xxx NE
, NE , NE
we NE xx NE
observed NE xxx NE
a NE x NE
rise NE xxx NE
in NE xx NE
intracellular NE xxx NE
Ca2+ G#other_name_B Xxd+ G#other_name_B
concentration G#other_name_E xxx G#other_name_E
, NE , NE
corresponding NE xxx NE
to NE xx NE
an NE xx NE
influx NE xxx NE
. NE . NE

This NE Xxxx NE
effect NE xxx NE
required NE xxx NE
surface NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
CD45 G#protein_molecule_B XXdd G#protein_molecule_B
PTPase G#protein_molecule_E XXXxxx G#protein_molecule_E
and NE xxx NE
was NE xxx NE
not NE xxx NE
observed NE xxx NE
in NE xx NE
CD45-deficient G#cell_line_B XXdd-xxx G#cell_line_B
variants G#cell_line_E xxx G#cell_line_E
of NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

In NE Xx NE
the NE xxx NE
CD45-negative G#cell_line_B XXdd-xxx G#cell_line_B
variant G#cell_line_E xxx G#cell_line_E
, NE , NE
the NE xxx NE
effect NE xxx NE
of NE xx NE
pervanadate G#other_organic_compound xxx G#other_organic_compound
on NE xx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
was NE xxx NE
globally NE xxx NE
decreased NE xxx NE
and NE xxx NE
some NE xxx NE
phosphorylated G#amino_acid_monomer_B xxx G#amino_acid_monomer_B
substrates G#amino_acid_monomer_E xxx G#amino_acid_monomer_E
were NE xxx NE
specifically NE xxx NE
missing NE xxx NE
. NE . NE

Pervanadate G#other_organic_compound Xxxx G#other_organic_compound
also NE xxx NE
stimulated NE xxx NE
transcription NE xxx NE
of NE xx NE
the NE xxx NE
c-fos G#DNA_domain_or_region_B x-xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
accumulation NE xxx NE
of NE xx NE
its NE xxx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
as NE xx NE
well NE xxx NE
as NE xx NE
several NE xxx NE
other NE xxx NE
hallmarks NE xxx NE
of NE xx NE
T-lymphocyte G#other_name_B X-xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
such NE xxx NE
as NE xx NE
surface NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
CD69 NE XXdd NE
antigen NE xxx NE
and NE xxx NE
the NE xxx NE
interleukin NE xxx NE
2 NE d NE
receptor NE xxx NE
alpha-chain NE xxx-xxx NE
(CD25) NE (XXdd) NE
. NE . NE

Pervanadate G#other_organic_compound Xxxx G#other_organic_compound
synergized NE xxx NE
with NE xxx NE
signals NE xxx NE
delivered NE xxx NE
by NE xx NE
T-cell G#other_name_B X-xxx G#other_name_B
antigen G#other_name_M xxx G#other_name_M
receptor G#other_name_M xxx G#other_name_M
engagement G#other_name_E xxx G#other_name_E
or NE xx NE
by NE xx NE
a NE x NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester G#other_organic_compound_E xxx G#other_organic_compound_E
to NE xx NE
induce NE xxx NE
interleukin NE xxx NE
2 NE d NE
production NE xxx NE
. NE . NE

Pervanadate G#protein_molecule_B Xxxx G#protein_molecule_B
activated G#protein_molecule_M xxx G#protein_molecule_M
NF-kappa G#protein_molecule_M XX-xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
as NE xx NE
shown NE xxx NE
by NE xx NE
an NE xx NE
increase NE xxx NE
in NE xx NE
DNA-binding G#other_name_B XXX-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
of NE xx NE
this NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

We NE Xx NE
thus NE xxx NE
conclude NE xxx NE
that NE xxx NE
PTPases G#protein_family_or_group XXXxxx G#protein_family_or_group
play NE xxx NE
a NE x NE
crucial NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
negative G#other_name_B xxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
of NE xx NE
signal NE xxx NE
transduction NE xxx NE
culminating NE xxx NE
in NE xx NE
T-lymphocyte G#other_name_B X-xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

Moreover NE Xxxx NE
, NE , NE
induction NE xxx NE
of NE xx NE
tyrosine G#atom_B xxx G#atom_B
phosphorylation G#atom_E xxx G#atom_E
appears NE xxx NE
sufficient NE xxx NE
per NE xxx NE
se NE xx NE
to NE xx NE
initiate NE xxx NE
a NE x NE
complete NE xxx NE
activation NE xxx NE
programme NE xxx NE
. NE . NE

Activation NE Xxxx NE
of NE xx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor-kappaB G#protein_molecule_E xxx-xxxX G#protein_molecule_E
via NE xxx NE
T G#protein_family_or_group_B X G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
requires NE xxx NE
a NE x NE
Raf G#protein_family_or_group_B Xxx G#protein_family_or_group_B
kinase G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
Ca2+ G#atom Xxd+ G#atom
influx NE xxx NE
. NE . NE

Functional NE Xxxx NE
synergy NE xxx NE
between NE xxx NE
Raf G#protein_family_or_group Xxx G#protein_family_or_group
and NE xxx NE
calcineurin G#protein_molecule xxx G#protein_molecule
. NE . NE

Signals NE Xxxx NE
transduced NE xxx NE
via NE xxx NE
the NE xxx NE
TCR G#protein_family_or_group XXX G#protein_family_or_group
activate NE xxx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor-kappaB G#protein_molecule_E xxx-xxxX G#protein_molecule_E
( NE ( NE
NF-kappaB G#protein_molecule XX-xxxX G#protein_molecule
) NE ) NE
, NE , NE
which NE xxx NE
, NE , NE
in NE xx NE
turn NE xxx NE
, NE , NE
is NE xx NE
critical NE xxx NE
to NE xx NE
the NE xxx NE
transcriptional NE xxx NE
induction NE xxx NE
of NE xx NE
many NE xxx NE
genes NE xxx NE
important NE xxx NE
for NE xxx NE
the NE xxx NE
proliferation NE xxx NE
and NE xxx NE
expression NE xxx NE
of NE xx NE
a NE x NE
differentiated G#other_name_B xxx G#other_name_B
phenotype G#other_name_E xxx G#other_name_E
. NE . NE

Treatment NE Xxxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
with NE xxx NE
the NE xxx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
activator NE xxx NE
PMA G#other_organic_compound XXX G#other_organic_compound
in NE xx NE
combination NE xxx NE
with NE xxx NE
Ca2+ G#other_organic_compound_B Xxd+ G#other_organic_compound_B
ionophores G#other_organic_compound_E xxx G#other_organic_compound_E
mimics NE xxx NE
this NE xxx NE
process NE xxx NE
, NE , NE
and NE xxx NE
the NE xxx NE
two NE xxx NE
agents NE xxx NE
are NE xxx NE
often NE xxx NE
substituted NE xxx NE
for NE xxx NE
TCR G#other_name_B XXX G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
, NE , NE
bypassing NE xxx NE
the NE xxx NE
TCR G#protein_family_or_group XXX G#protein_family_or_group
. NE . NE

Here NE Xxxx NE
we NE xx NE
identify NE xxx NE
intracellular NE xxx NE
signaling NE xxx NE
components NE xxx NE
involved NE xxx NE
in NE xx NE
activation NE xxx NE
of NE xx NE
NF-kappaB G#protein_molecule XX-xxxX G#protein_molecule
following NE xxx NE
TCR G#other_name_B XXX G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
. NE . NE

TCR G#protein_family_or_group XXX G#protein_family_or_group
signaling NE xxx NE
was NE xxx NE
triggered NE xxx NE
by NE xx NE
treating NE xxx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
PHA G#protein_molecule XXX G#protein_molecule
or NE xx NE
anti-CD3 G#protein_family_or_group_B xxx-XXd G#protein_family_or_group_B
Abs G#protein_family_or_group_E Xxx G#protein_family_or_group_E
, NE , NE
and NE xxx NE
NF-kappaB G#protein_molecule XX-xxxX G#protein_molecule
activation NE xxx NE
was NE xxx NE
monitored NE xxx NE
by NE xx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
and/or NE xxx/xx NE
by NE xx NE
kappaB NE xxxX NE
-dependent NE -xxx NE
reporter NE xxx NE
assays NE xxx NE
. NE . NE

Contrary NE Xxxx NE
to NE xx NE
the NE xxx NE
idea NE xxx NE
that NE xxx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
is NE xx NE
involved NE xxx NE
in NE xx NE
TCR NE XXX NE
-mediated NE -xxx NE
activation NE xxx NE
of NE xx NE
NF-kappaB NE XX-xxxX NE
, NE , NE
high NE xxx NE
doses NE xxx NE
of NE xx NE
staurosporine NE xxx NE
did NE xxx NE
not NE xxx NE
interfere NE xxx NE
with NE xxx NE
activation NE xxx NE
of NE xx NE
NF-kappaB NE XX-xxxX NE
by NE xx NE
PHA NE XXX NE
, NE , NE
while NE xxx NE
the NE xxx NE
same NE xxx NE
dose NE xxx NE
of NE xx NE
staurosporine NE xxx NE
completely NE xxx NE
blocked NE xxx NE
activation NE xxx NE
by NE xx NE
PMA NE XXX NE
. NE . NE

PHA G#protein_molecule XXX G#protein_molecule
-induced NE -xxx NE
kappaB-dependent NE xxxX-xxx NE
reporter NE xxx NE
activity NE xxx NE
was NE xxx NE
, NE , NE
however NE xxx NE
, NE , NE
effectively NE xxx NE
blocked NE xxx NE
by NE xx NE
a NE x NE
dominant NE xxx NE
negative NE xxx NE
form NE xxx NE
of NE xx NE
Raf-1 G#protein_molecule Xxx-d G#protein_molecule
, NE , NE
suggesting NE xxx NE
a NE x NE
critical NE xxx NE
role NE xxx NE
for NE xxx NE
a NE x NE
Raf G#protein_family_or_group_B Xxx G#protein_family_or_group_B
kinase G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

The NE Xxx NE
TCR NE XXX NE
-mediated NE -xxx NE
activation NE xxx NE
of NE xx NE
NF-kappaB NE XX-xxxX NE
was NE xxx NE
also NE xxx NE
dependent NE xxx NE
on NE xx NE
a NE x NE
Ca2+ NE Xxd+ NE
influx NE xxx NE
, NE , NE
because NE xxx NE
the NE xxx NE
Ca2+ NE Xxd+ NE
channel NE xxx NE
blocker NE xxx NE
, NE , NE
SK&F NE XX&X NE
96365 NE ddddd NE
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
other NE xxx NE
agents NE xxx NE
that NE xxx NE
prevented NE xxx NE
the NE xxx NE
Ca2+ NE Xxd+ NE
influx NE xxx NE
, NE , NE
inhibited NE xxx NE
NF-kappaB NE XX-xxxX NE
activation NE xxx NE
. NE . NE

Cotransfection NE Xxxx NE
of NE xx NE
a NE x NE
constitutively NE xxx NE
active NE xxx NE
form NE xxx NE
of NE xx NE
calcineurin G#protein_molecule xxx G#protein_molecule
largely NE xxx NE
substituted NE xxx NE
for NE xxx NE
the NE xxx NE
Ca2+ G#atom Xxd+ G#atom
requirement NE xxx NE
and NE xxx NE
reversed NE xxx NE
the NE xxx NE
blockade NE xxx NE
by NE xx NE
SK&F G#other_organic_compound_B XX&X G#other_organic_compound_B
96365 G#other_organic_compound_E ddddd G#other_organic_compound_E
. NE . NE

Consistent NE Xxxx NE
with NE xxx NE
these NE xxx NE
observations NE xxx NE
, NE , NE
coexpression NE xxx NE
of NE xx NE
constitutively NE xxx NE
active NE xxx NE
forms NE xxx NE
of NE xx NE
Raf-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
calcineurin G#protein_molecule xxx G#protein_molecule
synergistically NE xxx NE
induced NE xxx NE
kappaB NE xxxX NE
-dependent NE -xxx NE
reporter NE xxx NE
activity NE xxx NE
, NE , NE
suggesting NE xxx NE
a NE x NE
physiologically NE xxx NE
relevant NE xxx NE
functional NE xxx NE
interaction NE xxx NE
between NE xxx NE
the NE xxx NE
kinase NE xxx NE
and NE xxx NE
the NE xxx NE
phosphatase NE xxx NE
. NE . NE

Synergistic NE Xxxx NE
interactions NE xxx NE
between NE xxx NE
overlapping G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
binding G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
sites G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
for NE xxx NE
the NE xxx NE
serum G#protein_family_or_group_B xxx G#protein_family_or_group_B
response G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
ELK-1 G#protein_molecule_B XXX-d G#protein_molecule_B
proteins G#protein_molecule_E xxx G#protein_molecule_E
mediate NE xxx NE
both NE xxx NE
basal NE xxx NE
enhancement NE xxx NE
and NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester G#other_organic_compound_E xxx G#other_organic_compound_E
responsiveness NE xxx NE
of NE xx NE
primate G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
cytomegalovirus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
major G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
immediate-early G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
promoters G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
monocyte NE xxx NE
and NE xxx NE
T-lymphocyte G#cell_type X-xxx G#cell_type
cell NE xxx NE
types NE xxx NE
. NE . NE

Cytomegalovirus G#other_name_B Xxxx G#other_name_B
(CMV) G#other_name_M (XXX) G#other_name_M
infection G#other_name_E xxx G#other_name_E
is NE xx NE
nonpermissive NE xxx NE
or NE xx NE
persistent NE xxx NE
in NE xx NE
many NE xxx NE
lymphoid G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
type G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
myeloid G#cell_type_M xxx G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
type G#cell_type_E xxx G#cell_type_E
but NE xxx NE
can NE xxx NE
be NE xx NE
activated NE xxx NE
in NE xx NE
differentiated G#cell_type_B xxx G#cell_type_B
macrophages G#cell_type_E xxx G#cell_type_E
. NE . NE

We NE Xx NE
have NE xxx NE
shown NE xxx NE
elsewhere NE xxx NE
that NE xxx NE
both NE xxx NE
the NE xxx NE
major G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
immediate-early G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
MIE G#DNA_domain_or_region XXX G#DNA_domain_or_region
) NE ) NE
and NE xxx NE
lytic G#other_name_B xxx G#other_name_B
cycle G#other_name_M xxx G#other_name_M
infectious G#other_name_M xxx G#other_name_M
progeny G#other_name_M xxx G#other_name_M
virus G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
can NE xxx NE
be NE xx NE
induced NE xxx NE
in NE xx NE
otherwise NE xxx NE
nonpermissive NE xxx NE
monocyte-like G#cell_line_B xxx-xxx G#cell_line_B
U-937 G#cell_line_M X-ddd G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
cultures G#cell_line_E xxx G#cell_line_E
infected NE xxx NE
with NE xxx NE
either NE xxx NE
human G#virus_B xxx G#virus_B
CMV G#virus_E XXX G#virus_E
( NE ( NE
HCMV G#virus XXXX G#virus
) NE ) NE
or NE xx NE
simian G#virus_B xxx G#virus_B
CMV G#virus_E XXX G#virus_E
( NE ( NE
SCMV G#virus XXXX G#virus
) NE ) NE
by NE xx NE
treatment NE xxx NE
with NE xxx NE
the NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester G#other_organic_compound_E xxx G#other_organic_compound_E
12-O-tetradecanoylphorbol-13-acetate G#other_organic_compound dd-X-xxx-dd-xxx G#other_organic_compound
( NE ( NE
TPA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
. NE . NE

Two NE Xxx NE
multicopy G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
basal G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
enhancer G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
motifs G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
within NE xxx NE
the NE xxx NE
SCMV G#virus XXXX G#virus
MIE NE XXX NE
enhancer G#DNA_domain_or_region xxx G#DNA_domain_or_region
, NE , NE
namely NE xxx NE
, NE , NE
11 NE dd NE
copies NE xxx NE
of NE xx NE
the NE xxx NE
16-bp NE dd-xx NE
cyclic G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
AMP G#DNA_family_or_group_M XXX G#DNA_family_or_group_M
response G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
element G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
( NE ( NE
CRE G#DNA_domain_or_region XXX G#DNA_domain_or_region
) NE ) NE
and NE xxx NE
3 NE d NE
copies NE xxx NE
of NE xx NE
novel NE xxx NE
17-bp NE dd-xx NE
serum G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
response G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
factor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
( G#DNA_domain_or_region_E ( G#DNA_domain_or_region_E
SRF NE XXX NE
) NE ) NE
binding NE xxx NE
sites NE xxx NE
referred NE xxx NE
to NE xx NE
as NE xx NE
the NE xxx NE
SNE G#DNA_domain_or_region XXX G#DNA_domain_or_region
( NE ( NE
SRF/NFkappaB-like G#DNA_domain_or_region_B XXX/XXxxxX-xxx G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
) NE ) NE
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
four NE xxx NE
classical NE xxx NE
NFkappaB G#DNA_domain_or_region_B XXxxxX G#DNA_domain_or_region_B
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
within NE xxx NE
the NE xxx NE
HCMV G#virus XXXX G#virus
version NE xxx NE
, NE , NE
contribute NE xxx NE
to NE xx NE
TPA G#other_name_B XXX G#other_name_B
responsiveness G#other_name_E xxx G#other_name_E
in NE xx NE
transient G#other_name_B xxx G#other_name_B
assays G#other_name_E xxx G#other_name_E
in NE xx NE
monocyte G#cell_type_B xxx G#cell_type_B
type G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
T-cell G#cell_type_M X-xxx G#cell_type_M
type G#cell_type_E xxx G#cell_type_E

The NE Xxx NE
SCMV G#DNA_domain_or_region_B XXXX G#DNA_domain_or_region_B
SNE G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
contain NE xxx NE
potential NE xxx NE
overlapping NE xxx NE
core NE xxx NE
recognition NE xxx NE
binding NE xxx NE
motifs NE xxx NE
for NE xxx NE
SRF G#protein_family_or_group XXX G#protein_family_or_group
, NE , NE
Rel/NFkappaB G#protein_complex Xxx/XXxxxX G#protein_complex
, NE , NE
ETS G#protein_family_or_group XXX G#protein_family_or_group
, NE , NE
and NE xxx NE
YY1 G#protein_family_or_group_B XXd G#protein_family_or_group_B
class G#protein_family_or_group_M xxx G#protein_family_or_group_M
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
but NE xxx NE
fail NE xxx NE
to NE xx NE
respond NE xxx NE
to NE xx NE
either NE xxx NE
serum G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_M xxx G#protein_molecule_M
or G#protein_molecule_M xx G#protein_molecule_M
tumor G#protein_molecule_M xxx G#protein_molecule_M
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E

Therefore NE Xxxx NE
, NE , NE
to NE xx NE
evaluate NE xxx NE
the NE xxx NE
mechanism NE xxx NE
of NE xx NE
TPA G#other_organic_compound XXX G#other_organic_compound
responsiveness NE xxx NE
of NE xx NE
the NE xxx NE
SNE G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
motifs G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
of NE xx NE
a NE x NE
related NE xxx NE
16-bp NE dd-xx NE
SEE G#DNA_domain_or_region XXX G#DNA_domain_or_region
( NE ( NE
SRF/ G#DNA_domain_or_region XXX/ G#DNA_domain_or_region
ETS NE XXX NE
multimerized G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
wild-type G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
multimerized G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
mutant G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
HCMV NE XXXX NE
and NE xxx NE
HCMV G#DNA_domain_or_region_B XXXX G#DNA_domain_or_region_B
MIE G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
enhancer G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
chimpanzee G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
CMV G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
MIE G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
functional NE xxx NE
responses NE xxx NE
and NE xxx NE
protein G#other_name_B xxx G#other_name_B
binding G#other_name_M xxx G#other_name_M
properties G#other_name_E xxx G#other_name_E
of NE xx NE
multimerized NE xxx NE
wild-type NE xxx-xxx NE
and NE xxx NE
mutant NE xxx NE
elements NE xxx NE
added NE xxx NE
upstream NE xxx NE
to NE xx NE
the NE xxx NE
SCMV G#DNA_domain_or_region_B XXXX G#DNA_domain_or_region_B
MIE G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
or NE xx NE
simian G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
virus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
40 G#DNA_domain_or_region_M dd G#DNA_domain_or_region_M
minimal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
regions G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
U-937 G#cell_line X-ddd G#cell_line
, NE , NE
K-562 G#cell_line X-ddd G#cell_line
, NE , NE
HL-60 G#cell_line XX-dd G#cell_line
, NE , NE
THP-1 G#cell_line XXX-d G#cell_line
, NE , NE
and NE xxx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

Unlike NE Xxxx NE
classical NE xxx NE
NFkappaB G#DNA_domain_or_region_B XXxxxX G#DNA_domain_or_region_B
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
neither NE xxx NE
the NE xxx NE
SNE G#DNA_domain_or_region XXX G#DNA_domain_or_region
nor NE xxx NE
the NE xxx NE
SEE G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
responded NE xxx NE
to NE xx NE
phosphatase NE xxx NE
inhibition NE xxx NE
by NE xx NE
okadaic NE xxx NE
acid NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
the NE xxx NE
TPA G#other_organic_compound XXX G#other_organic_compound
responsiveness NE xxx NE
of NE xx NE
both NE xxx NE
CMV G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
elements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
proved NE xxx NE
to NE xx NE
involve NE xxx NE
synergistic NE xxx NE
interactions NE xxx NE
between NE xxx NE
the NE xxx NE
core NE xxx NE
SRF G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
CCATATATGG G#polynucleotide XXXXXXXXXX G#polynucleotide
) NE ) NE
and NE xxx NE
the NE xxx NE
adjacent NE xxx NE
inverted NE xxx NE
ETS G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
motifs G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
TTCC G#polynucleotide XXXX G#polynucleotide
) NE ) NE
, NE , NE
which NE xxx NE
correlated NE xxx NE
directly NE xxx NE
with NE xxx NE
formation NE xxx NE
of NE xx NE
a NE x NE
bound NE xxx NE
tripartite G#protein_complex_B xxx G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
containing NE xxx NE
both NE xxx NE
the NE xxx NE
cellular NE xxx NE
SRF G#protein_family_or_group XXX G#protein_family_or_group
and NE xxx NE
ELK-1 G#protein_molecule_B XXX-d G#protein_molecule_B
proteins G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

This NE Xxxx NE
protein G#protein_complex_B xxx G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
was NE xxx NE
more NE xxx NE
abundant NE xxx NE
in NE xx NE
U-937 G#cell_component_B X-ddd G#cell_component_B
cell G#cell_component_M xxx G#cell_component_M
extract G#cell_component_M xxx G#cell_component_M
and G#cell_component_M xxx G#cell_component_M
K-562 G#cell_component_M X-ddd G#cell_component_M
cell G#cell_component_M xxx G#cell_component_M
extract G#cell_component_M xxx G#cell_component_M
and G#cell_component_M xxx G#cell_component_M
HeLa G#cell_component_M XxXx G#cell_component_M
cell G#cell_component_M xxx G#cell_component_M
extract G#cell_component_E xxx G#cell_component_E
than NE xxx NE
in NE xx NE
Raji G#cell_line Xxxx G#cell_line
, NE , NE
HF G#cell_line XX G#cell_line
, NE , NE
BALB/c G#cell_line_B XXXX/x G#cell_line_B
3T3 G#cell_line_E dXd G#cell_line_E
, NE , NE
or NE xx NE
HL-60 G#cell_line_B XX-dd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
but NE xxx NE
the NE xxx NE
binding G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
altered NE xxx NE
only NE xxx NE
twofold NE xxx NE
after NE xxx NE
TPA G#other_organic_compound XXX G#other_organic_compound
treatment NE xxx NE
. NE . NE

A NE X NE
40-fold NE dd-xxx NE
stimulation NE xxx NE
of NE xx NE
chloramphenicol G#other_name_B xxx G#other_name_B
acetyltransferase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
mediated NE xxx NE
by NE xx NE
four NE xxx NE
tandem G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
repeats G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
SNE G#DNA_domain_or_region XXX G#DNA_domain_or_region
could NE xxx NE
be NE xx NE
induced NE xxx NE
within NE xxx NE
2 NE d NE
h NE x NE
(and NE (xxx NE
up NE xx NE
to NE xx NE
250-fold NE ddd-xxx NE
within NE xxx NE
6 NE d NE
h) NE x) NE
after NE xxx NE
addition NE xxx NE
of NE xx NE
TPA G#other_organic_compound XXX G#other_organic_compound
in NE xx NE
DNA-transfected G#cell_line_B XXX-xxx G#cell_line_B
U-937 G#cell_line_M X-ddd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
indicating NE xxx NE
that NE xxx NE
the NE xxx NE
stimulation NE xxx NE
appeared NE xxx NE
likely NE xxx NE
to NE xx NE
be NE xx NE
a NE x NE
true NE xxx NE
protein NE xxx NE
kinase NE xxx NE
C NE X NE
-mediated NE -xxx NE
signal NE xxx NE
transduction NE xxx NE
event NE xxx NE
rather NE xxx NE
than NE xxx NE
a NE x NE
differentiation NE xxx NE
response NE xxx NE
. NE . NE

Slight NE Xxxx NE
differences NE xxx NE
in NE xx NE
the NE xxx NE
sequence NE xxx NE
of NE xx NE
the NE xxx NE
core G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
SRF G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
compared NE xxx NE
with NE xxx NE
that NE xxx NE
of NE xx NE
the NE xxx NE
classical NE xxx NE
c-Fos G#DNA_domain_or_region_B x-Xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
serum G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
response G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
together NE xxx NE
with NE xxx NE
differences NE xxx NE
in NE xx NE
the NE xxx NE
spacing NE xxx NE
between NE xxx NE
the NE xxx NE
SRF G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
ETS G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
SCMV NE XXXX NE
SNEs NE XXXx NE
to NE xx NE
respond NE xxx NE
to NE xx NE
serum G#other_name_B xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
. NE . NE

T-cell NE X-xxx NE
-directed NE -xxx NE
TAL-1 NE XXX-d NE
expression NE xxx NE
induces NE xxx NE
T-cell NE X-xxx NE
malignancies NE xxx NE
in NE xx NE
transgenic NE xxx NE
mice NE xxx NE
. NE . NE

The NE Xxx NE
TAL-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
specifies NE xxx NE
for NE xxx NE
a NE x NE
basic NE xxx NE
domain-helix-loop-helix G#protein_family_or_group_B xxx-xxx-xxx-xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
which NE xxx NE
is NE xx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
control NE xxx NE
of NE xx NE
normal G#other_name_B xxx G#other_name_B
hematopoiesis G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
human NE xxx NE
pathology NE xxx NE
, NE , NE
the NE xxx NE
TAL-1 G#protein_molecule_B XXX-d G#protein_molecule_B
gene G#protein_molecule_M xxx G#protein_molecule_M
product G#protein_molecule_E xxx G#protein_molecule_E
is NE xx NE
expressed NE xxx NE
in NE xx NE
a NE x NE
high NE xxx NE
percentage NE xxx NE
of NE xx NE
T-cell G#other_name_B X-xxx G#other_name_B
acute G#other_name_M xxx G#other_name_M
lymphoblastic G#other_name_M xxx G#other_name_M
leukemias G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
pediatric NE xxx NE
age NE xxx NE
range NE xxx NE
; NE ; NE
however NE xxx NE
, NE , NE
it NE xx NE
has NE xxx NE
not NE xxx NE
been NE xxx NE
established NE xxx NE
whether NE xxx NE
the NE xxx NE
expression NE xxx NE
has NE xxx NE
a NE x NE
causal NE xxx NE
role NE xxx NE
in NE xx NE
oncogenesis G#other_name xxx G#other_name
. NE . NE

In NE Xx NE
this NE xxx NE
report NE xxx NE
, NE , NE
we NE xx NE
describe NE xxx NE
the NE xxx NE
phenotype NE xxx NE
of NE xx NE
mouse G#cell_line_B xxx G#cell_line_B
transgenic G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
obtained NE xxx NE
by NE xx NE
inducing NE xxx NE
tal-1 G#other_name_B xxx-d G#other_name_B
protein G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
lymphoid G#tissue_B xxx G#tissue_B
tissues G#tissue_E xxx G#tissue_E
using NE xxx NE
the NE xxx NE
LCK G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
survival NE xxx NE
rate NE xxx NE
of NE xx NE
tal-1 G#multi_cell_B xxx-d G#multi_cell_B
transgenic G#multi_cell_M xxx G#multi_cell_M
animals G#multi_cell_E xxx G#multi_cell_E
was NE xxx NE
much NE xxx NE
lower NE xxx NE
as NE xx NE
compared NE xxx NE
with NE xxx NE
control NE xxx NE
mice NE xxx NE
. NE . NE

Histopathological G#other_name_B Xxxx G#other_name_B
analysis G#other_name_E xxx G#other_name_E
revealed NE xxx NE
lymphomas G#other_name xxx G#other_name
of NE xx NE
T-cell G#other_name_B X-xxx G#other_name_B
type G#other_name_E xxx G#other_name_E
, NE , NE
often NE xxx NE
comprising NE xxx NE
a NE x NE
minor NE xxx NE
B-cell G#other_name_B X-xxx G#other_name_B
component G#other_name_E xxx G#other_name_E
. NE . NE

Some NE Xxxx NE
mice NE xxx NE
showed NE xxx NE
marked NE xxx NE
splenic NE xxx NE
lymphocyte G#other_name_B xxx G#other_name_B
depletion G#other_name_E xxx G#other_name_E
. NE . NE

Primary G#cell_line_B Xxxx G#cell_line_B
lymphocyte G#cell_line_M xxx G#cell_line_M
cultures G#cell_line_E xxx G#cell_line_E
showed NE xxx NE
partial NE xxx NE
independence NE xxx NE
from NE xxx NE
exogenous G#other_name_B xxx G#other_name_B
growth G#other_name_M xxx G#other_name_M
stimuli G#other_name_E xxx G#other_name_E
and NE xxx NE
increased NE xxx NE
resistance NE xxx NE
to NE xx NE
low-serum G#other_name_B xxx-xxx G#other_name_B
apoptosis G#other_name_E xxx G#other_name_E
. NE . NE

To NE Xx NE
further NE xxx NE
unravel NE xxx NE
the NE xxx NE
tal-1 G#other_name_B xxx-d G#other_name_B
oncogenic G#other_name_M xxx G#other_name_M
potential G#other_name_E xxx G#other_name_E
, NE , NE
a NE x NE
strain NE xxx NE
of NE xx NE
tal-1 G#DNA_domain_or_region xxx-d G#DNA_domain_or_region
transgenic G#multi_cell_B xxx G#multi_cell_B
mice G#multi_cell_E xxx G#multi_cell_E
was NE xxx NE
crossbred NE xxx NE
with NE xxx NE
p53-/- G#multi_cell_B xdd-/- G#multi_cell_B
mice G#multi_cell_E xxx G#multi_cell_E
; NE ; NE
the NE xxx NE
survival NE xxx NE
rate NE xxx NE
in NE xx NE
these NE xxx NE
animals NE xxx NE
was NE xxx NE
reduced NE xxx NE
by NE xx NE
more NE xxx NE
than NE xxx NE
one-half NE xxx-xxx NE
when NE xxx NE
compared NE xxx NE
with NE xxx NE
that NE xxx NE
of NE xx NE
tal-1 NE xxx-d NE
mice NE xxx NE
, NE , NE
and NE xxx NE
histopathological NE xxx NE
analysis NE xxx NE
revealed NE xxx NE
exclusively NE xxx NE
T-cell NE X-xxx NE
lymphomas NE xxx NE
. NE . NE

These NE Xxxx NE
data NE xxx NE
indicate NE xxx NE
that NE xxx NE
TAL-1 G#protein_molecule XXX-d G#protein_molecule
, NE , NE
expressed NE xxx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
is NE xx NE
per NE xxx NE
se NE xx NE
a NE x NE
potent NE xxx NE
oncogene NE xxx NE
, NE , NE
which NE xxx NE
may NE xxx NE
exert NE xxx NE
a NE x NE
key NE xxx NE
leukemogenetic G#other_name_B xxx G#other_name_B
role G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
majority NE xxx NE
of NE xx NE
T-cell G#other_name_B X-xxx G#other_name_B
acute G#other_name_M xxx G#other_name_M
lymphoblastic G#other_name_M xxx G#other_name_M
leukemias G#other_name_E xxx G#other_name_E
. NE . NE

Tissue NE Xxxx NE
and NE xxx NE
cell-type NE xxx-xxx NE
specific NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
tuberous G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sclerosis G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
TSC2 G#DNA_domain_or_region XXXd G#DNA_domain_or_region
, NE , NE
in NE xx NE
human G#tissue_B xxx G#tissue_B
tissues G#tissue_E xxx G#tissue_E
. NE . NE

TSC2 G#DNA_domain_or_region XXXd G#DNA_domain_or_region
is NE xx NE
a NE x NE
gene NE xxx NE
on NE xx NE
chromosome G#DNA_molecule_B xxx G#DNA_molecule_B
16p13.3 G#DNA_molecule_E ddxdd.d G#DNA_molecule_E
associated NE xxx NE
with NE xxx NE
the NE xxx NE
autosomal G#other_name_B xxx G#other_name_B
dominant G#other_name_M xxx G#other_name_M
neurocutaneous G#other_name_M xxx G#other_name_M
disorder G#other_name_E xxx G#other_name_E
, NE , NE
tuberous G#other_name_B xxx G#other_name_B
sclerosis G#other_name_M xxx G#other_name_M
complex G#other_name_E xxx G#other_name_E
( NE ( NE
TSC G#other_name XXX G#other_name
) NE ) NE
. NE . NE

By NE Xx NE
using NE xxx NE
a NE x NE
partial G#DNA_N/A_B xxx G#DNA_N/A_B
nucleotide G#DNA_N/A_M xxx G#DNA_N/A_M
sequence G#DNA_N/A_E xxx G#DNA_N/A_E
from NE xxx NE
the NE xxx NE
cloned NE xxx NE
TSC2 G#DNA_domain_or_region XXXd G#DNA_domain_or_region
and NE xxx NE
polymerase G#other_name_B xxx G#other_name_B
chain G#other_name_M xxx G#other_name_M
reaction G#other_name_M xxx G#other_name_M
methodology G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
constructed NE xxx NE
a NE x NE
digoxigenin-labeled G#DNA_molecule_B xxx-xxx G#DNA_molecule_B
complementary G#DNA_molecule_M xxx G#DNA_molecule_M
DNA G#DNA_molecule_M XXX G#DNA_molecule_M
probe G#DNA_molecule_E xxx G#DNA_molecule_E
to NE xx NE
examine NE xxx NE
TSC2 G#other_name_B XXXd G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
autopsy- NE xxx- NE
or NE xx NE
biopsy-derived NE xxx-xxx NE
human G#tissue_B xxx G#tissue_B
tissues G#tissue_E xxx G#tissue_E
by NE xx NE
in G#other_name_B xx G#other_name_B
situ G#other_name_M xxx G#other_name_M
hybridization G#other_name_E xxx G#other_name_E
. NE . NE

TSC2 G#RNA_molecule_B XXXd G#RNA_molecule_B
messenger G#RNA_molecule_M xxx G#RNA_molecule_M
RNA G#RNA_molecule_E XXX G#RNA_molecule_E
was NE xxx NE
widely NE xxx NE
expressed NE xxx NE
in NE xx NE
various NE xxx NE
cell NE xxx NE
types NE xxx NE
throughout NE xxx NE
the NE xxx NE
body NE xxx NE
, NE , NE
including NE xxx NE
epithelia G#tissue xxx G#tissue
, NE , NE
lymphocytes G#cell_type xxx G#cell_type
, NE , NE
and NE xxx NE
cells NE xxx NE
with NE xxx NE
endocrine G#other_name_B xxx G#other_name_B
functions G#other_name_E xxx G#other_name_E
, NE , NE
e.g. NE x.x. NE
, NE , NE
adrenal G#body_part_B xxx G#body_part_B
cortex G#body_part_E xxx G#body_part_E
and NE xxx NE
anterior G#body_part_B xxx G#body_part_B
pituitary G#body_part_E xxx G#body_part_E
. NE . NE

It NE Xx NE
was NE xxx NE
prominently NE xxx NE
and NE xxx NE
selectively NE xxx NE
(within NE (xxx NE
the NE xxx NE
central G#body_part_B xxx G#body_part_B
nervous G#body_part_M xxx G#body_part_M
system G#body_part_E xxx G#body_part_E
) NE ) NE
expressed NE xxx NE
in NE xx NE
pyramidal G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
of NE xx NE
the NE xxx NE
cerebral G#body_part_B xxx G#body_part_B
cortex G#body_part_E xxx G#body_part_E
and NE xxx NE
other NE xxx NE
motor G#cell_type_B xxx G#cell_type_B
neurons G#cell_type_E xxx G#cell_type_E
, NE , NE
e.g. NE x.x. NE
, NE , NE
in NE xx NE
spinal G#body_part_B xxx G#body_part_B
cord G#body_part_E xxx G#body_part_E
and NE xxx NE
brainstem G#tissue_B xxx G#tissue_B
nuclei G#tissue_E xxx G#tissue_E
. NE . NE

Visceral NE Xxxx NE
TSC2 G#DNA_domain_or_region XXXd G#DNA_domain_or_region
expression NE xxx NE
was NE xxx NE
comparable NE xxx NE
in NE xx NE
autopsy G#tissue_B xxx G#tissue_B
tissues G#tissue_E xxx G#tissue_E
from NE xxx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
and NE xxx NE
without NE xxx NE
TSC G#other_name XXX G#other_name
; NE ; NE
TSC2 G#DNA_domain_or_region XXXd G#DNA_domain_or_region
messenger NE xxx NE
RNA NE XXX NE
expression NE xxx NE
was NE xxx NE
most NE xxx NE
prominent NE xxx NE
in NE xx NE
cells NE xxx NE
with NE xxx NE
a NE x NE
rapid G#other_name_B xxx G#other_name_B
mitotic G#other_name_M xxx G#other_name_M
rate G#other_name_E xxx G#other_name_E
and NE xxx NE
turnover NE xxx NE
, NE , NE
e.g. NE x.x. NE
, NE , NE
epithelia G#tissue xxx G#tissue
and NE xxx NE
lymphocytes G#cell_type xxx G#cell_type
, NE , NE
with NE xxx NE
central G#body_part_B xxx G#body_part_B
nervous G#body_part_M xxx G#body_part_M
system G#body_part_E xxx G#body_part_E
pyramidal G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
other NE xxx NE
neurons NE xxx NE
being NE xxx NE
an NE xx NE
obvious NE xxx NE
exception NE xxx NE
, NE , NE
and/or NE xxx/xx NE
in NE xx NE
cells NE xxx NE
with NE xxx NE
important NE xxx NE
secretory/transport NE xxx/xxx NE
functions NE xxx NE
. NE . NE

This NE Xxxx NE
widespread NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
TSC2 G#DNA_domain_or_region_B XXXd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
supports NE xxx NE
the NE xxx NE
view NE xxx NE
that NE xxx NE
it NE xx NE
encodes NE xxx NE
a NE x NE
protein NE xxx NE
vital NE xxx NE
to NE xx NE
cell NE xxx NE
growth NE xxx NE
and NE xxx NE
metabolism NE xxx NE
or NE xx NE
one NE xxx NE
that NE xxx NE
functions NE xxx NE
as NE xx NE
a NE x NE
tumor/growth G#other_name_B xxx/xxx G#other_name_B
suppressor G#other_name_E xxx G#other_name_E
. NE . NE

Apoptosis G#other_name_B Xxxx G#other_name_B
signaling G#other_name_M xxx G#other_name_M
pathways G#other_name_E xxx G#other_name_E
in NE xx NE
normal NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
: NE : NE
differential NE xxx NE
activity NE xxx NE
of NE xx NE
Bcl-2 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
IL-1beta G#other_organic_compound XX-dxxx G#other_organic_compound
-converting NE -xxx NE
enzyme NE xxx NE
family NE xxx NE
protease NE xxx NE
inhibitors NE xxx NE
on NE xx NE
glucocorticoid-mediated G#other_name_B xxx-xxx G#other_name_B
cytotoxicity G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
Fas-mediated G#other_name_M Xxx-xxx G#other_name_M
cytotoxicity G#other_name_E xxx G#other_name_E

Fas NE Xxx NE
-mediated NE -xxx NE
apoptosis NE xxx NE
plays NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
regulating NE xxx NE
the NE xxx NE
immune NE xxx NE
response NE xxx NE
in NE xx NE
peripheral NE xxx NE
T NE X NE
cells NE xxx NE
. NE . NE

Restimulation NE Xxxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
blasts G#cell_type_E xxx G#cell_type_E
up-regulates NE xx-xxx NE
Fas G#protein_molecule Xxx G#protein_molecule
and NE xxx NE
Fas G#other_name_B Xxx G#other_name_B
ligand G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
, NE , NE
with NE xxx NE
subsequent NE xxx NE
interaction NE xxx NE
leading NE xxx NE
to NE xx NE
cell G#other_name_B xxx G#other_name_B
death G#other_name_E xxx G#other_name_E
. NE . NE

Overexpression NE Xxxx NE
of NE xx NE
Bcl-2 G#protein_molecule Xxx-d G#protein_molecule
in NE xx NE
tumor G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
blocks NE xxx NE
apoptosis NE xxx NE
induced NE xxx NE
by NE xx NE
many NE xxx NE
stimuli NE xxx NE
, NE , NE
but NE xxx NE
inhibition NE xxx NE
of NE xx NE
Fas NE Xxx NE
-mediated NE -xxx NE
killing NE xxx NE
has NE xxx NE
not NE xxx NE
been NE xxx NE
consistently NE xxx NE
observed NE xxx NE
. NE . NE

To NE Xx NE
examine NE xxx NE
the NE xxx NE
behavior NE xxx NE
of NE xx NE
Bcl-2 G#protein_molecule Xxx-d G#protein_molecule
in NE xx NE
normal G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
T G#cell_type_B X G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
blasts G#cell_type_E xxx G#cell_type_E
were NE xxx NE
transiently NE xxx NE
transfected NE xxx NE
with NE xxx NE
Bcl-2 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
related NE xxx NE
gene G#protein_family_or_group_B xxx G#protein_family_or_group_B
products G#protein_family_or_group_E xxx G#protein_family_or_group_E
to NE xx NE
determine NE xxx NE
the NE xxx NE
effect NE xxx NE
on NE xx NE
apoptotic NE xxx NE
signaling NE xxx NE
. NE . NE

Transient NE Xxxx NE
overexpression NE xxx NE
of NE xx NE
Bcl-2 G#protein_molecule Xxx-d G#protein_molecule
in NE xx NE
mouse NE xxx NE
and NE xxx NE
human NE xxx NE
T G#cell_type_B X G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
blasts G#cell_type_E xxx G#cell_type_E
did NE xxx NE
not NE xxx NE
block NE xxx NE
Fas G#other_name Xxx G#other_name
-mediated NE -xxx NE
apoptosis NE xxx NE
, NE , NE
whereas NE xxx NE
etoposide-induced G#other_name_B xxx-xxx G#other_name_B
cytotoxicity G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
glucocorticoid-induced G#other_name_M xxx-xxx G#other_name_M
cytotoxicity G#other_name_E xxx G#other_name_E

Expression NE Xxxx NE
of NE xx NE
Bcl-xL G#protein_molecule Xxx-xX G#protein_molecule
and NE xxx NE
adenovirus G#protein_molecule_B xxx G#protein_molecule_B
E1B G#protein_molecule_M XdX G#protein_molecule_M
19K G#protein_molecule_E ddX G#protein_molecule_E
did NE xxx NE
not NE xxx NE
interfere NE xxx NE
with NE xxx NE
anti- NE xxx- NE
Fas NE Xxx NE
killing NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
interleukin-1beta-converting G#other_organic_compound_B xxx-dxxx-xxx G#other_organic_compound_B
enzyme G#other_organic_compound_M xxx G#other_organic_compound_M
family G#other_organic_compound_M xxx G#other_organic_compound_M
protease G#other_organic_compound_M xxx G#other_organic_compound_M
inhibitors G#other_organic_compound_E xxx G#other_organic_compound_E
Ac-DEVD-CHO G#other_organic_compound Xx-XXXX-XXX G#other_organic_compound
and NE xxx NE
CrmA G#other_organic_compound XxxX G#other_organic_compound
blocked NE xxx NE
Fas NE Xxx NE
-mediated NE -xxx NE
apoptosis NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
peripheral G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
use NE xxx NE
distinct NE xxx NE
apoptosis G#other_name_B xxx G#other_name_B
signaling G#other_name_M xxx G#other_name_M
pathways G#other_name_E xxx G#other_name_E
with NE xxx NE
differential NE xxx NE
sensitivity NE xxx NE
to NE xx NE
Bcl-2 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
interleukin-1beta-converting G#other_organic_compound_B xxx-dxxx-xxx G#other_organic_compound_B
enzyme G#other_organic_compound_M xxx G#other_organic_compound_M
family G#other_organic_compound_M xxx G#other_organic_compound_M
protease G#other_organic_compound_M xxx G#other_organic_compound_M
inhibitors G#other_organic_compound_E xxx G#other_organic_compound_E
. NE . NE

Since NE Xxxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
normally NE xxx NE
express NE xxx NE
Bcl-2 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
Bcl-xL G#protein_molecule Xxx-xX G#protein_molecule
following NE xxx NE
activation NE xxx NE
, NE , NE
their NE xxx NE
inability NE xxx NE
to NE xx NE
block NE xxx NE
Fas NE Xxx NE
-mediated NE -xxx NE
apoptosis NE xxx NE
may NE xxx NE
allow NE xxx NE
for NE xxx NE
the NE xxx NE
elimination NE xxx NE
of NE xx NE
self-reactive NE xxx-xxx NE
cells NE xxx NE
and NE xxx NE
the NE xxx NE
appropriate NE xxx NE
regulation NE xxx NE
of NE xx NE
immune NE xxx NE
responses NE xxx NE
. NE . NE

Increased NE Xxxx NE
interleukin G#other_name_B xxx G#other_name_B
2 G#other_name_M d G#other_name_M
transcription G#other_name_E xxx G#other_name_E
in NE xx NE
murine G#cell_type_B xxx G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
by NE xx NE
ciprofloxacin G#other_organic_compound xxx G#other_organic_compound
. NE . NE

The NE Xxx NE
fluoroquinolone G#other_organic_compound_B xxx G#other_organic_compound_B
antibiotic G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
ciprofloxacin G#other_organic_compound xxx G#other_organic_compound
( NE ( NE
cipro G#other_organic_compound xxx G#other_organic_compound
) NE ) NE
, NE , NE
induces NE xxx NE
hyperproduction NE xxx NE
of NE xx NE
interleukin G#protein_molecule_B xxx G#protein_molecule_B
2 G#protein_molecule_E d G#protein_molecule_E
( NE ( NE
IL-2 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
and NE xxx NE
interferon-gamma G#protein_molecule xxx-xxx G#protein_molecule
( NE ( NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
) NE ) NE
in NE xx NE
stimulated NE xxx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

In NE Xx NE
this NE xxx NE
investigation NE xxx NE
an NE xx NE
enhanced NE xxx NE
and NE xxx NE
prolonged NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
response G#other_name_E xxx G#other_name_E
was NE xxx NE
also NE xxx NE
detected NE xxx NE
in NE xx NE
both NE xxx NE
stimulated NE xxx NE
( NE ( NE
T G#protein_family_or_group_B X G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
mitogens G#protein_family_or_group_E xxx G#protein_family_or_group_E
or NE xx NE
alloantigens G#protein_family_or_group xxx G#protein_family_or_group
) NE ) NE
murine G#cell_type_B xxx G#cell_type_B
splenocytes G#cell_type_E xxx G#cell_type_E
and NE xxx NE
in NE xx NE
the NE xxx NE
stimulated NE xxx NE
murine G#cell_line_B xxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
EL-4 G#cell_line_E XX-d G#cell_line_E
in NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
ciprofloxacin G#other_organic_compound xxx G#other_organic_compound
(5-80 NE (d-dd NE
micrograms/ml) NE xxx/xx) NE
as NE xx NE
compared NE xxx NE
to NE xx NE
control NE xxx NE
cells NE xxx NE
without NE xxx NE
antibiotics G#other_organic_compound xxx G#other_organic_compound
. NE . NE

However NE Xxxx NE
, NE , NE
in NE xx NE
contrast NE xxx NE
to NE xx NE
human G#cell_type_B xxx G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
production G#other_name_E xxx G#other_name_E
was NE xxx NE
inhibited NE xxx NE
and NE xxx NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
levels G#other_name_E xxx G#other_name_E
were NE xxx NE
unaffected NE xxx NE
at NE xx NE
24 NE dd NE
h NE x NE
and NE xxx NE
only NE xxx NE
slightly NE xxx NE
upregulated NE xxx NE
at NE xx NE
48 NE dd NE
and NE xxx NE
72 NE dd NE
h NE x NE
of NE xx NE
culture NE xxx NE
in NE xx NE
murine G#cell_type_B xxx G#cell_type_B
splenocytes G#cell_type_E xxx G#cell_type_E
incubated NE xxx NE
with NE xxx NE
cipro G#other_organic_compound xxx G#other_organic_compound
(20 NE (dd NE
micrograms/ml) NE xxx/xx) NE
. NE . NE

EL-4 G#cell_type_B XX-d G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
were NE xxx NE
transfected NE xxx NE
with NE xxx NE
a NE x NE
plasmid NE xxx NE
containing NE xxx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
enhancer G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
linked NE xxx NE
to NE xx NE
the NE xxx NE
chloramphenicol NE xxx NE
acetyltransferase NE xxx NE
( NE ( NE
CAT NE XXX NE
) NE ) NE
reporter NE xxx NE
gene NE xxx NE
. NE . NE

Analysis NE Xxxx NE
of NE xx NE
CAT G#other_name_B XXX G#other_name_B
activity G#other_name_E xxx G#other_name_E
revealed NE xxx NE
that NE xxx NE
cipro G#other_organic_compound xxx G#other_organic_compound
enhanced NE xxx NE
IL-2 NE XX-d NE
gene NE xxx NE
induction NE xxx NE
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
EL-4 G#cell_type_B XX-d G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
incubated NE xxx NE
with NE xxx NE
ciprofloxacin G#other_organic_compound xxx G#other_organic_compound
showed NE xxx NE
an NE xx NE
early NE xxx NE
peak NE xxx NE
and NE xxx NE
more NE xxx NE
activated NE xxx NE
nuclear NE xxx NE
factor NE xxx NE
of NE xx NE
activated G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
NFAT-1 G#protein_molecule XXXX-d G#protein_molecule
) NE ) NE
as NE xx NE
compared NE xxx NE
to NE xx NE
control NE xxx NE
cells NE xxx NE
without NE xxx NE
antibiotics G#other_organic_compound xxx G#other_organic_compound
. NE . NE

Cipro NE Xxxx NE
did NE xxx NE
not NE xxx NE
affect NE xxx NE
the NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
AP-1 G#protein_molecule XX-d G#protein_molecule
or NE xx NE
NFIL-2A G#protein_molecule XXXX-dX G#protein_molecule
. NE . NE

Taken NE Xxxx NE
together NE xxx NE
, NE , NE
cipro G#other_organic_compound xxx G#other_organic_compound
inhibited NE xxx NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
, NE , NE
but NE xxx NE
enhanced NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
production NE xxx NE
in NE xx NE
murine G#cell_type_B xxx G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
by NE xx NE
means NE xxx NE
of NE xx NE
influencing NE xxx NE
NFAT-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
causing NE xxx NE
an NE xx NE
increased NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
transcription G#other_name_E xxx G#other_name_E
. NE . NE

Human NE Xxxx NE
T-cell G#virus_B X-xxx G#virus_B
leukemia G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
type G#virus_M xxx G#virus_M
I G#virus_E X G#virus_E
Tax G#protein_molecule Xxx G#protein_molecule
associates NE xxx NE
with NE xxx NE
and NE xxx NE
is NE xx NE
negatively NE xxx NE
regulated NE xxx NE
by NE xx NE
the NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B2 G#protein_molecule_M Xd G#protein_molecule_M
p100 G#protein_molecule_M xddd G#protein_molecule_M
gene G#protein_molecule_M xxx G#protein_molecule_M
product G#protein_molecule_E xxx G#protein_molecule_E
: NE : NE
implications NE xxx NE
for NE xxx NE
viral NE xxx NE
latency NE xxx NE
. NE . NE

Human G#virus_B Xxxx G#virus_B
T-cell G#virus_M X-xxx G#virus_M
leukemia G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
type G#virus_M xxx G#virus_M
I G#virus_E X G#virus_E
( NE ( NE
HTLV-I G#virus XXXX-X G#virus
) NE ) NE
is NE xx NE
the NE xxx NE
etiologic NE xxx NE
agent NE xxx NE
of NE xx NE
the NE xxx NE
adult G#other_name_B xxx G#other_name_B
T-cell G#other_name_M X-xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
, NE , NE
an NE xx NE
aggressive NE xxx NE
and NE xxx NE
often NE xxx NE
fatal NE xxx NE
malignancy NE xxx NE
of NE xx NE
activated G#cell_line_B xxx G#cell_line_B
human G#cell_line_M xxx G#cell_line_M
CD4 G#cell_line_M XXd G#cell_line_M
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

HTLV-I G#virus XXXX-X G#virus
encodes NE xxx NE
an NE xx NE
essential NE xxx NE
40-kDa G#protein_molecule_B dd-xXx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
termed NE xxx NE
Tax G#protein_molecule Xxx G#protein_molecule
that NE xxx NE
not NE xxx NE
only NE xxx NE
transactivates NE xxx NE
the NE xxx NE
long NE xxx NE
terminal NE xxx NE
repeat NE xxx NE
of NE xx NE
this NE xxx NE
retrovirus G#virus xxx G#virus
but NE xxx NE
also NE xxx NE
induces NE xxx NE
an NE xx NE
array NE xxx NE
of NE xx NE
cellular G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

Tax NE Xxx NE
-mediated NE -xxx NE
transformation NE xxx NE
of NE xx NE
T NE X NE
cells NE xxx NE
likely NE xxx NE
involves NE xxx NE
the NE xxx NE
deregulated NE xxx NE
expression NE xxx NE
of NE xx NE
various NE xxx NE
cellular NE xxx NE
genes NE xxx NE
that NE xxx NE
normally NE xxx NE
regulate NE xxx NE
lymphocyte NE xxx NE
growth NE xxx NE
produced NE xxx NE
by NE xx NE
altered NE xxx NE
activity NE xxx NE
of NE xx NE
various NE xxx NE
endogenous NE xxx NE
host NE xxx NE
transcription NE xxx NE
factors NE xxx NE
. NE . NE

In NE Xx NE
particular NE xxx NE
, NE , NE
Tax G#protein_molecule Xxx G#protein_molecule
is NE xx NE
capable NE xxx NE
of NE xx NE
modulating NE xxx NE
the NE xxx NE
expression NE xxx NE
or NE xx NE
activity NE xxx NE
of NE xx NE
various NE xxx NE
host NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
including NE xxx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
NF-kappa G#protein_family_or_group_B XX-xxx G#protein_family_or_group_B
B/Rel G#protein_family_or_group_E X/Xxx G#protein_family_or_group_E
and NE xxx NE
CREB/ATF NE XXXX/XXX NE
families NE xxx NE
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
the NE xxx NE
cellular NE xxx NE
factors NE xxx NE
HEB-1 NE XXX-d NE
and NE xxx NE
p67SRF NE xddXXX NE
. NE . NE

An NE Xx NE
additional NE xxx NE
distinguishing NE xxx NE
characteristic NE xxx NE
of NE xx NE
HTLV-I G#virus XXXX-X G#virus
infection NE xxx NE
is NE xx NE
the NE xxx NE
profound NE xxx NE
state NE xxx NE
of NE xx NE
viral NE xxx NE
latency NE xxx NE
that NE xxx NE
is NE xx NE
present NE xxx NE
in NE xx NE
circulating NE xxx NE
primary G#cell_type_B xxx G#cell_type_B
leukemic G#cell_type_M xxx G#cell_type_M
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
we NE xx NE
demonstrate NE xxx NE
that NE xxx NE
HTLV-I G#virus XXXX-X G#virus
Tax G#protein_molecule Xxx G#protein_molecule
can NE xxx NE
physically NE xxx NE
associate NE xxx NE
with NE xxx NE
p100 G#protein_molecule xddd G#protein_molecule
, NE , NE
the NE xxx NE
product NE xxx NE
of NE xx NE
the NE xxx NE
Rel-related G#DNA_domain_or_region_B Xxx-xxx G#DNA_domain_or_region_B
NF-kappa G#DNA_domain_or_region_M XX-xxx G#DNA_domain_or_region_M
B2 G#DNA_domain_or_region_M Xd G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
both NE xxx NE
in NE xx NE
transfected G#cell_line_B xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
in NE xx NE
HTLV-I NE XXXX-X NE
-infected NE -xxx NE
leukemic NE xxx NE
T-cell NE X-xxx NE
lines NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
the NE xxx NE
physical NE xxx NE
interaction NE xxx NE
of NE xx NE
Tax G#protein_molecule Xxx G#protein_molecule
with NE xxx NE
p100 G#protein_molecule xddd G#protein_molecule
leads NE xxx NE
to NE xx NE
the NE xxx NE
inhibition NE xxx NE
of NE xx NE
Tax NE Xxx NE
-induced NE -xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
HTLV-I NE XXXX-X NE
and NE xxx NE
human NE xxx NE
immunodeficiency NE xxx NE
virus NE xxx NE
type NE xxx NE
1 NE d NE
long NE xxx NE
terminal NE xxx NE
repeats NE xxx NE
, NE , NE
reflecting NE xxx NE
p100 NE xddd NE
-mediated NE -xxx NE
cytoplasmic NE xxx NE
sequestration NE xxx NE
of NE xx NE
the NE xxx NE
normally NE xxx NE
nuclearly NE xxx NE
expressed NE xxx NE
Tax NE Xxx NE
protein NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
a NE x NE
mutant NE xxx NE
of NE xx NE
Tax G#protein_molecule Xxx G#protein_molecule
that NE xxx NE
selectively NE xxx NE
fails NE xxx NE
to NE xx NE
activate NE xxx NE
nuclear NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
expression NE xxx NE
does NE xxx NE
not NE xxx NE
associate NE xxx NE
with NE xxx NE
p100 G#protein_molecule xddd G#protein_molecule
. NE . NE

(ABSTRACT NE (XXXXXXXX NE
TRUNCATED NE XXXXXXXXX NE
AT NE XX NE
250 NE ddd NE
WORDS) NE XXXXX) NE

Rhabdomyosarcomas NE Xxxx NE
do NE xx NE
not NE xxx NE
contain NE xxx NE
mutations NE xxx NE
in NE xx NE
the NE xxx NE
DNA NE XXX NE
binding NE xxx NE
domains NE xxx NE
of NE xx NE
myogenic NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Skeletal NE Xxxx NE
myogenesis NE xxx NE
is NE xx NE
regulated NE xxx NE
by NE xx NE
a NE x NE
group NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
MyoD G#protein_molecule XxxX G#protein_molecule
, NE , NE
myogenin G#protein_molecule xxx G#protein_molecule
, NE , NE
myf5 G#protein_molecule xxxd G#protein_molecule
, NE , NE
and NE xxx NE
myf6 G#protein_molecule xxxd G#protein_molecule
) NE ) NE
that NE xxx NE
are NE xxx NE
"basic G#protein_family_or_group_B "xxx G#protein_family_or_group_B
helix-loop-helix" G#protein_family_or_group_M xxx-xxx-xxx" G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
bind NE xxx NE
to NE xx NE
the NE xxx NE
promoters G#DNA_domain_or_region xxx G#DNA_domain_or_region
of NE xx NE
muscle-specific G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
and NE xxx NE
promote NE xxx NE
their NE xxx NE
expression NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
previously NE xxx NE
shown NE xxx NE
that NE xxx NE
after NE xxx NE
a NE x NE
mutation NE xxx NE
of NE xx NE
Leu122 G#amino_acid_monomer Xxxddd G#amino_acid_monomer
to NE xx NE
Arg G#amino_acid_monomer Xxx G#amino_acid_monomer
the NE xxx NE
DNA G#protein_domain_or_region_B XXX G#protein_domain_or_region_B
binding G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
basic G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
MyoD G#protein_molecule XxxX G#protein_molecule
confers NE xxx NE
c-myc NE x-xxx NE
-like NE -xxx NE
functional NE xxx NE
characteristics NE xxx NE
to NE xx NE
the NE xxx NE
protein NE xxx NE
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
we NE xx NE
used NE xxx NE
single-strand G#other_name_B xxx-xxx G#other_name_B
conformation G#other_name_M xxx G#other_name_M
polymorphism G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
to NE xx NE
determine NE xxx NE
whether NE xxx NE
such NE xxx NE
mutations NE xxx NE
occur NE xxx NE
naturally NE xxx NE
in NE xx NE
rhabdomyosarcomas G#other_name xxx G#other_name
. NE . NE

We NE Xx NE
have NE xxx NE
found NE xxx NE
that NE xxx NE
the NE xxx NE
basic G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domains G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
all NE xxx NE
the NE xxx NE
myogenic G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
remain NE xxx NE
unaltered NE xxx NE
in NE xx NE
rhabdomyosarcomas G#other_name xxx G#other_name
. NE . NE

Selection NE Xxxx NE
against NE xxx NE
such NE xxx NE
mutations NE xxx NE
may NE xxx NE
be NE xx NE
the NE xxx NE
result NE xxx NE
of NE xx NE
functional NE xxx NE
redundancy NE xxx NE
of NE xx NE
these NE xxx NE
myogenic G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Function NE Xxxx NE
and NE xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
the NE xxx NE
immune G#other_name_B xxx G#other_name_B
system G#other_name_E xxx G#other_name_E
. NE . NE

NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
is NE xx NE
a NE x NE
ubiquitous G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Nevertheless NE Xxxx NE
, NE , NE
its NE xxx NE
properties NE xxx NE
seem NE xxx NE
to NE xx NE
be NE xx NE
most NE xxx NE
extensively NE xxx NE
exploited NE xxx NE
in NE xx NE
cells NE xxx NE
of NE xx NE
the NE xxx NE
immune G#other_name_B xxx G#other_name_B
system G#other_name_E xxx G#other_name_E
. NE . NE

Among NE Xxxx NE
these NE xxx NE
properties NE xxx NE
are NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
's NE 'x NE
rapid NE xxx NE
posttranslational NE xxx NE
activation NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
many NE xxx NE
pathogenic G#other_name_B xxx G#other_name_B
signals G#other_name_E xxx G#other_name_E
, NE , NE
its NE xxx NE
direct NE xxx NE
participation NE xxx NE
in NE xx NE
cytoplasmic/nuclear G#other_name_B xxx/xxx G#other_name_B
signaling G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
its NE xxx NE
potency NE xxx NE
to NE xx NE
activate NE xxx NE
transcription NE xxx NE
of NE xx NE
a NE x NE
great NE xxx NE
variety NE xxx NE
of NE xx NE
genes NE xxx NE
encoding NE xxx NE
immunologically G#protein_family_or_group_B xxx G#protein_family_or_group_B
relevant G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

In NE Xx NE
vertebrates NE xxx NE
, NE , NE
five NE xxx NE
distinct NE xxx NE
DNA G#protein_subunit_B XXX G#protein_subunit_B
binding G#protein_subunit_M xxx G#protein_subunit_M
subunits G#protein_subunit_E xxx G#protein_subunit_E
are NE xxx NE
currently NE xxx NE
known NE xxx NE
which NE xxx NE
might NE xxx NE
extensively NE xxx NE
heterodimerize NE xxx NE
, NE , NE
thereby NE xxx NE
forming NE xxx NE
complexes NE xxx NE
with NE xxx NE
distinct NE xxx NE
transcriptional NE xxx NE
activity NE xxx NE
, NE , NE
DNA NE XXX NE
sequence NE xxx NE
specificity NE xxx NE
, NE , NE
and NE xxx NE
cell NE xxx NE
type- NE xxx- NE
and NE xxx NE
cell NE xxx NE
stage-specific NE xxx-xxx NE
distribution NE xxx NE
. NE . NE

The NE Xxx NE
activity NE xxx NE
of NE xx NE
DNA G#protein_complex_B XXX G#protein_complex_B
binding G#protein_complex_M xxx G#protein_complex_M
NF-kappa G#protein_complex_M XX-xxx G#protein_complex_M
B G#protein_complex_M X G#protein_complex_M
dimers G#protein_complex_E xxx G#protein_complex_E
is NE xx NE
tightly NE xxx NE
controlled NE xxx NE
by NE xx NE
accessory G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
called NE xxx NE
I G#protein_subunit_B X G#protein_subunit_B
kappa G#protein_subunit_M xxx G#protein_subunit_M
B G#protein_subunit_M X G#protein_subunit_M
subunits G#protein_subunit_E xxx G#protein_subunit_E
of NE xx NE
which NE xxx NE
there NE xxx NE
are NE xxx NE
also NE xxx NE
five NE xxx NE
different NE xxx NE
species NE xxx NE
currently NE xxx NE
known NE xxx NE
in NE xx NE
vertebrates G#multi_cell xxx G#multi_cell
. NE . NE

I G#protein_family_or_group_B X G#protein_family_or_group_B
kappa G#protein_family_or_group_M xxx G#protein_family_or_group_M
B G#protein_family_or_group_M X G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
inhibit NE xxx NE
DNA NE XXX NE
binding NE xxx NE
and NE xxx NE
prevent NE xxx NE
nuclear NE xxx NE
uptake NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
complexes NE xxx NE
. NE . NE

An NE Xx NE
exception NE xxx NE
is NE xx NE
the NE xxx NE
Bcl-3 G#protein_molecule_B Xxx-d G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
which NE xxx NE
in NE xx NE
addition NE xxx NE
can NE xxx NE
function NE xxx NE
as NE xx NE
a NE x NE
transcription G#protein_subunit_B xxx G#protein_subunit_B
activating G#protein_subunit_M xxx G#protein_subunit_M
subunit G#protein_subunit_E xxx G#protein_subunit_E
in NE xx NE
th NE xx NE
nucleus G#cell_component xxx G#cell_component
. NE . NE

Other NE Xxxx NE
I G#protein_family_or_group_B X G#protein_family_or_group_B
kappa G#protein_family_or_group_M xxx G#protein_family_or_group_M
B G#protein_family_or_group_M X G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
are NE xxx NE
rather NE xxx NE
involved NE xxx NE
in NE xx NE
terminating NE xxx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
's NE 'x NE
activity NE xxx NE
in NE xx NE
the NE xxx NE
nucleus G#cell_component xxx G#cell_component
. NE . NE

The NE Xxx NE
intracellular NE xxx NE
events NE xxx NE
that NE xxx NE
lead NE xxx NE
to NE xx NE
the NE xxx NE
inactivation NE xxx NE
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
i.e NE x.x NE
. NE . NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
, NE , NE
are NE xxx NE
complex NE xxx NE
. NE . NE

They NE Xxxx NE
involve NE xxx NE
phosphorylation G#other_name xxx G#other_name
and NE xxx NE
proteolytic G#other_name_B xxx G#other_name_B
reactions G#other_name_E xxx G#other_name_E
and NE xxx NE
seem NE xxx NE
to NE xx NE
be NE xx NE
controlled NE xxx NE
by NE xx NE
the NE xxx NE
cells' NE xxx' NE
redox G#other_name_B xxx G#other_name_B
status G#other_name_E xxx G#other_name_E
. NE . NE

Interference NE Xxxx NE
with NE xxx NE
the NE xxx NE
activation NE xxx NE
or NE xx NE
activity NE xxx NE
of NE xx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
may NE xxx NE
be NE xx NE
beneficial NE xxx NE
in NE xx NE
suppressing NE xxx NE
toxic/septic G#other_name_B xxx/xxx G#other_name_B
shock G#other_name_E xxx G#other_name_E
, NE , NE
graft-vs-host G#other_name_B xxx-xx-xxx G#other_name_B
reactions G#other_name_E xxx G#other_name_E
, NE , NE
acute G#other_name_B xxx G#other_name_B
inflammatory G#other_name_M xxx G#other_name_M
reactions G#other_name_E xxx G#other_name_E
, NE , NE
acute G#other_name_B xxx G#other_name_B
phase G#other_name_M xxx G#other_name_M
response G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
radiation G#other_name_B xxx G#other_name_B
damage G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
inhibition NE xxx NE
of NE xx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
activation NE xxx NE
by NE xx NE
antioxidants G#other_organic_compound xxx G#other_organic_compound
and NE xxx NE
specific NE xxx NE
protease NE xxx NE
inhibitors NE xxx NE
may NE xxx NE
provide NE xxx NE
a NE x NE
pharmacological NE xxx NE
basis NE xxx NE
for NE xxx NE
interfering NE xxx NE
with NE xxx NE
these NE xxx NE
acute NE xxx NE
processes NE xxx NE
. NE . NE

Lack NE Xxxx NE
of NE xx NE
T-cell-mediated G#other_name_B X-xxx-xxx G#other_name_B
recognition G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
fusion NE xxx NE
region NE xxx NE
of NE xx NE
the NE xxx NE
pml/RAR-alpha G#protein_molecule_B xxx/XXX-xxx G#protein_molecule_B
hybrid G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
by NE xx NE
lymphocytes G#cell_type xxx G#cell_type
of NE xx NE
acute NE xxx NE
promyelocytic G#other_name_B xxx G#other_name_B
leukemia G#other_name_M xxx G#other_name_M
patients G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
previous NE xxx NE
studies NE xxx NE
, NE , NE
it NE xx NE
was NE xxx NE
shown NE xxx NE
that NE xxx NE
the NE xxx NE
fusion NE xxx NE
region NE xxx NE
of NE xx NE
the NE xxx NE
pml/RAR-alpha G#protein_molecule_B xxx/XXX-xxx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
expressed NE xxx NE
by NE xx NE
acute G#cell_line_B xxx G#cell_line_B
promyelocytic G#cell_line_M xxx G#cell_line_M
leukemia G#cell_line_M xxx G#cell_line_M
(APL) G#cell_line_M (XXX) G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
can NE xxx NE
be NE xx NE
specifically NE xxx NE
recognized NE xxx NE
in G#other_name_B xx G#other_name_B
vitro G#other_name_E xxx G#other_name_E
by NE xx NE
donor NE xxx NE
(D NE (X NE
. NE . NE
E.) NE X.) NE
CD4 G#cell_line_B XXd G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
in NE xx NE
a NE x NE
HLA G#other_name_B XXX G#other_name_B
class G#other_name_M xxx G#other_name_M
II G#other_name_M XX G#other_name_M
DR11-restricted G#other_name_M XXdd-xxx G#other_name_M
fashion G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
present NE xxx NE
here NE xxx NE
the NE xxx NE
results NE xxx NE
on NE xx NE
the NE xxx NE
recognition NE xxx NE
of NE xx NE
several NE xxx NE
pml/RAR-alpha G#peptide_B xxx/XXX-xxx G#peptide_B
peptides G#peptide_E xxx G#peptide_E
by NE xx NE
APL G#multi_cell_B XXX G#multi_cell_B
patients G#multi_cell_E xxx G#multi_cell_E
expressing NE xxx NE
HLA G#protein_molecule_B XXX G#protein_molecule_B
DR11 G#protein_molecule_E XXdd G#protein_molecule_E
. NE . NE

The NE Xxx NE
in NE xx NE
vitro NE xxx NE
immunization NE xxx NE
of NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
from NE xxx NE
four NE xxx NE
patients NE xxx NE
in NE xx NE
remission NE xxx NE
(S.R. NE (X.X. NE
, NE , NE
F.R. NE X.X. NE
, NE , NE
M.M. NE X.X. NE
, NE , NE
P NE X NE
. NE . NE
G.) NE X.) NE
with NE xxx NE
BCR1/25 G#peptide XXXd/dd G#peptide
, NE , NE
a NE x NE
25-mer NE dd-xxx NE
pml NE xxx NE
/ NE / NE
RAR-alpha G#protein_molecule XXX-xxx G#protein_molecule
, NE , NE
did NE xxx NE
not NE xxx NE
elicit NE xxx NE
either NE xxx NE
a NE x NE
polyclonal NE xxx NE
or NE xx NE
a NE x NE
clonal G#other_name_B xxx G#other_name_B
immune G#other_name_M xxx G#other_name_M
response G#other_name_E xxx G#other_name_E
specific NE xxx NE
to NE xx NE
the NE xxx NE
peptide G#peptide xxx G#peptide
. NE . NE

We NE Xx NE
then NE xxx NE
generated NE xxx NE
new NE xxx NE
donor NE xxx NE
anti-pml NE xxx-xxx NE
/ NE / NE
RAR-alpha NE XXX-xxx NE
CD4(+) NE XXd(+) NE
T-cell NE X-xxx NE
clones NE xxx NE
. NE . NE

These NE Xxxx NE
clones NE xxx NE
were NE xxx NE
tested NE xxx NE
for NE xxx NE
their NE xxx NE
recognition NE xxx NE
of NE xx NE
BCR1/25 G#peptide XXXd/dd G#peptide
. NE . NE

One NE Xxx NE
clone NE xxx NE
( NE ( NE
C3/5, G#cell_line_B Xd/d, G#cell_line_B
CD3(+), G#cell_line_M XXd(+), G#cell_line_M
CD4(+), G#cell_line_M XXd(+), G#cell_line_M
CD8(-) G#cell_line_E XXd(-) G#cell_line_E
) NE ) NE
was NE xxx NE
selected NE xxx NE
for NE xxx NE
further NE xxx NE
analysis NE xxx NE
. NE . NE

Clone G#cell_line_B Xxxx G#cell_line_B
C3/5 G#cell_line_E Xd/d G#cell_line_E
showed NE xxx NE
specific NE xxx NE
proliferation NE xxx NE
, NE , NE
cytotoxicity NE xxx NE
, NE , NE
and NE xxx NE
cytokine NE xxx NE
( NE ( NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
granulocyte-macrophage G#protein_molecule_B xxx-xxx G#protein_molecule_B
colony-stimulating G#protein_molecule_M xxx-xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
) NE ) NE
production NE xxx NE
when NE xxx NE
challenged NE xxx NE
with NE xxx NE
autologous G#cell_line_B xxx G#cell_line_B
lymphoblastic G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
pulsed NE xxx NE
with NE xxx NE
peptide NE xxx NE
BCR1/25 G#peptide XXXd/dd G#peptide
. NE . NE

C3/5 G#cell_line_B Xd/d G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
developed NE xxx NE
specific NE xxx NE
proliferation G#other_name xxx G#other_name
and NE xxx NE
cytotoxicity G#other_name xxx G#other_name
when NE xxx NE
challenged NE xxx NE
with NE xxx NE
peptide-pulsed G#cell_line_B xxx-xxx G#cell_line_B
lymphoblastic G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
and NE xxx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
from NE xxx NE
the NE xxx NE
four NE xxx NE
DR11(+) NE XXdd(+) NE
APL G#multi_cell_B XXX G#multi_cell_B
patients G#multi_cell_E xxx G#multi_cell_E
. NE . NE

APL G#cell_type_B XXX G#cell_type_B
blasts G#cell_type_E xxx G#cell_type_E
, NE , NE
available NE xxx NE
only NE xxx NE
from NE xxx NE
patients NE xxx NE
F.R NE X.X NE
. NE . NE
and NE xxx NE
P.G. NE X.X. NE
, NE , NE
were NE xxx NE
not NE xxx NE
lysed NE xxx NE
by NE xx NE
C3/5 G#cell_line Xd/d G#cell_line
and NE xxx NE
were NE xxx NE
unable NE xxx NE
to NE xx NE
present NE xxx NE
peptide NE xxx NE
BCR1/25 G#peptide XXXd/dd G#peptide
. NE . NE

Incubation NE Xxxx NE
of NE xx NE
APL G#cell_line_B XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
failed NE xxx NE
to NE xx NE
induce NE xxx NE
HLA G#protein_family_or_group_B XXX G#protein_family_or_group_B
class G#protein_family_or_group_M xxx G#protein_family_or_group_M
II G#protein_family_or_group_M XX G#protein_family_or_group_M
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
recognition NE xxx NE
by NE xx NE
the NE xxx NE
C3/5 G#cell_line_B Xd/d G#cell_line_B
clone G#cell_line_E xxx G#cell_line_E
. NE . NE

Since NE Xxxx NE
APL G#cell_line_B XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
do NE xx NE
not NE xxx NE
express NE xxx NE
HLA G#protein_family_or_group_B XXX G#protein_family_or_group_B
class G#protein_family_or_group_M xxx G#protein_family_or_group_M
II G#protein_family_or_group_M XX G#protein_family_or_group_M
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
we NE xx NE
tested NE xxx NE
in NE xx NE
two NE xxx NE
donors NE xxx NE
(D.E NE (X.X NE
. NE . NE
and NE xxx NE
C.H.R.) NE X.X.X.) NE
and NE xxx NE
in NE xx NE
patients NE xxx NE
S.R.and NE X.X.xxx NE
P.G.whether NE X.X.xxx NE
the NE xxx NE
use NE xxx NE
of NE xx NE
9-mer G#peptide_B d-xxx G#peptide_B
peptides G#peptide_E xxx G#peptide_E
( NE ( NE
BCR1/9 G#peptide XXXd/d G#peptide
) NE ) NE
would NE xxx NE
generate NE xxx NE
a NE x NE
CD8 NE XXd NE
/HLA NE /XXX NE
class NE xxx NE
I NE X NE
-restricted NE -xxx NE
response NE xxx NE
. NE . NE

No NE Xx NE
peptide-specific G#cell_line_B xxx-xxx G#cell_line_B
T-cell G#cell_line_M X-xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
or NE xx NE
clone NE xxx NE
could NE xxx NE
be NE xx NE
generated NE xxx NE
from NE xxx NE
both NE xxx NE
donors NE xxx NE
and NE xxx NE
patients G#multi_cell xxx G#multi_cell
. NE . NE

These NE Xxxx NE
findings NE xxx NE
are NE xxx NE
discussed NE xxx NE
in NE xx NE
relation NE xxx NE
to NE xx NE
possible NE xxx NE
therapeutic NE xxx NE
approaches NE xxx NE
to NE xx NE
the NE xxx NE
immunotherapy G#other_name xxx G#other_name
of NE xx NE
APL G#other_name XXX G#other_name
. NE . NE

The NE Xxx NE
proximal NE xxx NE
regulatory NE xxx NE
element NE xxx NE
of NE xx NE
the NE xxx NE
interferon-gamma G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
mediates NE xxx NE
selective NE xxx NE
expression NE xxx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Interferon-gamma G#protein_molecule Xxxx-xxx G#protein_molecule
( NE ( NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
) NE ) NE
is NE xx NE
produced NE xxx NE
by NE xx NE
natural G#cell_type_B xxx G#cell_type_B
killer G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
certain NE xxx NE
subsets NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
but NE xxx NE
the NE xxx NE
basis NE xxx NE
for NE xxx NE
its NE xxx NE
selective NE xxx NE
expression NE xxx NE
is NE xx NE
unknown NE xxx NE
. NE . NE

Within NE Xxxx NE
the NE xxx NE
region NE xxx NE
between NE xxx NE
-108 NE -ddd NE
and NE xxx NE
-40 NE -dd NE
base NE xxx NE
pairs NE xxx NE
of NE xx NE
the NE xxx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
promoter NE xxx NE
are NE xxx NE
two NE xxx NE
conserved NE xxx NE
and NE xxx NE
essential NE xxx NE
regulatory G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
which NE xxx NE
confer NE xxx NE
activation-specific NE xxx-xxx NE
expression NE xxx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

This NE Xxxx NE
report NE xxx NE
describes NE xxx NE
studies NE xxx NE
indicating NE xxx NE
that NE xxx NE
the NE xxx NE
most NE xxx NE
proximal NE xxx NE
of NE xx NE
these NE xxx NE
two NE xxx NE
regulatory G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
is NE xx NE
an NE xx NE
important NE xxx NE
determinant NE xxx NE
of NE xx NE
its NE xxx NE
restricted G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
proximal NE xxx NE
element NE xxx NE
is NE xx NE
a NE x NE
composite NE xxx NE
site NE xxx NE
that NE xxx NE
binds NE xxx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
CREB/ATF G#protein_family_or_group XXXX/XXX G#protein_family_or_group
, NE , NE
AP-1 G#protein_family_or_group XX-d G#protein_family_or_group
, NE , NE
and NE xxx NE
octamer NE xxx NE
families NE xxx NE
of NE xx NE
transcription NE xxx NE
factors NE xxx NE
. NE . NE

Jun G#protein_family_or_group Xxx G#protein_family_or_group
is NE xx NE
essential NE xxx NE
for NE xxx NE
activation-induced G#other_name_B xxx-xxx G#other_name_B
transcription G#other_name_E xxx G#other_name_E
and NE xxx NE
binds NE xxx NE
preferably NE xxx NE
as NE xx NE
a NE x NE
heterodimer NE xxx NE
with NE xxx NE
ATF-2 G#protein_molecule XXX-d G#protein_molecule
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
CREB G#protein_family_or_group XXXX G#protein_family_or_group
appears NE xxx NE
to NE xx NE
dampen NE xxx NE
transcription NE xxx NE
from NE xxx NE
this NE xxx NE
element NE xxx NE
. NE . NE

The NE Xxx NE
CpG G#nucleotide_B XxX G#nucleotide_B
dinucleotide G#nucleotide_E xxx G#nucleotide_E
in NE xx NE
this NE xxx NE
element G#DNA_domain_or_region xxx G#DNA_domain_or_region
is NE xx NE
selectively NE xxx NE
methylated NE xxx NE
in NE xx NE
Th2 G#cell_type_B Xxd G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
other NE xxx NE
cells NE xxx NE
that NE xxx NE
do NE xx NE
not NE xxx NE
express NE xxx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
, NE , NE
and NE xxx NE
methylation NE xxx NE
markedly NE xxx NE
reduces NE xxx NE
transcription G#other_name_B xxx G#other_name_B
factor G#other_name_M xxx G#other_name_M
binding G#other_name_E xxx G#other_name_E
. NE . NE

As NE Xx NE
a NE x NE
target NE xxx NE
for NE xxx NE
DNA G#other_name_B XXX G#other_name_B
methylation G#other_name_E xxx G#other_name_E
and NE xxx NE
for NE xxx NE
binding NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
mediate NE xxx NE
or NE xx NE
impede NE xxx NE
transcription NE xxx NE
, NE , NE
this NE xxx NE
element NE xxx NE
appears NE xxx NE
to NE xx NE
play NE xxx NE
a NE x NE
central NE xxx NE
role NE xxx NE
in NE xx NE
controlling NE xxx NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

CD40 G#protein_molecule XXdd G#protein_molecule
, NE , NE
but NE xxx NE
not NE xxx NE
lipopolysaccharide G#lipid xxx G#lipid
and NE xxx NE
anti-IgM G#other_name_B xxx-XxX G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
of NE xx NE
primary G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
leads NE xxx NE
to NE xx NE
a NE x NE
persistent NE xxx NE
nuclear NE xxx NE
accumulation NE xxx NE
of NE xx NE
RelB G#protein_molecule XxxX G#protein_molecule
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
we NE xx NE
analyzed NE xxx NE
the NE xxx NE
effect NE xxx NE
of NE xx NE
CD40 G#other_name_B XXdd G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
on NE xx NE
the NE xxx NE
activity NE xxx NE
and NE xxx NE
nuclear NE xxx NE
appearance NE xxx NE
of NE xx NE
Rel/nuclear NE Xxx/xxx NE
factor NE xxx NE
kappaB NE xxxX NE
( NE ( NE
NF-kappaB NE XX-xxxX NE
) NE ) NE
factors NE xxx NE
in NE xx NE
primary NE xxx NE
murine NE xxx NE
B NE X NE
lymphocytes NE xxx NE
. NE . NE

We NE Xx NE
show NE xxx NE
that NE xxx NE
triggering NE xxx NE
of NE xx NE
CD40 G#other_name_B XXdd G#other_name_B
signaling G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
(s) NE (x) NE
by NE xx NE
CD40 G#protein_family_or_group_B XXdd G#protein_family_or_group_B
ligands G#protein_family_or_group_E xxx G#protein_family_or_group_E
expressed NE xxx NE
on NE xx NE
L G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
led NE xxx NE
to NE xx NE
strong NE xxx NE
activation NE xxx NE
of NE xx NE
an NE xx NE
NF-kappaB-controlled G#DNA_domain_or_region_B XX-xxxX-xxx G#DNA_domain_or_region_B
beta-globin G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
reporter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
primary G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
from NE xxx NE
transgenic NE xxx NE
mice NE xxx NE
. NE . NE

Analyses NE Xxxx NE
of NE xx NE
nuclear NE xxx NE
translocation NE xxx NE
of NE xx NE
individual NE xxx NE
members NE xxx NE
of NE xx NE
Rel G#protein_family_or_group_B Xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
after NE xxx NE
CD40 G#protein_molecule XXdd G#protein_molecule
induction NE xxx NE
of NE xx NE
primary G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
showed NE xxx NE
a NE x NE
strong NE xxx NE
and NE xxx NE
long-lasting NE xxx-xxx NE
accumulation NE xxx NE
of NE xx NE
RelB G#protein_molecule XxxX G#protein_molecule
and NE xxx NE
, NE , NE
less NE xxx NE
pronounced NE xxx NE
, NE , NE
of NE xx NE
c-Rel G#protein_molecule x-Xxx G#protein_molecule
. NE . NE

LPS NE XXX NE
stimulation NE xxx NE
did NE xxx NE
not NE xxx NE
give NE xxx NE
rise NE xxx NE
to NE xx NE
a NE x NE
persistent NE xxx NE
nuclear NE xxx NE
accumulation NE xxx NE
of NE xx NE
RelB G#protein_molecule XxxX G#protein_molecule
and NE xxx NE
c-Rel G#protein_molecule x-Xxx G#protein_molecule
, NE , NE
whereas NE xxx NE
nuclear NE xxx NE
c-Rel G#protein_molecule x-Xxx G#protein_molecule
, NE , NE
but NE xxx NE
not NE xxx NE
RelB G#protein_molecule XxxX G#protein_molecule
, NE , NE
accumulated NE xxx NE
after NE xxx NE
B G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
receptor G#other_name_M xxx G#other_name_M
stimulation G#other_name_E xxx G#other_name_E
. NE . NE

CD40 G#protein_molecule XXdd G#protein_molecule
induced NE xxx NE
not NE xxx NE
only NE xxx NE
nuclear NE xxx NE
translocation NE xxx NE
but NE xxx NE
also NE xxx NE
de NE xx NE
novo NE xxx NE
synthesis NE xxx NE
of NE xx NE
RelB G#RNA_family_or_group_B XxxX G#RNA_family_or_group_B
RNA G#RNA_family_or_group_E XXX G#RNA_family_or_group_E
and NE xxx NE
protein NE xxx NE
. NE . NE

S107 G#cell_line_B Xddd G#cell_line_B
plasmacytoma G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
which NE xxx NE
express NE xxx NE
CD40 G#protein_molecule XXdd G#protein_molecule
but NE xxx NE
are NE xxx NE
defective NE xxx NE
for NE xxx NE
the NE xxx NE
nuclear NE xxx NE
appearance NE xxx NE
of NE xx NE
p50/p65-NF-kappaB G#protein_complex xdd/xdd-XX-xxxX G#protein_complex
, NE , NE
do NE xx NE
not NE xxx NE
express NE xxx NE
RelB G#protein_molecule XxxX G#protein_molecule
after NE xxx NE
CD40 G#protein_molecule XXdd G#protein_molecule
stimulation NE xxx NE
. NE . NE

In NE Xx NE
S107 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
stably NE xxx NE
transfected NE xxx NE
with NE xxx NE
relB G#DNA_family_or_group_B xxxX G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
stimulation NE xxx NE
of NE xx NE
nuclear NE xxx NE
RelB G#other_name_B XxxX G#other_name_B
translocation G#other_name_E xxx G#other_name_E
by NE xx NE
CD40 G#protein_molecule XXdd G#protein_molecule
was NE xxx NE
observed NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
stimulation NE xxx NE
of NE xx NE
CD40 G#other_name_B XXdd G#other_name_B
signaling G#other_name_M xxx G#other_name_M
pathways G#other_name_E xxx G#other_name_E
exerts NE xxx NE
a NE x NE
long-lasting NE xxx-xxx NE
stimulatory NE xxx NE
effect NE xxx NE
on NE xx NE
both NE xxx NE
the NE xxx NE
transcription NE xxx NE
and NE xxx NE
nuclear NE xxx NE
translocation NE xxx NE
of NE xx NE
RelB G#protein_molecule XxxX G#protein_molecule
. NE . NE

Since NE Xxxx NE
LPS G#lipid XXX G#lipid
and NE xxx NE
anti-IgM G#protein_family_or_group xxx-XxX G#protein_family_or_group
were NE xxx NE
unable NE xxx NE
to NE xx NE
activate NE xxx NE
RelB G#protein_molecule XxxX G#protein_molecule
, NE , NE
CD40 G#protein_molecule XXdd G#protein_molecule
appears NE xxx NE
to NE xx NE
trigger NE xxx NE
a NE x NE
special NE xxx NE
program NE xxx NE
of NE xx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
involved NE xxx NE
in NE xx NE
the NE xxx NE
proliferation G#other_name xxx G#other_name
and/or NE xxx/xx NE
differentiation G#other_name xxx G#other_name
of NE xx NE
B G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

Identification NE Xxxx NE
and NE xxx NE
characterization NE xxx NE
of NE xx NE
a NE x NE
leukocyte-specific G#cell_component_B xxx-xxx G#cell_component_B
component G#cell_component_E xxx G#cell_component_E
of NE xx NE
the NE xxx NE
nuclear G#cell_component_B xxx G#cell_component_B
body G#cell_component_E xxx G#cell_component_E
. NE . NE

The NE Xxx NE
nuclear G#cell_component_B xxx G#cell_component_B
body G#cell_component_E xxx G#cell_component_E
( NE ( NE
NB G#cell_component XX G#cell_component
) NE ) NE
is NE xx NE
a NE x NE
cellular G#cell_component_B xxx G#cell_component_B
organelle G#cell_component_E xxx G#cell_component_E
that NE xxx NE
is NE xx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
pathogenesis NE xxx NE
of NE xx NE
acute G#other_name_B xxx G#other_name_B
promyelocytic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
and NE xxx NE
viral G#other_name_B xxx G#other_name_B
infection G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
NB G#cell_component XX G#cell_component
is NE xx NE
also NE xxx NE
a NE x NE
target NE xxx NE
of NE xx NE
antibodies NE xxx NE
in NE xx NE
the NE xxx NE
serum NE xxx NE
of NE xx NE
patients NE xxx NE
with NE xxx NE
the NE xxx NE
autoimmune NE xxx NE
disease NE xxx NE
primary NE xxx NE
biliary NE xxx NE
cirrhosis NE xxx NE
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
serum NE xxx NE
from NE xxx NE
a NE x NE
patient NE xxx NE
with NE xxx NE
primary G#other_name_B xxx G#other_name_B
biliary G#other_name_M xxx G#other_name_M
cirrhosis G#other_name_E xxx G#other_name_E
was NE xxx NE
used NE xxx NE
to NE xx NE
identify NE xxx NE
a NE x NE
cDNA NE xXXX NE
encoding NE xxx NE
a NE x NE
novel NE xxx NE
component NE xxx NE
of NE xx NE
the NE xxx NE
NB G#cell_component XX G#cell_component
, NE , NE
a NE x NE
140-kDa G#protein_molecule_B ddd-xXx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
designated NE xxx NE
Sp140 G#protein_molecule Xxddd G#protein_molecule
. NE . NE

The NE Xxx NE
predicted NE xxx NE
amino G#protein_N/A_B xxx G#protein_N/A_B
acid G#protein_N/A_M xxx G#protein_N/A_M
sequence G#protein_N/A_E xxx G#protein_N/A_E
of NE xx NE
the NE xxx NE
amino-terminal G#protein_domain_or_region_B xxx-xxx G#protein_domain_or_region_B
portion G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
Sp140 G#protein_molecule Xxddd G#protein_molecule
was NE xxx NE
similar NE xxx NE
to NE xx NE
Sp100 G#protein_molecule Xxddd G#protein_molecule
, NE , NE
a NE x NE
previously NE xxx NE
identified NE xxx NE
NB G#protein_family_or_group_B XX G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

The NE Xxx NE
carboxyl G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
portion G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
Sp140 G#protein_molecule Xxddd G#protein_molecule
contained NE xxx NE
a NE x NE
zinc-finger G#protein_domain_or_region_B xxx-xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
and NE xxx NE
a NE x NE
bromodomain G#protein_domain_or_region xxx G#protein_domain_or_region
, NE , NE
motifs NE xxx NE
that NE xxx NE
are NE xxx NE
present NE xxx NE
in NE xx NE
proteins NE xxx NE
regulating NE xxx NE
gene G#other_name_B xxx G#other_name_B
transcription G#other_name_E xxx G#other_name_E
. NE . NE

High NE Xxxx NE
levels NE xxx NE
of NE xx NE
Sp140 G#RNA_molecule_B Xxddd G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
were NE xxx NE
detected NE xxx NE
in NE xx NE
human G#tissue_B xxx G#tissue_B
spleen G#tissue_E xxx G#tissue_E
and NE xxx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
leukocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
but NE xxx NE
not NE xxx NE
other NE xxx NE
human G#tissue_B xxx G#tissue_B
tissues G#tissue_E xxx G#tissue_E
. NE . NE

The NE Xxx NE
level NE xxx NE
of NE xx NE
SP140 G#RNA_molecule_B XXddd G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
in NE xx NE
myeloid G#cell_line_B xxx G#cell_line_B
precursor G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
HL60 G#cell_line XXdd G#cell_line
and NE xxx NE
NB4 G#cell_line XXd G#cell_line
markedly NE xxx NE
increased NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
chemically NE xxx NE
induced NE xxx NE
cellular NE xxx NE
differentiation NE xxx NE
. NE . NE

Immunohistochemical G#other_name_B Xxxx G#other_name_B
techniques G#other_name_E xxx G#other_name_E
were NE xxx NE
used NE xxx NE
to NE xx NE
demonstrate NE xxx NE
that NE xxx NE
SP140 G#protein_molecule XXddd G#protein_molecule
localized NE xxx NE
to NE xx NE
the NE xxx NE
NB G#cell_component XX G#cell_component
in NE xx NE
differentiated NE xxx NE
HL60 G#cell_line XXdd G#cell_line
and NE xxx NE
NB4 G#cell_line_B XXd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
location NE xxx NE
of NE xx NE
Sp140 G#protein_molecule Xxddd G#protein_molecule
in NE xx NE
the NE xxx NE
NB G#cell_component XX G#cell_component
, NE , NE
and NE xxx NE
expression NE xxx NE
of NE xx NE
this NE xxx NE
gene NE xxx NE
in NE xx NE
cells NE xxx NE
involved NE xxx NE
in NE xx NE
host NE xxx NE
defense NE xxx NE
, NE , NE
suggest NE xxx NE
that NE xxx NE
Sp140 G#protein_molecule Xxddd G#protein_molecule
may NE xxx NE
be NE xx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
pathogenesis NE xxx NE
of NE xx NE
acute G#other_name_B xxx G#other_name_B
promyelocytic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
and NE xxx NE
viral G#other_name_B xxx G#other_name_B
infection G#other_name_E xxx G#other_name_E
. NE . NE

Regulation NE Xxxx NE
of NE xx NE
cytokine G#protein_family_or_group xxx G#protein_family_or_group
and NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
by NE xx NE
glucocorticoids G#lipid xxx G#lipid
. NE . NE

Glucocorticoids G#lipid Xxxx G#lipid
( NE ( NE
GCS G#lipid XXX G#lipid
) NE ) NE
profoundly NE xxx NE
inhibit NE xxx NE
several NE xxx NE
aspects NE xxx NE
of NE xx NE
T NE X NE
cell NE xxx NE
immunity NE xxx NE
largely NE xxx NE
through NE xxx NE
inhibition NE xxx NE
of NE xx NE
cytokine G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
at NE xx NE
the NE xxx NE
transcriptional NE xxx NE
and NE xxx NE
posttranscriptional G#other_name_B xxx G#other_name_B
levels G#other_name_E xxx G#other_name_E
. NE . NE

GCS G#lipid XXX G#lipid
were NE xxx NE
also NE xxx NE
reported NE xxx NE
to NE xx NE
act NE xxx NE
indirectly NE xxx NE
by NE xx NE
inducing NE xxx NE
transforming NE xxx NE
growth G#other_name_B xxx G#other_name_B
factor-beta G#other_name_M xxx-xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
, NE , NE
which NE xxx NE
in NE xx NE
turn NE xxx NE
blocks NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
immunity G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
exerting NE xxx NE
their NE xxx NE
antiproliferative NE xxx NE
effects NE xxx NE
, NE , NE
GCS G#lipid XXX G#lipid
diffuse NE xxx NE
into NE xxx NE
target G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
where NE xxx NE
they NE xxx NE
bind NE xxx NE
their NE xxx NE
cytoplasmic G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
which NE xxx NE
in NE xx NE
turn NE xxx NE
translocates NE xxx NE
to NE xx NE
the NE xxx NE
nucleus G#cell_component xxx G#cell_component
where NE xxx NE
it NE xx NE
inhibits NE xxx NE
transcription NE xxx NE
of NE xx NE
cytokine G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
through NE xxx NE
direct NE xxx NE
binding NE xxx NE
to NE xx NE
the NE xxx NE
glucocorticoid G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
response G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
elements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
GRE G#DNA_domain_or_region XXX G#DNA_domain_or_region
) NE ) NE
, NE , NE
which NE xxx NE
are NE xxx NE
located NE xxx NE
in NE xx NE
the NE xxx NE
promoter NE xxx NE
region NE xxx NE
of NE xx NE
cytokine G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
or NE xx NE
, NE , NE
alternatively NE xxx NE
, NE , NE
through NE xxx NE
antagonism NE xxx NE
of NE xx NE
the NE xxx NE
action NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
required NE xxx NE
for NE xxx NE
optimal NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
contrast NE xxx NE
to NE xx NE
their NE xxx NE
inhibitory NE xxx NE
effects NE xxx NE
on NE xx NE
cytokine G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
, NE , NE
GCS G#lipid XXX G#lipid
up-regulate NE xx-xxx NE
cytokine G#other_name_B xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
that NE xxx NE
correlates NE xxx NE
with NE xxx NE
enhanced NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
effects G#other_name_E xxx G#other_name_E
on NE xx NE
target G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

In NE Xx NE
this NE xxx NE
review NE xxx NE
, NE , NE
we NE xx NE
summarize NE xxx NE
the NE xxx NE
current NE xxx NE
state NE xxx NE
of NE xx NE
knowledge NE xxx NE
of NE xx NE
the NE xxx NE
mechanism NE xxx NE
of NE xx NE
action NE xxx NE
of NE xx NE
GCS G#lipid XXX G#lipid
, NE , NE
including NE xxx NE
the NE xxx NE
phenomenon NE xxx NE
of NE xx NE
steroid-induced NE xxx-xxx NE
rebound NE xxx NE
, NE , NE
which NE xxx NE
ensues NE xxx NE
upon NE xxx NE
GCS G#other_name_B XXX G#other_name_B
withdrawal G#other_name_E xxx G#other_name_E
. NE . NE

Isolation NE Xxxx NE
and NE xxx NE
characterization NE xxx NE
of NE xx NE
murine G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
fra-1 G#DNA_domain_or_region_E xxx-d G#DNA_domain_or_region_E
: NE : NE
induction NE xxx NE
mediated NE xxx NE
by NE xx NE
CD40 G#protein_molecule XXdd G#protein_molecule
and NE xxx NE
surface G#protein_family_or_group_B xxx G#protein_family_or_group_B
Ig G#protein_family_or_group_E Xx G#protein_family_or_group_E
is NE xx NE
protein G#other_name_B xxx G#other_name_B
kinase G#other_name_M xxx G#other_name_M
C G#other_name_M X G#other_name_M
dependent G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
murine G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
fra-1 G#DNA_domain_or_region_M xxx-d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
encoding NE xxx NE
Fos-related G#protein_molecule_B Xxx-xxx G#protein_molecule_B
Ag G#protein_molecule_M Xx G#protein_molecule_M
1 G#protein_molecule_E d G#protein_molecule_E
, NE , NE
was NE xxx NE
isolated NE xxx NE
from NE xxx NE
a NE x NE
splenic G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
cDNA G#DNA_family_or_group_M xXXX G#DNA_family_or_group_M
library G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
and NE xxx NE
sequenced NE xxx NE
. NE . NE

Murine G#DNA_domain_or_region_B Xxxx G#DNA_domain_or_region_B
fra-1 G#DNA_domain_or_region_E xxx-d G#DNA_domain_or_region_E
was NE xxx NE
highly NE xxx NE
homologous NE xxx NE
to NE xx NE
rat G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
fra-1 G#DNA_domain_or_region_M xxx-d G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
human G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
fra-1 G#DNA_domain_or_region_E xxx-d G#DNA_domain_or_region_E

Oligonucleotide G#polynucleotide_B Xxxx G#polynucleotide_B
primers G#polynucleotide_E xxx G#polynucleotide_E
based NE xxx NE
on NE xx NE
the NE xxx NE
murine G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
were NE xxx NE
used NE xxx NE
to NE xx NE
construct NE xxx NE
a NE x NE
quantitative G#other_name_B xxx G#other_name_B
reverse G#other_name_M xxx G#other_name_M
transcription-PCR G#other_name_M xxx-XXX G#other_name_M
assay G#other_name_E xxx G#other_name_E
for NE xxx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

B G#other_name_B X G#other_name_B
lymphocyte G#other_name_M xxx G#other_name_M
stimulation G#other_name_E xxx G#other_name_E
via NE xxx NE
both NE xxx NE
CD40 G#protein_molecule XXdd G#protein_molecule
and NE xxx NE
surface NE xxx NE
Ig NE Xx NE
( NE ( NE
sIg NE xXx NE
) NE ) NE
receptors NE xxx NE
substantially NE xxx NE
induced NE xxx NE
fra-1 NE xxx-d NE
expression NE xxx NE
, NE , NE
and NE xxx NE
for NE xxx NE
both NE xxx NE
receptors NE xxx NE
, NE , NE
induction NE xxx NE
was NE xxx NE
protein NE xxx NE
kinase NE xxx NE
C NE X NE
( NE ( NE
PKC NE XXX NE
) NE ) NE
dependent NE xxx NE
. NE . NE

This NE Xxxx NE
contrasts NE xxx NE
with NE xxx NE
induction NE xxx NE
of NE xx NE
c-fos G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
by NE xx NE
both NE xxx NE
CD40 G#protein_molecule XXdd G#protein_molecule
and NE xxx NE
sIg G#protein_family_or_group xXx G#protein_family_or_group
, NE , NE
which NE xxx NE
is NE xx NE
PKC G#protein_molecule XXX G#protein_molecule
independent NE xxx NE
and NE xxx NE
indicates NE xxx NE
that NE xxx NE
CD40 G#protein_molecule XXdd G#protein_molecule
is NE xx NE
capable NE xxx NE
of NE xx NE
signaling NE xxx NE
through NE xxx NE
PKC G#protein_molecule XXX G#protein_molecule
or NE xx NE
a NE x NE
closely NE xxx NE
related NE xxx NE
kinase G#protein_family_or_group xxx G#protein_family_or_group
. NE . NE

Induction NE Xxxx NE
of NE xx NE
fra-1 G#DNA_domain_or_region xxx-d G#DNA_domain_or_region
following NE xxx NE
engagement NE xxx NE
of NE xx NE
CD40 G#protein_molecule XXdd G#protein_molecule
did NE xxx NE
not NE xxx NE
require NE xxx NE
protein G#other_name_B xxx G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
, NE , NE
suggesting NE xxx NE
that NE xxx NE
the NE xxx NE
PKC NE XXX NE
-dependent NE -xxx NE
linkage NE xxx NE
between NE xxx NE
CD40 NE XXdd NE
and NE xxx NE
fra-1 NE xxx-d NE
is NE xx NE
direct NE xxx NE
. NE . NE

CD40 G#protein_molecule XXdd G#protein_molecule
-mediated NE -xxx NE
fra-1 G#other_name_B xxx-d G#other_name_B
induction G#other_name_E xxx G#other_name_E
did NE xxx NE
require NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
kinase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
CD40 G#protein_molecule XXdd G#protein_molecule
, NE , NE
like NE xxx NE
sIg G#protein_family_or_group xXx G#protein_family_or_group
, NE , NE
may NE xxx NE
employ NE xxx NE
PKC G#protein_molecule XXX G#protein_molecule
in NE xx NE
producing NE xxx NE
select NE xxx NE
outcomes NE xxx NE
, NE , NE
that NE xxx NE
individual NE xxx NE
B G#protein_family_or_group_B X G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
may NE xxx NE
signal NE xxx NE
downstream NE xxx NE
events NE xxx NE
via NE xxx NE
both NE xxx NE
PKC-dependent G#other_name_B XXX-xxx G#other_name_B
pathway G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
PKC-independent G#other_name_M XXX-xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
multiple NE xxx NE
signal NE xxx NE
transduction NE xxx NE
pathways NE xxx NE
may NE xxx NE
be NE xx NE
used NE xxx NE
to NE xx NE
activate NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
closely NE xxx NE
related NE xxx NE
genes G#DNA_family_or_group xxx G#DNA_family_or_group
. NE . NE

Pentoxifylline G#other_organic_compound Xxxx G#other_organic_compound
for NE xxx NE
the NE xxx NE
treatment NE xxx NE
of NE xx NE
infection NE xxx NE
with NE xxx NE
human G#virus_B xxx G#virus_B
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_E xxx G#virus_E
. NE . NE

Cytokine NE Xxxx NE
dysregulation NE xxx NE
in NE xx NE
human NE xxx NE
immunodeficiency NE xxx NE
virus NE xxx NE
type NE xxx NE
1 NE d NE
( NE ( NE
HIV-1 NE XXX-d NE
) NE ) NE
infection NE xxx NE
has NE xxx NE
been NE xxx NE
documented NE xxx NE
in NE xx NE
numerous NE xxx NE
studies NE xxx NE
and NE xxx NE
has NE xxx NE
been NE xxx NE
cited NE xxx NE
as NE xx NE
an NE xx NE
important NE xxx NE
component NE xxx NE
in NE xx NE
the NE xxx NE
pathogenesis NE xxx NE
of NE xx NE
this NE xxx NE
retroviral NE xxx NE
infection NE xxx NE
. NE . NE

Pharmacological NE Xxxx NE
modification NE xxx NE
of NE xx NE
cytokine G#other_name_B xxx G#other_name_B
dysregulation G#other_name_E xxx G#other_name_E
, NE , NE
therefore NE xxx NE
, NE , NE
has NE xxx NE
been NE xxx NE
suggested NE xxx NE
as NE xx NE
a NE x NE
therapeutic G#other_name_B xxx G#other_name_B
modality G#other_name_E xxx G#other_name_E
for NE xxx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
infection G#other_name_E xxx G#other_name_E
. NE . NE

Dr NE Xx NE
. NE . NE
Dezube NE Xxxx NE
of NE xx NE
Beth NE Xxxx NE
Israel NE Xxxx NE
Hospital NE Xxxx NE
(Boston) NE (Xxxx) NE
concisely NE xxx NE
reviews NE xxx NE
the NE xxx NE
state NE xxx NE
of NE xx NE
our NE xxx NE
knowledge NE xxx NE
regarding NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
pentoxifylline G#other_organic_compound xxx G#other_organic_compound
on NE xx NE
expression NE xxx NE
of NE xx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor-alpha G#protein_molecule_E xxx-xxx G#protein_molecule_E
, NE , NE
a NE x NE
cytokine G#protein_family_or_group xxx G#protein_family_or_group
known NE xxx NE
to NE xx NE
influence NE xxx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
replication G#other_name_E xxx G#other_name_E
and NE xxx NE
to NE xx NE
play NE xxx NE
a NE x NE
possible NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
clinical NE xxx NE
manifestations NE xxx NE
of NE xx NE
advanced NE xxx NE
infection NE xxx NE
with NE xxx NE
this NE xxx NE
virus NE xxx NE
. NE . NE

Pentoxifylline G#other_organic_compound Xxxx G#other_organic_compound
, NE , NE
a NE x NE
trisubstituted G#other_organic_compound_B xxx G#other_organic_compound_B
xanthine G#other_organic_compound_M xxx G#other_organic_compound_M
derivative G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
has NE xxx NE
been NE xxx NE
used NE xxx NE
to NE xx NE
decrease NE xxx NE
blood G#other_name_B xxx G#other_name_B
viscosity G#other_name_E xxx G#other_name_E
and NE xxx NE
is NE xx NE
reasonably NE xxx NE
well NE xxx NE
tolerated NE xxx NE
by NE xx NE
most NE xxx NE
recipients NE xxx NE
of NE xx NE
the NE xxx NE
drug NE xxx NE
. NE . NE

Results NE Xxxx NE
of NE xx NE
preliminary NE xxx NE
studies NE xxx NE
, NE , NE
many NE xxx NE
of NE xx NE
which NE xxx NE
were NE xxx NE
conducted NE xxx NE
by NE xx NE
Dr. G#multi_cell_B Xx. G#multi_cell_B
Dezube G#multi_cell_E Xxxx G#multi_cell_E
, NE , NE
suggest NE xxx NE
that NE xxx NE
use NE xxx NE
of NE xx NE
this NE xxx NE
agent NE xxx NE
in NE xx NE
combination NE xxx NE
with NE xxx NE
antiretroviral NE xxx NE
compounds NE xxx NE
may NE xxx NE
prove NE xxx NE
useful NE xxx NE
in NE xx NE
the NE xxx NE
treatment NE xxx NE
of NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
HIV-1 G#virus XXX-d G#virus
infection NE xxx NE
. NE . NE

Activation NE Xxxx NE
of NE xx NE
the NE xxx NE
granulocyte-macrophage G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
colony-stimulating G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
factor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
requires NE xxx NE
cooperative NE xxx NE
binding NE xxx NE
of NE xx NE
Elf-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

The NE Xxx NE
granulocyte-macrophage NE xxx-xxx NE
colony-stimulating NE xxx-xxx NE
factor NE xxx NE
( NE ( NE
GM-CSF NE XX-XXX NE
) NE ) NE
gene NE xxx NE
has NE xxx NE
been NE xxx NE
studied NE xxx NE
extensively NE xxx NE
as NE xx NE
a NE x NE
model NE xxx NE
system NE xxx NE
of NE xx NE
transcriptional NE xxx NE
induction NE xxx NE
during NE xxx NE
T-lymphocyte NE X-xxx NE
activation NE xxx NE
. NE . NE

The NE Xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
not NE xxx NE
expressed NE xxx NE
in NE xx NE
resting G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
but NE xxx NE
is NE xx NE
rapidly NE xxx NE
induced NE xxx NE
at NE xx NE
the NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
level G#other_name_E xxx G#other_name_E
following NE xxx NE
activation NE xxx NE
through NE xxx NE
the NE xxx NE
cell G#protein_family_or_group_B xxx G#protein_family_or_group_B
surface G#protein_family_or_group_M xxx G#protein_family_or_group_M
T-cell G#protein_family_or_group_M X-xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

A NE X NE
highly NE xxx NE
conserved NE xxx NE
19-bp NE dd-xx NE
element NE xxx NE
located NE xxx NE
immediately NE xxx NE
5' NE d' NE
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
GM-CSF G#DNA_domain_or_region_M XX-XXX G#DNA_domain_or_region_M
TATA G#DNA_domain_or_region_M XXXX G#DNA_domain_or_region_M
box G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
bp G#DNA_domain_or_region_B xx G#DNA_domain_or_region_B
-34 G#DNA_domain_or_region_M -dd G#DNA_domain_or_region_M
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-52 G#DNA_domain_or_region_E -dd G#DNA_domain_or_region_E
) NE ) NE
, NE , NE
herein NE xxx NE
called NE xxx NE
purine G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
box G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
1 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
( NE ( NE
PB1 G#DNA_domain_or_region XXd G#DNA_domain_or_region
) NE ) NE
, NE , NE
has NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
bind NE xxx NE
a NE x NE
T-cell G#protein_complex_B X-xxx G#protein_complex_B
nuclear G#protein_complex_M xxx G#protein_complex_M
protein G#protein_complex_M xxx G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
and NE xxx NE
to NE xx NE
be NE xx NE
required NE xxx NE
for NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
following NE xxx NE
T-cell G#other_name_B X-xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
PB1 G#DNA_domain_or_region XXd G#DNA_domain_or_region
sequence NE xxx NE
motif NE xxx NE
is NE xx NE
highly NE xxx NE
conserved NE xxx NE
in NE xx NE
both NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
GM-CSF G#DNA_domain_or_region_M XX-XXX G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
murine G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
GM-CSF G#DNA_domain_or_region_M XX-XXX G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E

In NE Xx NE
this NE xxx NE
report NE xxx NE
, NE , NE
we NE xx NE
demonstrate NE xxx NE
that NE xxx NE
the NE xxx NE
PB1 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
alone NE xxx NE
confers NE xxx NE
inducibility NE xxx NE
on NE xx NE
a NE x NE
heterologous NE xxx NE
promoter NE xxx NE
following NE xxx NE
transfection NE xxx NE
into NE xxx NE
human G#cell_line_B xxx G#cell_line_B
Jurkat G#cell_line_M Xxxx G#cell_line_M
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
we NE xx NE
identify NE xxx NE
a NE x NE
major NE xxx NE
PB1 G#protein_complex_B XXd G#protein_complex_B
nuclear G#protein_complex_M xxx G#protein_complex_M
protein-binding G#protein_complex_M xxx-xxx G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
that NE xxx NE
is NE xx NE
not NE xxx NE
present NE xxx NE
in NE xx NE
resting G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
but NE xxx NE
is NE xx NE
rapidly NE xxx NE
induced NE xxx NE
following NE xxx NE
T-cell G#other_name_B X-xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

Sequence NE Xxxx NE
analysis NE xxx NE
revealed NE xxx NE
that NE xxx NE
PB1 G#DNA_domain_or_region XXd G#DNA_domain_or_region
is NE xx NE
composed NE xxx NE
of NE xx NE
adjacent G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
Ets G#protein_molecule Xxx G#protein_molecule
and NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

In G#other_name_B Xx G#other_name_B
vitro G#other_name_M xxx G#other_name_M
mutagenesis G#other_name_M xxx G#other_name_M
experiments G#other_name_E xxx G#other_name_E
demonstrated NE xxx NE
that NE xxx NE
both NE xxx NE
the NE xxx NE
Ets G#DNA_domain_or_region_B Xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
AP-1 G#DNA_domain_or_region_M XX-d G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
are NE xxx NE
required NE xxx NE
for NE xxx NE
binding NE xxx NE
of NE xx NE
the NE xxx NE
inducible NE xxx NE
PB1 G#protein_complex_B XXd G#protein_complex_B
nuclear G#protein_complex_M xxx G#protein_complex_M
protein G#protein_complex_M xxx G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
and NE xxx NE
for NE xxx NE
the NE xxx NE
transcriptional NE xxx NE
activity NE xxx NE
of NE xx NE
this NE xxx NE
element NE xxx NE
and NE xxx NE
the NE xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
activated G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

(ABSTRACT NE (XXXXXXXX NE
TRUNCATED NE XXXXXXXXX NE
AT NE XX NE
250 NE ddd NE
WORDS) NE XXXXX) NE

Steroid-resistant G#other_name_B Xxxx-xxx G#other_name_B
asthma G#other_name_E xxx G#other_name_E
. NE . NE

Cellular G#other_name_B Xxxx G#other_name_B
mechanisms G#other_name_E xxx G#other_name_E
contributing NE xxx NE
to NE xx NE
inadequate NE xxx NE
response NE xxx NE
to NE xx NE
glucocorticoid G#other_name_B xxx G#other_name_B
therapy G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
current NE xxx NE
study NE xxx NE
examined NE xxx NE
whether NE xxx NE
alterations NE xxx NE
in NE xx NE
glucocorticoid G#protein_molecule_B xxx G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
GR G#protein_family_or_group XX G#protein_family_or_group
) NE ) NE
binding NE xxx NE
contribute NE xxx NE
to NE xx NE
poor NE xxx NE
response NE xxx NE
to NE xx NE
glucocorticoid G#other_name_B xxx G#other_name_B
therapy G#other_name_E xxx G#other_name_E
in NE xx NE
asthma NE xxx NE
. NE . NE

29 NE dd NE
asthma G#multi_cell_B xxx G#multi_cell_B
patients G#multi_cell_E xxx G#multi_cell_E
with NE xxx NE
forced G#other_name_B xxx G#other_name_B
expiratory G#other_name_M xxx G#other_name_M
volume G#other_name_E xxx G#other_name_E
in NE xx NE
1 NE d NE
s NE x NE
( NE ( NE
FEV1 G#other_name XXXd G#other_name
) NE ) NE
< NE < NE
70% NE dd% NE
predicted NE xxx NE
were NE xxx NE
studied NE xxx NE
. NE . NE

Patients NE Xxxx NE
were NE xxx NE
classified NE xxx NE
as NE xx NE
steroid G#other_name_B xxx G#other_name_B
sensitive G#other_name_E xxx G#other_name_E
( NE ( NE
SS G#other_name XX G#other_name
) NE ) NE
if NE xx NE
their NE xxx NE
morning G#other_name_B xxx G#other_name_B
FEV1 G#other_name_E XXXd G#other_name_E
increased NE xxx NE
> NE > NE
30% NE dd% NE
after NE xxx NE
a NE x NE
1-wk NE d-xx NE
course NE xxx NE
of NE xx NE
oral G#lipid_B xxx G#lipid_B
prednisone G#lipid_E xxx G#lipid_E
20 NE dd NE
mg NE xx NE
twice NE xxx NE
daily NE xxx NE
and NE xxx NE
steroid G#other_name_B xxx G#other_name_B
resistant G#other_name_E xxx G#other_name_E
( NE ( NE
SR G#other_name XX G#other_name
) NE ) NE
if NE xx NE
they NE xxx NE
failed NE xxx NE
to NE xx NE
increase NE xxx NE
> NE > NE
15% NE dd% NE
. NE . NE

PBMC NE XXXX NE
obtained NE xxx NE
from NE xxx NE
these NE xxx NE
two NE xxx NE
groups NE xxx NE
, NE , NE
17 NE dd NE
SR G#other_name XX G#other_name
and NE xxx NE
12 NE dd NE
SS G#other_name XX G#other_name
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
12 NE dd NE
normal NE xxx NE
controls NE xxx NE
were NE xxx NE
analyzed NE xxx NE
. NE . NE
SR G#other_name XX G#other_name
patients G#multi_cell xxx G#multi_cell
had NE xxx NE
two NE xxx NE
distinguishable NE xxx NE
GR G#other_name_B XX G#other_name_B
binding G#other_name_E xxx G#other_name_E
abnormalities NE xxx NE
: NE : NE
15 NE dd NE
of NE xx NE
the NE xxx NE
17 NE dd NE
SR G#other_name XX G#other_name
patients G#multi_cell xxx G#multi_cell
demonstrated NE xxx NE
a NE x NE
significantly NE xxx NE
reduced NE xxx NE
GR G#other_name_B XX G#other_name_B
binding G#other_name_M xxx G#other_name_M
affinity G#other_name_E xxx G#other_name_E
, NE , NE
as NE xx NE
compared NE xxx NE
with NE xxx NE
SS G#other_name XX G#other_name
patients G#multi_cell xxx G#multi_cell
(P NE (X NE
= NE = NE
0.0001) NE d.dddd) NE
and NE xxx NE
normal NE xxx NE
controls G#multi_cell xxx G#multi_cell
(P NE (X NE
= NE = NE
0.0001) NE d.dddd) NE
. NE . NE

This NE Xxxx NE
defect NE xxx NE
was NE xxx NE
localized NE xxx NE
to NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
reverted NE xxx NE
to NE xx NE
normal NE xxx NE
after NE xxx NE
48 NE dd NE
h NE x NE
in NE xx NE
culture NE xxx NE
media NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
incubation NE xxx NE
with NE xxx NE
a NE x NE
combination NE xxx NE
of NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
sustained NE xxx NE
this NE xxx NE
abnormality NE xxx NE
. NE . NE

The NE Xxx NE
other NE xxx NE
two NE xxx NE
SR G#other_name XX G#other_name
patients G#multi_cell xxx G#multi_cell
had NE xxx NE
an NE xx NE
abnormally NE xxx NE
low NE xxx NE
GR G#protein_family_or_group XX G#protein_family_or_group
number NE xxx NE
with NE xxx NE
normal NE xxx NE
binding NE xxx NE
affinity NE xxx NE
that NE xxx NE
was NE xxx NE
not NE xxx NE
limited NE xxx NE
to NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
GR G#protein_family_or_group XX G#protein_family_or_group
number NE xxx NE
failed NE xxx NE
to NE xx NE
normalize NE xxx NE
after NE xxx NE
incubation NE xxx NE
in NE xx NE
media NE xxx NE
alone NE xxx NE
or NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
. NE . NE

Therefore NE Xxxx NE
, NE , NE
SR G#other_name_B XX G#other_name_B
asthma G#other_name_E xxx G#other_name_E
may NE xxx NE
be NE xx NE
due NE xxx NE
to NE xx NE
more NE xxx NE
than NE xxx NE
one NE xxx NE
abnormality NE xxx NE
, NE , NE
the NE xxx NE
majority NE xxx NE
related NE xxx NE
to NE xx NE
a NE x NE
reversible NE xxx NE
cytokine NE xxx NE
-induced NE -xxx NE
reduction NE xxx NE
in NE xx NE
GR NE XX NE
binding NE xxx NE
affinity NE xxx NE
and NE xxx NE
the NE xxx NE
second NE xxx NE
related NE xxx NE
to NE xx NE
an NE xx NE
irreversible NE xxx NE
reduction NE xxx NE
in NE xx NE
GR NE XX NE
number NE xxx NE
. NE . NE

These NE Xxxx NE
findings NE xxx NE
may NE xxx NE
have NE xxx NE
important NE xxx NE
implications NE xxx NE
for NE xxx NE
the NE xxx NE
design NE xxx NE
of NE xx NE
alternative NE xxx NE
treatment NE xxx NE
approaches NE xxx NE
for NE xxx NE
recalcitrant NE xxx NE
asthma NE xxx NE
. NE . NE

Prevalence NE Xxxx NE
of NE xx NE
aneuploidy G#other_name xxx G#other_name
, NE , NE
overexpressed NE xxx NE
ER G#protein_family_or_group XX G#protein_family_or_group
, NE , NE
and NE xxx NE
overexpressed NE xxx NE
EGFR G#protein_family_or_group XXXX G#protein_family_or_group
in NE xx NE
random NE xxx NE
breast G#tissue_B xxx G#tissue_B
aspirates G#tissue_E xxx G#tissue_E
of NE xx NE
women NE xxx NE
at NE xx NE
high NE xxx NE
and NE xxx NE
low NE xxx NE
risk NE xxx NE
for NE xxx NE
breast NE xxx NE
cancer NE xxx NE
. NE . NE

Breast G#tissue_B Xxxx G#tissue_B
tissue G#tissue_M xxx G#tissue_M
biomarkers G#tissue_E xxx G#tissue_E
which NE xxx NE
accurately NE xxx NE
predict NE xxx NE
breast G#other_name_B xxx G#other_name_B
cancer G#other_name_M xxx G#other_name_M
development G#other_name_E xxx G#other_name_E
within NE xxx NE
a NE x NE
10 NE dd NE
year NE xxx NE
period NE xxx NE
in NE xx NE
high G#multi_cell_B xxx G#multi_cell_B
risk G#multi_cell_M xxx G#multi_cell_M
women G#multi_cell_E xxx G#multi_cell_E
are NE xxx NE
needed NE xxx NE
but NE xxx NE
currently NE xxx NE
not NE xxx NE
available NE xxx NE
. NE . NE

We NE Xx NE
initiated NE xxx NE
this NE xxx NE
study NE xxx NE
to NE xx NE
determine NE xxx NE
1) NE d) NE
the NE xxx NE
prevalence NE xxx NE
of NE xx NE
one NE xxx NE
or NE xx NE
more NE xxx NE
breast NE xxx NE
tissue NE xxx NE
abnormalities NE xxx NE
in NE xx NE
a NE x NE
group NE xxx NE
of NE xx NE
women NE xxx NE
at NE xx NE
high NE xxx NE
risk NE xxx NE
for NE xxx NE
breast NE xxx NE
cancer NE xxx NE
, NE , NE
and NE xxx NE
2) NE d) NE
if NE xx NE
the NE xxx NE
prevalence NE xxx NE
of NE xx NE
biomarker NE xxx NE
abnormalities NE xxx NE
is NE xx NE
greater NE xxx NE
in NE xx NE
high NE xxx NE
risk NE xxx NE
than NE xxx NE
in NE xx NE
low NE xxx NE
risk NE xxx NE
women NE xxx NE
. NE . NE

Eligible NE Xxxx NE
high G#multi_cell_B xxx G#multi_cell_B
risk G#multi_cell_M xxx G#multi_cell_M
women G#multi_cell_E xxx G#multi_cell_E
were NE xxx NE
those NE xxx NE
with NE xxx NE
a NE x NE
first NE xxx NE
degree NE xxx NE
relative NE xxx NE
with NE xxx NE
breast G#other_name_B xxx G#other_name_B
cancer G#other_name_E xxx G#other_name_E
, NE , NE
prior NE xxx NE
breast G#other_name_B xxx G#other_name_B
cancer G#other_name_E xxx G#other_name_E
, NE , NE
or NE xx NE
precancerous G#other_name_B xxx G#other_name_B
mastopathy G#other_name_E xxx G#other_name_E
. NE . NE

Low NE Xxx NE
risk NE xxx NE
women NE xxx NE
were NE xxx NE
those NE xxx NE
without NE xxx NE
these NE xxx NE
or NE xx NE
other NE xxx NE
major NE xxx NE
identifiable NE xxx NE
risk NE xxx NE
factors NE xxx NE
. NE . NE

Ductal G#cell_type_B Xxxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
were NE xxx NE
obtained NE xxx NE
via NE xxx NE
random G#other_name_B xxx G#other_name_B
fine G#other_name_M xxx G#other_name_M
needle G#other_name_M xxx G#other_name_M
aspirations G#other_name_E xxx G#other_name_E
and NE xxx NE
cytologically NE xxx NE
classified NE xxx NE
. NE . NE

Biomarkers NE Xxxx NE
included NE xxx NE
DNA G#other_name_B XXX G#other_name_B
ploidy G#other_name_E xxx G#other_name_E
, NE , NE
estrogen G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
ER G#protein_family_or_group XX G#protein_family_or_group
) NE ) NE
, NE , NE
and NE xxx NE
epidermal G#protein_family_or_group_B xxx G#protein_family_or_group_B
growth G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
EGFR G#protein_family_or_group XXXX G#protein_family_or_group
) NE ) NE
. NE . NE

The NE Xxx NE
prevalence NE xxx NE
of NE xx NE
DNA NE XXX NE
aneuploidy G#other_name xxx G#other_name
was NE xxx NE
30% NE dd% NE
, NE , NE
overexpression NE xxx NE
of NE xx NE
ER G#protein_family_or_group XX G#protein_family_or_group
10% NE dd% NE
, NE , NE
and NE xxx NE
overexpression NE xxx NE
of NE xx NE
EGFR G#protein_family_or_group XXXX G#protein_family_or_group
35% NE dd% NE
, NE , NE
in NE xx NE
the NE xxx NE
206 NE ddd NE
high NE xxx NE
risk NE xxx NE
women G#multi_cell xxx G#multi_cell
whose NE xxx NE
median NE xxx NE
10 NE dd NE
year NE xxx NE
Gail G#other_name_B Xxxx G#other_name_B
risk G#other_name_E xxx G#other_name_E
(projected NE (xxx NE
probability) NE xxx) NE
of NE xx NE
developing NE xxx NE
breast G#other_name_B xxx G#other_name_B
cancer G#other_name_E xxx G#other_name_E
was NE xxx NE
4.5% NE d.d% NE
. NE . NE

The NE Xxx NE
prevalence NE xxx NE
of NE xx NE
aneuploidy G#other_name xxx G#other_name
and NE xxx NE
overexpressed NE xxx NE
EGFR G#protein_family_or_group XXXX G#protein_family_or_group
was NE xxx NE
significantly NE xxx NE
higher NE xxx NE
in NE xx NE
the NE xxx NE
high G#multi_cell_B xxx G#multi_cell_B
risk G#multi_cell_M xxx G#multi_cell_M
women G#multi_cell_E xxx G#multi_cell_E
than NE xxx NE
in NE xx NE
the NE xxx NE
25 NE dd NE
low NE xxx NE
risk NE xxx NE
controls NE xxx NE
(p NE (x NE
< NE < NE
0.002) NE d.ddd) NE
, NE , NE
whose NE xxx NE
median NE xxx NE
10 NE dd NE
year NE xxx NE
Gail NE Xxxx NE
risk NE xxx NE
was NE xxx NE
0.7% NE d.d% NE
. NE . NE

The NE Xxx NE
difference NE xxx NE
in NE xx NE
the NE xxx NE
prevalence NE xxx NE
of NE xx NE
ER G#other_name_B XX G#other_name_B
overexpression G#other_name_E xxx G#other_name_E
between NE xxx NE
high NE xxx NE
and NE xxx NE
low NE xxx NE
risk NE xxx NE
groups NE xxx NE
was NE xxx NE
not NE xxx NE
statistically NE xxx NE
significant NE xxx NE
(p NE (x NE
= NE = NE
0.095) NE d.ddd) NE
. NE . NE

This NE Xxxx NE
may NE xxx NE
be NE xx NE
due NE xxx NE
to NE xx NE
the NE xxx NE
low NE xxx NE
prevalence NE xxx NE
of NE xx NE
overexpressed NE xxx NE
ER G#protein_family_or_group XX G#protein_family_or_group
and NE xxx NE
the NE xxx NE
small NE xxx NE
number NE xxx NE
of NE xx NE
controls NE xxx NE
. NE . NE

A NE X NE
significant NE xxx NE
difference NE xxx NE
was NE xxx NE
noted NE xxx NE
in NE xx NE
the NE xxx NE
prevalence NE xxx NE
of NE xx NE
one NE xxx NE
or NE xx NE
more NE xxx NE
abnormal G#other_name_B xxx G#other_name_B
biomarkers G#other_name_E xxx G#other_name_E
between NE xxx NE
the NE xxx NE
high NE xxx NE
risk NE xxx NE
and NE xxx NE
low G#multi_cell_B xxx G#multi_cell_B
risk G#multi_cell_M xxx G#multi_cell_M
women G#multi_cell_E xxx G#multi_cell_E
(p NE (x NE
< NE < NE
0.001) NE d.ddd) NE
. NE . NE

A NE X NE
large NE xxx NE
prospective NE xxx NE
trial NE xxx NE
is NE xx NE
needed NE xxx NE
to NE xx NE
determine NE xxx NE
if NE xx NE
one NE xxx NE
or NE xx NE
more NE xxx NE
of NE xx NE
these NE xxx NE
biomarkers G#other_name xxx G#other_name
, NE , NE
is NE xx NE
predictive NE xxx NE
of NE xx NE
breast G#other_name_B xxx G#other_name_B
cancer G#other_name_M xxx G#other_name_M
development G#other_name_E xxx G#other_name_E
. NE . NE

Inhibition NE Xxxx NE
of NE xx NE
nuclear G#RNA_molecule_B xxx G#RNA_molecule_B
factor G#RNA_molecule_M xxx G#RNA_molecule_M
kappa G#RNA_molecule_M xxx G#RNA_molecule_M
B G#RNA_molecule_M X G#RNA_molecule_M
subunit G#RNA_molecule_M xxx G#RNA_molecule_M
p65 G#RNA_molecule_M xdd G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
accumulation NE xxx NE
in NE xx NE
lipopolysaccharide NE xxx NE
-stimulated NE -xxx NE
human NE xxx NE
monocytic NE xxx NE
cells NE xxx NE
treated NE xxx NE
with NE xxx NE
sodium NE xxx NE
salicylate NE xxx NE
. NE . NE

Lipopolysaccharide NE Xxxx NE
is NE xx NE
one NE xxx NE
of NE xx NE
the NE xxx NE
most NE xxx NE
potent NE xxx NE
trigger NE xxx NE
substances NE xxx NE
for NE xxx NE
monocytes NE xxx NE
and NE xxx NE
macrophages NE xxx NE
causing NE xxx NE
secretion NE xxx NE
of NE xx NE
inflammatory G#protein_family_or_group_B xxx G#protein_family_or_group_B
mediators G#protein_family_or_group_E xxx G#protein_family_or_group_E
such NE xxx NE
as NE xx NE
tumor G#protein_family_or_group_B xxx G#protein_family_or_group_B
necrosis G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
interleukin-1 G#protein_molecule xxx-d G#protein_molecule
. NE . NE

The NE Xxx NE
nature NE xxx NE
of NE xx NE
the NE xxx NE
nuclear NE xxx NE
factors NE xxx NE
involved NE xxx NE
in NE xx NE
regulation NE xxx NE
of NE xx NE
these NE xxx NE
cytokine G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
is NE xx NE
still NE xxx NE
unknown NE xxx NE
. NE . NE

Nuclear NE Xxxx NE
factor NE xxx NE
kappa NE xxx NE
B NE X NE
( NE ( NE
NF-kappa NE XX-xxx NE
B NE X NE
; NE ; NE
heterodimer NE xxx NE
of NE xx NE
p50 NE xdd NE
and NE xxx NE
p65 NE xdd NE
) NE ) NE
proteins NE xxx NE
have NE xxx NE
been NE xxx NE
suggested NE xxx NE
to NE xx NE
play NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
gene NE xxx NE
transcription NE xxx NE
of NE xx NE
inflammatory NE xxx NE
mediators NE xxx NE
when NE xxx NE
monocytes NE xxx NE
are NE xxx NE
stimulated NE xxx NE
with NE xxx NE
lipopolysaccharide NE xxx NE
. NE . NE

Nonsteroidal G#other_organic_compound_B Xxxx G#other_organic_compound_B
anti-inflammatory G#other_organic_compound_M xxx-xxx G#other_organic_compound_M
drugs G#other_organic_compound_E xxx G#other_organic_compound_E
such NE xxx NE
as NE xx NE
salicylates NE xxx NE
have NE xxx NE
been NE xxx NE
used NE xxx NE
to NE xx NE
treat NE xxx NE
symptoms NE xxx NE
of NE xx NE
inflammation G#other_name xxx G#other_name
, NE , NE
and NE xxx NE
a NE x NE
new NE xxx NE
mechanism NE xxx NE
of NE xx NE
drug NE xxx NE
action NE xxx NE
was NE xxx NE
suggested NE xxx NE
recently NE xxx NE
. NE . NE

Salicylates G#other_organic_compound Xxxx G#other_organic_compound
have NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
inhibit NE xxx NE
lipopolysaccharide G#lipid xxx G#lipid
-induced NE -xxx NE
gene G#other_name_B xxx G#other_name_B
transcription G#other_name_E xxx G#other_name_E
via NE xxx NE
inhibition NE xxx NE
of NE xx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
by NE xx NE
preventing NE xxx NE
the NE xxx NE
degradation NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_M X G#protein_molecule_M
inhibitor G#protein_molecule_E xxx G#protein_molecule_E
" NE " NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
" NE " NE
, NE , NE
blocking NE xxx NE
the NE xxx NE
translocation NE xxx NE
of NE xx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
into NE xxx NE
the NE xxx NE
nuclear G#cell_component_B xxx G#cell_component_B
compartment G#cell_component_E xxx G#cell_component_E
. NE . NE

However NE Xxxx NE
, NE , NE
the NE xxx NE
nature NE xxx NE
of NE xx NE
the NE xxx NE
subunit NE xxx NE
involved NE xxx NE
in NE xx NE
this NE xxx NE
mechanism NE xxx NE
has NE xxx NE
not NE xxx NE
been NE xxx NE
defined NE xxx NE
. NE . NE

To NE Xx NE
examine NE xxx NE
the NE xxx NE
mechanisms NE xxx NE
by NE xx NE
which NE xxx NE
salicylates G#other_organic_compound xxx G#other_organic_compound
affect NE xxx NE
cytokine G#protein_family_or_group xxx G#protein_family_or_group
gene G#other_name_B xxx G#other_name_B
transcription G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
amount NE xxx NE
of NE xx NE
active NE xxx NE
and NE xxx NE
inactive NE xxx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
and NE xxx NE
NF-kappa G#RNA_molecule_B XX-xxx G#RNA_molecule_B
B G#RNA_molecule_M X G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
, NE , NE
in NE xx NE
Porphyromonas NE Xxxx NE
gingivalis NE xxx NE
lipopolysaccharide NE xxx NE
-stimulated NE -xxx NE
human NE xxx NE
monocytic NE xxx NE
cells NE xxx NE
was NE xxx NE
assessed NE xxx NE
. NE . NE

High NE Xxxx NE
doses NE xxx NE
of NE xx NE
sodium G#other_organic_compound_B xxx G#other_organic_compound_B
salicylate G#other_organic_compound_E xxx G#other_organic_compound_E
suppressed NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
p65 G#other_name_M xdd G#other_name_M
mRNA G#other_name_M xXXX G#other_name_M
accumulation G#other_name_E xxx G#other_name_E
, NE , NE
resulting NE xxx NE
in NE xx NE
suppression NE xxx NE
of NE xx NE
total NE xxx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
, NE , NE
p50 G#protein_subunit xdd G#protein_subunit
on NE xx NE
tissue G#polynucleotide_B xxx G#polynucleotide_B
oligonucleotide G#polynucleotide_E xxx G#polynucleotide_E
had NE xxx NE
no NE xx NE
effects NE xxx NE
on NE xx NE
lipopolysaccharide NE xxx NE
-induced NE -xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
activation NE xxx NE
. NE . NE

The NE Xxx NE
data NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
the NE xxx NE
p65 G#protein_subunit xdd G#protein_subunit
subunit NE xxx NE
of NE xx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
is NE xx NE
inhibited NE xxx NE
by NE xx NE
salicylate G#other_name_B xxx G#other_name_B
treatment G#other_name_E xxx G#other_name_E
and NE xxx NE
highlight NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
salicylate NE xxx NE
in NE xx NE
the NE xxx NE
control NE xxx NE
of NE xx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
inflammatory G#protein_family_or_group_B xxx G#protein_family_or_group_B
mediators G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Glucocorticoid NE Xxxx NE
-mediated NE -xxx NE
inhibition NE xxx NE
of NE xx NE
RANTES NE XXXXXX NE
expression NE xxx NE
in NE xx NE
human NE xxx NE
T NE X NE
lymphocytes NE xxx NE
. NE . NE

The NE Xxx NE
chemokine G#protein_family_or_group xxx G#protein_family_or_group
RANTES G#protein_molecule XXXXXX G#protein_molecule
has NE xxx NE
been NE xxx NE
implicated NE xxx NE
in NE xx NE
the NE xxx NE
pathogenesis NE xxx NE
of NE xx NE
allergic G#other_name_B xxx G#other_name_B
inflammatory G#other_name_M xxx G#other_name_M
diseases G#other_name_E xxx G#other_name_E
including NE xxx NE
asthma G#other_name xxx G#other_name
and NE xxx NE
rhinitis G#other_name xxx G#other_name
which NE xxx NE
are NE xxx NE
frequently NE xxx NE
treated NE xxx NE
with NE xxx NE
glucocorticoids G#lipid xxx G#lipid
. NE . NE

We NE Xx NE
observed NE xxx NE
that NE xxx NE
dexamethasone G#lipid xxx G#lipid
dramatically NE xxx NE
inhibited NE xxx NE
RANTES G#other_name_B XXXXXX G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_E xxx G#other_name_E
dose NE xxx NE
dependently NE xxx NE
in NE xx NE
anti-CD3 G#cell_line_B xxx-XXd G#cell_line_B
activated G#cell_line_M xxx G#cell_line_M
Hut-78 G#cell_line_M Xxx-dd G#cell_line_M
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
human G#cell_type_B xxx G#cell_type_B
PBMCs G#cell_type_E XXXXx G#cell_type_E
. NE . NE

Inhibition NE Xxxx NE
of NE xx NE
RANTES G#other_name_B XXXXXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
did NE xxx NE
not NE xxx NE
appear NE xxx NE
to NE xx NE
be NE xx NE
secondary NE xxx NE
to NE xx NE
IL-2 G#other_name_B XX-d G#other_name_B
inhibition G#other_name_E xxx G#other_name_E
and NE xxx NE
required NE xxx NE
binding NE xxx NE
to NE xx NE
the NE xxx NE
intracellular NE xxx NE
glucocorticoid G#protein_molecule_B xxx G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

The NE Xxx NE
down-regulation NE xxx-xxx NE
of NE xx NE
RANTES G#other_name_B XXXXXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
by NE xx NE
glucocorticoids G#lipid xxx G#lipid
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
may NE xxx NE
directly NE xxx NE
contribute NE xxx NE
to NE xx NE
the NE xxx NE
efficacy NE xxx NE
of NE xx NE
these NE xxx NE
agents NE xxx NE
in NE xx NE
suppressing NE xxx NE
cellular G#other_name_B xxx G#other_name_B
infiltration G#other_name_E xxx G#other_name_E
and NE xxx NE
to NE xx NE
their NE xxx NE
anti-inflammatory NE xxx-xxx NE
properties NE xxx NE
. NE . NE

Association NE Xxxx NE
of NE xx NE
TRAF1 G#protein_molecule XXXXd G#protein_molecule
, NE , NE
TRAF2 G#protein_molecule XXXXd G#protein_molecule
, NE , NE
and NE xxx NE
TRAF3 G#protein_molecule XXXXd G#protein_molecule
with NE xxx NE
an NE xx NE
Epstein-Barr G#DNA_domain_or_region_B Xxxx-Xxxx G#DNA_domain_or_region_B
virus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
LMP1 G#DNA_domain_or_region_M XXXd G#DNA_domain_or_region_M
domain G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
important NE xxx NE
for NE xxx NE
B-lymphocyte G#other_name_B X-xxx G#other_name_B
transformation G#other_name_E xxx G#other_name_E
: NE : NE
role NE xxx NE
in NE xx NE
NF-kappaB G#other_name_B XX-xxxX G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
Epstein-Barr NE Xxxx-Xxxx NE
virus NE xxx NE
( NE ( NE
EBV NE XXX NE
) NE ) NE
transforming NE xxx NE
protein NE xxx NE
LMP1 NE XXXd NE
appears NE xxx NE
to NE xx NE
be NE xx NE
a NE x NE
constitutively NE xxx NE
activated NE xxx NE
tumor NE xxx NE
necrosis NE xxx NE
factor NE xxx NE
receptor NE xxx NE
( NE ( NE
TNFR NE XXXX NE
) NE ) NE
on NE xx NE
the NE xxx NE
basis NE xxx NE
of NE xx NE
an NE xx NE
intrinsic NE xxx NE
ability NE xxx NE
to NE xx NE
aggregate NE xxx NE
in NE xx NE
the NE xxx NE
plasma NE xxx NE
membrane NE xxx NE
and NE xxx NE
an NE xx NE
association NE xxx NE
of NE xx NE
its NE xxx NE
cytoplasmic NE xxx NE
carboxyl NE xxx NE
terminus NE xxx NE
( NE ( NE
CT NE XX NE
) NE ) NE
with NE xxx NE
TNFR NE XXXX NE
-associated NE -xxx NE
factors NE xxx NE
( NE ( NE
TRAFs NE XXXXx NE
) NE ) NE
. NE . NE

We NE Xx NE
now NE xxx NE
show NE xxx NE
that NE xxx NE
in NE xx NE
EBV-transformed G#cell_line_B XXX-xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
lymphocytes G#cell_line_E xxx G#cell_line_E
most NE xxx NE
of NE xx NE
TRAF1 G#protein_molecule XXXXd G#protein_molecule
or NE xx NE
TRAF3 G#protein_molecule XXXXd G#protein_molecule
and NE xxx NE
5% NE d% NE
of NE xx NE
TRAF2 G#protein_molecule XXXXd G#protein_molecule
are NE xxx NE
associated NE xxx NE
with NE xxx NE
LMP1 G#protein_molecule XXXd G#protein_molecule
and NE xxx NE
that NE xxx NE
most NE xxx NE
of NE xx NE
LMP1 G#protein_molecule XXXd G#protein_molecule
is NE xx NE
associated NE xxx NE
with NE xxx NE
TRAF1 G#protein_molecule XXXXd G#protein_molecule
or NE xx NE
TRAF3 G#protein_molecule XXXXd G#protein_molecule
. NE . NE

TRAF1 G#protein_molecule XXXXd G#protein_molecule
, NE , NE
TRAF2 G#protein_molecule XXXXd G#protein_molecule
, NE , NE
and NE xxx NE
TRAF3 G#protein_molecule XXXXd G#protein_molecule
bind NE xxx NE
to NE xx NE
a NE x NE
single NE xxx NE
site NE xxx NE
in NE xx NE
the NE xxx NE
LMP1 G#protein_domain_or_region_B XXXd G#protein_domain_or_region_B
CT G#protein_domain_or_region_E XX G#protein_domain_or_region_E
corresponding NE xxx NE
to NE xx NE
amino NE xxx NE
acids NE xxx NE
(aa) NE (xx) NE
199 NE ddd NE
to NE xx NE
214 NE ddd NE
, NE , NE
within NE xxx NE
a NE x NE
domain NE xxx NE
which NE xxx NE
is NE xx NE
important NE xxx NE
for NE xxx NE
B-lymphocyte G#other_name_B X-xxx G#other_name_B
growth G#other_name_M xxx G#other_name_M
transformation G#other_name_E xxx G#other_name_E
(aa NE (xx NE
187 NE ddd NE
to NE xx NE
231) NE ddd) NE
. NE . NE

Further NE Xxxx NE
deletional G#other_name_B xxx G#other_name_B
mutagenesis G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
alanine G#other_name_M xxx G#other_name_M
mutagenesis G#other_name_E xxx G#other_name_E
TRAF NE XXXX NE
binding G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sequences G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
CD40 G#virus XXdd G#virus
, NE , NE
in NE xx NE
CD30 G#virus XXdd G#virus
, NE , NE
and NE xxx NE
in NE xx NE
the NE xxx NE
LMP1 G#protein_molecule XXXd G#protein_molecule
of NE xx NE
other NE xxx NE
lymphycryptoviruses NE xxx NE
provide NE xxx NE
the NE xxx NE
first NE xxx NE
evidence NE xxx NE
that NE xxx NE
PXQXT/S G#DNA_domain_or_region XXXXX/X G#DNA_domain_or_region
is NE xx NE
a NE x NE
core NE xxx NE
TRAF G#DNA_domain_or_region_B XXXX G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
negative NE xxx NE
effects NE xxx NE
of NE xx NE
point NE xxx NE
mutations NE xxx NE
in NE xx NE
the NE xxx NE
LMP1 NE XXXd NE
(1-231) NE (d-ddd) NE
core NE xxx NE
TRAF NE XXXX NE
binding NE xxx NE
motif NE xxx NE
on NE xx NE
TRAF NE XXXX NE
binding NE xxx NE
and NE xxx NE
NF-kappaB NE XX-xxxX NE
activation NE xxx NE
genetically NE xxx NE
link NE xxx NE
the NE xxx NE
TRAFs NE XXXXx NE
to NE xx NE
LMP1 NE XXXd NE
(1-231)-mediated NE (d-ddd)-xxx NE
NF-kappaB NE XX-xxxX NE
activation NE xxx NE
. NE . NE

NF-kappaB G#other_name_B XX-xxxX G#other_name_B
activation G#other_name_E xxx G#other_name_E
by NE xx NE
LMP1 G#protein_molecule XXXd G#protein_molecule
(1-231) NE (d-ddd) NE
is NE xx NE
likely NE xxx NE
to NE xx NE
be NE xx NE
mediated NE xxx NE
by NE xx NE
TRAF1 G#protein_molecule XXXXd G#protein_molecule
/TRAF2 NE /XXXXd NE
heteroaggregates NE xxx NE
since NE xxx NE
TRAF1 NE XXXXd NE
is NE xx NE
unique NE xxx NE
among NE xxx NE
the NE xxx NE
TRAFs NE XXXXx NE
in NE xx NE
coactivating NE xxx NE
NF-kappaB NE XX-xxxX NE
with NE xxx NE
LMP1 NE XXXd NE
(1-231) NE (d-ddd) NE
, NE , NE
a NE x NE
TRAF2 G#protein_molecule XXXXd G#protein_molecule
dominant-negative NE xxx-xxx NE
mutant NE xxx NE
can NE xxx NE
block NE xxx NE
LMP1 NE XXXd NE
(1-231)-mediated NE (d-ddd)-xxx NE
NF-kappaB NE XX-xxxX NE
activation NE xxx NE
as NE xx NE
well NE xxx NE
as NE xx NE
TRAF1 NE XXXXd NE
coactivation NE xxx NE
, NE , NE
and NE xxx NE
30% NE dd% NE
of NE xx NE
TRAF2 NE XXXXd NE
is NE xx NE
associated NE xxx NE
with NE xxx NE
TRAF1 G#protein_molecule XXXXd G#protein_molecule
in NE xx NE
EBV-transformed NE XXX-xxx NE
B NE X NE
cells NE xxx NE
. NE . NE

TRAF3 G#protein_molecule XXXXd G#protein_molecule
is NE xx NE
a NE x NE
negative G#other_name_B xxx G#other_name_B
modulator G#other_name_E xxx G#other_name_E
of NE xx NE
LMP1 NE XXXd NE
(1-231)-mediated NE (d-ddd)-xxx NE
NF-kappaB NE XX-xxxX NE
activation NE xxx NE
. NE . NE

Surprisingly NE Xxxx NE
, NE , NE
TRAF1 G#protein_molecule_B XXXXd G#protein_molecule_B
or G#protein_molecule_M xx G#protein_molecule_M
TRAF-2 G#protein_molecule_M XXXX-d G#protein_molecule_M
or G#protein_molecule_M xx G#protein_molecule_M
TRAF-3 G#protein_molecule_E XXXX-d G#protein_molecule_E
does NE xxx NE
not NE xxx NE
interact NE xxx NE
with NE xxx NE
the NE xxx NE
terminal G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
LMP1 G#protein_domain_or_region_M XXXd G#protein_domain_or_region_M
CT G#protein_domain_or_region_E XX G#protein_domain_or_region_E
aa NE xx NE
333 NE ddd NE
to NE xx NE
386 NE ddd NE
which NE xxx NE
can NE xxx NE
independently NE xxx NE
mediate NE xxx NE
NF-kappaB G#other_name_B XX-xxxX G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
constitutive NE xxx NE
association NE xxx NE
of NE xx NE
TRAFs G#protein_family_or_group XXXXx G#protein_family_or_group
with NE xxx NE
LMP1 G#protein_molecule XXXd G#protein_molecule
through NE xxx NE
the NE xxx NE
aa G#protein_domain_or_region_B xx G#protein_domain_or_region_B
187 G#protein_domain_or_region_M ddd G#protein_domain_or_region_M
to G#protein_domain_or_region_M xx G#protein_domain_or_region_M
231 G#protein_domain_or_region_M ddd G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
which NE xxx NE
is NE xx NE
important NE xxx NE
in NE xx NE
NF-kappaB G#other_name_B XX-xxxX G#other_name_B
activation G#other_name_E xxx G#other_name_E
and NE xxx NE
primary G#other_name_B xxx G#other_name_B
B-lymphocyte G#other_name_M X-xxx G#other_name_M
growth G#other_name_M xxx G#other_name_M
transformation G#other_name_E xxx G#other_name_E
implicates NE xxx NE
TRAF G#other_name_B XXXX G#other_name_B
aggregation G#other_name_E xxx G#other_name_E
in NE xx NE
LMP1 G#other_name_B XXXd G#other_name_B
signaling G#other_name_E xxx G#other_name_E
. NE . NE

Lack NE Xxxx NE
of NE xx NE
IL-12 G#other_name_B XX-dd G#other_name_B
signaling G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_line_B xxx G#cell_line_B
allergen-specific G#cell_line_M xxx-xxx G#cell_line_M
Th2 G#cell_line_M Xxd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

IL-12 G#protein_molecule XX-dd G#protein_molecule
is NE xx NE
a NE x NE
powerful NE xxx NE
skewer NE xxx NE
of NE xx NE
CD4+ G#other_name_B XXd+ G#other_name_B
T G#other_name_M X G#other_name_M
cell G#other_name_M xxx G#other_name_M
responses G#other_name_E xxx G#other_name_E
toward NE xxx NE
the NE xxx NE
Th1 G#other_name_B Xxd G#other_name_B
phenotype G#other_name_E xxx G#other_name_E
by NE xx NE
inducing NE xxx NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
production G#other_name_E xxx G#other_name_E
in NE xx NE
naive G#cell_line_B xxx G#cell_line_B
Th G#cell_line_M Xx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

In NE Xx NE
the NE xxx NE
present NE xxx NE
study NE xxx NE
we NE xx NE
addressed NE xxx NE
the NE xxx NE
question NE xxx NE
of NE xx NE
whether NE xxx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
can NE xxx NE
reverse NE xxx NE
established NE xxx NE
Th2 G#other_name_B Xxd G#other_name_B
responses G#other_name_E xxx G#other_name_E
into NE xxx NE
Th1/Th0 G#other_name_B Xxd/Xxd G#other_name_B
responses G#other_name_E xxx G#other_name_E
by NE xx NE
inducing NE xxx NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
production G#other_name_E xxx G#other_name_E
in NE xx NE
memory G#cell_line_B xxx G#cell_line_B
Th2 G#cell_line_M Xxd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

To NE Xx NE
this NE xxx NE
aim NE xxx NE
, NE , NE
allergen-specific G#cell_line_B xxx-xxx G#cell_line_B
CD4+ G#cell_line_M XXd+ G#cell_line_M
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
clones G#cell_line_E xxx G#cell_line_E
( NE ( NE
TCC G#cell_line XXX G#cell_line
) NE ) NE
were NE xxx NE
generated NE xxx NE
from NE xxx NE
the NE xxx NE
peripheral G#tissue_B xxx G#tissue_B
blood G#tissue_E xxx G#tissue_E
of NE xx NE
three NE xxx NE
atopic G#multi_cell_B xxx G#multi_cell_B
patients G#multi_cell_E xxx G#multi_cell_E
, NE , NE
and NE xxx NE
their NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
profiles G#other_name_E xxx G#other_name_E
were NE xxx NE
analyzed NE xxx NE
. NE . NE

The NE Xxx NE
majority NE xxx NE
of NE xx NE
these NE xxx NE
TCC G#cell_line XXX G#cell_line
exhibited NE xxx NE
a NE x NE
strongly NE xxx NE
polarized G#other_name_B xxx G#other_name_B
Th2 G#other_name_M Xxd G#other_name_M
cytokine G#other_name_M xxx G#other_name_M
profile G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
the NE xxx NE
production NE xxx NE
of NE xx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
could NE xxx NE
not NE xxx NE
be NE xx NE
induced NE xxx NE
by NE xx NE
exogenous NE xxx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
. NE . NE

Only NE Xxxx NE
those NE xxx NE
TCC G#cell_line XXX G#cell_line
with NE xxx NE
low NE xxx NE
IFN-gamma NE XXX-xxx NE
levels NE xxx NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
IL-12 NE XX-dd NE
responded NE xxx NE
to NE xx NE
IL-12 NE XX-dd NE
by NE xx NE
additional NE xxx NE
enhancement NE xxx NE
of NE xx NE
IFN-gamma NE XXX-xxx NE
production NE xxx NE
. NE . NE

The NE Xxx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
nonresponsiveness NE xxx NE
of NE xx NE
the NE xxx NE
Th2 G#cell_line_B Xxd G#cell_line_B
clones G#cell_line_E xxx G#cell_line_E
was NE xxx NE
further NE xxx NE
evident NE xxx NE
by NE xx NE
the NE xxx NE
total NE xxx NE
lack NE xxx NE
of NE xx NE
IL-12 NE XX-dd NE
-induced NE -xxx NE
phosphorylation NE xxx NE
of NE xx NE
STAT4 NE XXXXd NE
( NE ( NE
signal NE xxx NE
transducer NE xxx NE
and NE xxx NE
activator NE xxx NE
of NE xx NE
transcription-4 NE xxx-d NE
) NE ) NE
, NE , NE
a NE x NE
transcription NE xxx NE
factor NE xxx NE
that NE xxx NE
is NE xx NE
typically NE xxx NE
involved NE xxx NE
in NE xx NE
IL-12 NE XX-dd NE
signaling NE xxx NE
. NE . NE

Consequently NE Xxxx NE
, NE , NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
also NE xxx NE
failed NE xxx NE
to NE xx NE
induce NE xxx NE
the NE xxx NE
DNA-binding G#other_name_B XXX-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
of NE xx NE
STAT4 NE XXXXd NE
-containing NE -xxx NE
complexes NE xxx NE
in NE xx NE
the NE xxx NE
nuclei NE xxx NE
of NE xx NE
these NE xxx NE
Th2 NE Xxd NE
clones NE xxx NE
. NE . NE

All NE Xxx NE
TCC G#cell_line XXX G#cell_line
expressed NE xxx NE
equal NE xxx NE
levels NE xxx NE
of NE xx NE
the NE xxx NE
low-affinity G#protein_subunit_B xxx-xxx G#protein_subunit_B
IL-12R G#protein_subunit_M XX-ddX G#protein_subunit_M
beta1 G#protein_subunit_M xxxd G#protein_subunit_M
subunit G#protein_subunit_E xxx G#protein_subunit_E
. NE . NE

Our NE Xxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
human NE xxx NE
allergen-specific NE xxx-xxx NE
Th NE Xx NE
cells NE xxx NE
with NE xxx NE
strongly NE xxx NE
polarized NE xxx NE
Th2 G#other_name_B Xxd G#other_name_B
cytokine G#other_name_M xxx G#other_name_M
profiles G#other_name_E xxx G#other_name_E
do NE xx NE
not NE xxx NE
respond NE xxx NE
to NE xx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
and NE xxx NE
, NE , NE
therefore NE xxx NE
, NE , NE
cannot NE xxx NE
be NE xx NE
induced NE xxx NE
to NE xx NE
produce NE xxx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
. NE . NE

The NE Xxx NE
apparent NE xxx NE
high NE xxx NE
frequency NE xxx NE
of NE xx NE
IL-12 NE XX-dd NE
-nonresponsive NE -xxx NE
Th NE Xx NE
cells NE xxx NE
within NE xxx NE
the NE xxx NE
allergen-specific NE xxx-xxx NE
populations NE xxx NE
in NE xx NE
atopic NE xxx NE
patients NE xxx NE
predicts NE xxx NE
a NE x NE
limited NE xxx NE
skewing NE xxx NE
potential NE xxx NE
of NE xx NE
IL-12 NE XX-dd NE
in NE xx NE
the NE xxx NE
case NE xxx NE
of NE xx NE
established NE xxx NE
Th2 NE Xxd NE
responses NE xxx NE
, NE , NE
but NE xxx NE
only NE xxx NE
affecting NE xxx NE
newly NE xxx NE
recruited NE xxx NE
naive NE xxx NE
Th NE Xx NE
cells NE xxx NE
. NE . NE

Cloning NE Xxxx NE
and NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
Epstein-Barr NE Xxxx-Xxxx NE
virus NE xxx NE
-encoded NE -xxx NE
dUTPase NE xXXXxxx NE
: NE : NE
patients NE xxx NE
with NE xxx NE
acute NE xxx NE
, NE , NE
reactivated NE xxx NE
or NE xx NE
chronic NE xxx NE
virus NE xxx NE
infection NE xxx NE
develop NE xxx NE
antibodies NE xxx NE
against NE xxx NE
the NE xxx NE
enzyme NE xxx NE
. NE . NE

The NE Xxx NE
gene NE xxx NE
encoding NE xxx NE
the NE xxx NE
Epstein-Barr NE Xxxx-Xxxx NE
virus NE xxx NE
( NE ( NE
EBV NE XXX NE
)-specific NE )-xxx NE
dUTPase NE xXXXxxx NE
was NE xxx NE
amplified NE xxx NE
from NE xxx NE
virus NE xxx NE
DNA NE XXX NE
by NE xx NE
PCR NE XXX NE
. NE . NE

The NE Xxx NE
active NE xxx NE
enzyme NE xxx NE
was NE xxx NE
expressed NE xxx NE
in NE xx NE
Escherichia G#mono_cell_B Xxxx G#mono_cell_B
coli G#mono_cell_E xxx G#mono_cell_E
and NE xxx NE
in NE xx NE
insect G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
as NE xx NE
a NE x NE
non-fusion G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

The NE Xxx NE
protein NE xxx NE
from NE xxx NE
E. G#mono_cell_B X. G#mono_cell_B
coli G#mono_cell_E xxx G#mono_cell_E
specifically NE xxx NE
converted NE xxx NE
dUTP G#nucleotide xXXX G#nucleotide
to NE xx NE
dUMP G#nucleotide xXXX G#nucleotide
and NE xxx NE
did NE xxx NE
not NE xxx NE
react NE xxx NE
with NE xxx NE
other NE xxx NE
dNTPs G#nucleotide xXXXx G#nucleotide
or NE xx NE
NTPs G#nucleotide XXXx G#nucleotide
. NE . NE

Preliminary NE Xxxx NE
experiments NE xxx NE
yielded NE xxx NE
a NE x NE
Km G#other_name_B Xx G#other_name_B
value G#other_name_E xxx G#other_name_E
of NE xx NE
about NE xxx NE
0.8 NE d.d NE
microM NE xxxX NE
for NE xxx NE
dUTP G#nucleotide xXXX G#nucleotide
. NE . NE

MAbs NE XXxx NE
against NE xxx NE
the NE xxx NE
dUTPase G#protein_molecule xXXXxxx G#protein_molecule
reacted NE xxx NE
with NE xxx NE
a NE x NE
protein NE xxx NE
of NE xx NE
approximately NE xxx NE
31 NE dd NE
kDa NE xXx NE
in NE xx NE
12-O-tetradecanoyl-phorbol-13-acetate G#cell_line_B dd-X-xxx-xxx-dd-xxx G#cell_line_B
( G#cell_line_E ( G#cell_line_E
TPA NE XXX NE
)-stimulated NE )-xxx NE
B NE X NE
cells NE xxx NE
harbouring NE xxx NE
either NE xxx NE
type G#virus_B xxx G#virus_B
1 G#virus_M d G#virus_M
EBV G#virus_M XXX G#virus_M
or G#virus_M xx G#virus_M
type G#virus_M xxx G#virus_M
2 G#virus_M d G#virus_M
EBV G#virus_E XXX G#virus_E

The NE Xxx NE
protein NE xxx NE
was NE xxx NE
found NE xxx NE
in NE xx NE
untreated G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
at NE xx NE
low NE xxx NE
levels NE xxx NE
, NE , NE
whereas NE xxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
lytic G#other_name_B xxx G#other_name_B
replication G#other_name_M xxx G#other_name_M
cycle G#other_name_E xxx G#other_name_E
by NE xx NE
TPA G#other_name_B XXX G#other_name_B
treatment G#other_name_E xxx G#other_name_E
or NE xx NE
by NE xx NE
providing NE xxx NE
the NE xxx NE
immediate G#protein_family_or_group_B xxx G#protein_family_or_group_B
early G#protein_family_or_group_M xxx G#protein_family_or_group_M
transactivator G#protein_family_or_group_E xxx G#protein_family_or_group_E
BZLF1 G#protein_molecule XXXXd G#protein_molecule
in NE xx NE
trans NE xxx NE
resulted NE xxx NE
in NE xx NE
increased G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
demonstrated NE xxx NE
that NE xxx NE
the NE xxx NE
virus G#protein_molecule_B xxx G#protein_molecule_B
dUTPase G#protein_molecule_E xXXXxxx G#protein_molecule_E
isolated NE xxx NE
from NE xxx NE
EBV NE XXX NE
-infected NE -xxx NE
cells NE xxx NE
is NE xx NE
a NE x NE
phosphoprotein NE xxx NE
. NE . NE

The NE Xxx NE
protein NE xxx NE
expressed NE xxx NE
in NE xx NE
insect G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
was NE xxx NE
used NE xxx NE
to NE xx NE
test NE xxx NE
for NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
specific NE xxx NE
antibodies NE xxx NE
in NE xx NE
sera NE xxx NE
from NE xxx NE
normal NE xxx NE
, NE , NE
healthy NE xxx NE
carriers NE xxx NE
and NE xxx NE
from NE xxx NE
patients NE xxx NE
with NE xxx NE
various NE xxx NE
diseases NE xxx NE
. NE . NE

While NE Xxxx NE
the NE xxx NE
sera G#tissue xxx G#tissue
of NE xx NE
EBV NE XXX NE
-negative NE -xxx NE
individuals NE xxx NE
(0/3) NE (d/d) NE
or NE xx NE
healthy NE xxx NE
carriers NE xxx NE
(0/33) NE (d/dd) NE
did NE xxx NE
not NE xxx NE
contain NE xxx NE
detectable NE xxx NE
levels NE xxx NE
of NE xx NE
antibodies NE xxx NE
, NE , NE
patients NE xxx NE
with NE xxx NE
mononucleosis NE xxx NE
(5/18) NE (d/dd) NE
, NE , NE
chronic NE xxx NE
EBV NE XXX NE
infection NE xxx NE
(2/7) NE (d/d) NE
, NE , NE
EBV NE XXX NE
reactivation NE xxx NE
(7/20) NE (d/dd) NE
and NE xxx NE
human NE xxx NE
immunodeficiency NE xxx NE
virus NE xxx NE
infection NE xxx NE
(5/24) NE (d/dd) NE
showed NE xxx NE
elevated NE xxx NE
antibody NE xxx NE
titres NE xxx NE
against NE xxx NE
the NE xxx NE
enzyme NE xxx NE
. NE . NE

This NE Xxxx NE
indicated NE xxx NE
that NE xxx NE
the NE xxx NE
dUTPase G#nucleotide xXXXxxx G#nucleotide
is NE xx NE
expressed NE xxx NE
during NE xxx NE
EBV G#other_name_B XXX G#other_name_B
replication G#other_name_E xxx G#other_name_E
and NE xxx NE
reactivation NE xxx NE
. NE . NE

The NE Xxx NE
enzyme NE xxx NE
might NE xxx NE
therefore NE xxx NE
be NE xx NE
a NE x NE
potential NE xxx NE
target NE xxx NE
for NE xxx NE
drug G#other_name_B xxx G#other_name_B
therapy G#other_name_E xxx G#other_name_E
under NE xxx NE
conditions NE xxx NE
of NE xx NE
active G#other_name_B xxx G#other_name_B
DNA G#other_name_M XXX G#other_name_M
replication G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
catalytic G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
pp56(lck) G#protein_molecule xxdd(xxx) G#protein_molecule
, NE , NE
but NE xxx NE
not NE xxx NE
its NE xxx NE
regulatory G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
, NE , NE
is NE xx NE
sufficient NE xxx NE
for NE xxx NE
inducing NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
production G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
lymphoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
src G#protein_family_or_group_M xxx G#protein_family_or_group_M
kinase G#protein_family_or_group_E xxx G#protein_family_or_group_E
pp56(lck) G#protein_molecule xxdd(xxx) G#protein_molecule
has NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
be NE xx NE
essential NE xxx NE
for NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
different NE xxx NE
T G#other_name_B X G#other_name_B
lymphocyte G#other_name_M xxx G#other_name_M
responses G#other_name_E xxx G#other_name_E
, NE , NE
including NE xxx NE
CD4 NE XXd NE
-mediated NE -xxx NE
enhancement NE xxx NE
of NE xx NE
Ag-induced NE Xx-xxx NE
T NE X NE
cell NE xxx NE
activation NE xxx NE
, NE , NE
early NE xxx NE
T NE X NE
cell NE xxx NE
differentiation NE xxx NE
, NE , NE
induction NE xxx NE
of NE xx NE
IL-2 NE XX-d NE
production NE xxx NE
, NE , NE
and NE xxx NE
cytotoxicity NE xxx NE
. NE . NE

It NE Xx NE
is NE xx NE
assumed NE xxx NE
that NE xxx NE
pp56(lck) G#protein_molecule xxdd(xxx) G#protein_molecule
acts NE xxx NE
on NE xx NE
these NE xxx NE
processes NE xxx NE
by NE xx NE
phosphorylating NE xxx NE
substrates NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
it NE xx NE
has NE xxx NE
been NE xxx NE
recently NE xxx NE
reported NE xxx NE
that NE xxx NE
the NE xxx NE
NH2 G#protein_molecule XXd G#protein_molecule
regulatory G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
is NE xx NE
sufficient NE xxx NE
to NE xx NE
mediate NE xxx NE
CD4 G#other_name_B XXd G#other_name_B
accessory G#other_name_M xxx G#other_name_M
function G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
this NE xxx NE
report NE xxx NE
we NE xx NE
address NE xxx NE
the NE xxx NE
contribution NE xxx NE
of NE xx NE
the NE xxx NE
regulatory G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
and G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
catalytic G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
pp56(lck) G#protein_molecule xxdd(xxx) G#protein_molecule
to NE xx NE
another NE xxx NE
function NE xxx NE
of NE xx NE
this NE xxx NE
enzyme NE xxx NE
independent NE xxx NE
of NE xx NE
CD4 G#protein_molecule XXd G#protein_molecule
: NE : NE
TCR-induced NE XXX-xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
production G#other_name_E xxx G#other_name_E
. NE . NE

Two NE Xxx NE
pp56(lck) G#protein_family_or_group_B xxdd(xxx) G#protein_family_or_group_B
mutants G#protein_family_or_group_E xxx G#protein_family_or_group_E
lacking NE xxx NE
either NE xxx NE
the NE xxx NE
entire NE xxx NE
catalytic G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
or NE xx NE
the NE xxx NE
entire NE xxx NE
NH2 G#protein_molecule XXd G#protein_molecule
regulatory G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
were NE xxx NE
generated NE xxx NE
, NE , NE
and NE xxx NE
their NE xxx NE
abilities NE xxx NE
to NE xx NE
trigger NE xxx NE
transactivation NE xxx NE
of NE xx NE
the NE xxx NE
TCR-regulated NE XXX-xxx NE
nuclear NE xxx NE
factor NE xxx NE
of NE xx NE
activated NE xxx NE
T NE X NE
cells NE xxx NE
( NE ( NE
NF-AT NE XX-XX NE
) NE ) NE
region NE xxx NE
of NE xx NE
the NE xxx NE
IL-2 NE XX-d NE
promoter NE xxx NE
were NE xxx NE
compared NE xxx NE
. NE . NE

Only NE Xxxx NE
the NE xxx NE
catalytic NE xxx NE
, NE , NE
but NE xxx NE
not NE xxx NE
the NE xxx NE
NH2 G#protein_molecule XXd G#protein_molecule
regulatory NE xxx NE
, NE , NE
domain NE xxx NE
of NE xx NE
pp56(lck) G#protein_molecule xxdd(xxx) G#protein_molecule
was NE xxx NE
able NE xxx NE
to NE xx NE
induce NE xxx NE
NF-AT G#other_name_B XX-XX G#other_name_B
region G#other_name_M xxx G#other_name_M
transactivation G#other_name_E xxx G#other_name_E
on NE xx NE
its NE xxx NE
own NE xxx NE
and NE xxx NE
to NE xx NE
cooperate NE xxx NE
with NE xxx NE
other NE xxx NE
intracellular NE xxx NE
signals NE xxx NE
to NE xx NE
trigger NE xxx NE
this NE xxx NE
response NE xxx NE
. NE . NE

Moreover NE Xxxx NE
, NE , NE
the NE xxx NE
catalytic G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
pp56(lck) G#protein_molecule xxdd(xxx) G#protein_molecule
was NE xxx NE
able NE xxx NE
to NE xx NE
induce NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
cytokine G#protein_family_or_group xxx G#protein_family_or_group
production NE xxx NE
to NE xx NE
an NE xx NE
extent NE xxx NE
similar NE xxx NE
to NE xx NE
that NE xxx NE
of NE xx NE
wild-type NE xxx-xxx NE
pp56(lck) G#protein_molecule xxdd(xxx) G#protein_molecule
. NE . NE

We NE Xx NE
conclude NE xxx NE
that NE xxx NE
different NE xxx NE
domains NE xxx NE
of NE xx NE
the NE xxx NE
pp56(lck) G#protein_molecule xxdd(xxx) G#protein_molecule
molecule NE xxx NE
contribute NE xxx NE
to NE xx NE
regulate NE xxx NE
distinct NE xxx NE
biologic G#other_name_B xxx G#other_name_B
functions G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
fact NE xxx NE
, NE , NE
while NE xxx NE
the NE xxx NE
NH2 G#protein_molecule XXd G#protein_molecule
regulatory G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
is NE xx NE
sufficient NE xxx NE
to NE xx NE
mediate NE xxx NE
CD4 NE XXd NE
accessory NE xxx NE
function NE xxx NE
, NE , NE
we NE xx NE
show NE xxx NE
here NE xxx NE
that NE xxx NE
the NE xxx NE
catalytic NE xxx NE
domain NE xxx NE
of NE xx NE
pp56(lck) NE xxdd(xxx) NE
is NE xx NE
sufficient NE xxx NE
for NE xxx NE
induction NE xxx NE
of NE xx NE
IL-2 NE XX-d NE
production NE xxx NE
, NE , NE
mimicking NE xxx NE
TCR NE XXX NE
ligation NE xxx NE
. NE . NE

[The NE [Xxx NE
changes NE xxx NE
in NE xx NE
glucocorticoid NE xxx NE
receptors NE xxx NE
in NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
leukocytes G#cell_type_E xxx G#cell_type_E
in NE xx NE
asthmatic G#multi_cell_B xxx G#multi_cell_B
subjects G#multi_cell_E xxx G#multi_cell_E
] NE ] NE

The NE Xxx NE
number NE xxx NE
of NE xx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
GCR G#protein_family_or_group XXX G#protein_family_or_group
) NE ) NE
in NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
leukocytes G#cell_type_E xxx G#cell_type_E
was NE xxx NE
determined NE xxx NE
by NE xx NE
radioligand-binding G#other_name_B xxx-xxx G#other_name_B
assay G#other_name_E xxx G#other_name_E
in NE xx NE
extrinsic NE xxx NE
and NE xxx NE
intrinsic NE xxx NE
asthmatics G#multi_cell xxx G#multi_cell
. NE . NE

Their NE Xxxx NE
corresponding NE xxx NE
plasma G#other_name_B xxx G#other_name_B
cortisol G#other_name_M xxx G#other_name_M
levels G#other_name_E xxx G#other_name_E
were NE xxx NE
assessed NE xxx NE
. NE . NE

The NE Xxx NE
results NE xxx NE
showed NE xxx NE
that NE xxx NE
the NE xxx NE
average NE xxx NE
number NE xxx NE
of NE xx NE
GCR G#protein_family_or_group XXX G#protein_family_or_group
in NE xx NE
asthmatics G#multi_cell xxx G#multi_cell
was NE xxx NE
significantly NE xxx NE
lower NE xxx NE
than NE xxx NE
that NE xxx NE
in NE xx NE
healthy NE xxx NE
subjects NE xxx NE
(P NE (X NE
< NE < NE
0.01) NE d.dd) NE
, NE , NE
and NE xxx NE
there NE xxx NE
was NE xxx NE
a NE x NE
linear NE xxx NE
correlation NE xxx NE
between NE xxx NE
the NE xxx NE
number NE xxx NE
of NE xx NE
GCR G#protein_family_or_group XXX G#protein_family_or_group
and NE xxx NE
the NE xxx NE
course NE xxx NE
of NE xx NE
asthma G#other_name xxx G#other_name
. NE . NE

Besides NE Xxxx NE
, NE , NE
there NE xxx NE
was NE xxx NE
also NE xxx NE
a NE x NE
linear NE xxx NE
correlation NE xxx NE
between NE xxx NE
the NE xxx NE
number NE xxx NE
of NE xx NE
GCR G#protein_family_or_group XXX G#protein_family_or_group
and NE xxx NE
the NE xxx NE
age NE xxx NE
of NE xx NE
the NE xxx NE
initial NE xxx NE
attack NE xxx NE
of NE xx NE
asthma G#other_name xxx G#other_name
. NE . NE

No NE Xx NE
difference NE xxx NE
in NE xx NE
plasma G#lipid_B xxx G#lipid_B
cortisol G#lipid_E xxx G#lipid_E
level NE xxx NE
was NE xxx NE
found NE xxx NE
between NE xxx NE
asthmatics G#multi_cell xxx G#multi_cell
and NE xxx NE
healthy G#multi_cell_B xxx G#multi_cell_B
subjects G#multi_cell_E xxx G#multi_cell_E
. NE . NE

These NE Xxxx NE
findings NE xxx NE
suggest NE xxx NE
that NE xxx NE
there NE xxx NE
is NE xx NE
no NE xx NE
primary NE xxx NE
and NE xxx NE
general NE xxx NE
impairment NE xxx NE
of NE xx NE
glucocorticoid G#other_name_B xxx G#other_name_B
metabolism G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
asthmatics G#multi_cell xxx G#multi_cell
, NE , NE
but NE xxx NE
the NE xxx NE
number NE xxx NE
of NE xx NE
GCR G#protein_family_or_group XXX G#protein_family_or_group
in NE xx NE
the NE xxx NE
asthmatics G#multi_cell xxx G#multi_cell
is NE xx NE
lower NE xxx NE
than NE xxx NE
that NE xxx NE
in NE xx NE
healthy NE xxx NE
controls NE xxx NE
. NE . NE

The NE Xxx NE
decrease NE xxx NE
of NE xx NE
the NE xxx NE
number NE xxx NE
of NE xx NE
GCR G#protein_family_or_group XXX G#protein_family_or_group
in NE xx NE
asthmatics G#multi_cell xxx G#multi_cell
, NE , NE
we NE xx NE
think NE xxx NE
, NE , NE
is NE xx NE
related NE xxx NE
to NE xx NE
heredity NE xxx NE
and NE xxx NE
repeated NE xxx NE
attacks NE xxx NE
of NE xx NE
asthma G#other_name xxx G#other_name
. NE . NE

Novel NE Xxxx NE
aldosterone G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
: NE : NE
specificity-conferring NE xxx-xxx NE
mechanism NE xxx NE
at NE xx NE
the NE xxx NE
level NE xxx NE
of NE xx NE
the NE xxx NE
cell G#cell_component_B xxx G#cell_component_B
membrane G#cell_component_E xxx G#cell_component_E
. NE . NE

Functional NE Xxxx NE
studies NE xxx NE
in NE xx NE
extra-renal, G#cell_type_B xxx-xxx, G#cell_type_B
nonepithelial G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
such NE xxx NE
as NE xx NE
smooth G#cell_type_B xxx G#cell_type_B
muscle G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
more NE xxx NE
recently NE xxx NE
circulating NE xxx NE
human G#cell_type_B xxx G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
have NE xxx NE
provided NE xxx NE
increasing NE xxx NE
evidence NE xxx NE
that NE xxx NE
aldosterone G#lipid xxx G#lipid
produces NE xxx NE
not NE xxx NE
only NE xxx NE
classical NE xxx NE
genomic NE xxx NE
effects NE xxx NE
, NE , NE
but NE xxx NE
also NE xxx NE
rapid NE xxx NE
non-genomic NE xxx-xxx NE
effects NE xxx NE
on NE xx NE
transmembrane G#other_name_B xxx G#other_name_B
electrolyte G#other_name_M xxx G#other_name_M
movements G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
involve NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
sodium/proton-exchanger G#protein_family_or_group xxx/xxx-xxx G#protein_family_or_group
of NE xx NE
the NE xxx NE
cell G#cell_component_B xxx G#cell_component_B
membrane G#cell_component_E xxx G#cell_component_E
at NE xx NE
very NE xxx NE
low NE xxx NE
, NE , NE
physiological NE xxx NE
concentrations NE xxx NE
of NE xx NE
aldosterone G#lipid xxx G#lipid
with NE xxx NE
an NE xx NE
acute NE xxx NE
onset NE xxx NE
within NE xxx NE
1-2 NE d-d NE
minutes NE xxx NE
. NE . NE

A NE X NE
second G#other_name_B xxx G#other_name_B
messenger G#other_name_M xxx G#other_name_M
cascade G#other_name_E xxx G#other_name_E
involved NE xxx NE
is NE xx NE
the NE xxx NE
inositol-1,4,5-trisphosphate NE xxx-d,d,d-xxx NE
/calcium NE /xxx NE
pathway NE xxx NE
which NE xxx NE
responds NE xxx NE
over NE xxx NE
the NE xxx NE
same NE xxx NE
rapid NE xxx NE
time NE xxx NE
course NE xxx NE
. NE . NE

Such NE Xxxx NE
changes NE xxx NE
clearly NE xxx NE
cannot NE xxx NE
be NE xx NE
explained NE xxx NE
by NE xx NE
genomic G#other_name_B xxx G#other_name_B
mechanisms G#other_name_E xxx G#other_name_E
, NE , NE
which NE xxx NE
are NE xxx NE
responsible NE xxx NE
for NE xxx NE
later NE xxx NE
effects NE xxx NE
than NE xxx NE
the NE xxx NE
membrane-related G#other_name_B xxx-xxx G#other_name_B
rapid G#other_name_M xxx G#other_name_M
responses G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
addition NE xxx NE
to NE xx NE
its NE xxx NE
rapid NE xxx NE
time NE xxx NE
course NE xxx NE
the NE xxx NE
unique NE xxx NE
characteristics NE xxx NE
of NE xx NE
this NE xxx NE
new NE xxx NE
pathway NE xxx NE
for NE xxx NE
steroid NE xxx NE
action NE xxx NE
include NE xxx NE
a NE x NE
10000-fold NE ddddd-xxx NE
selectivity NE xxx NE
for NE xxx NE
aldosterone G#lipid xxx G#lipid
over NE xxx NE
cortisol G#lipid xxx G#lipid
and NE xxx NE
the NE xxx NE
ineffectiveness NE xxx NE
of NE xx NE
spironolactones G#other_organic_compound xxx G#other_organic_compound
, NE , NE
classical NE xxx NE
mineralocorticoid G#other_organic_compound_B xxx G#other_organic_compound_B
antagonists G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
as NE xx NE
antagonists NE xxx NE
of NE xx NE
the NE xxx NE
response NE xxx NE
. NE . NE

Subsequently NE Xxxx NE
binding NE xxx NE
sites NE xxx NE
have NE xxx NE
been NE xxx NE
demonstrated NE xxx NE
in NE xx NE
the NE xxx NE
plasma G#cell_component_B xxx G#cell_component_B
membrane G#cell_component_E xxx G#cell_component_E
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
which NE xxx NE
show NE xxx NE
pharmacological NE xxx NE
( NE ( NE
aldosterone G#lipid xxx G#lipid
specificity) NE xxx) NE
and NE xxx NE
kinetic NE xxx NE
(high NE (xxx NE
turnover) NE xxx) NE
properties NE xxx NE
identical NE xxx NE
with NE xxx NE
those NE xxx NE
of NE xx NE
the NE xxx NE
rapid NE xxx NE
aldosterone G#lipid xxx G#lipid
effects NE xxx NE
in NE xx NE
the NE xxx NE
same NE xxx NE
cells NE xxx NE
. NE . NE

SDS-PAGE G#other_name_B XXX-XXXX G#other_name_B
analysis G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
receptor G#protein_family_or_group_B xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
has NE xxx NE
shown NE xxx NE
a NE x NE
molecular G#other_name_B xxx G#other_name_B
weight G#other_name_E xxx G#other_name_E
of NE xx NE
approximately NE xxx NE
50 G#other_name_B dd G#other_name_B
kD G#other_name_E xX G#other_name_E
. NE . NE

The NE Xxx NE
present NE xxx NE
paper NE xxx NE
reviews NE xxx NE
the NE xxx NE
data NE xxx NE
supporting NE xxx NE
a NE x NE
new NE xxx NE
, NE , NE
two-step NE xxx-xxx NE
model NE xxx NE
for NE xxx NE
non-genomic NE xxx-xxx NE
and NE xxx NE
genomic NE xxx NE
aldosterone G#lipid xxx G#lipid
effects NE xxx NE
. NE . NE

It NE Xx NE
also NE xxx NE
suggests NE xxx NE
a NE x NE
novel NE xxx NE
specificity-conferring G#other_name_B xxx-xxx G#other_name_B
mechanism G#other_name_E xxx G#other_name_E
for NE xxx NE
mineralocorticoid G#other_name_B xxx G#other_name_B
action G#other_name_E xxx G#other_name_E
at NE xx NE
the NE xxx NE
membrane G#other_name_B xxx G#other_name_B
level G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
macrophage G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
PU.1 G#protein_molecule XX.d G#protein_molecule
directs NE xxx NE
tissue-specific NE xxx-xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
macrophage G#protein_molecule_B xxx G#protein_molecule_B
colony-stimulating G#protein_molecule_M xxx-xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

The NE Xxx NE
macrophage NE xxx NE
colony-stimulating NE xxx-xxx NE
factor NE xxx NE
( NE ( NE
M-CSF NE X-XXX NE
) NE ) NE
receptor NE xxx NE
is NE xx NE
expressed NE xxx NE
in NE xx NE
a NE x NE
tissue-specific NE xxx-xxx NE
fashion NE xxx NE
from NE xxx NE
two NE xxx NE
distinct NE xxx NE
promoters NE xxx NE
in NE xx NE
monocytes/macrophages NE xxx/xxx NE
and NE xxx NE
the NE xxx NE
placenta NE xxx NE
. NE . NE

In NE Xx NE
order NE xxx NE
to NE xx NE
further NE xxx NE
understand NE xxx NE
the NE xxx NE
transcription NE xxx NE
factors NE xxx NE
which NE xxx NE
play NE xxx NE
a NE x NE
role NE xxx NE
in NE xx NE
the NE xxx NE
commitment NE xxx NE
of NE xx NE
multipotential G#cell_type_B xxx G#cell_type_B
progenitors G#cell_type_E xxx G#cell_type_E
to NE xx NE
the NE xxx NE
monocyte/macrophage NE xxx/xxx NE
lineage NE xxx NE
, NE , NE
we NE xx NE
have NE xxx NE
initiated NE xxx NE
an NE xx NE
investigation NE xxx NE
of NE xx NE
the NE xxx NE
factors NE xxx NE
which NE xxx NE
activate NE xxx NE
the NE xxx NE
M-CSF G#protein_molecule_B X-XXX G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
very NE xxx NE
early NE xxx NE
during NE xxx NE
the NE xxx NE
monocyte G#other_name_B xxx G#other_name_B
differentiation G#other_name_M xxx G#other_name_M
process G#other_name_E xxx G#other_name_E
. NE . NE

Here NE Xxxx NE
we NE xx NE
demonstrate NE xxx NE
that NE xxx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
monocytic G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
M-CSF G#DNA_domain_or_region_M X-XXX G#DNA_domain_or_region_M
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
directs NE xxx NE
reporter NE xxx NE
gene NE xxx NE
activity NE xxx NE
in NE xx NE
a NE x NE
tissue-specific G#other_name_B xxx-xxx G#other_name_B
fashion G#other_name_E xxx G#other_name_E
. NE . NE

Since NE Xxxx NE
one NE xxx NE
of NE xx NE
the NE xxx NE
few NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
which NE xxx NE
have NE xxx NE
been NE xxx NE
implicated NE xxx NE
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
monocyte G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
is NE xx NE
the NE xxx NE
macrophage- G#protein_molecule_B xxx- G#protein_molecule_B
and G#protein_molecule_M xxx G#protein_molecule_M
B-cell-specific G#protein_molecule_M X-xxx-xxx G#protein_molecule_M
PU.1 G#protein_molecule_E XX.d G#protein_molecule_E
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
we NE xx NE
investigated NE xxx NE
whether NE xxx NE
PU.1 G#protein_molecule XX.d G#protein_molecule
binds NE xxx NE
and NE xxx NE
activates NE xxx NE
the NE xxx NE
M-CSF G#DNA_domain_or_region_B X-XXX G#DNA_domain_or_region_B
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Here NE Xxxx NE
we NE xx NE
demonstrate NE xxx NE
that NE xxx NE
both NE xxx NE
in NE xx NE
vitro-translated G#protein_molecule_B xxx-xxx G#protein_molecule_B
PU.1 G#protein_molecule_E XX.d G#protein_molecule_E
and NE xxx NE
PU.1 G#protein_molecule XX.d G#protein_molecule
from NE xxx NE
nuclear G#cell_component_B xxx G#cell_component_B
extracts G#cell_component_E xxx G#cell_component_E
bind NE xxx NE
to NE xx NE
a NE x NE
specific NE xxx NE
site NE xxx NE
in NE xx NE
the NE xxx NE
M-CSF G#DNA_domain_or_region_B X-XXX G#DNA_domain_or_region_B
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
just NE xxx NE
upstream NE xxx NE
from NE xxx NE
the NE xxx NE
major G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
transcription G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
initiation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Mutations NE Xxxx NE
in NE xx NE
this NE xxx NE
site NE xxx NE
which NE xxx NE
eliminate NE xxx NE
PU.1 G#protein_molecule XX.d G#protein_molecule
binding NE xxx NE
decrease NE xxx NE
M-CSF G#protein_molecule_B X-XXX G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
promoter NE xxx NE
activity NE xxx NE
significantly NE xxx NE
in NE xx NE
macrophage G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
only NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
PU.1 G#protein_molecule XX.d G#protein_molecule
transactivates NE xxx NE
the NE xxx NE
M-CSF G#DNA_domain_or_region_B X-XXX G#DNA_domain_or_region_B
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
nonmacrophage G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
PU.1 G#protein_molecule XX.d G#protein_molecule
plays NE xxx NE
a NE x NE
major NE xxx NE
role NE xxx NE
in NE xx NE
macrophage G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
and NE xxx NE
development NE xxx NE
by NE xx NE
directing NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
a NE x NE
receptor NE xxx NE
for NE xxx NE
a NE x NE
key G#protein_family_or_group_B xxx G#protein_family_or_group_B
macrophage G#protein_family_or_group_M xxx G#protein_family_or_group_M
growth G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Increased NE Xxxx NE
natural G#other_name_B xxx G#other_name_B
killer G#other_name_M xxx G#other_name_M
cell G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
correlates NE xxx NE
with NE xxx NE
low NE xxx NE
or NE xx NE
negative NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
HER-2/neu G#DNA_domain_or_region_B XXX-d/xxx G#DNA_domain_or_region_B
oncogene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
breast G#other_name_B xxx G#other_name_B
cancer G#other_name_E xxx G#other_name_E
. NE . NE

BACKGROUND NE XXXXXXXXXX NE
. NE . NE

Increased NE Xxxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
HER-2/neu G#DNA_domain_or_region_B XXX-d/xxx G#DNA_domain_or_region_B
oncogene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
breast G#other_name_B xxx G#other_name_B
cancer G#other_name_E xxx G#other_name_E
correlates NE xxx NE
with NE xxx NE
decreased NE xxx NE
estrogen G#other_name_B xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
concentration G#other_name_E xxx G#other_name_E
and NE xxx NE
seems NE xxx NE
to NE xx NE
be NE xx NE
an NE xx NE
important NE xxx NE
prognostic NE xxx NE
factor NE xxx NE
. NE . NE

The NE Xxx NE
authors NE xxx NE
investigated NE xxx NE
whether NE xxx NE
there NE xxx NE
is NE xx NE
a NE x NE
correlation NE xxx NE
between NE xxx NE
HER-2/neu G#other_name_B XXX-d/xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
immunologic G#other_name_B xxx G#other_name_B
parameters G#other_name_E xxx G#other_name_E
representing NE xxx NE
tumor NE xxx NE
defense NE xxx NE
in NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
breast G#other_name_B xxx G#other_name_B
cancer G#other_name_E xxx G#other_name_E
. NE . NE

METHOD NE XXXXXX NE
. NE . NE

A NE X NE
Western G#other_name_B Xxxx G#other_name_B
blot G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
was NE xxx NE
used NE xxx NE
to NE xx NE
investigate NE xxx NE
HER-2/neu G#other_name_B XXX-d/xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
, NE , NE
whereas NE xxx NE
a NE x NE
chromium-release G#other_name_B xxx-xxx G#other_name_B
assay G#other_name_E xxx G#other_name_E
using NE xxx NE
the NE xxx NE
K562 G#cell_line_B Xddd G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
as NE xx NE
target NE xxx NE
was NE xxx NE
used NE xxx NE
to NE xx NE
measure NE xxx NE
natural G#other_name_B xxx G#other_name_B
killer G#other_name_M xxx G#other_name_M
(NK) G#other_name_M (XX) G#other_name_M
cell G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
. NE . NE

RESULTS NE XXXXXXX NE
. NE . NE

In NE Xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
breast G#other_name_B xxx G#other_name_B
cancer G#other_name_E xxx G#other_name_E
, NE , NE
NK G#other_name_B XX G#other_name_B
cell G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
significantly NE xxx NE
higher NE xxx NE
compared NE xxx NE
with NE xxx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
benign G#cell_type_B xxx G#cell_type_B
tumors G#cell_type_E xxx G#cell_type_E
(P NE (X NE
= NE = NE
0.006) NE d.ddd) NE
or NE xx NE
healthy G#multi_cell_B xxx G#multi_cell_B
control G#multi_cell_M xxx G#multi_cell_M
subjects G#multi_cell_E xxx G#multi_cell_E
(P NE (X NE
= NE = NE
0.002) NE d.ddd) NE
. NE . NE

Moreover NE Xxxx NE
, NE , NE
23.3% NE dd.d% NE
of NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
breast G#other_name_B xxx G#other_name_B
cancer G#other_name_E xxx G#other_name_E
showed NE xxx NE
an NE xx NE
overexpression NE xxx NE
of NE xx NE
HER-2/neu G#protein_molecule_B XXX-d/xxx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Within NE Xxxx NE
this NE xxx NE
group NE xxx NE
of NE xx NE
patients G#multi_cell xxx G#multi_cell
, NE , NE
NK G#other_name_B XX G#other_name_B
cell G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
significantly NE xxx NE
lower NE xxx NE
(45.6 NE (dd.d NE
+/- NE +/- NE
16.1%) NE dd.d%) NE
compared NE xxx NE
with NE xxx NE
the NE xxx NE
group NE xxx NE
with NE xxx NE
no NE xx NE
HER-2/neu G#protein_molecule XXX-d/xxx G#protein_molecule
overexpression NE xxx NE
(57.3 NE (dd.d NE
+/- NE +/- NE
11.0%) NE dd.d%) NE
. NE . NE

NK G#other_name_B XX G#other_name_B
cell G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
did NE xxx NE
not NE xxx NE
increase NE xxx NE
in NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
HER-2/neu G#other_name_B XXX-d/xxx G#other_name_B
overexpression G#other_name_E xxx G#other_name_E
. NE . NE

Thus NE Xxxx NE
, NE , NE
there NE xxx NE
was NE xxx NE
a NE x NE
statistically NE xxx NE
significant NE xxx NE
correlation NE xxx NE
of NE xx NE
cytolytic NE xxx NE
effector NE xxx NE
cell NE xxx NE
function NE xxx NE
with NE xxx NE
HER-2/neu G#other_name_B XXX-d/xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
tumor NE xxx NE
(P NE (X NE
= NE = NE
0.003) NE d.ddd) NE
, NE , NE
and NE xxx NE
HER-2/neu G#other_name_B XXX-d/xxx G#other_name_B
overexpression G#other_name_E xxx G#other_name_E
correlated NE xxx NE
with NE xxx NE
a NE x NE
negative NE xxx NE
estrogen G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
status NE xxx NE
(P NE (X NE
= NE = NE
0.005) NE d.ddd) NE
. NE . NE

CONCLUSION NE XXXXXXXXXX NE
. NE . NE

These NE Xxxx NE
data NE xxx NE
add NE xxx NE
further NE xxx NE
evidence NE xxx NE
to NE xx NE
previous NE xxx NE
observations NE xxx NE
from NE xxx NE
the NE xxx NE
authors' NE xxx' NE
laboratory NE xxx NE
that NE xxx NE
certain NE xxx NE
tumor G#other_name_B xxx G#other_name_B
characteristics G#other_name_E xxx G#other_name_E
may NE xxx NE
be NE xx NE
associated NE xxx NE
with NE xxx NE
reactions NE xxx NE
of NE xx NE
the NE xxx NE
host NE xxx NE
with NE xxx NE
breast G#other_name_B xxx G#other_name_B
cancer G#other_name_E xxx G#other_name_E
. NE . NE

[The NE [Xxx NE
value NE xxx NE
of NE xx NE
the NE xxx NE
clinical NE xxx NE
test NE xxx NE
of NE xx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
leukocytes G#cell_type_E xxx G#cell_type_E
in NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
chronic G#other_name_B xxx G#other_name_B
pulmonary G#other_name_M xxx G#other_name_M
heart G#other_name_M xxx G#other_name_M
disease G#other_name_E xxx G#other_name_E
] NE ] NE

In NE Xx NE
order NE xxx NE
to NE xx NE
inquire NE xxx NE
into NE xxx NE
the NE xxx NE
functional NE xxx NE
state NE xxx NE
of NE xx NE
adrenal G#body_part_B xxx G#body_part_B
cortex G#body_part_E xxx G#body_part_E
in NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
pulmonary G#other_name_B xxx G#other_name_B
heart G#other_name_M xxx G#other_name_M
disease G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
number NE xxx NE
of NE xx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
GCR G#protein_family_or_group XXX G#protein_family_or_group
) NE ) NE
of NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
leukocytes G#cell_type_E xxx G#cell_type_E
in NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
chronic G#other_name_B xxx G#other_name_B
pulmonary G#other_name_M xxx G#other_name_M
heart G#other_name_M xxx G#other_name_M
disease G#other_name_E xxx G#other_name_E
was NE xxx NE
determined NE xxx NE
with NE xxx NE
radioligand-binding G#other_name_B xxx-xxx G#other_name_B
assay G#other_name_E xxx G#other_name_E
and NE xxx NE
the NE xxx NE
corresponding NE xxx NE
plasma G#other_name_B xxx G#other_name_B
cortisol G#other_name_M xxx G#other_name_M
levels G#other_name_E xxx G#other_name_E
were NE xxx NE
assessed NE xxx NE
with NE xxx NE
radioimmune G#other_name_B xxx G#other_name_B
assays G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
results NE xxx NE
showed NE xxx NE
that NE xxx NE
the NE xxx NE
number NE xxx NE
of NE xx NE
GCR G#protein_family_or_group XXX G#protein_family_or_group
in NE xx NE
the NE xxx NE
patients G#multi_cell xxx G#multi_cell
was NE xxx NE
significantly NE xxx NE
reduced NE xxx NE
(P NE (X NE
< NE < NE
0.01) NE d.dd) NE
and NE xxx NE
it NE xx NE
was NE xxx NE
increased NE xxx NE
when NE xxx NE
their NE xxx NE
health NE xxx NE
state NE xxx NE
was NE xxx NE
improved NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
it NE xx NE
was NE xxx NE
still NE xxx NE
lower NE xxx NE
than NE xxx NE
that NE xxx NE
in NE xx NE
healthy G#multi_cell_B xxx G#multi_cell_B
subjects G#multi_cell_E xxx G#multi_cell_E
(P NE (X NE
< NE < NE
0.01) NE d.dd) NE
. NE . NE

The NE Xxx NE
number NE xxx NE
of NE xx NE
GCR G#protein_family_or_group XXX G#protein_family_or_group
in NE xx NE
the NE xxx NE
patients G#multi_cell xxx G#multi_cell
was NE xxx NE
greatly NE xxx NE
increased NE xxx NE
when NE xxx NE
these NE xxx NE
patients G#multi_cell xxx G#multi_cell
were NE xxx NE
treated NE xxx NE
with NE xxx NE
oxygen G#atom xxx G#atom
(P NE (X NE
< NE < NE
0.01) NE d.dd) NE
. NE . NE

No NE Xx NE
difference NE xxx NE
in NE xx NE
plasma G#lipid_B xxx G#lipid_B
cortisol G#lipid_E xxx G#lipid_E
was NE xxx NE
found NE xxx NE
between NE xxx NE
the NE xxx NE
patients G#multi_cell xxx G#multi_cell
and NE xxx NE
the NE xxx NE
healthy G#multi_cell_B xxx G#multi_cell_B
subjects G#multi_cell_E xxx G#multi_cell_E
(P NE (X NE
> NE > NE
0.05) NE d.dd) NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
the NE xxx NE
function NE xxx NE
of NE xx NE
adrenal G#body_part_B xxx G#body_part_B
cortex G#body_part_E xxx G#body_part_E
may NE xxx NE
be NE xx NE
improved NE xxx NE
by NE xx NE
the NE xxx NE
compensation NE xxx NE
mechanism NE xxx NE
of NE xx NE
the NE xxx NE
patients G#multi_cell xxx G#multi_cell
, NE , NE
but NE xxx NE
the NE xxx NE
lower NE xxx NE
GCR G#protein_family_or_group XXX G#protein_family_or_group
number NE xxx NE
was NE xxx NE
the NE xxx NE
result NE xxx NE
of NE xx NE
lacking NE xxx NE
of NE xx NE
oxygen G#atom xxx G#atom
in NE xx NE
the NE xxx NE
patients G#multi_cell xxx G#multi_cell
. NE . NE

The NE Xxx NE
number NE xxx NE
of NE xx NE
GCR G#protein_family_or_group XXX G#protein_family_or_group
may NE xxx NE
be NE xx NE
improved NE xxx NE
by NE xx NE
inhalation NE xxx NE
of NE xx NE
oxygen G#atom xxx G#atom
. NE . NE

Therefore NE Xxxx NE
oxygen G#other_name_B xxx G#other_name_B
therapy G#other_name_E xxx G#other_name_E
is NE xx NE
helpful NE xxx NE
in NE xx NE
raising NE xxx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
controlling NE xxx NE
the NE xxx NE
development NE xxx NE
of NE xx NE
the NE xxx NE
disease NE xxx NE
. NE . NE

Signaling NE Xxxx NE
via NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
JAK3 NE XXXd NE
-deficient NE -xxx NE
severe NE xxx NE
combined NE xxx NE
immunodeficiency NE xxx NE
lymphocytes NE xxx NE
: NE : NE
JAK3 NE XXXd NE
-dependent NE -xxx NE
and NE xxx NE
independent NE xxx NE
pathways NE xxx NE
. NE . NE

Both NE Xxxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
bind NE xxx NE
to NE xx NE
receptors NE xxx NE
containing NE xxx NE
the NE xxx NE
common G#protein_subunit_B xxx G#protein_subunit_B
gamma G#protein_subunit_M xxx G#protein_subunit_M
chain G#protein_subunit_E xxx G#protein_subunit_E
and NE xxx NE
JAK3 G#protein_molecule XXXd G#protein_molecule
. NE . NE

Although NE Xxxx NE
JAK3 G#protein_molecule XXXd G#protein_molecule
is NE xx NE
required NE xxx NE
for NE xxx NE
proper NE xxx NE
lymphoid G#other_name_B xxx G#other_name_B
development G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
precise NE xxx NE
roles NE xxx NE
of NE xx NE
this NE xxx NE
kinase NE xxx NE
in NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
signaling NE xxx NE
in NE xx NE
lymphocytes G#cell_type xxx G#cell_type
have NE xxx NE
not NE xxx NE
been NE xxx NE
defined NE xxx NE
. NE . NE

Here NE Xxxx NE
, NE , NE
we NE xx NE
have NE xxx NE
studied NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
signaling NE xxx NE
in NE xx NE
B G#cell_line_B X G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
lacking NE xxx NE
JAK3 G#protein_molecule XXXd G#protein_molecule
. NE . NE

Although NE Xxxx NE
IL-2 NE XX-d NE
-induced NE -xxx NE
phosphorylation NE xxx NE
of NE xx NE
IL-2R NE XX-dX NE
beta NE xxx NE
, NE , NE
JAK1 NE XXXd NE
, NE , NE
and NE xxx NE
STAT5 NE XXXXd NE
all NE xxx NE
required NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
JAK3 NE XXXd NE
, NE , NE
IL-4 NE XX-d NE
-mediated NE -xxx NE
phosphorylation NE xxx NE
of NE xx NE
JAK1 NE XXXd NE
, NE , NE
STAT6 NE XXXXd NE
, NE , NE
and NE xxx NE
insulin NE xxx NE
receptor NE xxx NE
substrates NE xxx NE
1 NE d NE
and NE xxx NE
2 NE d NE
did NE xxx NE
not NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
IL-4 NE XX-d NE
-induced NE -xxx NE
effects NE xxx NE
were NE xxx NE
clearly NE xxx NE
improved NE xxx NE
following NE xxx NE
JAK3 NE XXXd NE
expression NE xxx NE
. NE . NE

These NE Xxxx NE
data NE xxx NE
indicate NE xxx NE
that NE xxx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
signaling NE xxx NE
occurs NE xxx NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
of NE xx NE
JAK3 G#protein_molecule XXXd G#protein_molecule
, NE , NE
but NE xxx NE
is NE xx NE
comparatively NE xxx NE
inefficient NE xxx NE
. NE . NE

These NE Xxxx NE
findings NE xxx NE
may NE xxx NE
help NE xxx NE
in NE xx NE
understanding NE xxx NE
the NE xxx NE
pathogenesis G#other_name xxx G#other_name
of NE xx NE
the NE xxx NE
immunodeficiency G#other_name xxx G#other_name
that NE xxx NE
occurs NE xxx NE
with NE xxx NE
mutations NE xxx NE
of NE xx NE
JAK3 G#protein_molecule XXXd G#protein_molecule
and NE xxx NE
may NE xxx NE
suggest NE xxx NE
a NE x NE
mechanism NE xxx NE
for NE xxx NE
the NE xxx NE
pleiotropic G#other_name_B xxx G#other_name_B
effects G#other_name_E xxx G#other_name_E
of NE xx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
. NE . NE

Elf-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
Stat5 G#protein_molecule Xxxxd G#protein_molecule
bind NE xxx NE
to NE xx NE
a NE x NE
critical NE xxx NE
element NE xxx NE
in NE xx NE
a NE x NE
new NE xxx NE
enhancer NE xxx NE
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
interleukin-2 G#DNA_domain_or_region_M xxx-d G#DNA_domain_or_region_M
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
[published NE [xxx NE
erratum NE xxx NE
appears NE xxx NE
in NE xx NE
Mol NE Xxx NE
Cell NE Xxxx NE
Biol NE Xxxx NE
1997 NE dddd NE
Apr;17(4):2351] NE Xxx;dd(d):dddd] NE

The NE Xxx NE
interleukin NE xxx NE
2 NE d NE
receptor NE xxx NE
alpha-chain NE xxx-xxx NE
( NE ( NE
IL-2R NE XX-dX NE
alpha NE xxx NE
) NE ) NE
gene NE xxx NE
is NE xx NE
a NE x NE
key NE xxx NE
regulator NE xxx NE
of NE xx NE
lymphocyte NE xxx NE
proliferation NE xxx NE
. NE . NE

IL-2R G#protein_molecule_B XX-dX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
is NE xx NE
rapidly NE xxx NE
and NE xxx NE
potently NE xxx NE
induced NE xxx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
response NE xxx NE
to NE xx NE
mitogenic G#other_name_B xxx G#other_name_B
stimuli G#other_name_E xxx G#other_name_E
. NE . NE

Interleukin G#protein_molecule_B Xxxx G#protein_molecule_B
2 G#protein_molecule_E d G#protein_molecule_E
( NE ( NE
IL-2 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
stimulates NE xxx NE
IL-2R G#protein_molecule_B XX-dX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

transcription NE xxx NE
, NE , NE
thereby NE xxx NE
amplifying NE xxx NE
expression NE xxx NE
of NE xx NE
its NE xxx NE
own NE xxx NE
high-affinity G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

IL-2R G#other_name_B XX-dX G#other_name_B
alpha G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
is NE xx NE
at NE xx NE
least NE xxx NE
in NE xx NE
part NE xxx NE
controlled NE xxx NE
by NE xx NE
two NE xxx NE
positive G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
regulatory G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
regions G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
, NE , NE
PRRI G#DNA_domain_or_region XXXX G#DNA_domain_or_region
and NE xxx NE
PRRII G#DNA_domain_or_region XXXXX G#DNA_domain_or_region
. NE . NE

PRRI G#DNA_domain_or_region XXXX G#DNA_domain_or_region
is NE xx NE
an NE xx NE
inducible G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
proximal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
located NE xxx NE
between G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
nucleotides G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
-276 G#DNA_domain_or_region_M -ddd G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
-244 G#DNA_domain_or_region_E -ddd G#DNA_domain_or_region_E
, NE , NE
which NE xxx NE
contains NE xxx NE
NF-kappaB G#DNA_domain_or_region_B XX-xxxX G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
SRE/CArG G#DNA_domain_or_region_M XXX/XXxX G#DNA_domain_or_region_M
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E

PRRII G#DNA_domain_or_region XXXXX G#DNA_domain_or_region
is NE xx NE
a NE x NE
T-cell-specific G#DNA_domain_or_region_B X-xxx-xxx G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
located NE xxx NE
between NE xxx NE
nucleotides NE xxx NE
-137 NE -ddd NE
and NE xxx NE
-64 NE -dd NE
, NE , NE
which NE xxx NE
binds NE xxx NE
the NE xxx NE
T-cell-specific G#protein_family_or_group_B X-xxx-xxx G#protein_family_or_group_B
Ets G#protein_family_or_group_M Xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
Elf-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
HMG-I(Y) G#protein_family_or_group_B XXX-X(X) G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

However NE Xxxx NE
, NE , NE
none NE xxx NE
of NE xx NE
these NE xxx NE
proximal NE xxx NE
regions NE xxx NE
account NE xxx NE
for NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
IL-2R NE XX-dX NE
alpha NE xxx NE
transcription NE xxx NE
by NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
. NE . NE

To NE Xx NE
find NE xxx NE
new NE xxx NE
regulatory G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
regions G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
IL-2R G#DNA_domain_or_region_B XX-dX G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
8.5 NE d.d NE
kb NE xx NE
of NE xx NE
the NE xxx NE
5' NE d' NE
end NE xxx NE
noncoding NE xxx NE
sequence NE xxx NE
of NE xx NE
the NE xxx NE
IL-2R G#DNA_domain_or_region_B XX-dX G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
have NE xxx NE
been NE xxx NE
sequenced NE xxx NE
. NE . NE

We NE Xx NE
identified NE xxx NE
an NE xx NE
86-nucleotide NE dd-xxx NE
fragment NE xxx NE
that NE xxx NE
is NE xx NE
90% NE dd% NE
identical NE xxx NE
to NE xx NE
the NE xxx NE
recently NE xxx NE
characterized NE xxx NE
murine NE xxx NE
IL-2 NE XX-d NE
-responsive NE -xxx NE
element NE xxx NE
( NE ( NE
mIL-2rE NE xXX-dxX NE
) NE ) NE
. NE . NE

This NE Xxxx NE
putative NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
IL-2rE G#DNA_domain_or_region_E XX-dxX G#DNA_domain_or_region_E
, NE , NE
designated NE xxx NE
PRRIII G#DNA_domain_or_region XXXXXX G#DNA_domain_or_region
, NE , NE
confers NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
responsiveness NE xxx NE
on NE xx NE
a NE x NE
heterologous G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

PRRIII G#DNA_domain_or_region XXXXXX G#DNA_domain_or_region
contains NE xxx NE
a NE x NE
Stat G#DNA_domain_or_region_B Xxxx G#DNA_domain_or_region_B
protein G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
that NE xxx NE
overlaps NE xxx NE
with NE xxx NE
an NE xx NE
EBS G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
GASd/EBSd G#DNA_domain_or_region XXXx/XXXx G#DNA_domain_or_region
) NE ) NE
. NE . NE

These NE Xxxx NE
are NE xxx NE
essential NE xxx NE
for NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
inducibility G#other_name_E xxx G#other_name_E
of NE xx NE
PRRIII NE XXXXXX NE
/CAT NE /XXX NE
reporter NE xxx NE
constructs NE xxx NE
. NE . NE

IL-2 G#protein_molecule XX-d G#protein_molecule
induced NE xxx NE
the NE xxx NE
binding NE xxx NE
of NE xx NE
Stat5a G#protein_molecule_B Xxxxdx G#protein_molecule_B
protein G#protein_molecule_M xxx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
Stat5b G#protein_molecule_M Xxxxdx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
to NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
GASd G#DNA_domain_or_region_M XXXx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

To NE Xx NE
confirm NE xxx NE
the NE xxx NE
physiological NE xxx NE
relevance NE xxx NE
of NE xx NE
these NE xxx NE
findings NE xxx NE
, NE , NE
we NE xx NE
carried NE xxx NE
out NE xxx NE
in NE xx NE
vivo G#other_name_B xxx G#other_name_B
footprinting G#other_name_M xxx G#other_name_M
experiments G#other_name_E xxx G#other_name_E
which NE xxx NE
showed NE xxx NE
that NE xxx NE
stimulation NE xxx NE
of NE xx NE
IL-2R G#other_name_B XX-dX G#other_name_B
alpha G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
correlated NE xxx NE
with NE xxx NE
occupancy NE xxx NE
of NE xx NE
the NE xxx NE
GASd G#DNA_domain_or_region_B XXXx G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Our NE Xxx NE
data NE xxx NE
demonstrate NE xxx NE
a NE x NE
major NE xxx NE
role NE xxx NE
of NE xx NE
the NE xxx NE
GASd/EBSd G#DNA_domain_or_region_B XXXx/XXXx G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
IL-2R G#other_name_B XX-dX G#other_name_B
alpha G#other_name_M xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
and NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
T-cell-specific G#protein_family_or_group_B X-xxx-xxx G#protein_family_or_group_B
Elf-1 G#protein_family_or_group_M Xxx-d G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
can NE xxx NE
serve NE xxx NE
as NE xx NE
a NE x NE
transcriptional G#protein_family_or_group_B xxx G#protein_family_or_group_B
repressor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Signal NE Xxxx NE
transduction NE xxx NE
by NE xx NE
DR3 G#protein_molecule XXd G#protein_molecule
, NE , NE
a NE x NE
death NE xxx NE
domain NE xxx NE
-containing NE -xxx NE
receptor NE xxx NE
related NE xxx NE
to NE xx NE
TNFR-1 NE XXXX-d NE
and NE xxx NE
CD95 NE XXdd NE
. NE . NE

Tumor G#protein_molecule_B Xxxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
receptor-1 G#protein_molecule_E xxx-d G#protein_molecule_E
( NE ( NE
TNFR-1 G#protein_molecule XXXX-d G#protein_molecule
) NE ) NE
and NE xxx NE
CD95 G#protein_molecule XXdd G#protein_molecule
(also NE (xxx NE
called NE xxx NE
Fas G#protein_molecule Xxx G#protein_molecule
or NE xx NE
APO-1 G#protein_molecule XXX-d G#protein_molecule
) NE ) NE
are NE xxx NE
cytokine G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
engage NE xxx NE
the NE xxx NE
apoptosis G#other_name_B xxx G#other_name_B
pathway G#other_name_E xxx G#other_name_E
through NE xxx NE
a NE x NE
region NE xxx NE
of NE xx NE
intracellular G#other_name_B xxx G#other_name_B
homology G#other_name_E xxx G#other_name_E
, NE , NE
designated NE xxx NE
the NE xxx NE
" NE " NE
death G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
." NE ." NE
Another NE Xxxx NE
death NE xxx NE
domain NE xxx NE
-containing NE -xxx NE
member NE xxx NE
of NE xx NE
the NE xxx NE
TNFR NE XXXX NE
family NE xxx NE
, NE , NE
death NE xxx NE
receptor NE xxx NE
3 NE d NE
( NE ( NE
DR3 NE XXd NE
) NE ) NE
, NE , NE
was NE xxx NE
identified NE xxx NE
and NE xxx NE
was NE xxx NE
shown NE xxx NE
to NE xx NE
induce NE xxx NE
both NE xxx NE
apoptosis NE xxx NE
and NE xxx NE
activation NE xxx NE
of NE xx NE
nuclear NE xxx NE
factor NE xxx NE
kappaB NE xxxX NE
. NE . NE

Expression NE Xxxx NE
of NE xx NE
DR3 G#protein_molecule XXd G#protein_molecule
appears NE xxx NE
to NE xx NE
be NE xx NE
restricted NE xxx NE
to NE xx NE
tissues NE xxx NE
enriched NE xxx NE
in NE xx NE
lymphocytes G#cell_type xxx G#cell_type
. NE . NE

DR3 G#other_name_B XXd G#other_name_B
signal G#other_name_M xxx G#other_name_M
transduction G#other_name_E xxx G#other_name_E
is NE xx NE
mediated NE xxx NE
by NE xx NE
a NE x NE
complex NE xxx NE
of NE xx NE
intracellular G#protein_family_or_group_B xxx G#protein_family_or_group_B
signaling G#protein_family_or_group_M xxx G#protein_family_or_group_M
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
including NE xxx NE
TRADD G#protein_molecule XXXXX G#protein_molecule
, NE , NE
TRAF2 G#protein_molecule XXXXd G#protein_molecule
, NE , NE
FADD G#protein_molecule XXXX G#protein_molecule
, NE , NE
and NE xxx NE
FLICE G#protein_molecule XXXXX G#protein_molecule
. NE . NE

Thus NE Xxxx NE
, NE , NE
DR3 G#protein_molecule XXd G#protein_molecule
likely NE xxx NE
plays NE xxx NE
a NE x NE
role NE xxx NE
in NE xx NE
regulating NE xxx NE
lymphocyte G#other_name_B xxx G#other_name_B
homeostasis G#other_name_E xxx G#other_name_E
. NE . NE

Differential NE Xxxx NE
nuclear NE xxx NE
localization NE xxx NE
of NE xx NE
p50 G#protein_subunit xdd G#protein_subunit
, NE , NE
p52 G#protein_subunit xdd G#protein_subunit
, NE , NE
and NE xxx NE
RelB G#protein_molecule XxxX G#protein_molecule
proteins NE xxx NE
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
accessory G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
of NE xx NE
the NE xxx NE
immune G#other_name_B xxx G#other_name_B
response G#other_name_E xxx G#other_name_E
in G#other_name_B xx G#other_name_B
situ G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
Rel/NF-kappa G#protein_family_or_group_B Xxx/XX-xxx G#protein_family_or_group_B
B G#protein_family_or_group_M X G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
p50 G#protein_subunit xdd G#protein_subunit
, NE , NE
p52 G#protein_subunit xdd G#protein_subunit
, NE , NE
p65 G#protein_subunit xdd G#protein_subunit
, NE , NE
c-Rel G#protein_molecule x-Xxx G#protein_molecule
, NE , NE
and NE xxx NE
RelB G#protein_molecule XxxX G#protein_molecule
, NE , NE
constitute NE xxx NE
a NE x NE
family NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
involved NE xxx NE
in NE xx NE
the NE xxx NE
positive NE xxx NE
regulation NE xxx NE
of NE xx NE
a NE x NE
variety NE xxx NE
of NE xx NE
genes NE xxx NE
during NE xxx NE
the NE xxx NE
immune G#other_name_B xxx G#other_name_B
response G#other_name_E xxx G#other_name_E
. NE . NE

Recently NE Xxxx NE
, NE , NE
it NE xx NE
has NE xxx NE
been NE xxx NE
shown NE xxx NE
that NE xxx NE
RelB G#other_artificial_source_B XxxX G#other_artificial_source_B
knockout G#other_artificial_source_M xxx G#other_artificial_source_M
mice G#other_artificial_source_E xxx G#other_artificial_source_E
have NE xxx NE
no NE xx NE
dendritic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
DC G#cell_type XX G#cell_type
) NE ) NE
. NE . NE

An NE Xx NE
overexpression NE xxx NE
of NE xx NE
p50 G#protein_subunit xdd G#protein_subunit
has NE xxx NE
been NE xxx NE
described NE xxx NE
in NE xx NE
follicular G#cell_type_B xxx G#cell_type_B
dendritic G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
FDC G#cell_type XXX G#cell_type
) NE ) NE
. NE . NE

A NE X NE
constitutive NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activity G#other_name_E xxx G#other_name_E
has NE xxx NE
been NE xxx NE
reported NE xxx NE
in NE xx NE
mature G#cell_type_B xxx G#cell_type_B
macrophages G#cell_type_E xxx G#cell_type_E
. NE . NE

This NE Xxxx NE
led NE xxx NE
to NE xx NE
the NE xxx NE
hypothesis NE xxx NE
that NE xxx NE
some NE xxx NE
of NE xx NE
the NE xxx NE
Rel NE Xxx NE
/ NE / NE
NF-kappa NE XX-xxx NE
B NE X NE
proteins NE xxx NE
were NE xxx NE
key NE xxx NE
nuclear NE xxx NE
factors NE xxx NE
in NE xx NE
functions NE xxx NE
of NE xx NE
accessory NE xxx NE
cells NE xxx NE
of NE xx NE
the NE xxx NE
immune NE xxx NE
response NE xxx NE
. NE . NE

Therefore NE Xxxx NE
, NE , NE
we NE xx NE
investigated NE xxx NE
in NE xx NE
situ NE xxx NE
the NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
localization G#other_name_E xxx G#other_name_E
of NE xx NE
Rel NE Xxx NE
/ NE / NE
NF-kappa NE XX-xxx NE
B NE X NE
proteins NE xxx NE
in NE xx NE
accessory NE xxx NE
cells NE xxx NE
of NE xx NE
the NE xxx NE
immune NE xxx NE
system NE xxx NE
by NE xx NE
immunohistochemistry NE xxx NE
and NE xxx NE
double NE xxx NE
labeling NE xxx NE
by NE xx NE
immunofluorescence NE xxx NE
from NE xxx NE
five NE xxx NE
normal NE xxx NE
human NE xxx NE
tonsils NE xxx NE
and NE xxx NE
five NE xxx NE
lymph NE xxx NE
nodes NE xxx NE
with NE xxx NE
follicular NE xxx NE
hyperplasia NE xxx NE
. NE . NE

Nuclear NE Xxxx NE
p65 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
c-Rel G#protein_molecule x-Xxx G#protein_molecule
proteins NE xxx NE
were NE xxx NE
found NE xxx NE
in NE xx NE
all NE xxx NE
cell NE xxx NE
types NE xxx NE
including NE xxx NE
lymphocytes G#cell_type xxx G#cell_type
. NE . NE

In NE Xx NE
germinal G#tissue_B xxx G#tissue_B
centers G#tissue_E xxx G#tissue_E
GC G#tissue XX G#tissue
, NE , NE
p50 G#protein_subunit xdd G#protein_subunit
, NE , NE
p52 G#protein_subunit xdd G#protein_subunit
, NE , NE
and NE xxx NE
RelB G#protein_molecule XxxX G#protein_molecule
were NE xxx NE
found NE xxx NE
in NE xx NE
the NE xxx NE
nuclei G#cell_component xxx G#cell_component
of NE xx NE
FDC G#cell_type XXX G#cell_type
only NE xxx NE
and NE xxx NE
were NE xxx NE
not NE xxx NE
detected NE xxx NE
in NE xx NE
the NE xxx NE
nuclei G#cell_component xxx G#cell_component
of NE xx NE
CD68+ G#cell_line_B XXdd+ G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

In NE Xx NE
T G#tissue_B X G#tissue_B
cell G#tissue_M xxx G#tissue_M
areas G#tissue_E xxx G#tissue_E
, NE , NE
p50 G#protein_subunit xdd G#protein_subunit
, NE , NE
p52 G#protein_subunit xdd G#protein_subunit
, NE , NE
and NE xxx NE
RelB G#protein_molecule XxxX G#protein_molecule
were NE xxx NE
found NE xxx NE
in NE xx NE
the NE xxx NE
nuclei G#cell_component xxx G#cell_component
of NE xx NE
HLA-DR+ G#cell_line_B XXX-XX+ G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
an NE xx NE
antigen-presenting G#other_name_B xxx-xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
(APC) G#other_name_M (XXX) G#other_name_M
morphology G#other_name_E xxx G#other_name_E
. NE . NE

p52 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
RelB G#protein_molecule XxxX G#protein_molecule
were NE xxx NE
detected NE xxx NE
in NE xx NE
the NE xxx NE
nuclei G#cell_component xxx G#cell_component
in NE xx NE
both NE xxx NE
CD1a+ G#cell_line XXdx+ G#cell_line
and NE xxx NE
CD68+ G#cell_line_B XXdd+ G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
from NE xxx NE
the NE xxx NE
T G#tissue_B X G#tissue_B
cell G#tissue_M xxx G#tissue_M
area G#tissue_E xxx G#tissue_E
, NE , NE
whereas NE xxx NE
p50 G#protein_subunit xdd G#protein_subunit
was NE xxx NE
found NE xxx NE
only NE xxx NE
in NE xx NE
CD68- G#cell_line_B XXdd- G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
CD1a- G#cell_line_M XXdx- G#cell_line_M
cell G#cell_line_E xxx G#cell_line_E

Cells NE Xxxx NE
with NE xxx NE
nuclear NE xxx NE
p50 G#protein_subunit xdd G#protein_subunit
were NE xxx NE
negative NE xxx NE
for NE xxx NE
the NE xxx NE
CD38 G#protein_molecule XXdd G#protein_molecule
, NE , NE
CD20 G#protein_molecule XXdd G#protein_molecule
and NE xxx NE
CD2 G#protein_molecule_B XXd G#protein_molecule_B
markers G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
show NE xxx NE
that NE xxx NE
, NE , NE
physiologically NE xxx NE
, NE , NE
high NE xxx NE
levels NE xxx NE
of NE xx NE
nuclear NE xxx NE
of NE xx NE
p50 G#protein_subunit xdd G#protein_subunit
, NE , NE
p52 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
RelB G#protein_molecule XxxX G#protein_molecule
are NE xxx NE
restricted NE xxx NE
to NE xx NE
accessory G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
of NE xx NE
the NE xxx NE
immune G#body_part_B xxx G#body_part_B
system G#body_part_E xxx G#body_part_E
, NE , NE
which NE xxx NE
include NE xxx NE
FDC G#cell_type XXX G#cell_type
in NE xx NE
GC G#tissue XX G#tissue
, NE , NE
and NE xxx NE
DC G#cell_type XX G#cell_type
and NE xxx NE
macrophages NE xxx NE
in NE xx NE
the NE xxx NE
T G#tissue_B X G#tissue_B
cell G#tissue_M xxx G#tissue_M
zone G#tissue_E xxx G#tissue_E
, NE , NE
that NE xxx NE
specialized NE xxx NE
scavenger G#cell_type_B xxx G#cell_type_B
macrophages G#cell_type_E xxx G#cell_type_E
from NE xxx NE
GC G#cell_type XX G#cell_type
do NE xx NE
not NE xxx NE
have NE xxx NE
detectable NE xxx NE
levels NE xxx NE
of NE xx NE
p52 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
RelB G#protein_molecule XxxX G#protein_molecule
, NE , NE
whereas NE xxx NE
macrophages G#cell_type xxx G#cell_type
from NE xxx NE
the NE xxx NE
T G#tissue_B X G#tissue_B
cell G#tissue_M xxx G#tissue_M
area G#tissue_E xxx G#tissue_E
, NE , NE
known NE xxx NE
to NE xx NE
present NE xxx NE
the NE xxx NE
antigen NE xxx NE
to NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
do NE xx NE
have NE xxx NE
both NE xxx NE
nuclear NE xxx NE
p52 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
RelB G#protein_molecule XxxX G#protein_molecule
, NE , NE
and NE xxx NE
that NE xxx NE
in NE xx NE
the NE xxx NE
T G#tissue_B X G#tissue_B
cell G#tissue_M xxx G#tissue_M
zone G#tissue_E xxx G#tissue_E
, NE , NE
p52 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
RelB G#protein_molecule XxxX G#protein_molecule
are NE xxx NE
located NE xxx NE
in NE xx NE
nuclei G#cell_component xxx G#cell_component
of NE xx NE
both NE xxx NE
CD1a+ NE XXdx+ NE
, NE , NE
CD68+ NE XXdd+ NE
or NE xx NE
both NE xxx NE
, NE , NE
cells NE xxx NE
APC NE XXX NE
, NE , NE
whereas NE xxx NE
p50 NE xdd NE
is NE xx NE
restricted NE xxx NE
to NE xx NE
CD1a- NE XXdx- NE
and NE xxx NE
CD68- NE XXdd- NE
APC NE XXX NE
. NE . NE

The NE Xxx NE
different NE xxx NE
patterns NE xxx NE
of NE xx NE
p50 G#protein_subunit xdd G#protein_subunit
, NE , NE
p52 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
RelB G#protein_molecule XxxX G#protein_molecule
protein G#other_name_B xxx G#other_name_B
nuclear G#other_name_M xxx G#other_name_M
localization G#other_name_E xxx G#other_name_E
may NE xxx NE
provide NE xxx NE
insight NE xxx NE
into NE xxx NE
their NE xxx NE
different NE xxx NE
roles NE xxx NE
during NE xxx NE
the NE xxx NE
immune G#other_name_B xxx G#other_name_B
response G#other_name_M xxx G#other_name_M
in G#other_name_M xx G#other_name_M
vivo G#other_name_E xxx G#other_name_E
. NE . NE

Tyrosines NE Xxxx NE
tyrosine G#amino_acid_monomer_B xxx G#amino_acid_monomer_B
113 G#amino_acid_monomer_M ddd G#amino_acid_monomer_M
and G#amino_acid_monomer_M xxx G#amino_acid_monomer_M
tyrosine G#amino_acid_monomer_M xxx G#amino_acid_monomer_M
128 G#amino_acid_monomer_M ddd G#amino_acid_monomer_M
and G#amino_acid_monomer_M xxx G#amino_acid_monomer_M
tyrosine G#amino_acid_monomer_M xxx G#amino_acid_monomer_M
145 G#amino_acid_monomer_E ddd G#amino_acid_monomer_E
of NE xx NE
SLP-76 G#protein_molecule XXX-dd G#protein_molecule
are NE xxx NE
required NE xxx NE
for NE xxx NE
optimal NE xxx NE
augmentation NE xxx NE
of NE xx NE
NFAT G#other_name_B XXXX G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
. NE . NE

SLP-76 G#protein_molecule XXX-dd G#protein_molecule
( NE ( NE
SH2 G#protein_family_or_group_B XXd G#protein_family_or_group_B
domain G#protein_family_or_group_M xxx G#protein_family_or_group_M
leukocyte G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
76 NE dd NE
kDa) NE xXx) NE
is NE xx NE
a NE x NE
recently NE xxx NE
identified NE xxx NE
substrate NE xxx NE
of NE xx NE
the NE xxx NE
TCR-stimulated G#protein_family_or_group_B XXX-xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
tyrosine G#protein_family_or_group_B xxx G#protein_family_or_group_B
kinases G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
functions NE xxx NE
in NE xx NE
the NE xxx NE
signal NE xxx NE
transduction NE xxx NE
cascade NE xxx NE
linking NE xxx NE
the NE xxx NE
TCR G#protein_family_or_group XXX G#protein_family_or_group
with NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
this NE xxx NE
report NE xxx NE
, NE , NE
we NE xx NE
demonstrate NE xxx NE
that NE xxx NE
engagement NE xxx NE
of NE xx NE
the NE xxx NE
TCR G#protein_family_or_group XXX G#protein_family_or_group
results NE xxx NE
in NE xx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
SLP-76 G#protein_molecule XXX-dd G#protein_molecule
in NE xx NE
its NE xxx NE
amino-terminal G#protein_domain_or_region_B xxx-xxx G#protein_domain_or_region_B
acidic G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

Two NE Xxx NE
tyrosines G#amino_acid_monomer xxx G#amino_acid_monomer
( NE ( NE
Y113 G#amino_acid_monomer Xddd G#amino_acid_monomer
and NE xxx NE
Y128 G#amino_acid_monomer Xddd G#amino_acid_monomer
) NE ) NE
fall NE xxx NE
within NE xxx NE
an NE xx NE
identical NE xxx NE
five NE xxx NE
amino-acid NE xxx-xxx NE
motif NE xxx NE
and NE xxx NE
are NE xxx NE
shown NE xxx NE
to NE xx NE
be NE xx NE
phosphorylated NE xxx NE
upon NE xxx NE
TCR G#other_name_B XXX G#other_name_B
ligation G#other_name_E xxx G#other_name_E
. NE . NE

Although NE Xxxx NE
mutation NE xxx NE
of NE xx NE
either NE xxx NE
Y113 G#amino_acid_monomer Xddd G#amino_acid_monomer
and NE xxx NE
Y128 G#amino_acid_monomer Xddd G#amino_acid_monomer
has NE xxx NE
a NE x NE
minimal NE xxx NE
effect NE xxx NE
on NE xx NE
SLP-76 G#other_name_B XXX-dd G#other_name_B
function G#other_name_E xxx G#other_name_E
, NE , NE
mutation NE xxx NE
of NE xx NE
both NE xxx NE
residues NE xxx NE
decreases NE xxx NE
significantly NE xxx NE
the NE xxx NE
ability NE xxx NE
of NE xx NE
SLP-76 G#protein_molecule XXX-dd G#protein_molecule
to NE xx NE
promote NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

A NE X NE
third NE xxx NE
tyrosine G#amino_acid_monomer xxx G#amino_acid_monomer
within NE xxx NE
the NE xxx NE
amino-terminal G#protein_domain_or_region_B xxx-xxx G#protein_domain_or_region_B
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
( NE ( NE
Y145 G#amino_acid_monomer Xddd G#amino_acid_monomer
) NE ) NE
appears NE xxx NE
to NE xx NE
be NE xx NE
the NE xxx NE
most NE xxx NE
important NE xxx NE
for NE xxx NE
optimal NE xxx NE
SLP-76 G#protein_molecule XXX-dd G#protein_molecule
function NE xxx NE
, NE , NE
as NE xx NE
altering NE xxx NE
it NE xx NE
alone NE xxx NE
to NE xx NE
phenylalanine G#other_organic_compound xxx G#other_organic_compound
has NE xxx NE
a NE x NE
potent NE xxx NE
impact NE xxx NE
on NE xx NE
SLP-76 G#other_name_B XXX-dd G#other_name_B
augmentation G#other_name_E xxx G#other_name_E
of NE xx NE
NFAT G#other_name_B XXXX G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
. NE . NE

Human G#DNA_domain_or_region_B Xxxx G#DNA_domain_or_region_B
interferon G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
regulatory G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
factor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
2 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Intron-exon NE Xxxx-xxx NE
organization NE xxx NE
and NE xxx NE
functional NE xxx NE
analysis NE xxx NE
of NE xx NE
5'-flanking G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Interferon G#protein_molecule_B Xxxx G#protein_molecule_B
regulatory G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
2 G#protein_molecule_E d G#protein_molecule_E
( NE ( NE
IRF-2 G#protein_molecule XXX-d G#protein_molecule
) NE ) NE
is NE xx NE
a NE x NE
transcriptional G#protein_family_or_group_B xxx G#protein_family_or_group_B
regulatory G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
terminates NE xxx NE
interferon G#other_name_B xxx G#other_name_B
beta G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
initiated NE xxx NE
by NE xx NE
interferon G#protein_molecule_B xxx G#protein_molecule_B
regulatory G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
1 G#protein_molecule_E d G#protein_molecule_E
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
we NE xx NE
isolated NE xxx NE
the NE xxx NE
genomic G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
DNA G#DNA_family_or_group_E XXX G#DNA_family_or_group_E
for NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
IRF-2 G#DNA_domain_or_region_M XXX-d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
determined NE xxx NE
the NE xxx NE
intron-exon G#DNA_substructure_B xxx-xxx G#DNA_substructure_B
structure G#DNA_substructure_E xxx G#DNA_substructure_E
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
IRF-2 G#DNA_domain_or_region_M XXX-d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
mapped NE xxx NE
the NE xxx NE
major G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
transcription G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
initiation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
identified NE xxx NE
a NE x NE
number NE xxx NE
of NE xx NE
potential NE xxx NE
regulatory NE xxx NE
elements NE xxx NE
in NE xx NE
the NE xxx NE
5'-flanking G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
and NE xxx NE
localized NE xxx NE
the NE xxx NE
IRF-2 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
on NE xx NE
human G#DNA_molecule_B xxx G#DNA_molecule_B
chromosome G#DNA_molecule_M xxx G#DNA_molecule_M
4 G#DNA_molecule_E d G#DNA_molecule_E
. NE . NE

The NE Xxx NE
IRF-2 G#protein_molecule XXX-d G#protein_molecule
promoter G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
contains NE xxx NE
a NE x NE
CpG G#DNA_substructure_B XxX G#DNA_substructure_B
island G#DNA_substructure_E xxx G#DNA_substructure_E
, NE , NE
with NE xxx NE
several NE xxx NE
GC NE XX NE
boxes NE xxx NE
, NE , NE
a NE x NE
putative NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
-binding NE -xxx NE
site NE xxx NE
, NE , NE
and NE xxx NE
a NE x NE
CAAT NE XXXX NE
box NE xxx NE
, NE , NE
but NE xxx NE
no NE xx NE
TATA NE XXXX NE
box NE xxx NE
. NE . NE

When NE Xxxx NE
the NE xxx NE
promoter G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
linked NE xxx NE
with NE xxx NE
a NE x NE
heterologous G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
reporter G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
we NE xx NE
found NE xxx NE
that NE xxx NE
the NE xxx NE
promoter G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
inducible NE xxx NE
by NE xx NE
both NE xxx NE
interferons G#protein_family_or_group xxx G#protein_family_or_group
( NE ( NE
interferon-alpha G#protein_molecule_B xxx-xxx G#protein_molecule_B
and G#protein_molecule_M xxx G#protein_molecule_M
interferon-gamma G#protein_molecule_E xxx-xxx G#protein_molecule_E
interferon NE xxx NE
regulatory NE xxx NE
factor NE xxx NE
1 NE d NE
. NE . NE

The NE Xxx NE
region NE xxx NE
which NE xxx NE
induced NE xxx NE
these NE xxx NE
inductions NE xxx NE
was NE xxx NE
identified NE xxx NE
as NE xx NE
being NE xxx NE
confined NE xxx NE
to NE xx NE
40 G#DNA_domain_or_region_B dd G#DNA_domain_or_region_B
nucleotides G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
5' G#DNA_domain_or_region_E d' G#DNA_domain_or_region_E
to NE xx NE
the NE xxx NE
major G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
transcriptional G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
initiation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
by NE xx NE
testing NE xxx NE
a NE x NE
series NE xxx NE
of NE xx NE
clones NE xxx NE
with NE xxx NE
truncated G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
IRF-2 G#protein_molecule XXX-d G#protein_molecule
. NE . NE

This NE Xxxx NE
region NE xxx NE
contains NE xxx NE
elements NE xxx NE
which NE xxx NE
are NE xxx NE
shared NE xxx NE
with NE xxx NE
the NE xxx NE
transcriptional G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
enhancers G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
other NE xxx NE
genes NE xxx NE
including NE xxx NE
interferon G#protein_molecule_B xxx G#protein_molecule_B
regulatory G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
1 G#protein_molecule_E d G#protein_molecule_E
, NE , NE
interferon G#protein_molecule_B xxx G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
and NE xxx NE
interferon-inducible G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

These NE Xxxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
interferon G#protein_molecule_B xxx G#protein_molecule_B
regulatory G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
1 G#protein_molecule_E d G#protein_molecule_E
not NE xxx NE
only NE xxx NE
triggers NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
interferon G#other_name_B xxx G#other_name_B
signal G#other_name_M xxx G#other_name_M
transduction G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
, NE , NE
but NE xxx NE
also NE xxx NE
may NE xxx NE
play NE xxx NE
a NE x NE
role NE xxx NE
in NE xx NE
limiting NE xxx NE
the NE xxx NE
duration NE xxx NE
of NE xx NE
this NE xxx NE
response NE xxx NE
by NE xx NE
activating NE xxx NE
the NE xxx NE
transcription NE xxx NE
of NE xx NE
IRF-2 G#protein_molecule XXX-d G#protein_molecule
. NE . NE

Interferon G#protein_molecule_B Xxxx G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
selectively NE xxx NE
affects NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
human G#protein_molecule_B xxx G#protein_molecule_B
myeloid G#protein_molecule_M xxx G#protein_molecule_M
cell G#protein_molecule_M xxx G#protein_molecule_M
nuclear G#protein_molecule_M xxx G#protein_molecule_M
differentiation G#protein_molecule_M xxx G#protein_molecule_M
antigen G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
late G#cell_type_B xxx G#cell_type_B
stage G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
the NE xxx NE
monocytic NE xxx NE
but NE xxx NE
not NE xxx NE
the NE xxx NE
granulocytic NE xxx NE
lineage NE xxx NE
. NE . NE

The NE Xxx NE
human G#protein_molecule_B xxx G#protein_molecule_B
myeloid G#protein_molecule_M xxx G#protein_molecule_M
cell G#protein_molecule_M xxx G#protein_molecule_M
nuclear G#protein_molecule_M xxx G#protein_molecule_M
differentiation G#protein_molecule_M xxx G#protein_molecule_M
antigen G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
MNDA G#protein_molecule XXXX G#protein_molecule
) NE ) NE
is NE xx NE
expressed NE xxx NE
constitutively NE xxx NE
in NE xx NE
cells NE xxx NE
of NE xx NE
the NE xxx NE
myeloid G#cell_type_B xxx G#cell_type_B
lineage G#cell_type_E xxx G#cell_type_E
, NE , NE
appearing NE xxx NE
in NE xx NE
myeloblast G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
some NE xxx NE
cases NE xxx NE
of NE xx NE
acute G#other_name_B xxx G#other_name_B
myeloid G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
and NE xxx NE
consistently NE xxx NE
being NE xxx NE
detected NE xxx NE
in NE xx NE
promyelocyte G#cell_type_B xxx G#cell_type_B
stage G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
as NE xx NE
well NE xxx NE
as NE xx NE
in NE xx NE
all NE xxx NE
later G#cell_type_B xxx G#cell_type_B
stage G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
including NE xxx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
monocytes G#cell_type_E xxx G#cell_type_E
and NE xxx NE
granulocytes G#cell_type xxx G#cell_type
. NE . NE

The NE Xxx NE
human G#cell_line_B xxx G#cell_line_B
myeloid G#cell_line_M xxx G#cell_line_M
leukemia G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
, NE , NE
HL-60 G#cell_line XX-dd G#cell_line
, NE , NE
U937 G#cell_line Xddd G#cell_line
, NE , NE
and NE xxx NE
THP-1 G#cell_line XXX-d G#cell_line
, NE , NE
express NE xxx NE
similar NE xxx NE
levels NE xxx NE
of NE xx NE
immunochemically NE xxx NE
detectable NE xxx NE
MNDA G#protein_molecule XXXX G#protein_molecule
. NE . NE

Although NE Xxxx NE
, NE , NE
the NE xxx NE
level NE xxx NE
of NE xx NE
MNDA G#RNA_molecule_B XXXX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
in NE xx NE
primary G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
is NE xx NE
very NE xxx NE
low NE xxx NE
it NE xx NE
was NE xxx NE
up-regulated NE xx-xxx NE
at NE xx NE
6 NE d NE
h NE x NE
following NE xxx NE
the NE xxx NE
addition NE xxx NE
of NE xx NE
interferon G#protein_molecule_B xxx G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

The NE Xxx NE
effect NE xxx NE
of NE xx NE
interferon G#protein_molecule_B xxx G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
on NE xx NE
the NE xxx NE
MNDA G#RNA_molecule_B XXXX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
is NE xx NE
also NE xxx NE
observed NE xxx NE
in NE xx NE
the NE xxx NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
HL-60 G#cell_line XX-dd G#cell_line
, NE , NE
U937 G#cell_line Xddd G#cell_line
, NE , NE
and NE xxx NE
THP-1 G#cell_line XXX-d G#cell_line
. NE . NE

The NE Xxx NE
MNDA G#other_name_B XXXX G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
level G#other_name_E xxx G#other_name_E
in NE xx NE
primary G#cell_type_B xxx G#cell_type_B
granulocytes G#cell_type_E xxx G#cell_type_E
was NE xxx NE
unaffected NE xxx NE
by NE xx NE
addition NE xxx NE
of NE xx NE
interferon G#protein_molecule_B xxx G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
other NE xxx NE
agents NE xxx NE
including NE xxx NE
interferon G#protein_molecule_B xxx G#protein_molecule_B
gamma G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
endotoxin G#protein_family_or_group xxx G#protein_family_or_group
, NE , NE
poly G#protein_molecule_B xxx G#protein_molecule_B
(I).poly G#protein_molecule_M (X).xxx G#protein_molecule_M
(C) G#protein_molecule_E (X) G#protein_molecule_E
, NE , NE
and NE xxx NE
FMLP G#protein_molecule XXXX G#protein_molecule
. NE . NE

The NE Xxx NE
MNDA G#other_name_B XXXX G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
level G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
myeloid G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
was NE xxx NE
also NE xxx NE
unaffected NE xxx NE
by NE xx NE
the NE xxx NE
latter NE xxx NE
four NE xxx NE
agents NE xxx NE
. NE . NE

Induction NE Xxxx NE
of NE xx NE
differentiation NE xxx NE
in NE xx NE
the NE xxx NE
myeloid G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
with NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester G#other_organic_compound_E xxx G#other_organic_compound_E
induces NE xxx NE
monocyte NE xxx NE
differentiation NE xxx NE
which NE xxx NE
was NE xxx NE
accompanied NE xxx NE
by NE xx NE
a NE x NE
decrease NE xxx NE
in NE xx NE
MNDA G#other_name_B XXXX G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
level G#other_name_E xxx G#other_name_E
. NE . NE

This NE Xxxx NE
reduced NE xxx NE
level NE xxx NE
of NE xx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
could NE xxx NE
then NE xxx NE
be NE xx NE
elevated NE xxx NE
with NE xxx NE
subsequent NE xxx NE
interferon G#protein_molecule_B xxx G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
treatment NE xxx NE
. NE . NE

The NE Xxx NE
effects NE xxx NE
of NE xx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester G#other_organic_compound_E xxx G#other_organic_compound_E
on NE xx NE
MNDA G#RNA_molecule_B XXXX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
appeared NE xxx NE
to NE xx NE
be NE xx NE
associated NE xxx NE
with NE xxx NE
induced NE xxx NE
differentiation NE xxx NE
since NE xxx NE
inhibiting NE xxx NE
cell G#other_name_B xxx G#other_name_B
proliferation G#other_name_E xxx G#other_name_E
did NE xxx NE
not NE xxx NE
alter NE xxx NE
the NE xxx NE
level NE xxx NE
of NE xx NE
MNDA G#RNA_molecule_B XXXX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
and NE xxx NE
cell G#other_name_B xxx G#other_name_B
cycle G#other_name_M xxx G#other_name_M
variation G#other_name_E xxx G#other_name_E
in NE xx NE
MNDA G#other_name_B XXXX G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
levels G#other_name_E xxx G#other_name_E
were NE xxx NE
not NE xxx NE
observed NE xxx NE
. NE . NE

The NE Xxx NE
ability NE xxx NE
of NE xx NE
interferon G#protein_molecule_B xxx G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
to NE xx NE
up-regulate NE xx-xxx NE
MNDA G#RNA_molecule_B XXXX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
in NE xx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester G#other_organic_compound_E xxx G#other_organic_compound_E
treated NE xxx NE
myeloid G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
is NE xx NE
consistent NE xxx NE
with NE xxx NE
the NE xxx NE
observations NE xxx NE
made NE xxx NE
in NE xx NE
primary G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

(ABSTRACT NE (XXXXXXXX NE
TRUNCATED NE XXXXXXXXX NE
AT NE XX NE
250 NE ddd NE
WORDS) NE XXXXX) NE

Involvement NE Xxxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
YB-1 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
human G#other_name_B xxx G#other_name_B
T-cell G#other_name_M X-xxx G#other_name_M
lymphotropic G#other_name_M xxx G#other_name_M
virus G#other_name_M xxx G#other_name_M
type G#other_name_M xxx G#other_name_M
I G#other_name_M X G#other_name_M
basal G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

Sequences NE Xxxx NE
which NE xxx NE
control NE xxx NE
basal NE xxx NE
human NE xxx NE
T-cell G#virus_B X-xxx G#virus_B
lymphotropic G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
type G#virus_M xxx G#virus_M
I G#virus_E X G#virus_E
( NE ( NE
HTLV-I G#virus XXXX-X G#virus
) NE ) NE
transcription NE xxx NE
likely NE xxx NE
play NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
initiation NE xxx NE
and NE xxx NE
maintenance NE xxx NE
of NE xx NE
virus G#other_name_B xxx G#other_name_B
replication G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
previously NE xxx NE
identified NE xxx NE
and NE xxx NE
analyzed NE xxx NE
a NE x NE
45-nucleotide G#DNA_domain_or_region_B dd-xxx G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
downstream G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
regulatory G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
1 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
[ NE [ NE
DRE G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
1 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
]) NE ]) NE
, NE , NE
+195 G#DNA_domain_or_region_B +ddd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
+240 G#DNA_domain_or_region_E +ddd G#DNA_domain_or_region_E
, NE , NE
at NE xx NE
the NE xxx NE
boundary NE xxx NE
of NE xx NE
the NE xxx NE
R/U5 G#DNA_domain_or_region_B X/Xd G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
long G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
terminal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
repeat G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
which NE xxx NE
is NE xx NE
required NE xxx NE
for NE xxx NE
HTLV-I G#other_name_B XXXX-X G#other_name_B
basal G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
identified NE xxx NE
a NE x NE
protein NE xxx NE
, NE , NE
p37 NE xdd NE
, NE , NE
which NE xxx NE
specifically NE xxx NE
bound NE xxx NE
to NE xx NE
DRE G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
1 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
. NE . NE

An NE Xx NE
affinity NE xxx NE
column NE xxx NE
fraction NE xxx NE
, NE , NE
containing NE xxx NE
p37 G#protein_molecule xdd G#protein_molecule
, NE , NE
stimulated NE xxx NE
HTLV-I G#other_name_B XXXX-X G#other_name_B
transcription G#other_name_E xxx G#other_name_E
approximately NE xxx NE
12-fold NE dd-xxx NE
in NE xx NE
vitro NE xxx NE
. NE . NE

We NE Xx NE
now NE xxx NE
report NE xxx NE
the NE xxx NE
identification NE xxx NE
of NE xx NE
a NE x NE
cDNA G#DNA_molecule_B xXXX G#DNA_molecule_B
clone G#DNA_molecule_E xxx G#DNA_molecule_E
( NE ( NE
15B-7 G#DNA_molecule ddX-d G#DNA_molecule
) NE ) NE
, NE , NE
from NE xxx NE
a NE x NE
Jurkat G#DNA_family_or_group_B Xxxx G#DNA_family_or_group_B
expression G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
library G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
that NE xxx NE
binds NE xxx NE
specifically NE xxx NE
to NE xx NE
the NE xxx NE
DRE G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
1 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
regulatory G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Binding NE Xxxx NE
of NE xx NE
the NE xxx NE
cDNA G#protein_family_or_group_B xXXX G#protein_family_or_group_B
fusion G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
similarly NE xxx NE
to NE xx NE
the NE xxx NE
results NE xxx NE
obtained NE xxx NE
with NE xxx NE
purified NE xxx NE
Jurkat NE Xxxx NE
protein NE xxx NE
, NE , NE
was NE xxx NE
decreased NE xxx NE
by NE xx NE
introduction NE xxx NE
of NE xx NE
site-specific G#other_name_B xxx-xxx G#other_name_B
mutations G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
DRE G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
1 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
regulatory G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

In NE Xx NE
vitro NE xxx NE
transcription NE xxx NE
and NE xxx NE
translation NE xxx NE
of NE xx NE
15B-7 G#DNA_molecule_B ddX-d G#DNA_molecule_B
cDNA G#DNA_molecule_E xXXX G#DNA_molecule_E
produced NE xxx NE
a NE x NE
fusion G#protein_family_or_group_B xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
which NE xxx NE
bound NE xxx NE
specifically NE xxx NE
to NE xx NE
the NE xxx NE
HTLV-I G#polynucleotide_B XXXX-X G#polynucleotide_B
+195 G#polynucleotide_M +ddd G#polynucleotide_M
to G#polynucleotide_M xx G#polynucleotide_M
+240 G#polynucleotide_M +ddd G#polynucleotide_M
oligonucleotide G#polynucleotide_E xxx G#polynucleotide_E
. NE . NE

The NE Xxx NE
partial G#DNA_molecule_B xxx G#DNA_molecule_B
cDNA G#DNA_molecule_E xXXX G#DNA_molecule_E
encodes NE xxx NE
a NE x NE
protein NE xxx NE
which NE xxx NE
is NE xx NE
homologous NE xxx NE
to NE xx NE
the NE xxx NE
C-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
196 G#protein_domain_or_region_M ddd G#protein_domain_or_region_M
amino G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
acids G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
the NE xxx NE
36-kDa G#protein_molecule_B dd-xXx G#protein_molecule_B
transcription G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
YB-1 G#protein_molecule XX-d G#protein_molecule
. NE . NE

Cotransfection NE Xxxx NE
of NE xx NE
a NE x NE
YB-1 G#DNA_molecule_B XX-d G#DNA_molecule_B
expression G#DNA_molecule_M xxx G#DNA_molecule_M
plasmid G#DNA_molecule_E xxx G#DNA_molecule_E
increases NE xxx NE
HTLV-I G#other_name_B XXXX-X G#other_name_B
basal G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
approximately NE xxx NE
14-fold NE dd-xxx NE
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
lymphocytes G#cell_line_E xxx G#cell_line_E
. NE . NE

On NE Xx NE
the NE xxx NE
basis NE xxx NE
of NE xx NE
the NE xxx NE
molecular NE xxx NE
weight NE xxx NE
, NE , NE
DNA-binding NE XXX-xxx NE
characteristics NE xxx NE
, NE , NE
and NE xxx NE
in NE xx NE
vivo G#other_name_B xxx G#other_name_B
transactivation G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
previously NE xxx NE
identified NE xxx NE
DRE G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
1 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
-binding NE -xxx NE
protein NE xxx NE
, NE , NE
p37 G#protein_molecule xdd G#protein_molecule
, NE , NE
is NE xx NE
YB-1 G#protein_molecule XX-d G#protein_molecule
. NE . NE

Changes NE Xxxx NE
in NE xx NE
triiodothyronine NE xxx NE
( NE ( NE
T3 NE Xd NE
) NE ) NE
mononuclear NE xxx NE
leukocyte NE xxx NE
receptor NE xxx NE
kinetics NE xxx NE
after NE xxx NE
T3 NE Xd NE
administration NE xxx NE
and NE xxx NE
multiple NE xxx NE
cold-air NE xxx-xxx NE
exposures NE xxx NE
. NE . NE

Repeated NE Xxxx NE
cold-air G#other_name_B xxx-xxx G#other_name_B
exposures G#other_name_E xxx G#other_name_E
increase NE xxx NE
human NE xxx NE
triiodothyronine NE xxx NE
( NE ( NE
T3 NE Xd NE
) NE ) NE
plasma NE xxx NE
clearance NE xxx NE
rates NE xxx NE
. NE . NE

To NE Xx NE
study NE xxx NE
the NE xxx NE
response NE xxx NE
of NE xx NE
the NE xxx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
T3 G#protein_molecule_M Xd G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
NT3R G#protein_molecule XXdX G#protein_molecule
) NE ) NE
in NE xx NE
this NE xxx NE
condition NE xxx NE
, NE , NE
binding NE xxx NE
characteristics NE xxx NE
were NE xxx NE
analyzed NE xxx NE
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
mononuclear G#cell_type_M xxx G#cell_type_M
leukocytes G#cell_type_E xxx G#cell_type_E
( NE ( NE
MNL G#cell_type XXX G#cell_type
) NE ) NE
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
we NE xx NE
supplemented NE xxx NE
one NE xxx NE
group NE xxx NE
of NE xx NE
individuals NE xxx NE
with NE xxx NE
a NE x NE
daily NE xxx NE
oral NE xxx NE
replacement NE xxx NE
dose NE xxx NE
of NE xx NE
T3 G#amino_acid_monomer Xd G#amino_acid_monomer
to NE xx NE
isolate NE xxx NE
the NE xxx NE
influence NE xxx NE
of NE xx NE
serum G#other_name_B xxx G#other_name_B
thyroxine G#other_name_M xxx G#other_name_M
(T4) G#other_name_M (Xd) G#other_name_M
level G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
serum G#other_name_M xxx G#other_name_M
thyrotropin G#other_name_M xxx G#other_name_M
(TSH) G#other_name_M (XXX) G#other_name_M
level G#other_name_E xxx G#other_name_E

The NE Xxx NE
subjects NE xxx NE
were NE xxx NE
exposed NE xxx NE
to NE xx NE
cold NE xxx NE
air NE xxx NE
(4 NE (d NE
degrees NE xxx NE
C) NE X) NE
twice/d NE xxx/x NE
, NE , NE
30 NE dd NE
min/exposure NE xxx/xxx NE
, NE , NE
for NE xxx NE
a NE x NE
total NE xxx NE
of NE xx NE
80 NE dd NE
exposures NE xxx NE
. NE . NE

The NE Xxx NE
T3 G#amino_acid_monomer Xd G#amino_acid_monomer
-subjects NE -xxx NE
received NE xxx NE
placebo NE xxx NE
[n NE [x NE
= NE = NE
8] NE d] NE
and NE xxx NE
the NE xxx NE
T3 G#amino_acid_monomer Xd G#amino_acid_monomer
+ NE + NE
subjects NE xxx NE
received NE xxx NE
T3 G#amino_acid_monomer Xd G#amino_acid_monomer
(30 NE (dd NE
micrograms/d) NE xxx/x) NE
[n NE [x NE
= NE = NE
8] NE d] NE
in NE xx NE
a NE x NE
double-blind NE xxx-xxx NE
fashion NE xxx NE
. NE . NE

Mononuclear G#cell_type_B Xxxx G#cell_type_B
leukocytes G#cell_type_E xxx G#cell_type_E
were NE xxx NE
isolated NE xxx NE
from NE xxx NE
peripheral G#tissue_B xxx G#tissue_B
blood G#tissue_E xxx G#tissue_E
before NE xxx NE
the NE xxx NE
cold NE xxx NE
exposure NE xxx NE
and NE xxx NE
drug NE xxx NE
regimen NE xxx NE
began NE xxx NE
, NE , NE
and NE xxx NE
then NE xxx NE
after NE xxx NE
every NE xxx NE
20 NE dd NE
exposures NE xxx NE
. NE . NE

The NE Xxx NE
dissociation G#other_name_B xxx G#other_name_B
constant G#other_name_E xxx G#other_name_E
( NE ( NE
Kd G#other_name Xx G#other_name
) NE ) NE
and NE xxx NE
maximum G#other_name_B xxx G#other_name_B
binding G#other_name_M xxx G#other_name_M
capacity G#other_name_E xxx G#other_name_E
( NE ( NE
MBC G#other_name XXX G#other_name
) NE ) NE
of NE xx NE
the NE xxx NE
NT3R G#protein_molecule XXdX G#protein_molecule
values NE xxx NE
were NE xxx NE
log NE xxx NE
transformed NE xxx NE
to NE xx NE
minimize NE xxx NE
between-subject NE xxx-xxx NE
variability NE xxx NE
. NE . NE

In NE Xx NE
the NE xxx NE
T3 G#multi_cell Xd G#multi_cell
+ NE + NE
group NE xxx NE
, NE , NE
serum G#amino_acid_monomer_B xxx G#amino_acid_monomer_B
total G#amino_acid_monomer_M xxx G#amino_acid_monomer_M
thyroxine G#amino_acid_monomer_E xxx G#amino_acid_monomer_E
( NE ( NE
TT4 G#amino_acid_monomer XXd G#amino_acid_monomer
) NE ) NE
, NE , NE
free G#amino_acid_monomer_B xxx G#amino_acid_monomer_B
T4 G#amino_acid_monomer_E Xd G#amino_acid_monomer_E
( NE ( NE
FT4 G#amino_acid_monomer XXd G#amino_acid_monomer
) NE ) NE
, NE , NE
and NE xxx NE
TSH G#peptide XXX G#peptide
were NE xxx NE
approx NE xxx NE
50% NE dd% NE
lower NE xxx NE
than NE xxx NE
both NE xxx NE
basal-value G#other_name_B xxx-xxx G#other_name_B
and G#other_name_M xxx G#other_name_M
T3-value G#other_name_E Xd-xxx G#other_name_E

The NE Xxx NE
log10Kd G#other_name xxxddXx G#other_name
increased NE xxx NE
0.304 NE d.ddd NE
+/- NE +/- NE
0.139 NE d.ddd NE
(p NE (x NE
< NE < NE
0.04) NE d.dd) NE
and NE xxx NE
the NE xxx NE
log10MBC G#other_name xxxddXXX G#other_name
increased NE xxx NE
0.49 NE d.dd NE
+/- NE +/- NE
0.10 NE d.dd NE
(p NE (x NE
< NE < NE
0.001) NE d.ddd) NE
in NE xx NE
the NE xxx NE
T3 G#amino_acid_monomer Xd G#amino_acid_monomer
+ NE + NE
subjects NE xxx NE
compared NE xxx NE
to NE xx NE
baseline NE xxx NE
. NE . NE

This NE Xxxx NE
change NE xxx NE
in NE xx NE
MBC G#other_name XXX G#other_name
represents NE xxx NE
a NE x NE
311% NE ddd% NE
increase NE xxx NE
in NE xx NE
the NE xxx NE
MBC G#other_name XXX G#other_name
over NE xxx NE
baseline NE xxx NE
and NE xxx NE
a NE x NE
fivefold NE xxx NE
increase NE xxx NE
over NE xxx NE
placebo-treated G#multi_cell_B xxx-xxx G#multi_cell_B
subjects G#multi_cell_E xxx G#multi_cell_E
. NE . NE

The NE Xxx NE
T3 NE Xd NE
-group NE -xxx NE
showed NE xxx NE
no NE xx NE
change NE xxx NE
in NE xx NE
MBC NE XXX NE
over NE xxx NE
the NE xxx NE
study NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
describe NE xxx NE
for NE xxx NE
the NE xxx NE
first NE xxx NE
time NE xxx NE
the NE xxx NE
rapid NE xxx NE
modulation NE xxx NE
of NE xx NE
the NE xxx NE
NT3R G#protein_molecule XXdX G#protein_molecule
in NE xx NE
response NE xxx NE
to NE xx NE
the NE xxx NE
combined NE xxx NE
influence NE xxx NE
of NE xx NE
cold G#other_name_B xxx G#other_name_B
exposure G#other_name_E xxx G#other_name_E
and NE xxx NE
reduced NE xxx NE
circulating NE xxx NE
T4 G#amino_acid_monomer Xd G#amino_acid_monomer
and NE xxx NE
TSH G#peptide XXX G#peptide
. NE . NE

HIV-1 G#other_name_B XXX-d G#other_name_B
LTR G#other_name_M XXX G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_line_B xxx G#cell_line_B
CD40-activated G#cell_line_M XXdd-xxx G#cell_line_M
B G#cell_line_M X G#cell_line_M
lymphocytes G#cell_line_E xxx G#cell_line_E
is NE xx NE
dependent NE xxx NE
on NE xx NE
NF-kappaB G#protein_molecule XX-xxxX G#protein_molecule
. NE . NE

CD40-stimulated G#cell_line_B XXdd-xxx G#cell_line_B
human G#cell_line_M xxx G#cell_line_M
B G#cell_line_M X G#cell_line_M
lymphocytes G#cell_line_E xxx G#cell_line_E
are NE xxx NE
highly NE xxx NE
permissive NE xxx NE
to NE xx NE
a NE x NE
productive NE xxx NE
infection NE xxx NE
by NE xx NE
the NE xxx NE
human G#virus_B xxx G#virus_B
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
type G#virus_M xxx G#virus_M
1 G#virus_E d G#virus_E
. NE . NE

In NE Xx NE
these NE xxx NE
cells NE xxx NE
, NE , NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
involved NE xxx NE
in NE xx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
HIV-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
LTR G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
, NE , NE
which NE xxx NE
contains NE xxx NE
the NE xxx NE
transcriptional G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
control G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
of NE xx NE
the NE xxx NE
virus NE xxx NE
, NE , NE
are NE xxx NE
unknown NE xxx NE
. NE . NE

Transient NE Xxxx NE
expression NE xxx NE
assays NE xxx NE
with NE xxx NE
plasmids NE xxx NE
containing NE xxx NE
deleted NE xxx NE
parts NE xxx NE
of NE xx NE
the NE xxx NE
LTR G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
linked NE xxx NE
to NE xx NE
a NE x NE
reporter NE xxx NE
gene NE xxx NE
showed NE xxx NE
that NE xxx NE
the NE xxx NE
NF-kappaB G#DNA_domain_or_region_B XX-xxxX G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
essential NE xxx NE
for NE xxx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
LTR G#other_name_M XXX G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
CD40-stimulated G#cell_line_B XXdd-xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
lymphocytes G#cell_line_E xxx G#cell_line_E
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_E xxx G#other_name_E
and NE xxx NE
supershift G#other_name_B xxx G#other_name_B
assays G#other_name_E xxx G#other_name_E
revealed NE xxx NE
that NE xxx NE
important NE xxx NE
NF-kappaB G#other_name_B XX-xxxX G#other_name_B
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
composed NE xxx NE
of NE xx NE
at NE xx NE
least NE xxx NE
p50 G#protein_subunit xdd G#protein_subunit
, NE , NE
p65 G#protein_subunit xdd G#protein_subunit
, NE , NE
and NE xxx NE
c-Rel G#protein_subunit x-Xxx G#protein_subunit
NF-kappaB G#protein_subunit_B XX-xxxX G#protein_subunit_B
subunits G#protein_subunit_E xxx G#protein_subunit_E
was NE xxx NE
present NE xxx NE
in NE xx NE
nuclei NE xxx NE
of NE xx NE
CD40-stimulated NE XXdd-xxx NE
B NE X NE
cells NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
confirm NE xxx NE
at NE xx NE
a NE x NE
molecular NE xxx NE
level NE xxx NE
the NE xxx NE
ability NE xxx NE
of NE xx NE
HIV-1 G#virus XXX-d G#virus
to NE xx NE
replicate NE xxx NE
in NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
that NE xxx NE
this NE xxx NE
activity NE xxx NE
is NE xx NE
strongly NE xxx NE
associated NE xxx NE
with NE xxx NE
NF-kappaB G#protein_molecule XX-xxxX G#protein_molecule
. NE . NE

Sequence NE Xxxx NE
analysis NE xxx NE
and NE xxx NE
expression NE xxx NE
in NE xx NE
cultured G#cell_type_B xxx G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
of NE xx NE
the NE xxx NE
human NE xxx NE
FOSB G#DNA_domain_or_region_B XXXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
G0S3 G#DNA_domain_or_region XdXd G#DNA_domain_or_region
) NE ) NE
. NE . NE

G0S3 G#DNA_domain_or_region XdXd G#DNA_domain_or_region
is NE xx NE
a NE x NE
member NE xxx NE
of NE xx NE
a NE x NE
set NE xxx NE
of NE xx NE
putative G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
G0/G1 G#DNA_family_or_group_M Xd/Xd G#DNA_family_or_group_M
switch G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
regulatory G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
( NE ( NE
G0S G#DNA_family_or_group_B XdX G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
) NE ) NE
selected NE xxx NE
by NE xx NE
screening NE xxx NE
cDNA NE xXXX NE
libraries NE xxx NE
prepared NE xxx NE
from NE xxx NE
human NE xxx NE
blood NE xxx NE
mononuclear NE xxx NE
cells NE xxx NE
cultured NE xxx NE
for NE xxx NE
2 NE d NE
hr NE xx NE
with NE xxx NE
lectin NE xxx NE
and NE xxx NE
cycloheximide NE xxx NE
. NE . NE

The NE Xxx NE
sequence NE xxx NE
shows NE xxx NE
high NE xxx NE
homology NE xxx NE
with NE xxx NE
the NE xxx NE
murine G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
FOSB G#DNA_domain_or_region_M XXXX G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
which NE xxx NE
encodes NE xxx NE
a NE x NE
component NE xxx NE
of NE xx NE
the NE xxx NE
AP1 G#protein_family_or_group_B XXd G#protein_family_or_group_B
transcriptional G#protein_family_or_group_M xxx G#protein_family_or_group_M
regulator G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Comparison NE Xxxx NE
of NE xx NE
cDNA G#DNA_family_or_group xXXX G#DNA_family_or_group
and NE xxx NE
genomic G#DNA_N/A_B xxx G#DNA_N/A_B
sequences G#DNA_N/A_E xxx G#DNA_N/A_E
reveals NE xxx NE
a NE x NE
4-exon G#DNA_domain_or_region_B d-xxx G#DNA_domain_or_region_B
structure G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
characteristic NE xxx NE
of NE xx NE
the NE xxx NE
FOS G#DNA_family_or_group_B XXX G#DNA_family_or_group_B
family G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
of G#DNA_family_or_group_M xx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

Freshly NE Xxxx NE
isolated NE xxx NE
cells NE xxx NE
show NE xxx NE
high NE xxx NE
levels NE xxx NE
of NE xx NE
FOSB/G0S3 G#RNA_molecule_B XXXX/XdXd G#RNA_molecule_B
mRNA G#RNA_molecule_M xXXX G#RNA_molecule_M
and G#RNA_molecule_M xxx G#RNA_molecule_M
FOS/G0S7 G#RNA_molecule_M XXX/XdXd G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
culture NE xxx NE
medium NE xxx NE
. NE . NE

The NE Xxx NE
kinetics NE xxx NE
of NE xx NE
expression NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
high NE xxx NE
initial NE xxx NE
levels NE xxx NE
are NE xxx NE
caused NE xxx NE
by NE xx NE
the NE xxx NE
isolation NE xxx NE
procedure NE xxx NE
, NE , NE
and NE xxx NE
do NE xx NE
not NE xxx NE
reflect NE xxx NE
constitutive G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
cells NE xxx NE
preincubated NE xxx NE
for NE xxx NE
a NE x NE
day NE xxx NE
, NE , NE
levels NE xxx NE
of NE xx NE
FOS G#RNA_molecule_B XXX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
reach NE xxx NE
a NE x NE
maximum NE xxx NE
20 NE dd NE
min NE xxx NE
after NE xxx NE
the NE xxx NE
addition NE xxx NE
of NE xx NE
lectin G#protein_family_or_group xxx G#protein_family_or_group
and NE xxx NE
decline NE xxx NE
to NE xx NE
control NE xxx NE
levels NE xxx NE
over NE xxx NE
the NE xxx NE
next NE xxx NE
3 NE d NE
hr NE xx NE
. NE . NE

Levels NE Xxxx NE
of NE xx NE
FOSB G#RNA_molecule_B XXXX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
reach NE xxx NE
a NE x NE
maximum NE xxx NE
40 NE dd NE
min NE xxx NE
after NE xxx NE
the NE xxx NE
addition NE xxx NE
of NE xx NE
lectin G#protein_family_or_group xxx G#protein_family_or_group
and NE xxx NE
decline NE xxx NE
to NE xx NE
control NE xxx NE
levels NE xxx NE
over NE xxx NE
the NE xxx NE
next NE xxx NE
6 NE d NE
hr NE xx NE
. NE . NE

In NE Xx NE
freshly NE xxx NE
isolated NE xxx NE
cells NE xxx NE
, NE , NE
both NE xxx NE
FOS G#RNA_molecule_B XXX G#RNA_molecule_B
mRNA G#RNA_molecule_M xXXX G#RNA_molecule_M
and G#RNA_molecule_M xxx G#RNA_molecule_M
FOSB G#RNA_molecule_M XXXX G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
increase NE xxx NE
dramatically NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
the NE xxx NE
protein G#other_organic_compound_B xxx G#other_organic_compound_B
synthesis G#other_organic_compound_M xxx G#other_organic_compound_M
inhibitor G#other_organic_compound_E xxx G#other_organic_compound_E
cycloheximide NE xxx NE
. NE . NE

In NE Xx NE
preincubated NE xxx NE
cells NE xxx NE
, NE , NE
the NE xxx NE
cycloheximide G#other_organic_compound xxx G#other_organic_compound
response NE xxx NE
is NE xx NE
decreased NE xxx NE
, NE , NE
especially NE xxx NE
in NE xx NE
the NE xxx NE
case NE xxx NE
of NE xx NE
FOSB G#DNA_domain_or_region XXXX G#DNA_domain_or_region
. NE . NE

These NE Xxxx NE
differences NE xxx NE
in NE xx NE
expression NE xxx NE
of NE xx NE
FOS G#DNA_domain_or_region XXX G#DNA_domain_or_region
and NE xxx NE
FOSB G#DNA_domain_or_region XXXX G#DNA_domain_or_region
suggest NE xxx NE
different NE xxx NE
roles NE xxx NE
and NE xxx NE
regulation NE xxx NE
. NE . NE

Regions NE Xxxx NE
of NE xx NE
low NE xxx NE
base NE xxx NE
order-dependent G#other_name_B xxx-xxx G#other_name_B
stem-loop G#other_name_M xxx-xxx G#other_name_M
potential G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
region NE xxx NE
of NE xx NE
the NE xxx NE
gene NE xxx NE
are NE xxx NE
defined NE xxx NE
. NE . NE

These NE Xxxx NE
indicate NE xxx NE
where NE xxx NE
base NE xxx NE
order NE xxx NE
has NE xxx NE
been NE xxx NE
adapted NE xxx NE
for NE xxx NE
purposes NE xxx NE
other NE xxx NE
than NE xxx NE
stem-loop G#other_name_B xxx-xxx G#other_name_B
stability G#other_name_E xxx G#other_name_E
(e.g. NE (x.x. NE
, NE , NE
encoding NE xxx NE
proteins NE xxx NE
or NE xx NE
gene G#other_name_B xxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
) NE ) NE
. NE . NE

Regions NE Xxxx NE
of NE xx NE
low NE xxx NE
potential NE xxx NE
in NE xx NE
a NE x NE
68.5-kb NE dd.d-xx NE
genomic NE xxx NE
segment NE xxx NE
containing NE xxx NE
the NE xxx NE
FOSB G#DNA_domain_or_region_B XXXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
potential NE xxx NE
may NE xxx NE
help NE xxx NE
locate NE xxx NE
genes NE xxx NE
in NE xx NE
uncharted G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
DNA G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
sequences G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Susceptibility NE Xxxx NE
to NE xx NE
natural G#cell_type_B xxx G#cell_type_B
killer G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
down NE xxx NE
regulation NE xxx NE
of NE xx NE
MHC G#other_name_B XXX G#other_name_B
class G#other_name_M xxx G#other_name_M
I G#other_name_M X G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
adenovirus G#cell_line_B xxx G#cell_line_B
12 G#cell_line_M dd G#cell_line_M
transformed G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
are NE xxx NE
regulated NE xxx NE
by NE xx NE
different NE xxx NE
E1A G#DNA_domain_or_region_B XdX G#DNA_domain_or_region_B
domains G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

All NE Xxx NE
human NE xxx NE
adenoviruses NE xxx NE
transform NE xxx NE
rodent G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
vitro NE xxx NE
, NE , NE
but NE xxx NE
only NE xxx NE
cells NE xxx NE
transformed NE xxx NE
by NE xx NE
serotypes NE xxx NE
belonging NE xxx NE
to NE xx NE
subgroups NE xxx NE
subgroup G#virus_B xxx G#virus_B
A G#virus_M X G#virus_M
(Ad12) G#virus_M (Xxdd) G#virus_M
and G#virus_M xxx G#virus_M
subgroup G#virus_M xxx G#virus_M
B G#virus_M X G#virus_M
(Ad3) G#virus_E (Xxd) G#virus_E
are NE xxx NE
tumorigenic NE xxx NE
for NE xxx NE
immunocompetent G#multi_cell_B xxx G#multi_cell_B
animals G#multi_cell_E xxx G#multi_cell_E
. NE . NE

In NE Xx NE
these NE xxx NE
cells NE xxx NE
, NE , NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
MHC-class G#protein_family_or_group_B XXX-xxx G#protein_family_or_group_B
I G#protein_family_or_group_M X G#protein_family_or_group_M
antigens G#protein_family_or_group_E xxx G#protein_family_or_group_E
is NE xx NE
repressed NE xxx NE
and NE xxx NE
might NE xxx NE
allow NE xxx NE
them NE xxx NE
to NE xx NE
escape NE xxx NE
from NE xxx NE
recognition NE xxx NE
by NE xx NE
cytotoxic G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
( NE ( NE
CTL G#cell_type XXX G#cell_type
) NE ) NE
and NE xxx NE
to NE xx NE
develop NE xxx NE
in NE xx NE
tumor G#tissue xxx G#tissue
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
these NE xxx NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
appear NE xxx NE
resistant NE xxx NE
to NE xx NE
lysis NE xxx NE
by NE xx NE
natural G#cell_type_B xxx G#cell_type_B
killer G#cell_type_M xxx G#cell_type_M
(NK) G#cell_type_M (XX) G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

To NE Xx NE
determine NE xxx NE
the NE xxx NE
E1A G#DNA_domain_or_region_B XdX G#DNA_domain_or_region_B
domain G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
(s) NE (x) NE
responsible NE xxx NE
for NE xxx NE
these NE xxx NE
properties NE xxx NE
several NE xxx NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
were NE xxx NE
created NE xxx NE
by NE xx NE
transforming NE xxx NE
baby G#cell_line_B xxx G#cell_line_B
rat G#cell_line_M xxx G#cell_line_M
kidney G#cell_line_M xxx G#cell_line_M
(BRK) G#cell_line_M (XXX) G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
a NE x NE
set NE xxx NE
of NE xx NE
plasmids G#DNA_molecule xxx G#DNA_molecule
expressing NE xxx NE
different NE xxx NE
Ad2/Ad12 G#protein_family_or_group_B Xxd/Xxdd G#protein_family_or_group_B
hybrid G#protein_family_or_group_M xxx G#protein_family_or_group_M
E1A G#protein_family_or_group_M XdX G#protein_family_or_group_M
gene G#protein_family_or_group_M xxx G#protein_family_or_group_M
products G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

The NE Xxx NE
MHC G#other_name_B XXX G#other_name_B
class G#other_name_M xxx G#other_name_M
1 G#other_name_M d G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
was NE xxx NE
inhibited NE xxx NE
in NE xx NE
cells NE xxx NE
expressing NE xxx NE
the NE xxx NE
Ad12 G#protein_molecule_B Xxdd G#protein_molecule_B
13S G#protein_molecule_M ddX G#protein_molecule_M
mRNA G#protein_molecule_M xXXX G#protein_molecule_M
product G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
in NE xx NE
cells NE xxx NE
transformed NE xxx NE
with NE xxx NE
Ad2/Ad12 G#protein_molecule_B Xxd/Xxdd G#protein_molecule_B
hybrid G#protein_molecule_M xxx G#protein_molecule_M
E1A G#protein_molecule_M XdX G#protein_molecule_M
gene G#protein_molecule_M xxx G#protein_molecule_M
product G#protein_molecule_E xxx G#protein_molecule_E
harboring NE xxx NE
the NE xxx NE
C-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
part G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
the NE xxx NE
conserved G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
(CR) G#DNA_domain_or_region_M (XX) G#DNA_domain_or_region_M
3 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
of NE xx NE
Ad12 G#virus Xxdd G#virus
. NE . NE

Susceptibility NE Xxxx NE
of NE xx NE
these NE xxx NE
transformed NE xxx NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
to NE xx NE
NK G#cell_type_B XX G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
was NE xxx NE
determined NE xxx NE
by NE xx NE
cytolytic NE xxx NE
assays NE xxx NE
. NE . NE

The NE Xxx NE
results NE xxx NE
obtained NE xxx NE
suggest NE xxx NE
that NE xxx NE
two NE xxx NE
Ad12 G#DNA_domain_or_region_B Xxdd G#DNA_domain_or_region_B
E1A G#DNA_domain_or_region_M XdX G#DNA_domain_or_region_M
domains G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
are NE xxx NE
required NE xxx NE
to NE xx NE
induce NE xxx NE
resistance NE xxx NE
of NE xx NE
the NE xxx NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
to NE xx NE
NK G#cell_type_B XX G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Cell G#other_name_B Xxxx G#other_name_B
specific G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
of NE xx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
Bruton's G#DNA_domain_or_region_M Xxxx'x G#DNA_domain_or_region_M
agammaglobulinemia G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
tyrosine G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
kinase G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
Btk G#protein_molecule Xxx G#protein_molecule
) NE ) NE
is NE xx NE
regulated NE xxx NE
by NE xx NE
Sp1- G#protein_family_or_group Xxd- G#protein_family_or_group
and NE xxx NE
Spi-1/PU.1-family G#protein_family_or_group_B Xxx-d/XX.d-xxx G#protein_family_or_group_B
members G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Bruton's G#protein_molecule_B Xxxx'x G#protein_molecule_B
agammaglobulinemia G#protein_molecule_M xxx G#protein_molecule_M
tyrosine G#protein_molecule_M xxx G#protein_molecule_M
kinase G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
Btk G#protein_molecule Xxx G#protein_molecule
) NE ) NE
is NE xx NE
a NE x NE
cytoplasmic G#protein_family_or_group_B xxx G#protein_family_or_group_B
tyrosine G#protein_family_or_group_M xxx G#protein_family_or_group_M
kinase G#protein_family_or_group_E xxx G#protein_family_or_group_E
involved NE xxx NE
in NE xx NE
the NE xxx NE
human NE xxx NE
disease NE xxx NE
X-linked G#other_name_B X-xxx G#other_name_B
agammaglobulinemia G#other_name_E xxx G#other_name_E
( NE ( NE
XLA G#other_name XXX G#other_name
) NE ) NE
. NE . NE

The NE Xxx NE
gene NE xxx NE
is NE xx NE
expressed NE xxx NE
in NE xx NE
all NE xxx NE
hematopoietic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
with NE xxx NE
the NE xxx NE
exception NE xxx NE
of NE xx NE
T-cells G#cell_type X-xxx G#cell_type
and NE xxx NE
plasma G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

For NE Xxx NE
this NE xxx NE
expression NE xxx NE
pattern NE xxx NE
the NE xxx NE
first NE xxx NE
280 G#DNA_domain_or_region_B ddd G#DNA_domain_or_region_B
bp G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
upstream G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
major G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
transcriptional G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
start G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
seems NE xxx NE
to NE xx NE
be NE xx NE
sufficient NE xxx NE
. NE . NE

In G#other_name_B Xx G#other_name_B
vitro G#other_name_M xxx G#other_name_M
footprinting G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
within NE xxx NE
this NE xxx NE
part NE xxx NE
of NE xx NE
the NE xxx NE
promoter G#DNA_domain_or_region xxx G#DNA_domain_or_region
revealed NE xxx NE
two NE xxx NE
Sp1 G#DNA_domain_or_region_B Xxd G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
as NE xx NE
well NE xxx NE
as NE xx NE
a NE x NE
PU-box G#DNA_domain_or_region XX-xxx G#DNA_domain_or_region
. NE . NE

The NE Xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
Spi-1/PU.1 G#protein_molecule Xxx-d/XX.d G#protein_molecule
as NE xx NE
well NE xxx NE
as NE xx NE
the NE xxx NE
closely NE xxx NE
related NE xxx NE
factor NE xxx NE
Spi-B G#protein_molecule Xxx-X G#protein_molecule
bound NE xxx NE
to NE xx NE
the NE xxx NE
PU-box G#DNA_domain_or_region XX-xxx G#DNA_domain_or_region
in NE xx NE
B-cells NE X-xxx NE
. NE . NE

In NE Xx NE
the NE xxx NE
erythroleukemia G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
K562 G#cell_line_E Xddd G#cell_line_E
, NE , NE
due NE xxx NE
to NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
Spi-B G#protein_molecule Xxx-X G#protein_molecule
, NE , NE
only NE xxx NE
PU.1 G#protein_molecule XX.d G#protein_molecule
bound NE xxx NE
to NE xx NE
the NE xxx NE
Btk G#DNA_domain_or_region_B Xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Mutation NE Xxxx NE
of NE xx NE
either NE xxx NE
site NE xxx NE
reduced NE xxx NE
the NE xxx NE
expression NE xxx NE
in NE xx NE
transient NE xxx NE
transfection NE xxx NE
experiments NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
mutation NE xxx NE
of NE xx NE
the NE xxx NE
PU G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
box G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
had NE xxx NE
no NE xx NE
effect NE xxx NE
in NE xx NE
the NE xxx NE
T-cell G#cell_line_B X-xxx G#cell_line_B
line G#cell_line_M xxx G#cell_line_M
Jurkat G#cell_line_E Xxxx G#cell_line_E
, NE , NE
where NE xxx NE
none NE xxx NE
of NE xx NE
the NE xxx NE
Spi-1 G#protein_family_or_group_B Xxx-d G#protein_family_or_group_B
family G#protein_family_or_group_M xxx G#protein_family_or_group_M
members G#protein_family_or_group_E xxx G#protein_family_or_group_E
is NE xx NE
expressed NE xxx NE
. NE . NE

In NE Xx NE
addition NE xxx NE
Spi-B G#protein_molecule Xxx-X G#protein_molecule
as NE xx NE
well NE xxx NE
as NE xx NE
PU.1 G#protein_molecule XX.d G#protein_molecule
were NE xxx NE
able NE xxx NE
to NE xx NE
transactivate NE xxx NE
Btk G#other_name_B Xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
fetal G#body_part_B xxx G#body_part_B
liver G#body_part_E xxx G#body_part_E
of NE xx NE
PU.1-/- NE XX.d-/- NE
mice NE xxx NE
, NE , NE
which NE xxx NE
lack NE xxx NE
lymphoid G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
myeloid G#cell_type_M xxx G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E
Btk NE Xxx NE
was NE xxx NE
reduced NE xxx NE
two- NE xxx- NE
to NE xx NE
threefold NE xxx NE
but NE xxx NE
not NE xxx NE
abolished NE xxx NE
. NE . NE

Collectively NE Xxxx NE
this NE xxx NE
study NE xxx NE
shows NE xxx NE
that NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
Btk G#DNA_domain_or_region_B Xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
regulated NE xxx NE
by NE xx NE
the NE xxx NE
combined NE xxx NE
action NE xxx NE
of NE xx NE
Sp1-family G#protein_family_or_group_B Xxd-xxx G#protein_family_or_group_B
member G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
PU.1-family G#protein_family_or_group_M XX.d-xxx G#protein_family_or_group_M
member G#protein_family_or_group_E xxx G#protein_family_or_group_E

T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
response G#other_name_E xxx G#other_name_E
to NE xx NE
Epstein-Barr G#protein_family_or_group_B Xxxx-Xxxx G#protein_family_or_group_B
virus G#protein_family_or_group_M xxx G#protein_family_or_group_M
transactivators G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
chronic G#other_name_B xxx G#other_name_B
rheumatoid G#other_name_M xxx G#other_name_M
arthritis G#other_name_E xxx G#other_name_E
. NE . NE

Rheumatoid G#other_name_B Xxxx G#other_name_B
arthritis G#other_name_E xxx G#other_name_E
is NE xx NE
a NE x NE
multistep NE xxx NE
disorder NE xxx NE
associated NE xxx NE
with NE xxx NE
autoimmune G#other_name_B xxx G#other_name_B
features G#other_name_E xxx G#other_name_E
of NE xx NE
yet NE xxx NE
unknown NE xxx NE
etiology G#other_name xxx G#other_name
. NE . NE

Implication NE Xxxx NE
of NE xx NE
viruses NE xxx NE
such NE xxx NE
as NE xx NE
Epstein-Barr NE Xxxx-Xxxx NE
virus NE xxx NE
( NE ( NE
EBV NE XXX NE
) NE ) NE
in NE xx NE
rheumatoid NE xxx NE
arthritis NE xxx NE
pathogenesis NE xxx NE
has NE xxx NE
been NE xxx NE
suspected NE xxx NE
on NE xx NE
the NE xxx NE
basis NE xxx NE
of NE xx NE
several NE xxx NE
indirect NE xxx NE
observations NE xxx NE
, NE , NE
but NE xxx NE
thus NE xxx NE
far NE xxx NE
, NE , NE
a NE x NE
direct NE xxx NE
link NE xxx NE
between NE xxx NE
EBV NE XXX NE
and NE xxx NE
rheumatoid NE xxx NE
arthritis NE xxx NE
has NE xxx NE
not NE xxx NE
been NE xxx NE
provided NE xxx NE
. NE . NE

Here NE Xxxx NE
we NE xx NE
show NE xxx NE
that NE xxx NE
a NE x NE
large NE xxx NE
fraction NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
infiltrating NE xxx NE
affected NE xxx NE
joints NE xxx NE
from NE xxx NE
a NE x NE
patient G#multi_cell xxx G#multi_cell
with NE xxx NE
chronic G#other_name_B xxx G#other_name_B
rheumatoid G#other_name_M xxx G#other_name_M
arthritis G#other_name_E xxx G#other_name_E
recognizes NE xxx NE
two NE xxx NE
EBV G#protein_family_or_group_B XXX G#protein_family_or_group_B
transactivators G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
BZLF1 G#protein_molecule XXXXd G#protein_molecule
and NE xxx NE
BMLF1 G#protein_molecule XXXXd G#protein_molecule
) NE ) NE
in NE xx NE
a NE x NE
major NE xxx NE
histocompatibility NE xxx NE
complex NE xxx NE
-restricted NE -xxx NE
fashion NE xxx NE
. NE . NE

Responses NE Xxxx NE
to NE xx NE
these NE xxx NE
EBV G#protein_family_or_group_B XXX G#protein_family_or_group_B
antigens G#protein_family_or_group_E xxx G#protein_family_or_group_E
by NE xx NE
synovial NE xxx NE
lymphocytes NE xxx NE
from NE xxx NE
several NE xxx NE
other NE xxx NE
chronic G#other_name_B xxx G#other_name_B
rheumatoid G#other_name_M xxx G#other_name_M
arthritis G#other_name_E xxx G#other_name_E
patients G#multi_cell xxx G#multi_cell
were NE xxx NE
readily NE xxx NE
detectable NE xxx NE
. NE . NE

Thus NE Xxxx NE
these NE xxx NE
results NE xxx NE
suggest NE xxx NE
a NE x NE
direct NE xxx NE
contribution NE xxx NE
of NE xx NE
EBV G#virus XXX G#virus
to NE xx NE
chronic G#other_name_B xxx G#other_name_B
rheumatoid G#other_name_M xxx G#other_name_M
arthritis G#other_name_E xxx G#other_name_E
pathogenesis NE xxx NE
. NE . NE

They NE Xxxx NE
also NE xxx NE
demonstrate NE xxx NE
for NE xxx NE
the NE xxx NE
first NE xxx NE
time NE xxx NE
the NE xxx NE
occurrence NE xxx NE
of NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
responses G#other_name_E xxx G#other_name_E
against NE xxx NE
EBV G#protein_family_or_group_B XXX G#protein_family_or_group_B
transactivating G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
which NE xxx NE
might NE xxx NE
be NE xx NE
central NE xxx NE
in NE xx NE
the NE xxx NE
control NE xxx NE
of NE xx NE
virus G#other_name_B xxx G#other_name_B
reactivation G#other_name_E xxx G#other_name_E
. NE . NE

CD14 NE XXdd NE
-mediated NE -xxx NE
signal NE xxx NE
pathway NE xxx NE
of NE xx NE
Porphyromonas NE Xxxx NE
gingivalis NE xxx NE
lipopolysaccharide NE xxx NE
in NE xx NE
human NE xxx NE
gingival NE xxx NE
fibroblasts NE xxx NE
. NE . NE

Lipopolysaccharide G#lipid Xxxx G#lipid
( NE ( NE
LPS G#lipid XXX G#lipid
) NE ) NE
induces NE xxx NE
expression NE xxx NE
of NE xx NE
inflammatory G#protein_family_or_group_B xxx G#protein_family_or_group_B
cytokines G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
monocytes/macrophages G#cell_type xxx/xxx G#cell_type
via NE xxx NE
CD14 G#protein_molecule XXdd G#protein_molecule
, NE , NE
one NE xxx NE
of NE xx NE
the NE xxx NE
LPS G#protein_family_or_group_B XXX G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
which NE xxx NE
is NE xx NE
expressed NE xxx NE
predominantly NE xxx NE
in NE xx NE
these NE xxx NE
cells NE xxx NE
. NE . NE

It NE Xx NE
has NE xxx NE
been NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
Porphyromonas G#mono_cell_B Xxxx G#mono_cell_B
gingivalis G#mono_cell_E xxx G#mono_cell_E
LPS G#lipid XXX G#lipid
( NE ( NE
P- NE X- NE
LPS NE XXX NE
) NE ) NE
also NE xxx NE
is NE xx NE
able NE xxx NE
to NE xx NE
induce NE xxx NE
inflammatory NE xxx NE
cytokines NE xxx NE
in NE xx NE
human NE xxx NE
gingival NE xxx NE
fibroblasts NE xxx NE
. NE . NE

Therefore NE Xxxx NE
, NE , NE
it NE xx NE
is NE xx NE
important NE xxx NE
to NE xx NE
determine NE xxx NE
whether NE xxx NE
CD14 G#protein_molecule XXdd G#protein_molecule
is NE xx NE
expressed NE xxx NE
in NE xx NE
gingival G#cell_type_B xxx G#cell_type_B
fibroblasts G#cell_type_E xxx G#cell_type_E
and NE xxx NE
to NE xx NE
define NE xxx NE
the NE xxx NE
P- NE X- NE
LPS NE XXX NE
-mediated NE -xxx NE
signal-transducing NE xxx-xxx NE
mechanism NE xxx NE
in NE xx NE
the NE xxx NE
cells NE xxx NE
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
we NE xx NE
observed NE xxx NE
unexpectedly NE xxx NE
by NE xx NE
immunohistochemical, G#other_name_B xxx, G#other_name_B
Western G#other_name_M Xxxx G#other_name_M
blotting G#other_name_E xxx G#other_name_E
( NE ( NE
immunoblotting G#other_name xxx G#other_name
) NE ) NE
, NE , NE
and NE xxx NE
Northern G#other_name_B Xxxx G#other_name_B
(RNA) G#other_name_M (XXX) G#other_name_M
blotting G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
that NE xxx NE
CD14 G#protein_molecule XXdd G#protein_molecule
is NE xx NE
expressed NE xxx NE
at NE xx NE
high NE xxx NE
density NE xxx NE
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
gingival G#cell_type_M xxx G#cell_type_M
fibroblasts G#cell_type_E xxx G#cell_type_E
. NE . NE

P- NE X- NE
LPS NE XXX NE
-induced NE -xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
monocyte NE xxx NE
chemoattractant NE xxx NE
protein NE xxx NE
1 NE d NE
( NE ( NE
MCP-1 NE XXX-d NE
) NE ) NE
gene NE xxx NE
in NE xx NE
the NE xxx NE
cells NE xxx NE
was NE xxx NE
inhibited NE xxx NE
markedly NE xxx NE
by NE xx NE
treatment NE xxx NE
with NE xxx NE
anti-human NE xxx-xxx NE
CD14 NE XXdd NE
antibody NE xxx NE
and NE xxx NE
was NE xxx NE
completely NE xxx NE
inhibited NE xxx NE
by NE xx NE
herbimycin NE xxx NE
A NE X NE
, NE , NE
a NE x NE
potent NE xxx NE
inhibitor NE xxx NE
of NE xx NE
tyrosine NE xxx NE
kinase NE xxx NE
. NE . NE

The NE Xxx NE
inhibitor NE xxx NE
also NE xxx NE
dramatically NE xxx NE
inhibited NE xxx NE
monocyte NE xxx NE
chemotactic NE xxx NE
activity NE xxx NE
of NE xx NE
and NE xxx NE
MCP-1 G#other_name_B XXX-d G#other_name_B
production G#other_name_E xxx G#other_name_E
by NE xx NE
the NE xxx NE
cells NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
P- NE X- NE
LPS NE XXX NE
-induced NE -xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
MCP-1 NE XXX-d NE
gene NE xxx NE
in NE xx NE
the NE xxx NE
cells NE xxx NE
also NE xxx NE
was NE xxx NE
blocked NE xxx NE
by NE xx NE
inhibitors NE xxx NE
of NE xx NE
two NE xxx NE
transcription NE xxx NE
factors NE xxx NE
, NE , NE
i.e. NE x.x. NE
, NE , NE
curcumin NE xxx NE
, NE , NE
an NE xx NE
inhibitor NE xxx NE
of NE xx NE
AP-1 NE XX-d NE
, NE , NE
and NE xxx NE
pyrolidine NE xxx NE
dithiocarbamate NE xxx NE
, NE , NE
an NE xx NE
inhibitor NE xxx NE
of NE xx NE
NF-kappaB NE XX-xxxX NE
. NE . NE

Both NE Xxxx NE
inhibitors NE xxx NE
inhibited NE xxx NE
monocyte G#other_name_B xxx G#other_name_B
chemotactic G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
culture NE xxx NE
supernatant NE xxx NE
of NE xx NE
P- NE X- NE
LPS G#lipid XXX G#lipid
-treated NE -xxx NE
cells NE xxx NE
. NE . NE

Gel NE Xxx NE
shift NE xxx NE
mobility NE xxx NE
assay NE xxx NE
showed NE xxx NE
stimulation NE xxx NE
of NE xx NE
the NE xxx NE
AP-1 G#protein_family_or_group XX-d G#protein_family_or_group
and NE xxx NE
NF-kappaB G#protein_molecule XX-xxxX G#protein_molecule
contents NE xxx NE
in NE xx NE
P- NE X- NE
LPS G#lipid XXX G#lipid
-treated NE -xxx NE
cells NE xxx NE
. NE . NE

This NE Xxxx NE
study NE xxx NE
is NE xx NE
the NE xxx NE
first NE xxx NE
to NE xx NE
demonstrate NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
CD14 G#protein_molecule XXdd G#protein_molecule
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
gingival G#cell_type_M xxx G#cell_type_M
fibroblasts G#cell_type_E xxx G#cell_type_E
and NE xxx NE
to NE xx NE
show NE xxx NE
that NE xxx NE
the NE xxx NE
signal-transducing NE xxx-xxx NE
pathway NE xxx NE
of NE xx NE
P- NE X- NE
LPS G#lipid XXX G#lipid
in NE xx NE
the NE xxx NE
cells NE xxx NE
is NE xx NE
mediated NE xxx NE
by NE xx NE
CD14 G#protein_molecule XXdd G#protein_molecule
. NE . NE

rel G#protein_molecule xxx G#protein_molecule
Is NE Xx NE
rapidly NE xxx NE
tyrosine-phosphorylated NE xxx-xxx NE
following NE xxx NE
granulocyte-colony G#other_name_B xxx-xxx G#other_name_B
stimulating G#other_name_M xxx G#other_name_M
factor G#other_name_M xxx G#other_name_M
treatment G#other_name_E xxx G#other_name_E
of NE xx NE
human NE xxx NE
neutrophils NE xxx NE
. NE . NE

Stimulation NE Xxxx NE
of NE xx NE
neutrophils G#cell_type xxx G#cell_type
with NE xxx NE
granulocyte-colony G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
stimulating G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
G-CSF G#protein_family_or_group X-XXX G#protein_family_or_group
) NE ) NE
results NE xxx NE
in NE xx NE
an NE xx NE
enhanced G#other_name_B xxx G#other_name_B
respiratory G#other_name_M xxx G#other_name_M
burst G#other_name_E xxx G#other_name_E
, NE , NE
prolonged NE xxx NE
survival NE xxx NE
, NE , NE
and NE xxx NE
increased NE xxx NE
tumor G#other_name_B xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
killing G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
effects NE xxx NE
of NE xx NE
G-CSF G#protein_family_or_group X-XXX G#protein_family_or_group
are NE xxx NE
mediated NE xxx NE
by NE xx NE
binding NE xxx NE
to NE xx NE
specific NE xxx NE
, NE , NE
high NE xxx NE
affinity G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

G-CSF G#protein_family_or_group_B X-XXX G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
lack NE xxx NE
intrinsic NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
kinase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
, NE , NE
but NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
receptor NE xxx NE
results NE xxx NE
in NE xx NE
the NE xxx NE
rapid NE xxx NE
induction NE xxx NE
of NE xx NE
tyrosine G#other_name_B xxx G#other_name_B
kinase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
. NE . NE

Antiphosphotyrosine G#amino_acid_monomer Xxxx G#amino_acid_monomer
immunoblots NE xxx NE
of NE xx NE
whole NE xxx NE
cell NE xxx NE
lysates NE xxx NE
prepared NE xxx NE
from NE xxx NE
neutrophils G#cell_type xxx G#cell_type
show NE xxx NE
that NE xxx NE
the NE xxx NE
G-CSF G#protein_family_or_group X-XXX G#protein_family_or_group
rapidly NE xxx NE
induces NE xxx NE
prominent NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
a NE x NE
protein NE xxx NE
of NE xx NE
a NE x NE
relative NE xxx NE
molecular NE xxx NE
mass NE xxx NE
of NE xx NE
80 NE dd NE
kDa NE xXx NE
. NE . NE

Using NE Xxxx NE
monospecific NE xxx NE
antibodies NE xxx NE
, NE , NE
the NE xxx NE
80-kDa NE dd-xXx NE
tyrosine NE xxx NE
-phosphorylated NE -xxx NE
protein NE xxx NE
has NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
be NE xx NE
p80c-rel NE xddx-xxx NE
, NE , NE
a NE x NE
proto-oncogene NE xxx-xxx NE
belonging NE xxx NE
to NE xx NE
a NE x NE
family NE xxx NE
of NE xx NE
transcriptional NE xxx NE
regulators NE xxx NE
which NE xxx NE
include NE xxx NE
NF-kB NE XX-xX NE
. NE . NE

The NE Xxx NE
induction NE xxx NE
of NE xx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
p80c-rel G#protein_molecule xddx-xxx G#protein_molecule
was NE xxx NE
unique NE xxx NE
to NE xx NE
G-CSF G#protein_family_or_group X-XXX G#protein_family_or_group
in NE xx NE
that NE xxx NE
granulocyte-macrophage G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
colony G#protein_family_or_group_M xxx G#protein_family_or_group_M
stimulating G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
which NE xxx NE
also NE xxx NE
stimulates NE xxx NE
neutrophils G#cell_type xxx G#cell_type
and NE xxx NE
induces NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
does NE xxx NE
not NE xxx NE
result NE xxx NE
in NE xx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
p80c-rel G#protein_molecule xddx-xxx G#protein_molecule
. NE . NE

The NE Xxx NE
consequences NE xxx NE
of NE xx NE
p80c-rel G#protein_molecule xddx-xxx G#protein_molecule
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
are NE xxx NE
not NE xxx NE
yet NE xxx NE
known NE xxx NE
; NE ; NE
however NE xxx NE
, NE , NE
tyrosine G#amino_acid_monomer xxx G#amino_acid_monomer
-phosphorylated NE -xxx NE
p80c-rel G#protein_molecule xddx-xxx G#protein_molecule
is NE xx NE
capable NE xxx NE
of NE xx NE
binding NE xxx NE
to NE xx NE
DNA NE XXX NE
, NE , NE
and NE xxx NE
G-CSF G#other_name_B X-XXX G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
results NE xxx NE
in NE xx NE
an NE xx NE
increase NE xxx NE
in NE xx NE
the NE xxx NE
amount NE xxx NE
of NE xx NE
p80c-rel G#protein_molecule xddx-xxx G#protein_molecule
which NE xxx NE
binds NE xxx NE
to NE xx NE
DNA NE XXX NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
one NE xxx NE
of NE xx NE
the NE xxx NE
first NE xxx NE
biochemical G#other_name_B xxx G#other_name_B
events G#other_name_E xxx G#other_name_E
which NE xxx NE
occurs NE xxx NE
in NE xx NE
neutrophils G#cell_type xxx G#cell_type
following NE xxx NE
G-CSF G#other_name_B X-XXX G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
, NE , NE
activation NE xxx NE
of NE xx NE
a NE x NE
tyrosine G#protein_family_or_group_B xxx G#protein_family_or_group_B
kinase G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
leads NE xxx NE
directly NE xxx NE
to NE xx NE
the NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
p80c-rel G#protein_molecule xddx-xxx G#protein_molecule
. NE . NE

Thus NE Xxxx NE
, NE , NE
the NE xxx NE
tyrosine G#protein_family_or_group_B xxx G#protein_family_or_group_B
kinase G#protein_family_or_group_E xxx G#protein_family_or_group_E
activated NE xxx NE
by NE xx NE
G-CSF G#protein_family_or_group X-XXX G#protein_family_or_group
appears NE xxx NE
to NE xx NE
directly NE xxx NE
transduce NE xxx NE
a NE x NE
signal NE xxx NE
to NE xx NE
a NE x NE
protein NE xxx NE
which NE xxx NE
functions NE xxx NE
as NE xx NE
a NE x NE
transcriptional G#protein_family_or_group_B xxx G#protein_family_or_group_B
regulator G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Patterns NE Xxxx NE
of NE xx NE
Pan G#other_name_B Xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
role NE xxx NE
of NE xx NE
Pan G#protein_family_or_group_B Xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
endocrine NE xxx NE
cell NE xxx NE
type-specific G#other_name_B xxx-xxx G#other_name_B
complex G#other_name_M xxx G#other_name_M
formation G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
Pan G#DNA_domain_or_region_B Xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
encodes NE xxx NE
at NE xx NE
least NE xxx NE
two NE xxx NE
distinct NE xxx NE
transcripts NE xxx NE
, NE , NE
Pan-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
Pan-2 G#protein_molecule Xxx-d G#protein_molecule
(also NE (xxx NE
known NE xxx NE
as NE xx NE
E47 G#protein_molecule Xdd G#protein_molecule
and NE xxx NE
E12 G#protein_molecule Xdd G#protein_molecule
, NE , NE
respectively) NE xxx) NE
, NE , NE
by NE xx NE
the NE xxx NE
mechanism NE xxx NE
of NE xx NE
alternative NE xxx NE
RNA NE XXX NE
splicing NE xxx NE
. NE . NE

Northern NE Xxxx NE
blot NE xxx NE
analyses NE xxx NE
performed NE xxx NE
on NE xx NE
rat G#tissue_B xxx G#tissue_B
tissue G#tissue_M xxx G#tissue_M
and G#tissue_M xxx G#tissue_M
mouse G#tissue_M xxx G#tissue_M
tissue G#tissue_E xxx G#tissue_E
Pan NE Xxx NE
proteins NE xxx NE
have NE xxx NE
not NE xxx NE
been NE xxx NE
clearly NE xxx NE
defined NE xxx NE
. NE . NE

Studies NE Xxxx NE
of NE xx NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
representing NE xxx NE
endocrine G#cell_type_B xxx G#cell_type_B
lineage G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
fibroblast G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
lymphoid G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_E xxx G#cell_type_E
using NE xxx NE
polyclonal G#other_organic_compound_B xxx G#other_organic_compound_B
antisera G#other_organic_compound_E xxx G#other_organic_compound_E
to NE xx NE
detect NE xxx NE
E2A G#protein_family_or_group_B XdX G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
have NE xxx NE
suggested NE xxx NE
that NE xxx NE
significant NE xxx NE
E2A G#other_name_B XdX G#other_name_B
protein G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
is NE xx NE
restricted NE xxx NE
to NE xx NE
B-lymphocytes G#cell_type X-xxx G#cell_type
. NE . NE

We NE Xx NE
have NE xxx NE
developed NE xxx NE
a NE x NE
monoclonal G#protein_molecule_B xxx G#protein_molecule_B
antibody G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
Yae G#protein_molecule Xxx G#protein_molecule
, NE , NE
which NE xxx NE
is NE xx NE
specific NE xxx NE
for NE xxx NE
Pan/ G#protein_family_or_group Xxx/ G#protein_family_or_group
E2A NE XdX NE
proteins NE xxx NE
, NE , NE
and NE xxx NE
have NE xxx NE
used NE xxx NE
the NE xxx NE
Yae G#protein_molecule_B Xxx G#protein_molecule_B
antibody G#protein_molecule_E xxx G#protein_molecule_E
to NE xx NE
examine NE xxx NE
a NE x NE
variety NE xxx NE
of NE xx NE
endocrine G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
nonendocrine G#cell_type_M xxx G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_E xxx G#cell_type_E
E2A NE XdX NE
protein NE xxx NE
expression G#other_name xxx G#other_name
, NE , NE
subcellular NE xxx NE
localization NE xxx NE
, NE , NE
and NE xxx NE
heteromeric G#other_name_B xxx G#other_name_B
complex G#other_name_M xxx G#other_name_M
formation G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
contrast NE xxx NE
to NE xx NE
previous NE xxx NE
results NE xxx NE
obtained NE xxx NE
using NE xxx NE
polyclonal G#other_organic_compound_B xxx G#other_organic_compound_B
antiseras G#other_organic_compound_E xxx G#other_organic_compound_E
to NE xx NE
detect NE xxx NE
Pan NE Xxx NE
/ NE / NE
E2A G#protein_family_or_group_B XdX G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
we NE xx NE
report NE xxx NE
comparable NE xxx NE
levels NE xxx NE
of NE xx NE
Pan G#protein_family_or_group_B Xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
GH/PRL-producing G#cell_line_B XX/XXX-xxx G#cell_line_B
lymphocyte G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
insulin-producing G#cell_line_M xxx-xxx G#cell_line_M
lymphocyte G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
B-lymphocyte G#cell_line_M X-xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
T-lymphocyte G#cell_line_M X-xxx G#cell_line_M
cell G#cell_line_E xxx G#cell_line_E

IEF-1 G#protein_complex XXX-d G#protein_complex
, NE , NE
a NE x NE
pancreatic NE xxx NE
beta-cell NE xxx-xxx NE
type-specific NE xxx-xxx NE
complex NE xxx NE
believed NE xxx NE
to NE xx NE
regulate NE xxx NE
insulin G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
, NE , NE
is NE xx NE
demonstrated NE xxx NE
to NE xx NE
consist NE xxx NE
of NE xx NE
at NE xx NE
least NE xxx NE
two NE xxx NE
distinct NE xxx NE
species NE xxx NE
, NE , NE
one NE xxx NE
of NE xx NE
which NE xxx NE
does NE xxx NE
not NE xxx NE
contain NE xxx NE
Pan G#protein_family_or_group_B Xxx G#protein_family_or_group_B
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Although NE Xxxx NE
it NE xx NE
has NE xxx NE
been NE xxx NE
postulated NE xxx NE
that NE xxx NE
pituitary G#cell_type_B xxx G#cell_type_B
endocrine G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
pancreatic G#cell_type_B xxx G#cell_type_B
endocrine G#cell_type_M xxx G#cell_type_M
beta-cells G#cell_type_E xxx-xxx G#cell_type_E
share NE xxx NE
identical NE xxx NE
Pan/E2A NE Xxx/XdX NE
complexes NE xxx NE
, NE , NE
native-Western NE xxx-Xxxx NE
analyses NE xxx NE
of NE xx NE
pituitary NE xxx NE
and NE xxx NE
endocrine NE xxx NE
beta-cells NE xxx-xxx NE
detect NE xxx NE
Pan NE Xxx NE
proteins NE xxx NE
in NE xx NE
distinct NE xxx NE
cell NE xxx NE
type-specific NE xxx-xxx NE
complexes NE xxx NE
. NE . NE

Visualization NE Xxxx NE
of NE xx NE
the NE xxx NE
endogenous G#protein_subunit_B xxx G#protein_subunit_B
NF-kappa G#protein_subunit_M XX-xxx G#protein_subunit_M
B G#protein_subunit_M X G#protein_subunit_M
p50 G#protein_subunit_M xdd G#protein_subunit_M
subunit G#protein_subunit_E xxx G#protein_subunit_E
in NE xx NE
the NE xxx NE
nucleus G#cell_component xxx G#cell_component
of NE xx NE
follicular G#cell_type_B xxx G#cell_type_B
dendritic G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
germinal G#tissue_B xxx G#tissue_B
centers G#tissue_E xxx G#tissue_E
. NE . NE

NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
, NE , NE
a NE x NE
50 G#protein_complex_B dd G#protein_complex_B
kDa/65 G#protein_complex_M xXx/dd G#protein_complex_M
kDa G#protein_complex_M xXx G#protein_complex_M
(p50/p65) G#protein_complex_M (xdd/xdd) G#protein_complex_M
heterodimer G#protein_complex_E xxx G#protein_complex_E
, NE , NE
is NE xx NE
a NE x NE
ubiquitous G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
involved NE xxx NE
in NE xx NE
the NE xxx NE
positive NE xxx NE
regulation NE xxx NE
of NE xx NE
various NE xxx NE
immune G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

The NE Xxx NE
aim NE xxx NE
of NE xx NE
this NE xxx NE
study NE xxx NE
was NE xxx NE
to NE xx NE
determine NE xxx NE
whether NE xxx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
is NE xx NE
related NE xxx NE
to NE xx NE
a NE x NE
particular NE xxx NE
cell NE xxx NE
type NE xxx NE
and/or NE xxx/xx NE
differentiation NE xxx NE
step NE xxx NE
during NE xxx NE
immunopoiesis G#other_name xxx G#other_name
. NE . NE

Using NE Xxxx NE
in G#other_name_B xx G#other_name_B
situ G#other_name_M xxx G#other_name_M
hybridization G#other_name_E xxx G#other_name_E
on NE xx NE
sections NE xxx NE
from NE xxx NE
non NE xxx NE
HIV G#body_part_B XXX G#body_part_B
hyperplastic G#body_part_M xxx G#body_part_M
lymph G#body_part_M xxx G#body_part_M
nodes G#body_part_E xxx G#body_part_E
, NE , NE
we NE xx NE
found NE xxx NE
that NE xxx NE
the NE xxx NE
gene NE xxx NE
of NE xx NE
the NE xxx NE
105 G#protein_molecule_B ddd G#protein_molecule_B
kDa G#protein_molecule_M xXx G#protein_molecule_M
precursor G#protein_molecule_E xxx G#protein_molecule_E
of NE xx NE
p50 G#protein_molecule xdd G#protein_molecule
was NE xxx NE
overexpressed NE xxx NE
in NE xx NE
the NE xxx NE
light NE xxx NE
zone NE xxx NE
of NE xx NE
germinal G#tissue_B xxx G#tissue_B
centers G#tissue_E xxx G#tissue_E
, NE , NE
with NE xxx NE
a NE x NE
network NE xxx NE
aspect NE xxx NE
, NE , NE
which NE xxx NE
suggested NE xxx NE
the NE xxx NE
involvement NE xxx NE
of NE xx NE
follicular G#cell_type_B xxx G#cell_type_B
dendritic G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
FDC G#cell_type XXX G#cell_type
) NE ) NE
. NE . NE

By NE Xx NE
immunohistochemistry G#other_name xxx G#other_name
, NE , NE
p50 G#protein_molecule xdd G#protein_molecule
protein NE xxx NE
was NE xxx NE
detected NE xxx NE
in NE xx NE
the NE xxx NE
cytoplasm NE xxx NE
and NE xxx NE
nucleus G#cell_component xxx G#cell_component
of NE xx NE
FDC G#cell_type XXX G#cell_type
, NE , NE
confirming NE xxx NE
the NE xxx NE
involvement NE xxx NE
of NE xx NE
FDC G#cell_type XXX G#cell_type
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
p50 G#protein_molecule xdd G#protein_molecule
protein NE xxx NE
was NE xxx NE
detected NE xxx NE
in NE xx NE
the NE xxx NE
cytoplasm G#cell_component xxx G#cell_component
of NE xx NE
all NE xxx NE
lymphocytes G#cell_type xxx G#cell_type
. NE . NE

Thus NE Xxxx NE
, NE , NE
we NE xx NE
focused NE xxx NE
our NE xxx NE
study NE xxx NE
on NE xx NE
isolated NE xxx NE
FDC G#cell_type XXX G#cell_type
clusters NE xxx NE
from NE xxx NE
normal NE xxx NE
tonsils NE xxx NE
. NE . NE

As NE Xx NE
showed NE xxx NE
on NE xx NE
tissue G#tissue_B xxx G#tissue_B
sections G#tissue_E xxx G#tissue_E
, NE , NE
we NE xx NE
detected NE xxx NE
the NE xxx NE
p50 G#protein_molecule xdd G#protein_molecule
in NE xx NE
both NE xxx NE
cytoplasm G#cell_component xxx G#cell_component
and NE xxx NE
nucleus G#cell_component xxx G#cell_component
of NE xx NE
FDC G#cell_type XXX G#cell_type
. NE . NE

Nuclei NE Xxxx NE
of NE xx NE
lymphocytes G#cell_type xxx G#cell_type
from NE xxx NE
FDC G#cell_type XXX G#cell_type
clusters NE xxx NE
were NE xxx NE
negative NE xxx NE
. NE . NE

We NE Xx NE
next NE xxx NE
studied NE xxx NE
p65 G#other_name_B xdd G#other_name_B
protein G#other_name_M xxx G#other_name_M
expression G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
c-Rel G#other_name_M x-Xxx G#other_name_M
protein G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
FDC NE XXX NE
clusters NE xxx NE
. NE . NE

p65 G#protein_subunit xdd G#protein_subunit
was NE xxx NE
detected NE xxx NE
in NE xx NE
the NE xxx NE
cytoplasm G#cell_component xxx G#cell_component
of NE xx NE
FDC G#cell_type XXX G#cell_type
, NE , NE
whereas NE xxx NE
nuclei NE xxx NE
were NE xxx NE
negative NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
p65 G#protein_subunit xdd G#protein_subunit
was NE xxx NE
detected NE xxx NE
in NE xx NE
the NE xxx NE
nuclei NE xxx NE
of NE xx NE
some NE xxx NE
lymphocytes NE xxx NE
. NE . NE

c-Rel G#protein_family_or_group_B x-Xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
was NE xxx NE
detected NE xxx NE
only NE xxx NE
in NE xx NE
the NE xxx NE
cytoplasm G#cell_component xxx G#cell_component
of NE xx NE
lymphocytes G#cell_type xxx G#cell_type
and NE xxx NE
not NE xxx NE
in NE xx NE
the NE xxx NE
nucleus G#cell_component xxx G#cell_component
and NE xxx NE
cytoplasm G#cell_component xxx G#cell_component
of NE xx NE
FDC G#cell_type XXX G#cell_type
. NE . NE

Our NE Xxx NE
results NE xxx NE
indicated NE xxx NE
that NE xxx NE
, NE , NE
in NE xx NE
the NE xxx NE
context NE xxx NE
of NE xx NE
T G#other_name_B X G#other_name_B
cell-dependent G#other_name_M xxx-xxx G#other_name_M
B G#other_name_M X G#other_name_M
cell G#other_name_M xxx G#other_name_M
immunopoiesis G#other_name_E xxx G#other_name_E
occurring NE xxx NE
in NE xx NE
FDC G#cell_type XXX G#cell_type
clusters NE xxx NE
, NE , NE
p50 G#protein_molecule xdd G#protein_molecule
is NE xx NE
mainly NE xxx NE
related NE xxx NE
to NE xx NE
FDC G#cell_type XXX G#cell_type
with NE xxx NE
a NE x NE
massive NE xxx NE
overexpression G#other_name xxx G#other_name
in NE xx NE
the NE xxx NE
nuclei NE xxx NE
, NE , NE
whereas NE xxx NE
p65 NE xdd NE
is NE xx NE
expressed NE xxx NE
in NE xx NE
a NE x NE
scattered NE xxx NE
manner NE xxx NE
in NE xx NE
the NE xxx NE
nuclei NE xxx NE
of NE xx NE
lymphocytes NE xxx NE
and NE xxx NE
c-Rel NE x-Xxx NE
protein NE xxx NE
exclusively NE xxx NE
in NE xx NE
the NE xxx NE
cytoplasm NE xxx NE
of NE xx NE
lymphocytes NE xxx NE
from NE xxx NE
FDC NE XXX NE
clusters NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggested NE xxx NE
that NE xxx NE
the NE xxx NE
two NE xxx NE
subunits NE xxx NE
of NE xx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
and NE xxx NE
the NE xxx NE
c-Rel G#protein_family_or_group_B x-Xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
have NE xxx NE
different NE xxx NE
roles NE xxx NE
in NE xx NE
different NE xxx NE
cell NE xxx NE
types NE xxx NE
during NE xxx NE
B NE X NE
cell NE xxx NE
immunopoiesis G#other_name xxx G#other_name
. NE . NE

Cloning NE Xxxx NE
and NE xxx NE
characterization NE xxx NE
of NE xx NE
NF-ATc G#protein_molecule XX-XXx G#protein_molecule
and NE xxx NE
NF-ATp G#protein_molecule XX-XXx G#protein_molecule
: NE : NE
the NE xxx NE
cytoplasmic NE xxx NE
components NE xxx NE
of NE xx NE
NF-AT NE XX-XX NE
. NE . NE

Present NE Xxxx NE
evidence NE xxx NE
indicates NE xxx NE
a NE x NE
pathway NE xxx NE
of NE xx NE
signal G#other_name_B xxx G#other_name_B
transmission G#other_name_E xxx G#other_name_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
that NE xxx NE
is NE xx NE
outlined NE xxx NE
in NE xx NE
figure NE xxx NE
1 NE d NE
. NE . NE

The NE Xxx NE
elevation NE xxx NE
in NE xx NE
intracellular G#atom_B xxx G#atom_B
calcium G#atom_E xxx G#atom_E
that NE xxx NE
is NE xx NE
induced NE xxx NE
by NE xx NE
interactions NE xxx NE
at NE xx NE
the NE xxx NE
antigen G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
leads NE xxx NE
to NE xx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
calcium-dependent G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
phosphatase G#protein_family_or_group_E xxx G#protein_family_or_group_E
calcineurin G#protein_molecule xxx G#protein_molecule
. NE . NE

This NE Xxxx NE
in NE xx NE
turn NE xxx NE
leads NE xxx NE
to NE xx NE
the NE xxx NE
nuclear NE xxx NE
association NE xxx NE
of NE xx NE
the NE xxx NE
cytosolic G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
component G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
NF-ATc G#protein_molecule XX-XXx G#protein_molecule
. NE . NE

The NE Xxx NE
activation NE xxx NE
of NE xx NE
calcineurin G#protein_molecule xxx G#protein_molecule
and NE xxx NE
the NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
import G#other_name_E xxx G#other_name_E
of NE xx NE
NF-ATc G#protein_molecule XX-XXx G#protein_molecule
can NE xxx NE
both NE xxx NE
be NE xx NE
blocked NE xxx NE
by NE xx NE
cyclosporin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
or NE xx NE
FK506 G#other_organic_compound XXddd G#other_organic_compound
in NE xx NE
complex NE xxx NE
with NE xxx NE
their NE xxx NE
respective NE xxx NE
immunophilins G#protein_family_or_group xxx G#protein_family_or_group
. NE . NE

Once NE Xxxx NE
in NE xx NE
the NE xxx NE
nucleus G#cell_component xxx G#cell_component
, NE , NE
NF-ATc G#protein_molecule XX-XXx G#protein_molecule
interacts NE xxx NE
with NE xxx NE
NF-ATn G#protein_molecule XX-XXx G#protein_molecule
to NE xx NE
form NE xxx NE
an NE xx NE
active G#protein_complex_B xxx G#protein_complex_B
transcriptional G#protein_complex_M xxx G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
. NE . NE

NF-ATn G#protein_molecule XX-XXx G#protein_molecule
is NE xx NE
a NE x NE
ubiquitous NE xxx NE
protein NE xxx NE
, NE , NE
can NE xxx NE
be NE xx NE
synthesized NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
PMA G#other_organic_compound XXX G#other_organic_compound
, NE , NE
and NE xxx NE
has NE xxx NE
many NE xxx NE
similarities NE xxx NE
to NE xx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
. NE . NE

The NE Xxx NE
mechanism NE xxx NE
by NE xx NE
which NE xxx NE
NF-ATc G#protein_molecule XX-XXx G#protein_molecule
enters NE xxx NE
the NE xxx NE
nucleus G#cell_component xxx G#cell_component
is NE xx NE
unknown NE xxx NE
, NE , NE
and NE xxx NE
although NE xxx NE
it NE xx NE
appears NE xxx NE
to NE xx NE
require NE xxx NE
calcineurin G#protein_molecule xxx G#protein_molecule
, NE , NE
NF-ATc G#protein_molecule XX-XXx G#protein_molecule
has NE xxx NE
not NE xxx NE
yet NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
be NE xx NE
an NE xx NE
in NE xx NE
vivo NE xxx NE
substrate NE xxx NE
of NE xx NE
calcineurin G#protein_molecule xxx G#protein_molecule
. NE . NE

Alternative NE Xxxx NE
mechanisms NE xxx NE
include NE xxx NE
the NE xxx NE
possibility NE xxx NE
that NE xxx NE
NF-ATc G#protein_molecule XX-XXx G#protein_molecule
operates NE xxx NE
on NE xx NE
some NE xxx NE
cytoplasmic G#protein_family_or_group_B xxx G#protein_family_or_group_B
anchor G#protein_family_or_group_E xxx G#protein_family_or_group_E
or NE xx NE
that NE xxx NE
other NE xxx NE
proteins NE xxx NE
that NE xxx NE
are NE xxx NE
controlled NE xxx NE
by NE xx NE
calcineurin G#protein_molecule xxx G#protein_molecule
carry NE xxx NE
out NE xxx NE
the NE xxx NE
nuclear NE xxx NE
import NE xxx NE
of NE xx NE
NF-ATc G#protein_molecule XX-XXx G#protein_molecule
. NE . NE

Although NE Xxxx NE
NF-ATp G#protein_molecule XX-XXx G#protein_molecule
copurifies NE xxx NE
with NE xxx NE
NF-ATc G#protein_molecule XX-XXx G#protein_molecule
, NE , NE
there NE xxx NE
is NE xx NE
as NE xx NE
yet NE xxx NE
no NE xx NE
understanding NE xxx NE
of NE xx NE
how NE xxx NE
NF-ATp G#protein_molecule XX-XXx G#protein_molecule
is NE xx NE
functioning NE xxx NE
in NE xx NE
vivo NE xxx NE
. NE . NE

Now NE Xxx NE
that NE xxx NE
these NE xxx NE
proteins NE xxx NE
are NE xxx NE
purified NE xxx NE
and NE xxx NE
cloned NE xxx NE
, NE , NE
the NE xxx NE
major NE xxx NE
goals NE xxx NE
will NE xxx NE
be NE xx NE
to NE xx NE
understand NE xxx NE
their NE xxx NE
role NE xxx NE
and NE xxx NE
the NE xxx NE
roles NE xxx NE
of NE xx NE
other NE xxx NE
family NE xxx NE
members NE xxx NE
in NE xx NE
thymic G#other_name_B xxx G#other_name_B
development G#other_name_E xxx G#other_name_E
. NE . NE

Induction NE Xxxx NE
of NE xx NE
vascular G#protein_molecule_B xxx G#protein_molecule_B
cell G#protein_molecule_M xxx G#protein_molecule_M
adhesion G#protein_molecule_M xxx G#protein_molecule_M
molecule-1 G#protein_molecule_E xxx-d G#protein_molecule_E
by NE xx NE
low-density G#protein_molecule_B xxx-xxx G#protein_molecule_B
lipoprotein G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Low-density G#protein_molecule_B Xxx-xxx G#protein_molecule_B
lipoprotein G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
LDL G#protein_molecule XXX G#protein_molecule
) NE ) NE
is NE xx NE
a NE x NE
well-established NE xxx-xxx NE
risk NE xxx NE
factor NE xxx NE
for NE xxx NE
atherosclerosis G#other_name xxx G#other_name
. NE . NE

When NE Xxxx NE
endothelial NE xxx NE
cells NE xxx NE
are NE xxx NE
incubated NE xxx NE
with NE xxx NE
this NE xxx NE
lipoprotein NE xxx NE
in NE xx NE
pathophysiologic NE xxx NE
amounts NE xxx NE
, NE , NE
the NE xxx NE
cells NE xxx NE
are NE xxx NE
activated NE xxx NE
. NE . NE

Among NE Xxxx NE
the NE xxx NE
documented NE xxx NE
cellular NE xxx NE
responses NE xxx NE
to NE xx NE
LDL G#protein_molecule XXX G#protein_molecule
is NE xx NE
increased NE xxx NE
recruitment NE xxx NE
of NE xx NE
monocytes G#cell_type xxx G#cell_type
, NE , NE
which NE xxx NE
are NE xxx NE
believed NE xxx NE
to NE xx NE
play NE xxx NE
a NE x NE
major NE xxx NE
role NE xxx NE
in NE xx NE
promoting NE xxx NE
intimal NE xxx NE
plaque NE xxx NE
formation NE xxx NE
. NE . NE

The NE Xxx NE
findings NE xxx NE
presented NE xxx NE
here NE xxx NE
link NE xxx NE
an NE xx NE
atheogenic G#protein_family_or_group_B xxx G#protein_family_or_group_B
lipoprotein G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
LDL G#protein_molecule XXX G#protein_molecule
, NE , NE
with NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
an NE xx NE
adhesion NE xxx NE
molecule NE xxx NE
important NE xxx NE
in NE xx NE
atherogenesis NE xxx NE
Human NE Xxxx NE
LDL G#protein_molecule XXX G#protein_molecule
induces NE xxx NE
the NE xxx NE
vascular G#protein_molecule_B xxx G#protein_molecule_B
cell G#protein_molecule_M xxx G#protein_molecule_M
adhesion G#protein_molecule_M xxx G#protein_molecule_M
molecule-1 G#protein_molecule_E xxx-d G#protein_molecule_E
( NE ( NE
VCAM-1 G#protein_molecule XXXX-d G#protein_molecule
) NE ) NE
transcriptionally NE xxx NE
with NE xxx NE
an NE xx NE
increase NE xxx NE
in NE xx NE
mRNA G#other_name_B xXXX G#other_name_B
levels G#other_name_E xxx G#other_name_E
through NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
VCAM G#DNA_domain_or_region_B XXXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

This NE Xxxx NE
effect NE xxx NE
is NE xx NE
blocked NE xxx NE
by NE xx NE
anti-VCAM NE xxx-XXXX NE
antibodies NE xxx NE
. NE . NE

After NE Xxxx NE
a NE x NE
2-day NE d-xxx NE
incubation NE xxx NE
in NE xx NE
LDL G#protein_molecule XXX G#protein_molecule
, NE , NE
the NE xxx NE
binding NE xxx NE
of NE xx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
, NE , NE
which NE xxx NE
is NE xx NE
believed NE xxx NE
to NE xx NE
be NE xx NE
a NE x NE
key NE xxx NE
oxidative-stress NE xxx-xxx NE
sensor NE xxx NE
for NE xxx NE
VCAM G#other_name_B XXXX G#other_name_B
regulation G#other_name_E xxx G#other_name_E
, NE , NE
remains NE xxx NE
at NE xx NE
basal NE xxx NE
level NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
the NE xxx NE
binding NE xxx NE
activities NE xxx NE
of NE xx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
GATA G#protein_family_or_group XXXX G#protein_family_or_group
, NE , NE
on NE xx NE
the NE xxx NE
other NE xxx NE
hand NE xxx NE
, NE , NE
are NE xxx NE
increased NE xxx NE
by NE xx NE
LDL G#protein_molecule XXX G#protein_molecule
. NE . NE

Thus NE Xxxx NE
, NE , NE
a NE x NE
component NE xxx NE
of NE xx NE
LDL NE XXX NE
-enhanced NE -xxx NE
endothelial NE xxx NE
recruitment NE xxx NE
of NE xx NE
monocytes NE xxx NE
is NE xx NE
attributed NE xxx NE
to NE xx NE
VCAM-1 NE XXXX-d NE
expression NE xxx NE
, NE , NE
which NE xxx NE
appears NE xxx NE
to NE xx NE
be NE xx NE
mediated NE xxx NE
through NE xxx NE
AP-1 NE XX-d NE
and NE xxx NE
GATA NE XXXX NE
. NE . NE

These NE Xxxx NE
data NE xxx NE
identify NE xxx NE
LDL G#protein_molecule XXX G#protein_molecule
as NE xx NE
a NE x NE
VCAM NE XXXX NE
-inducer NE -xxx NE
possibly NE xxx NE
distinct NE xxx NE
from NE xxx NE
cytokines NE xxx NE
and NE xxx NE
endotoxin NE xxx NE
. NE . NE

Involvement NE Xxxx NE
of NE xx NE
nuclear G#other_name_B xxx G#other_name_B
factor-kappa G#other_name_M xxx-xxx G#other_name_M
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
in NE xx NE
IgE G#other_name_B XxX G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Nuclear G#protein_complex_B Xxxx G#protein_complex_B
factor-kappa G#protein_complex_M xxx-xxx G#protein_complex_M
B G#protein_complex_E X G#protein_complex_E
( NE ( NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
) NE ) NE
is NE xx NE
a NE x NE
transcription NE xxx NE
factor NE xxx NE
that NE xxx NE
binds NE xxx NE
to NE xx NE
the NE xxx NE
consensus G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
DNA G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
cis-acting G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
of NE xx NE
various G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

Although NE Xxxx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
activates NE xxx NE
the NE xxx NE
expression G#other_name xxx G#other_name
of NE xx NE
many NE xxx NE
genes NE xxx NE
involved NE xxx NE
in NE xx NE
immune G#other_name_B xxx G#other_name_B
response G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
inflammatory G#other_name_M xxx G#other_name_M
response G#other_name_E xxx G#other_name_E
activation NE xxx NE
in NE xx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
IgE NE XxX NE
synthesis NE xxx NE
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Therefore NE Xxxx NE
we NE xx NE
first NE xxx NE
examined NE xxx NE
the NE xxx NE
participation NE xxx NE
of NE xx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
in NE xx NE
germline G#other_name_B xxx G#other_name_B
C G#other_name_M X G#other_name_M
epsilon G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
in NE xx NE
a NE x NE
human G#cell_line_B xxx G#cell_line_B
Burkitt G#cell_line_M Xxxx G#cell_line_M
lymphoma G#cell_line_M xxx G#cell_line_M
B G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
DND39 G#cell_line XXXdd G#cell_line
. NE . NE

Stimulation NE Xxxx NE
of NE xx NE
DND39 G#cell_line_B XXXdd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
or NE xx NE
anti-CD40 G#protein_molecule_B xxx-XXdd G#protein_molecule_B
monoclonal G#protein_molecule_M xxx G#protein_molecule_M
antibody G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
mAb G#protein_family_or_group xXx G#protein_family_or_group
) NE ) NE
activated NE xxx NE
phosphatidylinositol G#protein_molecule_B xxx G#protein_molecule_B
3-kinase G#protein_molecule_E d-xxx G#protein_molecule_E
and NE xxx NE
subsequently NE xxx NE
induced NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
, NE , NE
which NE xxx NE
was NE xxx NE
identified NE xxx NE
by NE xx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
. NE . NE

n-Acetyl-L-cysteine G#amino_acid_monomer x-Xxxx-X-xxx G#amino_acid_monomer
( NE ( NE
NAC G#amino_acid_monomer XXX G#amino_acid_monomer
) NE ) NE
, NE , NE
a NE x NE
potent NE xxx NE
antioxidant NE xxx NE
, NE , NE
blocked NE xxx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
activation NE xxx NE
caused NE xxx NE
by NE xx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
by NE xx NE
anti-CD40 G#protein_molecule_B xxx-XXdd G#protein_molecule_B
mAb G#protein_molecule_E xXx G#protein_molecule_E
. NE . NE

Although NE Xxxx NE
inhibition NE xxx NE
of NE xx NE
IL-4 NE XX-d NE
-driven NE -xxx NE
germline NE xxx NE
C NE X NE
epsilon NE xxx NE
transcription NE xxx NE
by NE xx NE
NAC NE XXX NE
was NE xxx NE
not NE xxx NE
sufficient NE xxx NE
, NE , NE
the NE xxx NE
agent NE xxx NE
remarkably NE xxx NE
diminished NE xxx NE
anti-CD40 NE xxx-XXdd NE
mAb NE xXx NE
-mediated NE -xxx NE
up-regulation NE xx-xxx NE
of NE xx NE
germline NE xxx NE
C NE X NE
epsilon NE xxx NE
transcription NE xxx NE
. NE . NE

Second NE Xxxx NE
, NE , NE
we NE xx NE
studied NE xxx NE
the NE xxx NE
effect NE xxx NE
of NE xx NE
NAC G#amino_acid_monomer XXX G#amino_acid_monomer
on NE xx NE
IgE G#other_name_B XxX G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
in NE xx NE
human NE xxx NE
normal NE xxx NE
B NE X NE
cells NE xxx NE
costimulated NE xxx NE
with NE xxx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
anti-CD40 G#protein_molecule_B xxx-XXdd G#protein_molecule_B
mAb G#protein_molecule_E xXx G#protein_molecule_E
. NE . NE

NAC G#amino_acid_monomer XXX G#amino_acid_monomer
was NE xxx NE
effective NE xxx NE
in NE xx NE
inhibiting NE xxx NE
mature G#other_name_B xxx G#other_name_B
C G#other_name_M X G#other_name_M
epsilon G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
and NE xxx NE
IgE G#other_name_B XxX G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
T G#other_name_B X G#other_name_B
cell-independent G#other_name_M xxx-xxx G#other_name_M
culture G#other_name_M xxx G#other_name_M
system G#other_name_E xxx G#other_name_E
. NE . NE

However NE Xxxx NE
, NE , NE
NAC G#amino_acid_monomer XXX G#amino_acid_monomer
did NE xxx NE
not NE xxx NE
significantly NE xxx NE
affect NE xxx NE
the NE xxx NE
spontaneous NE xxx NE
production NE xxx NE
of NE xx NE
IgE G#protein_family_or_group XxX G#protein_family_or_group
by NE xx NE
atopic G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
activity NE xxx NE
is NE xx NE
commonly NE xxx NE
inducible NE xxx NE
in NE xx NE
DND39 G#cell_line_B XXXdd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
by NE xx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
anti-CD40 G#protein_molecule_B xxx-XXdd G#protein_molecule_B
mAb G#protein_molecule_E xXx G#protein_molecule_E
and NE xxx NE
suggest NE xxx NE
that NE xxx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
sensitive NE xxx NE
to NE xx NE
NAC G#amino_acid_monomer XXX G#amino_acid_monomer
may NE xxx NE
play NE xxx NE
a NE x NE
role NE xxx NE
in NE xx NE
regulating NE xxx NE
IgE G#other_name_B XxX G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
in NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Prostaglandin G#other_name_B Xxxx G#other_name_B
E2 G#other_name_M Xd G#other_name_M
induction G#other_name_E xxx G#other_name_E
of NE xx NE
binding NE xxx NE
activity NE xxx NE
to NE xx NE
CRE G#DNA_domain_or_region XXX G#DNA_domain_or_region
and NE xxx NE
AP-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
elements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

Prostaglandins G#lipid Xxxx G#lipid
of NE xx NE
the NE xxx NE
E NE X NE
series NE xxx NE
are NE xxx NE
immunomodulatory G#other_name_B xxx G#other_name_B
agents G#other_name_E xxx G#other_name_E
which NE xxx NE
exert NE xxx NE
inhibitory NE xxx NE
as NE xx NE
well NE xxx NE
as NE xx NE
stimulatory NE xxx NE
effects NE xxx NE
on NE xx NE
a NE x NE
variety NE xxx NE
of NE xx NE
immune G#other_name_B xxx G#other_name_B
responses G#other_name_E xxx G#other_name_E
. NE . NE

Since NE Xxxx NE
it NE xx NE
is NE xx NE
known NE xxx NE
that NE xxx NE
PGE2 G#lipid XXXd G#lipid
is NE xx NE
able NE xxx NE
to NE xx NE
increase NE xxx NE
cAMP G#other_name_B xXXX G#other_name_B
levels G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
investigated NE xxx NE
whether NE xxx NE
it NE xx NE
can NE xxx NE
affect NE xxx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
through NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
which NE xxx NE
bind NE xxx NE
enhancer NE xxx NE
elements NE xxx NE
in NE xx NE
the NE xxx NE
promoter NE xxx NE
regions NE xxx NE
of NE xx NE
cAMP NE xXXX NE
-regulated NE -xxx NE
genes NE xxx NE
. NE . NE

Using NE Xxxx NE
electrophoretic NE xxx NE
mobility NE xxx NE
shift NE xxx NE
assay NE xxx NE
, NE , NE
we NE xx NE
demonstrated NE xxx NE
that NE xxx NE
a NE x NE
short NE xxx NE
treatment NE xxx NE
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
with NE xxx NE
PGE2 G#lipid XXXd G#lipid
induces NE xxx NE
specific NE xxx NE
binding NE xxx NE
activity NE xxx NE
to NE xx NE
CRE G#DNA_domain_or_region XXX G#DNA_domain_or_region
and NE xxx NE
AP-2 NE XX-d NE
, NE , NE
but NE xxx NE
not NE xxx NE
AP-1 NE XX-d NE
, NE , NE
DNA NE XXX NE
elements NE xxx NE
. NE . NE

Since NE Xxxx NE
the NE xxx NE
okadaic G#other_organic_compound_B xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
a NE x NE
potent NE xxx NE
protein G#other_organic_compound_B xxx G#other_organic_compound_B
phosphatase G#other_organic_compound_M xxx G#other_organic_compound_M
inhibitor G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
prolongs NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
binding NE xxx NE
activity NE xxx NE
, NE , NE
phosphorylation G#other_name_B xxx G#other_name_B
events G#other_name_E xxx G#other_name_E
are NE xxx NE
likely NE xxx NE
to NE xx NE
occur NE xxx NE
. NE . NE

This NE Xxxx NE
activity NE xxx NE
seems NE xxx NE
to NE xx NE
be NE xx NE
due NE xxx NE
to NE xx NE
increased NE xxx NE
cAMP G#other_name_B xXXX G#other_name_B
levels G#other_name_E xxx G#other_name_E
because NE xxx NE
forskolin G#other_organic_compound xxx G#other_organic_compound
and NE xxx NE
IBMX G#other_organic_compound XXXX G#other_organic_compound
mimic NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
PGE2 G#lipid XXXd G#lipid
. NE . NE

More NE Xxxx NE
interestingly NE xxx NE
, NE , NE
transfection G#other_name_B xxx G#other_name_B
experiments G#other_name_E xxx G#other_name_E
with NE xxx NE
CRE NE XXX NE
-CAT NE -XXX NE
plasmide NE xxx NE
show NE xxx NE
that NE xxx NE
PGE2 NE XXXd NE
activates NE xxx NE
the NE xxx NE
transcription NE xxx NE
of NE xx NE
a NE x NE
CRE NE XXX NE
-containing NE -xxx NE
promoter NE xxx NE
. NE . NE

These NE Xxxx NE
data NE xxx NE
support NE xxx NE
the NE xxx NE
positive NE xxx NE
role NE xxx NE
for NE xxx NE
PGE2 G#lipid XXXd G#lipid
on NE xx NE
some NE xxx NE
immune G#other_name_B xxx G#other_name_B
functions G#other_name_E xxx G#other_name_E
. NE . NE

Nasal G#cell_type_B Xxxx G#cell_type_B
NK-cell G#cell_type_M XX-xxx G#cell_type_M
lymphoma G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
T-cell G#cell_type_M X-xxx G#cell_type_M
lymphoma G#cell_type_E xxx G#cell_type_E
share NE xxx NE
the NE xxx NE
same NE xxx NE
type NE xxx NE
of NE xx NE
Epstein-Barr G#other_name_B Xxxx-Xxxx G#other_name_B
virus G#other_name_M xxx G#other_name_M
latency G#other_name_E xxx G#other_name_E
as NE xx NE
nasopharyngeal G#tissue_B xxx G#tissue_B
carcinoma G#tissue_E xxx G#tissue_E
and NE xxx NE
Hodgkin's G#other_name_B Xxxx'x G#other_name_B
disease G#other_name_E xxx G#other_name_E
. NE . NE

Nasal G#cell_type_B Xxxx G#cell_type_B
T/NK-cell G#cell_type_M X/XX-xxx G#cell_type_M
lymphomas G#cell_type_E xxx G#cell_type_E
can NE xxx NE
be NE xx NE
further NE xxx NE
separated NE xxx NE
into NE xxx NE
those NE xxx NE
of NE xx NE
natural G#cell_type_B xxx G#cell_type_B
killer G#cell_type_M xxx G#cell_type_M
(NK) G#cell_type_M (XX) G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_E xxx G#cell_type_E
or NE xx NE
of NE xx NE
T-cell G#cell_type_B X-xxx G#cell_type_B
lineage G#cell_type_E xxx G#cell_type_E
, NE , NE
with NE xxx NE
differences NE xxx NE
in NE xx NE
cellular NE xxx NE
phenotype NE xxx NE
, NE , NE
T-cell G#other_name_B X-xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
(TcR) G#other_name_M (XxX) G#other_name_M
gene G#other_name_M xxx G#other_name_M
rearrangement G#other_name_E xxx G#other_name_E
and NE xxx NE
TcR NE XxX NE
transcript NE xxx NE
expression NE xxx NE
. NE . NE

Both NE Xxxx NE
NK-cell G#cell_type_B XX-xxx G#cell_type_B
subtype G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
T-cell G#cell_type_M X-xxx G#cell_type_M
subtype G#cell_type_E xxx G#cell_type_E
are NE xxx NE
closely NE xxx NE
associated NE xxx NE
with NE xxx NE
Epstein-Barr G#virus_B Xxxx-Xxxx G#virus_B
virus G#virus_E xxx G#virus_E
( NE ( NE
EBV G#virus XXX G#virus
) NE ) NE
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
EBV G#other_name_B XXX G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
was NE xxx NE
determined NE xxx NE
in NE xx NE
23 NE dd NE
cases NE xxx NE
of NE xx NE
nasal G#tissue_B xxx G#tissue_B
lymphoma G#tissue_E xxx G#tissue_E
( NE ( NE
NL G#tissue XX G#tissue
) NE ) NE
by NE xx NE
in G#other_name_B xx G#other_name_B
situ G#other_name_M xxx G#other_name_M
hybridisation G#other_name_E xxx G#other_name_E
( NE ( NE
ISH G#other_name XXX G#other_name
) NE ) NE
, NE , NE
reverse NE xxx NE
transcriptase NE xxx NE
-polymerase NE -xxx NE
chain NE xxx NE
reaction NE xxx NE
( NE ( NE
RT-PCR NE XX-XXX NE
) NE ) NE
and NE xxx NE
immunohistochemistry NE xxx NE
( NE ( NE
IH NE XX NE
) NE ) NE
. NE . NE

Of NE Xx NE
the NE xxx NE
23 NE dd NE
cases NE xxx NE
, NE , NE
19 NE dd NE
were NE xxx NE
classified NE xxx NE
as NE xx NE
NK-cell NE XX-xxx NE
and NE xxx NE
4 NE d NE
as NE xx NE
T-cell NE X-xxx NE
tumours NE xxx NE
. NE . NE

ISH G#other_name XXX G#other_name
for NE xxx NE
EBV NE XXX NE
-encoded NE -xxx NE
small NE xxx NE
non-polyadenylated NE xxx-xxx NE
RNAs NE XXXx NE
showed NE xxx NE
that NE xxx NE
all NE xxx NE
cases NE xxx NE
, NE , NE
whether NE xxx NE
NK NE XX NE
or NE xx NE
T NE X NE
, NE , NE
harboured NE xxx NE
EBV NE XXX NE
in NE xx NE
virtually NE xxx NE
all NE xxx NE
tumour NE xxx NE
cells NE xxx NE
. NE . NE

RT-PCR G#other_name XX-XXX G#other_name
demonstrated NE xxx NE
that NE xxx NE
NL G#cell_type XX G#cell_type
of NE xx NE
both NE xxx NE
subtypes NE xxx NE
expressed NE xxx NE
EBNAI G#protein_molecule XXXXX G#protein_molecule
of NE xx NE
the NE xxx NE
QUK G#other_name_B XXX G#other_name_B
splice G#other_name_M xxx G#other_name_M
pattern G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
latent G#protein_family_or_group_B xxx G#protein_family_or_group_B
membrane G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
LMP1 G#protein_molecule_B XXXd G#protein_molecule_B
and G#protein_molecule_M xxx G#protein_molecule_M
LMP2 G#protein_molecule_E XXXd G#protein_molecule_E
BamHI NE XxxXX NE
A NE X NE
rightward NE xxx NE
transcripts NE xxx NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
EBNA2 G#RNA_family_or_group_B XXXXd G#RNA_family_or_group_B
mRNAs G#RNA_family_or_group_E xXXXx G#RNA_family_or_group_E
, NE , NE
compatible NE xxx NE
with NE xxx NE
the NE xxx NE
latency G#other_name_B xxx G#other_name_B
type G#other_name_M xxx G#other_name_M
II G#other_name_M XX G#other_name_M
pattern G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
analysis NE xxx NE
of NE xx NE
EBV G#other_name_B XXX G#other_name_B
protein G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
by NE xx NE
IH G#other_name XX G#other_name
revealed NE xxx NE
a NE x NE
heterogeneous NE xxx NE
pattern NE xxx NE
of NE xx NE
EBV G#other_name_B XXX G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
at NE xx NE
the NE xxx NE
single-cell NE xxx-xxx NE
level NE xxx NE
consisting NE xxx NE
of NE xx NE
both NE xxx NE
LMP1+ G#cell_type_B XXXd+ G#cell_type_B
tumour G#cell_type_M xxx G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
LMP1- G#cell_type_M XXXd- G#cell_type_M
tumour G#cell_type_M xxx G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E

Although NE Xxxx NE
2 NE d NE
early G#protein_family_or_group_B xxx G#protein_family_or_group_B
lytic G#protein_family_or_group_M xxx G#protein_family_or_group_M
transcripts G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
BZLF1 G#protein_molecule XXXXd G#protein_molecule
and NE xxx NE
BHRF1 G#protein_molecule XXXXd G#protein_molecule
, NE , NE
were NE xxx NE
also NE xxx NE
detected NE xxx NE
in NE xx NE
13 NE dd NE
and NE xxx NE
10 NE dd NE
cases NE xxx NE
, NE , NE
respectively NE xxx NE
, NE , NE
the NE xxx NE
lack NE xxx NE
of NE xx NE
ZEBRA G#other_name_B XXXXX G#other_name_B
staining G#other_name_E xxx G#other_name_E
in NE xx NE
any NE xxx NE
case NE xxx NE
indicates NE xxx NE
that NE xxx NE
these NE xxx NE
lytic NE xxx NE
transcripts NE xxx NE
are NE xxx NE
most NE xxx NE
likely NE xxx NE
expressed NE xxx NE
by NE xx NE
rare NE xxx NE
cells NE xxx NE
in NE xx NE
the NE xxx NE
biopsies NE xxx NE
entering NE xxx NE
lytic NE xxx NE
cycle NE xxx NE
. NE . NE

The NE Xxx NE
viral G#other_name_B xxx G#other_name_B
transcriptional G#other_name_M xxx G#other_name_M
pattern G#other_name_E xxx G#other_name_E
similar NE xxx NE
to NE xx NE
that NE xxx NE
of NE xx NE
nasopharyngeal G#tissue_B xxx G#tissue_B
carcinoma G#tissue_E xxx G#tissue_E
and NE xxx NE
Hodgkin's G#other_name_B Xxxx'x G#other_name_B
disease G#other_name_E xxx G#other_name_E
suggests NE xxx NE
that NE xxx NE
EBV G#virus XXX G#virus
can NE xxx NE
exploit NE xxx NE
common G#other_name_B xxx G#other_name_B
regulatory G#other_name_M xxx G#other_name_M
mechanisms G#other_name_E xxx G#other_name_E
for NE xxx NE
gene G#other_name_B xxx G#other_name_B
transcription G#other_name_E xxx G#other_name_E
in NE xx NE
diverse NE xxx NE
host NE xxx NE
cell NE xxx NE
types NE xxx NE
. NE . NE

Down-regulation NE Xxxx-xxx NE
of NE xx NE
immunogenic G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
EBNA2-EBNA6 G#protein_family_or_group XXXXd-XXXXd G#protein_family_or_group
) NE ) NE
in NE xx NE
nasal NE xxx NE
lymphoma NE xxx NE
may NE xxx NE
enable NE xxx NE
tumour G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
to NE xx NE
evade NE xxx NE
host NE xxx NE
cytotoxic G#other_name_B xxx G#other_name_B
T-cell G#other_name_M X-xxx G#other_name_M
surveillance G#other_name_E xxx G#other_name_E
. NE . NE

Potent NE Xxxx NE
gene NE xxx NE
regulatory NE xxx NE
and NE xxx NE
antiproliferative NE xxx NE
activities NE xxx NE
of NE xx NE
20-methyl NE dd-xxx NE
analogues NE xxx NE
of NE xx NE
1,25 NE d,dd NE
dihydroxyvitamin NE xxx NE
D3 NE Xd NE
. NE . NE

The NE Xxx NE
biological NE xxx NE
active NE xxx NE
form NE xxx NE
of NE xx NE
vitamin G#lipid_B xxx G#lipid_B
D3 G#lipid_E Xd G#lipid_E
, NE , NE
1,25-dihydroxyvitamin G#lipid_B d,dd-xxx G#lipid_B
D3 G#lipid_E Xd G#lipid_E
( NE ( NE
VD G#lipid XX G#lipid
) NE ) NE
, NE , NE
regulates NE xxx NE
cellular G#other_name_B xxx G#other_name_B
growth G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

This NE Xxxx NE
provides NE xxx NE
the NE xxx NE
hormone NE xxx NE
with NE xxx NE
an NE xx NE
interesting NE xxx NE
therapeutic NE xxx NE
potential NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
hypercalcemia G#other_name xxx G#other_name
is NE xx NE
a NE x NE
side NE xxx NE
effect NE xxx NE
, NE , NE
which NE xxx NE
is NE xx NE
caused NE xxx NE
by NE xx NE
VD G#lipid XX G#lipid
's NE 'x NE
classical NE xxx NE
action NE xxx NE
, NE , NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
calcium G#other_name_B xxx G#other_name_B
homeostasis G#other_name_E xxx G#other_name_E
. NE . NE

This NE Xxxx NE
made NE xxx NE
the NE xxx NE
need NE xxx NE
for NE xxx NE
VD G#lipid XX G#lipid
analogues NE xxx NE
with NE xxx NE
selectively NE xxx NE
increased NE xxx NE
cell NE xxx NE
regulatory NE xxx NE
properties NE xxx NE
. NE . NE

Studies NE Xxxx NE
with NE xxx NE
20-epi G#other_organic_compound_B dd-xxx G#other_organic_compound_B
analogues G#other_organic_compound_E xxx G#other_organic_compound_E
pointed NE xxx NE
out NE xxx NE
the NE xxx NE
importance NE xxx NE
of NE xx NE
the NE xxx NE
carbon-20 NE xxx-dd NE
position NE xxx NE
and NE xxx NE
led NE xxx NE
to NE xx NE
the NE xxx NE
development NE xxx NE
of NE xx NE
20-methyl G#other_organic_compound_B dd-xxx G#other_organic_compound_B
derivatives G#other_organic_compound_E xxx G#other_organic_compound_E
of NE xx NE
VD G#lipid XX G#lipid
. NE . NE

In NE Xx NE
this NE xxx NE
report NE xxx NE
the NE xxx NE
biological NE xxx NE
properties NE xxx NE
of NE xx NE
the NE xxx NE
compounds NE xxx NE
ZK161422 G#other_organic_compound XXdddddd G#other_organic_compound
and NE xxx NE
ZK157202 G#other_organic_compound XXdddddd G#other_organic_compound
, NE , NE
which NE xxx NE
are NE xxx NE
20-methyl-eneanalogue G#other_organic_compound_B dd-xxx-xxx G#other_organic_compound_B
and G#other_organic_compound_M xxx G#other_organic_compound_M
20-methyl-23-eneanalogue G#other_organic_compound_E dd-xxx-dd-xxx G#other_organic_compound_E
VD NE XX NE
. NE . NE

Both NE Xxxx NE
compounds NE xxx NE
show NE xxx NE
about NE xxx NE
2-fold NE d-xxx NE
lower NE xxx NE
affinity NE xxx NE
to NE xx NE
the NE xxx NE
VD G#lipid XX G#lipid
receptor NE xxx NE
(VDR) NE (XXX) NE
than NE xxx NE
VD G#lipid XX G#lipid
. NE . NE

However NE Xxxx NE
, NE , NE
compared NE xxx NE
to NE xx NE
VD G#lipid XX G#lipid
, NE , NE
their NE xxx NE
antiproliferative NE xxx NE
effect NE xxx NE
is NE xx NE
up NE xx NE
to NE xx NE
30-fold NE dd-xxx NE
higher NE xxx NE
on NE xx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
even NE xxx NE
up NE xx NE
to NE xx NE
300-fold NE ddd-xxx NE
higher NE xxx NE
on NE xx NE
human G#cell_line_B xxx G#cell_line_B
breast G#cell_line_M xxx G#cell_line_M
cancer G#cell_line_M xxx G#cell_line_M
MCF-7 G#cell_line_M XXX-d G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Whereas NE Xxxx NE
the NE xxx NE
hypercalcemic NE xxx NE
effect NE xxx NE
for NE xxx NE
ZK157202 G#other_organic_compound XXdddddd G#other_organic_compound
is NE xx NE
also NE xxx NE
increased NE xxx NE
10-fold NE dd-xxx NE
, NE , NE
ZK161422 G#other_organic_compound XXdddddd G#other_organic_compound
has NE xxx NE
the NE xxx NE
same NE xxx NE
calcium NE xxx NE
-mobilizing NE -xxx NE
potency NE xxx NE
as NE xx NE
VD NE XX NE
. NE . NE

Moreover NE Xxxx NE
, NE , NE
ZK161422 G#other_organic_compound XXdddddd G#other_organic_compound
, NE , NE
but NE xxx NE
not NE xxx NE
ZK157202 G#other_organic_compound XXdddddd G#other_organic_compound
, NE , NE
showed NE xxx NE
preference NE xxx NE
for NE xxx NE
gene NE xxx NE
activation NE xxx NE
from NE xxx NE
a NE x NE
promoter G#DNA_domain_or_region xxx G#DNA_domain_or_region
carrying NE xxx NE
a NE x NE
VD G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
response G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
with NE xxx NE
a NE x NE
palindromic G#DNA_substructure_B xxx G#DNA_substructure_B
arrangement G#DNA_substructure_E xxx G#DNA_substructure_E
of NE xx NE
two NE xxx NE
hexameric G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
spaced NE xxx NE
by NE xx NE
9 G#polynucleotide_B d G#polynucleotide_B
nucleotides G#polynucleotide_E xxx G#polynucleotide_E
( NE ( NE
IP9 G#polynucleotide XXd G#polynucleotide
) NE ) NE
rather NE xxx NE
than NE xxx NE
for NE xxx NE
activation NE xxx NE
from NE xxx NE
a NE x NE
response G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
formed NE xxx NE
by NE xx NE
a NE x NE
direct NE xxx NE
repeat NE xxx NE
spaced NE xxx NE
by NE xx NE
3 G#polynucleotide_B d G#polynucleotide_B
nucleotides G#polynucleotide_E xxx G#polynucleotide_E
( NE ( NE
DR3 G#polynucleotide XXd G#polynucleotide
) NE ) NE
. NE . NE

This NE Xxxx NE
observation NE xxx NE
supports NE xxx NE
a NE x NE
model NE xxx NE
, NE , NE
in NE xx NE
which NE xxx NE
promoter G#other_name_B xxx G#other_name_B
selectivity G#other_name_E xxx G#other_name_E
reflects NE xxx NE
the NE xxx NE
selectively NE xxx NE
increased NE xxx NE
antiproliferative G#other_name_B xxx G#other_name_B
effect G#other_name_E xxx G#other_name_E
of NE xx NE
VD G#other_organic_compound_B XX G#other_organic_compound_B
analogues G#other_organic_compound_E xxx G#other_organic_compound_E
. NE . NE

Calcium NE Xxxx NE
-dependent NE -xxx NE
immediate-early NE xxx-xxx NE
gene NE xxx NE
induction NE xxx NE
in NE xx NE
lymphocytes NE xxx NE
is NE xx NE
negatively NE xxx NE
regulated NE xxx NE
by NE xx NE
p21Ha-ras NE xddXx-xxx NE
. NE . NE

The NE Xxx NE
induction NE xxx NE
of NE xx NE
immediate-early G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
(IE) G#DNA_family_or_group_M (XX) G#DNA_family_or_group_M
response G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
such NE xxx NE
as NE xx NE
egr-1 G#DNA_domain_or_region xxx-d G#DNA_domain_or_region
, NE , NE
c-fos G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
, NE , NE
and NE xxx NE
c-jun G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
, NE , NE
occurs NE xxx NE
rapidly NE xxx NE
after NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
process NE xxx NE
of NE xx NE
activation NE xxx NE
involves NE xxx NE
calcium G#other_name_B xxx G#other_name_B
mobilization G#other_name_E xxx G#other_name_E
, NE , NE
activation NE xxx NE
of NE xx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
PKC G#protein_molecule XXX G#protein_molecule
) NE ) NE
, NE , NE
and NE xxx NE
phosphorylation NE xxx NE
of NE xx NE
tyrosine G#protein_family_or_group_B xxx G#protein_family_or_group_B
kinases G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

p21(ras) G#protein_molecule xdd(xxx) G#protein_molecule
, NE , NE
a NE x NE
guanine G#protein_family_or_group_B xxx G#protein_family_or_group_B
nucleotide G#protein_family_or_group_M xxx G#protein_family_or_group_M
binding G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
mediates NE xxx NE
T-cell G#other_name_B X-xxx G#other_name_B
signal G#other_name_M xxx G#other_name_M
transduction G#other_name_E xxx G#other_name_E
through NE xxx NE
PKC NE XXX NE
-dependent NE -xxx NE
and NE xxx NE
PKC NE XXX NE
-independent NE -xxx NE
pathways NE xxx NE
. NE . NE

The NE Xxx NE
involvement NE xxx NE
of NE xx NE
p21(ras) G#protein_molecule xdd(xxx) G#protein_molecule
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
calcium NE xxx NE
-dependent NE -xxx NE
signals NE xxx NE
has NE xxx NE
been NE xxx NE
suggested NE xxx NE
through NE xxx NE
analysis NE xxx NE
of NE xx NE
its NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
NF-AT NE XX-XX NE
. NE . NE

We NE Xx NE
have NE xxx NE
investigated NE xxx NE
the NE xxx NE
inductions NE xxx NE
of NE xx NE
the NE xxx NE
IE G#DNA_family_or_group_B XX G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
in NE xx NE
response NE xxx NE
to NE xx NE
calcium G#atom xxx G#atom
signals NE xxx NE
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
(in NE (xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
activated NE xxx NE
p21(ras) G#protein_molecule xdd(xxx) G#protein_molecule
) NE ) NE
and NE xxx NE
their NE xxx NE
correlated NE xxx NE
consequences NE xxx NE
. NE . NE

The NE Xxx NE
expression NE xxx NE
of NE xx NE
activated NE xxx NE
p21(ras) G#protein_molecule xdd(xxx) G#protein_molecule
negatively NE xxx NE
regulated NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
IE G#DNA_family_or_group_B XX G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
by NE xx NE
calcium G#atom xxx G#atom
ionophore NE xxx NE
. NE . NE

This NE Xxxx NE
inhibition NE xxx NE
of NE xx NE
calcium NE xxx NE
-activated NE -xxx NE
IE NE XX NE
gene NE xxx NE
induction NE xxx NE
was NE xxx NE
reversed NE xxx NE
by NE xx NE
treatment NE xxx NE
with NE xxx NE
cyclosporin NE xxx NE
A NE X NE
, NE , NE
suggesting NE xxx NE
the NE xxx NE
involvement NE xxx NE
of NE xx NE
calcineurin NE xxx NE
in NE xx NE
this NE xxx NE
regulation NE xxx NE
. NE . NE

A NE X NE
later NE xxx NE
result NE xxx NE
of NE xx NE
inhibition NE xxx NE
of NE xx NE
this NE xxx NE
activation G#other_name_B xxx G#other_name_B
pathway G#other_name_E xxx G#other_name_E
by NE xx NE
p21(ras) G#protein_molecule xdd(xxx) G#protein_molecule
was NE xxx NE
down-regulation NE xxx-xxx NE
of NE xx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
AP-1 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
subsequent NE xxx NE
coordinate NE xxx NE
reductions NE xxx NE
in NE xx NE
IL-2 G#other_name_B XX-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
protein G#other_name_B xxx G#other_name_B
production G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
p2l(ras) G#protein_molecule xdx(xxx) G#protein_molecule
is NE xx NE
an NE xx NE
essential G#other_name_B xxx G#other_name_B
mediator G#other_name_E xxx G#other_name_E
in NE xx NE
generating NE xxx NE
not NE xxx NE
only NE xxx NE
positive NE xxx NE
but NE xxx NE
also NE xxx NE
negative G#other_name_B xxx G#other_name_B
modulatory G#other_name_M xxx G#other_name_M
mechanisms G#other_name_E xxx G#other_name_E
controlling NE xxx NE
the NE xxx NE
competence NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
response NE xxx NE
to NE xx NE
inductive G#other_name_B xxx G#other_name_B
stimulations G#other_name_E xxx G#other_name_E
. NE . NE

Calcineurin G#protein_molecule Xxxx G#protein_molecule
acts NE xxx NE
in NE xx NE
synergy NE xxx NE
with NE xxx NE
PMA G#other_organic_compound XXX G#other_organic_compound
to NE xx NE
inactivate NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B/MAD3 G#protein_molecule_E X/XXXd G#protein_molecule_E
, NE , NE
an NE xx NE
inhibitor NE xxx NE
of NE xx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
. NE . NE

The NE Xxx NE
interleukin-2 NE xxx-d NE
( NE ( NE
IL-2 NE XX-d NE
) NE ) NE
promoter NE xxx NE
consists NE xxx NE
of NE xx NE
several NE xxx NE
independent NE xxx NE
T NE X NE
cell NE xxx NE
receptor NE xxx NE
( NE ( NE
TcR NE XxX NE
) NE ) NE
responsive NE xxx NE
elements NE xxx NE
. NE . NE

The NE Xxx NE
induction NE xxx NE
of NE xx NE
promoters G#DNA_domain_or_region xxx G#DNA_domain_or_region
dependent NE xxx NE
on NE xx NE
these NE xxx NE
elements NE xxx NE
is NE xx NE
inhibitable NE xxx NE
by NE xx NE
the NE xxx NE
immunosuppressants G#other_organic_compound xxx G#other_organic_compound
cyclosporin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
( NE ( NE
CsA G#other_organic_compound XxX G#other_organic_compound
) NE ) NE
and NE xxx NE
tacrolimus G#other_organic_compound xxx G#other_organic_compound
( NE ( NE
FK-506 G#other_organic_compound XX-ddd G#other_organic_compound
) NE ) NE
. NE . NE

Calcineurin G#protein_molecule Xxxx G#protein_molecule
, NE , NE
a NE x NE
Ca2+ NE Xxd+ NE
/calmodulin-dependent NE /xxx-xxx NE
protein NE xxx NE
phosphatase NE xxx NE
, NE , NE
is NE xx NE
the NE xxx NE
FK-506 NE XX-ddd NE
-and NE -xxx NE
CsA NE XxX NE
-sensitive NE -xxx NE
enzyme NE xxx NE
required NE xxx NE
for NE xxx NE
TcR NE XxX NE
mediated NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
IL-2 NE XX-d NE
promoter NE xxx NE
. NE . NE

We NE Xx NE
report NE xxx NE
that NE xxx NE
a NE x NE
constitutively NE xxx NE
active NE xxx NE
form NE xxx NE
of NE xx NE
calcineurin G#protein_molecule xxx G#protein_molecule
partially NE xxx NE
substitutes NE xxx NE
for NE xxx NE
the NE xxx NE
Ca2+ G#other_name_B Xxd+ G#other_name_B
co-stimulus G#other_name_E xx-xxx G#other_name_E
required NE xxx NE
to NE xx NE
activate NE xxx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
elements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
IL-2A G#DNA_domain_or_region XX-dX G#DNA_domain_or_region
(which NE (xxx NE
binds NE xxx NE
the NE xxx NE
factors NE xxx NE
OAP G#protein_molecule XXX G#protein_molecule
and NE xxx NE
Oct-1 G#protein_molecule Xxx-d G#protein_molecule
) NE ) NE
and NE xxx NE
IL-2E G#DNA_domain_or_region XX-dX G#DNA_domain_or_region
(which NE (xxx NE
binds NE xxx NE
NF-AT G#protein_family_or_group XX-XX G#protein_family_or_group
) NE ) NE
, NE , NE
and NE xxx NE
completely NE xxx NE
substitutes NE xxx NE
for NE xxx NE
the NE xxx NE
Ca2+ G#other_name_B Xxd+ G#other_name_B
co-stimulus G#other_name_E xx-xxx G#other_name_E
required NE xxx NE
to NE xx NE
stimulate NE xxx NE
an NE xx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
-dependent NE -xxx NE
element NE xxx NE
. NE . NE

Calcineurin G#protein_molecule Xxxx G#protein_molecule
stimulates NE xxx NE
the NE xxx NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
by NE xx NE
enhancing NE xxx NE
inactivation NE xxx NE
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B/MAD3 G#protein_molecule_E X/XXXd G#protein_molecule_E
, NE , NE
an NE xx NE
inhibitor NE xxx NE
of NE xx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
, NE , NE
thereby NE xxx NE
increasing NE xxx NE
the NE xxx NE
amount NE xxx NE
of NE xx NE
nuclear NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
DNA G#other_name_M XXX G#other_name_M
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
data NE xxx NE
provide NE xxx NE
the NE xxx NE
first NE xxx NE
demonstration NE xxx NE
in G#other_name_B xx G#other_name_B
vivo G#other_name_E xxx G#other_name_E
that NE xxx NE
activation NE xxx NE
of NE xx NE
a NE x NE
protein G#protein_family_or_group_B xxx G#protein_family_or_group_B
phosphatase G#protein_family_or_group_E xxx G#protein_family_or_group_E
can NE xxx NE
inactivate NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
and NE xxx NE
suggest NE xxx NE
one NE xxx NE
possible NE xxx NE
explanation NE xxx NE
for NE xxx NE
mechanism-based NE xxx-xxx NE
toxicities NE xxx NE
associated NE xxx NE
with NE xxx NE
FK-506 NE XX-ddd NE
and NE xxx NE
CsA NE XxX NE
by NE xx NE
demonstrating NE xxx NE
that NE xxx NE
these NE xxx NE
drugs NE xxx NE
can NE xxx NE
inhibit NE xxx NE
the NE xxx NE
calcineurin NE xxx NE
-dependent NE -xxx NE
activation NE xxx NE
of NE xx NE
a NE x NE
virtually NE xxx NE
ubiquitous NE xxx NE
transcription NE xxx NE
factor NE xxx NE
. NE . NE

Detection NE Xxxx NE
of NE xx NE
minimal G#other_name_B xxx G#other_name_B
residual G#other_name_M xxx G#other_name_M
disease G#other_name_E xxx G#other_name_E
in NE xx NE
a NE x NE
patient G#multi_cell xxx G#multi_cell
with NE xxx NE
acute G#other_name_B xxx G#other_name_B
promyelocytic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
by NE xx NE
RT-PCR G#other_name XX-XXX G#other_name
: NE : NE
necessity NE xxx NE
of NE xx NE
chemotherapy G#other_name xxx G#other_name
following NE xxx NE
ATRA G#other_name_B XXXX G#other_name_B
therapy G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
PML/RAR G#DNA_domain_or_region_B XXX/XXX G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
fusion G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
resulting NE xxx NE
from NE xxx NE
the NE xxx NE
t G#DNA_domain_or_region_B x G#DNA_domain_or_region_B
(15;17) G#DNA_domain_or_region_M (dd;dd) G#DNA_domain_or_region_M
translocation G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
a NE x NE
specific NE xxx NE
marker NE xxx NE
for NE xxx NE
acute G#other_name_B xxx G#other_name_B
promyelocytic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
( NE ( NE
APL G#other_name XXX G#other_name
) NE ) NE
. NE . NE

We NE Xx NE
examined NE xxx NE
bone NE xxx NE
marrow NE xxx NE
cells NE xxx NE
by NE xx NE
reverse NE xxx NE
transcriptase-polymerase NE xxx-xxx NE
chain NE xxx NE
reaction NE xxx NE
( NE ( NE
RT-PCR G#other_name XX-XXX G#other_name
) NE ) NE
to NE xx NE
detect NE xxx NE
residual NE xxx NE
PML/RAR NE XXX/XXX NE
alpha NE xxx NE
mRNA NE xXXX NE
-containing NE -xxx NE
cells NE xxx NE
following NE xxx NE
treatment NE xxx NE
with NE xxx NE
all-trans NE xxx-xxx NE
retinoic NE xxx NE
acid NE xxx NE
( NE ( NE
ATRA NE XXXX NE
) NE ) NE
and NE xxx NE
cytotoxic NE xxx NE
chemotherapy NE xxx NE
in NE xx NE
a NE x NE
patient NE xxx NE
with NE xxx NE
APL NE XXX NE
. NE . NE

This NE Xxxx NE
RT-PCR G#other_name_B XX-XXX G#other_name_B
assay G#other_name_E xxx G#other_name_E
can NE xxx NE
detect NE xxx NE
one NE xxx NE
leukemic G#cell_type_B xxx G#cell_type_B
cell G#cell_type_E xxx G#cell_type_E
in NE xx NE
10(2) NE dd(d) NE
normal G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
vitro NE xxx NE
. NE . NE

We NE Xx NE
show NE xxx NE
that NE xxx NE
PML/RAR G#RNA_molecule_B XXX/XXX G#RNA_molecule_B
alpha G#RNA_molecule_M xxx G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
was NE xxx NE
still NE xxx NE
detectable NE xxx NE
despite NE xxx NE
clinical NE xxx NE
remission NE xxx NE
following NE xxx NE
ATRA G#other_name_B XXXX G#other_name_B
treatment G#other_name_E xxx G#other_name_E
, NE , NE
but NE xxx NE
undetectable NE xxx NE
following NE xxx NE
consolidation NE xxx NE
with NE xxx NE
chemotherapy G#other_name xxx G#other_name
. NE . NE

These NE Xxxx NE
data NE xxx NE
show NE xxx NE
that NE xxx NE
this NE xxx NE
technique NE xxx NE
is NE xx NE
useful NE xxx NE
for NE xxx NE
the NE xxx NE
identification NE xxx NE
of NE xx NE
minimal G#other_name_B xxx G#other_name_B
residual G#other_name_M xxx G#other_name_M
disease G#other_name_E xxx G#other_name_E
in NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
APL G#other_name XXX G#other_name
and NE xxx NE
that NE xxx NE
cytotoxic G#other_name_B xxx G#other_name_B
chemotherapy G#other_name_E xxx G#other_name_E
following NE xxx NE
ATRA G#other_name_B XXXX G#other_name_B
therapy G#other_name_E xxx G#other_name_E
is NE xx NE
required NE xxx NE
for NE xxx NE
the NE xxx NE
elimination NE xxx NE
of NE xx NE
APL G#cell_type_B XXX G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Glucocorticoid G#other_name Xxxx G#other_name
-mediated NE -xxx NE
inhibition NE xxx NE
of NE xx NE
interleukin-2 G#other_name_B xxx-d G#other_name_B
receptor G#other_name_M xxx G#other_name_M
alpha G#other_name_M xxx G#other_name_M
subunit G#other_name_M xxx G#other_name_M
expression G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
interleukin-2 G#other_name_M xxx-d G#other_name_M
receptor G#other_name_M xxx G#other_name_M
-beta G#other_name_M -xxx G#other_name_M
subunit G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E

To NE Xx NE
determine NE xxx NE
the NE xxx NE
mechanism NE xxx NE
of NE xx NE
glucocorticoid NE xxx NE
( NE ( NE
GC NE XX NE
)-mediated NE )-xxx NE
inhibition NE xxx NE
of NE xx NE
T NE X NE
cell NE xxx NE
functions NE xxx NE
, NE , NE
the NE xxx NE
effect NE xxx NE
of NE xx NE
dexamethasone NE xxx NE
( NE ( NE
DM NE XX NE
) NE ) NE
on NE xx NE
T NE X NE
cell NE xxx NE
proliferation NE xxx NE
and NE xxx NE
interleukin-2 NE xxx-d NE
receptor NE xxx NE
( NE ( NE
IL-2R NE XX-dX NE
) NE ) NE
generation NE xxx NE
were NE xxx NE
studied NE xxx NE
. NE . NE

Dexamethasone G#lipid Xxxx G#lipid
inhibited NE xxx NE
IL-2 NE XX-d NE
-induced NE -xxx NE
T NE X NE
cell NE xxx NE
proliferation NE xxx NE
by NE xx NE
30%-88% NE dd%-dd% NE
, NE , NE
relative NE xxx NE
to NE xx NE
its NE xxx NE
concentration NE xxx NE
within NE xxx NE
the NE xxx NE
cultures NE xxx NE
. NE . NE

The NE Xxx NE
effect NE xxx NE
of NE xx NE
DM G#lipid XX G#lipid
on NE xx NE
expression NE xxx NE
of NE xx NE
IL-2R G#protein_molecule_B XX-dX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
Tac G#protein_molecule Xxx G#protein_molecule
, NE , NE
p55 G#protein_molecule xdd G#protein_molecule
, NE , NE
CD25 G#protein_molecule XXdd G#protein_molecule
) NE ) NE
and NE xxx NE
beta G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
(p75) G#DNA_domain_or_region_M (xdd) G#DNA_domain_or_region_M
genes G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
activated G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
was NE xxx NE
examined NE xxx NE
next NE xxx NE
. NE . NE

In NE Xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
stimulated NE xxx NE
with NE xxx NE
purified NE xxx NE
phytohemagglutinin G#protein_molecule xxx G#protein_molecule
( NE ( NE
PHA-p G#protein_molecule XXX-x G#protein_molecule
) NE ) NE
and NE xxx NE
4 G#other_organic_compound_B d G#other_organic_compound_B
beta-phorbol G#other_organic_compound_M xxx-xxx G#other_organic_compound_M
12-myristate G#other_organic_compound_M dd-xxx G#other_organic_compound_M
13-acetate G#other_organic_compound_E dd-xxx G#other_organic_compound_E
( NE ( NE
PMA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
addition NE xxx NE
of NE xx NE
DM G#lipid XX G#lipid
to NE xx NE
the NE xxx NE
cultures NE xxx NE
resulted NE xxx NE
in NE xx NE
a NE x NE
60% NE dd% NE
reduction NE xxx NE
in NE xx NE
IL-2R G#protein_molecule_B XX-dX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
a NE x NE
30% NE dd% NE
reduction NE xxx NE
in NE xx NE
IL-2R G#other_name_B XX-dX G#other_name_B
beta G#other_name_M xxx G#other_name_M
membrane G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
compared NE xxx NE
to NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
cultured NE xxx NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
DM G#lipid XX G#lipid
(p NE (x NE
< NE < NE
0.01) NE d.dd) NE
. NE . NE

Inhibition NE Xxxx NE
of NE xx NE
membrane G#cell_component xxx G#cell_component
IL-2R G#protein_molecule_B XX-dX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
IL-2R G#protein_molecule_B XX-dX G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
expression NE xxx NE
by NE xx NE
10(-6) NE dd(-d) NE
M NE X NE
DM G#lipid XX G#lipid
was NE xxx NE
partially NE xxx NE
reversible NE xxx NE
by NE xx NE
recombinant G#protein_molecule_B xxx G#protein_molecule_B
human G#protein_molecule_M xxx G#protein_molecule_M
IL-2 G#protein_molecule_E XX-d G#protein_molecule_E
( NE ( NE
rhIL-2 G#protein_molecule xxXX-d G#protein_molecule
) NE ) NE
. NE . NE

By NE Xx NE
Northern NE Xxxx NE
blot NE xxx NE
analysis NE xxx NE
, NE , NE
DM G#lipid XX G#lipid
caused NE xxx NE
a NE x NE
comparable NE xxx NE
decrease NE xxx NE
in NE xx NE
IL-2R G#protein_molecule_B XX-dX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
in NE xx NE
IL-2R G#other_name_B XX-dX G#other_name_B
beta G#other_name_M xxx G#other_name_M
mRNA G#other_name_M xXXX G#other_name_M
levels G#other_name_E xxx G#other_name_E
to NE xx NE
membrane G#other_name_B xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
mitogen-stimulated G#cell_type_B xxx-xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

By NE Xx NE
in G#other_name_B xx G#other_name_B
vitro G#other_name_M xxx G#other_name_M
transcription G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
, NE , NE
DM G#lipid XX G#lipid
regulated NE xxx NE
IL-2R G#other_name_B XX-dX G#other_name_B
alpha G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
at NE xx NE
a NE x NE
transcriptional NE xxx NE
level NE xxx NE
while NE xxx NE
transcription NE xxx NE
of NE xx NE
IL-2R G#DNA_domain_or_region_B XX-dX G#DNA_domain_or_region_B
beta G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
unaffected NE xxx NE
by NE xx NE
DM G#lipid XX G#lipid
. NE . NE

The NE Xxx NE
mechanism NE xxx NE
of NE xx NE
action NE xxx NE
of NE xx NE
DM G#lipid XX G#lipid
on NE xx NE
IL-2R G#other_name_B XX-dX G#other_name_B
alpha G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
was NE xxx NE
examined NE xxx NE
by NE xx NE
determining NE xxx NE
the NE xxx NE
mRNA G#other_name_B xXXX G#other_name_B
levels G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
p50 NE xdd NE
subunit NE xxx NE
of NE xx NE
nuclear NE xxx NE
factor NE xxx NE
kappa NE xxx NE
B NE X NE
( NE ( NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
) NE ) NE
, NE , NE
a NE x NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
stimulates NE xxx NE
IL-2R G#other_name_B XX-dX G#other_name_B
alpha G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
data NE xxx NE
indicate NE xxx NE
that NE xxx NE
10(-6) NE dd(-d) NE
M NE X NE
DM G#lipid XX G#lipid
increased NE xxx NE
T G#cell_type_B X G#cell_type_B
cell G#cell_type_E xxx G#cell_type_E
p50 NE xdd NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
mRNA G#other_name_M xXXX G#other_name_M
levels G#other_name_E xxx G#other_name_E
by NE xx NE
four-fold NE xxx-xxx NE
compared NE xxx NE
to NE xx NE
the NE xxx NE
levels NE xxx NE
obtained NE xxx NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
DM G#lipid XX G#lipid
. NE . NE

Further NE Xxxx NE
, NE , NE
the NE xxx NE
level NE xxx NE
of NE xx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
capable NE xxx NE
of NE xx NE
binding NE xxx NE
to NE xx NE
the NE xxx NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
activated G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
increased NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
DM G#lipid XX G#lipid
. NE . NE

In NE Xx NE
sum NE xxx NE
, NE , NE
DM G#lipid XX G#lipid
regulates NE xxx NE
T G#cell_type_B X G#cell_type_B
cell G#cell_type_E xxx G#cell_type_E
membrane NE xxx NE
expression NE xxx NE
of NE xx NE
IL-2R G#protein_family_or_group XX-dX G#protein_family_or_group
by NE xx NE
more NE xxx NE
than NE xxx NE
one NE xxx NE
molecular G#other_name_B xxx G#other_name_B
mechanism G#other_name_E xxx G#other_name_E
. NE . NE

Alteration NE Xxxx NE
of NE xx NE
structural NE xxx NE
order NE xxx NE
of NE xx NE
human G#cell_component_B xxx G#cell_component_B
erythrocyte G#cell_component_M xxx G#cell_component_M
ghost G#cell_component_M xxx G#cell_component_M
membrane G#cell_component_E xxx G#cell_component_E
by NE xx NE
glucocorticoids G#lipid xxx G#lipid
and NE xxx NE
the NE xxx NE
influence NE xxx NE
of NE xx NE
the NE xxx NE
glucocorticoid G#other_organic_compound_B xxx G#other_organic_compound_B
receptor G#other_organic_compound_M xxx G#other_organic_compound_M
antagonist G#other_organic_compound_E xxx G#other_organic_compound_E
RU NE XX NE
486 NE ddd NE
. NE . NE

High-dose NE Xxxx-xxx NE
pulse G#other_name_B xxx G#other_name_B
glucocorticoid G#other_name_M xxx G#other_name_M
therapy G#other_name_E xxx G#other_name_E
has NE xxx NE
been NE xxx NE
used NE xxx NE
successfully NE xxx NE
in NE xx NE
the NE xxx NE
clinic NE xxx NE
in NE xx NE
severe NE xxx NE
pathological NE xxx NE
conditions NE xxx NE
for NE xxx NE
about NE xxx NE
20 NE dd NE
years NE xxx NE
. NE . NE

The NE Xxx NE
mode NE xxx NE
of NE xx NE
glucocorticoid G#other_name_B xxx G#other_name_B
action G#other_name_E xxx G#other_name_E
after NE xxx NE
administration NE xxx NE
of NE xx NE
such NE xxx NE
megadoses NE xxx NE
is NE xx NE
inexplicable NE xxx NE
up NE xx NE
to NE xx NE
now NE xxx NE
. NE . NE

It NE Xx NE
is NE xx NE
supposed NE xxx NE
that NE xxx NE
some NE xxx NE
effects NE xxx NE
may NE xxx NE
be NE xx NE
due NE xxx NE
to NE xx NE
membrane G#other_name_B xxx G#other_name_B
alterations G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
the NE xxx NE
present NE xxx NE
in-vitro NE xx-xxx NE
experiments NE xxx NE
the NE xxx NE
effect NE xxx NE
of NE xx NE
dexamethasone G#lipid xxx G#lipid
, NE , NE
of NE xx NE
further NE xxx NE
glucocorticoids G#lipid xxx G#lipid
, NE , NE
and NE xxx NE
of NE xx NE
the NE xxx NE
glucocorticoid G#other_organic_compound_B xxx G#other_organic_compound_B
receptor G#other_organic_compound_M xxx G#other_organic_compound_M
antagonist G#other_organic_compound_E xxx G#other_organic_compound_E
RU G#other_organic_compound_B XX G#other_organic_compound_B
486 G#other_organic_compound_E ddd G#other_organic_compound_E
, NE , NE
on NE xx NE
structural NE xxx NE
order NE xxx NE
of NE xx NE
human G#cell_component_B xxx G#cell_component_B
erythrocyte G#cell_component_M xxx G#cell_component_M
ghost G#cell_component_M xxx G#cell_component_M
membranes G#cell_component_E xxx G#cell_component_E
was NE xxx NE
investigated NE xxx NE
by NE xx NE
determining NE xxx NE
the NE xxx NE
steady-state G#other_name_B xxx-xxx G#other_name_B
fluorescence G#other_name_M xxx G#other_name_M
anisotropy G#other_name_E xxx G#other_name_E
of NE xx NE
diphenylhexatriene G#other_organic_compound xxx G#other_organic_compound
( NE ( NE
DPH G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
. NE . NE

Dexamethasone G#lipid Xxxx G#lipid
was NE xxx NE
found NE xxx NE
to NE xx NE
induce NE xxx NE
a NE x NE
significant NE xxx NE
decrease NE xxx NE
in NE xx NE
membrane G#other_name_B xxx G#other_name_B
structural G#other_name_M xxx G#other_name_M
order G#other_name_E xxx G#other_name_E
at NE xx NE
concentrations NE xxx NE
of NE xx NE
about NE xxx NE
10(-6) NE dd(-d) NE
M NE X NE
in NE xx NE
a NE x NE
concentration-dependent G#other_name_B xxx-xxx G#other_name_B
manner G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
found NE xxx NE
a NE x NE
correlation NE xxx NE
between NE xxx NE
the NE xxx NE
uptake NE xxx NE
of NE xx NE
dexamethasone G#lipid xxx G#lipid
by NE xx NE
the NE xxx NE
ghost G#cell_component_B xxx G#cell_component_B
membranes G#cell_component_E xxx G#cell_component_E
and NE xxx NE
the NE xxx NE
decrease NE xxx NE
in NE xx NE
the NE xxx NE
structural NE xxx NE
order NE xxx NE
. NE . NE

The NE Xxx NE
other NE xxx NE
glucocorticoids G#lipid xxx G#lipid
tested NE xxx NE
, NE , NE
methylprednisolone G#lipid xxx G#lipid
and NE xxx NE
corticosterone G#lipid xxx G#lipid
, NE , NE
were NE xxx NE
also NE xxx NE
effective NE xxx NE
at NE xx NE
concentrations NE xxx NE
of NE xx NE
10(-5) NE dd(-d) NE
M NE X NE
or NE xx NE
greater NE xxx NE
. NE . NE

We NE Xx NE
observed NE xxx NE
no NE xx NE
change NE xxx NE
in NE xx NE
membrane G#other_name_B xxx G#other_name_B
structural G#other_name_M xxx G#other_name_M
order G#other_name_E xxx G#other_name_E
with NE xxx NE
RU G#other_organic_compound_B XX G#other_organic_compound_B
486 G#other_organic_compound_E ddd G#other_organic_compound_E
up NE xx NE
to NE xx NE
a NE x NE
concentration NE xxx NE
of NE xx NE
10(-4) NE dd(-d) NE
M NE X NE
. NE . NE

However NE Xxxx NE
, NE , NE
simultaneous NE xxx NE
incubation NE xxx NE
of NE xx NE
RU G#other_organic_compound_B XX G#other_organic_compound_B
486 G#other_organic_compound_E ddd G#other_organic_compound_E
with NE xxx NE
dexamethasone G#lipid xxx G#lipid
caused NE xxx NE
a NE x NE
distinct NE xxx NE
interference NE xxx NE
of NE xx NE
RU G#other_organic_compound_B XX G#other_organic_compound_B
486 G#other_organic_compound_E ddd G#other_organic_compound_E
with NE xxx NE
dexamethasone G#lipid xxx G#lipid
. NE . NE

Thus NE Xxxx NE
, NE , NE
the NE xxx NE
glucocorticoid NE xxx NE
-induced NE -xxx NE
membrane NE xxx NE
perturbation NE xxx NE
, NE , NE
the NE xxx NE
possibility NE xxx NE
to NE xx NE
inhibit NE xxx NE
it NE xx NE
by NE xx NE
RU NE XX NE
486 NE ddd NE
, NE , NE
and NE xxx NE
the NE xxx NE
inactivity NE xxx NE
of NE xx NE
the NE xxx NE
structurally NE xxx NE
related NE xxx NE
progesterone NE xxx NE
, NE , NE
refer NE xxx NE
to NE xx NE
relatively NE xxx NE
specific NE xxx NE
binding NE xxx NE
sites NE xxx NE
for NE xxx NE
the NE xxx NE
glucocorticoids NE xxx NE
in NE xx NE
the NE xxx NE
membrane NE xxx NE
of NE xx NE
erythrocyte NE xxx NE
ghosts NE xxx NE
. NE . NE

Mutation NE Xxxx NE
of NE xx NE
tyrosines G#amino_acid_monomer xxx G#amino_acid_monomer
492/493 G#amino_acid_monomer ddd/ddd G#amino_acid_monomer
in NE xx NE
the NE xxx NE
kinase G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
ZAP-70 G#protein_molecule XXX-dd G#protein_molecule
affects NE xxx NE
multiple NE xxx NE
T-cell G#other_name_B X-xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
signaling G#other_name_M xxx G#other_name_M
pathways G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
protein-tyrosine G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
kinase G#protein_family_or_group_E xxx G#protein_family_or_group_E
ZAP-70 G#protein_molecule XXX-dd G#protein_molecule
is NE xx NE
implicated NE xxx NE
, NE , NE
together NE xxx NE
with NE xxx NE
the NE xxx NE
Src G#protein_family_or_group_B Xxx G#protein_family_or_group_B
kinase G#protein_family_or_group_E xxx G#protein_family_or_group_E
p56(lck) G#protein_molecule xdd(xxx) G#protein_molecule
, NE , NE
in NE xx NE
controlling NE xxx NE
the NE xxx NE
early NE xxx NE
steps NE xxx NE
of NE xx NE
the NE xxx NE
T-cell NE X-xxx NE
antigen NE xxx NE
receptor NE xxx NE
( NE ( NE
TCR NE XXX NE
) NE ) NE
signaling NE xxx NE
cascade NE xxx NE
. NE . NE

To NE Xx NE
help NE xxx NE
elucidate NE xxx NE
further NE xxx NE
the NE xxx NE
mechanism NE xxx NE
by NE xx NE
which NE xxx NE
ZAP-70 G#protein_molecule XXX-dd G#protein_molecule
regulates NE xxx NE
these NE xxx NE
initial NE xxx NE
events NE xxx NE
, NE , NE
we NE xx NE
used NE xxx NE
a NE x NE
dominant-negative G#other_name_B xxx-xxx G#other_name_B
mutant G#other_name_M xxx G#other_name_M
approach G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
overexpressed NE xxx NE
in NE xx NE
the NE xxx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T-cell G#cell_line_M X-xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
ZAP-70 G#protein_molecule XXX-dd G#protein_molecule
mutated NE xxx NE
on NE xx NE
Tyr-492 G#amino_acid_monomer Xxx-ddd G#amino_acid_monomer
and NE xxx NE
Tyr-493 G#amino_acid_monomer Xxx-ddd G#amino_acid_monomer
in NE xx NE
the NE xxx NE
putative NE xxx NE
regulatory NE xxx NE
loop NE xxx NE
of NE xx NE
its NE xxx NE
kinase G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

This NE Xxxx NE
mutant NE xxx NE
inhibited NE xxx NE
TCR NE XXX NE
-induced NE -xxx NE
activation NE xxx NE
of NE xx NE
nuclear NE xxx NE
factor NE xxx NE
of NE xx NE
activated NE xxx NE
T NE X NE
cells NE xxx NE
by NE xx NE
interfering NE xxx NE
with NE xxx NE
both NE xxx NE
intracellular NE xxx NE
calcium NE xxx NE
increase NE xxx NE
and NE xxx NE
Ras NE Xxx NE
-regulated NE -xxx NE
activation NE xxx NE
of NE xx NE
extracellular NE xxx NE
signal-regulated NE xxx-xxx NE
kinases NE xxx NE
. NE . NE

Moreover NE Xxxx NE
, NE , NE
TCR NE XXX NE
-induced NE -xxx NE
phosphorylation NE xxx NE
of NE xx NE
pp36-38 NE xxdd-dd NE
, NE , NE
thought NE xxx NE
to NE xx NE
play NE xxx NE
a NE x NE
role NE xxx NE
upstream NE xxx NE
of NE xx NE
these NE xxx NE
pathways NE xxx NE
, NE , NE
was NE xxx NE
found NE xxx NE
to NE xx NE
be NE xx NE
reduced NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
overexpression NE xxx NE
of NE xx NE
wild-type G#protein_molecule_B xxx-xxx G#protein_molecule_B
ZAP-70 G#protein_molecule_E XXX-dd G#protein_molecule_E
induced NE xxx NE
constitutive NE xxx NE
activation NE xxx NE
of NE xx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
of G#protein_molecule_M xx G#protein_molecule_M
activated G#protein_molecule_M xxx G#protein_molecule_M
T G#protein_molecule_M X G#protein_molecule_M
cells G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

The NE Xxx NE
ZAP-70 G#protein_molecule XXX-dd G#protein_molecule
mutant NE xxx NE
studied NE xxx NE
here NE xxx NE
could NE xxx NE
be NE xx NE
phosphorylated NE xxx NE
on NE xx NE
tyrosine G#amino_acid_monomer xxx G#amino_acid_monomer
when NE xxx NE
associated NE xxx NE
to NE xx NE
the NE xxx NE
TCR G#protein_subunit_B XXX G#protein_subunit_B
zeta G#protein_subunit_M xxx G#protein_subunit_M
chain G#protein_subunit_E xxx G#protein_subunit_E
and NE xxx NE
was NE xxx NE
able NE xxx NE
to NE xx NE
bind NE xxx NE
p56(lck) G#protein_molecule xdd(xxx) G#protein_molecule
. NE . NE

This NE Xxxx NE
result NE xxx NE
demonstrates NE xxx NE
that NE xxx NE
Tyr-492 G#amino_acid_monomer Xxx-ddd G#amino_acid_monomer
and NE xxx NE
Tyr-493 G#amino_acid_monomer Xxx-ddd G#amino_acid_monomer
are NE xxx NE
not NE xxx NE
responsible NE xxx NE
for NE xxx NE
the NE xxx NE
Src NE Xxx NE
homology NE xxx NE
domain NE xxx NE
2-mediated NE d-xxx NE
association NE xxx NE
of NE xx NE
p56(lck) G#protein_molecule xdd(xxx) G#protein_molecule
with NE xxx NE
ZAP-70 G#protein_molecule XXX-dd G#protein_molecule
. NE . NE

Our NE Xxx NE
data NE xxx NE
are NE xxx NE
most NE xxx NE
consistent NE xxx NE
with NE xxx NE
a NE x NE
model NE xxx NE
in NE xx NE
which NE xxx NE
recruitment NE xxx NE
to NE xx NE
the NE xxx NE
TCR G#protein_family_or_group XXX G#protein_family_or_group
allows NE xxx NE
ZAP-70 G#other_name_B XXX-dd G#other_name_B
autophosphorylation G#other_name_E xxx G#other_name_E
and NE xxx NE
binding NE xxx NE
to NE xx NE
p56(lck) G#protein_molecule xdd(xxx) G#protein_molecule
, NE , NE
which NE xxx NE
in NE xx NE
turn NE xxx NE
phosphorylates NE xxx NE
Tyr-492 G#amino_acid_monomer Xxx-ddd G#amino_acid_monomer
and/or NE xxx/xx NE
Tyr-493 G#amino_acid_monomer Xxx-ddd G#amino_acid_monomer
with NE xxx NE
consequent NE xxx NE
up-regulation NE xx-xxx NE
of NE xx NE
the NE xxx NE
ZAP-70 G#other_name_B XXX-dd G#other_name_B
kinase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
. NE . NE

ZAP-70 G#protein_molecule XXX-dd G#protein_molecule
will NE xxx NE
then NE xxx NE
be NE xx NE
able NE xxx NE
to NE xx NE
effectively NE xxx NE
control NE xxx NE
phosphorylation NE xxx NE
of NE xx NE
its NE xxx NE
substrates NE xxx NE
and NE xxx NE
lead NE xxx NE
to NE xx NE
gene G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

Effects NE Xxxx NE
of NE xx NE
glucocorticoids G#lipid xxx G#lipid
on NE xx NE
lymphocyte G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
in NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
steroid-sensitive G#other_name_B xxx-xxx G#other_name_B
asthma G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
steroid-resistant G#other_name_M xxx-xxx G#other_name_M
asthma G#other_name_E xxx G#other_name_E

BACKGROUND NE XXXXXXXXXX NE
: NE : NE
Glucocorticoids G#lipid Xxxx G#lipid
are NE xxx NE
important NE xxx NE
medications NE xxx NE
used NE xxx NE
to NE xx NE
control NE xxx NE
the NE xxx NE
airway G#other_name_B xxx G#other_name_B
inflammation G#other_name_E xxx G#other_name_E
associated NE xxx NE
with NE xxx NE
asthma G#other_name xxx G#other_name
. NE . NE

Synthetic NE Xxxx NE
glucocorticoids G#lipid xxx G#lipid
vary NE xxx NE
in NE xx NE
their NE xxx NE
binding NE xxx NE
affinity NE xxx NE
for NE xxx NE
the NE xxx NE
glucocorticoid NE xxx NE
receptor NE xxx NE
(GCR) NE (XXX) NE
. NE . NE

METHODS NE XXXXXXX NE
: NE : NE
We NE Xx NE
compared NE xxx NE
hydrocortisone G#lipid xxx G#lipid
, NE , NE
beclomethasone G#lipid_B xxx G#lipid_B
dipropionate G#lipid_E xxx G#lipid_E
, NE , NE
triamcinolone G#lipid_B xxx G#lipid_B
acetonide G#lipid_E xxx G#lipid_E
, NE , NE
flunisolide G#other_organic_compound xxx G#other_organic_compound
, NE , NE
and NE xxx NE
budesonide G#other_organic_compound xxx G#other_organic_compound
with NE xxx NE
regard NE xxx NE
to NE xx NE
their NE xxx NE
capacity NE xxx NE
to NE xx NE
inhibit NE xxx NE
phytohemagglutinin NE xxx NE
-induced NE -xxx NE
peripheral NE xxx NE
blood NE xxx NE
mononuclear NE xxx NE
cell NE xxx NE
proliferation NE xxx NE
from NE xxx NE
six NE xxx NE
patients NE xxx NE
with NE xxx NE
steroid-sensitive NE xxx-xxx NE
asthma NE xxx NE
and NE xxx NE
seven NE xxx NE
patients NE xxx NE
with NE xxx NE
steroid-resistant NE xxx-xxx NE
asthma NE xxx NE
. NE . NE

Peripheral NE Xxxx NE
blood NE xxx NE
mononuclear NE xxx NE
cell NE xxx NE
GCR NE XXX NE
binding NE xxx NE
affinities NE xxx NE
for NE xxx NE
dexamethasone NE xxx NE
and NE xxx NE
budesonide NE xxx NE
were NE xxx NE
also NE xxx NE
determined NE xxx NE
for NE xxx NE
both NE xxx NE
patient NE xxx NE
groups NE xxx NE
by NE xx NE
using NE xxx NE
a NE x NE
radioligand NE xxx NE
binding NE xxx NE
assay NE xxx NE
and NE xxx NE
Scatchard NE Xxxx NE
analysis NE xxx NE
. NE . NE

RESULTS NE XXXXXXX NE
: NE : NE
Dose-dependent G#other_name_B Xxxx-xxx G#other_name_B
inhibition G#other_name_E xxx G#other_name_E
was NE xxx NE
demonstrated NE xxx NE
for NE xxx NE
all NE xxx NE
glucocorticoids G#lipid xxx G#lipid
in NE xx NE
both NE xxx NE
patient G#multi_cell xxx G#multi_cell
groups NE xxx NE
, NE , NE
with NE xxx NE
the NE xxx NE
steroid-resistant G#multi_cell_B xxx-xxx G#multi_cell_B
group G#multi_cell_E xxx G#multi_cell_E
requiring NE xxx NE
approximately NE xxx NE
2 NE d NE
log-fold NE xxx-xxx NE
more NE xxx NE
glucocorticoids G#lipid xxx G#lipid
for NE xxx NE
an NE xx NE
equivalent NE xxx NE
degree NE xxx NE
of NE xx NE
inhibition NE xxx NE
. NE . NE

The NE Xxx NE
mean NE xxx NE
concentrations NE xxx NE
necessary NE xxx NE
to NE xx NE
cause NE xxx NE
50% NE dd% NE
inhibition NE xxx NE
of NE xx NE
lymphocyte G#other_name_B xxx G#other_name_B
proliferation G#other_name_E xxx G#other_name_E
( NE ( NE
IC50s G#other_name XXddx G#other_name
) NE ) NE
for NE xxx NE
the NE xxx NE
steroid-sensitive NE xxx-xxx NE
group NE xxx NE
ranged NE xxx NE
from NE xxx NE
2 NE d NE
x NE x NE
10(-10) NE dd(-dd) NE
mol/L NE xxx/X NE
for NE xxx NE
budesonide G#other_organic_compound xxx G#other_organic_compound
to NE xx NE
7 NE d NE
x NE x NE
10(-8) NE dd(-d) NE
mol/L NE xxx/X NE
for NE xxx NE
hydrocortisone G#lipid xxx G#lipid
, NE , NE
whereas NE xxx NE
the NE xxx NE
mean NE xxx NE
IC50s G#other_name XXddx G#other_name
for NE xxx NE
the NE xxx NE
steroid-resistant G#multi_cell_B xxx-xxx G#multi_cell_B
group G#multi_cell_E xxx G#multi_cell_E
ranged NE xxx NE
from NE xxx NE
approximately NE xxx NE
2 NE d NE
x NE x NE
10(-8) NE dd(-d) NE
mol/L NE xxx/X NE
for NE xxx NE
budesonide G#other_organic_compound xxx G#other_organic_compound
to NE xx NE
greater NE xxx NE
than NE xxx NE
10(-6) NE dd(-d) NE
mol/L NE xxx/X NE
for NE xxx NE
hydrocortisone G#lipid xxx G#lipid
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
a NE x NE
significant NE xxx NE
correlation NE xxx NE
was NE xxx NE
noted NE xxx NE
between NE xxx NE
the NE xxx NE
degree NE xxx NE
of NE xx NE
inhibition NE xxx NE
of NE xx NE
lymphocyte G#other_name_B xxx G#other_name_B
proliferation G#other_name_E xxx G#other_name_E
( NE ( NE
IC50 G#other_name XXdd G#other_name
) NE ) NE
and NE xxx NE
the NE xxx NE
binding NE xxx NE
affinity NE xxx NE
of NE xx NE
dexamethasone G#lipid xxx G#lipid
to NE xx NE
the NE xxx NE
GCR G#protein_family_or_group XXX G#protein_family_or_group
. NE . NE

Patients NE Xxxx NE
with NE xxx NE
steroid-resistant G#other_name_B xxx-xxx G#other_name_B
asthma G#other_name_E xxx G#other_name_E
have NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
have NE xxx NE
a NE x NE
reduced NE xxx NE
GCR G#other_name_B XXX G#other_name_B
binding G#other_name_M xxx G#other_name_M
affinity G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
GCR G#other_name_B XXX G#other_name_B
binding G#other_name_M xxx G#other_name_M
affinity G#other_name_E xxx G#other_name_E
for NE xxx NE
budesonide G#other_organic_compound xxx G#other_organic_compound
was NE xxx NE
significantly NE xxx NE
higher NE xxx NE
in NE xx NE
both NE xxx NE
groups NE xxx NE
(i.e. NE (x.x. NE
, NE , NE
lower NE xxx NE
dissociation G#other_name_B xxx G#other_name_B
constant G#other_name_E xxx G#other_name_E
) NE ) NE
than NE xxx NE
that NE xxx NE
obtained NE xxx NE
for NE xxx NE
dexamethasone G#lipid xxx G#lipid
. NE . NE

CONCLUSION NE XXXXXXXXXX NE
: NE : NE
These NE Xxxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
glucocorticoids G#lipid xxx G#lipid
such NE xxx NE
as NE xx NE
budesonide G#other_organic_compound xxx G#other_organic_compound
, NE , NE
by NE xx NE
virtue NE xxx NE
of NE xx NE
their NE xxx NE
high NE xxx NE
GCR NE XXX NE
binding NE xxx NE
affinities NE xxx NE
and NE xxx NE
greater NE xxx NE
ability NE xxx NE
to NE xx NE
suppress NE xxx NE
lymphocyte NE xxx NE
proliferation NE xxx NE
, NE , NE
may NE xxx NE
therefore NE xxx NE
be NE xx NE
beneficial NE xxx NE
in NE xx NE
the NE xxx NE
management NE xxx NE
of NE xx NE
difficult-to-control NE xxx-xx-xxx NE
asthma NE xxx NE
. NE . NE

Characterization NE Xxxx NE
of NE xx NE
the NE xxx NE
murine G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
cyclin-dependent G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
kinase G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
inhibitor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
p27Kip1 G#DNA_domain_or_region xddXxxd G#DNA_domain_or_region
. NE . NE

The NE Xxx NE
cyclin-dependent G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
kinase G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
inhibitor G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
p27Kip1 G#DNA_domain_or_region xddXxxd G#DNA_domain_or_region
plays NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
regulating NE xxx NE
cell-cycle NE xxx-xxx NE
progression NE xxx NE
. NE . NE

p27Kip1 G#DNA_domain_or_region xddXxxd G#DNA_domain_or_region
directly NE xxx NE
inhibits NE xxx NE
the NE xxx NE
catalytic G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
of NE xx NE
cyclin/cdks NE xxx/xxx NE
( NE ( NE
cyclin-dependent NE xxx-xxx NE
kinase NE xxx NE
) NE ) NE
complexes NE xxx NE
and/or NE xxx/xx NE
interferes NE xxx NE
physically NE xxx NE
with NE xxx NE
cyclin/cdks NE xxx/xxx NE
activation NE xxx NE
by NE xx NE
CAK NE XXX NE
. NE . NE

Interestingly NE Xxxx NE
, NE , NE
the NE xxx NE
expression NE xxx NE
level NE xxx NE
of NE xx NE
p27Kip1 G#RNA_molecule_B xddXxxd G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
was NE xxx NE
maximal NE xxx NE
in NE xx NE
resting G#cell_type_B xxx G#cell_type_B
Go G#cell_type_M Xx G#cell_type_M
T-cells G#cell_type_E X-xxx G#cell_type_E
and NE xxx NE
rapidly NE xxx NE
declined NE xxx NE
following NE xxx NE
anti-CD3 G#other_name_B xxx-XXd G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
report NE xxx NE
here NE xxx NE
the NE xxx NE
cloning NE xxx NE
of NE xx NE
p27Kip1 G#DNA_domain_or_region_B xddXxxd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
from NE xxx NE
murine G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genomic G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
DNA G#DNA_family_or_group_E XXX G#DNA_family_or_group_E
and NE xxx NE
the NE xxx NE
functional NE xxx NE
analysis NE xxx NE
of NE xx NE
the NE xxx NE
promoter NE xxx NE
of NE xx NE
the NE xxx NE
p27Kip1 G#DNA_domain_or_region xddXxxd G#DNA_domain_or_region
gene NE xxx NE
. NE . NE

The NE Xxx NE
gene NE xxx NE
consists NE xxx NE
of NE xx NE
at NE xx NE
least NE xxx NE
three NE xxx NE
exons NE xxx NE
and NE xxx NE
spans NE xxx NE
more NE xxx NE
than NE xxx NE
5.6 G#DNA_domain_or_region_B d.d G#DNA_domain_or_region_B
kb G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
of G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
DNA G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
. NE . NE

Primer G#other_name_B Xxxx G#other_name_B
extension G#other_name_E xxx G#other_name_E
and NE xxx NE
nuclease G#other_name_B xxx G#other_name_B
S1 G#other_name_M Xd G#other_name_M
protection G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
revealed NE xxx NE
two NE xxx NE
major NE xxx NE
transcription G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
initiation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
promoter G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
lacked NE xxx NE
a NE x NE
TATA G#DNA_domain_or_region_B XXXX G#DNA_domain_or_region_B
box G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
but NE xxx NE
contained NE xxx NE
potential NE xxx NE
binding NE xxx NE
sites NE xxx NE
for NE xxx NE
the NE xxx NE
transcriptional G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
including NE xxx NE
two NE xxx NE
Sp1 G#protein_molecule Xxd G#protein_molecule
, NE , NE
CRE G#protein_molecule XXX G#protein_molecule
, NE , NE
Myb G#protein_molecule Xxx G#protein_molecule
and NE xxx NE
NFkB G#protein_molecule XXxX G#protein_molecule
located NE xxx NE
at NE xx NE
positions NE xxx NE
position G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
-153 G#DNA_domain_or_region_M -ddd G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
position G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
-178 G#DNA_domain_or_region_M -ddd G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
position G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
-286 G#DNA_domain_or_region_M -ddd G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
position G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
-875 G#DNA_domain_or_region_M -ddd G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
position G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
-1011 G#DNA_domain_or_region_E -dddd G#DNA_domain_or_region_E

To NE Xx NE
analyze NE xxx NE
the NE xxx NE
regulatory G#other_name_B xxx G#other_name_B
mechanisms G#other_name_E xxx G#other_name_E
controlling NE xxx NE
p27Kip1 G#DNA_domain_or_region xddXxxd G#DNA_domain_or_region
gene NE xxx NE
expression NE xxx NE
, NE , NE
we NE xx NE
characterized NE xxx NE
the NE xxx NE
5'-flanking G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
from NE xxx NE
nt G#DNA_domain_or_region_B xx G#DNA_domain_or_region_B
-1609 G#DNA_domain_or_region_M -dddd G#DNA_domain_or_region_M
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
+178 G#DNA_domain_or_region_E +ddd G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
-326 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-615 G#DNA_domain_or_region_M -ddd G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
contained NE xxx NE
positive G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
regulatory G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

Nuclear G#protein_molecule_B Xxxx G#protein_molecule_B
NF-ATp G#protein_molecule_E XX-XXx G#protein_molecule_E
is NE xx NE
a NE x NE
hallmark NE xxx NE
of NE xx NE
unstimulated G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
from NE xxx NE
B-CLL G#multi_cell_B X-XXX G#multi_cell_B
patients G#multi_cell_E xxx G#multi_cell_E
. NE . NE

B G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
from NE xxx NE
the NE xxx NE
peripheral G#tissue_B xxx G#tissue_B
blood G#tissue_E xxx G#tissue_E
of NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
chronic G#other_name_B xxx G#other_name_B
lymphocytic G#other_name_M xxx G#other_name_M
leukaemia G#other_name_E xxx G#other_name_E
( NE ( NE
CLL G#other_name XXX G#other_name
) NE ) NE
were NE xxx NE
analysed NE xxx NE
for NE xxx NE
the NE xxx NE
nuclear NE xxx NE
presence NE xxx NE
and NE xxx NE
DNA NE XXX NE
binding NE xxx NE
of NE xx NE
a NE x NE
panel NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
which NE xxx NE
are NE xxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
gene NE xxx NE
control NE xxx NE
of NE xx NE
lymphoid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
following NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
were NE xxx NE
studied NE xxx NE
: NE : NE
the NE xxx NE
Octamer G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
Oct-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
, NE , NE
members NE xxx NE
of NE xx NE
the NE xxx NE
AP-1 G#protein_family_or_group_B XX-d G#protein_family_or_group_B
factor G#protein_family_or_group_M xxx G#protein_family_or_group_M
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
NF-AT G#protein_family_or_group_B XX-XX G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
in NE xx NE
particular NE xxx NE
NF-ATp G#protein_molecule XX-XXx G#protein_molecule
, NE , NE
and NE xxx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
Rel/NF-kB G#protein_family_or_group_B Xxx/XX-xX G#protein_family_or_group_B
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

We NE Xx NE
show NE xxx NE
that NE xxx NE
the NE xxx NE
constitutive NE xxx NE
nuclear NE xxx NE
translocation NE xxx NE
of NE xx NE
NF-ATp G#protein_molecule XX-XXx G#protein_molecule
, NE , NE
a NE x NE
member NE xxx NE
of NE xx NE
the NE xxx NE
growing NE xxx NE
family NE xxx NE
of NE xx NE
NF-AT G#protein_family_or_group_B XX-XX G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
is NE xx NE
a NE x NE
hallmark NE xxx NE
of NE xx NE
nonstimulated G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
from NE xxx NE
CLL G#other_name XXX G#other_name
patients G#multi_cell xxx G#multi_cell
that NE xxx NE
distinguishes NE xxx NE
B-CLL G#cell_type_B X-XXX G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
from NE xxx NE
'normal' G#cell_type_B 'xxx' G#cell_type_B
B G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

Constitutive NE Xxxx NE
nuclear NE xxx NE
appearance NE xxx NE
was NE xxx NE
also NE xxx NE
observed NE xxx NE
for NE xxx NE
NF-kB2/p52 NE XX-xXd/xdd NE
. NE . NE

Constitutive NE Xxxx NE
binding NE xxx NE
of NE xx NE
further NE xxx NE
factor G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
to NE xx NE
DNA NE XXX NE
, NE , NE
such NE xxx NE
as NE xx NE
JunD G#protein_molecule XxxX G#protein_molecule
, NE , NE
c-Fos G#protein_molecule x-Xxx G#protein_molecule
and NE xxx NE
FosB G#protein_molecule XxxX G#protein_molecule
, NE , NE
was NE xxx NE
detected NE xxx NE
in NE xx NE
several NE xxx NE
patients G#multi_cell xxx G#multi_cell
whereas NE xxx NE
the NE xxx NE
localisation NE xxx NE
and NE xxx NE
DNA G#other_name_B XXX G#other_name_B
binding G#other_name_E xxx G#other_name_E
of NE xx NE
other NE xxx NE
factors NE xxx NE
such NE xxx NE
as NE xx NE
c-Jun G#protein_molecule x-Xxx G#protein_molecule
, NE , NE
RelA/p65 G#protein_complex XxxX/xdd G#protein_complex
and NE xxx NE
c-Rel G#protein_molecule x-Xxx G#protein_molecule
was NE xxx NE
unaltered NE xxx NE
. NE . NE

It NE Xx NE
is NE xx NE
remarkable NE xxx NE
that NE xxx NE
in NE xx NE
B-CLL G#cell_type_B X-XXX G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
the NE xxx NE
nuclear NE xxx NE
appearance NE xxx NE
and NE xxx NE
DNA G#other_name_B XXX G#other_name_B
binding G#other_name_E xxx G#other_name_E
of NE xx NE
specific NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
is NE xx NE
dramatically NE xxx NE
affected NE xxx NE
whereas NE xxx NE
other NE xxx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
same NE xxx NE
factor G#protein_family_or_group_B xxx G#protein_family_or_group_B
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
remained NE xxx NE
unaltered NE xxx NE
in NE xx NE
these NE xxx NE
leukemic NE xxx NE
cells NE xxx NE
. NE . NE

It NE Xx NE
remains NE xxx NE
to NE xx NE
be NE xx NE
shown NE xxx NE
which NE xxx NE
molecular NE xxx NE
events NE xxx NE
lead NE xxx NE
to NE xx NE
the NE xxx NE
specific NE xxx NE
'pre-activation' G#other_name 'xxx-xxx' G#other_name
, NE , NE
i.e NE x.x NE
. NE . NE

constitutive NE xxx NE
nuclear NE xxx NE
translocation NE xxx NE
and NE xxx NE
DNA G#other_name_B XXX G#other_name_B
binding G#other_name_E xxx G#other_name_E
, NE , NE
of NE xx NE
these NE xxx NE
members NE xxx NE
of NE xx NE
NF-AT G#protein_family_or_group XX-XX G#protein_family_or_group
, NE , NE
NF-kB G#protein_family_or_group XX-xX G#protein_family_or_group
and NE xxx NE
AP-1 NE XX-d NE
factor NE xxx NE
families NE xxx NE
. NE . NE

Naive G#cell_type_B Xxxx G#cell_type_B
(CD45RA+) G#cell_type_M (XXddXX+) G#cell_type_M
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
are NE xxx NE
more NE xxx NE
sensitive NE xxx NE
to NE xx NE
oxidative G#other_name_B xxx G#other_name_B
stress-induced G#other_name_M xxx-xxx G#other_name_M
signals G#other_name_E xxx G#other_name_E
than NE xxx NE
memory G#cell_type_B xxx G#cell_type_B
(CD45RO+) G#cell_type_M (XXddXX+) G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Formation NE Xxxx NE
of NE xx NE
reactive G#inorganic_B xxx G#inorganic_B
oxygen G#inorganic_M xxx G#inorganic_M
intermediates G#inorganic_E xxx G#inorganic_E
( NE ( NE
ROI G#inorganic XXX G#inorganic
) NE ) NE
after NE xxx NE
oxidative NE xxx NE
stress NE xxx NE
has NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
be NE xx NE
an NE xx NE
activation NE xxx NE
signal NE xxx NE
for NE xxx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
e.g. NE x.x. NE
, NE , NE
expression NE xxx NE
of NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
its NE xxx NE
receptor NE xxx NE
are NE xxx NE
induced NE xxx NE
. NE . NE

These NE Xxxx NE
ROI NE XXX NE
-induced NE -xxx NE
effects NE xxx NE
can NE xxx NE
, NE , NE
to NE xx NE
a NE x NE
large NE xxx NE
extent NE xxx NE
, NE , NE
be NE xx NE
attributed NE xxx NE
to NE xx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
transcription NE xxx NE
factor NE xxx NE
NF-kappaB NE XX-xxxX NE
. NE . NE

Now NE Xxx NE
we NE xx NE
have NE xxx NE
examined NE xxx NE
whether NE xxx NE
naive G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
lymphocyte G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
memory G#cell_type_M xxx G#cell_type_M
T G#cell_type_M X G#cell_type_M
lymphocyte G#cell_type_E xxx G#cell_type_E
differ NE xxx NE
in NE xx NE
their NE xxx NE
sensitivity NE xxx NE
to NE xx NE
ROI G#other_name XXX G#other_name
-mediated NE -xxx NE
signals NE xxx NE
. NE . NE

When NE Xxxx NE
CD45RA+ NE XXddXX+ NE
(naive) NE (xxx) NE
and NE xxx NE
CD45RO+ NE XXddXX+ NE
(memory) NE (xxx) NE
T NE X NE
lymphocytes NE xxx NE
were NE xxx NE
directly NE xxx NE
stimulated NE xxx NE
with NE xxx NE
H2O2 NE XdXd NE
, NE , NE
NF-kappaB NE XX-xxxX NE
nuclear NE xxx NE
translocation NE xxx NE
was NE xxx NE
stronger NE xxx NE
in NE xx NE
naive NE xxx NE
cells NE xxx NE
than NE xxx NE
in NE xx NE
memory NE xxx NE
cells NE xxx NE
and NE xxx NE
it NE xx NE
could NE xxx NE
be NE xx NE
induced NE xxx NE
with NE xxx NE
lower NE xxx NE
doses NE xxx NE
. NE . NE

The NE Xxx NE
composition NE xxx NE
of NE xx NE
the NE xxx NE
induced NE xxx NE
nuclear G#protein_complex_B xxx G#protein_complex_B
NF-kappaB G#protein_complex_E XX-xxxX G#protein_complex_E
(levels NE (xxx NE
of NE xx NE
p50 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
RelA G#protein_molecule_B XxxX G#protein_molecule_B
proteins G#protein_molecule_E xxx G#protein_molecule_E
) NE ) NE
was NE xxx NE
similar NE xxx NE
in NE xx NE
these NE xxx NE
cell NE xxx NE
types NE xxx NE
. NE . NE

The NE Xxx NE
magnitude NE xxx NE
and NE xxx NE
kinetics NE xxx NE
of NE xx NE
intracellular G#inorganic_B xxx G#inorganic_B
ROI G#inorganic_E XXX G#inorganic_E
were NE xxx NE
similar NE xxx NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
there NE xxx NE
were NE xxx NE
no NE xx NE
differences NE xxx NE
in NE xx NE
ROI NE XXX NE
-forming NE -xxx NE
mechanisms NE xxx NE
or NE xx NE
antioxidative NE xxx NE
capacities NE xxx NE
. NE . NE

The NE Xxx NE
probable NE xxx NE
regulatory NE xxx NE
point NE xxx NE
was NE xxx NE
the NE xxx NE
cytoplasmic G#other_organic_compound_B xxx G#other_organic_compound_B
IkappaB G#other_organic_compound_M XxxxX G#other_organic_compound_M
inhibitor G#other_organic_compound_E xxx G#other_organic_compound_E
: NE : NE
in NE xx NE
CD45RA+ NE XXddXX+ NE
cells NE xxx NE
, NE , NE
H2O2 G#inorganic XdXd G#inorganic
caused NE xxx NE
a NE x NE
more NE xxx NE
profound NE xxx NE
depression NE xxx NE
in NE xx NE
the NE xxx NE
levels NE xxx NE
of NE xx NE
IkappaB G#protein_molecule_B XxxxX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

These NE Xxxx NE
findings NE xxx NE
indicate NE xxx NE
that NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
representing NE xxx NE
different NE xxx NE
activation NE xxx NE
and/or NE xxx/xx NE
differentiation G#other_name_B xxx G#other_name_B
stages G#other_name_E xxx G#other_name_E
can NE xxx NE
be NE xx NE
differentially NE xxx NE
responsive NE xxx NE
to NE xx NE
ROI NE XXX NE
-mediated NE -xxx NE
signals NE xxx NE
. NE . NE

Rapid NE Xxxx NE
shuttling NE xxx NE
of NE xx NE
NF-AT G#protein_family_or_group XX-XX G#protein_family_or_group
in NE xx NE
discrimination NE xxx NE
of NE xx NE
Ca2+ G#other_name_B Xxd+ G#other_name_B
signals G#other_name_E xxx G#other_name_E
and NE xxx NE
immunosuppression NE xxx NE
. NE . NE

Cells NE Xxxx NE
need NE xxx NE
to NE xx NE
distinguish NE xxx NE
between NE xxx NE
transient NE xxx NE
Ca2+ G#other_name_B Xxd+ G#other_name_B
signals G#other_name_E xxx G#other_name_E
that NE xxx NE
induce NE xxx NE
events NE xxx NE
such NE xxx NE
as NE xx NE
muscle G#other_name_B xxx G#other_name_B
contraction G#other_name_E xxx G#other_name_E
, NE , NE
secretion G#other_name xxx G#other_name
, NE , NE
adhesion G#other_name xxx G#other_name
and NE xxx NE
synaptic G#other_name_B xxx G#other_name_B
transmission G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
sustained NE xxx NE
Ca2+ G#other_name_B Xxd+ G#other_name_B
signals G#other_name_E xxx G#other_name_E
that NE xxx NE
are NE xxx NE
involved NE xxx NE
in NE xx NE
cell G#other_name_B xxx G#other_name_B
proliferation G#other_name_E xxx G#other_name_E
and NE xxx NE
differentiation G#other_name xxx G#other_name
. NE . NE

The NE Xxx NE
latter NE xxx NE
class NE xxx NE
of NE xx NE
events NE xxx NE
is NE xx NE
blocked NE xxx NE
in NE xx NE
lymphocytes G#cell_type xxx G#cell_type
by NE xx NE
the NE xxx NE
immunosuppressive G#other_organic_compound_B xxx G#other_organic_compound_B
drugs G#other_organic_compound_E xxx G#other_organic_compound_E
cyclosporin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
and NE xxx NE
FK506 G#other_organic_compound XXddd G#other_organic_compound
, NE , NE
which NE xxx NE
inhibit NE xxx NE
calcineurin G#protein_molecule xxx G#protein_molecule
, NE , NE
a NE x NE
Ca2+ NE Xxd+ NE
-activated NE -xxx NE
serine/threonine NE xxx/xxx NE
phosphatase NE xxx NE
necessary NE xxx NE
for NE xxx NE
the NE xxx NE
nuclear NE xxx NE
import NE xxx NE
of NE xx NE
NF-AT NE XX-XX NE
transcription NE xxx NE
factors NE xxx NE
. NE . NE

Here NE Xxxx NE
we NE xx NE
report NE xxx NE
that NE xxx NE
sustained NE xxx NE
high NE xxx NE
concentrations NE xxx NE
of NE xx NE
Ca2+ G#atom Xxd+ G#atom
, NE , NE
but NE xxx NE
not NE xxx NE
transient G#other_name_B xxx G#other_name_B
pulses G#other_name_E xxx G#other_name_E
, NE , NE
are NE xxx NE
required NE xxx NE
to NE xx NE
maintain NE xxx NE
NF-AT G#protein_family_or_group XX-XX G#protein_family_or_group
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
the NE xxx NE
nucleus NE xxx NE
, NE , NE
where NE xxx NE
they NE xxx NE
participate NE xxx NE
in NE xx NE
Ca2+ NE Xxd+ NE
-dependent NE -xxx NE
induction NE xxx NE
of NE xx NE
genes NE xxx NE
required NE xxx NE
for NE xxx NE
lymphocyte NE xxx NE
activation NE xxx NE
and NE xxx NE
proliferation NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
overexpression NE xxx NE
and NE xxx NE
constitutive G#other_name_B xxx G#other_name_B
nuclear G#other_name_M xxx G#other_name_M
localization G#other_name_E xxx G#other_name_E
of NE xx NE
NF-AT G#protein_family_or_group XX-XX G#protein_family_or_group
, NE , NE
but NE xxx NE
not NE xxx NE
Jun G#protein_family_or_group_B Xxx G#protein_family_or_group_B
family G#protein_family_or_group_M xxx G#protein_family_or_group_M
member G#protein_family_or_group_M xxx G#protein_family_or_group_M
or G#protein_family_or_group_M xx G#protein_family_or_group_M
Fos G#protein_family_or_group_M Xxx G#protein_family_or_group_M
family G#protein_family_or_group_M xxx G#protein_family_or_group_M
member G#protein_family_or_group_M xxx G#protein_family_or_group_M
or G#protein_family_or_group_M xx G#protein_family_or_group_M
NF-kappaB G#protein_family_or_group_M XX-xxxX G#protein_family_or_group_M
family G#protein_family_or_group_M xxx G#protein_family_or_group_M
member G#protein_family_or_group_M xxx G#protein_family_or_group_M
or G#protein_family_or_group_M xx G#protein_family_or_group_M
Oct G#protein_family_or_group_M Xxx G#protein_family_or_group_M
family G#protein_family_or_group_M xxx G#protein_family_or_group_M
member G#protein_family_or_group_M xxx G#protein_family_or_group_M
or G#protein_family_or_group_M xx G#protein_family_or_group_M
Ets G#protein_family_or_group_M Xxx G#protein_family_or_group_M
family G#protein_family_or_group_M xxx G#protein_family_or_group_M
member G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
lymphocytes G#cell_line_E xxx G#cell_line_E
resistant NE xxx NE
to NE xx NE
FK506 G#other_organic_compound XXddd G#other_organic_compound
and NE xxx NE
cyclosporin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
. NE . NE

Thus NE Xxxx NE
a NE x NE
primary NE xxx NE
effect NE xxx NE
of NE xx NE
these NE xxx NE
immunosuppressive G#other_organic_compound_B xxx G#other_organic_compound_B
reagents G#other_organic_compound_E xxx G#other_organic_compound_E
is NE xx NE
to NE xx NE
control NE xxx NE
the NE xxx NE
subcellular NE xxx NE
localization NE xxx NE
of NE xx NE
the NE xxx NE
NF-AT G#protein_family_or_group XX-XX G#protein_family_or_group
family NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Autoregulation NE Xxxx NE
of NE xx NE
the NE xxx NE
NF-kappa G#protein_family_or_group_B XX-xxx G#protein_family_or_group_B
B G#protein_family_or_group_M X G#protein_family_or_group_M
transactivator G#protein_family_or_group_E xxx G#protein_family_or_group_E
RelA G#protein_subunit XxxX G#protein_subunit
( NE ( NE
p65 G#protein_subunit xdd G#protein_subunit
) NE ) NE
by NE xx NE
multiple NE xxx NE
cytoplasmic G#protein_family_or_group_B xxx G#protein_family_or_group_B
inhibitors G#protein_family_or_group_E xxx G#protein_family_or_group_E
containing NE xxx NE
ankyrin G#protein_substructure_B xxx G#protein_substructure_B
motifs G#protein_substructure_E xxx G#protein_substructure_E
. NE . NE

RelA G#protein_subunit XxxX G#protein_subunit
( NE ( NE
p65 G#protein_subunit xdd G#protein_subunit
) NE ) NE
functions NE xxx NE
as NE xx NE
the NE xxx NE
critical NE xxx NE
transactivating NE xxx NE
component NE xxx NE
of NE xx NE
the NE xxx NE
heterodimeric NE xxx NE
p50- NE xdd- NE
p65 NE xdd NE
NF-kappa NE XX-xxx NE
B NE X NE
complex NE xxx NE
and NE xxx NE
contains NE xxx NE
a NE x NE
high-affinity NE xxx-xxx NE
binding NE xxx NE
site NE xxx NE
for NE xxx NE
its NE xxx NE
cytoplasmic NE xxx NE
inhibitor NE xxx NE
, NE , NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
. NE . NE

After NE Xxxx NE
cellular NE xxx NE
activation NE xxx NE
, NE , NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
is NE xx NE
rapidly NE xxx NE
degraded NE xxx NE
in NE xx NE
concert NE xxx NE
with NE xxx NE
the NE xxx NE
induced NE xxx NE
nuclear NE xxx NE
translocation NE xxx NE
of NE xx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
. NE . NE

The NE Xxx NE
present NE xxx NE
study NE xxx NE
demonstrates NE xxx NE
that NE xxx NE
tumor NE xxx NE
necrosis NE xxx NE
factor NE xxx NE
alpha NE xxx NE
-induced NE -xxx NE
degradation NE xxx NE
of NE xx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
in NE xx NE
human NE xxx NE
T NE X NE
cells NE xxx NE
is NE xx NE
preceded NE xxx NE
by NE xx NE
its NE xxx NE
rapid NE xxx NE
phosphorylation NE xxx NE
in NE xx NE
vivo NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
these NE xxx NE
effects NE xxx NE
on NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
result NE xxx NE
in NE xx NE
nuclear NE xxx NE
mobilization NE xxx NE
of NE xx NE
only NE xxx NE
a NE x NE
fraction NE xxx NE
of NE xx NE
the NE xxx NE
entire NE xxx NE
cytoplasmic G#other_name_B xxx G#other_name_B
pool G#other_name_E xxx G#other_name_E
of NE xx NE
RelA G#protein_subunit XxxX G#protein_subunit
. NE . NE

Subsequent NE Xxxx NE
studies NE xxx NE
have NE xxx NE
revealed NE xxx NE
that NE xxx NE
(i) NE (x) NE
cytoplasmic G#protein_subunit_B xxx G#protein_subunit_B
RelA G#protein_subunit_E XxxX G#protein_subunit_E
is NE xx NE
stably NE xxx NE
associated NE xxx NE
not NE xxx NE
only NE xxx NE
with NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
but NE xxx NE
also NE xxx NE
with NE xxx NE
other NE xxx NE
ankyrin G#protein_family_or_group_B xxx G#protein_family_or_group_B
motif-rich G#protein_family_or_group_M xxx-xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
including NE xxx NE
the NE xxx NE
products NE xxx NE
of NE xx NE
the NE xxx NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B2 G#DNA_domain_or_region_M Xd G#DNA_domain_or_region_M
(p100) G#DNA_domain_or_region_M (xddd) G#DNA_domain_or_region_M
genes G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
NF-kappa G#DNA_domain_or_region_M XX-xxx G#DNA_domain_or_region_M
B1 G#DNA_domain_or_region_M Xd G#DNA_domain_or_region_M
(p105) G#DNA_domain_or_region_M (xddd) G#DNA_domain_or_region_M
genes G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
RelA NE XxxX NE
-I NE -X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
, NE , NE
RelA G#protein_subunit XxxX G#protein_subunit
-p100 NE -xddd NE
cytoplasmic NE xxx NE
complexes NE xxx NE
are NE xxx NE
not NE xxx NE
dissociated NE xxx NE
following NE xxx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
activation NE xxx NE
; NE ; NE
(iii) NE (xxx) NE
p100 G#protein_complex xddd G#protein_complex
functions NE xxx NE
as NE xx NE
a NE x NE
potent NE xxx NE
inhibitor NE xxx NE
of NE xx NE
RelA G#other_name XxxX G#other_name
-mediated NE -xxx NE
transcription NE xxx NE
in NE xx NE
vivo NE xxx NE
; NE ; NE
(iv) NE (xx) NE
the NE xxx NE
interaction NE xxx NE
of NE xx NE
RelA G#protein_subunit XxxX G#protein_subunit
and NE xxx NE
p100 G#protein_molecule xddd G#protein_molecule
involves NE xxx NE
the NE xxx NE
conserved G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
Rel G#protein_domain_or_region_M Xxx G#protein_domain_or_region_M
homology G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
both NE xxx NE
proteins NE xxx NE
but NE xxx NE
not NE xxx NE
the NE xxx NE
nuclear G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
localization G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
signal G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
RelA G#protein_subunit XxxX G#protein_subunit
, NE , NE
which NE xxx NE
is NE xx NE
required NE xxx NE
for NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
binding NE xxx NE
; NE ; NE
(v) NE (x) NE
p100 G#protein_molecule xddd G#protein_molecule
inhibition NE xxx NE
of NE xx NE
RelA G#protein_subunit XxxX G#protein_subunit
function NE xxx NE
requires NE xxx NE
the NE xxx NE
C-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
ankyrin G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
motif G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
, NE , NE
which NE xxx NE
mediates NE xxx NE
cytoplasmic NE xxx NE
retention NE xxx NE
of NE xx NE
RelA G#protein_subunit XxxX G#protein_subunit
; NE ; NE
and NE xxx NE
(vi) NE (xx) NE
as NE xx NE
observed NE xxx NE
with NE xxx NE
I G#other_name_B X G#other_name_B
kappa G#other_name_M xxx G#other_name_M
B G#other_name_M X G#other_name_M
alpha G#other_name_E xxx G#other_name_E
, NE , NE
nuclear NE xxx NE
RelA G#protein_subunit XxxX G#protein_subunit
stimulates NE xxx NE
p100 G#protein_molecule xddd G#protein_molecule
mRNA NE xXXX NE
and NE xxx NE
protein G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
findings NE xxx NE
thus NE xxx NE
reveal NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
a NE x NE
second NE xxx NE
inducible G#other_name_B xxx G#other_name_B
autoregulated G#other_name_M xxx G#other_name_M
inhibitory G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
that NE xxx NE
helps NE xxx NE
ensure NE xxx NE
the NE xxx NE
rapid NE xxx NE
but NE xxx NE
transient NE xxx NE
action NE xxx NE
of NE xx NE
nuclear G#protein_complex_B xxx G#protein_complex_B
NF-kappa G#protein_complex_M XX-xxx G#protein_complex_M
B G#protein_complex_E X G#protein_complex_E
. NE . NE

Effects NE Xxxx NE
of NE xx NE
CD45 G#protein_molecule XXdd G#protein_molecule
on NE xx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
. NE . NE

Implications NE Xxxx NE
for NE xxx NE
replication NE xxx NE
of NE xx NE
HIV-1 G#virus XXX-d G#virus
. NE . NE

Increased NE Xxxx NE
levels NE xxx NE
of NE xx NE
replication NE xxx NE
of NE xx NE
the NE xxx NE
HIV G#virus_B XXX G#virus_B
type G#virus_M xxx G#virus_M
1 G#virus_E d G#virus_E
are NE xxx NE
observed NE xxx NE
after NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
infected G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
through NE xxx NE
the NE xxx NE
TCR G#protein_family_or_group XXX G#protein_family_or_group
. NE . NE

However NE Xxxx NE
, NE , NE
anti- NE xxx- NE
CD45 G#protein_molecule XXdd G#protein_molecule
antibodies NE xxx NE
inhibit NE xxx NE
these NE xxx NE
effects NE xxx NE
in NE xx NE
cells NE xxx NE
from NE xxx NE
infected NE xxx NE
individuals NE xxx NE
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
we NE xx NE
examined NE xxx NE
interrelationships NE xxx NE
between NE xxx NE
CD45 G#protein_molecule XXdd G#protein_molecule
and NE xxx NE
HIV-1 G#virus XXX-d G#virus
further NE xxx NE
. NE . NE

We NE Xx NE
measured NE xxx NE
effects NE xxx NE
on NE xx NE
the NE xxx NE
HIV-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
LTR G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
in NE xx NE
T G#cell_line_B X G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
that NE xxx NE
were NE xxx NE
stimulated NE xxx NE
with NE xxx NE
antibodies NE xxx NE
against NE xxx NE
CD45 G#protein_molecule XXdd G#protein_molecule
and NE xxx NE
in NE xx NE
those NE xxx NE
that NE xxx NE
lacked NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
CD45 G#protein_molecule XXdd G#protein_molecule
on NE xx NE
their NE xxx NE
surfaces NE xxx NE
. NE . NE

First NE Xxxx NE
, NE , NE
anti- NE xxx- NE
CD45 NE XXdd NE
antibodies NE xxx NE
did NE xxx NE
not NE xxx NE
affect NE xxx NE
basal NE xxx NE
but NE xxx NE
decreased NE xxx NE
activated NE xxx NE
levels NE xxx NE
of NE xx NE
expression NE xxx NE
from NE xxx NE
the NE xxx NE
HIV-1 NE XXX-d NE
LTR NE XXX NE
. NE . NE

Second NE Xxxx NE
, NE , NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
which NE xxx NE
lack NE xxx NE
CD45 G#protein_molecule XXdd G#protein_molecule
and NE xxx NE
cannot NE xxx NE
signal NE xxx NE
via NE xxx NE
the NE xxx NE
TCR G#protein_family_or_group XXX G#protein_family_or_group
, NE , NE
supported NE xxx NE
higher NE xxx NE
levels NE xxx NE
of NE xx NE
viral NE xxx NE
replication NE xxx NE
and NE xxx NE
gene NE xxx NE
expression NE xxx NE
. NE . NE

This NE Xxxx NE
was NE xxx NE
due NE xxx NE
to NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
active NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
complexes NE xxx NE
in NE xx NE
the NE xxx NE
nucleus NE xxx NE
of NE xx NE
CD45 NE XXdd NE
-T NE -X NE
cells NE xxx NE
. NE . NE

Additionally NE Xxxx NE
, NE , NE
infected G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
displayed NE xxx NE
lower NE xxx NE
levels NE xxx NE
of NE xx NE
CD45 G#protein_molecule XXdd G#protein_molecule
on NE xx NE
their NE xxx NE
surfaces NE xxx NE
. NE . NE

Thus NE Xxxx NE
, NE , NE
CD45 G#protein_molecule XXdd G#protein_molecule
plays NE xxx NE
an NE xx NE
active NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
physiology NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
in NE xx NE
the NE xxx NE
replication NE xxx NE
of NE xx NE
HIV-1 G#virus XXX-d G#virus
. NE . NE

Calcineurin G#protein_molecule Xxxx G#protein_molecule
potentiates NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
granulocyte-macrophage G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
colony-stimulating G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
factor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
: NE : NE
involvement NE xxx NE
of NE xx NE
the NE xxx NE
conserved G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
lymphokine G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
0 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
. NE . NE

Granulocyte-macrophage G#protein_molecule_B Xxxx-xxx G#protein_molecule_B
colony-stimulating G#protein_molecule_M xxx-xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
) NE ) NE
and NE xxx NE
interleukin-2 G#protein_molecule xxx-d G#protein_molecule
( NE ( NE
IL-2 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
are NE xxx NE
produced NE xxx NE
by NE xx NE
stimulation NE xxx NE
with NE xxx NE
phorbol-12-myristate G#other_organic_compound_B xxx-dd-xxx G#other_organic_compound_B
acetate G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
PMA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
and NE xxx NE
calcium G#other_organic_compound_B xxx G#other_organic_compound_B
ionophore G#other_organic_compound_E xxx G#other_organic_compound_E
(A23187) NE (Xddddd) NE
in NE xx NE
human G#cell_line_B xxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
leukemia G#cell_line_M xxx G#cell_line_M
Jurkat G#cell_line_M Xxxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
expression NE xxx NE
of NE xx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
and NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
is NE xx NE
inhibited NE xxx NE
by NE xx NE
immunosuppressive G#other_organic_compound_B xxx G#other_organic_compound_B
drugs G#other_organic_compound_E xxx G#other_organic_compound_E
such NE xxx NE
as NE xx NE
cyclosporin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
( NE ( NE
CsA G#other_organic_compound XxX G#other_organic_compound
) NE ) NE
and NE xxx NE
FK506 G#other_organic_compound XXddd G#other_organic_compound
. NE . NE

Earlier NE Xxxx NE
studies NE xxx NE
on NE xx NE
the NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
showed NE xxx NE
that NE xxx NE
overexpression NE xxx NE
of NE xx NE
calcineurin G#protein_molecule xxx G#protein_molecule
( NE ( NE
CN G#protein_molecule XX G#protein_molecule
) NE ) NE
, NE , NE
a NE x NE
Ca2+/calmodulin-dependent G#protein_family_or_group_B Xxd+/xxx-xxx G#protein_family_or_group_B
protein G#protein_family_or_group_M xxx G#protein_family_or_group_M
phosphatase G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
can NE xxx NE
stimulate NE xxx NE
transcription G#other_name xxx G#other_name
from NE xxx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
through NE xxx NE
the NE xxx NE
NF-AT-binding G#DNA_domain_or_region_B XX-XX-xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
we NE xx NE
obtained NE xxx NE
evidence NE xxx NE
that NE xxx NE
transfection NE xxx NE
of NE xx NE
the NE xxx NE
cDNAs G#DNA_family_or_group xXXXx G#DNA_family_or_group
for NE xxx NE
CN G#protein_subunit_B XX G#protein_subunit_B
A G#protein_subunit_M X G#protein_subunit_M
(catalytic) G#protein_subunit_M (xxx) G#protein_subunit_M
subunit G#protein_subunit_M xxx G#protein_subunit_M
and G#protein_subunit_M xxx G#protein_subunit_M
CN G#protein_subunit_M XX G#protein_subunit_M
B G#protein_subunit_M X G#protein_subunit_M
(regulatory) G#protein_subunit_M (xxx) G#protein_subunit_M
subunit G#protein_subunit_E xxx G#protein_subunit_E
also NE xxx NE
augments NE xxx NE
transcription NE xxx NE
from NE xxx NE
the NE xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
recovers NE xxx NE
the NE xxx NE
transcription NE xxx NE
inhibited NE xxx NE
by NE xx NE
CsA G#other_organic_compound XxX G#other_organic_compound
. NE . NE

The NE Xxx NE
constitutively NE xxx NE
active NE xxx NE
type NE xxx NE
of NE xx NE
the NE xxx NE
CN G#protein_subunit_B XX G#protein_subunit_B
A G#protein_subunit_M X G#protein_subunit_M
subunit G#protein_subunit_E xxx G#protein_subunit_E
, NE , NE
which NE xxx NE
lacks NE xxx NE
the NE xxx NE
auto-inhibitory NE xxx-xxx NE
and NE xxx NE
calmodulin-binding NE xxx-xxx NE
domains NE xxx NE
, NE , NE
acts NE xxx NE
in NE xx NE
synergy NE xxx NE
with NE xxx NE
PMA NE XXX NE
to NE xx NE
activate NE xxx NE
transcription NE xxx NE
from NE xxx NE
the NE xxx NE
GM-CSF NE XX-XXX NE
promoter NE xxx NE
. NE . NE

We NE Xx NE
also NE xxx NE
found NE xxx NE
that NE xxx NE
the NE xxx NE
active NE xxx NE
CN G#protein_molecule XX G#protein_molecule
partially NE xxx NE
replaces NE xxx NE
calcium G#other_organic_compound_B xxx G#other_organic_compound_B
ionophore G#other_organic_compound_E xxx G#other_organic_compound_E
in NE xx NE
synergy NE xxx NE
with NE xxx NE
PMA G#other_organic_compound XXX G#other_organic_compound
to NE xx NE
induce NE xxx NE
expression NE xxx NE
of NE xx NE
endogenous NE xxx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
and NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
. NE . NE

By NE Xx NE
multimerizing NE xxx NE
the NE xxx NE
regulatory G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
of NE xx NE
the NE xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
we NE xx NE
found NE xxx NE
that NE xxx NE
one NE xxx NE
of NE xx NE
the NE xxx NE
target G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
the NE xxx NE
CN G#protein_molecule XX G#protein_molecule
action NE xxx NE
is NE xx NE
the NE xxx NE
conserved G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
lymphokine G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
0 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
( NE ( NE
CLE0 G#DNA_domain_or_region XXXd G#DNA_domain_or_region
) NE ) NE
, NE , NE
located NE xxx NE
at NE xx NE
positions NE xxx NE
between NE xxx NE
-54 G#DNA_substructure_B -dd G#DNA_substructure_B
and G#DNA_substructure_M xxx G#DNA_substructure_M
-40 G#DNA_substructure_E -dd G#DNA_substructure_E
. NE . NE

Mobility G#other_name_B Xxxx G#other_name_B
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
showed NE xxx NE
that NE xxx NE
the NE xxx NE
CLE0 G#DNA_domain_or_region XXXd G#DNA_domain_or_region
sequence NE xxx NE
has NE xxx NE
an NE xx NE
AP1-binding G#DNA_domain_or_region_B XXd-xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
is NE xx NE
associated NE xxx NE
with NE xxx NE
an NE xx NE
NF-AT-like G#protein_family_or_group_B XX-XX-xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
termed NE xxx NE
NF- NE XX- NE
CLE0 NE XXXd NE
gamma NE xxx NE
. NE . NE

NF- NE XX- NE
CLE0 G#DNA_domain_or_region XXXd G#DNA_domain_or_region
gamma NE xxx NE
binding NE xxx NE
is NE xx NE
induced NE xxx NE
by NE xx NE
PMA G#other_organic_compound XXX G#other_organic_compound
/A23187 NE /Xddddd NE
and NE xxx NE
is NE xx NE
inhibited NE xxx NE
by NE xx NE
treatment NE xxx NE
with NE xxx NE
CsA G#other_organic_compound XxX G#other_organic_compound
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
CN G#protein_molecule XX G#protein_molecule
is NE xx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
coordinated NE xxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
IL-2 G#DNA_domain_or_region_M XX-d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
GM-CSF G#DNA_domain_or_region XX-XXX G#DNA_domain_or_region
CLE0 NE XXXd NE
sequence G#DNA_domain_or_region xxx G#DNA_domain_or_region
of NE xx NE
the NE xxx NE
GM-CSF NE XX-XXX NE
gene NE xxx NE
is NE xx NE
a NE x NE
functional NE xxx NE
analogue NE xxx NE
of NE xx NE
the NE xxx NE
NF-AT-binding G#DNA_domain_or_region_B XX-XX-xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
which NE xxx NE
mediates NE xxx NE
signals NE xxx NE
downstream NE xxx NE
of NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

Alternate NE Xxxx NE
immune G#other_name_B xxx G#other_name_B
system G#other_name_M xxx G#other_name_M
targets G#other_name_E xxx G#other_name_E
for NE xxx NE
TCDD G#other_organic_compound XXXX G#other_organic_compound
: NE : NE
lymphocyte G#cell_type_B xxx G#cell_type_B
stem G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
extrathymic G#other_name_B xxx G#other_name_B
T-cell G#other_name_M X-xxx G#other_name_M
development G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
here NE xxx NE
summarize NE xxx NE
evidence NE xxx NE
that NE xxx NE
thymic G#other_name_B xxx G#other_name_B
atrophy G#other_name_E xxx G#other_name_E
induced NE xxx NE
by NE xx NE
2,3,7,8-tetrachlorodibenzo-p-dioxin G#other_organic_compound d,d,d,d-xxx-x-xxx G#other_organic_compound
( NE ( NE
TCDD G#other_organic_compound XXXX G#other_organic_compound
) NE ) NE
can NE xxx NE
be NE xx NE
mediated NE xxx NE
, NE , NE
at NE xx NE
least NE xxx NE
in NE xx NE
part NE xxx NE
, NE , NE
by NE xx NE
damage NE xxx NE
to NE xx NE
extrathymic G#cell_type_B xxx G#cell_type_B
T-cell G#cell_type_M X-xxx G#cell_type_M
precursors G#cell_type_E xxx G#cell_type_E
in NE xx NE
bone G#tissue_B xxx G#tissue_B
marrow G#tissue_E xxx G#tissue_E
and NE xxx NE
fetal G#body_part_B xxx G#body_part_B
liver G#body_part_E xxx G#body_part_E
. NE . NE

This NE Xxxx NE
atrophy G#other_name_B xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
does NE xxx NE
not NE xxx NE
involve NE xxx NE
apoptotic G#other_name_B xxx G#other_name_B
mechanisms G#other_name_E xxx G#other_name_E
in NE xx NE
thymocytes G#cell_type xxx G#cell_type
affected NE xxx NE
by NE xx NE
the NE xxx NE
bcl-2 G#DNA_domain_or_region_B xxx-d G#DNA_domain_or_region_B
proto-oncogene G#DNA_domain_or_region_E xxx-xxx G#DNA_domain_or_region_E
. NE . NE

TCDD G#other_organic_compound XXXX G#other_organic_compound
mediates NE xxx NE
atrophy G#other_name_B xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
through NE xxx NE
its NE xxx NE
specific NE xxx NE
receptor NE xxx NE
(the NE (xxx NE
AhR G#protein_molecule XxX G#protein_molecule
) NE ) NE
and NE xxx NE
not NE xxx NE
through NE xxx NE
effects NE xxx NE
on NE xx NE
the NE xxx NE
estrogen NE xxx NE
receptor NE xxx NE
. NE . NE

Both NE Xxxx NE
TCDD G#other_organic_compound XXXX G#other_organic_compound
and NE xxx NE
estradiol G#lipid xxx G#lipid
induce NE xxx NE
extrathymic G#other_name_B xxx G#other_name_B
T-cell G#other_name_M X-xxx G#other_name_M
differentiation G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
liver G#body_part xxx G#body_part
. NE . NE

These NE Xxxx NE
extrathymic G#cell_type_B xxx G#cell_type_B
T-cell G#cell_type_M X-xxx G#cell_type_M
populations G#cell_type_E xxx G#cell_type_E
include NE xxx NE
cells NE xxx NE
expressing NE xxx NE
elevated NE xxx NE
levels NE xxx NE
of NE xx NE
V G#protein_molecule_B X G#protein_molecule_B
beta G#protein_molecule_M xxx G#protein_molecule_M
T-cell G#protein_molecule_M X-xxx G#protein_molecule_M
receptors G#protein_molecule_E xxx G#protein_molecule_E
that NE xxx NE
are NE xxx NE
normally NE xxx NE
deleted NE xxx NE
in NE xx NE
thymic G#other_name_B xxx G#other_name_B
development G#other_name_E xxx G#other_name_E
. NE . NE

Identification NE Xxxx NE
of NE xx NE
Bcd G#DNA_domain_or_region Xxx G#DNA_domain_or_region
, NE , NE
a NE x NE
novel NE xxx NE
proto-oncogene G#DNA_family_or_group xxx-xxx G#DNA_family_or_group
expressed NE xxx NE
in NE xx NE
B-cells G#cell_type X-xxx G#cell_type
. NE . NE

A NE X NE
novel G#cell_type_B xxx G#cell_type_B
B-cell G#cell_type_E X-xxx G#cell_type_E
derived NE xxx NE
( NE ( NE
Bcd G#DNA_domain_or_region Xxx G#DNA_domain_or_region
) NE ) NE
oncogene G#DNA_family_or_group xxx G#DNA_family_or_group
has NE xxx NE
been NE xxx NE
isolated NE xxx NE
from NE xxx NE
the NE xxx NE
peripheral NE xxx NE
blood NE xxx NE
lymphocytes NE xxx NE
of NE xx NE
one NE xxx NE
B-cell NE X-xxx NE
chronic NE xxx NE
lymphocytic NE xxx NE
leukemia NE xxx NE
( NE ( NE
B-CLL NE X-XXX NE
) NE ) NE
patient NE xxx NE
using NE xxx NE
DNA NE XXX NE
transfer NE xxx NE
and NE xxx NE
a NE x NE
mouse NE xxx NE
tumorigenicity NE xxx NE
assay NE xxx NE
. NE . NE

The NE Xxx NE
Bcd G#DNA_domain_or_region Xxx G#DNA_domain_or_region
proto-oncogene G#DNA_family_or_group xxx-xxx G#DNA_family_or_group
was NE xxx NE
activated NE xxx NE
by NE xx NE
a NE x NE
truncation NE xxx NE
in NE xx NE
the NE xxx NE
5' G#DNA_domain_or_region_B d' G#DNA_domain_or_region_B
UTR G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
. NE . NE

It NE Xx NE
predicts NE xxx NE
for NE xxx NE
two NE xxx NE
open G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
reading G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
frames G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
ORFs G#DNA_domain_or_region XXXx G#DNA_domain_or_region
) NE ) NE
. NE . NE

ORF1 G#DNA_domain_or_region XXXd G#DNA_domain_or_region
consists NE xxx NE
of NE xx NE
240 G#polynucleotide_B ddd G#polynucleotide_B
bp G#polynucleotide_E xx G#polynucleotide_E
that NE xxx NE
would NE xxx NE
encode NE xxx NE
80 G#peptide_B dd G#peptide_B
amino G#peptide_M xxx G#peptide_M
acids G#peptide_E xxx G#peptide_E
, NE , NE
while NE xxx NE
the NE xxx NE
major G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
ORF2 G#DNA_domain_or_region_E XXXd G#DNA_domain_or_region_E
consists NE xxx NE
of NE xx NE
648 G#polynucleotide_B ddd G#polynucleotide_B
bp G#polynucleotide_E xx G#polynucleotide_E
capable NE xxx NE
of NE xx NE
coding NE xxx NE
for NE xxx NE
216 G#peptide_B ddd G#peptide_B
amino G#peptide_M xxx G#peptide_M
acids G#peptide_E xxx G#peptide_E
. NE . NE

Predicted G#protein_domain_or_region_B Xxxx G#protein_domain_or_region_B
peptide G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
sequence G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
ORF2 G#DNA_domain_or_region XXXd G#DNA_domain_or_region
contained NE xxx NE
a NE x NE
zinc G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
finger G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
which NE xxx NE
showed NE xxx NE
significant NE xxx NE
homology NE xxx NE
to NE xx NE
GC G#protein_family_or_group_B XX G#protein_family_or_group_B
box G#protein_family_or_group_M xxx G#protein_family_or_group_M
binding G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
BTEB2 G#protein_molecule XXXXd G#protein_molecule
and NE xxx NE
SP1 G#protein_molecule XXd G#protein_molecule
. NE . NE

Transfection NE Xxxx NE
of NE xx NE
an NE xx NE
expression G#DNA_molecule_B xxx G#DNA_molecule_B
vector G#DNA_molecule_E xxx G#DNA_molecule_E
containing NE xxx NE
ORF2 G#DNA_domain_or_region XXXd G#DNA_domain_or_region
but NE xxx NE
not NE xxx NE
full G#DNA_molecule_B xxx G#DNA_molecule_B
length G#DNA_molecule_M xxx G#DNA_molecule_M
cDNA G#DNA_molecule_E xXXX G#DNA_molecule_E
was NE xxx NE
able NE xxx NE
to NE xx NE
transform NE xxx NE
NIH3T3 G#cell_line_B XXXdXd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
induce NE xxx NE
tumors G#tissue xxx G#tissue
in NE xx NE
nude NE xxx NE
mice NE xxx NE
. NE . NE

Bcd G#RNA_molecule_B Xxx G#RNA_molecule_B
mRNA G#RNA_molecule_M xXXX G#RNA_molecule_M
transcripts G#RNA_molecule_E xxx G#RNA_molecule_E
of NE xx NE
< NE < NE
or NE xx NE
= NE = NE
2.6 NE d.d NE
kb NE xx NE
were NE xxx NE
selectively NE xxx NE
expressed NE xxx NE
in NE xx NE
PBL G#cell_line XXX G#cell_line
and NE xxx NE
testis G#body_part xxx G#body_part
of NE xx NE
healthy G#multi_cell_B xxx G#multi_cell_B
individuals G#multi_cell_E xxx G#multi_cell_E
. NE . NE

Within NE Xxxx NE
the NE xxx NE
PBL G#cell_type XXX G#cell_type
, NE , NE
Bcd G#other_name_B Xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
was NE xxx NE
restricted NE xxx NE
to NE xx NE
CD19+ G#cell_type_B XXdd+ G#cell_type_B
B-cells G#cell_type_E X-xxx G#cell_type_E
and NE xxx NE
absent NE xxx NE
from NE xxx NE
CD14+ G#cell_type_B XXdd+ G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
and NE xxx NE
T-cells G#cell_type X-xxx G#cell_type
. NE . NE

Bcd G#DNA_domain_or_region Xxx G#DNA_domain_or_region
transcripts NE xxx NE
were NE xxx NE
detected NE xxx NE
in NE xx NE
all NE xxx NE
normal NE xxx NE
PBL G#cell_type XXX G#cell_type
samples NE xxx NE
tested NE xxx NE
but NE xxx NE
not NE xxx NE
in NE xx NE
several NE xxx NE
malignant G#cell_line_B xxx G#cell_line_B
human G#cell_line_M xxx G#cell_line_M
B-cell G#cell_line_M X-xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
and NE xxx NE
not NE xxx NE
in NE xx NE
50% NE dd% NE
of NE xx NE
B-cells G#cell_type X-xxx G#cell_type
from NE xxx NE
B-CLL G#multi_cell_B X-XXX G#multi_cell_B
patients G#multi_cell_E xxx G#multi_cell_E
. NE . NE

However NE Xxxx NE
, NE , NE
stimulation NE xxx NE
of NE xx NE
B-cells G#cell_type X-xxx G#cell_type
from NE xxx NE
B-CLL G#multi_cell_B X-XXX G#multi_cell_B
patients G#multi_cell_E xxx G#multi_cell_E
under NE xxx NE
conditions NE xxx NE
which NE xxx NE
induced NE xxx NE
differentiation NE xxx NE
into NE xxx NE
plasma G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
was NE xxx NE
associated NE xxx NE
with NE xxx NE
induction NE xxx NE
of NE xx NE
Bcd G#other_name_B Xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
Bcd G#DNA_domain_or_region_B Xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
may NE xxx NE
therefore NE xxx NE
play NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
B-cell G#other_name_B X-xxx G#other_name_B
growth G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
B-cell G#other_name_M X-xxx G#other_name_M
development G#other_name_E xxx G#other_name_E

A NE X NE
novel G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
SP-1 G#DNA_domain_or_region_M XX-d G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
interleukin-1 G#DNA_domain_or_region_M xxx-d G#DNA_domain_or_region_M
beta G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
confers NE xxx NE
preferential G#other_name_B xxx G#other_name_B
transcriptional G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
keratinocytes G#cell_type xxx G#cell_type
. NE . NE

To NE Xx NE
investigate NE xxx NE
the NE xxx NE
mechanisms NE xxx NE
of NE xx NE
transcriptional G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
of NE xx NE
interleukin-1beta G#protein_molecule xxx-dxxx G#protein_molecule
( NE ( NE
IL-1beta G#protein_molecule XX-dxxx G#protein_molecule
) NE ) NE
in NE xx NE
non-monocytic NE xxx-xxx NE
cells NE xxx NE
, NE , NE
we NE xx NE
constructed NE xxx NE
a NE x NE
series NE xxx NE
of NE xx NE
reporter NE xxx NE
plasmids NE xxx NE
with NE xxx NE
the NE xxx NE
bacterial NE xxx NE
chloramphenicol NE xxx NE
acetyltransferase NE xxx NE
gene NE xxx NE
linked NE xxx NE
to NE xx NE
various NE xxx NE
parts NE xxx NE
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
IL-1beta G#DNA_domain_or_region_M XX-dxxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
performed NE xxx NE
transient G#other_name_B xxx G#other_name_B
transfection G#other_name_M xxx G#other_name_M
experiments G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
identified NE xxx NE
a NE x NE
promoter NE xxx NE
segment NE xxx NE
that NE xxx NE
activates NE xxx NE
transcription NE xxx NE
most NE xxx NE
efficiently NE xxx NE
in NE xx NE
keratinocytes G#cell_type xxx G#cell_type
. NE . NE

Electrophoretic G#other_name_B Xxxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
( NE ( NE
EMSA G#other_name XXXX G#other_name
) NE ) NE
with NE xxx NE
a NE x NE
43-mer G#DNA_domain_or_region_B dd-xxx G#DNA_domain_or_region_B
oligonucleotide G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
derived NE xxx NE
from NE xxx NE
the NE xxx NE
functionally NE xxx NE
identified NE xxx NE
cis-acting G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
revealed NE xxx NE
specific NE xxx NE
complexes NE xxx NE
. NE . NE

By NE Xx NE
competition NE xxx NE
analysis NE xxx NE
with NE xxx NE
transcription G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
factor G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
consensus G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
sequence G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
oligonucleotides G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
and NE xxx NE
by NE xx NE
immunosupershift G#other_name xxx G#other_name
, NE , NE
transcription G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
SP-1 G#protein_molecule_E XX-d G#protein_molecule_E
or NE xx NE
a NE x NE
closely NE xxx NE
related NE xxx NE
protein NE xxx NE
was NE xxx NE
shown NE xxx NE
to NE xx NE
bind NE xxx NE
to NE xx NE
this NE xxx NE
regulatory G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
closest NE xxx NE
match NE xxx NE
to NE xx NE
the NE xxx NE
known NE xxx NE
SP-1 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
consensus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
within NE xxx NE
the NE xxx NE
respective NE xxx NE
region NE xxx NE
is NE xx NE
a NE x NE
TCCCCTCCCCT G#DNA_domain_or_region_B XXXXXXXXXXX G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Mutation NE Xxxx NE
of NE xx NE
this NE xxx NE
motif NE xxx NE
almost NE xxx NE
completely NE xxx NE
, NE , NE
and NE xxx NE
specifically NE xxx NE
, NE , NE
abolished NE xxx NE
the NE xxx NE
binding NE xxx NE
of NE xx NE
two NE xxx NE
low-mobility NE xxx-xxx NE
complexes NE xxx NE
and NE xxx NE
led NE xxx NE
to NE xx NE
a NE x NE
95% NE dd% NE
decrease NE xxx NE
of NE xx NE
constitutive NE xxx NE
transcriptional NE xxx NE
activation NE xxx NE
of NE xx NE
a NE x NE
reporter NE xxx NE
construct NE xxx NE
IL-1beta NE XX-dxxx NE
(-170/+108) NE (-ddd/+ddd) NE
. NE . NE

Likewise NE Xxxx NE
, NE , NE
activation NE xxx NE
of NE xx NE
this NE xxx NE
reporter NE xxx NE
construct NE xxx NE
by NE xx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor-alpha G#protein_molecule_E xxx-xxx G#protein_molecule_E
depended NE xxx NE
on NE xx NE
the NE xxx NE
SP-1 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

These NE Xxxx NE
observations NE xxx NE
suggest NE xxx NE
that NE xxx NE
a NE x NE
so-far-unrecognized NE xx-xxx-xxx NE
SP-1 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
IL-1beta G#DNA_domain_or_region_M XX-dxxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
may NE xxx NE
participate NE xxx NE
in NE xx NE
the NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
of NE xx NE
this NE xxx NE
gene NE xxx NE
in NE xx NE
keratinocytes G#cell_type xxx G#cell_type
. NE . NE

Expression NE Xxxx NE
of NE xx NE
Egr-1 G#protein_molecule Xxx-d G#protein_molecule
correlates NE xxx NE
with NE xxx NE
the NE xxx NE
transformed NE xxx NE
phenotype NE xxx NE
and NE xxx NE
the NE xxx NE
type NE xxx NE
of NE xx NE
viral NE xxx NE
latency NE xxx NE
in NE xx NE
EBV G#cell_line_B XXX G#cell_line_B
genome G#cell_line_M xxx G#cell_line_M
positive G#cell_line_M xxx G#cell_line_M
lymphoid G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

In NE Xx NE
this NE xxx NE
paper NE xxx NE
we NE xx NE
have NE xxx NE
investigated NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
Egr-1 G#protein_molecule Xxx-d G#protein_molecule
in NE xx NE
B G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
growth G#other_name_M xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
by NE xx NE
examining NE xxx NE
the NE xxx NE
gene NE xxx NE
expression NE xxx NE
in NE xx NE
a NE x NE
panel NE xxx NE
of NE xx NE
B G#cell_line_B X G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
, NE , NE
including NE xxx NE
both NE xxx NE
EBV G#DNA_family_or_group_B XXX G#DNA_family_or_group_B
genome G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
negative NE xxx NE
and NE xxx NE
EBV G#cell_line_B XXX G#cell_line_B
carrying G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

Egr-1 G#protein_molecule Xxx-d G#protein_molecule
expression NE xxx NE
correlates NE xxx NE
with NE xxx NE
the NE xxx NE
cellular G#other_name_B xxx G#other_name_B
phenotype G#other_name_E xxx G#other_name_E
and NE xxx NE
the NE xxx NE
specific NE xxx NE
pattern NE xxx NE
of NE xx NE
viral G#other_name_B xxx G#other_name_B
latency G#other_name_E xxx G#other_name_E
established NE xxx NE
within NE xxx NE
the NE xxx NE
individual G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

Thus NE Xxxx NE
, NE , NE
constitutive NE xxx NE
activation NE xxx NE
of NE xx NE
Egr-1 G#protein_molecule Xxx-d G#protein_molecule
gene NE xxx NE
is NE xx NE
invariably NE xxx NE
associated NE xxx NE
with NE xxx NE
unrestricted NE xxx NE
expression NE xxx NE
of NE xx NE
viral NE xxx NE
latent NE xxx NE
genes NE xxx NE
in NE xx NE
all NE xxx NE
group G#cell_line_B xxx G#cell_line_B
III G#cell_line_M XXX G#cell_line_M
EBV G#cell_line_M XXX G#cell_line_M
genome G#cell_line_M xxx G#cell_line_M
carrying G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
Egr-1 G#other_name_B Xxx-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
is NE xx NE
abrogated NE xxx NE
in NE xx NE
group G#cell_line_B xxx G#cell_line_B
I G#cell_line_M X G#cell_line_M
Burkitt G#cell_line_M Xxxx G#cell_line_M
tumor G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
irrespective NE xxx NE
of NE xx NE
the NE xxx NE
EBV G#DNA_family_or_group_B XXX G#DNA_family_or_group_B
genome G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
carrying NE xxx NE
status NE xxx NE
. NE . NE

Activated NE Xxxx NE
viral G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
associated NE xxx NE
with NE xxx NE
phenotypic NE xxx NE
conversion NE xxx NE
of NE xx NE
group G#cell_line_B xxx G#cell_line_B
I G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
in NE xx NE
to NE xx NE
group G#cell_line_B xxx G#cell_line_B
II G#cell_line_E XX G#cell_line_E
or NE xx NE
III NE XXX NE
restores NE xxx NE
the NE xxx NE
Egr-1 NE Xxx-d NE
gene NE xxx NE
expression NE xxx NE
. NE . NE

Several NE Xxxx NE
forms NE xxx NE
of NE xx NE
EGR-1 G#protein_molecule_B XXX-d G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
are NE xxx NE
found NE xxx NE
within NE xxx NE
the NE xxx NE
different NE xxx NE
groups NE xxx NE
of NE xx NE
cell NE xxx NE
lines NE xxx NE
, NE , NE
and NE xxx NE
the NE xxx NE
binding NE xxx NE
activity NE xxx NE
to NE xx NE
DNA G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
consensus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequences G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
investigated NE xxx NE
. NE . NE

Finally NE Xxxx NE
, NE , NE
time NE xxx NE
course NE xxx NE
analysis NE xxx NE
of NE xx NE
Egr-1 G#other_name_B Xxx-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
during NE xxx NE
the NE xxx NE
early NE xxx NE
steps NE xxx NE
of NE xx NE
EBV G#other_name_B XXX G#other_name_B
infection G#other_name_E xxx G#other_name_E
in NE xx NE
vitro NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
Egr-1 G#protein_molecule Xxx-d G#protein_molecule
is NE xx NE
upregulated NE xxx NE
within NE xxx NE
minutes NE xxx NE
from NE xxx NE
the NE xxx NE
initial NE xxx NE
interaction NE xxx NE
with NE xxx NE
the NE xxx NE
B G#cell_type_B X G#cell_type_B
lymphocyte G#cell_type_E xxx G#cell_type_E
. NE . NE

Expression NE Xxxx NE
of NE xx NE
erythroid-specific G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
in NE xx NE
megakaryoblastic G#other_name_B xxx G#other_name_B
disorders G#other_name_E xxx G#other_name_E
. NE . NE

Currently NE Xxxx NE
available NE xxx NE
data NE xxx NE
indicate NE xxx NE
that NE xxx NE
erythroid G#other_name_B xxx G#other_name_B
differentiation G#other_name_M xxx G#other_name_M
pathway G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
megakaryocytic G#other_name_M xxx G#other_name_M
differentiation G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
progenitor NE xxx NE
cells NE xxx NE
common NE xxx NE
to NE xx NE
those NE xxx NE
two NE xxx NE
lineages NE xxx NE
may NE xxx NE
exist NE xxx NE
. NE . NE

Acute G#other_name_B Xxxx G#other_name_B
megakaryoblastic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
( NE ( NE
AML-M7 G#other_name XXX-Xd G#other_name
) NE ) NE
and NE xxx NE
transient G#other_name_B xxx G#other_name_B
myeloproliferative G#other_name_M xxx G#other_name_M
disorder G#other_name_E xxx G#other_name_E
in NE xx NE
Down's G#other_name_B Xxxx'x G#other_name_B
syndrome G#other_name_E xxx G#other_name_E
( NE ( NE
TMD G#other_name XXX G#other_name
) NE ) NE
are NE xxx NE
characterized NE xxx NE
by NE xx NE
rapid NE xxx NE
growth NE xxx NE
of NE xx NE
abnormal G#cell_type_B xxx G#cell_type_B
blast G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
which NE xxx NE
express NE xxx NE
megakaryocytic G#protein_family_or_group_B xxx G#protein_family_or_group_B
markers G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

These NE Xxxx NE
blast G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
express NE xxx NE
lineage-specific G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
such NE xxx NE
as NE xx NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
common NE xxx NE
to NE xx NE
these NE xxx NE
lineages NE xxx NE
and NE xxx NE
frequently NE xxx NE
express NE xxx NE
erythroid-specific G#RNA_molecule_B xxx-xxx G#RNA_molecule_B
mRNAs G#RNA_molecule_E xXXXx G#RNA_molecule_E
such NE xxx NE
as NE xx NE
gamma-globin G#protein_family_or_group xxx-xxx G#protein_family_or_group
and NE xxx NE
erythroid G#protein_molecule_B xxx G#protein_molecule_B
delta-aminolevulinate G#protein_molecule_M xxx-xxx G#protein_molecule_M
synthase G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
ALAS-E G#protein_molecule XXXX-X G#protein_molecule
) NE ) NE
, NE , NE
indicating NE xxx NE
that NE xxx NE
most NE xxx NE
of NE xx NE
the NE xxx NE
blasts NE xxx NE
in NE xx NE
M7 G#other_name_B Xd G#other_name_B
case G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
TMD G#other_name_M XXX G#other_name_M
case G#other_name_E xxx G#other_name_E
have NE xxx NE
erythroid G#other_name_B xxx G#other_name_B
phenotype G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
megakaryocytic G#other_name_M xxx G#other_name_M
phenotype G#other_name_E xxx G#other_name_E

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
blasts G#cell_type xxx G#cell_type
in NE xx NE
M7 G#other_name Xd G#other_name
and NE xxx NE
TMD G#other_name XXX G#other_name
may NE xxx NE
correspond NE xxx NE
to NE xx NE
progenitors G#cell_type xxx G#cell_type
of NE xx NE
both NE xxx NE
erythroid G#cell_type_B xxx G#cell_type_B
lineage G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
megakaryocytic G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_E xxx G#cell_type_E

Stat3 G#protein_molecule Xxxxd G#protein_molecule
recruitment NE xxx NE
by NE xx NE
two NE xxx NE
distinct NE xxx NE
ligand-induced, G#protein_domain_or_region_B xxx-xxx, G#protein_domain_or_region_B
tyrosine-phosphorylated G#protein_domain_or_region_M xxx-xxx G#protein_domain_or_region_M
docking G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
sites G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
in NE xx NE
the NE xxx NE
interleukin-10 G#protein_domain_or_region_B xxx-dd G#protein_domain_or_region_B
receptor G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
intracellular G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

Recent NE Xxxx NE
work NE xxx NE
has NE xxx NE
shown NE xxx NE
that NE xxx NE
IL-10 G#protein_molecule XX-dd G#protein_molecule
induces NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
JAK NE XXX NE
-STAT NE -XXXX NE
signaling NE xxx NE
pathway NE xxx NE
. NE . NE

To NE Xx NE
define NE xxx NE
the NE xxx NE
mechanism NE xxx NE
underlying NE xxx NE
signal G#protein_molecule_B xxx G#protein_molecule_B
transducer G#protein_molecule_M xxx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
activator G#protein_molecule_M xxx G#protein_molecule_M
of G#protein_molecule_M xx G#protein_molecule_M
transcription G#protein_molecule_M xxx G#protein_molecule_M
(STAT) G#protein_molecule_M (XXXX) G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
recruitment NE xxx NE
to NE xx NE
the NE xxx NE
interleukin NE xxx NE
10 NE dd NE
( NE ( NE
IL-10 NE XX-dd NE
) NE ) NE
receptor NE xxx NE
, NE , NE
the NE xxx NE
STAT NE XXXX NE
proteins NE xxx NE
activated NE xxx NE
by NE xx NE
IL-10 NE XX-dd NE
in NE xx NE
different NE xxx NE
cell NE xxx NE
populations NE xxx NE
were NE xxx NE
first NE xxx NE
defined NE xxx NE
using NE xxx NE
electrophoretic NE xxx NE
mobility NE xxx NE
shift NE xxx NE
assays NE xxx NE
. NE . NE

In NE Xx NE
all NE xxx NE
cells NE xxx NE
tested NE xxx NE
, NE , NE
IL-10 G#protein_molecule XX-dd G#protein_molecule
activated NE xxx NE
Stat1 G#protein_molecule Xxxxd G#protein_molecule
and NE xxx NE
Stat3 G#protein_molecule Xxxxd G#protein_molecule
and NE xxx NE
induced NE xxx NE
the NE xxx NE
formation NE xxx NE
of NE xx NE
three NE xxx NE
distinct NE xxx NE
DNA NE XXX NE
binding NE xxx NE
complexes NE xxx NE
that NE xxx NE
contained NE xxx NE
different NE xxx NE
combinations NE xxx NE
of NE xx NE
these NE xxx NE
two NE xxx NE
transcription NE xxx NE
factors NE xxx NE
. NE . NE

IL-10 G#protein_molecule XX-dd G#protein_molecule
also NE xxx NE
activated NE xxx NE
Stat5 G#protein_molecule Xxxxd G#protein_molecule
in NE xx NE
Ba/F3 G#cell_line_B Xx/Xd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
that NE xxx NE
stably NE xxx NE
expressed NE xxx NE
the NE xxx NE
murine NE xxx NE
IL-10 G#protein_molecule_B XX-dd G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Using NE Xxxx NE
a NE x NE
structure-function NE xxx-xxx NE
mutagenesis NE xxx NE
approach NE xxx NE
, NE , NE
two NE xxx NE
tyrosine G#amino_acid_monomer_B xxx G#amino_acid_monomer_B
residues G#amino_acid_monomer_E xxx G#amino_acid_monomer_E
( NE ( NE
Tyr427 G#amino_acid_monomer Xxxddd G#amino_acid_monomer
and NE xxx NE
Tyr477 G#amino_acid_monomer Xxxddd G#amino_acid_monomer
) NE ) NE
in NE xx NE
the NE xxx NE
intracellular G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
the NE xxx NE
murine NE xxx NE
IL-10 G#protein_molecule XX-dd G#protein_molecule
receptor NE xxx NE
were NE xxx NE
found NE xxx NE
to NE xx NE
be NE xx NE
redundantly NE xxx NE
required NE xxx NE
for NE xxx NE
receptor G#other_name_B xxx G#other_name_B
function G#other_name_E xxx G#other_name_E
and NE xxx NE
for NE xxx NE
activation NE xxx NE
of NE xx NE
Stat3 G#protein_molecule Xxxxd G#protein_molecule
but NE xxx NE
not NE xxx NE
for NE xxx NE
Stat1 G#protein_molecule Xxxxd G#protein_molecule
or NE xx NE
Stat5 G#protein_molecule Xxxxd G#protein_molecule
. NE . NE

Twelve NE Xxxx NE
amino G#peptide_B xxx G#peptide_B
acid G#peptide_M xxx G#peptide_M
peptides G#peptide_E xxx G#peptide_E
encompassing NE xxx NE
either NE xxx NE
of NE xx NE
these NE xxx NE
two NE xxx NE
tyrosine G#amino_acid_monomer_B xxx G#amino_acid_monomer_B
residues G#amino_acid_monomer_E xxx G#amino_acid_monomer_E
in NE xx NE
phosphorylated G#protein_molecule_B xxx G#protein_molecule_B
form G#protein_molecule_E xxx G#protein_molecule_E
coprecipitated NE xxx NE
Stat3 G#protein_molecule Xxxxd G#protein_molecule
but NE xxx NE
not NE xxx NE
Stat1 G#protein_molecule Xxxxd G#protein_molecule
and NE xxx NE
blocked NE xxx NE
IL-10 NE XX-dd NE
-induced NE -xxx NE
Stat3 NE Xxxxd NE
phosphorylation NE xxx NE
in NE xx NE
a NE x NE
cell-free NE xxx-xxx NE
system NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
tyrosine-phosphorylated G#peptide_B xxx-xxx G#peptide_B
peptides G#peptide_E xxx G#peptide_E
containing NE xxx NE
Tyr374 G#amino_acid_monomer Xxxddd G#amino_acid_monomer
or NE xx NE
Tyr396 G#amino_acid_monomer Xxxddd G#amino_acid_monomer
did NE xxx NE
not NE xxx NE
interact NE xxx NE
with NE xxx NE
Stat3 G#protein_molecule Xxxxd G#protein_molecule
or NE xx NE
block NE xxx NE
Stat3 G#protein_molecule Xxxxd G#protein_molecule
activation NE xxx NE
. NE . NE

These NE Xxxx NE
data NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
Stat3 G#protein_molecule Xxxxd G#protein_molecule
but NE xxx NE
not NE xxx NE
Stat1 G#protein_molecule Xxxxd G#protein_molecule
or NE xx NE
Stat5 G#protein_molecule Xxxxd G#protein_molecule
is NE xx NE
directly NE xxx NE
recruited NE xxx NE
to NE xx NE
the NE xxx NE
ligand-activated G#protein_molecule_B xxx-xxx G#protein_molecule_B
IL-10 G#protein_molecule_M XX-dd G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
by NE xx NE
binding NE xxx NE
to NE xx NE
specific NE xxx NE
but NE xxx NE
redundant NE xxx NE
receptor G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
intracellular G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
sequences G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
containing NE xxx NE
phosphotyrosine G#amino_acid_monomer xxx G#amino_acid_monomer
. NE . NE

This NE Xxxx NE
study NE xxx NE
thus NE xxx NE
supports NE xxx NE
the NE xxx NE
concept NE xxx NE
that NE xxx NE
utilization NE xxx NE
of NE xx NE
distinct NE xxx NE
STAT G#protein_family_or_group_B XXXX G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
by NE xx NE
different NE xxx NE
cytokine G#protein_molecule_B xxx G#protein_molecule_B
receptors G#protein_molecule_E xxx G#protein_molecule_E
is NE xx NE
dependent NE xxx NE
on NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
particular NE xxx NE
ligand-activatable NE xxx-xxx NE
, NE , NE
tyrosine-containing G#protein_domain_or_region_B xxx-xxx G#protein_domain_or_region_B
STAT G#protein_domain_or_region_M XXXX G#protein_domain_or_region_M
docking G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
sites G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
in NE xx NE
receptor G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
intracellular G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domains G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

Silencing NE Xxxx NE
of NE xx NE
human G#other_name_B xxx G#other_name_B
fetal G#other_name_M xxx G#other_name_M
globin G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
is NE xx NE
impaired NE xxx NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
the NE xxx NE
adult G#protein_family_or_group_B xxx G#protein_family_or_group_B
beta-globin G#protein_family_or_group_M xxx-xxx G#protein_family_or_group_M
gene G#protein_family_or_group_M xxx G#protein_family_or_group_M
activator G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
EKLF G#protein_molecule XXXX G#protein_molecule
. NE . NE

Globin G#DNA_family_or_group_B Xxxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
are NE xxx NE
subject NE xxx NE
to NE xx NE
tissue-specific G#other_name_B xxx-xxx G#other_name_B
regulation G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
developmental G#other_name_M xxx G#other_name_M
stage-specific G#other_name_M xxx-xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E

A NE X NE
switch NE xxx NE
from NE xxx NE
human NE xxx NE
fetal NE xxx NE
(gamma) NE (xxx) NE
-to NE -xx NE
adult NE xxx NE
(beta)-globin NE (xxx)-xxx NE
expression NE xxx NE
occurs NE xxx NE
within NE xxx NE
erythroid NE xxx NE
precursor NE xxx NE
cells NE xxx NE
of NE xx NE
the NE xxx NE
adult NE xxx NE
lineage NE xxx NE
. NE . NE

Previously NE Xxxx NE
we NE xx NE
and NE xxx NE
others NE xxx NE
showed NE xxx NE
by NE xx NE
targeted NE xxx NE
gene G#other_name_B xxx G#other_name_B
disruption G#other_name_E xxx G#other_name_E
that NE xxx NE
the NE xxx NE
zinc G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
finger G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
erythroid G#protein_molecule_B xxx G#protein_molecule_B
Kruppel-like G#protein_molecule_M Xxxx-xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
EKLF G#protein_molecule XXXX G#protein_molecule
) NE ) NE
, NE , NE
is NE xx NE
required NE xxx NE
for NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
beta-globin G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
in NE xx NE
mice NE xxx NE
, NE , NE
presumably NE xxx NE
through NE xxx NE
interaction NE xxx NE
with NE xxx NE
a NE x NE
high-affinity NE xxx-xxx NE
binding NE xxx NE
site NE xxx NE
in NE xx NE
the NE xxx NE
proximal NE xxx NE
promoter NE xxx NE
. NE . NE

To NE Xx NE
examine NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
EKLF G#protein_molecule XXXX G#protein_molecule
in NE xx NE
the NE xxx NE
developmental NE xxx NE
regulation NE xxx NE
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
gamma-globin G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
we NE xx NE
interbred NE xxx NE
EKLF G#protein_family_or_group_B XXXX G#protein_family_or_group_B
heterozygotes G#protein_family_or_group_E xxx G#protein_family_or_group_E
(+/-) NE (+/-) NE
with NE xxx NE
mice NE xxx NE
harboring NE xxx NE
a NE x NE
human NE xxx NE
beta-globin NE xxx-xxx NE
yeast NE xxx NE
artificial NE xxx NE
chromosome NE xxx NE
transgene NE xxx NE
. NE . NE

We NE Xx NE
find NE xxx NE
that NE xxx NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
EKLF G#protein_molecule XXXX G#protein_molecule
, NE , NE
while NE xxx NE
human G#other_name_B xxx G#other_name_B
beta-globin G#other_name_M xxx-xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
is NE xx NE
dramatically NE xxx NE
reduced NE xxx NE
, NE , NE
gamma-globin G#RNA_family_or_group_B xxx-xxx G#RNA_family_or_group_B
transcripts G#RNA_family_or_group_E xxx G#RNA_family_or_group_E
are NE xxx NE
elevated NE xxx NE
approximately NE xxx NE
5-fold NE d-xxx NE
. NE . NE

Impaired NE Xxxx NE
silencing NE xxx NE
of NE xx NE
gamma-globin G#other_name_B xxx-xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
identifies NE xxx NE
EKLF G#protein_molecule XXXX G#protein_molecule
as NE xx NE
the NE xxx NE
first NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
participating NE xxx NE
quantitatively NE xxx NE
in NE xx NE
the NE xxx NE
gamma-globin G#other_name_B xxx-xxx G#other_name_B
to G#other_name_M xx G#other_name_M
beta-globin G#other_name_M xxx-xxx G#other_name_M
switch G#other_name_E xxx G#other_name_E
. NE . NE

Our NE Xxx NE
findings NE xxx NE
are NE xxx NE
compatible NE xxx NE
with NE xxx NE
a NE x NE
competitive NE xxx NE
model NE xxx NE
of NE xx NE
switching NE xxx NE
in NE xx NE
which NE xxx NE
EKLF G#protein_molecule XXXX G#protein_molecule
mediates NE xxx NE
an NE xx NE
adult G#other_name_B xxx G#other_name_B
stage-specific G#other_name_M xxx-xxx G#other_name_M
interaction G#other_name_E xxx G#other_name_E
between NE xxx NE
the NE xxx NE
beta-globin G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
the NE xxx NE
locus G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
control G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
that NE xxx NE
excludes NE xxx NE
the NE xxx NE
gamma-globin G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Stimulation NE Xxxx NE
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
zinc G#atom xxx G#atom
and NE xxx NE
related NE xxx NE
cations G#atom xxx G#atom
. NE . NE

Zinc G#atom Xxxx G#atom
is NE xx NE
an NE xx NE
important NE xxx NE
trace G#atom_B xxx G#atom_B
element G#atom_E xxx G#atom_E
for NE xxx NE
immune G#other_name_B xxx G#other_name_B
function G#other_name_E xxx G#other_name_E
. NE . NE

Here NE Xxxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
zinc G#atom xxx G#atom
addition NE xxx NE
in NE xx NE
a NE x NE
serum- NE xxx- NE
and NE xxx NE
lipopolysaccharide-free NE xxx-xxx NE
cell NE xxx NE
culture NE xxx NE
system NE xxx NE
leads NE xxx NE
to NE xx NE
significantly NE xxx NE
enhanced NE xxx NE
levels NE xxx NE
of NE xx NE
interleukin G#protein_molecule_B xxx G#protein_molecule_B
1 G#protein_molecule_M d G#protein_molecule_M
beta G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
IL-1 G#protein_molecule_B XX-d G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
) NE ) NE
and NE xxx NE
tumour G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
) NE ) NE
and NE xxx NE
to NE xx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
corresponding NE xxx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
PBMC G#cell_type XXXX G#cell_type
) NE ) NE
. NE . NE

Structurally NE Xxxx NE
related NE xxx NE
divalent NE xxx NE
cations G#atom xxx G#atom
like NE xxx NE
cobalt NE xxx NE
, NE , NE
nickel NE xxx NE
, NE , NE
and NE xxx NE
mercury NE xxx NE
also NE xxx NE
partially NE xxx NE
increase NE xxx NE
monokine NE xxx NE
secretion NE xxx NE
but NE xxx NE
to NE xx NE
a NE x NE
much NE xxx NE
lower NE xxx NE
and NE xxx NE
thus NE xxx NE
insignificant NE xxx NE
extent NE xxx NE
. NE . NE

They NE Xxxx NE
fail NE xxx NE
to NE xx NE
induce NE xxx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
of NE xx NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
after NE xxx NE
3 NE d NE
h NE x NE
of NE xx NE
culture NE xxx NE
. NE . NE

Therefore NE Xxxx NE
, NE , NE
monokine G#other_name_B xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
is NE xx NE
a NE x NE
zinc NE xxx NE
-specific NE -xxx NE
effect NE xxx NE
influenced NE xxx NE
by NE xx NE
the NE xxx NE
physicochemical NE xxx NE
properties NE xxx NE
of NE xx NE
the NE xxx NE
ion NE xxx NE
. NE . NE

Confirmation NE Xxxx NE
of NE xx NE
the NE xxx NE
unique NE xxx NE
significance NE xxx NE
of NE xx NE
zinc G#atom xxx G#atom
for NE xxx NE
immune G#other_name_B xxx G#other_name_B
function G#other_name_E xxx G#other_name_E
provides NE xxx NE
a NE x NE
better NE xxx NE
understanding NE xxx NE
of NE xx NE
the NE xxx NE
mechanisms NE xxx NE
of NE xx NE
specific NE xxx NE
zinc NE xxx NE
-mediated NE -xxx NE
immune NE xxx NE
modulation NE xxx NE
. NE . NE

E3 G#protein_molecule Xd G#protein_molecule
, NE , NE
a NE x NE
hematopoietic-specific G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
transcript G#protein_family_or_group_E xxx G#protein_family_or_group_E
directly NE xxx NE
regulated NE xxx NE
by NE xx NE
the NE xxx NE
retinoic G#protein_molecule_B xxx G#protein_molecule_B
acid G#protein_molecule_M xxx G#protein_molecule_M
receptor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Retinoic NE Xxxx NE
acid NE xxx NE
( NE ( NE
RA NE XX NE
)-induced NE )-xxx NE
maturation NE xxx NE
mediated NE xxx NE
by NE xx NE
the NE xxx NE
retinoic NE xxx NE
acid NE xxx NE
receptor NE xxx NE
alpha NE xxx NE
( NE ( NE
RAR NE XXX NE
alpha NE xxx NE
) NE ) NE
has NE xxx NE
been NE xxx NE
implicated NE xxx NE
in NE xx NE
myeloid NE xxx NE
development NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
used NE xxx NE
differential G#other_name_B xxx G#other_name_B
hybridization G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
of NE xx NE
a NE x NE
cDNA G#DNA_family_or_group_B xXXX G#DNA_family_or_group_B
library G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
constructed NE xxx NE
from NE xxx NE
the NE xxx NE
murine NE xxx NE
RA NE XX NE
-inducible NE -xxx NE
MPRO NE XXXX NE
promyelocyte NE xxx NE
cell NE xxx NE
line NE xxx NE
to NE xx NE
identify NE xxx NE
immediate-early NE xxx-xxx NE
genes NE xxx NE
induced NE xxx NE
by NE xx NE
RA NE XX NE
during NE xxx NE
granulocytic NE xxx NE
differentiation NE xxx NE
. NE . NE

E3 G#protein_molecule Xd G#protein_molecule
, NE , NE
one NE xxx NE
of NE xx NE
nine NE xxx NE
sequences NE xxx NE
identified NE xxx NE
, NE , NE
was NE xxx NE
upregulated NE xxx NE
in NE xx NE
an NE xx NE
immediate-early G#other_name_B xxx-xxx G#other_name_B
manner G#other_name_E xxx G#other_name_E
, NE , NE
with NE xxx NE
transcript NE xxx NE
levels NE xxx NE
peaking NE xxx NE
after NE xxx NE
60 NE dd NE
minutes NE xxx NE
exposure NE xxx NE
to NE xx NE
RA G#other_organic_compound XX G#other_organic_compound
. NE . NE

E3 G#protein_molecule_B Xd G#protein_molecule_B
transcripts G#protein_molecule_E xxx G#protein_molecule_E
were NE xxx NE
RA NE XX NE
-inducible NE -xxx NE
in NE xx NE
HL60 NE XXdd NE
cells NE xxx NE
, NE , NE
but NE xxx NE
not NE xxx NE
in NE xx NE
an NE xx NE
RA NE XX NE
-resistant NE -xxx NE
subclone NE xxx NE
, NE , NE
HL60R NE XXddX NE
, NE , NE
that NE xxx NE
harbors NE xxx NE
a NE x NE
mutated NE xxx NE
RAR NE XXX NE
alpha NE xxx NE
gene NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
when NE xxx NE
HL60R G#cell_line_B XXddX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
were NE xxx NE
transduced NE xxx NE
with NE xxx NE
a NE x NE
functional NE xxx NE
copy NE xxx NE
of NE xx NE
the NE xxx NE
RAR G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
RA G#other_organic_compound XX G#other_organic_compound
induced NE xxx NE
a NE x NE
10-fold NE dd-xxx NE
increase NE xxx NE
in NE xx NE
E3 G#other_name_B Xd G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
levels G#other_name_E xxx G#other_name_E
. NE . NE

E3 G#protein_molecule_B Xd G#protein_molecule_B
transcripts G#protein_molecule_E xxx G#protein_molecule_E
are NE xxx NE
present NE xxx NE
in NE xx NE
the NE xxx NE
myeloid G#cell_type_B xxx G#cell_type_B
lineage G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
B-lymphoid G#cell_type_M X-xxx G#cell_type_M
lineage G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
erythroid G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_E xxx G#cell_type_E
myeloid G#cell_type xxx G#cell_type
nonhematopoietic NE xxx NE
cells NE xxx NE
, NE , NE
and NE xxx NE
encode NE xxx NE
a NE x NE
highly NE xxx NE
hydrophobic, G#peptide_B xxx, G#peptide_B
potentially G#peptide_M xxx G#peptide_M
phosphorylated G#peptide_M xxx G#peptide_M
polypeptide G#peptide_E xxx G#peptide_E
of NE xx NE
unknown NE xxx NE
function NE xxx NE
with NE xxx NE
significant NE xxx NE
homology NE xxx NE
to NE xx NE
a NE x NE
putative NE xxx NE
protein NE xxx NE
expressed NE xxx NE
in NE xx NE
myeloid NE xxx NE
cells NE xxx NE
. NE . NE

The NE Xxx NE
murine NE xxx NE
E3 G#DNA_domain_or_region_B Xd G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
harbors NE xxx NE
a NE x NE
single NE xxx NE
bipartite G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
retinoic G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
acid G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
response G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
which NE xxx NE
in NE xx NE
transient G#other_name_B xxx G#other_name_B
transfection G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
conferred NE xxx NE
RA G#other_name_B XX G#other_name_B
sensitivity G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
E3 G#protein_molecule Xd G#protein_molecule
is NE xx NE
a NE x NE
hematopoietic-specific G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
that NE xxx NE
is NE xx NE
an NE xx NE
immediate NE xxx NE
target NE xxx NE
for NE xxx NE
the NE xxx NE
activated NE xxx NE
RAR G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
during NE xxx NE
myelopoiesis G#other_name xxx G#other_name
. NE . NE

Multifactor G#other_name_B Xxxx G#other_name_B
cis-dominant G#other_name_M xxx-xxx G#other_name_M
negative G#other_name_M xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
of NE xx NE
IL-2 G#other_name_B XX-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
anergized G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
molecular NE xxx NE
mechanism NE xxx NE
underlying NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
transcriptional G#other_name_M xxx G#other_name_M
blockade G#other_name_E xxx G#other_name_E
in NE xx NE
anergic G#cell_line_B xxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
clones G#cell_line_E xxx G#cell_line_E
is NE xx NE
not NE xxx NE
fully NE xxx NE
understood NE xxx NE
. NE . NE

To NE Xx NE
examine NE xxx NE
whether NE xxx NE
an NE xx NE
active NE xxx NE
negative NE xxx NE
regulatory NE xxx NE
process NE xxx NE
occurs NE xxx NE
, NE , NE
we NE xx NE
created NE xxx NE
a NE x NE
reporter G#DNA_molecule_B xxx G#DNA_molecule_B
construct G#DNA_molecule_E xxx G#DNA_molecule_E
containing NE xxx NE
as NE xx NE
an NE xx NE
enhancer G#DNA_domain_or_region xxx G#DNA_domain_or_region
four NE xxx NE
copies NE xxx NE
of NE xx NE
the NE xxx NE
NF-AT G#DNA_domain_or_region_B XX-XX G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
one NE xxx NE
copy NE xxx NE
of NE xx NE
the NE xxx NE
octamer G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
4X G#DNA_domain_or_region_B dX G#DNA_domain_or_region_B
NF-AT-Oct G#DNA_domain_or_region_E XX-XX-Xxx G#DNA_domain_or_region_E
) NE ) NE
. NE . NE

This NE Xxxx NE
construct NE xxx NE
was NE xxx NE
only NE xxx NE
slightly NE xxx NE
reduced NE xxx NE
(1.3-fold) NE (d.d-xxx) NE
in NE xx NE
its NE xxx NE
expression NE xxx NE
when NE xxx NE
stimulated NE xxx NE
under NE xxx NE
anergic G#other_name_B xxx G#other_name_B
conditions G#other_name_E xxx G#other_name_E
, NE , NE
while NE xxx NE
a NE x NE
whole NE xxx NE
mouse NE xxx NE
IL-2 G#DNA_molecule_B XX-d G#DNA_molecule_B
enhancer G#DNA_molecule_M xxx G#DNA_molecule_M
construct G#DNA_molecule_E xxx G#DNA_molecule_E
showed NE xxx NE
a NE x NE
reduction NE xxx NE
of NE xx NE
4.3-fold NE d.d-xxx NE
. NE . NE

Addition NE Xxxx NE
of NE xx NE
the NE xxx NE
-176 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-96 G#DNA_domain_or_region_M -dd G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
to NE xx NE
the NE xxx NE
4X G#DNA_molecule_B dX G#DNA_molecule_B
NF-AT-Oct G#DNA_molecule_M XX-XX-Xxx G#DNA_molecule_M
construct G#DNA_molecule_E xxx G#DNA_molecule_E
did NE xxx NE
not NE xxx NE
impart NE xxx NE
the NE xxx NE
ability NE xxx NE
to NE xx NE
be NE xx NE
affected NE xxx NE
by NE xx NE
anergy NE xxx NE
, NE , NE
but NE xxx NE
addition NE xxx NE
of NE xx NE
the NE xxx NE
-236 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-96 G#DNA_domain_or_region_M -dd G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
did NE xxx NE
, NE , NE
demonstrating NE xxx NE
that NE xxx NE
anergy NE xxx NE
is NE xx NE
an NE xx NE
active NE xxx NE
inhibitory NE xxx NE
process NE xxx NE
and NE xxx NE
that NE xxx NE
more NE xxx NE
than NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
the NE xxx NE
-150 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
AP-1 G#DNA_domain_or_region_M XX-d G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
-152 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-147 G#DNA_domain_or_region_E -ddd G#DNA_domain_or_region_E
) NE ) NE
is NE xx NE
required NE xxx NE
to NE xx NE
mediate NE xxx NE
the NE xxx NE
effect NE xxx NE
. NE . NE

Mutational NE Xxxx NE
studies NE xxx NE
of NE xx NE
the NE xxx NE
-236 NE -ddd NE
to NE xx NE
-96 NE -dd NE
sequence NE xxx NE
indicated NE xxx NE
that NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
both NE xxx NE
the NE xxx NE
-130 NE -ddd NE
AP-1-like NE XX-d-xxx NE
site NE xxx NE
( NE ( NE
-187 NE -ddd NE
to NE xx NE
-181 NE -ddd NE
) NE ) NE
and NE xxx NE
the NE xxx NE
-150 NE -ddd NE
proximal NE xxx NE
AP-1 NE XX-d NE
site NE xxx NE
were NE xxx NE
necessary NE xxx NE
to NE xx NE
observe NE xxx NE
anergy NE xxx NE
. NE . NE

Because NE Xxxx NE
the NE xxx NE
-180 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
not NE xxx NE
required NE xxx NE
for NE xxx NE
trans-activation G#other_name xxx-xxx G#other_name
, NE , NE
it NE xx NE
was NE xxx NE
possible NE xxx NE
to NE xx NE
confirm NE xxx NE
by NE xx NE
mutation NE xxx NE
in NE xx NE
the NE xxx NE
normal NE xxx NE
mouse G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
IL-2 G#DNA_domain_or_region_M XX-d G#DNA_domain_or_region_M
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
that NE xxx NE
this NE xxx NE
site NE xxx NE
is NE xx NE
absolutely NE xxx NE
essential NE xxx NE
for NE xxx NE
anergy G#other_name_B xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
simplest NE xxx NE
model NE xxx NE
to NE xx NE
explain NE xxx NE
these NE xxx NE
results NE xxx NE
is NE xx NE
that NE xxx NE
anergy G#other_name xxx G#other_name
is NE xx NE
mediated NE xxx NE
by NE xx NE
a NE x NE
complex NE xxx NE
of NE xx NE
multiple NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
exert NE xxx NE
a NE x NE
cis-acting G#other_name_B xxx-xxx G#other_name_B
dominant G#other_name_M xxx G#other_name_M
negative G#other_name_M xxx G#other_name_M
regulatory G#other_name_M xxx G#other_name_M
effect G#other_name_E xxx G#other_name_E
on NE xx NE
the NE xxx NE
trans-activation NE xxx-xxx NE
of NE xx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Severe G#other_name_B Xxxx G#other_name_B
combined G#other_name_M xxx G#other_name_M
immunodeficiency G#other_name_E xxx G#other_name_E
due NE xxx NE
to NE xx NE
defective NE xxx NE
binding NE xxx NE
of NE xx NE
the NE xxx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
of G#protein_molecule_M xx G#protein_molecule_M
activated G#protein_molecule_M xxx G#protein_molecule_M
T G#protein_molecule_M X G#protein_molecule_M
cells G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
of NE xx NE
two NE xxx NE
male G#multi_cell_B xxx G#multi_cell_B
siblings G#multi_cell_E xxx G#multi_cell_E
. NE . NE

Peripheral G#cell_type_B Xxxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
( NE ( NE
PBL G#cell_type XXX G#cell_type
) NE ) NE
and NE xxx NE
alloreactive G#cell_line_B xxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
of NE xx NE
two NE xxx NE
male G#multi_cell_B xxx G#multi_cell_B
infants G#multi_cell_E xxx G#multi_cell_E
born NE xxx NE
to NE xx NE
consanguinous G#multi_cell_B xxx G#multi_cell_B
parents G#multi_cell_E xxx G#multi_cell_E
and NE xxx NE
presenting NE xxx NE
with NE xxx NE
severe G#other_name_B xxx G#other_name_B
combined G#other_name_M xxx G#other_name_M
immunodeficiency G#other_name_E xxx G#other_name_E
( NE ( NE
SCID G#other_name XXXX G#other_name
) NE ) NE
showed NE xxx NE
a NE x NE
pronounced NE xxx NE
deficiency NE xxx NE
in NE xx NE
T NE X NE
cell NE xxx NE
activation NE xxx NE
. NE . NE

Although NE Xxxx NE
phenotypically NE xxx NE
normal NE xxx NE
, NE , NE
the NE xxx NE
proliferative NE xxx NE
response NE xxx NE
of NE xx NE
the NE xxx NE
childrens' NE xxx' NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
was NE xxx NE
strongly NE xxx NE
reduced NE xxx NE
but NE xxx NE
could NE xxx NE
be NE xx NE
improved NE xxx NE
by NE xx NE
the NE xxx NE
addition NE xxx NE
of NE xx NE
interleukin-2 G#protein_molecule xxx-d G#protein_molecule
( NE ( NE
IL-2 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
. NE . NE

Furthermore NE Xxxx NE
both NE xxx NE
childrens' NE xxx' NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
were NE xxx NE
unable NE xxx NE
to NE xx NE
produce NE xxx NE
the NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
IL-2 G#protein_molecule XX-d G#protein_molecule
, NE , NE
interferon-gamma G#protein_molecule xxx-xxx G#protein_molecule
( NE ( NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
) NE ) NE
, NE , NE
IL-4 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor-alpha G#protein_molecule_E xxx-xxx G#protein_molecule_E
( NE ( NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
) NE ) NE
. NE . NE

This NE Xxxx NE
multiple NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
production G#other_name_M xxx G#other_name_M
deficiency G#other_name_E xxx G#other_name_E
could NE xxx NE
not NE xxx NE
be NE xx NE
restored NE xxx NE
by NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
or NE xx NE
co-stimulatory G#other_name_B xx-xxx G#other_name_B
signals G#other_name_E xxx G#other_name_E
provided NE xxx NE
by NE xx NE
antigen-presenting G#cell_type_B xxx-xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
APC G#cell_type XXX G#cell_type
) NE ) NE
. NE . NE

Moreover NE Xxxx NE
, NE , NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
for NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
could NE xxx NE
not NE xxx NE
be NE xx NE
detected NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
activation-dependent G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
surface G#protein_family_or_group_M xxx G#protein_family_or_group_M
markers G#protein_family_or_group_E xxx G#protein_family_or_group_E
CD25 G#protein_molecule XXdd G#protein_molecule
and NE xxx NE
CD69 G#protein_molecule XXdd G#protein_molecule
was NE xxx NE
within NE xxx NE
normal NE xxx NE
limits NE xxx NE
. NE . NE

To NE Xx NE
determine NE xxx NE
whether NE xxx NE
the NE xxx NE
functional NE xxx NE
defect NE xxx NE
of NE xx NE
the NE xxx NE
patients' NE xxx' NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
was NE xxx NE
due NE xxx NE
to NE xx NE
the NE xxx NE
absence NE xxx NE
or NE xx NE
abnormal NE xxx NE
binding NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
involved NE xxx NE
in NE xx NE
cytokine G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
, NE , NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
were NE xxx NE
used NE xxx NE
to NE xx NE
examine NE xxx NE
the NE xxx NE
DNA NE XXX NE
binding NE xxx NE
of NE xx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
, NE , NE
Oct G#protein_family_or_group Xxx G#protein_family_or_group
, NE , NE
CREB G#protein_family_or_group XXXX G#protein_family_or_group
, NE , NE
SP1 G#protein_molecule XXd G#protein_molecule
, NE , NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_E X G#protein_complex_E
and NE xxx NE
the NE xxx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
of G#protein_molecule_M xx G#protein_molecule_M
activated G#protein_molecule_M xxx G#protein_molecule_M
T G#protein_molecule_M X G#protein_molecule_M
cells G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
NF-AT G#protein_molecule XX-XX G#protein_molecule
) NE ) NE
to NE xx NE
their NE xxx NE
respective NE xxx NE
response G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
elements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
promoter G#DNA_domain_or_region xxx G#DNA_domain_or_region
of NE xx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Whereas NE Xxxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
, NE , NE
NF-kappa NE XX-xxx NE
B NE X NE
, NE , NE
Oct G#protein_family_or_group Xxx G#protein_family_or_group
, NE , NE
CREB G#protein_family_or_group XXXX G#protein_family_or_group
and NE xxx NE
SP1 G#protein_molecule XXd G#protein_molecule
displayed NE xxx NE
normal NE xxx NE
binding NE xxx NE
activities NE xxx NE
in NE xx NE
nuclear NE xxx NE
extracts NE xxx NE
, NE , NE
the NE xxx NE
binding NE xxx NE
of NE xx NE
NF-AT NE XX-XX NE
to NE xx NE
its NE xxx NE
IL-2 NE XX-d NE
promoter NE xxx NE
response NE xxx NE
element NE xxx NE
was NE xxx NE
barely NE xxx NE
detectable NE xxx NE
both NE xxx NE
before NE xxx NE
and NE xxx NE
after NE xxx NE
T NE X NE
cell NE xxx NE
stimulation NE xxx NE
. NE . NE

Our NE Xxx NE
results NE xxx NE
strongly NE xxx NE
suggest NE xxx NE
that NE xxx NE
this NE xxx NE
NF-AT NE XX-XX NE
/DNA NE /XXX NE
binding NE xxx NE
defect NE xxx NE
is NE xx NE
responsible NE xxx NE
for NE xxx NE
the NE xxx NE
multiple NE xxx NE
cytokine NE xxx NE
deficiency NE xxx NE
and NE xxx NE
the NE xxx NE
SCID NE XXXX NE
phenotype NE xxx NE
observed NE xxx NE
in NE xx NE
the NE xxx NE
two NE xxx NE
infant NE xxx NE
brothers NE xxx NE
. NE . NE

oriP G#DNA_domain_or_region xxxX G#DNA_domain_or_region
is NE xx NE
essential NE xxx NE
for NE xxx NE
EBNA G#other_name_B XXXX G#other_name_B
gene G#other_name_M xxx G#other_name_M
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
Epstein-Barr G#cell_line_B Xxxx-Xxxx G#cell_line_B
virus-immortalized G#cell_line_M xxx-xxx G#cell_line_M
lymphoblastoid G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

During NE Xxxx NE
Epstein-Barr G#other_name_B Xxxx-Xxxx G#other_name_B
virus G#other_name_M xxx G#other_name_M
latent G#other_name_M xxx G#other_name_M
infection G#other_name_E xxx G#other_name_E
of NE xx NE
B G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
in NE xx NE
vitro NE xxx NE
, NE , NE
six NE xxx NE
viral G#protein_family_or_group_B xxx G#protein_family_or_group_B
nuclear G#protein_family_or_group_M xxx G#protein_family_or_group_M
antigens G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
EBNAs G#protein_family_or_group XXXXx G#protein_family_or_group
) NE ) NE
are NE xxx NE
expressed NE xxx NE
from NE xxx NE
one NE xxx NE
of NE xx NE
two NE xxx NE
promoters G#DNA_domain_or_region xxx G#DNA_domain_or_region
, NE , NE
Cp G#DNA_domain_or_region Xx G#DNA_domain_or_region
or NE xx NE
Wp G#DNA_domain_or_region Xx G#DNA_domain_or_region
, NE , NE
whose NE xxx NE
activities NE xxx NE
are NE xxx NE
mutually NE xxx NE
exclusive NE xxx NE
. NE . NE

Upon NE Xxxx NE
infection NE xxx NE
, NE , NE
Wp G#DNA_domain_or_region Xx G#DNA_domain_or_region
is NE xx NE
initially NE xxx NE
active NE xxx NE
, NE , NE
followed NE xxx NE
by NE xx NE
a NE x NE
switch NE xxx NE
to NE xx NE
Cp G#DNA_domain_or_region Xx G#DNA_domain_or_region
for NE xxx NE
the NE xxx NE
duration NE xxx NE
of NE xx NE
latency G#other_name xxx G#other_name
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
the NE xxx NE
region NE xxx NE
upstream NE xxx NE
of NE xx NE
Cp G#DNA_domain_or_region Xx G#DNA_domain_or_region
was NE xxx NE
analyzed NE xxx NE
for NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
cis NE xxx NE
elements NE xxx NE
involved NE xxx NE
in NE xx NE
regulating NE xxx NE
the NE xxx NE
activities NE xxx NE
of NE xx NE
the NE xxx NE
EBNA G#DNA_domain_or_region_B XXXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoters G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
established NE xxx NE
in G#cell_line_B xx G#cell_line_B
vitro G#cell_line_M xxx G#cell_line_M
immortalized G#cell_line_M xxx G#cell_line_M
lymphoblastoid G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
( NE ( NE
LCLs G#cell_line XXXx G#cell_line
) NE ) NE
. NE . NE

It NE Xx NE
was NE xxx NE
determined NE xxx NE
that NE xxx NE
oriP G#DNA_domain_or_region xxxX G#DNA_domain_or_region
, NE , NE
the NE xxx NE
origin NE xxx NE
for NE xxx NE
episomal NE xxx NE
maintenance NE xxx NE
during NE xxx NE
latency G#other_name xxx G#other_name
, NE , NE
is NE xx NE
essential NE xxx NE
for NE xxx NE
efficient NE xxx NE
transcription G#other_name_B xxx G#other_name_B
initiation G#other_name_E xxx G#other_name_E
from NE xxx NE
either NE xxx NE
Cp G#DNA_domain_or_region Xx G#DNA_domain_or_region
or NE xx NE
Wp G#DNA_domain_or_region Xx G#DNA_domain_or_region
in NE xx NE
LCLs G#cell_line XXXx G#cell_line
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
in NE xx NE
some NE xxx NE
Burkitt's G#cell_line_B Xxxx'x G#cell_line_B
lymphoma G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

Deletion NE Xxxx NE
of NE xx NE
the NE xxx NE
EBNA2-dependent G#DNA_domain_or_region_B XXXXd-xxx G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
located NE xxx NE
upstream NE xxx NE
of NE xx NE
Cp G#DNA_domain_or_region Xx G#DNA_domain_or_region
resulted NE xxx NE
in NE xx NE
a NE x NE
ca NE xx NE
. NE . NE
two- NE xxx- NE
to NE xx NE
fivefold NE xxx NE
reduction NE xxx NE
in NE xx NE
Cp G#other_name_B Xx G#other_name_B
activity G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
LCLs G#cell_line XXXx G#cell_line
assayed NE xxx NE
. NE . NE

More NE Xxxx NE
extensive NE xxx NE
deletion NE xxx NE
of NE xx NE
sequences NE xxx NE
upstream NE xxx NE
of NE xx NE
Cp G#DNA_domain_or_region Xx G#DNA_domain_or_region
, NE , NE
including NE xxx NE
the NE xxx NE
EBNA2-dependent G#DNA_domain_or_region_B XXXXd-xxx G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
resulted NE xxx NE
in NE xx NE
nearly NE xxx NE
complete NE xxx NE
loss NE xxx NE
of NE xx NE
Cp G#other_name_B Xx G#other_name_B
activity G#other_name_E xxx G#other_name_E
. NE . NE

This NE Xxxx NE
loss NE xxx NE
of NE xx NE
activity NE xxx NE
was NE xxx NE
shown NE xxx NE
to NE xx NE
correlate NE xxx NE
with NE xxx NE
deletion NE xxx NE
of NE xx NE
two NE xxx NE
CCAAT NE XXXXX NE
boxes NE xxx NE
, NE , NE
a NE x NE
proximal NE xxx NE
CCAAT NE XXXXX NE
box NE xxx NE
located NE xxx NE
at NE xx NE
bp NE xx NE
-61 NE -dd NE
to NE xx NE
-65 NE -dd NE
and NE xxx NE
a NE x NE
distal NE xxx NE
CCAAT G#DNA_domain_or_region_B XXXXX G#DNA_domain_or_region_B
box G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
located NE xxx NE
at NE xx NE
bp NE xx NE
-253 NE -ddd NE
to NE xx NE
-257 NE -ddd NE
, NE , NE
upstream NE xxx NE
of NE xx NE
Cp NE Xx NE
. NE . NE

Site-directed G#other_name_B Xxxx-xxx G#other_name_B
mutagenesis G#other_name_E xxx G#other_name_E
of NE xx NE
these NE xxx NE
cis G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
demonstrated NE xxx NE
that NE xxx NE
Cp G#other_name_B Xx G#other_name_B
activity G#other_name_E xxx G#other_name_E
is NE xx NE
highly NE xxx NE
dependent NE xxx NE
on NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
a NE x NE
properly NE xxx NE
positioned NE xxx NE
CCAAT G#DNA_domain_or_region_B XXXXX G#DNA_domain_or_region_B
box G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
with NE xxx NE
the NE xxx NE
dependence NE xxx NE
on NE xx NE
the NE xxx NE
distal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
CCAAT G#DNA_domain_or_region_M XXXXX G#DNA_domain_or_region_M
box G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
apparent NE xxx NE
only NE xxx NE
when NE xxx NE
the NE xxx NE
proximal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
CCAAT G#DNA_domain_or_region_M XXXXX G#DNA_domain_or_region_M
box G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
deleted NE xxx NE
or NE xx NE
mutated NE xxx NE
. NE . NE

Deletion NE Xxxx NE
of NE xx NE
the NE xxx NE
glucocorticoid NE xxx NE
response NE xxx NE
elements NE xxx NE
located NE xxx NE
at NE xx NE
ca. G#DNA_domain_or_region_B xx. G#DNA_domain_or_region_B
bp G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-850 G#DNA_domain_or_region_E -ddd G#DNA_domain_or_region_E
upstream NE xxx NE
of NE xx NE
Cp G#DNA_domain_or_region Xx G#DNA_domain_or_region
did NE xxx NE
not NE xxx NE
result NE xxx NE
in NE xx NE
a NE x NE
significant NE xxx NE
loss NE xxx NE
in NE xx NE
activity NE xxx NE
. NE . NE

In NE Xx NE
general NE xxx NE
, NE , NE
deletions NE xxx NE
which NE xxx NE
diminished NE xxx NE
Cp G#DNA_domain_or_region Xx G#DNA_domain_or_region
activity NE xxx NE
resulted NE xxx NE
in NE xx NE
induction NE xxx NE
of NE xx NE
Wp G#other_name_B Xx G#other_name_B
activity G#other_name_E xxx G#other_name_E
, NE , NE
consistent NE xxx NE
with NE xxx NE
suppression NE xxx NE
of NE xx NE
Wp G#DNA_domain_or_region Xx G#DNA_domain_or_region
activity NE xxx NE
by NE xx NE
transcriptional NE xxx NE
interference NE xxx NE
from NE xxx NE
Cp G#DNA_domain_or_region Xx G#DNA_domain_or_region
. NE . NE

The NE Xxx NE
identification NE xxx NE
of NE xx NE
oriP G#DNA_domain_or_region xxxX G#DNA_domain_or_region
and NE xxx NE
the NE xxx NE
EBNA2-dependent G#DNA_domain_or_region_B XXXXd-xxx G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
as NE xx NE
the NE xxx NE
major NE xxx NE
positive NE xxx NE
cis G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
involved NE xxx NE
in NE xx NE
regulating NE xxx NE
Cp G#DNA_domain_or_region Xx G#DNA_domain_or_region
activity NE xxx NE
in NE xx NE
LCL G#cell_line XXX G#cell_line
suggests NE xxx NE
that NE xxx NE
EBNA G#other_name_B XXXX G#other_name_B
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
is NE xx NE
largely NE xxx NE
autoregulated NE xxx NE
by NE xx NE
EBNA G#protein_molecule_B XXXX G#protein_molecule_B
1 G#protein_molecule_E d G#protein_molecule_E
and NE xxx NE
EBNA G#protein_molecule_B XXXX G#protein_molecule_B
2 G#protein_molecule_E d G#protein_molecule_E
. NE . NE

Protein-tyrosine G#other_name_B Xxxx-xxx G#other_name_B
kinase G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
is NE xx NE
required NE xxx NE
for NE xxx NE
lipopolysaccharide G#other_name_B xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
of NE xx NE
interleukin G#protein_molecule_B xxx G#protein_molecule_B
1beta G#protein_molecule_E dxxx G#protein_molecule_E
and NE xxx NE
NFkappaB G#other_name_B XXxxxX G#other_name_B
activation G#other_name_E xxx G#other_name_E
, NE , NE
but NE xxx NE
not NE xxx NE
NFkappaB G#other_name_B XXxxxX G#other_name_B
nuclear G#other_name_M xxx G#other_name_M
translocation G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
human G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
interleukin G#other_name_B xxx G#other_name_B
1beta G#other_name_M dxxx G#other_name_M
protein G#other_name_M xxx G#other_name_M
production G#other_name_E xxx G#other_name_E
and NE xxx NE
steady G#other_name_B xxx G#other_name_B
state G#other_name_M xxx G#other_name_M
mRNA G#other_name_M xXXX G#other_name_M
levels G#other_name_E xxx G#other_name_E
are NE xxx NE
increased NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
lipopolysaccharide G#lipid xxx G#lipid
, NE , NE
predominantly NE xxx NE
as NE xx NE
a NE x NE
result NE xxx NE
of NE xx NE
increased NE xxx NE
transcription NE xxx NE
of NE xx NE
the NE xxx NE
interleukin G#protein_molecule_B xxx G#protein_molecule_B
1beta G#protein_molecule_E dxxx G#protein_molecule_E
gene NE xxx NE
. NE . NE

Expression NE Xxxx NE
of NE xx NE
interleukin G#protein_molecule_B xxx G#protein_molecule_B
1beta G#protein_molecule_E dxxx G#protein_molecule_E
and NE xxx NE
other NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
, NE , NE
such NE xxx NE
as NE xx NE
interleukin G#protein_molecule_B xxx G#protein_molecule_B
6 G#protein_molecule_E d G#protein_molecule_E
and NE xxx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
has NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
be NE xx NE
dependent NE xxx NE
on NE xx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
NFkappaB G#protein_complex XXxxxX G#protein_complex
. NE . NE

Since NE Xxxx NE
recent NE xxx NE
studies NE xxx NE
have NE xxx NE
shown NE xxx NE
that NE xxx NE
lipopolysaccharide NE xxx NE
-induced NE -xxx NE
tyrosine NE xxx NE
kinase NE xxx NE
activation NE xxx NE
is NE xx NE
not NE xxx NE
required NE xxx NE
for NE xxx NE
NFkappaB NE XXxxxX NE
nuclear NE xxx NE
translocation NE xxx NE
, NE , NE
we NE xx NE
sought NE xxx NE
to NE xx NE
determine NE xxx NE
whether NE xxx NE
NFkappaB NE XXxxxX NE
translocated NE xxx NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
tyrosine NE xxx NE
kinase NE xxx NE
activity NE xxx NE
was NE xxx NE
active NE xxx NE
in NE xx NE
stimulating NE xxx NE
transcription NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
found NE xxx NE
that NE xxx NE
, NE , NE
in NE xx NE
the NE xxx NE
human NE xxx NE
pro-monocytic G#cell_line_B xxx-xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
THP-1 G#cell_line XXX-d G#cell_line
, NE , NE
the NE xxx NE
lipopolysaccharide NE xxx NE
-induced NE -xxx NE
expression NE xxx NE
of NE xx NE
interleukin NE xxx NE
1beta NE dxxx NE
is NE xx NE
dependent NE xxx NE
on NE xx NE
tyrosine NE xxx NE
kinase NE xxx NE
activation NE xxx NE
. NE . NE

Tyrosine NE Xxxx NE
kinases NE xxx NE
are NE xxx NE
not NE xxx NE
required NE xxx NE
for NE xxx NE
lipopolysaccharide G#lipid xxx G#lipid
-mediated NE -xxx NE
nuclear G#other_name_B xxx G#other_name_B
translocation G#other_name_E xxx G#other_name_E
of NE xx NE
NFkappaB G#protein_complex XXxxxX G#protein_complex
. NE . NE

However NE Xxxx NE
, NE , NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
tyrosine G#other_name_B xxx G#other_name_B
kinase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
ability NE xxx NE
of NE xx NE
NFkappaB G#protein_complex XXxxxX G#protein_complex
to NE xx NE
stimulate NE xxx NE
transcription G#other_name xxx G#other_name
is NE xx NE
impaired NE xxx NE
. NE . NE

This NE Xxxx NE
inhibition NE xxx NE
of NE xx NE
transcription G#other_name xxx G#other_name
is NE xx NE
specific NE xxx NE
for NE xxx NE
NFkappaB G#protein_complex XXxxxX G#protein_complex
; NE ; NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
tyrosine G#other_name_B xxx G#other_name_B
kinase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
, NE , NE
AP-1 NE XX-d NE
-dependent NE -xxx NE
transcription NE xxx NE
is NE xx NE
enhanced NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
, NE , NE
while NE xxx NE
lipopolysaccharide NE xxx NE
-induced NE -xxx NE
expression NE xxx NE
of NE xx NE
inflammatory NE xxx NE
mediators NE xxx NE
requires NE xxx NE
tyrosine NE xxx NE
kinase NE xxx NE
activity NE xxx NE
, NE , NE
tyrosine NE xxx NE
kinase NE xxx NE
activity NE xxx NE
is NE xx NE
not NE xxx NE
obligatory NE xxx NE
for NE xxx NE
lipopolysaccharide NE xxx NE
signal NE xxx NE
transduction NE xxx NE
. NE . NE

Chronic NE Xxxx NE
human G#other_name_B xxx G#other_name_B
immunodeficiency G#other_name_M xxx G#other_name_M
virus G#other_name_M xxx G#other_name_M
type G#other_name_M xxx G#other_name_M
1 G#other_name_M d G#other_name_M
infection G#other_name_E xxx G#other_name_E
of NE xx NE
myeloid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
disrupts NE xxx NE
the NE xxx NE
autoregulatory G#other_name_B xxx G#other_name_B
control G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
NF-kappaB/Rel G#other_name_B XX-xxxX/Xxx G#other_name_B
pathway G#other_name_E xxx G#other_name_E
via NE xxx NE
enhanced NE xxx NE
IkappaBalpha G#other_name_B XxxxXxxx G#other_name_B
degradation G#other_name_E xxx G#other_name_E
. NE . NE

Productive NE Xxxx NE
human G#virus_B xxx G#virus_B
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
type G#virus_M xxx G#virus_M
1 G#virus_E d G#virus_E
(HIV-1) NE (XXX-d) NE
infection NE xxx NE
causes NE xxx NE
sustained NE xxx NE
NF-kappaB G#other_name_B XX-xxxX G#other_name_B
DNA-binding G#other_name_M XXX-xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
chronically NE xxx NE
infected NE xxx NE
monocytic NE xxx NE
cells NE xxx NE
. NE . NE

A NE X NE
direct NE xxx NE
temporal NE xxx NE
correlation NE xxx NE
exists NE xxx NE
between NE xxx NE
HIV NE XXX NE
infection NE xxx NE
and NE xxx NE
the NE xxx NE
appearance NE xxx NE
of NE xx NE
NF-kappaB G#other_name_B XX-xxxX G#other_name_B
DNA-binding G#other_name_M XXX-xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
myelomonoblastic G#cell_line_B xxx G#cell_line_B
PLB-985 G#cell_line_M XXX-ddd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

To NE Xx NE
examine NE xxx NE
the NE xxx NE
molecular NE xxx NE
basis NE xxx NE
of NE xx NE
constitutive NE xxx NE
NF-kappaB G#other_name_B XX-xxxX G#other_name_B
DNA-binding G#other_name_M XXX-xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
HIV1 G#cell_type_B XXXd G#cell_type_B
-infected G#cell_type_M -xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
we NE xx NE
analyzed NE xxx NE
the NE xxx NE
phosphorylation NE xxx NE
and NE xxx NE
turnover NE xxx NE
of NE xx NE
IkappaBalpha G#protein_molecule XxxxXxxx G#protein_molecule
protein NE xxx NE
, NE , NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
the NE xxx NE
double-stranded G#protein_molecule_B xxx-xxx G#protein_molecule_B
RNA-dependent G#protein_molecule_M XXX-xxx G#protein_molecule_M
protein G#protein_molecule_M xxx G#protein_molecule_M
kinase G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
PKR G#protein_molecule XXX G#protein_molecule
) NE ) NE
and NE xxx NE
the NE xxx NE
intracellular NE xxx NE
levels NE xxx NE
of NE xx NE
NF-kappaB G#protein_subunit_B XX-xxxX G#protein_subunit_B
subunits G#protein_subunit_E xxx G#protein_subunit_E
in NE xx NE
the NE xxx NE
PLB-985 G#cell_line XXX-ddd G#cell_line
and NE xxx NE
U937 G#cell_line_B Xddd G#cell_line_B
myeloid G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
models G#cell_line_E xxx G#cell_line_E
. NE . NE

HIV-1 G#other_name_B XXX-d G#other_name_B
infection G#other_name_E xxx G#other_name_E
resulted NE xxx NE
in NE xx NE
constitutive NE xxx NE
, NE , NE
low-level G#other_name_B xxx-xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
type G#protein_molecule_B xxx G#protein_molecule_B
1 G#protein_molecule_M d G#protein_molecule_M
interferon G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
IFN G#protein_family_or_group XXX G#protein_family_or_group
) NE ) NE
at NE xx NE
the NE xxx NE
mRNA G#other_name_B xXXX G#other_name_B
level G#other_name_E xxx G#other_name_E
. NE . NE

Constitutive G#other_name_B Xxxx G#other_name_B
PKR G#other_name_M XXX G#other_name_M
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
also NE xxx NE
detected NE xxx NE
in NE xx NE
HIV-1 NE XXX-d NE
-infected NE -xxx NE
cells NE xxx NE
as NE xx NE
a NE x NE
result NE xxx NE
of NE xx NE
low-level NE xxx-xxx NE
IFN NE XXX NE
production NE xxx NE
, NE , NE
since NE xxx NE
the NE xxx NE
addition NE xxx NE
of NE xx NE
anti-IFN-alpha/beta NE xxx-XXX-xxx/xxx NE
antibody NE xxx NE
to NE xx NE
the NE xxx NE
cells NE xxx NE
decreased NE xxx NE
PKR NE XXX NE
expression NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
the NE xxx NE
analysis NE xxx NE
of NE xx NE
IkappaBalpha G#protein_molecule XxxxXxxx G#protein_molecule
turnover NE xxx NE
demonstrated NE xxx NE
an NE xx NE
increased NE xxx NE
degradation NE xxx NE
of NE xx NE
IkappaBalpha G#protein_molecule XxxxXxxx G#protein_molecule
in NE xx NE
HIV-1 NE XXX-d NE
-infected NE -xxx NE
cells NE xxx NE
that NE xxx NE
may NE xxx NE
account NE xxx NE
for NE xxx NE
the NE xxx NE
constitutive NE xxx NE
DNA NE XXX NE
binding NE xxx NE
activity NE xxx NE
. NE . NE

A NE X NE
dramatic NE xxx NE
increase NE xxx NE
in NE xx NE
the NE xxx NE
intracellular G#other_name_B xxx G#other_name_B
levels G#other_name_E xxx G#other_name_E
of NE xx NE
NF-kappaB G#protein_complex XX-xxxX G#protein_complex
subunits NE xxx NE
c-Rel G#protein_subunit x-Xxx G#protein_subunit
and NE xxx NE
NF-kappaB2 G#protein_subunit_B XX-xxxXd G#protein_subunit_B
p100 G#protein_subunit_E xddd G#protein_subunit_E
and NE xxx NE
a NE x NE
moderate NE xxx NE
increase NE xxx NE
in NE xx NE
NF-kappaB2 G#protein_subunit_B XX-xxxXd G#protein_subunit_B
p52 G#protein_subunit_E xdd G#protein_subunit_E
and NE xxx NE
RelA(p65) G#protein_subunit XxxX(xdd) G#protein_subunit
were NE xxx NE
detected NE xxx NE
in NE xx NE
HIV-1 NE XXX-d NE
-infected NE -xxx NE
cells NE xxx NE
, NE , NE
whereas NE xxx NE
NF-kappaB1 NE XX-xxxXd NE
p105/p50 NE xddd/xdd NE
levels NE xxx NE
were NE xxx NE
not NE xxx NE
altered NE xxx NE
relative NE xxx NE
to NE xx NE
the NE xxx NE
levels NE xxx NE
in NE xx NE
uninfected NE xxx NE
cells NE xxx NE
. NE . NE

We NE Xx NE
suggest NE xxx NE
that NE xxx NE
HIV-1 NE XXX-d NE
infection NE xxx NE
of NE xx NE
myeloid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
induces NE xxx NE
IFN G#other_name_B XXX G#other_name_B
production G#other_name_E xxx G#other_name_E
and NE xxx NE
PKR G#protein_molecule XXX G#protein_molecule
activity NE xxx NE
, NE , NE
which NE xxx NE
in NE xx NE
turn NE xxx NE
contribute NE xxx NE
to NE xx NE
enhanced NE xxx NE
IkappaBalpha G#protein_molecule XxxxXxxx G#protein_molecule
phosphorylation NE xxx NE
and NE xxx NE
subsequent NE xxx NE
degradation NE xxx NE
. NE . NE

Nuclear NE Xxxx NE
translocation NE xxx NE
of NE xx NE
NF-kappaB G#protein_subunit_B XX-xxxX G#protein_subunit_B
subunits G#protein_subunit_E xxx G#protein_subunit_E
may NE xxx NE
ultimately NE xxx NE
increase NE xxx NE
the NE xxx NE
intracellular NE xxx NE
pool NE xxx NE
of NE xx NE
NF-kappaB NE XX-xxxX NE
/IkappaBalpha NE /XxxxXxxx NE
by NE xx NE
an NE xx NE
autoregulatory NE xxx NE
mechanism NE xxx NE
. NE . NE

Enhanced NE Xxxx NE
turnover NE xxx NE
of NE xx NE
IkappaBalpha G#protein_molecule XxxxXxxx G#protein_molecule
and NE xxx NE
the NE xxx NE
accumulation NE xxx NE
of NE xx NE
NF-kappaB NE XX-xxxX NE
/Rel NE /Xxx NE
proteins NE xxx NE
may NE xxx NE
contribute NE xxx NE
to NE xx NE
the NE xxx NE
chronically NE xxx NE
activated NE xxx NE
state NE xxx NE
of NE xx NE
HIV-1 NE XXX-d NE
-infected NE -xxx NE
cells NE xxx NE
. NE . NE

The NE Xxx NE
c-Jun G#protein_domain_or_region_B x-Xxx G#protein_domain_or_region_B
delta-domain G#protein_domain_or_region_E xxx-xxx G#protein_domain_or_region_E
inhibits NE xxx NE
neuroendocrine G#other_name_B xxx G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
a NE x NE
DNA G#other_name_B XXX G#other_name_B
sequence-specific G#other_name_M xxx-xxx G#other_name_M
manner G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
pituitary-specific G#other_name_M xxx-xxx G#other_name_M
manner G#other_name_E xxx G#other_name_E

The NE Xxx NE
transcription G#other_name_B xxx G#other_name_B
and G#other_name_M xxx G#other_name_M
transformation G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
of NE xx NE
c-Jun G#protein_molecule x-Xxx G#protein_molecule
is NE xx NE
governed NE xxx NE
by NE xx NE
a NE x NE
27-amino G#protein_domain_or_region_B dd-xxx G#protein_domain_or_region_B
acid G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
regulatory G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
motif G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
, NE , NE
labeled NE xxx NE
the NE xxx NE
delta-domain G#protein_domain_or_region xxx-xxx G#protein_domain_or_region
, NE , NE
which NE xxx NE
is NE xx NE
deleted NE xxx NE
in NE xx NE
v-Jun G#protein_molecule x-Xxx G#protein_molecule
. NE . NE

We NE Xx NE
have NE xxx NE
previously NE xxx NE
shown NE xxx NE
that NE xxx NE
c-Jun G#protein_molecule x-Xxx G#protein_molecule
is NE xx NE
a NE x NE
potent NE xxx NE
inhibitor NE xxx NE
of NE xx NE
the NE xxx NE
rat G#other_name_B xxx G#other_name_B
prolactin G#other_name_M xxx G#other_name_M
(rPRL) G#other_name_M (xXXX) G#other_name_M
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
induced NE xxx NE
by NE xx NE
either NE xxx NE
oncogenic G#protein_molecule_B xxx G#protein_molecule_B
Ras G#protein_molecule_E Xxx G#protein_molecule_E
or NE xx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
esters G#other_organic_compound_E xxx G#other_organic_compound_E
. NE . NE

Here NE Xxxx NE
, NE , NE
we NE xx NE
have NE xxx NE
characterized NE xxx NE
the NE xxx NE
structural NE xxx NE
and NE xxx NE
cell-specific G#other_name_B xxx-xxx G#other_name_B
requirements G#other_name_E xxx G#other_name_E
for NE xxx NE
this NE xxx NE
c-Jun G#protein_molecule x-Xxx G#protein_molecule
inhibitory NE xxx NE
response NE xxx NE
, NE , NE
and NE xxx NE
we NE xx NE
show NE xxx NE
that NE xxx NE
this NE xxx NE
c-Jun G#other_name_B x-Xxx G#other_name_B
inhibitory G#other_name_M xxx G#other_name_M
response G#other_name_E xxx G#other_name_E
mapped NE xxx NE
to NE xx NE
the NE xxx NE
rPRL G#DNA_domain_or_region_B xXXX G#DNA_domain_or_region_B
footprint G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
II G#DNA_domain_or_region_M XX G#DNA_domain_or_region_M
repressor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
was NE xxx NE
pituitary-specific NE xxx-xxx NE
and NE xxx NE
required NE xxx NE
the NE xxx NE
c-Jun G#protein_domain_or_region_B x-Xxx G#protein_domain_or_region_B
delta-domain G#protein_domain_or_region_E xxx-xxx G#protein_domain_or_region_E
. NE . NE

Moreover NE Xxxx NE
, NE , NE
alteration NE xxx NE
of NE xx NE
any NE xxx NE
one NE xxx NE
of NE xx NE
these NE xxx NE
features NE xxx NE
(e.g. NE (x.x. NE
, NE , NE
cis-element G#DNA_family_or_group xxx-xxx G#DNA_family_or_group
, NE , NE
trans-factor G#DNA_family_or_group xxx-xxx G#DNA_family_or_group
, NE , NE
or NE xx NE
cell-specific G#other_name_B xxx-xxx G#other_name_B
background G#other_name_E xxx G#other_name_E
) NE ) NE
switched NE xxx NE
c-Jun G#protein_molecule x-Xxx G#protein_molecule
to NE xx NE
a NE x NE
transcriptional G#protein_family_or_group_B xxx G#protein_family_or_group_B
activator G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
the NE xxx NE
rPRL G#DNA_domain_or_region_B xXXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

In NE Xx NE
HeLa G#cell_line_B XxXx G#cell_line_B
nonpituitary G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
c-Jun G#protein_molecule x-Xxx G#protein_molecule
alone NE xxx NE
activated NE xxx NE
the NE xxx NE
rPRL G#DNA_domain_or_region_B xXXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
via NE xxx NE
the NE xxx NE
most NE xxx NE
proximal NE xxx NE
GHF-1/Pit-1 G#DNA_domain_or_region_B XXX-d/Xxx-d G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
footprint G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
I G#DNA_domain_or_region_E X G#DNA_domain_or_region_E
, NE , NE
and NE xxx NE
synergized NE xxx NE
with NE xxx NE
GHF-1 G#protein_molecule XXX-d G#protein_molecule
. NE . NE

Finally NE Xxxx NE
, NE , NE
recombinant NE xxx NE
GHF-1 G#protein_molecule XXX-d G#protein_molecule
interacted NE xxx NE
directly NE xxx NE
with NE xxx NE
c-Jun G#protein_molecule x-Xxx G#protein_molecule
but NE xxx NE
not NE xxx NE
c-Fos G#protein_molecule_B x-Xxx G#protein_molecule_B
proteins G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

These NE Xxxx NE
data NE xxx NE
provide NE xxx NE
important NE xxx NE
fundamental NE xxx NE
insights NE xxx NE
into NE xxx NE
the NE xxx NE
molecular NE xxx NE
mechanisms NE xxx NE
by NE xx NE
which NE xxx NE
the NE xxx NE
c-Jun G#protein_domain_or_region_B x-Xxx G#protein_domain_or_region_B
delta-domain G#protein_domain_or_region_E xxx-xxx G#protein_domain_or_region_E
functions NE xxx NE
as NE xx NE
a NE x NE
modulatory G#other_name_B xxx G#other_name_B
switch G#other_name_E xxx G#other_name_E
and NE xxx NE
further NE xxx NE
imply NE xxx NE
that NE xxx NE
the NE xxx NE
functional NE xxx NE
role NE xxx NE
of NE xx NE
c-Jun G#protein_molecule x-Xxx G#protein_molecule
is NE xx NE
dictated NE xxx NE
by NE xx NE
cell-specific NE xxx-xxx NE
influences NE xxx NE
and NE xxx NE
the NE xxx NE
delta-domain G#protein_domain_or_region_B xxx-xxx G#protein_domain_or_region_B
motif G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

Retinoic G#other_organic_compound_B Xxxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
activates NE xxx NE
interferon G#other_name_B xxx G#other_name_B
regulatory G#other_name_M xxx G#other_name_M
factor-1 G#other_name_M xxx-d G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
myeloid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

All-trans-retinoic G#other_organic_compound_B Xxx-xxx-xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
ATRA G#other_organic_compound XXXX G#other_organic_compound
) NE ) NE
is NE xx NE
the NE xxx NE
drug NE xxx NE
of NE xx NE
choice NE xxx NE
in NE xx NE
the NE xxx NE
treatment NE xxx NE
of NE xx NE
acute G#other_name_B xxx G#other_name_B
promyelocytic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
( NE ( NE
APL G#other_name XXX G#other_name
) NE ) NE
. NE . NE

ATRA G#other_organic_compound XXXX G#other_organic_compound
induces NE xxx NE
both NE xxx NE
in NE xx NE
vitro NE xxx NE
and NE xxx NE
in NE xx NE
vivo NE xxx NE
differentiation NE xxx NE
of NE xx NE
APL G#cell_line_B XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
into NE xxx NE
mature G#cell_type_B xxx G#cell_type_B
granulocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

However NE Xxxx NE
, NE , NE
the NE xxx NE
molecular NE xxx NE
mechanisms NE xxx NE
involved NE xxx NE
in NE xx NE
ATRA NE XXXX NE
-dependent NE -xxx NE
growth NE xxx NE
inhibition NE xxx NE
and NE xxx NE
cellular NE xxx NE
differentiation NE xxx NE
are NE xxx NE
not NE xxx NE
presently NE xxx NE
understood NE xxx NE
. NE . NE

The NE Xxx NE
NB4 G#cell_line_B XXd G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
which NE xxx NE
is NE xx NE
derived NE xxx NE
from NE xxx NE
the NE xxx NE
bone G#tissue_B xxx G#tissue_B
marrow G#tissue_E xxx G#tissue_E
of NE xx NE
a NE x NE
patient G#multi_cell xxx G#multi_cell
with NE xxx NE
APL G#other_name XXX G#other_name
during NE xxx NE
relapse NE xxx NE
, NE , NE
can NE xxx NE
be NE xx NE
used NE xxx NE
as NE xx NE
a NE x NE
model NE xxx NE
system NE xxx NE
to NE xx NE
study NE xxx NE
the NE xxx NE
growth NE xxx NE
and NE xxx NE
differentiation NE xxx NE
of NE xx NE
APL G#cell_line_B XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Because NE Xxxx NE
interferon G#protein_family_or_group_B xxx G#protein_family_or_group_B
(IFN) G#protein_family_or_group_M (XXX) G#protein_family_or_group_M
regulatory G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
IRF-1 G#protein_molecule XXX-d G#protein_molecule
and NE xxx NE
IRF-2 G#protein_molecule XXX-d G#protein_molecule
) NE ) NE
and NE xxx NE
other NE xxx NE
IFN-inducible G#protein_family_or_group_B XXX-xxx G#protein_family_or_group_B
gene G#protein_family_or_group_M xxx G#protein_family_or_group_M
products G#protein_family_or_group_E xxx G#protein_family_or_group_E
regulate NE xxx NE
cell G#other_name_B xxx G#other_name_B
growth G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
analyzed NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
ATRA G#other_organic_compound XXXX G#other_organic_compound
on NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
these NE xxx NE
genes NE xxx NE
. NE . NE

